Clustering O 0 0.1757340133190155
of O 0 0.027794359251856804
missense O 0 0.20615817606449127
mutations O 0 0.10279742628335953
in O 0 0.016714967787265778
the O 0 0.032066624611616135
ataxia B-Disease 1 1.0
- I-Disease 1 0.998859167098999
telangiectasia I-Disease 1 0.9999642372131348
gene O 0 0.10128309577703476
in O 0 0.016068512573838234
a O 0 0.027706021443009377
sporadic B-Disease 1 0.94284588098526
T I-Disease 1 0.9999951124191284
- I-Disease 1 0.986935019493103
cell I-Disease 1 0.952491283416748
leukaemia I-Disease 1 0.999998927116394
. O 0 0.046087831258773804

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9996505975723267
telangiectasia I-Disease 1 0.9999916553497314
( O 0 0.06684081256389618
A B-Disease 1 0.9928600192070007
- I-Disease 1 0.9926369190216064
T I-Disease 1 0.999932050704956
) O 0 0.020952675491571426
is O 0 0.012422719970345497
a O 0 0.020857544615864754
recessive B-Disease 1 0.9992007613182068
multi I-Disease 1 0.9997174143791199
- I-Disease 1 0.9987938404083252
system I-Disease 1 0.9726414084434509
disorder I-Disease 1 0.9999998807907104
caused O 0 0.27655455470085144
by O 0 0.01593545265495777
mutations O 0 0.07781099528074265
in O 0 0.013690327294170856
the O 0 0.019338347017765045
ATM O 0 0.15126089751720428
gene O 0 0.09611068665981293
at O 0 0.04075155779719353
11q22 O 1 0.8837250471115112
- O 0 0.15191656351089478
q23 O 0 0.372737854719162
( O 0 0.057011932134628296
ref O 0 0.1681600660085678
. O 0 0.016544315963983536
3 O 0 0.032355133444070816
) O 0 0.027233947068452835
. O 0 0.023072801530361176

The O 0 0.033515918999910355
risk O 1 0.9406126141548157
of O 0 0.021197352558374405
cancer B-Disease 1 0.9999997615814209
, O 0 0.021156691014766693
especially O 0 0.03710871562361717
lymphoid B-Disease 1 0.998440682888031
neoplasias I-Disease 1 0.9318374991416931
, O 0 0.014617537148296833
is O 0 0.014669787138700485
substantially O 0 0.04297680780291557
elevated O 0 0.07205425202846527
in O 0 0.01605118252336979
A B-Disease 1 0.999614953994751
- I-Disease 1 0.9999871253967285
T I-Disease 1 1.0
patients O 1 0.9999958276748657
and O 0 0.009043104015290737
has O 0 0.010442721657454967
long O 0 0.016670729964971542
been O 0 0.011532420292496681
associated O 0 0.02026779018342495
with O 0 0.02120460569858551
chromosomal O 1 0.9988260865211487
instability O 1 0.9911351203918457
. O 0 0.039908528327941895

By O 0 0.04309413209557533
analysing O 0 0.1749405860900879
tumour B-Disease 1 0.9999991655349731
DNA O 0 0.09543392062187195
from O 0 0.02535886876285076
patients O 1 0.9998480081558228
with O 0 0.01940368488430977
sporadic B-Disease 1 0.9616748690605164
T I-Disease 1 0.9999964237213135
- I-Disease 1 0.8601111173629761
cell I-Disease 0 0.4002590477466583
prolymphocytic I-Disease 1 0.9996691942214966
leukaemia I-Disease 1 1.0
( O 1 0.6166898012161255
T B-Disease 1 0.9999938011169434
- I-Disease 1 0.8918481469154358
PLL I-Disease 1 0.9998748302459717
) O 0 0.03239818289875984
, O 0 0.014041878283023834
a O 0 0.022178890183568
rare O 0 0.06884728372097015
clonal B-Disease 0 0.45390501618385315
malignancy I-Disease 1 0.9995250701904297
with O 0 0.016968438401818275
similarities O 0 0.02825593762099743
to O 0 0.010092864744365215
a O 0 0.02519550733268261
mature B-Disease 1 0.7664627432823181
T I-Disease 1 0.9999946355819702
- I-Disease 1 0.9577650427818298
cell I-Disease 1 0.7682515382766724
leukaemia I-Disease 1 0.9999980926513672
seen O 0 0.032160717993974686
in O 0 0.014025990851223469
A B-Disease 1 0.9945125579833984
- I-Disease 1 0.9985277652740479
T I-Disease 1 0.9999829530715942
, O 0 0.013705789111554623
we O 0 0.007606213912367821
demonstrate O 0 0.022324763238430023
a O 0 0.01448298990726471
high O 0 0.02761334925889969
frequency O 0 0.04229847714304924
of O 0 0.014747226610779762
ATM O 0 0.17777320742607117
mutations O 0 0.12535594403743744
in O 0 0.030513891950249672
T B-Disease 1 0.9999817609786987
- I-Disease 1 0.8515416979789734
PLL I-Disease 1 0.9995700716972351
. O 0 0.05135621130466461

In O 0 0.024267185479402542
marked O 0 0.0353800393640995
contrast O 0 0.026633363217115402
to O 0 0.008650721982121468
the O 0 0.01531204767525196
ATM O 0 0.18923582136631012
mutation O 0 0.1317765712738037
pattern O 0 0.049479130655527115
in O 0 0.01433574315160513
A B-Disease 1 0.9939336180686951
- I-Disease 1 0.9986541271209717
T I-Disease 1 0.9999743700027466
, O 0 0.012612460181117058
the O 0 0.010178627446293831
most O 0 0.012003595009446144
frequent O 0 0.053079281002283096
nucleotide O 0 0.07129715383052826
changes O 0 0.018537694588303566
in O 0 0.012170136906206608
this O 0 0.0194940734654665
leukaemia B-Disease 1 0.9999980926513672
were O 0 0.032463084906339645
missense O 0 0.3643375337123871
mutations O 0 0.16507455706596375
. O 0 0.037278834730386734

These O 0 0.01830199919641018
clustered O 0 0.04959666356444359
in O 0 0.009010162204504013
the O 0 0.009628239087760448
region O 0 0.02457563765347004
corresponding O 0 0.018782328814268112
to O 0 0.009760887362062931
the O 0 0.015490401536226273
kinase O 0 0.1749056726694107
domain O 0 0.0336214154958725
, O 0 0.010031847283244133
which O 0 0.00927356630563736
is O 0 0.011454873718321323
highly O 0 0.023829620331525803
conserved O 0 0.038651756942272186
in O 0 0.018243709579110146
ATM O 1 0.65813148021698
- O 0 0.07646125555038452
related O 0 0.0361974872648716
proteins O 0 0.03986366093158722
in O 0 0.017987985163927078
mouse O 0 0.1161077693104744
, O 0 0.02110687829554081
yeast O 0 0.10753046721220016
and O 0 0.019234169274568558
Drosophila O 0 0.11191791296005249
. O 0 0.028993958607316017

The O 0 0.03364604339003563
resulting O 0 0.0714612603187561
amino O 0 0.10032663494348526
- O 0 0.12733697891235352
acid O 0 0.1495913863182068
substitutions O 0 0.05666705593466759
are O 0 0.009533650241792202
predicted O 0 0.03328757733106613
to O 0 0.01200859434902668
interfere O 0 0.04802143573760986
with O 0 0.020539306104183197
ATP O 1 0.6170682907104492
binding O 0 0.05980810150504112
or O 0 0.027643881738185883
substrate O 0 0.09196837246417999
recognition O 0 0.041726768016815186
. O 0 0.025424405932426453

Two O 0 0.01590692810714245
of O 0 0.013231635093688965
seventeen O 0 0.06687942147254944
mutated O 1 0.7050033807754517
T B-Disease 1 0.9999442100524902
- I-Disease 0 0.33519378304481506
PLL I-Disease 1 0.9932629466056824
samples O 0 0.05686008930206299
had O 0 0.01820269599556923
a O 0 0.016479618847370148
previously O 0 0.022490842267870903
reported O 0 0.03576674312353134
A B-Disease 1 0.9037156701087952
- I-Disease 1 0.9885756373405457
T I-Disease 1 0.999950647354126
allele O 0 0.19101646542549133
. O 0 0.03560958057641983

In O 0 0.027250058948993683
contrast O 0 0.04310491681098938
, O 0 0.01482588890939951
no O 0 0.020016470924019814
mutations O 0 0.07067635655403137
were O 0 0.013727502897381783
detected O 0 0.05432984232902527
in O 0 0.010377663187682629
the O 0 0.017237316817045212
p53 O 0 0.16272027790546417
gene O 0 0.07766378670930862
, O 0 0.016288533806800842
suggesting O 0 0.03529607504606247
that O 0 0.011070354841649532
this O 0 0.021435368806123734
tumour B-Disease 1 0.9999996423721313
suppressor O 1 0.9041510820388794
is O 0 0.01794377714395523
not O 0 0.010636049322783947
frequently O 0 0.025412606075406075
altered O 0 0.030772801488637924
in O 0 0.012621893547475338
this O 0 0.021552858874201775
leukaemia B-Disease 1 0.9999996423721313
. O 0 0.034863971173763275

Occasional O 0 0.17979750037193298
missense O 0 0.26597273349761963
mutations O 0 0.13302697241306305
in O 0 0.016901319846510887
ATM O 0 0.08867276459932327
were O 0 0.008984128944575787
also O 0 0.009238348342478275
found O 0 0.015758171677589417
in O 0 0.017353704199194908
tumour B-Disease 1 0.9999994039535522
DNA O 0 0.07116307318210602
from O 0 0.023042749613523483
patients O 1 0.9998992681503296
with O 0 0.018817836418747902
B B-Disease 1 0.9988032579421997
- I-Disease 1 0.6321350336074829
cell I-Disease 0 0.20230959355831146
non I-Disease 0 0.42738839983940125
- I-Disease 1 0.9994569420814514
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999916553497314
( O 0 0.06549464166164398
B B-Disease 1 0.9240097999572754
- I-Disease 0 0.08138269186019897
NHL I-Disease 0 0.08310320973396301
) O 0 0.01597781479358673
and O 0 0.00884645152837038
a O 0 0.022113604471087456
B B-Disease 1 0.8878983855247498
- I-Disease 0 0.11153655499219894
NHL I-Disease 0 0.13261198997497559
cell O 0 0.08989566564559937
line O 0 0.041097722947597504
. O 0 0.027661938220262527

The O 0 0.01800420880317688
evidence O 0 0.014456056989729404
of O 0 0.006839186418801546
a O 0 0.012394221499562263
significant O 0 0.015139328315854073
proportion O 0 0.024988815188407898
of O 0 0.009845983237028122
loss O 1 0.7382071018218994
- O 0 0.06029307842254639
of O 0 0.014735176227986813
- O 0 0.07965658605098724
function O 0 0.04574156552553177
mutations O 0 0.06617825478315353
and O 0 0.008417624980211258
a O 0 0.013900763355195522
complete O 0 0.01958584226667881
absence O 0 0.024088233709335327
of O 0 0.005912947002798319
the O 0 0.009563174098730087
normal O 0 0.0307517908513546
copy O 0 0.025591395795345306
of O 0 0.009854544885456562
ATM O 0 0.07348816841840744
in O 0 0.008054847829043865
the O 0 0.008351591415703297
majority O 0 0.01856258139014244
of O 0 0.017439428716897964
mutated O 1 0.8962430953979492
tumours B-Disease 1 0.9999936819076538
establishes O 1 0.8947564959526062
somatic O 0 0.34038615226745605
inactivation O 0 0.18527506291866302
of O 0 0.010357129387557507
this O 0 0.01058704312890768
gene O 0 0.043308746069669724
in O 0 0.009386730380356312
the O 0 0.014125967398285866
pathogenesis O 1 0.9996724128723145
of O 0 0.018073149025440216
sporadic B-Disease 1 0.971515417098999
T I-Disease 1 0.999998927116394
- I-Disease 1 0.9410051107406616
PLL I-Disease 1 0.9998610019683838
and O 0 0.016888584941625595
suggests O 0 0.032792963087558746
that O 0 0.011188799515366554
ATM O 0 0.09763576090335846
acts O 0 0.022612858563661575
as O 0 0.013451053760945797
a O 0 0.043800391256809235
tumour B-Disease 1 0.9999996423721313
suppressor O 1 0.9903222918510437
. O 0 0.035943713039159775

As O 0 0.021303260698914528
constitutional O 0 0.027554817497730255
DNA O 0 0.04827973246574402
was O 0 0.01365698967128992
not O 0 0.006953847128897905
available O 0 0.009617350995540619
, O 0 0.009038928896188736
a O 0 0.02151408977806568
putative O 0 0.1392238736152649
hereditary O 1 0.9930405616760254
predisposition O 1 0.999305248260498
to O 0 0.03397315368056297
T B-Disease 1 0.9999982118606567
- I-Disease 1 0.9711560606956482
PLL I-Disease 1 0.9998037219047546
will O 0 0.017442991957068443
require O 0 0.024864517152309418
further O 0 0.015084057115018368
investigation O 0 0.03524348884820938
. O 0 0.014695781283080578
. O 0 0.023848634213209152

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.19661055505275726
kinase O 0 0.26737791299819946
is O 0 0.014805390499532223
involved O 0 0.016205906867980957
in O 0 0.007634720299392939
the O 0 0.013017678633332253
modulation O 0 0.08878522366285324
of O 0 0.010927959345281124
the O 0 0.028269117698073387
Ca2 O 1 0.9948611855506897
+ O 1 0.8688838481903076
homeostasis O 1 0.9823875427246094
in O 0 0.039955344051122665
skeletal O 1 0.9999741315841675
muscle O 1 0.9999748468399048
cells O 0 0.14042632281780243
. O 0 0.033128928393125534

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999091625213623
DM B-Disease 1 1.0
) O 0 0.029621560126543045
, O 0 0.008886847645044327
the O 0 0.008730544708669186
most O 0 0.015767376869916916
prevalent O 1 0.9991556406021118
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.019081255421042442
adults O 0 0.08859740942716599
, O 0 0.010163212195038795
is O 0 0.013118202798068523
caused O 0 0.046000175178050995
by O 0 0.015069493092596531
( O 0 0.042931605130434036
CTG O 1 0.9994470477104187
) O 0 0.04276497662067413
n O 0 0.07281400263309479
- O 0 0.07949014753103256
repeat O 0 0.07747519016265869
expansion O 0 0.03690279647707939
in O 0 0.013365783728659153
a O 0 0.024164898321032524
gene O 0 0.07865682244300842
encoding O 0 0.053390733897686005
a O 0 0.03629409894347191
protein O 0 0.10327214747667313
kinase O 1 0.5927594900131226
( O 0 0.09655517339706421
DM B-Disease 1 0.9999992847442627
protein O 0 0.17374350130558014
kinase O 0 0.2848522663116455
; O 0 0.04536598175764084
DMPK O 1 0.9731019735336304
) O 0 0.02031644992530346
and O 0 0.010066081769764423
involves O 0 0.03383103385567665
changes O 0 0.017189400270581245
in O 0 0.012556372210383415
cytoarchitecture O 1 0.7523711919784546
and O 0 0.022857246920466423
ion O 0 0.17287057638168335
homeostasis O 1 0.95494145154953
. O 0 0.038076017051935196

To O 0 0.02124977670609951
obtain O 0 0.031287435442209244
clues O 0 0.03587518259882927
to O 0 0.008422581478953362
the O 0 0.010365626774728298
normal O 0 0.03643094375729561
biological O 0 0.031842198222875595
role O 0 0.02252615988254547
of O 0 0.013896366581320763
DMPK O 1 0.9752301573753357
in O 0 0.02462407760322094
cellular O 0 0.0988302081823349
ion O 0 0.19560962915420532
homeostasis O 1 0.8662062287330627
, O 0 0.01436576433479786
we O 0 0.00858321599662304
have O 0 0.007685348857194185
compared O 0 0.02135331556200981
the O 0 0.017126791179180145
resting O 1 0.7535108923912048
[ O 0 0.16958186030387878
Ca2 O 1 0.9937337040901184
+ O 1 0.6937714219093323
] O 0 0.08332318812608719
i O 0 0.020905351266264915
, O 0 0.007337784860283136
the O 0 0.010354109108448029
amplitude O 0 0.06233187019824982
and O 0 0.01342841237783432
shape O 0 0.044884245842695236
of O 0 0.01881478540599346
depolarization O 1 0.9996354579925537
- O 1 0.989702582359314
induced O 1 0.9994118213653564
Ca2 O 1 0.9971314668655396
+ O 1 0.6896762847900391
transients O 1 0.6439886689186096
, O 0 0.011750645004212856
and O 0 0.007624185178428888
the O 0 0.008544763550162315
content O 0 0.016055047512054443
of O 0 0.012944023124873638
ATP O 1 0.9952340722084045
- O 0 0.10993880778551102
driven O 0 0.10273200273513794
ion O 0 0.15379972755908966
pumps O 0 0.1401931643486023
in O 0 0.027632679790258408
cultured O 1 0.6193657517433167
skeletal O 1 0.9999669790267944
muscle O 1 0.9998692274093628
cells O 0 0.0668729841709137
of O 0 0.01093856617808342
wild O 0 0.04906975105404854
- O 0 0.09181992709636688
type O 0 0.06495753675699234
and O 0 0.020093774423003197
DMPK O 1 0.999901533126831
[ O 1 0.954682469367981
- O 1 0.9965236783027649
/ O 1 0.9997095465660095
- O 0 0.24015121161937714
] O 0 0.13568083941936493
knockout O 0 0.21118444204330444
mice O 0 0.19786441326141357
. O 0 0.038591235876083374

In O 0 0.036177437752485275
vitro O 0 0.16286277770996094
- O 0 0.13001103699207306
differentiated O 0 0.1825237274169922
DMPK O 1 0.9997281432151794
[ O 1 0.9573580026626587
- O 1 0.9940453767776489
/ O 1 0.999626874923706
- O 0 0.17638790607452393
] O 0 0.11574483662843704
myotubes O 0 0.4142138659954071
exhibit O 0 0.059090711176395416
a O 0 0.024712108075618744
higher O 0 0.03970542922616005
resting O 0 0.34197789430618286
[ O 0 0.14045113325119019
Ca2 O 1 0.9898169040679932
+ O 1 0.7409747838973999
] O 0 0.08707460761070251
i O 0 0.02019716054201126
than O 0 0.011859974823892117
do O 0 0.016731606796383858
wild O 0 0.045135363936424255
- O 0 0.0939909964799881
type O 0 0.08862029016017914
myotubes O 0 0.26263105869293213
because O 0 0.01605091243982315
of O 0 0.006494912784546614
an O 0 0.01206380594521761
altered O 0 0.03844398632645607
open O 0 0.036567434668540955
probability O 0 0.03654668480157852
of O 0 0.014653983525931835
voltage O 0 0.09898561984300613
- O 0 0.1072625145316124
dependent O 0 0.11015807837247849
l O 1 0.9634634256362915
- O 0 0.16549773514270782
type O 0 0.13757570087909698
Ca2 O 1 0.9537979364395142
+ O 0 0.17573215067386627
and O 0 0.028502728790044785
Na O 1 0.7737494707107544
+ O 0 0.15739838778972626
channels O 0 0.06342404335737228
. O 0 0.028776241466403008

The O 0 0.039288055151700974
mutant O 0 0.16549800336360931
myotubes O 0 0.31721416115760803
exhibit O 0 0.07257688790559769
smaller O 0 0.027902670204639435
and O 0 0.01859174482524395
slower O 0 0.08852296322584152
Ca2 O 1 0.9362249374389648
+ O 0 0.16456685960292816
responses O 0 0.06015438586473465
upon O 0 0.026036150753498077
triggering O 0 0.10118889063596725
by O 0 0.025763656944036484
acetylcholine O 0 0.2967088222503662
or O 0 0.02826295979321003
high O 0 0.04391049966216087
external O 0 0.06630849838256836
K O 0 0.445905476808548
+ O 0 0.16363433003425598
. O 0 0.030350258573889732

In O 0 0.020592745393514633
addition O 0 0.020900869742035866
, O 0 0.01065884530544281
we O 0 0.009243438951671124
observed O 0 0.021621283143758774
that O 0 0.008409068919718266
these O 0 0.01502037700265646
Ca2 O 1 0.9911562204360962
+ O 1 0.9033926725387573
transients O 1 0.9757035970687866
partially O 0 0.0743773877620697
result O 0 0.022607695311307907
from O 0 0.009756999090313911
an O 0 0.01149042509496212
influx O 0 0.0604272224009037
of O 0 0.01955508068203926
extracellular O 0 0.15732699632644653
Ca2 O 1 0.7717883586883545
+ O 0 0.12920011579990387
through O 0 0.024202829226851463
the O 0 0.02318752184510231
l O 1 0.9876584410667419
- O 0 0.15699544548988342
type O 0 0.14415360987186432
Ca2 O 1 0.6763254404067993
+ O 0 0.17447905242443085
channel O 0 0.07512027025222778
. O 0 0.031128084287047386

Neither O 0 0.04495818912982941
the O 0 0.014368060044944286
content O 0 0.01897691935300827
nor O 0 0.02309916913509369
the O 0 0.009938887320458889
activity O 0 0.031007306650280952
of O 0 0.017891451716423035
Na O 1 0.9977217316627502
+ O 1 0.9909018874168396
/ O 1 0.9960145950317383
K O 0 0.2616027295589447
+ O 0 0.2058250904083252
ATPase O 1 0.7401833534240723
and O 0 0.04278263449668884
sarcoplasmic O 1 0.9997184872627258
reticulum O 1 0.9985666871070862
Ca2 O 1 0.9984815716743469
+ O 1 0.9734345078468323
- O 0 0.16902212798595428
ATPase O 1 0.8539047241210938
are O 0 0.018198737874627113
affected O 0 0.04611840471625328
by O 0 0.018704399466514587
DMPK O 1 0.9980853796005249
absence O 0 0.06697551906108856
. O 0 0.02974003180861473

In O 0 0.022083252668380737
conclusion O 0 0.02563541568815708
, O 0 0.010478885844349861
our O 0 0.011125086806714535
data O 0 0.013997307047247887
suggest O 0 0.02417631819844246
that O 0 0.011516602709889412
DMPK O 1 0.9347383975982666
is O 0 0.014531268738210201
involved O 0 0.02006678283214569
in O 0 0.012461213394999504
modulating O 0 0.14275427162647247
the O 0 0.014482487924396992
initial O 0 0.035844650119543076
events O 0 0.021273525431752205
of O 0 0.015518262051045895
excitation O 1 0.7827351093292236
- O 0 0.22824454307556152
contraction O 0 0.16979481279850006
coupling O 0 0.13231460750102997
in O 0 0.031099949032068253
skeletal O 1 0.9999604225158691
muscle O 1 0.999821126461029
. O 0 0.02172681875526905
. O 0 0.028335651382803917

Constitutional O 0 0.10849198698997498
RB1 O 1 0.9999903440475464
- O 1 0.5693668127059937
gene O 0 0.16206806898117065
mutations O 0 0.13813957571983337
in O 0 0.02473372034728527
patients O 1 0.9997982382774353
with O 0 0.020928196609020233
isolated O 0 0.11633411049842834
unilateral B-Disease 0 0.33083969354629517
retinoblastoma I-Disease 1 0.9999426603317261
. O 0 0.04021128639578819

In O 0 0.025812968611717224
most O 0 0.022209346294403076
patients O 1 0.9998863935470581
with O 0 0.020322661846876144
isolated O 0 0.10226774960756302
unilateral B-Disease 1 0.5057113766670227
retinoblastoma I-Disease 1 0.9999948740005493
, O 0 0.03415093198418617
tumor B-Disease 1 0.9999715089797974
development O 0 0.028774308040738106
is O 0 0.015550026670098305
initiated O 0 0.04910288006067276
by O 0 0.0210528876632452
somatic O 0 0.16762590408325195
inactivation O 0 0.13918405771255493
of O 0 0.009816562756896019
both O 0 0.012480733916163445
alleles O 0 0.09184937924146652
of O 0 0.013952075503766537
the O 0 0.03513600677251816
RB1 O 1 0.9999852180480957
gene O 0 0.13874545693397522
. O 0 0.0357896126806736

However O 0 0.021672330796718597
, O 0 0.008520071394741535
some O 0 0.005450197495520115
of O 0 0.005984549410641193
these O 0 0.011083683930337429
patients O 1 0.9999797344207764
can O 0 0.024134425446391106
transmit O 0 0.1276405155658722
retinoblastoma B-Disease 1 0.9999721050262451
predisposition O 1 0.9929220676422119
to O 0 0.012913407757878304
their O 0 0.01300523430109024
offspring O 0 0.08478035032749176
. O 0 0.030175544321537018

To O 0 0.016984522342681885
determine O 0 0.020974960178136826
the O 0 0.01297625433653593
frequency O 0 0.03712282329797745
and O 0 0.008441231213510036
nature O 0 0.018392512574791908
of O 0 0.010481382720172405
constitutional O 0 0.04284735396504402
RB1 O 1 0.9999995231628418
- O 1 0.5948696136474609
gene O 0 0.13206331431865692
mutations O 0 0.12559467554092407
in O 0 0.02172810398042202
patients O 1 0.9998419284820557
with O 0 0.02508724108338356
isolated O 0 0.11193734407424927
unilateral B-Disease 0 0.20463858544826508
retinoblastoma I-Disease 1 0.9999020099639893
, O 0 0.01772160828113556
we O 0 0.012154609896242619
analyzed O 0 0.04243297874927521
DNA O 0 0.06184851750731468
from O 0 0.023766793310642242
peripheral O 1 0.99903404712677
blood O 1 0.9828553795814514
and O 0 0.01596115157008171
from O 0 0.0342240110039711
tumor B-Disease 1 0.9999984502792358
tissue O 1 0.9982894062995911
. O 0 0.03507551923394203

The O 0 0.022651640698313713
analysis O 0 0.03050973452627659
of O 0 0.017468653619289398
tumors B-Disease 1 0.9999890327453613
from O 0 0.02105420082807541
54 O 0 0.053889401257038116
( O 0 0.030260590836405754
71 O 0 0.06203757971525192
% O 0 0.022551098838448524
) O 0 0.0170066449791193
of O 0 0.010255211964249611
76 O 0 0.08443799614906311
informative O 0 0.09648428857326508
patients O 1 0.9999620914459229
showed O 0 0.039082854986190796
loss O 0 0.04335146024823189
of O 0 0.012237937189638615
constitutional O 0 0.03826923295855522
heterozygosity O 1 0.9996950626373291
( O 0 0.11154124140739441
LOH O 1 0.999993085861206
) O 0 0.0414823442697525
at O 0 0.038228295743465424
intragenic O 1 0.6358023285865784
loci O 0 0.20568712055683136
. O 0 0.034903962165117264

Three O 0 0.019555872306227684
of O 0 0.01518638152629137
13 O 0 0.04737408831715584
uninformative O 1 0.9997774958610535
patients O 1 0.9999607801437378
had O 0 0.026827752590179443
constitutional O 0 0.03209894523024559
deletions O 0 0.10274099558591843
. O 0 0.03227756917476654

For O 0 0.025847211480140686
39 O 0 0.05765531584620476
randomly O 0 0.06760958582162857
selected O 0 0.04738248512148857
tumors B-Disease 1 0.999984860420227
, O 0 0.02809535339474678
SSCP O 1 0.9991686344146729
, O 0 0.03270052745938301
hetero O 1 0.9998563528060913
- O 0 0.15652720630168915
duplex O 1 0.5381198525428772
analysis O 0 0.03703031316399574
, O 0 0.01468885038048029
sequencing O 0 0.04848018288612366
, O 0 0.011333554051816463
and O 0 0.00940532237291336
Southern O 0 0.035158462822437286
blot O 0 0.153622105717659
analysis O 0 0.020564617589116096
were O 0 0.006642421707510948
used O 0 0.009972580708563328
to O 0 0.010712185874581337
identify O 0 0.04913013055920601
mutations O 0 0.12678372859954834
. O 0 0.032368242740631104

Mutations O 0 0.17170585691928864
were O 0 0.022971002385020256
detected O 0 0.07066003978252411
in O 0 0.015521950088441372
21 O 0 0.030344419181346893
( O 0 0.02854149229824543
91 O 0 0.0766807422041893
% O 0 0.025119680911302567
) O 0 0.017405109480023384
of O 0 0.011958945542573929
23 O 0 0.050699714571237564
tumors B-Disease 1 0.9999990463256836
with O 0 0.04196079820394516
LOH O 1 0.9999967813491821
. O 0 0.0402844101190567

In O 0 0.029303738847374916
6 O 0 0.038611508905887604
( O 0 0.027557779103517532
38 O 0 0.03703448921442032
% O 0 0.02115151472389698
) O 0 0.01624474674463272
of O 0 0.009318237192928791
16 O 0 0.03878171369433403
tumors B-Disease 1 0.9999997615814209
without O 0 0.03454139456152916
LOH O 1 0.9999897480010986
, O 0 0.020608721300959587
one O 0 0.02086947299540043
mutation O 0 0.11606182903051376
was O 0 0.027221595868468285
detected O 0 0.06215909495949745
, O 0 0.00883055292069912
and O 0 0.00769549747928977
in O 0 0.010967363603413105
9 O 0 0.02870449796319008
( O 0 0.025112098082900047
56 O 0 0.04254278540611267
% O 0 0.019668688997626305
) O 0 0.01243551541119814
of O 0 0.006789864506572485
the O 0 0.023906368762254715
tumors B-Disease 1 0.9999998807907104
without O 0 0.04128234460949898
LOH O 1 0.9999970197677612
, O 0 0.018376970663666725
both O 0 0.01649663597345352
mutations O 0 0.08198757469654083
were O 0 0.011920428834855556
found O 0 0.02342967316508293
. O 0 0.025074804201722145

Thus O 0 0.03051064908504486
, O 0 0.010092649608850479
a O 0 0.011402873322367668
total O 0 0.012191984802484512
of O 0 0.009281337261199951
45 O 0 0.03585706651210785
mutations O 0 0.07793600112199783
were O 0 0.010847016237676144
identified O 0 0.027020910754799843
in O 0 0.01845274120569229
tumors B-Disease 1 0.9999942779541016
of O 0 0.01644175872206688
36 O 0 0.06092449277639389
patients O 1 0.9999642372131348
. O 0 0.030981751158833504

Thirty O 0 0.08525853604078293
- O 0 0.06303748488426208
nine O 0 0.018806375563144684
of O 0 0.008772488683462143
the O 0 0.01741808094084263
mutations O 0 0.11213767528533936
- O 0 0.06260214000940323
including O 0 0.01520211435854435
34 O 0 0.03809360787272453
small O 0 0.027588360011577606
mutations O 0 0.09247303754091263
, O 0 0.014255817048251629
2 O 0 0.02104470133781433
large O 0 0.01740453951060772
structural O 0 0.0656839981675148
alterations O 0 0.04637683555483818
, O 0 0.012113126926124096
and O 0 0.01316968072205782
hypermethylation O 1 0.9985672235488892
in O 0 0.023489708080887794
3 O 0 0.059166256338357925
tumors O 1 0.9999998807907104
- O 0 0.05656953155994415
were O 0 0.010206062346696854
not O 0 0.010546522215008736
detected O 0 0.043770164251327515
in O 0 0.008320149034261703
the O 0 0.011631728149950504
corresponding O 0 0.04076642915606499
peripheral O 1 0.9996166229248047
blood O 1 0.9979075193405151
DNA O 0 0.09019917249679565
. O 0 0.030038142576813698

In O 0 0.028384339064359665
6 O 0 0.03923773393034935
( O 0 0.029290001839399338
17 O 0 0.028265822678804398
% O 0 0.020619304850697517
) O 0 0.013354859314858913
of O 0 0.0067756627686321735
the O 0 0.013674180954694748
36 O 0 0.05077555403113365
patients O 1 0.9997872710227966
, O 0 0.01551539171487093
a O 0 0.0245949849486351
mutation O 0 0.11838988959789276
was O 0 0.02297271229326725
detected O 0 0.059511780738830566
in O 0 0.009901867248117924
constitutional O 0 0.018886635079979897
DNA O 0 0.04497427120804787
, O 0 0.008049560710787773
and O 0 0.006723479833453894
1 O 0 0.013260266743600368
of O 0 0.005600590258836746
these O 0 0.009609815664589405
mutations O 0 0.07080031931400299
is O 0 0.012045235373079777
known O 0 0.014699993655085564
to O 0 0.006502614822238684
be O 0 0.007449712138622999
associated O 0 0.018270380795001984
with O 0 0.01485287956893444
reduced O 0 0.06945320218801498
expressivity O 1 0.9955908060073853
. O 0 0.04006955400109291

The O 0 0.023664571344852448
presence O 0 0.028674650937318802
of O 0 0.00737934373319149
a O 0 0.01632915623486042
constitutional O 0 0.024563876911997795
mutation O 0 0.09399962425231934
was O 0 0.015215905383229256
not O 0 0.006887631956487894
associated O 0 0.01377955824136734
with O 0 0.007601396180689335
an O 0 0.009971403516829014
early O 0 0.02104022353887558
age O 0 0.03104800544679165
at O 0 0.029349589720368385
treatment O 1 0.9997941851615906
. O 0 0.026348181068897247

In O 0 0.03401831537485123
1 O 0 0.04421176388859749
patient O 1 0.9986684322357178
, O 0 0.027990857139229774
somatic O 0 0.26759564876556396
mosaicism O 1 0.9972768425941467
was O 0 0.025849202647805214
demonstrated O 0 0.03829621896147728
by O 0 0.011882858350872993
molecular O 0 0.047909192740917206
analysis O 0 0.021350087597966194
of O 0 0.009544603526592255
DNA O 0 0.05417800694704056
and O 0 0.015226003713905811
RNA O 0 0.09120360016822815
from O 0 0.029715076088905334
peripheral O 1 0.99951171875
blood O 1 0.983171820640564
. O 0 0.03237199783325195

In O 0 0.03371161222457886
2 O 0 0.04516945779323578
patients O 1 0.9993404746055603
without O 0 0.019128594547510147
a O 0 0.029651610180735588
detectable O 0 0.15827982127666473
mutation O 0 0.15979596972465515
in O 0 0.03042721003293991
peripheral O 1 0.9998121857643127
blood O 1 0.999380350112915
, O 0 0.025151479989290237
mosaicism O 1 0.9995948672294617
was O 0 0.02008671499788761
suggested O 0 0.023906022310256958
because O 0 0.012782808393239975
1 O 0 0.010688895359635353
of O 0 0.006334610283374786
the O 0 0.01631895825266838
patients O 1 0.9999996423721313
showed O 1 0.9980794191360474
multifocal O 1 1.0
tumors B-Disease 1 0.9999998807907104
and O 0 0.009447135031223297
the O 0 0.006982804276049137
other O 0 0.005212736781686544
later O 0 0.01386954914778471
developed O 0 0.03586113825440407
bilateral B-Disease 0 0.058577269315719604
retinoblastoma I-Disease 1 0.999763548374176
. O 0 0.04255799576640129

In O 0 0.022362789139151573
conclusion O 0 0.032140444964170456
, O 0 0.01036796998232603
our O 0 0.01211466733366251
results O 0 0.021034684032201767
emphasize O 0 0.031362440437078476
that O 0 0.007156694773584604
the O 0 0.01159135065972805
manifestation O 0 0.2649189829826355
and O 0 0.01892182044684887
transmissibility O 1 0.9490259885787964
of O 0 0.01793711446225643
retinoblastoma B-Disease 1 0.9988319277763367
depend O 0 0.023214930668473244
on O 0 0.006922130938619375
the O 0 0.007911423221230507
nature O 0 0.016836797818541527
of O 0 0.0056604743003845215
the O 0 0.009400317445397377
first O 0 0.01703769713640213
mutation O 0 0.09303358197212219
, O 0 0.010143722407519817
its O 0 0.008246621116995811
time O 0 0.009745518676936626
in O 0 0.00792022980749607
development O 0 0.015965091064572334
, O 0 0.00647380156442523
and O 0 0.005240926519036293
the O 0 0.006137489806860685
number O 0 0.0068793026730418205
and O 0 0.0069695450365543365
types O 0 0.018882401287555695
of O 0 0.009347991086542606
cells O 0 0.05357857048511505
that O 0 0.007581190671771765
are O 0 0.006970159709453583
affected O 0 0.039575956761837006
. O 0 0.014682667329907417
. O 0 0.020484553650021553

Hereditary B-Disease 1 0.999991774559021
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.012620490044355392
the I-Disease 0 0.01215030625462532
fifth I-Disease 0 0.03610902279615402
component I-Disease 0 0.03959332033991814
of I-Disease 0 0.009038285352289677
complement I-Disease 0 0.044093284755945206
in O 0 0.014966771006584167
man O 0 0.04286305978894234
. O 0 0.0256404597312212

I O 0 0.08330743759870529
. O 0 0.03261379152536392

Clinical O 1 0.9969379901885986
, O 0 0.028794225305318832
immunochemical O 1 0.7731001377105713
, O 0 0.01279897429049015
and O 0 0.00957410503178835
family O 0 0.029942285269498825
studies O 0 0.03410397469997406
. O 0 0.022517547011375427

The O 0 0.018024448305368423
first O 0 0.014897823333740234
recognized O 0 0.028329795226454735
human O 0 0.03350048139691353
kindred O 1 0.9998581409454346
with O 0 0.030032683163881302
hereditary B-Disease 1 0.9999963045120239
deficiency I-Disease 1 1.0
of I-Disease 0 0.011062802746891975
the I-Disease 0 0.013899573124945164
fifth I-Disease 0 0.03773625195026398
component I-Disease 0 0.04647381976246834
of I-Disease 0 0.013968819752335548
complement I-Disease 0 0.06795977801084518
( O 0 0.04602181911468506
C5 O 1 0.9947677850723267
) O 0 0.022153757512569427
is O 0 0.015775348991155624
described O 0 0.03357722610235214
. O 0 0.025178033858537674

The O 0 0.030247075483202934
proband O 0 0.2556570768356323
, O 0 0.013410250656306744
a O 0 0.01816510409116745
20 O 0 0.024043481796979904
- O 0 0.06721445918083191
year O 0 0.027472931891679764
- O 0 0.07420976459980011
old O 0 0.041052624583244324
black O 0 0.0659523606300354
female O 0 0.07767423987388611
with O 1 0.5958734750747681
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.0409383624792099
age O 0 0.029078708961606026
11 O 0 0.02105051651597023
, O 0 0.016163213178515434
lacked O 1 0.9276161193847656
serum O 1 0.9999822378158569
hemolytic O 1 0.9999998807907104
complement O 0 0.09519071877002716
activity O 0 0.04293636232614517
, O 0 0.012114985845983028
even O 0 0.014378746971487999
during O 0 0.03233034163713455
remission O 1 0.9999217987060547
. O 0 0.036670491099357605

C5 O 1 0.986504077911377
was O 0 0.04066649079322815
undetectable O 1 0.7668659687042236
in O 0 0.013775914907455444
her O 0 0.028570562601089478
serum O 1 0.893123209476471
by O 0 0.012959079816937447
both O 0 0.015391696244478226
immunodiffusion O 1 0.9774123430252075
and O 0 0.03377319127321243
hemolytic O 1 0.9999997615814209
assays O 0 0.1481604427099228
. O 0 0.03779233619570732

Other O 0 0.01907281018793583
complement O 0 0.04904641956090927
components O 0 0.026583710685372353
were O 0 0.00956721231341362
normal O 0 0.0377357117831707
during O 0 0.03183731809258461
remission O 1 0.9999760389328003
of O 0 0.026125937700271606
lupus O 1 1.0
, O 0 0.025081206113100052
but O 0 0.02101195603609085
C1 O 1 0.9999973773956299
, O 0 0.02812613733112812
C4 O 1 0.9917041063308716
, O 0 0.02794967032968998
C2 O 1 0.9999276399612427
, O 0 0.02026326023042202
and O 0 0.01926332339644432
C3 O 1 0.9992282390594482
levels O 0 0.062335748225450516
fell O 0 0.0662245973944664
during O 0 0.057789504528045654
exacerbations O 1 0.9998836517333984
. O 0 0.04042326286435127

A O 0 0.05033285170793533
younger O 0 0.04940486699342728
half O 0 0.03107096627354622
- O 0 0.07669832557439804
sister O 0 0.05402044951915741
, O 0 0.013557377271354198
who O 0 0.014980921521782875
had O 0 0.01677192747592926
no O 0 0.017902832478284836
underlying O 1 0.9985485672950745
disease O 1 0.9999998807907104
, O 0 0.012095712125301361
was O 0 0.01129018235951662
also O 0 0.007715919986367226
found O 0 0.011557435616850853
to O 0 0.010060609318315983
lack O 0 0.04800988361239433
immunochemically O 1 0.9875276684761047
detectable O 0 0.49748700857162476
C5 O 1 0.9922142624855042
. O 0 0.04525129869580269

By O 0 0.06896119564771652
hemolytic O 1 0.999998927116394
assay O 0 0.1864602416753769
, O 0 0.022010143846273422
she O 0 0.024716831743717194
exhibited O 0 0.051076263189315796
1 O 0 0.02912564016878605
- O 0 0.05864498391747475
2 O 0 0.024266734719276428
% O 0 0.015415040776133537
of O 0 0.007134056184440851
the O 0 0.016035420820116997
normal O 0 0.08269122987985611
serum O 1 0.9971720576286316
C5 O 1 0.9942237734794617
level O 0 0.03384634107351303
and O 0 0.012833761051297188
normal O 0 0.04447731003165245
concentrations O 0 0.05667946860194206
of O 0 0.00732211722061038
other O 0 0.008431406691670418
complement O 0 0.05150236189365387
components O 0 0.04219958558678627
. O 0 0.02585216984152794

C5 O 1 0.9654131531715393
levels O 0 0.044823143631219864
of O 0 0.008336787112057209
other O 0 0.008057852275669575
family O 0 0.020060399547219276
members O 0 0.010768849402666092
were O 0 0.007037719711661339
either O 0 0.015020080842077732
normal O 0 0.0316619947552681
or O 0 0.015874477103352547
approximately O 0 0.02158515527844429
half O 0 0.022937225177884102
- O 0 0.06570294499397278
normal O 0 0.040560051798820496
, O 0 0.013716867193579674
consistent O 0 0.03610159084200859
with O 0 0.02088596113026142
autosomal O 1 0.9981216788291931
codominant O 1 0.9825992584228516
inheritance O 0 0.06403366476297379
of O 0 0.011164223775267601
the O 0 0.02060779556632042
gene O 0 0.12195784598588943
determining O 0 0.11907309293746948
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0454489029943943

Normal O 1 0.9392321109771729
hemolytic O 1 0.9999992847442627
titers O 1 0.9876657724380493
were O 0 0.018296625465154648
restored O 0 0.03481614217162132
to O 0 0.011719443835318089
both O 0 0.018628813326358795
homozygous O 0 0.2750871479511261
C5 B-Disease 1 0.9999982118606567
- I-Disease 1 0.9972521662712097
deficient I-Disease 1 0.9999876022338867
( O 0 0.07689256221055984
C5D B-Disease 1 0.9999959468841553
) O 0 0.03593960031867027
sera O 0 0.09402158856391907
by O 0 0.009547784924507141
addition O 0 0.01426454447209835
of O 0 0.009660339914262295
highly O 0 0.042169276624917984
purified O 0 0.13420511782169342
human O 0 0.06160428747534752
C5 O 1 0.9927323460578918
. O 0 0.03899359703063965

In O 0 0.03037589229643345
specific O 0 0.04707031697034836
C5 O 1 0.9988853335380554
titrations O 1 0.9930879473686218
, O 0 0.015721112489700317
however O 0 0.009589487686753273
, O 0 0.007786656729876995
it O 0 0.006459195166826248
was O 0 0.01112349797040224
noted O 0 0.012479335069656372
that O 0 0.00659521808847785
when O 0 0.011812112294137478
limited O 0 0.019945424050092697
amounts O 0 0.023608030751347542
of O 0 0.012629586271941662
C5 O 1 0.7504677176475525
were O 0 0.0128478379920125
assayed O 0 0.09059102833271027
in O 0 0.008877393789589405
the O 0 0.008954162709414959
presence O 0 0.023579688742756844
of O 0 0.009671102277934551
low O 0 0.05421992763876915
dilutions O 1 0.9028927087783813
of O 0 0.01629992574453354
either O 0 0.04180069640278816
C5D B-Disease 1 0.9999978542327881
serum O 1 0.9984513521194458
, O 0 0.02015126310288906
curving O 0 0.07155066728591919
rather O 0 0.01959802955389023
than O 0 0.018043557181954384
linear O 0 0.09874895215034485
dose O 1 0.9998118281364441
- O 0 0.09773959219455719
response O 0 0.041001126170158386
plots O 0 0.031793925911188126
were O 0 0.009546532295644283
consistently O 0 0.03136340156197548
obtained O 0 0.017235830426216125
, O 0 0.011173677630722523
suggesting O 0 0.039194539189338684
some O 0 0.016848372295498848
inhibitory O 0 0.18466275930404663
effect O 0 0.05447985604405403
. O 0 0.0286753848195076

Further O 0 0.03347628191113472
studies O 0 0.038017842918634415
suggested O 0 0.02798936329782009
that O 0 0.012605306692421436
low O 0 0.061013124883174896
dilutions O 1 0.8834588527679443
of O 0 0.030822878703475
C5D B-Disease 1 0.9999852180480957
serum O 1 0.994985818862915
contain O 0 0.03841867297887802
a O 0 0.028363309800624847
factor O 0 0.061541128903627396
( O 0 0.024621380493044853
or O 0 0.01830131560564041
factors O 0 0.0314253494143486
) O 0 0.01819286309182644
interfering O 0 0.04682886600494385
at O 0 0.013651927933096886
some O 0 0.006967294495552778
step O 0 0.01920771412551403
in O 0 0.011389389634132385
the O 0 0.026848675683140755
hemolytic O 1 0.9999990463256836
assay O 0 0.15095949172973633
of O 0 0.0198162030428648
C5 O 1 0.9931567311286926
, O 0 0.012873341329395771
rather O 0 0.011701707728207111
than O 0 0.008906899951398373
a O 0 0.018570981919765472
true O 0 0.04765256494283676
C5 O 1 0.9991723299026489
inhibitor O 1 0.989897608757019
or O 0 0.037181977182626724
inactivator O 1 0.9580544829368591
. O 0 0.03403928875923157

Of O 0 0.026477569714188576
clinical O 1 0.726453423500061
interest O 0 0.02128441445529461
are O 0 0.007691802456974983
( O 0 0.01512069720774889
a O 0 0.01379627175629139
) O 0 0.012483878992497921
the O 0 0.009288860484957695
documentation O 0 0.033323224633932114
of O 0 0.020958686247467995
membranous O 1 0.9999995231628418
glomerulonephritis B-Disease 1 1.0
, O 0 0.32636529207229614
vasculitis B-Disease 1 1.0
, O 0 0.024875175207853317
and O 0 0.024639412760734558
arthritis B-Disease 1 1.0
in O 0 0.013958807103335857
an O 0 0.013486465439200401
individual O 0 0.02779914066195488
lacking O 0 0.28065016865730286
C5 O 1 0.9980524778366089
( O 0 0.02035856433212757
and O 0 0.007609819062054157
its O 0 0.013795837759971619
biologic O 0 0.3854483962059021
functions O 0 0.021950241178274155
) O 0 0.0170326828956604
, O 0 0.009960902854800224
and O 0 0.011004013940691948
( O 0 0.027625447139143944
b O 0 0.0628092959523201
) O 0 0.01635655388236046
a O 0 0.01734769530594349
remarkable O 0 0.04138583317399025
propensity O 1 0.9169883131980896
to O 0 0.030258966609835625
bacterial B-Disease 1 0.9999998807907104
infections I-Disease 1 1.0
in O 0 0.014574863947927952
the O 0 0.013741383329033852
proband O 1 0.9772377610206604
, O 0 0.011154254898428917
even O 0 0.010798443108797073
during O 0 0.014611083082854748
periods O 0 0.028843743726611137
of O 0 0.009459271095693111
low O 0 0.060141392052173615
- O 0 0.22722987830638885
dose O 1 0.9800062775611877
or O 0 0.02392217516899109
alternate O 0 0.045311421155929565
- O 0 0.16934478282928467
day O 0 0.06973081827163696
corticosteroid O 1 0.9999986886978149
therapy O 1 0.9999879598617554
. O 0 0.03553146868944168

Other O 0 0.01974629983305931
observations O 0 0.038570892065763474
indicate O 0 0.02582027018070221
that O 0 0.00734194740653038
the O 0 0.013028175570070744
C5D B-Disease 1 0.9998258948326111
state O 0 0.014056118205189705
is O 0 0.012972998432815075
compatible O 0 0.030344517901539803
with O 0 0.015557918697595596
normal O 0 0.06936140358448029
coagulation O 1 0.9635524749755859
function O 0 0.027758875861763954
and O 0 0.006277295760810375
the O 0 0.007592467591166496
capacity O 0 0.01668403297662735
to O 0 0.01083902083337307
mount O 0 0.06570589542388916
a O 0 0.047813184559345245
neutrophilic O 1 0.9999896287918091
leukocytosis O 1 0.9999527931213379
during O 0 0.3694685995578766
pyogenic B-Disease 1 0.9999992847442627
infection I-Disease 1 0.9999996423721313
. O 0 0.02333652600646019
. O 0 0.02709105797111988

Susceptibility O 1 0.9963080883026123
to O 0 0.06640366464853287
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.03280854970216751
twins O 0 0.16115380823612213
: O 0 0.014686815440654755
the O 0 0.008328099735081196
role O 0 0.01550128310918808
of O 0 0.009194993413984776
genes O 0 0.05316908657550812
, O 0 0.026277093216776848
HLA O 1 0.9999222755432129
, O 0 0.013124593533575535
and O 0 0.008752856403589249
the O 0 0.011934107169508934
environment O 0 0.03783091902732849
. O 0 0.025438427925109863

OBJECTIVE O 0 0.06137675791978836
To O 0 0.011446614749729633
determine O 0 0.017651772126555443
the O 0 0.010474891401827335
relative O 0 0.03464924171566963
effects O 0 0.05892755091190338
of O 0 0.010384790599346161
genetic O 0 0.05193474888801575
and O 0 0.010205397382378578
environmental O 0 0.03144834563136101
factors O 0 0.02890382520854473
in O 0 0.019051728770136833
susceptibility O 1 0.9987181425094604
to O 0 0.05186060816049576
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.06573550403118134
AS B-Disease 0 0.03664768487215042
) O 0 0.024027863517403603
. O 0 0.02037363499403

METHODS O 0 0.07579369843006134
Twins O 0 0.09408016502857208
with O 0 0.013888219371438026
AS B-Disease 0 0.017138319090008736
were O 0 0.00759161589667201
identified O 0 0.01653306744992733
from O 0 0.008492724038660526
the O 0 0.01031702570617199
Royal O 0 0.047035183757543564
National O 0 0.03497104346752167
Hospital O 1 0.9999995231628418
for O 0 0.050981346517801285
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999998807907104
database O 0 0.06822734326124191
. O 0 0.028514359146356583

Clinical O 1 0.9960731267929077
and O 0 0.025863977149128914
radiographic O 1 0.9945916533470154
examinations O 0 0.0726865753531456
were O 0 0.010434776544570923
performed O 0 0.022114289924502373
to O 0 0.009600761346518993
establish O 0 0.03708876296877861
diagnoses O 1 0.9999841451644897
, O 0 0.019585056230425835
and O 0 0.020538680255413055
disease O 1 1.0
severity O 1 0.9998668432235718
was O 0 0.01879846304655075
assessed O 0 0.039000704884529114
using O 0 0.013655910268425941
a O 0 0.018030505627393723
combination O 0 0.0476081445813179
of O 0 0.010669167153537273
validated O 0 0.05659065768122673
scoring O 0 0.033007748425006866
systems O 0 0.050396475940942764
. O 0 0.027779988944530487

HLA O 1 0.9986442923545837
typing O 0 0.17387565970420837
for O 0 0.03804267197847366
HLA O 1 0.9999831914901733
- O 0 0.17226892709732056
B27 O 1 0.5711925625801086
, O 0 0.04312646761536598
HLA O 1 0.9999676942825317
- O 0 0.14690154790878296
B60 O 0 0.18225747346878052
, O 0 0.02415127493441105
and O 0 0.023828355595469475
HLA O 1 0.9999916553497314
- O 0 0.20434322953224182
DR1 O 1 0.9940745234489441
was O 0 0.03261866793036461
performed O 0 0.03621148318052292
by O 0 0.019402721896767616
polymerase O 0 0.16630451381206512
chain O 0 0.08766885846853256
reaction O 0 0.0629281997680664
with O 0 0.015054048970341682
sequence O 0 0.0373694933950901
- O 0 0.067073293030262
specific O 0 0.028289563953876495
primers O 0 0.12195045500993729
, O 0 0.01437373273074627
and O 0 0.01284992415457964
zygosity O 0 0.21021613478660583
was O 0 0.026079032570123672
assessed O 0 0.06513885408639908
using O 0 0.03548979386687279
microsatellite O 1 0.7023636102676392
markers O 0 0.1158226728439331
. O 0 0.038174621760845184

Genetic O 0 0.1164771020412445
and O 0 0.0171185415238142
environmental O 0 0.041738152503967285
variance O 0 0.046326298266649246
components O 0 0.024929270148277283
were O 0 0.00979740172624588
assessed O 0 0.034216247498989105
with O 0 0.009595530107617378
the O 0 0.014819871634244919
program O 0 0.05643031373620033
Mx O 1 0.9929015040397644
, O 0 0.012732469476759434
using O 0 0.011687600053846836
data O 0 0.00997152179479599
from O 0 0.007805778644979
this O 0 0.006174086593091488
and O 0 0.006893818266689777
previous O 0 0.014606388285756111
studies O 0 0.022191401571035385
of O 0 0.008898708038032055
twins O 0 0.07383166998624802
with O 0 0.013562212698161602
AS B-Disease 0 0.03072473220527172
. O 0 0.02347741462290287

RESULTS O 0 0.05517710745334625
Six O 0 0.020964698866009712
of O 0 0.013699453324079514
8 O 0 0.0487523227930069
monozygotic O 1 0.9923489093780518
( O 0 0.07750339806079865
MZ O 1 0.9999685287475586
) O 0 0.05057844519615173
twin O 0 0.11771678924560547
pairs O 0 0.070742666721344
were O 0 0.023048611357808113
disease O 1 0.9999982118606567
concordant O 1 0.6702155470848083
, O 0 0.017034398391842842
compared O 0 0.020213905721902847
with O 0 0.008873878978192806
4 O 0 0.017986347898840904
of O 0 0.010886382311582565
15 O 0 0.034017980098724365
B27 O 1 0.8013343811035156
- O 0 0.13234049081802368
positive O 0 0.10094103962182999
dizygotic O 1 0.9816054701805115
( O 0 0.08041685819625854
DZ O 1 0.9996554851531982
) O 0 0.043099306523799896
twin O 0 0.1072237640619278
pairs O 0 0.06698314845561981
( O 0 0.03470879793167114
27 O 0 0.0342337004840374
% O 0 0.023002328351140022
) O 0 0.014697949402034283
and O 0 0.0071679516695439816
4 O 0 0.016108443960547447
of O 0 0.01111839059740305
32 O 0 0.05810421705245972
DZ O 1 0.9979323148727417
twin O 0 0.13537950813770294
pairs O 0 0.06105085089802742
overall O 0 0.04910587519407272
( O 0 0.026164831593632698
12 O 0 0.018353113904595375
. O 0 0.010830620303750038
5 O 0 0.02096923626959324
% O 0 0.025719786062836647
) O 0 0.023327693343162537
. O 0 0.021283386275172234

Nonsignificant O 1 0.9082659482955933
increases O 0 0.06214587762951851
in O 0 0.012646925635635853
similarity O 0 0.02893356792628765
with O 0 0.009385351091623306
regard O 0 0.019323162734508514
to O 0 0.011360229924321175
age O 0 0.037538908421993256
at O 0 0.17849835753440857
disease O 1 1.0
onset O 1 0.9999902248382568
and O 0 0.00830952450633049
all O 0 0.005154277663677931
of O 0 0.007652855943888426
the O 0 0.022062016651034355
disease O 1 1.0
severity O 1 0.9998843669891357
scores O 0 0.042862433940172195
assessed O 0 0.04231968894600868
were O 0 0.009572934359312057
noted O 0 0.018639463931322098
in O 0 0.022704532369971275
disease O 1 1.0
- O 1 0.9953043460845947
concordant O 1 0.9981918931007385
MZ O 1 0.9999933242797852
twins O 0 0.19486021995544434
compared O 0 0.05298227071762085
with O 0 0.030847569927573204
concordant O 1 0.9718338251113892
DZ O 1 0.9999146461486816
twins O 0 0.20839989185333252
. O 0 0.03889990970492363

HLA O 1 0.999984860420227
- O 0 0.20736078917980194
B27 O 0 0.198751762509346
and O 0 0.023745078593492508
B60 O 0 0.12007702887058258
were O 0 0.011267836205661297
associated O 0 0.014775276184082031
with O 0 0.009780093096196651
the O 0 0.01797422207891941
disease O 1 0.999998927116394
in O 0 0.017065316438674927
probands O 1 0.9639474153518677
, O 0 0.009353666566312313
and O 0 0.0057268301025033
the O 0 0.01055992767214775
rate O 0 0.02850033901631832
of O 0 0.015137054026126862
disease O 1 0.9999990463256836
concordance O 0 0.31073227524757385
was O 0 0.023052074015140533
significantly O 0 0.04309019073843956
increased O 0 0.03471078723669052
among O 0 0.029603956267237663
DZ O 1 0.9993857145309448
twin O 0 0.10547091066837311
pairs O 0 0.037035681307315826
in O 0 0.009170164354145527
which O 0 0.008614912629127502
the O 0 0.014803450554609299
co O 1 0.9551477432250977
- O 0 0.08526936173439026
twin O 0 0.08962956815958023
was O 0 0.018746284767985344
positive O 0 0.028231501579284668
for O 0 0.009322277270257473
both O 0 0.014416368678212166
B27 O 0 0.21496768295764923
and O 0 0.025498315691947937
DR1 O 1 0.9994762539863586
. O 0 0.035447027534246445

Additive O 0 0.2572327256202698
genetic O 0 0.13293351233005524
effects O 0 0.07860635221004486
were O 0 0.010688087902963161
estimated O 0 0.01866047829389572
to O 0 0.01062656007707119
contribute O 0 0.04328460991382599
97 O 0 0.06418538838624954
% O 0 0.016778867691755295
of O 0 0.005999126937240362
the O 0 0.011535955592989922
population O 0 0.02788008190691471
variance O 0 0.061742011457681656
. O 0 0.027572238817811012

CONCLUSION O 0 0.10956882685422897
Susceptibility O 0 0.35638007521629333
to O 0 0.013842400163412094
AS B-Disease 0 0.021717509254813194
is O 0 0.013309720903635025
largely O 0 0.022061584517359734
genetically O 0 0.0416639968752861
determined O 0 0.026821967214345932
, O 0 0.00818629190325737
and O 0 0.00640890235081315
the O 0 0.009678041562438011
environmental O 0 0.034026436507701874
trigger O 0 0.0753060057759285
for O 0 0.010350069031119347
the O 0 0.016581136733293533
disease O 1 0.9999996423721313
is O 0 0.021412942558526993
probably O 0 0.03753700852394104
ubiquitous O 0 0.07829305529594421
. O 0 0.030214333906769753

HLA O 1 0.9999611377716064
- O 0 0.17598266899585724
B27 O 0 0.15249955654144287
accounts O 0 0.024679604917764664
for O 0 0.008081787265837193
a O 0 0.012778578326106071
minority O 0 0.01979696750640869
of O 0 0.007461847737431526
the O 0 0.01271333172917366
overall O 0 0.05302797257900238
genetic O 0 0.09692202508449554
susceptibility O 1 0.7900249361991882
to O 0 0.015152336098253727
AS B-Disease 0 0.03175881877541542
. O 0 0.023713121190667152

Cell O 0 0.4037072956562042
cycle O 0 0.14592748880386353
- O 0 0.11324331909418106
dependent O 0 0.09601832926273346
colocalization O 0 0.1708867996931076
of O 0 0.020673543214797974
BARD1 O 1 0.9910666346549988
and O 0 0.025008343160152435
BRCA1 O 1 0.9272597432136536
proteins O 0 0.05198231339454651
in O 0 0.01534929871559143
discrete O 0 0.05822175741195679
nuclear O 0 0.05586834251880646
domains O 0 0.0657539814710617
. O 0 0.033087946474552155

Germ O 1 0.9998916387557983
- O 0 0.1412489116191864
line O 0 0.05631386116147041
mutations O 0 0.08966000378131866
of O 0 0.013045165687799454
the O 0 0.02684541419148445
BRCA1 O 1 0.998295247554779
gene O 0 0.16148923337459564
predispose O 1 0.8242010474205017
women O 0 0.029282517731189728
to O 0 0.012217957526445389
early O 0 0.03766369819641113
- O 1 0.9999138116836548
onset O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 1 0.9965261816978455
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.021317144855856895
compromising O 0 0.07462161034345627
the O 0 0.021151576191186905
genes O 0 0.06555590033531189
presumptive O 1 0.5253757834434509
function O 0 0.038617976009845734
as O 0 0.01452954113483429
a O 0 0.04094678536057472
tumor B-Disease 1 0.999953031539917
suppressor O 1 0.9363015294075012
. O 0 0.043441012501716614

Although O 0 0.02563646249473095
the O 0 0.016555815935134888
biochemical O 0 0.0931335985660553
properties O 0 0.03985539451241493
of O 0 0.01833929866552353
BRCA1 O 1 0.9984831213951111
polypeptides O 0 0.09722240269184113
are O 0 0.008802026510238647
not O 0 0.00856697279959917
understood O 0 0.025799037888646126
, O 0 0.008746412582695484
their O 0 0.008845636621117592
expression O 0 0.04346218705177307
pattern O 0 0.0512482188642025
and O 0 0.01423401478677988
subcellular O 0 0.11004425585269928
localization O 0 0.07984276860952377
suggest O 0 0.026585333049297333
a O 0 0.014440792612731457
role O 0 0.020264461636543274
in O 0 0.015541678294539452
cell O 0 0.363900363445282
- O 0 0.10541699081659317
cycle O 0 0.10787596553564072
regulation O 0 0.06730645895004272
. O 0 0.029599370434880257

When O 0 0.05233055725693703
resting O 1 0.675536036491394
cells O 0 0.07961919903755188
are O 0 0.015446821227669716
induced O 1 0.6121823787689209
to O 0 0.015015975572168827
proliferate O 0 0.08049997687339783
, O 0 0.010358748026192188
the O 0 0.011022045277059078
steady O 0 0.05953564494848251
- O 0 0.05655890703201294
state O 0 0.01537882350385189
levels O 0 0.03565872088074684
of O 0 0.016004279255867004
BRCA1 O 1 0.9556285738945007
increase O 0 0.028910385444760323
in O 0 0.011353254318237305
late O 0 0.03623444214463234
G1 O 1 0.9874714016914368
and O 0 0.012932654470205307
reach O 0 0.025024112313985825
a O 0 0.019101636484265327
maximum O 0 0.042886149138212204
during O 0 0.03487627953290939
S O 1 0.9719048738479614
phase O 0 0.08899866044521332
. O 0 0.0327410064637661

Moreover O 0 0.06535274535417557
, O 0 0.017210714519023895
in O 0 0.01917930692434311
S O 1 0.9963157773017883
phase O 0 0.12184852361679077
cells O 0 0.09652626514434814
, O 0 0.026643354445695877
BRCA1 O 1 0.9768425226211548
polypeptides O 0 0.12199810147285461
are O 0 0.016902269795536995
hyperphosphorylated O 0 0.1463015377521515
and O 0 0.016323689371347427
accumulate O 0 0.08333133906126022
into O 0 0.022025732323527336
discrete O 0 0.09069866687059402
subnuclear O 1 0.5046114325523376
foci O 0 0.3425670862197876
termed O 0 0.14044897258281708
" O 0 0.04650479927659035
BRCA1 O 1 0.9932700991630554
nuclear O 0 0.10075576603412628
dots O 0 0.1426532119512558
. O 0 0.03985283896327019

" O 0 0.06574521958827972
BRCA1 O 1 0.9983658194541931
associates O 1 0.8487696647644043
in O 0 0.02264019101858139
vivo O 0 0.11030875891447067
with O 0 0.014206529594957829
a O 0 0.02795642800629139
structurally O 0 0.11549381911754608
related O 0 0.04907139018177986
protein O 0 0.09032365679740906
termed O 0 0.14534670114517212
BARD1 O 1 0.9977637529373169
. O 0 0.03910345956683159

Here O 0 0.0234066154807806
we O 0 0.01093336008489132
show O 0 0.013521503657102585
that O 0 0.0052145253866910934
the O 0 0.010346787050366402
steady O 0 0.05335443839430809
- O 0 0.04644725099205971
state O 0 0.015297099016606808
levels O 0 0.03151679411530495
of O 0 0.010958092287182808
BARD1 O 1 0.9966009259223938
, O 0 0.012344539165496826
unlike O 0 0.018240176141262054
those O 0 0.007790160831063986
of O 0 0.011734453961253166
BRCA1 O 1 0.9987478256225586
, O 0 0.016160672530531883
remain O 0 0.021107450127601624
relatively O 0 0.028716690838336945
constant O 0 0.04317564517259598
during O 0 0.03663910925388336
cell O 0 0.18349617719650269
cycle O 0 0.16247877478599548
progression O 1 0.8544834852218628
. O 0 0.03438078612089157

However O 0 0.03495858237147331
, O 0 0.02264825440943241
immunostaining O 1 0.5148849487304688
revealed O 0 0.044782135635614395
that O 0 0.01579691655933857
BARD1 O 1 0.9612942934036255
resides O 0 0.07418207079172134
within O 0 0.02761261537671089
BRCA1 O 1 0.9768252372741699
nuclear O 0 0.07480131834745407
dots O 0 0.09838416427373886
during O 0 0.029883431270718575
S O 1 0.6457951664924622
phase O 0 0.045840051025152206
of O 0 0.007625866681337357
the O 0 0.01380889117717743
cell O 0 0.07739581167697906
cycle O 0 0.06476513296365738
, O 0 0.009498373605310917
but O 0 0.0064241476356983185
not O 0 0.006370409857481718
during O 0 0.014973696321249008
the O 0 0.018505241721868515
G1 O 1 0.999574601650238
phase O 0 0.124848872423172
. O 0 0.03268321231007576

Nevertheless O 0 0.06804949045181274
, O 0 0.030314236879348755
BARD1 O 1 0.8881158828735352
polypeptides O 0 0.0964645966887474
are O 0 0.008950644172728062
found O 0 0.01265383418649435
exclusively O 0 0.013703572563827038
in O 0 0.006718485150486231
the O 0 0.009898083284497261
nuclear O 0 0.027392199262976646
fractions O 0 0.024371948093175888
of O 0 0.008432659320533276
both O 0 0.018203992396593094
G1 O 1 0.9999648332595825
- O 0 0.0965813547372818
and O 0 0.022049542516469955
S O 1 0.9997965693473816
- O 0 0.1602480709552765
phase O 0 0.11171497404575348
cells O 0 0.10992775112390518
. O 0 0.0317060761153698

Therefore O 0 0.045310016721487045
, O 0 0.02162572555243969
progression O 0 0.13377010822296143
to O 0 0.016670089215040207
S O 1 0.8592780232429504
phase O 0 0.06475246697664261
is O 0 0.012310123071074486
accompanied O 0 0.0244932658970356
by O 0 0.0076956432312726974
the O 0 0.011615237221121788
aggregation O 0 0.05410867556929588
of O 0 0.012248312123119831
nuclear O 0 0.056264542043209076
BARD1 O 1 0.8012826442718506
polypeptides O 0 0.1218046173453331
into O 0 0.03662927821278572
BRCA1 O 1 0.9862915873527527
nuclear O 0 0.09216257929801941
dots O 0 0.1340387910604477
. O 0 0.03662700578570366

This O 0 0.034117478877305984
cell O 0 0.10907349735498428
cycle O 0 0.12773215770721436
- O 0 0.10117485374212265
dependent O 0 0.08413524925708771
colocalization O 0 0.1654147058725357
of O 0 0.019115686416625977
BARD1 O 1 0.992108166217804
and O 0 0.0250567439943552
BRCA1 O 1 0.9908531308174133
indicates O 0 0.05372495576739311
a O 0 0.016547519713640213
role O 0 0.020413964986801147
for O 0 0.012261760421097279
BARD1 O 1 0.9969691634178162
in O 0 0.027300484478473663
BRCA1 O 1 0.9999916553497314
- O 1 0.9968289732933044
mediated O 1 0.9989525079727173
tumor B-Disease 1 0.9999903440475464
suppression O 1 0.9146496653556824
. O 0 0.03666631877422333

Ethnic O 0 0.02985607273876667
differences O 0 0.0247984379529953
in O 0 0.015839802101254463
the O 0 0.027263587340712547
HFE O 1 0.999072790145874
codon O 0 0.22897210717201233
282 O 0 0.20990507304668427
( O 0 0.10084151476621628
Cys O 1 0.9999587535858154
/ O 1 0.9981727600097656
Tyr O 1 0.9973505735397339
) O 0 0.054836519062519073
polymorphism O 0 0.13994313776493073
. O 0 0.03027328848838806

Recent O 0 0.041286539286375046
studies O 0 0.027373142540454865
have O 0 0.010905789211392403
shown O 0 0.025564618408679962
that O 0 0.019765803590416908
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9918724894523621
HH B-Disease 1 1.0
) O 0 0.0284790750592947
is O 0 0.011847302317619324
likely O 0 0.01458439975976944
to O 0 0.007559827528893948
be O 0 0.009254549629986286
caused O 0 0.042771123349666595
by O 0 0.013520320877432823
homozygosity O 0 0.13398616015911102
for O 0 0.01516044419258833
a O 0 0.03108152002096176
Cys282Tyr O 1 0.7040790915489197
mutation O 0 0.1222430169582367
in O 0 0.014846602454781532
the O 0 0.024475466459989548
HFE O 1 0.9993948936462402
gene O 0 0.11638008803129196
located O 0 0.04086145758628845
4 O 0 0.034828294068574905
. O 0 0.02743254043161869

5 O 0 0.08076704293489456
Mb O 1 0.9396198987960815
telomeric O 1 0.9421941637992859
to O 0 0.03919901326298714
HLA O 1 0.999982476234436
- O 0 0.10334575921297073
A O 0 0.04553762078285217
. O 0 0.03312263265252113

Population O 0 0.04356015473604202
studies O 0 0.029898935928940773
of O 0 0.009101282805204391
this O 0 0.012684407643973827
polymorphism O 0 0.0864044800400734
are O 0 0.010259789414703846
facilitated O 0 0.04726959392428398
by O 0 0.008613304235041142
the O 0 0.008761756122112274
fact O 0 0.012258929200470448
that O 0 0.00812671147286892
the O 0 0.020429732277989388
Cys282Tyr O 1 0.987643837928772
mutation O 0 0.18985842168331146
creates O 0 0.0752752274274826
a O 0 0.033721357583999634
Rsal O 1 0.7194551229476929
restriction O 0 0.06336343288421631
site O 0 0.037381794303655624
. O 0 0.02544669434428215

We O 0 0.01794888637959957
have O 0 0.011315513402223587
studied O 0 0.02670837566256523
the O 0 0.02196425013244152
codon O 0 0.15831626951694489
282 O 0 0.1895778775215149
( O 0 0.09701500833034515
Cys O 1 0.9999769926071167
/ O 1 0.998330295085907
Tyr O 1 0.9982579350471497
) O 0 0.040481992065906525
polymorphism O 0 0.07248201221227646
in O 0 0.009009625762701035
different O 0 0.007580250967293978
ethnic O 0 0.016536567360162735
groups O 0 0.024536676704883575
. O 0 0.024636955931782722

In O 0 0.01689380221068859
agreement O 0 0.01603003591299057
with O 0 0.009086892008781433
previous O 0 0.01721566542983055
observations O 0 0.031342584639787674
the O 0 0.01833290606737137
Tyr O 1 0.9977418184280396
allele O 0 0.1541832834482193
appeared O 0 0.0269134771078825
to O 0 0.010293933562934399
be O 0 0.010498063638806343
rare O 0 0.03505802899599075
or O 0 0.019672157242894173
absent O 0 0.05511228367686272
in O 0 0.01569901406764984
Asiatic O 1 0.9986571073532104
( O 0 0.02630261704325676
Indian O 0 0.026172073557972908
, O 0 0.012063327245414257
Chinese O 0 0.01926490291953087
) O 0 0.028483033180236816
populations O 0 0.05643417686223984
. O 0 0.02724315971136093

The O 0 0.0315093919634819
highest O 0 0.062491364777088165
allele O 0 0.1698252558708191
frequency O 0 0.08178678900003433
( O 0 0.029940685257315636
7 O 0 0.022561613470315933
. O 0 0.01008133590221405
5 O 0 0.02083810232579708
% O 0 0.02225000597536564
) O 0 0.016376234591007233
was O 0 0.013989708386361599
found O 0 0.016302164644002914
in O 0 0.01331656239926815
Swedes O 0 0.09297119826078415
. O 0 0.03011653572320938

Saamis O 1 0.8635664582252502
( O 0 0.04836071655154228
2 O 0 0.03234471380710602
% O 0 0.024398181587457657
) O 0 0.018490711227059364
and O 0 0.015111795626580715
Mordvinians O 1 0.6370651125907898
( O 0 0.027750736102461815
1 O 0 0.01969822309911251
. O 0 0.009971852414309978
8 O 0 0.02227618172764778
% O 0 0.02061610296368599
) O 0 0.01702023297548294
had O 0 0.016281278803944588
significantly O 0 0.03709113970398903
lower O 0 0.031034408137202263
frequencies O 0 0.027904842048883438
of O 0 0.009212416596710682
the O 0 0.022657055407762527
Tyr O 1 0.9977061748504639
allele O 0 0.22847138345241547
. O 0 0.04177437722682953

Comparisons O 0 0.07194434106349945
with O 0 0.023708833381533623
allele O 0 0.13717880845069885
frequencies O 0 0.05012180283665657
based O 0 0.018516184762120247
on O 0 0.013773493468761444
prevalence O 1 0.9773554801940918
estimates O 0 0.03800725191831589
of O 0 0.01795615255832672
HH B-Disease 1 0.9999997615814209
showed O 0 0.036724671721458435
some O 0 0.011014848947525024
disagreements O 0 0.030520783737301826
with O 0 0.01139143668115139
the O 0 0.018236106261610985
RFLP O 1 0.768778920173645
data O 0 0.01895558089017868
, O 0 0.01022299937903881
particularly O 0 0.01760782115161419
in O 0 0.013653597794473171
Finns O 0 0.10325409471988678
. O 0 0.03167969733476639

The O 0 0.027842305600643158
newly O 0 0.05756552144885063
described O 0 0.07048848271369934
HFE O 1 0.9991182684898376
marker O 0 0.11090285331010818
provides O 0 0.03260718658566475
a O 0 0.01347288303077221
new O 0 0.011980048380792141
approach O 0 0.02312011830508709
to O 0 0.007210050243884325
the O 0 0.01189271081238985
screening O 0 0.07118648290634155
of O 0 0.01678844913840294
HH B-Disease 1 0.9999996423721313
as O 0 0.011819327250123024
well O 0 0.00855910312384367
as O 0 0.006144235841929913
studies O 0 0.012911304831504822
of O 0 0.00417103199288249
the O 0 0.00820138119161129
relationship O 0 0.024734102189540863
between O 0 0.013793911784887314
the O 0 0.021569497883319855
HFE O 1 0.9999793767929077
Tyr O 1 0.9996432065963745
allele O 0 0.18912367522716522
and O 0 0.018739202991127968
different O 0 0.023515015840530396
disorders O 1 0.9999996423721313
including O 0 0.038236938416957855
cancer B-Disease 1 0.9999998807907104

Autosomal B-Disease 1 0.9996034502983093
dominant I-Disease 1 0.9838876128196716
neurohypophyseal I-Disease 1 0.9999957084655762
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999994039535522
associated O 0 0.040984928607940674
with O 0 0.01602286286652088
a O 0 0.03074006550014019
missense O 0 0.20778627693653107
mutation O 0 0.19050316512584686
encoding O 0 0.10945229977369308
Gly23 O 1 0.9987591505050659
- O 1 0.9777337908744812
- O 0 0.4755827486515045
> O 0 0.2695290744304657
Val O 1 0.7686251401901245
in O 0 0.03591151908040047
neurophysin O 1 0.91752028465271
II O 0 0.4242040812969208
. O 0 0.03844543173909187

Autosomal B-Disease 1 0.9994704127311707
dominant I-Disease 1 0.9666604399681091
neurohypophyseal I-Disease 1 0.999994158744812
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
( O 0 0.08257342875003815
ADNDI B-Disease 1 0.9997579455375671
) O 0 0.023685811087489128
is O 0 0.014294350519776344
an O 0 0.026848193258047104
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9950531125068665
by O 0 0.019916139543056488
progressive O 1 0.998789370059967
degeneration O 1 0.9999974966049194
of O 0 0.012679213657975197
the O 0 0.02357742190361023
magnocellular O 1 0.9997053742408752
neurons O 0 0.11000842601060867
of O 0 0.009075134992599487
the O 0 0.0181185994297266
hypothalamus O 1 0.8125415444374084
leading O 0 0.02793121710419655
to O 0 0.011816799640655518
decreased O 0 0.04893934354186058
ability O 0 0.022573383525013924
to O 0 0.008492627181112766
produce O 0 0.017679359763860703
the O 0 0.021119680255651474
hormone O 1 0.9768245816230774
arginine O 1 0.6800111532211304
vasopressin O 1 0.9944666028022766
( O 0 0.06541234999895096
AVP O 1 0.9998366832733154
) O 0 0.0332571342587471
. O 0 0.024652758613228798

Affected O 0 0.08240139484405518
individuals O 0 0.02297169715166092
are O 0 0.00865634623914957
not O 0 0.015103843063116074
symptomatic O 1 0.9999711513519287
at O 0 0.023975975811481476
birth O 0 0.03592755272984505
, O 0 0.009224863722920418
but O 0 0.009933059103786945
usually O 0 0.024218278005719185
develop O 1 0.7914499640464783
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999990463256836
at O 0 0.043668054044246674
1 O 0 0.03668094426393509
- O 0 0.08930172771215439
6 O 0 0.05083347111940384
yr O 0 0.33552268147468567
of O 0 0.018121061846613884
age O 0 0.043941475450992584
. O 0 0.03225158900022507

The O 0 0.03064713068306446
genetic O 0 0.08305404335260391
locus O 0 0.1097620502114296
of O 0 0.012984562665224075
the O 0 0.021525226533412933
disease O 1 0.9999961853027344
is O 0 0.018268892541527748
the O 0 0.021818876266479492
AVP O 1 0.999996542930603
- O 1 0.5419741868972778
neurophysin O 1 0.9765783548355103
II O 1 0.9187639355659485
( O 0 0.0514693409204483
NPII O 1 0.9987061023712158
) O 0 0.03148256987333298
gene O 0 0.062333304435014725
, O 0 0.012107716873288155
and O 0 0.01208016648888588
mutations O 0 0.09161512553691864
that O 0 0.014818687923252583
cause O 1 0.5649698972702026
ADNDI B-Disease 1 0.9995467066764832
have O 0 0.011137626133859158
been O 0 0.009293214417994022
found O 0 0.009787802584469318
in O 0 0.005555410403758287
both O 0 0.007362500298768282
the O 0 0.011735886335372925
signal O 0 0.05262242630124092
peptide O 0 0.08270218968391418
of O 0 0.00945405475795269
the O 0 0.021716728806495667
prepro O 1 0.998685896396637
- O 1 0.9323246479034424
AVP O 1 0.9999566078186035
- O 0 0.2851688861846924
NPII O 1 0.9608038067817688
precursor O 0 0.10154324024915695
and O 0 0.015386088751256466
within O 0 0.023753365501761436
NPII O 1 0.9951707720756531
itself O 0 0.04455576837062836
. O 0 0.02740444801747799

An O 0 0.04047888144850731
affected O 0 0.07198421657085419
girl O 0 0.13562801480293274
who O 0 0.02148030325770378
presented O 0 0.022333072498440742
at O 0 0.019252032041549683
9 O 0 0.02096371538937092
months O 0 0.014820929616689682
of O 0 0.007220591884106398
age O 0 0.017812946811318398
and O 0 0.00872895959764719
her O 0 0.019795000553131104
similarly O 0 0.04290876165032387
affected O 0 0.05086570233106613
younger O 0 0.0414702333509922
brother O 0 0.031124597415328026
and O 0 0.008999868296086788
father O 0 0.01692194864153862
were O 0 0.006004181690514088
all O 0 0.004430209752172232
found O 0 0.010598462074995041
to O 0 0.006332308053970337
have O 0 0.007072331849485636
a O 0 0.017026757821440697
novel O 0 0.044169895350933075
missense O 0 0.2133205384016037
mutation O 0 0.18957851827144623
( O 0 0.06244812533259392
G1758 O 1 0.998593270778656
- O 1 0.9871596097946167
- O 1 0.7857426404953003
> O 1 0.6317201256752014
T O 1 0.7883623838424683
) O 0 0.025995096191763878
encoding O 0 0.03604517877101898
the O 0 0.01692921482026577
amino O 0 0.07862140238285065
acid O 0 0.15981607139110565
substitution O 0 0.1357073187828064
Gly23 O 1 0.999277651309967
- O 1 0.9662824273109436
- O 0 0.326063334941864
> O 0 0.2677147388458252
Val O 1 0.690175473690033
within O 0 0.04469010978937149
NPII O 1 0.9815675616264343
. O 0 0.04180324822664261

The O 0 0.04190204665064812
mutation O 0 0.1505926102399826
was O 0 0.029331188648939133
confirmed O 0 0.03934513032436371
by O 0 0.01884308084845543
restriction O 0 0.08207479864358902
endonuclease O 0 0.3838743567466736
analysis O 0 0.05615834891796112
. O 0 0.02906041592359543

A O 0 0.08909159153699875
T1 O 1 0.9996660947799683
- O 0 0.11674255132675171
weighted O 0 0.08606137335300446
magnetic O 0 0.09623994678258896
resonance O 0 0.12022586911916733
imaging O 0 0.11169231683015823
of O 0 0.012092224322259426
the O 0 0.02161123789846897
fathers O 0 0.11479169130325317
pituitary O 1 0.9999449253082275
gland O 1 0.9997687935829163
demonstrates O 0 0.09447737038135529
an O 0 0.032802384346723557
attenuated O 1 0.997735857963562
posterior O 1 0.9997301697731018
pituitary O 1 0.9999918937683105
bright O 1 0.6888976693153381
spot O 0 0.06572692096233368
. O 0 0.02532798983156681

This O 0 0.03257981315255165
mutation O 0 0.12935592234134674
may O 0 0.02071508578956127
be O 0 0.007126065902411938
valuable O 0 0.015624950639903545
for O 0 0.007976395078003407
developing O 0 0.03061714954674244
models O 0 0.030243104323744774
of O 0 0.015765298157930374
dominantly B-Disease 1 0.9842389822006226
inherited I-Disease 1 0.9998761415481567
neurodegeneration I-Disease 1 0.9999998807907104
, O 0 0.017240766435861588
as O 0 0.007909622974693775
the O 0 0.008005183190107346
early O 0 0.01736064814031124
age O 0 0.024520842358469963
of O 0 0.014948911033570766
onset O 1 0.999991774559021
of O 0 0.022423429414629936
symptoms O 1 1.0
suggests O 0 0.038899682462215424
that O 0 0.009085376746952534
this O 0 0.011095126159489155
mutation O 0 0.1195741593837738
may O 0 0.019283315166831017
be O 0 0.008710622787475586
particularly O 0 0.02238391526043415
deleterious O 0 0.11925715953111649
to O 0 0.013870456255972385
the O 0 0.02486397884786129
magnocellular O 1 0.9998921155929565
neuron O 1 0.9952113032341003
. O 0 0.02368704043328762
. O 0 0.027415169402956963

Frequent O 0 0.1583428978919983
inactivation O 1 0.7311047315597534
of O 0 0.03869147598743439
PTEN O 1 0.9999951124191284
/ O 1 0.9998229146003723
MMAC1 O 1 0.9983779191970825
in O 0 0.03088385984301567
primary O 1 0.9966855645179749
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0417805053293705

Sporadic B-Disease 1 0.9998300075531006
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.017500650137662888
the O 0 0.0092427097260952
most O 0 0.010850152000784874
common O 0 0.03062872774899006
male B-Disease 1 0.8097602725028992
cancer I-Disease 1 0.9999964237213135
in O 0 0.008936570025980473
the O 0 0.008561357855796814
Western O 0 0.022088492289185524
world O 0 0.017099929973483086
, O 0 0.008884329348802567
yet O 0 0.010288072749972343
many O 0 0.0043749152682721615
of O 0 0.0044925459660589695
the O 0 0.008986898697912693
major O 0 0.021855145692825317
genetic O 0 0.05219925940036774
events O 0 0.017863105982542038
involved O 0 0.01655021868646145
in O 0 0.007804515305906534
the O 0 0.013191214762628078
progression O 1 0.5977557301521301
of O 0 0.009631977416574955
this O 0 0.013276048004627228
often O 0 0.04464266076683998
fatal O 1 0.9999998807907104
cancer B-Disease 1 0.9999998807907104
remain O 0 0.017705852165818214
to O 0 0.009345650672912598
be O 0 0.012318422086536884
elucidated O 0 0.13079652190208435
. O 0 0.03222733363509178

Numerous O 0 0.060178276151418686
cytogenetic O 1 0.94288170337677
and O 0 0.02083384431898594
allelotype O 1 0.7475168108940125
studies O 0 0.029896169900894165
have O 0 0.010023786686360836
reported O 0 0.024286435917019844
frequent O 0 0.0429193414747715
loss O 0 0.04137266054749489
of O 0 0.013202454894781113
heterozygosity O 1 0.9736461639404297
on O 0 0.02550572156906128
chromosomal O 0 0.45164164900779724
arm O 1 0.9954437017440796
10q O 1 0.9692138433456421
in O 0 0.03014516457915306
sporadic B-Disease 1 0.9999330043792725
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04167474806308746

Deletion O 0 0.22708535194396973
mapping O 0 0.09407944977283478
studies O 0 0.0388941653072834
have O 0 0.01301619503647089
unambiguously O 0 0.06810832768678665
identified O 0 0.02552974224090576
a O 0 0.01771862991154194
region O 0 0.030307115986943245
of O 0 0.014076816849410534
chromosome O 0 0.13705752789974213
10q23 O 0 0.12273592501878738
to O 0 0.009706629440188408
be O 0 0.00738799013197422
the O 0 0.010069407522678375
minimal O 0 0.04039818421006203
area O 0 0.02075940929353237
of O 0 0.011135210283100605
loss O 0 0.07651909440755844
. O 0 0.02574460580945015

A O 0 0.056939952075481415
new O 0 0.049464672803878784
tumor B-Disease 1 0.999934196472168
suppressor O 1 0.9346504211425781
gene O 0 0.14829248189926147
, O 0 0.04374035820364952
PTEN O 1 0.9999969005584717
/ O 1 0.9998308420181274
MMAC1 O 1 0.9983875751495361
, O 0 0.01675141602754593
was O 0 0.019325127825140953
isolated O 0 0.055197544395923615
recently O 0 0.02792755886912346
at O 0 0.01434018462896347
this O 0 0.008110257796943188
region O 0 0.028680698946118355
of O 0 0.015404058620333672
chromosome O 0 0.15222808718681335
10q23 O 0 0.13395516574382782
and O 0 0.011174541898071766
found O 0 0.012533177621662617
to O 0 0.008561587892472744
be O 0 0.011213070712983608
inactivated O 0 0.09043236076831818
by O 0 0.018241142854094505
mutation O 0 0.10004935413599014
in O 0 0.01728259213268757
three O 0 0.04154518246650696
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.6399102807044983
lines O 0 0.039030078798532486
. O 0 0.02424752525985241

We O 0 0.040492646396160126
screened O 0 0.13262517750263214
80 O 0 0.3256968557834625
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999972581863403
by O 0 0.03048822470009327
microsatellite O 0 0.25286149978637695
analysis O 0 0.038134049624204636
and O 0 0.01442298199981451
found O 0 0.026267241686582565
chromosome O 0 0.1311407834291458
10q23 O 0 0.11282671242952347
to O 0 0.011684372089803219
be O 0 0.009502761997282505
deleted O 0 0.03568997234106064
in O 0 0.013025442138314247
23 O 0 0.02858400158584118
cases O 0 0.035111814737319946
. O 0 0.02818119339644909

We O 0 0.019557982683181763
then O 0 0.015934525057673454
proceeded O 0 0.02873958833515644
with O 0 0.00908632855862379
sequence O 0 0.02268303744494915
analysis O 0 0.014612813480198383
of O 0 0.005837488919496536
the O 0 0.01481164526194334
entire O 0 0.06969554722309113
PTEN O 1 0.9999910593032837
/ O 1 0.9988387227058411
MMAC1 O 1 0.9930439591407776
coding O 0 0.1315566748380661
region O 0 0.040468763560056686
and O 0 0.013703102245926857
tested O 0 0.05962038040161133
for O 0 0.014288540929555893
homozygous O 0 0.12454041093587875
deletion O 0 0.1195172443985939
with O 0 0.017260368913412094
new O 0 0.02530057728290558
intragenic O 1 0.8692191243171692
markers O 0 0.05827542766928673
in O 0 0.008939932100474834
these O 0 0.006534034851938486
23 O 0 0.02179279737174511
cases O 0 0.020828943699598312
with O 0 0.017478691413998604
10q23 O 1 0.8330926895141602
loss O 0 0.06685006618499756
of O 0 0.020469261333346367
heterozygosity O 1 0.9984949827194214
. O 0 0.04282720014452934

The O 0 0.019550597295165062
identification O 0 0.026413794606924057
of O 0 0.007516518700867891
the O 0 0.011824219487607479
second O 0 0.029889168217778206
mutational O 1 0.8900699019432068
event O 0 0.04332812875509262
in O 0 0.01292103249579668
10 O 0 0.019061926752328873
( O 0 0.02398420311510563
43 O 0 0.040555600076913834
% O 0 0.03777517378330231
) O 0 0.0518224872648716
tumors B-Disease 1 0.9999984502792358
establishes O 1 0.9962128400802612
PTEN O 1 0.9999969005584717
/ O 1 0.9995052814483643
MMAC1 O 1 0.9441490769386292
as O 0 0.012562427669763565
a O 0 0.015544815920293331
main O 0 0.02507270686328411
inactivation O 0 0.12138281762599945
target O 0 0.030064160004258156
of O 0 0.012663554400205612
10q O 1 0.9710301160812378
loss O 0 0.29048919677734375
in O 0 0.025145143270492554
sporadic B-Disease 1 0.9999912977218628
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.02306022122502327
. O 0 0.02081577107310295

Risk O 1 0.918739914894104
reversals O 0 0.13557857275009155
in O 0 0.021449102088809013
predictive O 0 0.13141129910945892
testing O 0 0.08036729693412781
for O 0 0.0334189310669899
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.041758738458156586

The O 0 0.021123910322785378
first O 0 0.023618819192051888
predictive O 0 0.11937358230352402
testing O 0 0.0643400177359581
for O 0 0.02792867086827755
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.05019046738743782
HD B-Disease 1 0.5156574845314026
) O 0 0.019024968147277832
was O 0 0.010645181871950626
based O 0 0.010756152682006359
on O 0 0.006792270112782717
analysis O 0 0.015026874840259552
of O 0 0.010850510559976101
linked O 0 0.0824316143989563
polymorphic O 0 0.21176788210868835
DNA O 0 0.08498509973287582
markers O 0 0.06394694000482559
to O 0 0.011205545626580715
estimate O 0 0.023848887532949448
the O 0 0.011332923546433449
likelihood O 0 0.04530233517289162
of O 0 0.009880349971354008
inheriting O 0 0.09749381244182587
the O 0 0.02116798609495163
mutation O 0 0.1252773255109787
for O 0 0.01975240372121334
HD B-Disease 0 0.28391894698143005
. O 0 0.03949733451008797

Limits O 0 0.04756598174571991
to O 0 0.01265336386859417
accuracy O 0 0.030461765825748444
included O 0 0.01636216975748539
recombination O 0 0.0957048311829567
between O 0 0.012653499841690063
the O 0 0.012445040978491306
DNA O 0 0.060053322464227676
markers O 0 0.05474499985575676
and O 0 0.01195479929447174
the O 0 0.018690375611186028
mutation O 0 0.11828567832708359
, O 0 0.019683685153722763
pedigree O 0 0.09179048240184784
structure O 0 0.024124717339873314
, O 0 0.010121434926986694
and O 0 0.007652428932487965
whether O 0 0.016537249088287354
DNA O 0 0.04786433279514313
samples O 0 0.028818463906645775
were O 0 0.006952256895601749
available O 0 0.010232226923108101
from O 0 0.01062239520251751
family O 0 0.021731944754719734
members O 0 0.018174024298787117
. O 0 0.022647440433502197

With O 0 0.022806068882346153
direct O 0 0.02943909354507923
tests O 0 0.03294909745454788
for O 0 0.009603454731404781
the O 0 0.020028455182909966
HD B-Disease 1 0.7268962264060974
mutation O 0 0.12054000794887543
, O 0 0.014180615544319153
we O 0 0.008606861345469952
have O 0 0.0071873911656439304
assessed O 0 0.031774308532476425
the O 0 0.009324225597083569
accuracy O 0 0.021001365035772324
of O 0 0.006290254183113575
results O 0 0.017806660383939743
obtained O 0 0.014925000257790089
by O 0 0.012239371426403522
linkage O 0 0.11344145238399506
approaches O 0 0.05013809725642204
when O 0 0.015397636219859123
requested O 0 0.02217681147158146
to O 0 0.0078376904129982
do O 0 0.008614114485681057
so O 0 0.006525997072458267
by O 0 0.006429430563002825
the O 0 0.011299222707748413
test O 0 0.03509511426091194
individuals O 0 0.02469918690621853
. O 0 0.024689212441444397

For O 0 0.015711715444922447
six O 0 0.015162665396928787
such O 0 0.009252176620066166
individuals O 0 0.01626860722899437
, O 0 0.009635048918426037
there O 0 0.008342482149600983
was O 0 0.01321022305637598
significant O 0 0.017806624993681908
disparity O 0 0.05875139310956001
between O 0 0.011194144375622272
the O 0 0.01334958802908659
tests O 0 0.052195608615875244
. O 0 0.02679561823606491

Three O 0 0.019683782011270523
went O 0 0.026448359712958336
from O 0 0.012791156768798828
a O 0 0.02012801729142666
decreased O 0 0.10962183028459549
risk O 0 0.12641210854053497
to O 0 0.0085783451795578
an O 0 0.011181704699993134
increased O 0 0.030134575441479683
risk O 0 0.47888579964637756
, O 0 0.008281096816062927
while O 0 0.007703293580561876
in O 0 0.006537217181175947
another O 0 0.009518974460661411
three O 0 0.007457653526216745
the O 0 0.013219262473285198
risk O 1 0.5569952726364136
was O 0 0.023854771628975868
decreased O 0 0.07989868521690369
. O 0 0.02708558179438114

Knowledge O 0 0.0311872661113739
of O 0 0.008514856919646263
the O 0 0.010613564401865005
potential O 0 0.026377398520708084
reasons O 0 0.014932025223970413
for O 0 0.005610057618469
these O 0 0.00489367451518774
changes O 0 0.011062437668442726
in O 0 0.008486233651638031
results O 0 0.018019692972302437
and O 0 0.008340442553162575
impact O 0 0.023266442120075226
of O 0 0.007368238642811775
these O 0 0.010603159666061401
risk O 1 0.8638249039649963
reversals O 0 0.08620880544185638
on O 0 0.010899421758949757
both O 0 0.013059895485639572
patients O 1 0.9998769760131836
and O 0 0.00909957941621542
the O 0 0.013168157078325748
counseling O 1 0.9874512553215027
team O 0 0.025681449100375175
can O 0 0.01203075796365738
assist O 0 0.023557191714644432
in O 0 0.006905130110681057
the O 0 0.006576000712811947
development O 0 0.013011600822210312
of O 0 0.006310716271400452
strategies O 0 0.04073115438222885
for O 0 0.00776625843718648
the O 0 0.012845443561673164
prevention O 1 0.9997037053108215
and O 0 0.008339251391589642
, O 0 0.008220634423196316
where O 0 0.008932085707783699
necessary O 0 0.013395017012953758
, O 0 0.008803167380392551
management O 0 0.026617050170898438
of O 0 0.008104168809950352
a O 0 0.022876692935824394
risk O 1 0.8785243034362793
reversal O 0 0.07086580991744995
in O 0 0.01220267079770565
any O 0 0.01407962292432785
predictive O 0 0.10828050225973129
testing O 0 0.06259752810001373
program O 0 0.03692242503166199
. O 0 0.014804967679083347
. O 0 0.023370753973722458

A O 0 0.05395350605249405
novel O 0 0.05682217702269554
common O 0 0.055229708552360535
missense O 0 0.22932635247707367
mutation O 0 0.17880158126354218
G301C O 0 0.1325908750295639
in O 0 0.013828353956341743
the O 0 0.017272140830755234
N O 0 0.1533057987689972
- O 0 0.1887853890657425
acetylgalactosamine O 1 0.982492208480835
- O 0 0.1748180240392685
6 O 0 0.0794060155749321
- O 1 0.6867935061454773
sulfate O 1 0.9988704323768616
sulfatase O 1 0.9994348883628845
gene O 0 0.13167434930801392
in O 0 0.03657868504524231
mucopolysaccharidosis B-Disease 1 0.9974787831306458
IVA I-Disease 1 0.9998372793197632
. O 0 0.04323713481426239

Mucopolysaccharidosis B-Disease 1 0.9988597631454468
IVA I-Disease 1 0.9999032020568848
( O 0 0.083144910633564
MPS B-Disease 1 0.9977643489837646
IVA I-Disease 1 0.9999967813491821
) O 0 0.030772270634770393
is O 0 0.016316616907715797
an O 0 0.023987948894500732
autosomal B-Disease 1 0.9999659061431885
recessive I-Disease 1 0.9999964237213135
lysosomal I-Disease 1 0.9999997615814209
storage I-Disease 1 0.9999485015869141
disorder I-Disease 1 1.0
caused O 1 0.5844459533691406
by O 0 0.014104844070971012
a O 0 0.026484407484531403
genetic B-Disease 1 0.9137369990348816
defect I-Disease 1 0.9998860359191895
in O 0 0.02489868551492691
N O 0 0.3810965418815613
- O 0 0.41687673330307007
acetylgalactosamine O 1 0.9941840767860413
- O 0 0.34436941146850586
6 O 0 0.08210684359073639
- O 1 0.967752993106842
sulfate O 1 0.9998828172683716
sulfatase O 1 0.9999589920043945
( O 0 0.0766548216342926
GALNS O 1 0.9958562254905701
) O 0 0.03913251310586929
. O 0 0.026646742597222328

In O 0 0.019016319885849953
previous O 0 0.02013140171766281
studies O 0 0.023449348285794258
, O 0 0.00885058008134365
we O 0 0.006791212130337954
have O 0 0.005795268341898918
found O 0 0.010483643040060997
two O 0 0.008476749993860722
common O 0 0.030475573614239693
mutations O 0 0.08634722232818604
in O 0 0.01638992875814438
Caucasians O 1 0.5999937653541565
and O 0 0.011411025188863277
Japanese O 0 0.025014109909534454
, O 0 0.011897103860974312
respectively O 0 0.024025192484259605
. O 0 0.02195553295314312

To O 0 0.03108854405581951
characterize O 0 0.09863705188035965
the O 0 0.028671685606241226
mutational O 1 0.9423871040344238
spectrum O 0 0.057348597794771194
in O 0 0.00863419659435749
various O 0 0.006423959042876959
ethnic O 0 0.01555038895457983
groups O 0 0.01993512362241745
, O 0 0.014591692946851254
mutations O 0 0.0715457946062088
in O 0 0.012419391423463821
the O 0 0.017138369381427765
GALNS O 1 0.9954562187194824
gene O 0 0.07972490787506104
in O 0 0.020831335335969925
Colombian O 0 0.18525303900241852
MPS B-Disease 1 0.9998983144760132
IVA I-Disease 1 1.0
patients O 1 0.9999881982803345
were O 0 0.013908556662499905
investigated O 0 0.04265623167157173
, O 0 0.009813856333494186
and O 0 0.011209813877940178
genetic O 0 0.058851245790719986
backgrounds O 0 0.04001154378056526
were O 0 0.01080250833183527
extensively O 0 0.030251018702983856
analyzed O 0 0.03284934535622597
to O 0 0.011275914497673512
identify O 0 0.027781333774328232
racial O 0 0.03664981573820114
origin O 0 0.01991768553853035
, O 0 0.010663763619959354
based O 0 0.015395302325487137
on O 0 0.013531416654586792
mitochondrial O 0 0.0965222492814064
DNA O 0 0.08230491727590561
( O 0 0.042137324810028076
mtDNA O 0 0.14137549698352814
) O 0 0.032454825937747955
lineages O 0 0.09446794539690018
. O 0 0.03141413629055023

Three O 0 0.03792080655694008
novel O 0 0.06651224195957184
missense O 0 0.24529927968978882
mutations O 0 0.13666552305221558
never O 0 0.030645547434687614
identified O 0 0.021654242649674416
previously O 0 0.015159987844526768
in O 0 0.007996054366230965
other O 0 0.006425581872463226
populations O 0 0.027042340487241745
and O 0 0.00782967172563076
found O 0 0.011661569587886333
in O 0 0.007913945242762566
16 O 0 0.01301455870270729
out O 0 0.009184177964925766
of O 0 0.009908845648169518
19 O 0 0.034687746316194534
Colombian O 0 0.10285037010908127
MPS B-Disease 1 0.9827327728271484
IVA I-Disease 1 0.9999885559082031
unrelated O 0 0.09857580065727234
alleles O 0 0.13997766375541687
account O 0 0.023764153942465782
for O 0 0.014870801009237766
84 O 0 0.08187432587146759
. O 0 0.02979881316423416

2 O 0 0.03767737001180649
% O 0 0.018613552674651146
of O 0 0.007001304998993874
the O 0 0.012298225425183773
alleles O 0 0.1045476496219635
in O 0 0.013071425259113312
this O 0 0.011743924580514431
study O 0 0.0306625347584486
. O 0 0.026568949222564697

The O 0 0.04207286983728409
G301C O 0 0.175431028008461
and O 0 0.025839300826191902
S162F O 0 0.20267798006534576
mutations O 0 0.10996741056442261
account O 0 0.022248031571507454
for O 0 0.01315051969140768
68 O 0 0.06503836810588837
. O 0 0.025131775066256523

4 O 0 0.041211314499378204
% O 0 0.02292872779071331
and O 0 0.011489557102322578
10 O 0 0.020840246230363846
. O 0 0.02324162796139717

5 O 0 0.04307086765766144
% O 0 0.02557900734245777
of O 0 0.014610176905989647
mutations O 0 0.08466790616512299
, O 0 0.012447770684957504
respectively O 0 0.020729949697852135
, O 0 0.010038441978394985
whereas O 0 0.01979818381369114
the O 0 0.009498011320829391
remaining O 0 0.023564226925373077
F69V O 1 0.9407685399055481
is O 0 0.013774348422884941
limited O 0 0.017118459567427635
to O 0 0.007507307920604944
a O 0 0.016153773292899132
single O 0 0.03515373915433884
allele O 0 0.16650237143039703
. O 0 0.03652646765112877

The O 0 0.037614259868860245
skewed O 0 0.13313661515712738
prevalence O 1 0.7135540843009949
of O 0 0.015380441211163998
G301C O 0 0.12368691712617874
in O 0 0.011825990863144398
only O 0 0.012302576564252377
Colombian O 0 0.11275701969861984
patients O 1 0.9999334812164307
and O 0 0.020183606073260307
haplotype O 1 0.9766709208488464
analysis O 0 0.031121665611863136
by O 0 0.015022139064967632
restriction O 0 0.05674414709210396
fragment O 0 0.08495844900608063
length O 0 0.03932073712348938
polymorphisms O 0 0.10155268013477325
in O 0 0.014596438966691494
the O 0 0.0223971176892519
GALNS O 1 0.9976155757904053
gene O 0 0.09719524532556534
suggest O 0 0.033399660140275955
that O 0 0.014348313212394714
G301C O 0 0.13645417988300323
originated O 0 0.04279378801584244
from O 0 0.011654060333967209
a O 0 0.016966959461569786
common O 0 0.027616553008556366
ancestor O 0 0.07550106942653656
. O 0 0.03149819001555443

Investigation O 0 0.04868392273783684
of O 0 0.010167057625949383
the O 0 0.01533610001206398
genetic O 0 0.06270141154527664
background O 0 0.03307438641786575
by O 0 0.01059879269450903
means O 0 0.0199468694627285
of O 0 0.012724469415843487
mtDNA O 0 0.13831152021884918
lineages O 0 0.09521562606096268
indicate O 0 0.03072948381304741
that O 0 0.006718685384839773
all O 0 0.006082535721361637
our O 0 0.01430957019329071
patients O 1 0.999570906162262
are O 0 0.0069763073697686195
probably O 0 0.01750650443136692
of O 0 0.007113724946975708
native O 0 0.021046362817287445
American O 0 0.03824852406978607
descent O 0 0.1255800426006317

Low O 0 0.11449985951185226
frequency O 0 0.07545759528875351
of O 0 0.025972876697778702
BRCA1 O 1 0.9972103238105774
germline O 1 0.8241158723831177
mutations O 0 0.12429308146238327
in O 0 0.01895865797996521
45 O 0 0.05090180039405823
German O 1 0.9999542236328125
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.05410550534725189
. O 0 0.029925230890512466

In O 0 0.018081989139318466
this O 0 0.008907056413590908
study O 0 0.022287609055638313
we O 0 0.011134885251522064
investigated O 0 0.04486694186925888
45 O 0 0.040947407484054565
German O 1 0.9996427297592163
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.040849748998880386
for O 0 0.020688261836767197
germline O 1 0.8698464035987854
mutations O 0 0.09810442477464676
in O 0 0.015388141386210918
the O 0 0.026989294216036797
BRCA1 O 1 0.9985612034797668
gene O 0 0.14208197593688965
. O 0 0.03630995750427246

We O 0 0.026923630386590958
identified O 0 0.03449258208274841
four O 0 0.025354905053973198
germline O 0 0.47229743003845215
mutations O 0 0.10562307387590408
in O 0 0.018045775592327118
three O 0 0.026488453149795532
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.022363493219017982
and O 0 0.007470950484275818
in O 0 0.010718696750700474
one O 0 0.20710614323616028
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0392942912876606
. O 0 0.00893720705062151
among O 0 0.008742710575461388
these O 0 0.005453918129205704
were O 0 0.00823751650750637
one O 0 0.022615347057580948
frameshift O 1 0.9583832621574402
mutation O 0 0.14767208695411682
, O 0 0.01908339373767376
one O 0 0.019782470539212227
nonsense O 0 0.08793168514966965
mutation O 0 0.12482373416423798
, O 0 0.01643829047679901
one O 0 0.01608065515756607
novel O 0 0.04562005028128624
splice O 0 0.18250985443592072
site O 0 0.045926373451948166
mutation O 0 0.1158611997961998
, O 0 0.013581784442067146
and O 0 0.010309399105608463
one O 0 0.02600904181599617
missense O 0 0.21658992767333984
mutation O 0 0.19288519024848938
. O 0 0.04126760736107826

The O 0 0.05427210405468941
missense O 0 0.2505802810192108
mutation O 0 0.1542246788740158
was O 0 0.021710915490984917
also O 0 0.010886711068451405
found O 0 0.014462132938206196
in O 0 0.011485626921057701
2 O 0 0.02549952268600464
. O 0 0.023499421775341034

8 O 0 0.0379045195877552
% O 0 0.01633841171860695
of O 0 0.0055990987457334995
the O 0 0.00862068124115467
general O 0 0.012855103239417076
population O 0 0.016749421134591103
, O 0 0.009416075423359871
suggesting O 0 0.0262458436191082
that O 0 0.006404179148375988
it O 0 0.007091461215168238
is O 0 0.010949568822979927
not O 0 0.014356125146150589
disease O 1 0.9999996423721313
associated O 0 0.033417489379644394
. O 0 0.025300990790128708

The O 0 0.02396368980407715
average O 0 0.04216848686337471
age O 0 0.03611563518643379
of O 0 0.021807707846164703
disease O 1 1.0
onset O 1 0.999994158744812
in O 0 0.01337326131761074
those O 0 0.012377039529383183
families O 0 0.04371347650885582
harbouring O 1 0.9998300075531006
causative O 1 0.9958100318908691
mutations O 0 0.13672780990600586
was O 0 0.02409161813557148
between O 0 0.018894482403993607
32 O 0 0.04080407693982124
. O 0 0.023932304233312607

3 O 0 0.04103092849254608
and O 0 0.016377480700612068
37 O 0 0.04513288661837578
. O 0 0.02675488032400608

4 O 0 0.04012100398540497
years O 0 0.01763763837516308
, O 0 0.011975731700658798
whereas O 0 0.02715671807527542
the O 0 0.01293368823826313
family O 0 0.03923819959163666
harbouring O 1 0.9565896391868591
the O 0 0.02969304472208023
missense O 0 0.20313088595867157
mutation O 0 0.13078449666500092
had O 0 0.019466539844870567
an O 0 0.014907456003129482
average O 0 0.03365270048379898
age O 0 0.026914924383163452
of O 0 0.0143194068223238
onset O 1 0.999225378036499
of O 0 0.016355464234948158
51 O 0 0.05984295532107353
. O 0 0.026091279461979866

2 O 0 0.04664187878370285
years O 0 0.029226504266262054
. O 0 0.02695871889591217

These O 0 0.016168344765901566
findings O 0 0.03735131770372391
show O 0 0.026230648159980774
that O 0 0.016465596854686737
BRCA1 O 1 0.9781661629676819
is O 0 0.02074427157640457
implicated O 0 0.06529298424720764
in O 0 0.0092229675501585
a O 0 0.01298745907843113
small O 0 0.016229063272476196
fraction O 0 0.03946482017636299
of O 0 0.030492732301354408
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03778485953807831
suggesting O 0 0.03459726646542549
the O 0 0.011567904613912106
involvement O 0 0.037537865340709686
of O 0 0.01075062807649374
another O 0 0.03508186712861061
susceptibility O 1 0.9417711496353149
gene O 0 0.1163812205195427
( O 0 0.05258597061038017
s O 1 0.5871718525886536
) O 0 0.05049709230661392

Paternal O 0 0.43488752841949463
transmission O 1 0.796118974685669
of O 0 0.05784085765480995
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.06883782148361206

We O 0 0.01781236194074154
report O 0 0.01471816934645176
a O 0 0.014453312382102013
rare O 0 0.028045646846294403
case O 0 0.02049778215587139
of O 0 0.01675034873187542
paternally O 1 0.99951171875
transmitted O 1 0.9999691247940063
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9995303153991699
DM B-Disease 1 1.0
) O 0 0.045549701899290085
. O 0 0.029126306995749474

The O 0 0.03111710585653782
proband O 0 0.15238802134990692
is O 0 0.01402595080435276
a O 0 0.016491089016199112
23 O 0 0.02164163812994957
year O 0 0.016774335876107216
old O 0 0.03267107531428337
, O 0 0.026675330474972725
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999929666519165
male O 1 0.7070398330688477
who O 1 0.922645628452301
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999978542327881
. O 0 0.03528387472033501

He O 0 0.024991294369101524
presented O 0 0.027422882616519928
with O 0 0.02475285716354847
respiratory O 1 1.0
and O 0 0.016688795760273933
feeding O 0 0.08860435336828232
difficulties O 0 0.07862261682748795
at O 0 0.023971740156412125
birth O 0 0.05373721942305565
. O 0 0.026510555297136307

His O 0 0.03271033614873886
two O 0 0.028692129999399185
sibs O 1 0.99997878074646
suffer O 1 0.9999063014984131
from O 0 0.03702474385499954
childhood O 1 0.9999864101409912
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.053657736629247665

Their O 0 0.019642606377601624
late O 0 0.02711951732635498
father O 0 0.02187865413725376
had O 0 0.012536087073385715
the O 0 0.011408491991460323
adult O 0 0.04248373210430145
type O 0 0.05803262069821358
of O 0 0.024110611528158188
DM B-Disease 1 1.0
, O 0 0.019585268571972847
with O 0 0.0200869869440794
onset O 1 0.9992737174034119
around O 0 0.023429913446307182
30 O 0 0.02094174176454544
years O 0 0.01886197179555893
. O 0 0.02435895800590515

Only O 0 0.01604473777115345
six O 0 0.015426305122673512
other O 0 0.006442337296903133
cases O 0 0.020276937633752823
of O 0 0.011212082579731941
paternal O 0 0.24329428374767303
transmission O 1 0.8696442246437073
of O 0 0.03384257107973099
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.017909297719597816
been O 0 0.01587034948170185
reported O 0 0.031282972544431686
recently O 0 0.03631678968667984
. O 0 0.021984295919537544

We O 0 0.017914826050400734
review O 0 0.022592201828956604
the O 0 0.011701824143528938
sex O 0 0.039152685552835464
related O 0 0.030523043125867844
effects O 0 0.06033899635076523
on O 0 0.013024087063968182
transmission O 0 0.3592987060546875
of O 0 0.03325639292597771
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.04708842188119888

Decreased O 0 0.40965646505355835
fertility O 1 0.5150300860404968
of O 0 0.01431895513087511
males O 0 0.051331065595149994
with O 0 0.02082698792219162
adult O 1 0.6215695142745972
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
and O 0 0.02017109841108322
contraction O 0 0.07988134771585464
of O 0 0.008358781225979328
the O 0 0.012660603038966656
repeat O 0 0.0719420462846756
upon O 0 0.023495502769947052
male O 0 0.06283501535654068
transmission O 0 0.09038388729095459
contribute O 0 0.03485569730401039
to O 0 0.007881208322942257
the O 0 0.00883390847593546
almost O 0 0.0197290126234293
absent O 0 0.06509416550397873
occurrence O 0 0.06843537092208862
of O 0 0.015622823499143124
paternal O 0 0.21513515710830688
transmission O 1 0.8923560380935669
of O 0 0.04063485935330391
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.05828312784433365

Also O 0 0.01761201024055481
the O 0 0.011934877373278141
fathers O 0 0.03643680363893509
of O 0 0.008645575493574142
the O 0 0.014093092642724514
reported O 0 0.06334768980741501
congenitally O 1 0.999836802482605
affected O 0 0.07013653218746185
children O 0 0.029099982231855392
showed O 0 0.024647098034620285
, O 0 0.008140325546264648
on O 0 0.00862666592001915
average O 0 0.03102901764214039
, O 0 0.016679299995303154
shorter O 0 0.08452755957841873
CTG O 1 0.9957600235939026
repeat O 0 0.09393566101789474
lengths O 0 0.056907057762145996
and O 0 0.013387677259743214
hence O 0 0.03748558461666107
less O 0 0.03252921253442764
severe O 1 0.9999996423721313
clinical O 1 0.9999991655349731
symptoms O 1 0.9999998807907104
than O 0 0.010824792087078094
the O 0 0.011329424567520618
mothers O 0 0.07789138704538345
of O 0 0.009826069697737694
children O 0 0.04392687976360321
with O 0 0.04699447378516197
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.05094694346189499

We O 0 0.02449953183531761
conclude O 0 0.05658450722694397
that O 0 0.014439101330935955
paternal O 0 0.11403140425682068
transmission O 1 0.6595526337623596
of O 0 0.039741724729537964
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.02661712095141411
rare O 0 0.03669719025492668
and O 0 0.01467407587915659
preferentially O 0 0.1228664293885231
occurs O 0 0.060558777302503586
with O 0 0.022633671760559082
onset O 1 0.9998574256896973
of O 0 0.03158828243613243
DM B-Disease 1 1.0
past O 0 0.02842615358531475
30 O 0 0.01786838471889496
years O 0 0.010476774536073208
in O 0 0.007055575493723154
the O 0 0.009418428875505924
father O 0 0.02716546319425106
. O 0 0.014727970585227013
. O 0 0.026503074914216995

The O 0 0.06898602843284607
RB1 O 1 0.9999035596847534
gene O 0 0.1479826420545578
mutation O 0 0.12258734554052353
in O 0 0.013411101885139942
a O 0 0.01831650175154209
child O 0 0.05048798397183418
with O 0 0.03283242881298065
ectopic B-Disease 1 0.9999959468841553
intracranial I-Disease 1 0.9999997615814209
retinoblastoma I-Disease 1 0.9999898672103882
. O 0 0.044293198734521866

The O 0 0.06409852206707001
RB1 O 1 0.9999290704727173
gene O 0 0.14764432609081268
mutation O 0 0.13349772989749908
was O 0 0.020236626267433167
investigated O 0 0.03431321680545807
in O 0 0.009183813817799091
a O 0 0.016319401562213898
child O 0 0.044278811663389206
with O 0 0.02989453263580799
ectopic B-Disease 1 0.9999411106109619
intracranial I-Disease 1 0.999994158744812
retinoblastoma I-Disease 1 0.9995040893554688
using O 0 0.031094320118427277
DNA O 0 0.05117390677332878
obtained O 0 0.01643565110862255
from O 0 0.009182971902191639
both O 0 0.00898890383541584
the O 0 0.018522270023822784
pineal B-Disease 1 0.999994158744812
and I-Disease 0 0.03278402239084244
retinal I-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999979734420776
of O 0 0.0165543332695961
the O 0 0.023256072774529457
patient O 1 0.9999269247055054
. O 0 0.027380911633372307

A O 0 0.08104729652404785
nonsense O 0 0.1303432136774063
mutation O 0 0.14726245403289795
in O 0 0.022252002730965614
exon O 0 0.1581500768661499
17 O 0 0.05723198130726814
( O 0 0.0498044490814209
codon O 0 0.1490669697523117
556 O 0 0.1551409214735031
) O 0 0.024046434089541435
of O 0 0.010841834358870983
the O 0 0.027533704414963722
RB1 O 1 0.9999752044677734
gene O 0 0.08885830640792847
was O 0 0.01869278959929943
found O 0 0.011765782721340656
to O 0 0.006471630651503801
be O 0 0.007382879499346018
present O 0 0.016509702429175377
homozygously O 0 0.10032571852207184
in O 0 0.009306310676038265
both O 0 0.009549425914883614
the O 0 0.017925342544913292
retinal B-Disease 1 0.9999853372573853
and I-Disease 0 0.014068552292883396
the I-Disease 0 0.02831188216805458
pineal I-Disease 1 0.9999994039535522
tumours I-Disease 1 0.9999990463256836
. O 0 0.04402647539973259

The O 0 0.02644052542746067
same O 0 0.026948992162942886
mutation O 0 0.1217423677444458
was O 0 0.021455898880958557
present O 0 0.021455878391861916
heterozygously O 0 0.15828028321266174
in O 0 0.010708887130022049
the O 0 0.010397632606327534
DNA O 0 0.035781603306531906
from O 0 0.010162756778299809
the O 0 0.008752522058784962
constitutional O 0 0.017485521733760834
cells O 0 0.04457846283912659
of O 0 0.008320164866745472
the O 0 0.015794727951288223
patient O 1 0.9998451471328735
, O 0 0.013712023384869099
proving O 0 0.03435102477669716
it O 0 0.005011245142668486
to O 0 0.005586054176092148
be O 0 0.006734742783010006
of O 0 0.011029298417270184
germline O 0 0.19054661691188812
origin O 0 0.03279690444469452
. O 0 0.027922924607992172

The O 0 0.029732720926404
initial O 0 0.06878889352083206
mutation O 0 0.12242180109024048
was O 0 0.01835937798023224
shown O 0 0.017204219475388527
to O 0 0.0058952863328158855
have O 0 0.006717962678521872
occurred O 0 0.020251529291272163
in O 0 0.00790875032544136
the O 0 0.017449988052248955
paternally O 0 0.21113227307796478
derived O 0 0.10006915032863617
RB1 O 1 0.9998212456703186
allele O 0 0.2511768937110901
. O 0 0.044056326150894165

The O 0 0.03723150119185448
mutation O 0 0.116395965218544
is O 0 0.012338221073150635
in O 0 0.006865061819553375
an O 0 0.008548468351364136
area O 0 0.015223067253828049
of O 0 0.005274759605526924
the O 0 0.010997689329087734
gene O 0 0.05327128991484642
that O 0 0.009444191120564938
encodes O 0 0.05440749600529671
the O 0 0.018194327130913734
protein O 0 0.07127904891967773
- O 0 0.06650850176811218
binding O 0 0.04737665131688118
region O 0 0.03422361612319946
known O 0 0.019133251160383224
as O 0 0.00816616415977478
the O 0 0.012131702154874802
pocket O 0 0.09573157876729965
region O 0 0.025104744359850883
and O 0 0.008291597478091717
has O 0 0.009904393926262856
been O 0 0.011128933168947697
detected O 0 0.043345823884010315
in O 0 0.006573528051376343
other O 0 0.006035661790519953
cases O 0 0.018777750432491302
of O 0 0.013154290616512299
retinoblastoma B-Disease 1 0.9999886751174927
. O 0 0.01875278539955616
. O 0 0.02476983144879341

Low O 0 0.08974272012710571
levels O 0 0.04550420865416527
of O 0 0.015147450380027294
beta O 0 0.08870863169431686
hexosaminidase O 0 0.22658774256706238
A O 0 0.0281086303293705
in O 0 0.015048635192215443
healthy O 0 0.11738738417625427
individuals O 0 0.01874535158276558
with O 0 0.016597354784607887
apparent O 1 0.9984242916107178
deficiency O 1 1.0
of O 0 0.015429274179041386
this O 0 0.018558762967586517
enzyme O 0 0.10920027643442154
. O 0 0.031155791133642197

Appreciable O 0 0.24136851727962494
beta O 0 0.1401657611131668
hexosaminidase O 0 0.20331117510795593
A O 0 0.04406527429819107
( O 0 0.0337139256298542
hex O 0 0.08813126385211945
A O 0 0.033236656337976456
) O 0 0.020515797659754753
activity O 0 0.025839803740382195
has O 0 0.01276289951056242
been O 0 0.015633033588528633
detected O 0 0.06380525231361389
in O 0 0.01944027468562126
cultured O 1 0.9960588216781616
skin O 1 1.0
fibroblasts O 1 0.9999696016311646
and O 0 0.09843184798955917
melanoma B-Disease 1 1.0
tissue O 1 0.999692440032959
from O 0 0.02158547192811966
healthy O 0 0.48203566670417786
individuals O 0 0.019797001034021378
previously O 0 0.019422924146056175
reported O 0 0.024544792249798775
as O 0 0.011977001093327999
having O 0 0.08468390256166458
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.015426015481352806
hex I-Disease 0 0.0831819400191307
A I-Disease 0 0.027887333184480667
activity O 0 0.03831563889980316
indistinguishable O 0 0.053591445088386536
from O 0 0.010483242571353912
that O 0 0.007002823520451784
of O 0 0.011375299654901028
patients O 1 0.9999996423721313
with O 1 0.6982608437538147
Tay B-Disease 1 1.0
- I-Disease 1 0.9999978542327881
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.14702413976192474
TSD B-Disease 1 0.9999909400939941
) O 0 0.04232830926775932
. O 0 0.02758537232875824

Identification O 0 0.06253430247306824
and O 0 0.02138846553862095
quantitation O 0 0.1575281023979187
of O 0 0.017355352640151978
hex O 0 0.08383095264434814
A O 0 0.025713494047522545
, O 0 0.013346448540687561
amounting O 0 0.047135431319475174
to O 0 0.014413096010684967
3 O 0 0.03280084952712059
. O 0 0.024117236956954002

5 O 0 0.05553549528121948
% O 0 0.04305689409375191
- O 0 0.09268222004175186
6 O 0 0.04957493394613266
. O 0 0.031072400510311127

9 O 0 0.040692757815122604
% O 0 0.01902715303003788
of O 0 0.009502277709543705
total O 0 0.027861112728714943
beta O 0 0.10327079147100449
hexosaminidase O 1 0.5029154419898987
activity O 0 0.03912999853491783
, O 0 0.010365105234086514
has O 0 0.010401410982012749
been O 0 0.009262388572096825
obtained O 0 0.01615183614194393
by O 0 0.015260841697454453
cellulose O 0 0.16939297318458557
acetate O 1 0.8281030654907227
gel O 1 0.9867956638336182
electrophoresis O 0 0.44971203804016113
, O 0 0.04156476631760597
DEAE O 1 0.9997058510780334
- O 0 0.22461804747581482
cellulose O 0 0.22631698846817017
ion O 0 0.1905079483985901
- O 0 0.10029661655426025
exchange O 0 0.0592617504298687
chromatography O 0 0.2015017718076706
, O 0 0.029974045231938362
radial O 1 0.9772884249687195
immunodiffusion O 1 0.8940349221229553
, O 0 0.017442654818296432
and O 0 0.01688515581190586
radioimmunoassay O 1 0.8704231381416321
. O 0 0.035657837986946106

Previous O 0 0.0397992841899395
family O 0 0.03731614723801613
studies O 0 0.02676069177687168
suggested O 0 0.017982957884669304
that O 0 0.005449897609651089
these O 0 0.005195240024477243
individuals O 0 0.01425592415034771
may O 0 0.016169771552085876
be O 0 0.011090261861681938
compound O 0 0.07546540349721909
heterozygotes O 0 0.407273530960083
for O 0 0.008790019899606705
the O 0 0.011221988126635551
common O 0 0.03531251847743988
mutant O 0 0.17544525861740112
TSD B-Disease 1 0.9999697208404541
gene O 0 0.08173959702253342
and O 0 0.011335708200931549
a O 0 0.02255292795598507
rare O 0 0.05109656974673271
( O 0 0.042031511664390564
allelic O 1 0.6747821569442749
) O 0 0.040123239159584045
mutant O 0 0.1332705318927765
gene O 0 0.11619611829519272
. O 0 0.035839930176734924

Thus O 0 0.03291875496506691
, O 0 0.012578741647303104
the O 0 0.016592539846897125
postulated O 0 0.1025075912475586
rate O 0 0.063907191157341
mutant O 0 0.12595027685165405
gene O 0 0.08148420602083206
appears O 0 0.02739359624683857
to O 0 0.007542985025793314
code O 0 0.013431653380393982
for O 0 0.005938281770795584
the O 0 0.00944407470524311
expression O 0 0.027397584170103073
of O 0 0.008008196949958801
low O 0 0.037290990352630615
amounts O 0 0.02892923727631569
of O 0 0.011456125415861607
hex O 0 0.09238553047180176
A O 0 0.038498349487781525
. O 0 0.02764262445271015

Heterozygotes O 1 0.6256159543991089
for O 0 0.016975725069642067
the O 0 0.01768076792359352
rare O 0 0.05535224825143814
mutant O 0 0.10662827640771866
may O 0 0.02409358136355877
be O 0 0.010621127672493458
indistinguishable O 0 0.0634198859333992
from O 0 0.01821054518222809
heterozygotes O 1 0.5099716186523438
for O 0 0.01116966549307108
the O 0 0.01505584642291069
common O 0 0.05014236271381378
TSD B-Disease 1 0.9999728202819824
mutant O 0 0.16757865250110626
. O 0 0.03702656552195549

However O 0 0.02436187118291855
, O 0 0.01447257399559021
direct O 0 0.02773161418735981
visualization O 0 0.08883447200059891
and O 0 0.01418180949985981
quantitation O 0 0.14986547827720642
of O 0 0.011199935339391232
hex O 0 0.06517499685287476
A O 0 0.019179724156856537
by O 0 0.00814843736588955
the O 0 0.010251851752400398
methods O 0 0.023544318974018097
described O 0 0.028661295771598816
may O 0 0.02305912971496582
prevent O 0 0.04482239857316017
false O 0 0.05158306285738945
- O 0 0.32188624143600464
positive O 0 0.07972444593906403
prenatal O 1 0.9999399185180664
diagnosis O 1 0.9999912977218628
of O 0 0.02377299964427948
TSD B-Disease 1 0.9999959468841553
in O 0 0.019757796078920364
fetuses O 0 0.11985232681035995
having O 0 0.02100357972085476
the O 0 0.012826001271605492
incomplete O 0 0.03988908976316452
hex B-Disease 0 0.12257032841444016
A I-Disease 0 0.06713908165693283
deficiency I-Disease 1 0.9999991655349731
of O 0 0.010432377457618713
the O 0 0.013254103250801563
type O 0 0.0455051027238369
described O 0 0.02085365168750286
in O 0 0.008086471818387508
the O 0 0.011334959417581558
four O 0 0.018974121659994125
healthy O 0 0.10021357238292694
individuals O 0 0.049972984939813614

The O 0 0.06747420132160187
tumor B-Disease 1 0.9999125003814697
suppressor O 1 0.9717625379562378
gene O 0 0.23442640900611877
Smad4 O 1 0.9986893534660339
/ O 1 0.9981398582458496
Dpc4 O 1 0.8131246566772461
is O 0 0.014144385233521461
required O 0 0.014587923884391785
for O 0 0.010959628038108349
gastrulation O 1 0.9459014534950256
and O 0 0.010228008031845093
later O 0 0.011435598134994507
for O 0 0.011231886222958565
anterior O 1 0.9373287558555603
development O 0 0.019535064697265625
of O 0 0.007991671562194824
the O 0 0.016151607036590576
mouse O 0 0.14495320618152618
embryo O 0 0.1349266916513443
. O 0 0.03335276246070862

Mutations O 0 0.1357649266719818
in O 0 0.017440637573599815
the O 0 0.026509054005146027
SMAD4 O 1 0.9999904632568359
/ O 1 0.9999762773513794
DPC4 O 1 0.9999678134918213
tumor B-Disease 1 0.9999793767929077
suppressor O 1 0.973944365978241
gene O 0 0.0934881716966629
, O 0 0.01258082501590252
a O 0 0.01770690642297268
key O 0 0.0257581640034914
signal O 0 0.059825748205184937
transducer O 0 0.14424462616443634
in O 0 0.013142219744622707
most O 0 0.015115443617105484
TGFbeta O 1 0.9996868371963501
- O 0 0.17795825004577637
related O 0 0.04940620809793472
pathways O 0 0.09232576191425323
, O 0 0.010154088959097862
are O 0 0.0054844217374920845
involved O 0 0.015311873517930508
in O 0 0.009515274316072464
50 O 0 0.02109677344560623
% O 0 0.021942922845482826
of O 0 0.019660957157611847
pancreatic B-Disease 1 0.9999995231628418
cancers I-Disease 1 0.9999971389770508
. O 0 0.041023388504981995

Homozygous O 0 0.29371166229248047
Smad4 O 1 0.9748921990394592
mutant O 0 0.2690843939781189
mice O 1 0.9602290391921997
die O 1 0.6070846915245056
before O 0 0.02717883698642254
day O 0 0.02896716818213463
7 O 0 0.03171383962035179
. O 0 0.0261833593249321

5 O 0 0.039975181221961975
of O 0 0.019608130678534508
embryogenesis O 0 0.33611056208610535
. O 0 0.04172408580780029

Mutant O 0 0.1711147576570511
embryos O 0 0.06965652853250504
have O 0 0.017069227993488312
reduced O 0 0.03697103634476662
size O 0 0.02407626248896122
, O 0 0.013786479830741882
fail O 0 0.05111723765730858
to O 0 0.014773618429899216
gastrulate O 0 0.29166117310523987
or O 0 0.019770806655287743
express O 0 0.043827079236507416
a O 0 0.026061909273266792
mesodermal O 1 0.9903755784034729
marker O 0 0.08407971262931824
, O 0 0.01347703393548727
and O 0 0.011425720527768135
show O 0 0.043019965291023254
abnormal O 1 0.9604006409645081
visceral O 1 0.9821701049804688
endoderm O 1 0.9945700764656067
development O 0 0.04276962950825691
. O 0 0.02855328656733036

Growth B-Disease 1 0.9878333806991577
retardation I-Disease 1 0.9999769926071167
of O 0 0.01613502763211727
the O 0 0.024467291310429573
Smad4 O 1 0.9999415874481201
- O 1 0.8957609534263611
deficient O 1 0.9934638142585754
embryos O 0 0.0638609528541565
results O 0 0.027959631755948067
from O 0 0.01753014326095581
reduced O 0 0.051170188933610916
cell O 0 0.09430806338787079
proliferation O 0 0.06775178760290146
rather O 0 0.017742671072483063
than O 0 0.014893590472638607
increased O 0 0.046019405126571655
apoptosis O 0 0.15644988417625427
. O 0 0.028761938214302063

Aggregation O 0 0.1333349198102951
of O 0 0.023534925654530525
mutant O 0 0.17169250547885895
Smad4 O 1 0.9959237575531006
ES O 1 0.9944145679473877
cells O 0 0.08192475140094757
with O 0 0.01683819480240345
wild O 0 0.0536760538816452
- O 0 0.11927670985460281
type O 0 0.1283235102891922
tetraploid O 1 0.5291730761528015
morulae O 1 0.9725427031517029
rescues O 1 0.5908809304237366
the O 0 0.04044518247246742
gastrulation B-Disease 1 0.999799907207489
defect I-Disease 1 0.9981460571289062
. O 0 0.04082382470369339

These O 0 0.01891462691128254
results O 0 0.029630478471517563
indicate O 0 0.030964940786361694
that O 0 0.01259013544768095
Smad4 O 0 0.27745795249938965
is O 0 0.014449060894548893
initially O 0 0.01836426369845867
required O 0 0.011561124585568905
for O 0 0.006515062879770994
the O 0 0.008236242458224297
differentiation O 0 0.04076603800058365
of O 0 0.008274211548268795
the O 0 0.01605641096830368
visceral O 1 0.982379138469696
endoderm O 1 0.9967721104621887
and O 0 0.011618304066359997
that O 0 0.007865825667977333
the O 0 0.018782366067171097
gastrulation B-Disease 1 0.9996863603591919
defect I-Disease 1 0.985170304775238
in O 0 0.013997991569340229
the O 0 0.01939193718135357
epiblast O 1 0.9994877576828003
is O 0 0.018985727801918983
secondary O 0 0.03477565571665764
and O 0 0.011830762028694153
non O 0 0.045806169509887695
- O 0 0.09592467546463013
cell O 0 0.07930784672498703
autonomous O 0 0.04982146993279457
. O 0 0.030477413907647133

Rescued O 0 0.26037687063217163
embryos O 0 0.10964649170637131
show O 0 0.07417857646942139
severe O 1 0.9998196959495544
anterior O 1 0.9998261332511902
truncations O 1 0.8548138737678528
, O 0 0.020005621016025543
indicating O 0 0.038472678512334824
a O 0 0.016161566600203514
second O 0 0.015814270824193954
important O 0 0.010864460840821266
role O 0 0.019312512129545212
for O 0 0.014346507377922535
Smad4 O 1 0.9012179374694824
in O 0 0.02187134325504303
anterior O 1 0.999637246131897
patterning O 1 0.995179295539856
during O 0 0.05333905667066574
embryogenesis O 1 0.9282487630844116
. O 0 0.03477729856967926

Prevalence O 1 0.9839431047439575
of O 0 0.028943657875061035
p16 O 1 0.9570302963256836
and O 0 0.03278248384594917
CDK4 O 1 0.9992122650146484
germline O 1 0.9248483180999756
mutations O 0 0.12750665843486786
in O 0 0.02914048172533512
48 O 0 0.4530664086341858
melanoma B-Disease 1 1.0
- O 1 0.9741889834403992
prone O 1 0.8219113349914551
families O 0 0.033959001302719116
in O 0 0.015096467919647694
France O 0 0.04625125229358673
. O 0 0.024889931082725525

The O 0 0.03780151531100273
French O 0 0.1958232969045639
Familial B-Disease 1 0.9999997615814209
Melanoma I-Disease 1 1.0
Study O 0 0.06693080812692642
Group O 0 0.049653131514787674
. O 0 0.026297535747289658

Germline O 1 0.7384358644485474
mutations O 0 0.14450152218341827
in O 0 0.01883622258901596
the O 0 0.022453557699918747
p16 O 1 0.9305716156959534
and O 0 0.024104995653033257
CDK4 O 1 0.9952443242073059
genes O 0 0.04859394207596779
have O 0 0.00984560139477253
been O 0 0.010106922127306461
reported O 0 0.019123615697026253
in O 0 0.00795804150402546
a O 0 0.01829143799841404
subset O 0 0.06265541166067123
of O 0 0.02327999472618103
melanoma B-Disease 1 1.0
pedigrees O 1 0.5765923261642456
, O 0 0.014604699797928333
but O 0 0.008334154263138771
their O 0 0.010957974940538406
prevalence O 1 0.9950057864189148
is O 0 0.011681102216243744
not O 0 0.00677899457514286
well O 0 0.010012426413595676
known O 0 0.022687140852212906
. O 0 0.022735290229320526

We O 0 0.020186249166727066
searched O 0 0.04614710435271263
for O 0 0.011086836457252502
such O 0 0.017200013622641563
germline O 0 0.289989173412323
mutations O 0 0.12225301563739777
in O 0 0.019109560176730156
48 O 0 0.0591585673391819
French O 1 0.9869650602340698
melanoma B-Disease 1 1.0
- O 1 0.9820752739906311
prone O 1 0.9308432936668396
families O 0 0.024080561473965645
selected O 0 0.013890924863517284
according O 0 0.007920672185719013
to O 0 0.0054346490651369095
two O 0 0.006404610350728035
major O 0 0.014608995988965034
criteria O 0 0.022652000188827515
families O 0 0.016994036734104156
with O 0 0.010241696611046791
at O 0 0.01466150488704443
least O 0 0.0123197166249156
three O 0 0.009461228735744953
affected O 0 0.04061950743198395
members O 0 0.018471993505954742
( O 0 0.033497944474220276
n O 0 0.08017902076244354
= O 0 0.09111256152391434
20 O 0 0.023385604843497276
) O 0 0.016787836328148842
or O 0 0.01251488458365202
families O 0 0.016801686957478523
with O 0 0.008588399738073349
two O 0 0.007941163145005703
affected O 0 0.033415261656045914
members O 0 0.012189515866339207
, O 0 0.00822954997420311
one O 0 0.007666030898690224
of O 0 0.0053932624869048595
them O 0 0.006825758144259453
affected O 0 0.030627712607383728
before O 0 0.012494374997913837
the O 0 0.010013552382588387
age O 0 0.022794650867581367
of O 0 0.009747741743922234
50 O 0 0.03317775949835777
( O 0 0.03362836316227913
n O 0 0.08016712218523026
= O 0 0.09805992245674133
28 O 0 0.032036203891038895
) O 0 0.016256744042038918
, O 0 0.00793306902050972
and O 0 0.006916226353496313
one O 0 0.009363994933664799
additional O 0 0.021808559074997902
minor O 0 0.051776278764009476
criterion O 0 0.07566893100738525
. O 0 0.03203630819916725

Sixteen O 0 0.07678345590829849
different O 0 0.03431044891476631
p16 O 1 0.9958168864250183
germline O 1 0.9696048498153687
mutations O 0 0.10710367560386658
were O 0 0.010401269420981407
found O 0 0.014213677495718002
in O 0 0.009379874914884567
21 O 0 0.020514821633696556
families O 0 0.01691461354494095
, O 0 0.009239456616342068
while O 0 0.013827486895024776
one O 0 0.025345919653773308
germline O 1 0.8877872824668884
mutation O 0 0.1607973873615265
, O 0 0.02537704072892666
Arg24His O 1 0.7737964391708374
, O 0 0.015783116221427917
was O 0 0.020606519654393196
detected O 0 0.057700466364622116
in O 0 0.01063433475792408
the O 0 0.019032228738069534
CDK4 O 1 0.9971811771392822
gene O 0 0.1128351092338562
. O 0 0.02814839407801628

The O 0 0.03150825947523117
frequency O 0 0.07155586779117584
of O 0 0.025046929717063904
p16 O 1 0.9231101274490356
gene O 0 0.13126330077648163
mutation O 0 0.11920550465583801
in O 0 0.013319650664925575
our O 0 0.016294948756694794
sample O 0 0.040820419788360596
( O 0 0.025334300473332405
44 O 0 0.030896978452801704
% O 0 0.02131838910281658
) O 0 0.01417502947151661
is O 0 0.008751684799790382
among O 0 0.008113379590213299
the O 0 0.00868351012468338
highest O 0 0.031842153519392014
rates O 0 0.03593107685446739
yet O 0 0.01705070212483406
reported O 0 0.022419201210141182
and O 0 0.008773318491876125
the O 0 0.017729729413986206
CDK4 O 1 0.9986873269081116
mutation O 0 0.1229763925075531
is O 0 0.014443726278841496
the O 0 0.013412105850875378
second O 0 0.033853378146886826
mutation O 0 0.15569841861724854
detected O 0 0.07674795389175415
in O 0 0.012056016363203526
this O 0 0.012718802317976952
gene O 0 0.08033128082752228
worldwide O 0 0.055430810898542404
. O 0 0.0286231841892004

In O 0 0.024702582508325577
summary O 0 0.04044937714934349
, O 0 0.012756899930536747
our O 0 0.011992426589131355
results O 0 0.022513890638947487
show O 0 0.02295215055346489
frequent O 0 0.04327116161584854
involvement O 0 0.040383804589509964
of O 0 0.01010800153017044
the O 0 0.020987579599022865
p16 O 1 0.9983818531036377
gene O 0 0.11092256009578705
in O 0 0.03124278597533703
familial B-Disease 1 0.9999998807907104
melanoma I-Disease 1 1.0
and O 0 0.014955210499465466
confirm O 0 0.022598713636398315
the O 0 0.006989963352680206
role O 0 0.013740316964685917
of O 0 0.006741837132722139
the O 0 0.017078978940844536
CDK4 O 1 0.99664306640625
gene O 0 0.0746704488992691
as O 0 0.01673094742000103
a O 0 0.04949619993567467
melanoma B-Disease 1 1.0
- O 1 0.8888640999794006
predisposing O 1 0.8117628693580627
gene O 0 0.11498261988162994
. O 0 0.021187931299209595
. O 0 0.030180232599377632

Progression O 0 0.38137221336364746
of O 0 0.03027230314910412
somatic O 0 0.259670227766037
CTG O 1 0.9941391944885254
repeat O 0 0.10496286302804947
length O 0 0.04433760046958923
heterogeneity O 0 0.09275206923484802
in O 0 0.012321201153099537
the O 0 0.01628236472606659
blood O 1 0.9951262474060059
cells O 1 0.5722982287406921
of O 0 0.03776617348194122
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.04031291976571083

The O 0 0.026618683710694313
genetic O 0 0.06760978698730469
basis O 0 0.024598712101578712
of O 0 0.031838543713092804
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9987919926643372
DM B-Disease 1 1.0
) O 0 0.027430208399891853
is O 0 0.008894940838217735
the O 0 0.00750439940020442
expansion O 0 0.02275192365050316
of O 0 0.009790679439902306
an O 0 0.024717900902032852
unstable O 1 0.9963921904563904
CTG O 1 0.999182403087616
repeat O 0 0.07372473925352097
in O 0 0.011201909743249416
the O 0 0.012607596814632416
34 O 0 0.04104015231132507
UTR O 0 0.15567028522491455
of O 0 0.015571538358926773
the O 0 0.03517812862992287
DM B-Disease 1 0.9999996423721313
protein O 0 0.17574487626552582
kinase O 0 0.256843239068985
gene O 0 0.08637791126966476
on O 0 0.02098025567829609
chromosome O 0 0.13351225852966309
19 O 0 0.04190075770020485
. O 0 0.025051604956388474

One O 0 0.01623164303600788
of O 0 0.00794229842722416
the O 0 0.010746268555521965
principal O 0 0.025788037106394768
features O 0 0.018895015120506287
of O 0 0.011713304556906223
the O 0 0.032738324254751205
DM B-Disease 1 1.0
mutation O 0 0.17662379145622253
is O 0 0.017097685486078262
an O 0 0.014064367860555649
extraordinarily O 0 0.07944007962942123
high O 0 0.030677106231451035
level O 0 0.02761257067322731
of O 0 0.014805098064243793
somatic O 0 0.2871969938278198
mosaicism O 1 0.9973589777946472
, O 0 0.015765393152832985
due O 0 0.014056653715670109
to O 0 0.008168200962245464
an O 0 0.01236597541719675
extremely O 0 0.03853778913617134
high O 0 0.0296718068420887
degree O 0 0.026537472382187843
of O 0 0.011936782859265804
somatic O 0 0.14414620399475098
instability O 0 0.07086171209812164
both O 0 0.009288675151765347
within O 0 0.009107803925871849
and O 0 0.006158555392175913
between O 0 0.009114265441894531
different O 0 0.012546894140541553
tissues O 0 0.11353318393230438
. O 0 0.027755344286561012

This O 0 0.030395474284887314
instability O 0 0.10505542904138565
appears O 0 0.038854729384183884
to O 0 0.009845081716775894
be O 0 0.008992483839392662
biased O 0 0.04506310075521469
towards O 0 0.019319754093885422
further O 0 0.014420785941183567
expansion O 0 0.02631380595266819
and O 0 0.00902603566646576
continuous O 0 0.029670223593711853
throughout O 0 0.011635280214250088
the O 0 0.007022005505859852
life O 0 0.011931043118238449
of O 0 0.005240410566329956
an O 0 0.00895941723138094
individual O 0 0.01633620448410511
, O 0 0.009311222471296787
features O 0 0.015338483266532421
that O 0 0.006498334463685751
could O 0 0.009945607744157314
be O 0 0.0062582166865468025
associated O 0 0.012107614427804947
with O 0 0.007288428954780102
the O 0 0.011043782345950603
progressive O 0 0.061303943395614624
nature O 0 0.02167225070297718
of O 0 0.008911416865885258
the O 0 0.02432495914399624
disease O 1 0.9999995231628418
. O 0 0.034280285239219666

Although O 0 0.03329291194677353
increasing O 0 0.038448479026556015
measured O 0 0.055361077189445496
allele O 0 0.14258676767349243
size O 0 0.034373629838228226
between O 0 0.02577844448387623
patients O 1 0.9999593496322632
clearly O 0 0.030210712924599648
correlates O 0 0.06213812530040741
with O 0 0.009994850493967533
an O 0 0.012956377118825912
increased O 0 0.03637668862938881
severity O 1 0.9996378421783447
of O 0 0.016572298482060432
symptoms O 1 0.9999996423721313
and O 0 0.009470551274716854
an O 0 0.00989520363509655
earlier O 0 0.016710814088582993
age O 0 0.02495678886771202
of O 0 0.014172939583659172
onset O 1 0.9999393224716187
, O 0 0.014468629844486713
this O 0 0.01041998527944088
correlation O 0 0.053509850054979324
is O 0 0.012372161261737347
not O 0 0.00787303689867258
precise O 0 0.024345509707927704
and O 0 0.011053995229303837
measured O 0 0.0449378564953804
allele O 0 0.10842842608690262
length O 0 0.028561929240822792
cannot O 0 0.018457533791661263
be O 0 0.0064718942157924175
used O 0 0.008778194896876812
as O 0 0.006767343729734421
an O 0 0.010115867480635643
accurate O 0 0.03467881679534912
predictor O 0 0.12831813097000122
of O 0 0.011433657258749008
age O 0 0.029045218601822853
of O 0 0.018909374251961708
onset O 1 0.9999721050262451
. O 0 0.035582613199949265

In O 0 0.015820953994989395
order O 0 0.01074178796261549
to O 0 0.0074761961586773396
further O 0 0.01304769515991211
characterize O 0 0.060596249997615814
the O 0 0.01585952565073967
dynamics O 0 0.07865464687347412
of O 0 0.03350954130291939
DM B-Disease 1 1.0
CTG O 1 0.9999474287033081
repeat O 0 0.38643816113471985
somatic O 0 0.25236788392066956
instability O 0 0.1187991350889206
, O 0 0.014178336597979069
we O 0 0.009012330323457718
have O 0 0.008868513628840446
studied O 0 0.02796958200633526
repeat O 0 0.05514209344983101
length O 0 0.0221351757645607
changes O 0 0.013807735405862331
over O 0 0.010122681967914104
time O 0 0.015690380707383156
in O 0 0.01897938922047615
111 O 1 0.9999068975448608
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999996423721313
with O 0 0.018513796851038933
varying O 0 0.056581493467092514
clinical O 1 0.999916672706604
severity O 1 0.9996976852416992
and O 0 0.023816369473934174
CTG O 1 0.99978107213974
repeat O 0 0.07375098019838333
size O 0 0.021686146035790443
over O 0 0.011265925131738186
time O 0 0.014187644235789776
intervals O 0 0.03263204172253609
of O 0 0.009941580705344677
1 O 0 0.027940448373556137
- O 0 0.06465493887662888
7 O 0 0.031812675297260284
years O 0 0.0194279532879591
. O 0 0.0237117912620306

We O 0 0.016348822042346
have O 0 0.009877830743789673
found O 0 0.013616057112812996
a O 0 0.017008747905492783
direct O 0 0.027902783825993538
progression O 0 0.09515829384326935
of O 0 0.006961071863770485
the O 0 0.010668377391994
size O 0 0.026413993909955025
heterogeneity O 0 0.09040582925081253
over O 0 0.014262118376791477
time O 0 0.013310980051755905
related O 0 0.02022484317421913
to O 0 0.013716673478484154
initial O 0 0.0625864639878273
CTG O 1 0.997442364692688
repeat O 0 0.09487085044384003
size O 0 0.02384047396481037
and O 0 0.0073236143216490746
the O 0 0.009451054036617279
time O 0 0.015603548847138882
interval O 0 0.054425548762083054
and O 0 0.010614720173180103
always O 0 0.020629972219467163
biased O 0 0.04236947372555733
towards O 0 0.022081511095166206
further O 0 0.015775036066770554
expansion O 0 0.037381190806627274
. O 0 0.023408178240060806

Attempts O 0 0.048349276185035706
to O 0 0.016729911789298058
mathematically O 0 0.05775386840105057
model O 0 0.030197836458683014
the O 0 0.013977748341858387
dynamics O 0 0.055980224162340164
have O 0 0.013275573961436749
proved O 0 0.03202500566840172
only O 0 0.010544447228312492
partially O 0 0.05009603500366211
successful O 0 0.031998518854379654
suggesting O 0 0.03302328661084175
that O 0 0.008736154064536095
individual O 0 0.016293754801154137
specific O 0 0.020582769066095352
genetic O 0 0.058659832924604416
and O 0 0.017997683957219124
/ O 1 0.9994679093360901
or O 0 0.018779423087835312
environmental O 0 0.030619902536273003
factors O 0 0.02286154218018055
also O 0 0.007993544451892376
play O 0 0.009461862966418266
a O 0 0.011759629473090172
role O 0 0.022562533617019653
in O 0 0.016840452328324318
somatic O 1 0.5874250531196594
mosaicism O 1 0.9983310103416443
. O 0 0.02140967920422554
. O 0 0.025554629042744637

Aspartylglucosaminuria B-Disease 1 0.9978506565093994
among O 0 0.03349766880273819
Palestinian O 0 0.05289551988244057
Arabs O 0 0.07075199484825134
. O 0 0.03423728048801422

Aspartylglucosaminuria B-Disease 1 0.9999704360961914
( O 0 0.16635841131210327
AGU B-Disease 1 0.9999996423721313
) O 0 0.02917102724313736
is O 0 0.014704187400639057
a O 0 0.020748473703861237
rare O 0 0.4200719892978668
disorder B-Disease 1 0.9999967813491821
of I-Disease 0 0.024858957156538963
glycoprotein I-Disease 1 0.9993380904197693
metabolism I-Disease 1 0.9970605969429016
caused O 0 0.07574491947889328
by O 0 0.013223991729319096
the O 0 0.02126576378941536
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.013204528950154781
the I-Disease 0 0.024264398962259293
lysosomal I-Disease 1 0.9994219541549683
enzyme I-Disease 0 0.20990127325057983
aspartylglucosaminidase I-Disease 1 0.9918984174728394
( O 0 0.05900424346327782
AGA O 1 0.9983997941017151
) O 0 0.03750891983509064
. O 0 0.028240947052836418

AGU B-Disease 1 0.9999986886978149
is O 0 0.04009568691253662
inherited O 0 0.16038434207439423
as O 0 0.01533414889127016
an O 0 0.029201220721006393
autosomal O 1 0.9999097585678101
recessive O 1 0.9998866319656372
trait O 1 0.9859200716018677
and O 0 0.015770137310028076
occurs O 0 0.03423897176980972
with O 0 0.009459316730499268
a O 0 0.014313303865492344
high O 0 0.028261253610253334
frequency O 0 0.03421538695693016
in O 0 0.009822655469179153
Finland O 0 0.029513027518987656
because O 0 0.010287893004715443
of O 0 0.0068381307646632195
a O 0 0.020765507593750954
founder O 0 0.060268525034189224
effect O 0 0.04911985248327255
. O 0 0.028157370164990425

While O 0 0.02691689319908619
very O 0 0.019534174352884293
few O 0 0.022364329546689987
patients O 1 0.9999529123306274
with O 0 0.024896908551454544
AGU B-Disease 1 0.9999998807907104
have O 0 0.013497261330485344
been O 0 0.011541186831891537
reported O 0 0.02513384260237217
from O 0 0.012233735993504524
non O 0 0.03632603585720062
- O 0 0.07052741944789886
Finnish O 0 0.06599795073270798
origin O 0 0.023685602471232414
, O 0 0.015612400136888027
we O 0 0.01719651371240616
diagnosed O 1 1.0
the O 0 0.026592785492539406
disorder O 1 0.9999995231628418
in O 0 0.018928226083517075
8 O 0 0.03966901823878288
patients O 1 0.999568521976471
originating O 0 0.053572654724121094
from O 0 0.014712443575263023
3 O 0 0.024657301604747772
unrelated O 0 0.041167546063661575
families O 0 0.02313840761780739
, O 0 0.008147667162120342
all O 0 0.006059281527996063
Palestinian O 0 0.03110424429178238
Arabs O 0 0.032550159841775894
from O 0 0.011951032094657421
the O 0 0.011073397472500801
region O 0 0.026994800195097923
of O 0 0.010986865498125553
Jerusalem O 0 0.045247506350278854
. O 0 0.029277026653289795

The O 0 0.04485846310853958
clinical O 1 0.9998689889907837
diagnosis O 1 0.999993085861206
of O 0 0.030510060489177704
AGU B-Disease 1 1.0
is O 0 0.019495870918035507
often O 0 0.013332195580005646
difficult O 0 0.016297508031129837
, O 0 0.007267454639077187
in O 0 0.006366849411278963
particular O 0 0.011758384294807911
early O 0 0.011866279877722263
in O 0 0.005741866771131754
the O 0 0.007389850914478302
course O 0 0.024113571271300316
of O 0 0.007371573708951473
the O 0 0.01614825800061226
disease O 1 0.9999997615814209
, O 0 0.009308213368058205
and O 0 0.005410393234342337
most O 0 0.006297504063695669
of O 0 0.006058667320758104
the O 0 0.015623974613845348
patients O 1 0.9999963045120239
are O 0 0.015548083931207657
diagnosed O 1 1.0
after O 0 0.019289715215563774
the O 0 0.009570680558681488
age O 0 0.020336177200078964
of O 0 0.008420271798968315
5 O 0 0.022347984835505486
years O 0 0.019076397642493248
. O 0 0.02475913055241108

However O 0 0.023137453943490982
, O 0 0.012372295372188091
since O 0 0.015133612789213657
these O 0 0.012852611020207405
patients O 1 0.999822199344635
excrete O 0 0.39216148853302
early O 0 0.02314191311597824
large O 0 0.014899068512022495
amounts O 0 0.024683725088834763
of O 0 0.013096477836370468
aspartylglucosamine O 1 0.5402636528015137
in O 0 0.02023938298225403
urine O 0 0.11784818023443222
, O 0 0.020443923771381378
biochemical O 0 0.10128667950630188
screening O 0 0.0802670270204544
is O 0 0.014303122647106647
easy O 0 0.024343794211745262
by O 0 0.013878115452826023
urine O 0 0.12989549338817596
chromatography O 1 0.6639220118522644
. O 0 0.01997450739145279
. O 0 0.023855390027165413

Detection O 0 0.14153675734996796
of O 0 0.01972869783639908
heterozygous O 0 0.12014759331941605
carriers O 0 0.07068124413490295
of O 0 0.013939839787781239
the O 0 0.033841345459222794
ataxia B-Disease 1 1.0
- I-Disease 1 0.9991500377655029
telangiectasia I-Disease 1 0.9999630451202393
( O 0 0.07626993209123611
ATM O 0 0.20449605584144592
) O 0 0.034676458686590195
gene O 0 0.08170115202665329
by O 0 0.029862867668271065
G2 O 1 0.9997928738594055
phase O 0 0.16801945865154266
chromosomal O 0 0.2593129277229309
radiosensitivity O 0 0.3521445691585541
of O 0 0.030091790482401848
peripheral O 1 0.9998987913131714
blood O 1 0.9998455047607422
lymphocytes O 1 0.9996092915534973
. O 0 0.039493851363658905

In O 0 0.06583830714225769
ataxia B-Disease 1 1.0
- I-Disease 1 0.9995468258857727
telangiectasia I-Disease 1 0.9999942779541016
( O 0 0.15758909285068512
A B-Disease 1 0.9997605681419373
- I-Disease 1 0.9998326301574707
T I-Disease 1 0.9999992847442627
) O 0 0.05648554861545563
patients O 1 0.9998077750205994
, O 0 0.017301052808761597
mutations O 0 0.06747984141111374
in O 0 0.010667311027646065
a O 0 0.018806643784046173
single O 0 0.0320286862552166
gene O 0 0.07199493050575256
, O 0 0.017772706225514412
ATM O 0 0.09397131949663162
, O 0 0.010727215558290482
result O 0 0.018298037350177765
in O 0 0.014547939412295818
an O 0 0.038303498178720474
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.02019759826362133
embraces O 0 0.06676112115383148
a O 0 0.013887468725442886
variety O 0 0.01588078774511814
of O 0 0.010861033573746681
clinical O 1 0.966065526008606
features O 0 0.021351652219891548
and O 0 0.012376046739518642
manifests O 0 0.24393463134765625
extreme O 0 0.08100822567939758
radiosensitivity O 0 0.484328955411911
and O 0 0.009805806912481785
a O 0 0.014357893727719784
strong O 0 0.026259081438183784
pre O 1 0.8670819997787476
- O 0 0.30349451303482056
disposition O 0 0.3253946602344513
to O 0 0.032005202025175095
malignancy B-Disease 1 0.9999269247055054
. O 0 0.03748320788145065

Heterozygotes O 0 0.42564165592193604
for O 0 0.019429780542850494
the O 0 0.021172596141695976
ATM O 0 0.14139312505722046
gene O 0 0.06320211291313171
have O 0 0.01169440895318985
no O 0 0.014818638563156128
clinical O 0 0.42560356855392456
expression O 0 0.026973197236657143
of O 0 0.009665564633905888
A B-Disease 1 0.9985597729682922
- I-Disease 1 0.9998892545700073
T I-Disease 1 0.9999986886978149
but O 0 0.015650905668735504
may O 0 0.02196132391691208
be O 0 0.016305766999721527
cancer B-Disease 1 0.9999994039535522
prone O 1 0.7541148066520691
with O 0 0.011047178879380226
a O 0 0.016944292932748795
moderate O 0 0.03980616480112076
increase O 0 0.019603542983531952
in O 0 0.011672048829495907
in O 0 0.017432861030101776
vitro O 0 0.14163583517074585
radiosensitivity O 1 0.9086465835571289
. O 0 0.03567911311984062

We O 0 0.025192147120833397
performed O 0 0.03518631309270859
a O 0 0.025637434795498848
blind O 0 0.12407010048627853
chromosomal O 0 0.14805907011032104
analysis O 0 0.03147977590560913
on O 0 0.021985454484820366
G2 O 1 0.9999978542327881
- O 0 0.16685980558395386
phase O 0 0.1253446787595749
lymphocytes O 0 0.4440005421638489
from O 0 0.02024984173476696
7 O 0 0.030108746141195297
unrelated O 0 0.056714002043008804
A B-Disease 1 0.9969351291656494
- I-Disease 1 0.9997978806495667
T I-Disease 1 0.9999995231628418
patients O 1 0.999841570854187
, O 0 0.015822120010852814
13 O 0 0.025639036670327187
obligate O 0 0.19260121881961823
A B-Disease 1 0.9922916293144226
- I-Disease 1 0.9992972612380981
T I-Disease 1 0.9999967813491821
heterozygotes O 1 0.9933659434318542
( O 0 0.031834423542022705
parents O 0 0.02468331716954708
of O 0 0.008512422442436218
the O 0 0.017553431913256645
patients O 1 0.9999393224716187
) O 0 0.01827513426542282
, O 0 0.008807878941297531
and O 0 0.0075197601690888405
14 O 0 0.020349638536572456
normal O 0 0.031119221821427345
controls O 0 0.03981481119990349
following O 0 0.02870326116681099
X O 0 0.412032812833786
- O 0 0.09152835607528687
irradiation O 0 0.11849187314510345
with O 0 0.02021685428917408
1 O 0 0.039304278790950775
Gy O 0 0.22013376653194427
in O 0 0.011872007511556149
order O 0 0.010713893920183182
to O 0 0.010821250267326832
evaluate O 0 0.054693326354026794
this O 0 0.015523785725235939
cytogenetic O 0 0.2892382740974426
method O 0 0.03038070909678936
as O 0 0.009473812766373158
a O 0 0.01646934263408184
tool O 0 0.038199905306100845
for O 0 0.013594490475952625
detection O 0 0.07668246328830719
of O 0 0.018317097797989845
ATM O 0 0.23478488624095917
carriers O 0 0.11955839395523071
. O 0 0.03413751721382141

Both O 0 0.03213711455464363
A B-Disease 1 0.9713417291641235
- I-Disease 1 0.9989783763885498
T I-Disease 1 0.9999951124191284
homozygotes O 1 0.9957733750343323
and O 0 0.02969180792570114
heterozygotes O 1 0.9308601021766663
showed O 0 0.044591907411813736
significantly O 0 0.04188767075538635
increased O 0 0.027121419087052345
levels O 0 0.03665222227573395
of O 0 0.017938770353794098
radiation O 1 0.999994158744812
- O 1 0.9956722259521484
induced O 1 0.9996870756149292
chromatid O 1 0.9996639490127563
damage O 0 0.2431124895811081
relative O 0 0.028232168406248093
to O 0 0.0073011708445847034
that O 0 0.005974774248898029
of O 0 0.007530009374022484
normal O 0 0.045222241431474686
controls O 0 0.05449255183339119
. O 0 0.02934280037879944

These O 0 0.016473250463604927
results O 0 0.023868216201663017
show O 0 0.016556391492486
that O 0 0.00807628221809864
the O 0 0.019494183361530304
G2 O 1 0.9999980926513672
- O 0 0.23750975728034973
phase O 0 0.15052977204322815
chromosomal O 0 0.26473382115364075
radiosensitivity O 1 0.8853716850280762
assay O 0 0.13491693139076233
can O 0 0.01248310785740614
be O 0 0.005257818847894669
used O 0 0.007860821671783924
for O 0 0.005720940884202719
the O 0 0.009895933791995049
detection O 0 0.05986630544066429
of O 0 0.01335656177252531
A B-Disease 1 0.994438648223877
- I-Disease 1 0.9994163513183594
T I-Disease 1 0.9999945163726807
heterozygotes O 1 0.9873849153518677
. O 0 0.04123992472887039

In O 0 0.02924848347902298
combination O 0 0.07488095760345459
with O 0 0.01896485686302185
molecular O 0 0.06979755312204361
genetic O 0 0.06844538450241089
analyses O 0 0.040138550102710724
, O 0 0.010784190148115158
this O 0 0.007752066478133202
test O 0 0.03128057345747948
may O 0 0.012966913171112537
be O 0 0.004248541314154863
of O 0 0.004207506775856018
value O 0 0.008536812849342823
in O 0 0.0076916893012821674
studies O 0 0.01949586719274521
of O 0 0.010314494371414185
familial B-Disease 1 0.9999635219573975
and I-Disease 0 0.019209235906600952
sporadic I-Disease 1 0.8796663284301758
cancers I-Disease 1 0.9999487400054932
aimed O 0 0.04299941658973694
at O 0 0.01681702956557274
determination O 0 0.02372141368687153
of O 0 0.005618331488221884
the O 0 0.009992999956011772
potential O 0 0.031656574457883835
involvement O 0 0.04891325905919075
of O 0 0.016285747289657593
ATM O 1 0.791841983795166
mutations O 0 0.12268314510583878
in O 0 0.02830212563276291
tumor B-Disease 1 0.9999994039535522
risk O 1 0.9948729872703552
or O 0 0.016452860087156296
development O 0 0.020444275811314583
. O 0 0.012795167975127697
. O 0 0.021261075511574745

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9991859793663025
telangiectasia I-Disease 1 0.9999758005142212
: O 0 0.036153003573417664
identification O 0 0.030805515125393867
and O 0 0.011319360695779324
detection O 0 0.06528130173683167
of O 0 0.011511263437569141
founder O 0 0.0896238163113594
- O 0 0.09177080541849136
effect O 0 0.056508395820856094
mutations O 0 0.07908882945775986
in O 0 0.01212340034544468
the O 0 0.01673143170773983
ATM O 0 0.1345566213130951
gene O 0 0.06275103986263275
in O 0 0.013497932814061642
ethnic O 0 0.023103240877389908
populations O 0 0.060917265713214874
. O 0 0.03278578072786331

To O 0 0.019725244492292404
facilitate O 0 0.032775331288576126
the O 0 0.016115278005599976
evaluation O 0 0.05492519587278366
of O 0 0.016059868037700653
ATM O 0 0.4753247797489166
heterozygotes O 1 0.9803635478019714
for O 0 0.019276605919003487
susceptibility O 0 0.30497807264328003
to O 0 0.013779492117464542
other O 0 0.012642007321119308
diseases O 1 0.9999953508377075
, O 0 0.009475575760006905
such O 0 0.008359437808394432
as O 0 0.023380005732178688
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.010680070146918297
we O 0 0.006362343207001686
have O 0 0.005554376635700464
attempted O 0 0.019328676164150238
to O 0 0.007105798460543156
define O 0 0.020770911127328873
the O 0 0.008391881361603737
most O 0 0.010426335036754608
common O 0 0.026594892144203186
mutations O 0 0.06656283885240555
and O 0 0.007164043374359608
their O 0 0.008895058184862137
frequencies O 0 0.04082345589995384
in O 0 0.02616427280008793
ataxia B-Disease 1 1.0
- I-Disease 1 0.9995390176773071
telangiectasia I-Disease 1 0.9999957084655762
( O 0 0.08163408190011978
A B-Disease 1 0.9978716373443604
- I-Disease 1 0.998568058013916
T I-Disease 1 0.9999821186065674
) O 0 0.04709281027317047
homozygotes O 1 0.7859176993370056
from O 0 0.018520742654800415
10 O 0 0.018529044464230537
ethnic O 0 0.027335574850440025
populations O 0 0.07208811491727829
. O 0 0.03414521366357803

Both O 0 0.03621314838528633
genomic O 0 0.15323738753795624
mutations O 0 0.10198869556188583
and O 0 0.009873722679913044
their O 0 0.010603454895317554
effects O 0 0.0627593845129013
on O 0 0.014230937696993351
cDNA O 0 0.10808248817920685
were O 0 0.01587069407105446
characterized O 0 0.0866447389125824
. O 0 0.03138794004917145

Protein O 0 0.15130680799484253
- O 0 0.13714762032032013
truncation O 0 0.15369921922683716
testing O 0 0.05321473628282547
of O 0 0.008438441902399063
the O 0 0.014051392674446106
entire O 0 0.04661902040243149
ATM O 0 0.18093974888324738
cDNA O 0 0.19131897389888763
detected O 0 0.1272110939025879
92 O 0 0.10533281415700912
( O 0 0.041231025010347366
66 O 0 0.07361120730638504
% O 0 0.03538212180137634
) O 0 0.034411512315273285
truncating O 0 0.21836446225643158
mutations O 0 0.11556225270032883
in O 0 0.02314125746488571
140 O 0 0.08362415432929993
mutant O 0 0.162423238158226
alleles O 0 0.21687696874141693
screened O 0 0.14036975800991058
. O 0 0.03769035264849663

The O 0 0.035120926797389984
haplotyping O 1 0.7721807360649109
of O 0 0.022156205028295517
patients O 1 0.9999467134475708
with O 0 0.017572881653904915
identical O 0 0.047124262899160385
mutations O 0 0.1058201715350151
indicates O 0 0.03273587301373482
that O 0 0.00628029415383935
almost O 0 0.008116339333355427
all O 0 0.003955243155360222
of O 0 0.004406377673149109
these O 0 0.005628770217299461
represent O 0 0.012496918439865112
common O 0 0.021935472264885902
ancestry O 0 0.039282508194446564
and O 0 0.008093558251857758
that O 0 0.007513477932661772
very O 0 0.014046684838831425
few O 0 0.020334310829639435
spontaneously O 0 0.12129195034503937
recurring O 1 0.6281811594963074
ATM O 1 0.625188946723938
mutations O 0 0.14142540097236633
exist O 0 0.028411448001861572
. O 0 0.02661745995283127

Assays O 0 0.16152288019657135
requiring O 0 0.06918279081583023
minimal O 0 0.05825775861740112
amounts O 0 0.02901177667081356
of O 0 0.01355922594666481
genomic O 0 0.10068854689598083
DNA O 0 0.04933139681816101
were O 0 0.009348480962216854
designed O 0 0.022402022033929825
to O 0 0.00987521093338728
allow O 0 0.02276574820280075
rapid O 0 0.06726603209972382
screening O 0 0.07058806717395782
for O 0 0.012150810100138187
common O 0 0.024585936218500137
ethnic O 0 0.03257056698203087
mutations O 0 0.14125767350196838
. O 0 0.039187170565128326

These O 0 0.0331781767308712
rapid O 0 0.13871507346630096
assays O 0 0.16679048538208008
detected O 0 0.13438251614570618
mutations O 0 0.10715217888355255
in O 0 0.018239649012684822
76 O 0 0.06063959747552872
% O 0 0.020155364647507668
of O 0 0.011427922174334526
Costa O 0 0.06801284849643707
Rican O 0 0.11301213502883911
patients O 1 0.9999023675918579
( O 0 0.02916942536830902
3 O 0 0.023340800777077675
) O 0 0.015991363674402237
, O 0 0.009996728971600533
50 O 0 0.020178237929940224
% O 0 0.01792324334383011
of O 0 0.010092134587466717
Norwegian O 0 0.06402836740016937
patients O 1 0.9997574687004089
( O 0 0.032610151916742325
1 O 0 0.02314308099448681
) O 0 0.014261876232922077
, O 0 0.008540436625480652
25 O 0 0.015168881975114346
% O 0 0.016549939289689064
of O 0 0.012272038497030735
Polish O 0 0.49406635761260986
patients O 1 0.9999481439590454
( O 0 0.028685852885246277
4 O 0 0.023062271997332573
) O 0 0.014116394333541393
, O 0 0.007667524740099907
and O 0 0.007672104984521866
14 O 0 0.01681278645992279
% O 0 0.017635464668273926
of O 0 0.011948171071708202
Italian O 0 0.17846758663654327
patients O 1 0.9999539852142334
( O 0 0.03090374544262886
1 O 0 0.01963014155626297
) O 0 0.012384788133203983
, O 0 0.0064935581758618355
as O 0 0.005879602394998074
well O 0 0.006458491086959839
as O 0 0.0067994315177202225
in O 0 0.011748353019356728
patients O 1 0.9996557235717773
of O 0 0.016365794464945793
Amish O 1 0.9863423705101013
/ O 1 0.9921839833259583
Mennonite O 0 0.12109839916229248
and O 0 0.014606463722884655
Irish O 0 0.036249738186597824
English O 0 0.022747717797756195
backgrounds O 0 0.05233100801706314
. O 0 0.025202183052897453

Additional O 0 0.0571252778172493
mutations O 0 0.09341951459646225
were O 0 0.013381236232817173
observed O 0 0.027266325429081917
in O 0 0.009322578087449074
Japanese O 0 0.02607518807053566
, O 0 0.014293423853814602
Utah O 0 0.05402395874261856
Mormon O 0 0.04884395748376846
, O 0 0.010695014148950577
and O 0 0.010723096318542957
African O 0 0.040291111916303635
American O 0 0.04878479242324829
patients O 1 0.9999579191207886
. O 0 0.03182179108262062

These O 0 0.019564466550946236
assays O 0 0.06473355740308762
should O 0 0.013682525604963303
facilitate O 0 0.029937902465462685
screening O 0 0.06365673243999481
for O 0 0.014827740378677845
A B-Disease 1 0.9823930263519287
- I-Disease 1 0.9988653659820557
T I-Disease 1 0.9999938011169434
heterozygotes O 1 0.8284680843353271
in O 0 0.01347553264349699
the O 0 0.013528921641409397
populations O 0 0.045102670788764954
studied O 0 0.029893342405557632
. O 0 0.013531798496842384
. O 0 0.02278248779475689

The O 0 0.05313390493392944
von B-Disease 1 0.991932213306427
Hippel I-Disease 1 0.9998732805252075
- I-Disease 1 0.995002806186676
Lindau I-Disease 1 0.9999048709869385
tumor I-Disease 1 0.9999617338180542
suppressor O 1 0.9030779600143433
gene O 0 0.09664896875619888
is O 0 0.01692938804626465
required O 0 0.017948515713214874
for O 0 0.013195137493312359
cell O 0 0.08769852668046951
cycle O 0 0.09487125277519226
exit O 0 0.08025967329740524
upon O 0 0.03002430498600006
serum O 1 0.9818856120109558
withdrawal O 0 0.11827141791582108
. O 0 0.032475631684064865

The O 0 0.02832307480275631
inactivation O 0 0.13697585463523865
of O 0 0.013064180500805378
the O 0 0.022960150614380836
von B-Disease 1 0.997090220451355
Hippel I-Disease 1 0.9999598264694214
- I-Disease 1 0.9803425669670105
Lindau I-Disease 1 0.9997101426124573
( I-Disease 0 0.11133664101362228
VHL I-Disease 1 0.9999898672103882
) I-Disease 0 0.09351417422294617
tumor I-Disease 1 0.9999805688858032
suppressor O 1 0.9928057789802551
gene O 0 0.18399837613105774
predisposes O 1 0.9979559183120728
affected O 0 0.05322053283452988
individuals O 0 0.016036774963140488
to O 0 0.008164407685399055
the O 0 0.016871800646185875
human O 1 0.941222071647644
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.011812307871878147
is O 0 0.011162514798343182
associated O 0 0.020131677389144897
with O 0 0.017852164804935455
sporadic B-Disease 1 0.9984133243560791
renal I-Disease 1 1.0
cell I-Disease 1 0.9998769760131836
carcinomas I-Disease 1 0.9999998807907104
( O 0 0.3930521011352539
RCC B-Disease 1 0.9999996423721313
) O 0 0.035049110651016235
and O 0 0.02092796005308628
brain B-Disease 1 0.9987651109695435
hemangioblastomas I-Disease 1 0.979749321937561
. O 0 0.033889640122652054

VHL O 1 0.9998736381530762
- O 0 0.3957863450050354
negative O 0 0.1332358717918396
786 O 1 0.9982049465179443
- O 0 0.3231339156627655
0 O 0 0.11798550933599472
RCC B-Disease 1 0.999982476234436
cells O 0 0.08700386434793472
are O 0 0.012282365933060646
tumorigenic O 0 0.1702495515346527
in O 0 0.018784118816256523
nude O 0 0.16002820432186127
mice O 0 0.11971487104892731
which O 0 0.012732702307403088
is O 0 0.013289335183799267
suppressed O 0 0.04381550848484039
by O 0 0.009527928195893764
the O 0 0.014957093633711338
reintroduction O 0 0.121817447245121
of O 0 0.028462734073400497
VHL B-Disease 1 0.9999222755432129
. O 0 0.040589962154626846

Remarkably O 0 0.10466127842664719
, O 0 0.015565435402095318
this O 0 0.010417493991553783
occurs O 0 0.04010332375764847
without O 0 0.014068149961531162
affecting O 0 0.03808912634849548
the O 0 0.0121582867577672
growth O 0 0.028643961995840073
rate O 0 0.028588270768523216
and O 0 0.013106546364724636
cell O 0 0.0695943832397461
cycle O 0 0.07013989984989166
profile O 0 0.03786081820726395
of O 0 0.008151574991643429
these O 0 0.009853443130850792
cells O 0 0.05943530052900314
in O 0 0.01371502224355936
culture O 0 0.03259483352303505
. O 0 0.02714286930859089

The O 0 0.04215493053197861
786 O 1 0.9958052635192871
- O 0 0.13992515206336975
0 O 0 0.07768746465444565
cell O 0 0.06667982041835785
line O 0 0.02307233400642872
, O 0 0.010636446997523308
like O 0 0.015629513189196587
many O 0 0.015955086797475815
cancer B-Disease 1 0.9999994039535522
cells O 0 0.08353346586227417
, O 0 0.0172645915299654
fails O 0 0.05989240109920502
to O 0 0.011700903065502644
exit O 0 0.052645258605480194
the O 0 0.017010806128382683
cell O 0 0.08341426402330399
cycle O 0 0.09243089705705643
upon O 0 0.036702029407024384
serum O 1 0.9848408102989197
withdrawal O 0 0.11308436095714569
. O 0 0.03471807762980461

Here O 0 0.022727936506271362
, O 0 0.009480688720941544
it O 0 0.006691512651741505
is O 0 0.008051793090999126
shown O 0 0.01502355094999075
that O 0 0.007506522815674543
reintroduction O 0 0.06716804951429367
of O 0 0.007632151711732149
the O 0 0.013867859728634357
wild O 0 0.05678461119532585
- O 0 0.152910515666008
type O 0 0.2312917709350586
VHL B-Disease 1 0.9998207688331604
gene O 0 0.125911146402359
restores O 0 0.0975615605711937
the O 0 0.013032149523496628
ability O 0 0.031834643334150314
of O 0 0.020834380760788918
VHL O 1 0.9999994039535522
- O 1 0.9941184520721436
negative O 1 0.8625255823135376
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cells O 0 0.07534179091453552
to O 0 0.013471038080751896
exit O 0 0.05284958705306053
the O 0 0.016622373834252357
cell O 0 0.07456254959106445
cycle O 0 0.07079193741083145
and O 0 0.016172941774129868
enter O 0 0.07086072862148285
G0 O 1 0.9999980926513672
/ O 1 0.9996418952941895
quiescence O 1 0.9595271944999695
in O 0 0.024451278150081635
low O 0 0.08360955119132996
serum O 1 0.9875774383544922
. O 0 0.03707430139183998

Both O 0 0.05325783044099808
VHL O 1 0.9999728202819824
- O 0 0.14621202647686005
positive O 0 0.06311289966106415
and O 0 0.026999900117516518
VHL O 1 0.9999986886978149
- O 1 0.8669898509979248
negative O 0 0.12810903787612915
RCC B-Disease 1 0.999991774559021
cells O 0 0.12139029800891876
exit O 0 0.07539672404527664
the O 0 0.017977267503738403
cell O 0 0.0795864537358284
cycle O 0 0.07650037109851837
by O 0 0.018940696492791176
contact O 0 0.0773320123553276
inhibition O 0 0.17095579206943512
. O 0 0.03687870502471924

The O 0 0.054471034556627274
cyclin O 1 0.9807438254356384
- O 0 0.1923770159482956
dependent O 0 0.15947990119457245
kinase O 1 0.8355386853218079
inhibitor O 1 0.9757046699523926
, O 0 0.04049758240580559
p27 O 1 0.9861562252044678
, O 0 0.028747117146849632
accumulates O 0 0.12666723132133484
upon O 0 0.03280946984887123
serum O 1 0.9847054481506348
withdrawal O 0 0.06925076246261597
, O 0 0.008891587145626545
only O 0 0.005599953234195709
in O 0 0.006182223092764616
the O 0 0.009220202453434467
presence O 0 0.028075452893972397
of O 0 0.014482902362942696
VHL B-Disease 1 0.9999277591705322
, O 0 0.01361341867595911
as O 0 0.00883078295737505
a O 0 0.012338669039309025
result O 0 0.014507116749882698
of O 0 0.005325755104422569
the O 0 0.010962068103253841
stabilization O 0 0.21610234677791595
of O 0 0.010170213878154755
the O 0 0.01700815185904503
protein O 0 0.07151273638010025
. O 0 0.02742358297109604

We O 0 0.021631373092532158
propose O 0 0.03944626823067665
that O 0 0.007901054807007313
the O 0 0.010344463400542736
loss O 0 0.0380948930978775
of O 0 0.012344609014689922
wild O 0 0.06072264164686203
- O 1 0.6493116617202759
type O 1 0.6189433932304382
VHL B-Disease 1 0.9997969269752502
gene O 0 0.08552169799804688
results O 0 0.023628493770956993
in O 0 0.00841769389808178
a O 0 0.01416316069662571
specific O 0 0.02301640994846821
cellular O 0 0.08601776510477066
defect O 1 0.9664655923843384
in O 0 0.023276029154658318
serum O 1 0.9997078776359558
- O 0 0.10684391856193542
dependent O 0 0.06723036617040634
growth O 0 0.036374107003211975
control O 0 0.027745593339204788
, O 0 0.011805713176727295
which O 0 0.01247125118970871
may O 0 0.0317666195333004
initiate O 0 0.29144996404647827
tumor B-Disease 1 0.9999105930328369
formation O 0 0.08781091123819351
. O 0 0.031303081661462784

This O 0 0.020161595195531845
is O 0 0.016890689730644226
corrected O 0 0.054279617965221405
by O 0 0.009600426070392132
the O 0 0.012377511709928513
reintroduction O 0 0.1052100881934166
of O 0 0.01549217477440834
wild O 0 0.06160639971494675
- O 0 0.42962130904197693
type O 1 0.6645450592041016
VHL B-Disease 1 0.9999586343765259
, O 0 0.033027373254299164
implicating O 1 0.7226038575172424
VHL B-Disease 1 0.9991044402122498
as O 0 0.01354282721877098
the O 0 0.012605526484549046
first O 0 0.02990744449198246
tumor B-Disease 1 0.9999520778656006
suppressor O 0 0.37676283717155457
involved O 0 0.024449924007058144
in O 0 0.008989064022898674
the O 0 0.009987964294850826
regulation O 0 0.034789860248565674
of O 0 0.01275928970426321
cell O 0 0.09520240128040314
cycle O 0 0.08999931067228317
exit O 0 0.06336308270692825
, O 0 0.010072093456983566
which O 0 0.007742066867649555
is O 0 0.008592087775468826
consistent O 0 0.01928095892071724
with O 0 0.007635266054421663
its O 0 0.011928165331482887
gatekeeper O 1 0.8492411375045776
function O 0 0.02784878946840763
in O 0 0.012041485868394375
the O 0 0.01990579441189766
kidney O 1 0.9999995231628418
. O 0 0.0205297339707613
. O 0 0.02403591200709343

Piebaldism B-Disease 1 0.9999758005142212
with O 0 0.05258433148264885
deafness B-Disease 1 1.0
: O 0 0.02752598375082016
molecular O 0 0.03995892405509949
evidence O 0 0.012585600838065147
for O 0 0.007197439670562744
an O 0 0.01688862405717373
expanded O 0 0.06733224540948868
syndrome O 1 1.0
. O 0 0.040136467665433884

In O 0 0.02118835225701332
a O 0 0.021348603069782257
South O 0 0.03106645680963993
African O 0 0.046781912446022034
girl O 0 0.07968387007713318
of O 0 0.015531185083091259
Xhosa O 1 0.995590329170227
stock O 0 0.07960440963506699
with O 0 0.024706443771719933
severe O 1 0.999988317489624
piebaldism B-Disease 1 0.9997929930686951
and O 0 0.029177570715546608
profound O 1 0.9999716281890869
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.01958424411714077
identified O 0 0.02618326246738434
a O 0 0.019363434985280037
novel O 0 0.042685724794864655
missense O 0 0.16987352073192596
substitution O 0 0.07829614728689194
at O 0 0.02373860776424408
a O 0 0.01990807242691517
highly O 0 0.0358484610915184
conserved O 0 0.052039049565792084
residue O 0 0.08301974087953568
in O 0 0.013060756027698517
the O 0 0.021384768187999725
intracellular O 0 0.1831197291612625
kinase O 0 0.19656339287757874
domain O 0 0.03593502193689346
of O 0 0.009719797410070896
the O 0 0.02016754448413849
KIT O 1 0.9992119073867798
proto O 1 0.9970154762268066
- O 1 0.5932528376579285
oncogene O 1 0.9551265239715576
, O 0 0.042032819241285324
R796G O 0 0.18378128111362457
. O 0 0.03850886970758438

Though O 0 0.06586054712533951
auditory B-Disease 1 0.9976415634155273
anomalies I-Disease 1 0.7682345509529114
have O 0 0.011835373938083649
been O 0 0.01208020094782114
observed O 0 0.025792831555008888
in O 0 0.014165345579385757
mice O 0 0.09869842231273651
with O 0 0.0187271386384964
dominant O 0 0.06748869270086288
white O 0 0.2005125731229782
spotting O 1 0.9986026883125305
( O 0 0.060774195939302444
W O 1 0.9993595480918884
) O 0 0.021406743675470352
due O 0 0.01960747502744198
to O 0 0.01644197478890419
KIT O 1 0.9981960654258728
mutations O 0 0.16416680812835693
, O 0 0.033490460366010666
deafness B-Disease 1 0.9999996423721313
is O 0 0.017724622040987015
not O 0 0.009554487653076649
typical O 0 0.033647678792476654
in O 0 0.01247413083910942
human O 0 0.034075696021318436
piebaldism B-Disease 1 0.9508308172225952
. O 0 0.03406650200486183

Thus O 0 0.030380232259631157
, O 0 0.011723863892257214
the O 0 0.012502004392445087
occurrence O 0 0.08506831526756287
of O 0 0.02708168886601925
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.020180119201540947
this O 0 0.014779004268348217
patient O 1 0.9994415640830994
extends O 0 0.05700676888227463
considerably O 0 0.031508445739746094
the O 0 0.012601093389093876
phenotypic O 0 0.06718921661376953
range O 0 0.02726132422685623
of O 0 0.010789435356855392
piebaldism B-Disease 0 0.4567427933216095
due O 0 0.02655397728085518
to O 0 0.016688577830791473
KIT O 1 0.9848605394363403
gene O 0 0.1243315041065216
mutation O 0 0.13183201849460602
in O 0 0.01666923053562641
humans O 0 0.04097282141447067
and O 0 0.01745867356657982
tightens O 1 0.9928522706031799
the O 0 0.020460013300180435
clinical O 1 0.862385094165802
similarity O 0 0.05104590579867363
between O 0 0.015729136765003204
piebaldism B-Disease 0 0.34034451842308044
and O 0 0.007787423674017191
the O 0 0.0069914162158966064
various O 0 0.006962690502405167
forms O 0 0.027599405497312546
of O 0 0.029870619997382164
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.025192854925990105
. O 0 0.025720959529280663

Cycloheximide O 1 0.5571275353431702
facilitates O 0 0.10720732808113098
the O 0 0.01688213460147381
identification O 0 0.033626116812229156
of O 0 0.01672573946416378
aberrant O 0 0.1573183387517929
transcripts O 0 0.05555737763643265
resulting O 0 0.037353772670030594
from O 0 0.013186871074140072
a O 0 0.01996423862874508
novel O 0 0.046012986451387405
splice O 0 0.20549854636192322
- O 0 0.10509553551673889
site O 0 0.04812776669859886
mutation O 0 0.12381923198699951
in O 0 0.019036361947655678
COL17A1 O 1 0.9738311767578125
in O 0 0.015324066393077374
a O 0 0.029134660959243774
patient O 1 0.9998724460601807
with O 0 0.02839326113462448
generalized O 1 0.9994969367980957
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999994039535522
. O 0 0.063472680747509

Patients O 1 0.9999827146530151
with O 0 0.04293961450457573
generalized O 1 0.9996410608291626
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999998927116394
often O 0 0.04398145154118538
show O 0 0.03672611340880394
decreased O 0 0.06891503930091858
expression O 0 0.03601332753896713
of O 0 0.013515724800527096
type O 1 0.9780020117759705
XVII O 1 0.9999994039535522
collagen O 1 0.9996672868728638
, O 0 0.02070467360317707
a O 0 0.03078378364443779
transmembrane O 0 0.1706506311893463
hemidesmosomal O 0 0.19763895869255066
protein O 0 0.06369681656360626
encoded O 0 0.03233036771416664
by O 0 0.021478231996297836
COL17A1 O 1 0.9736440181732178
. O 0 0.040517088025808334

This O 0 0.01721501722931862
report O 0 0.015649927780032158
documents O 0 0.012130380608141422
a O 0 0.02210768684744835
novel O 0 0.04569895938038826
splice O 0 0.19181828200817108
- O 0 0.1046743243932724
site O 0 0.04782284423708916
mutation O 0 0.10902667790651321
in O 0 0.018314499408006668
COL17A1 O 1 0.9498955011367798
in O 0 0.013505822978913784
a O 0 0.02240927889943123
patient O 1 0.9996987581253052
with O 0 0.02777901291847229
generalized O 1 0.9996614456176758
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999986886978149
, O 0 0.0233947541564703
and O 0 0.010395179502665997
applies O 0 0.028757330030202866
a O 0 0.013368104584515095
new O 0 0.013804035261273384
methodology O 0 0.03505386412143707
to O 0 0.009978053160011768
define O 0 0.024626566097140312
and O 0 0.011388881132006645
characterize O 0 0.061999641358852386
the O 0 0.01654604636132717
resulting O 0 0.054888732731342316
mRNA O 0 0.10097865760326385
splice O 0 0.1958434134721756
variants O 0 0.0931200385093689
. O 0 0.03980380669236183

Mutational O 1 0.7319488525390625
analysis O 0 0.044233206659555435
of O 0 0.016529293730854988
COL17A1 O 1 0.9523574113845825
identified O 0 0.037528395652770996
a O 0 0.025276973843574524
maternally O 0 0.2531014680862427
inherited O 1 0.9873981475830078
G O 1 0.9967225193977356
- O 0 0.10290013998746872
to O 0 0.02529316022992134
- O 1 0.5021544098854065
T O 1 0.9970610737800598
transversion O 0 0.3655224144458771
at O 0 0.021328220143914223
the O 0 0.01470878068357706
- O 0 0.05432680621743202
1 O 0 0.021522199735045433
position O 0 0.017426393926143646
of O 0 0.011984946206212044
exon O 0 0.13410858809947968
32 O 0 0.05648350343108177
. O 0 0.02947300858795643

This O 0 0.03650188073515892
acceptor O 0 0.27121254801750183
splice O 0 0.27855589985847473
- O 0 0.1348966807126999
site O 0 0.0495353601872921
mutation O 0 0.11227741837501526
led O 0 0.024993985891342163
to O 0 0.009537851437926292
the O 0 0.01184654887765646
formation O 0 0.04282030090689659
of O 0 0.013885111548006535
aberrant O 0 0.1389218121767044
transcripts O 0 0.04933839663863182
present O 0 0.019864438101649284
at O 0 0.02303108386695385
extremely O 0 0.04125276580452919
low O 0 0.051404304802417755
levels O 0 0.05317537114024162
. O 0 0.024177396669983864

Based O 0 0.027749931439757347
on O 0 0.010620095767080784
our O 0 0.015081139281392097
recent O 0 0.021723981946706772
finding O 0 0.03321218490600586
that O 0 0.01917685568332672
cycloheximide O 1 0.9218505620956421
stabilized O 1 0.9404830932617188
mutant O 0 0.16828374564647675
COL17A1 O 1 0.9896519780158997
transcripts O 0 0.06378031522035599
in O 0 0.023663902655243874
keratinocytes O 0 0.4488634169101715
homozygous O 0 0.11570026725530624
for O 0 0.017212970182299614
a O 0 0.04094238579273224
frameshift O 1 0.9305185675621033
mutation O 0 0.13597610592842102
, O 0 0.012899764813482761
the O 0 0.012758941389620304
effects O 0 0.04721005633473396
of O 0 0.008961021900177002
the O 0 0.020643655210733414
splice O 0 0.22741816937923431
- O 0 0.10610445588827133
site O 0 0.05015992745757103
mutation O 0 0.1076902374625206
on O 0 0.014809445478022099
splicing O 0 0.09180491417646408
of O 0 0.01928490400314331
COL17A1 O 1 0.9638081192970276
transcripts O 0 0.049160610884428024
were O 0 0.011793019250035286
determined O 0 0.030798228457570076
using O 0 0.027750210836529732
reverse O 0 0.12112035602331161
transcriptase O 0 0.29042258858680725
polymerase O 0 0.2164478451013565
chain O 0 0.10056488960981369
reaction O 0 0.06005633622407913
of O 0 0.010250023566186428
total O 0 0.026050133630633354
RNA O 0 0.09352006763219833
from O 0 0.02490658313035965
keratinocytes O 0 0.4281352460384369
incubated O 0 0.11346449702978134
for O 0 0.020189056172966957
2 O 0 0.0314183384180069
. O 0 0.02832949161529541

5 O 0 0.056031327694654465
h O 0 0.08421904593706131
in O 0 0.009765064343810081
the O 0 0.010611471720039845
presence O 0 0.029455136507749557
or O 0 0.01675872504711151
absence O 0 0.02890603616833687
of O 0 0.009348534978926182
10 O 0 0.026724200695753098
microg O 1 0.7985622882843018
cycloheximide O 1 0.6703349947929382
per O 0 0.05145559832453728
ml O 1 0.5488590598106384
. O 0 0.04228946939110756

Using O 0 0.027577372267842293
this O 0 0.011345116421580315
approach O 0 0.032272785902023315
, O 0 0.013019951060414314
an O 0 0.019864486530423164
abnormally O 1 0.6267725825309753
spliced O 0 0.13651375472545624
transcript O 0 0.07147718966007233
was O 0 0.017208067700266838
identified O 0 0.021162299439311028
that O 0 0.006228589918464422
contains O 0 0.011983073316514492
an O 0 0.011966677382588387
extra O 0 0.03696407377719879
264 O 0 0.08640135824680328
bases O 0 0.04051823541522026
upstream O 0 0.0663909837603569
from O 0 0.023319343104958534
exon O 0 0.1284753829240799
32 O 0 0.04021349549293518
, O 0 0.014825908467173576
resulting O 0 0.029597444459795952
in O 0 0.013392306864261627
a O 0 0.034141406416893005
premature O 1 0.965451717376709
termination O 1 0.6897265911102295
codon O 0 0.17370261251926422
27 O 0 0.05700630322098732
bp O 0 0.12571339309215546
downstream O 0 0.0807114765048027
from O 0 0.017521200701594353
the O 0 0.022089317440986633
cryptic O 0 0.1495671272277832
splice O 0 0.2000308632850647
site O 0 0.04816271364688873
. O 0 0.0313219353556633

Three O 0 0.023436591029167175
other O 0 0.016463814303278923
splice O 0 0.1668584942817688
variants O 0 0.05531179532408714
, O 0 0.010698092170059681
including O 0 0.008357247337698936
one O 0 0.009719889611005783
derived O 0 0.018100786954164505
from O 0 0.009837739169597626
the O 0 0.01194758154451847
skipping O 0 0.07521241158246994
of O 0 0.015161597169935703
exon O 0 0.11656681448221207
32 O 0 0.033581361174583435
, O 0 0.010638739913702011
were O 0 0.008220797404646873
also O 0 0.010701277293264866
identified O 0 0.029051044955849648
. O 0 0.02441408298909664

These O 0 0.017057226970791817
results O 0 0.02526768110692501
indicate O 0 0.02574152499437332
the O 0 0.012507385574281216
usefulness O 0 0.06880509853363037
of O 0 0.016067324206233025
cycloheximide O 1 0.9995790123939514
treatment O 1 0.9996790885925293
in O 0 0.012248513288795948
evaluating O 0 0.052193716168403625
the O 0 0.018082845956087112
abnormal O 0 0.26355504989624023
processing O 0 0.026203453540802002
of O 0 0.01002412661910057
mRNA O 0 0.05198708549141884
due O 0 0.023581501096487045
to O 0 0.017906976863741875
splice O 0 0.19313862919807434
- O 0 0.10994584858417511
site O 0 0.05573491007089615
mutations O 0 0.10043208301067352
, O 0 0.01759912818670273
because O 0 0.021320797502994537
( O 0 0.03161851689219475
i O 0 0.030380969867110252
) O 0 0.029571058228611946
aberrant O 0 0.15643909573554993
splicing O 0 0.1235182136297226
often O 0 0.02983301505446434
generates O 0 0.07032950222492218
a O 0 0.03856312483549118
premature O 1 0.928320050239563
termination O 1 0.7502354979515076
codon O 0 0.16016215085983276
, O 0 0.026875602081418037
( O 0 0.036129847168922424
ii O 0 0.06685047596693039
) O 0 0.024384917691349983
transcripts O 0 0.05094510689377785
with O 0 0.02638758346438408
premature O 1 0.9687041640281677
termination O 1 0.8715159893035889
codons O 0 0.11872441321611404
can O 0 0.021418174728751183
occur O 0 0.0352904349565506
at O 0 0.020498640835285187
low O 0 0.04125367850065231
or O 0 0.027940552681684494
undetectable O 1 0.9947362542152405
levels O 0 0.050223689526319504
due O 0 0.02476201020181179
to O 0 0.01646682433784008
nonsense O 0 0.08673863857984543
- O 0 0.10162215679883957
mediated O 0 0.1805473119020462
mRNA O 0 0.09797240793704987
decay O 0 0.07187339663505554
, O 0 0.013801113702356815
and O 0 0.012401397339999676
( O 0 0.029261505231261253
iii O 0 0.06804539263248444
) O 0 0.015304398722946644
the O 0 0.009719393216073513
levels O 0 0.02354452759027481
of O 0 0.006110898219048977
these O 0 0.005892458837479353
transcripts O 0 0.027848998084664345
can O 0 0.009170706383883953
be O 0 0.0068309130147099495
increased O 0 0.021299075335264206
by O 0 0.015185887925326824
cycloheximide O 1 0.669240415096283
. O 0 0.02917693927884102

A O 0 0.07990925014019012
deletion O 0 0.2056320607662201
mutation O 0 0.1430034041404724
in O 0 0.019570840522646904
COL17A1 O 1 0.8987417817115784
in O 0 0.013703159056603909
five O 0 0.019359780475497246
Austrian O 0 0.07427044212818146
families O 0 0.029044080525636673
with O 0 0.026676082983613014
generalized O 1 0.9989529848098755
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999961853027344
represents O 0 0.08077740669250488
propagation O 0 0.06863287091255188
of O 0 0.009409032762050629
an O 0 0.01786794140934944
ancestral O 0 0.09511441737413406
allele O 0 0.20841963589191437
. O 0 0.042676590383052826

Patients O 1 0.999985933303833
with O 0 0.04253178462386131
generalized O 1 0.9997530579566956
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999991655349731
, O 0 0.022787224501371384
a O 0 0.020011382177472115
usually O 0 0.028048360720276833
nonlethal O 0 0.11792019009590149
form O 0 0.02911446988582611
of O 0 0.02527693100273609
junctional B-Disease 1 0.9999934434890747
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999984502792358
, O 0 0.030050693079829216
have O 0 0.01952754147350788
generalized O 1 0.8421867489814758
blistering B-Disease 1 0.9981988072395325
, O 0 0.04221929982304573
nail B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
, O 0 0.10524317622184753
patchy B-Disease 1 0.9999994039535522
alopecia I-Disease 1 1.0
, O 0 0.028209930285811424
and O 0 0.02708296850323677
dental B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9997069239616394
. O 0 0.03704662248492241

Skin B-Disease 1 0.9999998807907104
fragility I-Disease 1 0.9996460676193237
in O 0 0.01617870293557644
most O 0 0.011268527247011662
cases O 0 0.021888023242354393
is O 0 0.009038510732352734
due O 0 0.014799931086599827
to O 0 0.010969235561788082
mutations O 0 0.0634409710764885
in O 0 0.009847810491919518
the O 0 0.014205435290932655
gene O 0 0.09224050492048264
encoding O 0 0.08071250468492508
type O 1 0.579535722732544
XVII O 1 0.999992847442627
collagen O 1 0.999904990196228
( O 0 0.059532128274440765
COL17A1 O 1 0.9994396567344666
) O 0 0.033784475177526474
. O 0 0.0243073683232069

Recently O 0 0.05483892932534218
, O 0 0.01540397759526968
we O 0 0.00978026818484068
reported O 0 0.02513381838798523
five O 0 0.016905464231967926
Austrian O 0 0.06839270144701004
families O 0 0.034549638628959656
with O 0 0.02904346212744713
generalized O 1 0.9985326528549194
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999995231628418
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999990463256836
who O 0 0.038734953850507736
share O 0 0.02596595324575901
the O 0 0.014708385802805424
same O 0 0.02726380154490471
COL17A1 O 1 0.9987775683403015
mutation O 0 0.19996097683906555
. O 0 0.03779609873890877

Affected O 0 0.08179434388875961
individuals O 0 0.024057907983660698
in O 0 0.009158387780189514
three O 0 0.00994439609348774
families O 0 0.020712029188871384
are O 0 0.009056593291461468
homozygous O 0 0.07774999737739563
for O 0 0.01686408929526806
4003delTC O 0 0.32841968536376953
, O 0 0.012129923328757286
whereas O 0 0.02091877907514572
those O 0 0.006382790394127369
in O 0 0.006192879285663366
two O 0 0.0064311763271689415
others O 0 0.015539461746811867
are O 0 0.010842867195606232
compound O 0 0.1014278307557106
heterozygotes O 1 0.9862244129180908
. O 0 0.038065582513809204

To O 0 0.01829272136092186
determine O 0 0.022955268621444702
if O 0 0.012003861367702484
the O 0 0.012298759073019028
occurrence O 0 0.06886164844036102
of O 0 0.011433598585426807
4003delTC O 0 0.15105952322483063
in O 0 0.011782372370362282
these O 0 0.009349669329822063
unrelated O 0 0.04594188928604126
families O 0 0.0335591584444046
signifies O 0 0.0883777067065239
propagation O 0 0.05683938041329384
of O 0 0.008398359641432762
an O 0 0.014205227605998516
ancestral O 0 0.07129915058612823
allele O 0 0.14810965955257416
or O 0 0.02942638471722603
a O 0 0.034981805831193924
mutational O 1 0.9944792985916138
hot O 0 0.09676945954561234
spot O 0 0.05726723000407219
, O 0 0.020342830568552017
haplotypes O 0 0.13668309152126312
were O 0 0.011113525368273258
determined O 0 0.025946151465177536
for O 0 0.010979986749589443
polymorphisms O 0 0.0832957923412323
both O 0 0.009732527658343315
within O 0 0.012466566637158394
and O 0 0.014093343168497086
flanking O 1 0.5216091871261597
COL17A1 O 1 0.9983099699020386
. O 0 0.03788967803120613

Five O 0 0.05590047687292099
intragenic O 0 0.25300857424736023
polymorphisms O 0 0.13625802099704742
were O 0 0.01236135233193636
chosen O 0 0.018214188516139984
based O 0 0.013959207572042942
on O 0 0.008174460381269455
their O 0 0.014110474847257137
informativeness O 1 0.6386851072311401
. O 0 0.02901095524430275

One O 0 0.015978939831256866
of O 0 0.00661613792181015
these O 0 0.006165189668536186
, O 0 0.007726126350462437
not O 0 0.0065304492600262165
previously O 0 0.015065868385136127
reported O 0 0.022543177008628845
, O 0 0.010228808969259262
was O 0 0.01890243962407112
2988 O 0 0.13534824550151825
A O 0 0.029062755405902863
or O 0 0.020068222656846046
C O 0 0.08118221163749695
that O 0 0.010318857617676258
introduces O 0 0.04420134425163269
a O 0 0.016009792685508728
new O 0 0.01541173830628395
restriction O 0 0.03736244514584541
site O 0 0.022978905588388443
for O 0 0.016084013506770134
Eco0109 O 0 0.38969966769218445
I O 0 0.0483846440911293
. O 0 0.022926906123757362

All O 0 0.01549685187637806
the O 0 0.02198789082467556
4003delTC O 0 0.29714256525039673
alleles O 0 0.1475115269422531
showed O 0 0.03435220569372177
the O 0 0.012234104797244072
same O 0 0.021204784512519836
haplotype O 1 0.8645600080490112
for O 0 0.009799818508327007
these O 0 0.00862593948841095
five O 0 0.025240929797291756
polymorphic O 0 0.22563107311725616
markers O 0 0.11610392481088638
. O 0 0.03527030721306801

Fourteen O 0 0.11258074641227722
microsatellite O 0 0.31902626156806946
polymorphisms O 0 0.1299695521593094
were O 0 0.010454720817506313
selected O 0 0.01299159787595272
based O 0 0.011675575748085976
on O 0 0.00707528879866004
their O 0 0.00884199608117342
high O 0 0.036786071956157684
heterozygosity O 1 0.5793731808662415
and O 0 0.011015077121555805
their O 0 0.009057245217263699
location O 0 0.029040515422821045
within O 0 0.023343659937381744
10q23 O 1 0.8255665898323059
- O 0 0.12251578271389008
q25 O 0 0.23382937908172607
near O 0 0.09482797980308533
COL17A1 O 1 0.9866970181465149
. O 0 0.03925352543592453

Three O 0 0.023952214047312737
families O 0 0.03886282816529274
shared O 0 0.05985220894217491
microsatellite O 0 0.3215046525001526
polymorphisms O 0 0.16310158371925354
covering O 0 0.04685027897357941
at O 0 0.022924290969967842
most O 0 0.013098283670842648
19 O 0 0.029731234535574913
cM O 0 0.04804418236017227
, O 0 0.0105457017198205
whereas O 0 0.022084519267082214
the O 0 0.00916946679353714
others O 0 0.014965154230594635
shared O 0 0.02159208059310913
smaller O 0 0.01860005035996437
regions O 0 0.02609960548579693
consistent O 0 0.03321656212210655
with O 0 0.012157273478806019
cross O 0 0.03448282927274704
- O 0 0.05192466080188751
over O 0 0.013856940902769566
events O 0 0.019163858145475388
during O 0 0.017806725576519966
passage O 0 0.021374929696321487
of O 0 0.00791905727237463
this O 0 0.012684701941907406
mutation O 0 0.08774762600660324
through O 0 0.01625385507941246
several O 0 0.01075446791946888
generations O 0 0.04054969921708107
. O 0 0.028089327737689018

These O 0 0.02072698250412941
results O 0 0.028314316645264626
indicate O 0 0.029309077188372612
that O 0 0.012985894456505775
4003delTC O 0 0.16142845153808594
occurs O 0 0.03770201653242111
on O 0 0.007319181691855192
a O 0 0.014849655330181122
single O 0 0.027628149837255478
ancestral O 0 0.08332610875368118
allele O 0 0.162797749042511
. O 0 0.023715656250715256
. O 0 0.027005115523934364

The O 0 0.053766895085573196
haptoglobin O 1 0.9924004077911377
- O 0 0.1620807647705078
gene O 0 0.13883647322654724
deletion O 0 0.14800307154655457
responsible O 0 0.04911374673247337
for O 0 0.018844809383153915
anhaptoglobinemia B-Disease 1 0.9464438557624817
. O 0 0.030584298074245453

We O 0 0.018250146880745888
have O 0 0.008728505112230778
found O 0 0.015713943168520927
an O 0 0.018753807991743088
allelic O 0 0.20157545804977417
deletion O 0 0.10927121341228485
of O 0 0.013142034411430359
the O 0 0.025886187329888344
haptoglobin O 1 0.9904748797416687
( O 0 0.053077828139066696
Hp O 0 0.4486161470413208
) O 0 0.025741595774888992
gene O 0 0.04824694246053696
from O 0 0.009325585328042507
an O 0 0.009649133309721947
individual O 0 0.018063103780150414
with O 0 0.01877458021044731
anhaptoglobinemia B-Disease 1 0.8662133812904358
. O 0 0.03366803005337715

The O 0 0.041438695043325424
Hp O 0 0.46977102756500244
gene O 0 0.10820800811052322
cluster O 0 0.06766347587108612
consists O 0 0.022340938448905945
of O 0 0.00990795623511076
coding O 0 0.07740537822246552
regions O 0 0.02353721857070923
of O 0 0.00896780751645565
the O 0 0.01780136115849018
alpha O 0 0.07455356419086456
chain O 0 0.05948711931705475
and O 0 0.015769263729453087
beta O 0 0.07033751904964447
chain O 0 0.04976429417729378
of O 0 0.010130459442734718
the O 0 0.022205110639333725
haptoglobin O 1 0.9852514266967773
gene O 0 0.1219676062464714
( O 0 0.04111667349934578
Hp O 0 0.34962567687034607
) O 0 0.01416050549596548
and O 0 0.005663350224494934
of O 0 0.005731021054089069
the O 0 0.013456649146974087
alpha O 0 0.07022875547409058
chain O 0 0.06138743460178375
and O 0 0.014256514608860016
beta O 0 0.0676865428686142
chain O 0 0.04758955538272858
of O 0 0.009450416080653667
the O 0 0.02279600501060486
haptoglobin O 1 0.9977263808250427
- O 0 0.12564139068126678
related O 0 0.056777115911245346
gene O 0 0.11884637176990509
( O 0 0.0561983585357666
Hpr O 1 0.9916819930076599
) O 0 0.022025216370821
, O 0 0.010117394849658012
in O 0 0.009358193725347519
tandem O 0 0.0581933930516243
from O 0 0.01109414640814066
the O 0 0.01159743219614029
5 O 0 0.026145271956920624
side O 0 0.036163728684186935
. O 0 0.02630888856947422

Southern O 0 0.08572695404291153
blot O 0 0.38067543506622314
and O 0 0.026283036917448044
PCR O 0 0.1682145595550537
analyses O 0 0.041549570858478546
have O 0 0.009928494691848755
indicated O 0 0.02253117598593235
that O 0 0.004671897739171982
the O 0 0.0068097468465566635
individual O 0 0.01578444242477417
with O 0 0.016630755737423897
anhaptoglobinemia B-Disease 0 0.45317819714546204
was O 0 0.024764474481344223
homozygous O 0 0.07395561784505844
for O 0 0.01054637786000967
the O 0 0.01311195082962513
gene O 0 0.0818352997303009
deletion O 0 0.09065524488687515
and O 0 0.00948395300656557
that O 0 0.007734172977507114
the O 0 0.016704047098755836
gene O 0 0.08807802945375443
deletion O 0 0.10231202840805054
was O 0 0.015795713290572166
included O 0 0.011626575142145157
at O 0 0.015222351998090744
least O 0 0.011432185769081116
from O 0 0.008351259864866734
the O 0 0.01268860138952732
promoter O 0 0.09640640765428543
region O 0 0.03136395290493965
of O 0 0.012237966060638428
Hp O 0 0.1379680037498474
to O 0 0.021735528483986855
Hpr O 1 0.9713783860206604
alpha O 0 0.07445338368415833
but O 0 0.012676331214606762
not O 0 0.010055330581963062
to O 0 0.018704917281866074
Hpr O 1 0.9931325316429138
beta O 0 0.13498573005199432
( O 0 0.050166837871074677
Hpdel O 1 0.8123152256011963
) O 0 0.03372528776526451
. O 0 0.024324744939804077

In O 0 0.01831626147031784
addition O 0 0.01738709770143032
, O 0 0.009739824570715427
we O 0 0.007333451882004738
found O 0 0.009886621497571468
seven O 0 0.010472356341779232
individuals O 0 0.013140474446117878
with O 0 0.011549343355000019
hypohaptoglobinemia B-Disease 0 0.33512529730796814
in O 0 0.009523309767246246
three O 0 0.008177538402378559
families O 0 0.018299883231520653
, O 0 0.00797954574227333
and O 0 0.006500065326690674
the O 0 0.01057190541177988
genotypes O 0 0.11214851588010788
of O 0 0.0069650583900511265
six O 0 0.010607381351292133
of O 0 0.005714327096939087
the O 0 0.00789920799434185
seven O 0 0.013089203275740147
individuals O 0 0.012028048746287823
were O 0 0.005737308878451586
found O 0 0.010435780510306358
to O 0 0.008896205574274063
be O 0 0.01648963801562786
Hp2 O 1 0.9994854927062988
/ O 1 0.9984629154205322
Hpdel O 1 0.9313738942146301
. O 0 0.034021101891994476

The O 0 0.03435250744223595
phenotypes O 0 0.1509632021188736
and O 0 0.019087286666035652
genotypes O 0 0.1369425654411316
in O 0 0.00936910416930914
one O 0 0.007123786024749279
of O 0 0.005138867534697056
these O 0 0.004676934331655502
three O 0 0.008300628513097763
families O 0 0.018794940784573555
showed O 0 0.02290232665836811
the O 0 0.009650672785937786
father O 0 0.02224266715347767
to O 0 0.011366477236151695
be O 0 0.014094014652073383
hypohaptoglobinemic B-Disease 1 0.8800135850906372
( O 0 0.04617755487561226
Hp2 O 1 0.7876244187355042
) O 0 0.027227217331528664
and O 0 0.01889321766793728
Hp2 O 1 0.999256432056427
/ O 1 0.9960440397262573
Hpdel O 1 0.6480948328971863
, O 0 0.012350749224424362
the O 0 0.01016351580619812
mother O 0 0.026729753240942955
to O 0 0.009801589883863926
be O 0 0.013678946532309055
Hp2 O 1 0.9178615212440491
- O 0 0.08668547123670578
1 O 0 0.033172640949487686
and O 0 0.02067846804857254
Hp1 O 1 0.9988856911659241
/ O 1 0.9946684241294861
Hp2 O 1 0.5401829481124878
, O 0 0.008988689631223679
one O 0 0.006128258537501097
of O 0 0.004101913422346115
the O 0 0.006898040417581797
two O 0 0.006784345023334026
children O 0 0.01866493560373783
to O 0 0.01068158634006977
be O 0 0.014108829200267792
hypohaptoglobinemic B-Disease 1 0.58136385679245
( O 0 0.039805300533771515
Hp2 O 1 0.8786528706550598
) O 0 0.027886537835001945
and O 0 0.018346281722187996
Hp2 O 1 0.9994096755981445
/ O 1 0.9985849857330322
Hpdel O 1 0.8244102597236633
, O 0 0.010539911687374115
and O 0 0.005469783209264278
the O 0 0.0065743629820644855
other O 0 0.0065964893437922
child O 0 0.027377387508749962
to O 0 0.009285490959882736
be O 0 0.01210023183375597
Hp1 O 1 0.718012273311615
and O 0 0.025332694873213768
Hp1 O 1 0.9996170997619629
/ O 1 0.9990416169166565
Hpdel O 1 0.8932772874832153
, O 0 0.015001397579908371
showing O 0 0.030087627470493317
an O 0 0.01888544298708439
anomalous O 0 0.1334698647260666
inheritance O 0 0.058924801647663116
of O 0 0.01684870570898056
Hp O 1 0.9300787448883057
phenotypes O 0 0.12552645802497864
in O 0 0.012581322342157364
the O 0 0.013423776254057884
child O 0 0.050627920776605606
with O 0 0.022862203419208527
Hp1 O 1 0.9871606826782227
. O 0 0.034834928810596466

The O 0 0.04501846805214882
Hp2 O 1 0.9993112087249756
/ O 1 0.9994408488273621
Hpdel O 1 0.9134166836738586
individuals O 0 0.02247430384159088
had O 0 0.013817411847412586
an O 0 0.011956454254686832
extremely O 0 0.03313376381993294
low O 0 0.036244750022888184
level O 0 0.023078864440321922
of O 0 0.011473204009234905
Hp O 1 0.7042888402938843
( O 0 0.04183477163314819
mean O 0 0.05985577031970024
+ O 1 0.9917271137237549
/ O 1 0.9988031387329102
- O 0 0.13707582652568817
SD O 0 0.2998749613761902
= O 0 0.15418465435504913
0 O 0 0.07378042489290237
. O 0 0.02986377291381359
049 O 1 0.9981254935264587
+ O 1 0.9731964468955994
/ O 1 0.9775493144989014
- O 0 0.1092267706990242
0 O 0 0.0718933492898941
. O 0 0.031927067786455154
043 O 1 0.9911928772926331
mg O 1 0.9986020922660828
/ O 1 0.9979200959205627
ml O 1 0.7829136252403259
; O 0 0.04228826239705086
n O 0 0.08696028590202332
= O 0 0.11246379464864731
6 O 0 0.03581782802939415
) O 0 0.01910138502717018
, O 0 0.008598381653428078
compared O 0 0.014918334782123566
with O 0 0.007277038414031267
the O 0 0.010435258969664574
level O 0 0.028481096029281616
( O 0 0.024576829746365547
1 O 0 0.018199224025011063
. O 0 0.011575834825634956
64 O 0 0.05611509084701538
+ O 1 0.9235974550247192
/ O 1 0.9823606014251709
- O 0 0.0752255767583847
1 O 0 0.03533263877034187
. O 0 0.024744577705860138
07 O 1 0.8730181455612183
mg O 1 0.9972000122070312
/ O 1 0.9958531856536865
ml O 0 0.2851715385913849
) O 0 0.027343429625034332
obtained O 0 0.01958150416612625
from O 0 0.015220128931105137
52 O 0 0.05699044093489647
healthy O 0 0.08436743170022964
volunteers O 0 0.07388033717870712
having O 0 0.04981791228055954
phenotype O 1 0.9628056883811951
Hp2 O 1 0.7413160800933838
, O 0 0.019132643938064575
whereas O 0 0.03338463231921196
the O 0 0.02312975749373436
serum O 1 0.9850639700889587
Hp O 0 0.10589160770177841
level O 0 0.025889931246638298
of O 0 0.007199156563729048
an O 0 0.009824139066040516
individual O 0 0.020054396241903305
with O 0 0.024309098720550537
Hp1 O 1 0.9996377229690552
/ O 1 0.998708963394165
Hpdel O 1 0.8631126880645752
was O 0 0.030805431306362152
0 O 0 0.05420004576444626
. O 0 0.025050314143300056

50 O 0 0.11449311673641205
mg O 1 0.9968563318252563
/ O 1 0.9955223798751831
ml O 0 0.22837601602077484
, O 0 0.014227467589080334
which O 0 0.007850424386560917
was O 0 0.011461214162409306
approximately O 0 0.014291118830442429
half O 0 0.01131079439073801
the O 0 0.008963566273450851
level O 0 0.021457185968756676
of O 0 0.00995306670665741
Hp O 0 0.11424423009157181
in O 0 0.016241295263171196
control O 0 0.04687058553099632
sera O 0 0.26540449261665344
from O 0 0.017261112108826637
the O 0 0.022636815905570984
Hp1 O 1 0.9861409664154053
phenotype O 1 0.8157908916473389
( O 0 0.03289102762937546
1 O 0 0.019570058211684227
. O 0 0.012817231006920338
26 O 0 0.044499557465314865
+ O 1 0.9050214886665344
/ O 1 0.9766597747802734
- O 0 0.08746518194675446
0 O 0 0.05534778907895088
. O 0 0.01940084435045719
33 O 0 0.06879201531410217
mg O 1 0.9962080717086792
/ O 1 0.9924547672271729
ml O 0 0.49701693654060364
; O 0 0.04647928476333618
n O 0 0.08693341165781021
= O 0 0.10769462585449219
9 O 0 0.0324053019285202
) O 0 0.016060464084148407
, O 0 0.008908567018806934
showing O 0 0.029740385711193085
a O 0 0.029399391263723373
gene O 0 0.13333706557750702
- O 0 0.3591654896736145
dosage O 1 0.9962087869644165
effect O 0 0.06983745843172073
. O 0 0.032053716480731964

The O 0 0.022506996989250183
other O 0 0.017145374789834023
allele O 0 0.1696814000606537
( O 0 0.04666014388203621
Hp2 O 1 0.5233207941055298
) O 0 0.019551031291484833
of O 0 0.007566738873720169
individuals O 0 0.019237415865063667
with O 0 0.022037789225578308
Hp2 O 1 0.9998397827148438
/ O 1 0.9993459582328796
Hpdel O 1 0.9428335428237915
was O 0 0.01720324531197548
found O 0 0.010922745801508427
to O 0 0.006570536643266678
have O 0 0.006115319672971964
, O 0 0.006591919343918562
in O 0 0.006143077276647091
all O 0 0.008289370685815811
exons O 0 0.07513530552387238
, O 0 0.014323943294584751
no O 0 0.020861314609646797
mutation O 0 0.09955421090126038
, O 0 0.012639413587749004
by O 0 0.014293416403234005
DNA O 0 0.07480472326278687
sequencing O 0 0.08292846381664276
. O 0 0.03296785056591034

On O 0 0.013340075500309467
the O 0 0.008006349205970764
basis O 0 0.007735029328614473
of O 0 0.004761721473187208
the O 0 0.007887572050094604
present O 0 0.013390700332820415
study O 0 0.017900655046105385
, O 0 0.007436027284711599
the O 0 0.00952352024614811
mechanism O 0 0.04148637130856514
of O 0 0.010567864403128624
anhaptoglobinemia B-Disease 0 0.32650014758110046
and O 0 0.00769044877961278
the O 0 0.009097334928810596
mechanism O 0 0.044096749275922775
of O 0 0.012771663255989552
anomalous O 0 0.27862149477005005
inheritance O 0 0.07116835564374924
of O 0 0.018389888107776642
Hp O 1 0.974494218826294
phenotypes O 0 0.1373574584722519
were O 0 0.012435725890100002
well O 0 0.014201241545379162
explained O 0 0.03653901442885399
. O 0 0.0238102525472641

However O 0 0.023325147107243538
, O 0 0.01177043467760086
the O 0 0.01120042148977518
mechanism O 0 0.046849630773067474
of O 0 0.01503663882613182
hypohaptoglobinemia B-Disease 1 0.9111295938491821
remains O 0 0.04948335513472557
unknown O 0 0.07739996910095215

ATM O 0 0.3914848268032074
mutations O 0 0.14384953677654266
and O 0 0.020312607288360596
phenotypes O 0 0.1800980120897293
in O 0 0.0428217388689518
ataxia B-Disease 1 1.0
- I-Disease 1 0.9993935823440552
telangiectasia I-Disease 1 0.9999743700027466
families O 0 0.038471922278404236
in O 0 0.013043330051004887
the O 0 0.013093255460262299
British O 0 0.040087684988975525
Isles O 0 0.10192672908306122
: O 0 0.02025768533349037
expression O 0 0.03035258688032627
of O 0 0.010656291618943214
mutant O 0 0.10795814543962479
ATM O 0 0.10360211879014969
and O 0 0.010393972508609295
the O 0 0.013900947757065296
risk O 1 0.9870641231536865
of O 0 0.025365380570292473
leukemia B-Disease 1 1.0
, O 1 0.9955963492393494
lymphoma B-Disease 1 1.0
, O 0 0.02691691927611828
and O 0 0.05765962228178978
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.03555598855018616

We O 0 0.018607409670948982
report O 0 0.01570376753807068
the O 0 0.0123529601842165
spectrum O 0 0.04340686276555061
of O 0 0.012147518806159496
59 O 0 0.07727029919624329
ATM O 0 0.16576926410198212
mutations O 0 0.12255188822746277
observed O 0 0.04880272224545479
in O 0 0.035765163600444794
ataxia B-Disease 1 1.0
- I-Disease 1 0.9996540546417236
telangiectasia I-Disease 1 0.9999957084655762
( O 0 0.10416392236948013
A B-Disease 1 0.9996989965438843
- I-Disease 1 0.9999268054962158
T I-Disease 1 0.9999996423721313
) O 0 0.03946496546268463
patients O 1 0.9989049434661865
in O 0 0.00958504993468523
the O 0 0.011591240763664246
British O 0 0.038250286132097244
Isles O 0 0.12340342253446579
. O 0 0.02922540158033371

Of O 0 0.027801446616649628
51 O 0 0.09190923720598221
ATM O 0 0.23224812746047974
mutations O 0 0.11849524825811386
identified O 0 0.03136430308222771
in O 0 0.012037821114063263
families O 0 0.018988942727446556
native O 0 0.01488348376005888
to O 0 0.008171213790774345
the O 0 0.010937044396996498
British O 0 0.032464757561683655
Isles O 0 0.07643359154462814
, O 0 0.01189795695245266
11 O 0 0.01791379600763321
were O 0 0.012607650831341743
founder O 0 0.06121925637125969
mutations O 0 0.08490945398807526
, O 0 0.011430473066866398
and O 0 0.007135119754821062
2 O 0 0.012814052402973175
of O 0 0.005301190540194511
these O 0 0.006389101967215538
11 O 0 0.020830892026424408
conferred O 0 0.059354882687330246
a O 0 0.031374167650938034
milder O 1 0.9945640563964844
clinical O 1 0.9971689581871033
phenotype O 1 0.7734176516532898
with O 0 0.012759187258780003
respect O 0 0.017036356031894684
to O 0 0.008790510706603527
both O 0 0.019878460094332695
cerebellar B-Disease 1 0.9999994039535522
degeneration I-Disease 1 0.9999998807907104
and O 0 0.02116863988339901
cellular O 0 0.07515548914670944
features O 0 0.034417860209941864
. O 0 0.024855758994817734

We O 0 0.01669294387102127
report O 0 0.014026702381670475
, O 0 0.007369821425527334
in O 0 0.006176396273076534
two O 0 0.008790610358119011
A B-Disease 1 0.8582648634910583
- I-Disease 1 0.9783627986907959
T I-Disease 1 0.9999592304229736
families O 0 0.03254709020256996
, O 0 0.014801600947976112
an O 0 0.022313913330435753
ATM O 0 0.1763267070055008
mutation O 0 0.18025726079940796
( O 0 0.06302420794963837
7271T O 1 0.996953010559082
- O 1 0.9640066027641296
- O 0 0.4595690965652466
> O 0 0.2862384617328644
G O 0 0.17056956887245178
) O 0 0.019751405343413353
that O 0 0.007378656417131424
may O 0 0.012216323986649513
be O 0 0.005531711969524622
associated O 0 0.011546535417437553
with O 0 0.007457557134330273
an O 0 0.01207668986171484
increased O 0 0.03405043110251427
risk O 1 0.9864645004272461
of O 0 0.022658642381429672
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.013649668544530869
both O 0 0.016860270872712135
homozygotes O 1 0.9987493753433228
and O 0 0.021537065505981445
heterozygotes O 1 0.9976146221160889
( O 0 0.03808385878801346
relative O 0 0.05095884948968887
risk O 0 0.09242457151412964
12 O 0 0.021456917747855186
. O 0 0.01244842167943716
7 O 0 0.029735468327999115
; O 0 0.030213404446840286
P O 1 0.9407886862754822
= O 0 0.13131649792194366
. O 0 0.027814891189336777
0025 O 1 0.9929674863815308
) O 0 0.02303285151720047
, O 0 0.009263325482606888
although O 0 0.008788563311100006
there O 0 0.0061469851061701775
is O 0 0.0090507036074996
a O 0 0.01420570258051157
less O 0 0.02241426706314087
severe O 1 0.9999969005584717
A B-Disease 1 0.9998062252998352
- I-Disease 1 0.9995278120040894
T I-Disease 1 0.9999915361404419
phenotype O 0 0.3760206699371338
in O 0 0.009220876730978489
terms O 0 0.008727301843464375
of O 0 0.0047208284959197044
the O 0 0.009610704146325588
degree O 0 0.033406876027584076
of O 0 0.019907411187887192
cerebellar B-Disease 1 0.9999996423721313
degeneration I-Disease 1 0.9999998807907104
. O 0 0.04137978330254555

This O 0 0.03619737923145294
mutation O 0 0.1712741106748581
( O 0 0.05519400164484978
7271T O 1 0.988286554813385
- O 1 0.9115832448005676
- O 0 0.3655690848827362
> O 0 0.2332998663187027
G O 0 0.15849480032920837
) O 0 0.02324608713388443
also O 0 0.011944087222218513
allows O 0 0.021468793973326683
expression O 0 0.0272058192640543
of O 0 0.008666238747537136
full O 0 0.025669429451227188
- O 0 0.07635094970464706
length O 0 0.05086783692240715
ATM O 0 0.1358242928981781
protein O 0 0.05241122841835022
at O 0 0.017351143062114716
a O 0 0.01442051399499178
level O 0 0.022919246926903725
comparable O 0 0.025942083448171616
with O 0 0.007624474354088306
that O 0 0.008123709820210934
in O 0 0.01278279721736908
unaffected O 1 0.5783058404922485
individuals O 0 0.027812499552965164
. O 0 0.025968244299292564

In O 0 0.019199524074792862
addition O 0 0.017558613792061806
, O 0 0.00914875976741314
we O 0 0.00601388281211257
have O 0 0.006216377019882202
studied O 0 0.018506398424506187
18 O 0 0.02157655730843544
A B-Disease 1 0.9979841709136963
- I-Disease 1 0.9999372959136963
T I-Disease 1 0.9999998807907104
patients O 1 0.9999444484710693
, O 0 0.010085477493703365
in O 0 0.007913712412118912
15 O 0 0.01416628435254097
families O 0 0.01940801739692688
, O 0 0.012591497972607613
who O 0 0.02592048980295658
developed O 1 0.9801011085510254
leukemia B-Disease 1 1.0
, O 1 0.8148802518844604
lymphoma B-Disease 1 1.0
, O 0 0.03838082030415535
preleukemic O 1 0.9999909400939941
T O 1 0.999998927116394
- O 1 0.893436849117279
cell O 0 0.31369680166244507
proliferation O 0 0.305801123380661
, O 0 0.024200085550546646
or O 1 0.9630418419837952
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.020477987825870514
mostly O 0 0.016512727364897728
in O 0 0.01454665046185255
childhood O 1 0.8930257558822632
. O 0 0.03166769817471504

A O 0 0.042195338755846024
wide O 0 0.03307560831308365
variety O 0 0.0244562067091465
of O 0 0.017308933660387993
ATM O 0 0.2275293469429016
mutation O 0 0.14645877480506897
types O 0 0.031044503673911095
, O 0 0.013754087500274181
including O 0 0.016988113522529602
missense O 0 0.17711851000785828
mutations O 0 0.10049757361412048
and O 0 0.012202493846416473
in O 0 0.013802632689476013
- O 0 0.07954617589712143
frame O 0 0.06447821110486984
deletions O 0 0.07296436280012131
, O 0 0.011386620812118053
were O 0 0.007800472434610128
seen O 0 0.016302799805998802
in O 0 0.008719665929675102
these O 0 0.010772131383419037
patients O 1 0.9999328851699829
. O 0 0.0243375226855278

We O 0 0.018185405060648918
also O 0 0.011321010068058968
show O 0 0.016426490619778633
that O 0 0.006484095938503742
25 O 0 0.011287892237305641
% O 0 0.010525311343371868
of O 0 0.005136372521519661
all O 0 0.0081560667604208
A B-Disease 1 0.9986515641212463
- I-Disease 1 0.9999197721481323
T I-Disease 1 0.9999996423721313
patients O 1 0.9998388290405273
carried O 0 0.023119399324059486
in O 0 0.013802476227283478
- O 0 0.08779231458902359
frame O 0 0.07761546224355698
deletions O 0 0.12006805092096329
or O 0 0.0425352044403553
missense O 0 0.3675011098384857
mutations O 0 0.10121715068817139
, O 0 0.009496561251580715
many O 0 0.005608201026916504
of O 0 0.004711217246949673
which O 0 0.006501413881778717
were O 0 0.00607392517849803
also O 0 0.008331325836479664
associated O 0 0.013798023574054241
with O 0 0.009797115810215473
expression O 0 0.0312989167869091
of O 0 0.013859430328011513
mutant O 0 0.14228670299053192
ATM O 0 0.18673789501190186
protein O 0 0.08820486813783646
. O 0 0.03388308361172676

The O 0 0.0404689647257328
DMPK O 1 0.9930903315544128
gene O 0 0.09526480734348297
of O 0 0.024338070303201675
severely O 1 0.9999382495880127
affected O 1 0.999972939491272
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
is O 0 0.033241771161556244
hypermethylated O 1 0.9937413334846497
proximal O 1 0.9724436402320862
to O 0 0.010821735486388206
the O 0 0.010376771911978722
largely O 0 0.030609188601374626
expanded O 0 0.05144938454031944
CTG O 1 0.997505247592926
repeat O 0 0.1365698277950287
. O 0 0.036672864109277725

Using O 0 0.053989022970199585
methylation O 0 0.14864614605903625
- O 0 0.10470462590456009
sensitive O 0 0.06929627805948257
restriction O 0 0.06398701667785645
enzymes O 0 0.0571870431303978
, O 0 0.01449140626937151
we O 0 0.01200647372752428
characterized O 0 0.05372696742415428
the O 0 0.017781781032681465
methylation O 0 0.09591465443372726
pattern O 0 0.044152721762657166
on O 0 0.007924330420792103
the O 0 0.00849695410579443
5 O 0 0.015435664914548397
side O 0 0.01760077103972435
of O 0 0.0074176606722176075
the O 0 0.016027230769395828
CTG O 1 0.999173104763031
repeat O 0 0.07529962062835693
in O 0 0.012989642098546028
the O 0 0.020026464015245438
DMPK O 1 0.9880130290985107
gene O 0 0.06896290928125381
of O 0 0.010007900185883045
normal O 0 0.03550407662987709
individuals O 0 0.016397293657064438
and O 0 0.007808411959558725
of O 0 0.011573477648198605
patients O 1 0.9999992847442627
affected O 1 0.6095830798149109
with O 0 0.06857564300298691
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.02505313791334629
showing O 0 0.03471765294671059
expansions O 0 0.041607629507780075
of O 0 0.009211798198521137
the O 0 0.01799865812063217
repetitive O 0 0.1442139446735382
sequence O 0 0.055137913674116135
. O 0 0.028933346271514893

The O 0 0.03645128756761551
gene O 0 0.10107272118330002
segment O 0 0.07465019077062607
analyzed O 0 0.04371872916817665
corresponds O 0 0.03793421760201454
to O 0 0.01164940930902958
the O 0 0.018363673239946365
genomic O 0 0.16553053259849548
SacI O 1 0.9955192804336548
- O 0 0.15704576671123505
HindIII O 0 0.25749456882476807
fragment O 0 0.10546348989009857
carrying O 0 0.054653044790029526
exons O 0 0.10824038088321686
11 O 0 0.047039713710546494
- O 0 0.08315536379814148
15 O 0 0.03722776472568512
. O 0 0.02959640510380268

There O 0 0.027227919548749924
is O 0 0.024822304025292397
constitutive O 0 0.13096505403518677
methylation O 0 0.11217302829027176
in O 0 0.026820946484804153
intron O 0 0.39486658573150635
12 O 0 0.03698035702109337
at O 0 0.021964116021990776
restriction O 0 0.033346015959978104
sites O 0 0.017571112141013145
of O 0 0.012172234244644642
SacII O 1 0.74089515209198
and O 0 0.021091092377901077
HhaI O 1 0.7130502462387085
, O 0 0.02216794714331627
localized O 0 0.1022106409072876
1 O 0 0.029630670323967934
, O 0 0.016359500586986542
159 O 0 0.09255384653806686
- O 0 0.08285383135080338
1 O 0 0.031122596934437752
, O 0 0.016734108328819275
232 O 0 0.09471813589334488
bp O 0 0.10345268994569778
upstream O 0 0.05100209265947342
of O 0 0.010527288541197777
the O 0 0.023709552362561226
CTG O 1 0.9996283054351807
repeat O 0 0.09522515535354614
, O 0 0.015743765980005264
whereas O 0 0.023684855550527573
most O 0 0.007975692860782146
, O 0 0.007763059344142675
if O 0 0.007318118121474981
not O 0 0.004176652058959007
all O 0 0.004048611968755722
, O 0 0.004813019651919603
of O 0 0.003646790748462081
the O 0 0.006319369189441204
other O 0 0.006260007154196501
sites O 0 0.014107954688370228
of O 0 0.01163510512560606
SacII O 1 0.9503078460693359
, O 0 0.022952044382691383
HhaI O 1 0.8940753936767578
, O 0 0.013107569888234138
and O 0 0.01220040675252676
HpaII O 0 0.368009477853775
in O 0 0.010092134587466717
this O 0 0.009127147495746613
region O 0 0.0245383158326149
are O 0 0.010800999589264393
unmethylated O 1 0.840996503829956
, O 0 0.013217397034168243
in O 0 0.009795921854674816
normal O 0 0.03194278106093407
individuals O 0 0.013729838654398918
and O 0 0.006125102750957012
most O 0 0.006470539607107639
of O 0 0.00666611734777689
the O 0 0.019879499450325966
patients O 1 0.9999834299087524
. O 0 0.02960173971951008

In O 0 0.016800260171294212
a O 0 0.015174061991274357
number O 0 0.007148641627281904
of O 0 0.007423869799822569
young O 0 0.03348540514707565
and O 0 0.018124453723430634
severely O 1 0.9998937845230103
affected O 1 0.9815639853477478
patients O 1 0.9999936819076538
, O 0 0.009924201294779778
however O 0 0.009045463055372238
, O 0 0.008627012372016907
complete O 0 0.020002974197268486
methylation O 0 0.05142953619360924
of O 0 0.007521913852542639
these O 0 0.007158384658396244
restriction O 0 0.034469716250896454
sites O 0 0.01730189472436905
was O 0 0.012312511913478374
found O 0 0.011375815607607365
in O 0 0.008576479740440845
the O 0 0.016938431188464165
mutated O 0 0.16958776116371155
allele O 0 0.2210846245288849
. O 0 0.04333409667015076

In O 0 0.01568610966205597
most O 0 0.009553356096148491
of O 0 0.006840826012194157
these O 0 0.010392799973487854
patients O 1 0.9999423027038574
, O 0 0.010331973433494568
the O 0 0.013446497730910778
onset O 1 0.9999433755874634
of O 0 0.012639930471777916
the O 0 0.026691623032093048
disease O 1 1.0
was O 1 0.8919535279273987
congenital O 1 1.0
. O 0 0.03638971969485283

Preliminary O 0 0.061095256358385086
in O 0 0.034547314047813416
vivo O 1 0.6282634735107422
footprinting O 1 0.9982339143753052
data O 0 0.021767161786556244
gave O 0 0.019968433305621147
evidence O 0 0.01493648812174797
for O 0 0.012437746860086918
protein O 0 0.06732954829931259
- O 0 0.07208859920501709
DNA O 0 0.06258033961057663
contact O 0 0.045391205698251724
in O 0 0.013986919075250626
normal O 0 0.04360145330429077
genes O 0 0.051447950303554535
at O 0 0.02389000542461872
an O 0 0.023131947964429855
Sp1 O 1 0.9953054189682007
consensus O 0 0.03864837810397148
binding O 0 0.04041485860943794
site O 0 0.025815319269895554
upstream O 0 0.03780485689640045
of O 0 0.009121507406234741
the O 0 0.020252259448170662
CTG O 1 0.9991766810417175
repeat O 0 0.07304558902978897
and O 0 0.009150895290076733
for O 0 0.00684381602331996
a O 0 0.013527240604162216
significant O 0 0.01942375674843788
reduction O 0 0.03819042444229126
of O 0 0.007600307464599609
this O 0 0.008008310571312904
interaction O 0 0.027911491692066193
in O 0 0.011409992352128029
cells O 0 0.05063888430595398
with O 0 0.01341423112899065
a O 0 0.02851700596511364
hypermethylated O 1 0.9928922653198242
DMPK O 1 0.9987515211105347
gene O 0 0.10416530817747116
. O 0 0.020774636417627335
. O 0 0.02691744826734066

The O 0 0.07137593626976013
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.14351049065589905
product O 0 0.04257561266422272
complexes O 0 0.07141964137554169
with O 0 0.012902448885142803
the O 0 0.020311439409852028
transferrin O 1 0.9932070374488831
receptor O 0 0.17467865347862244
and O 0 0.017688700929284096
lowers O 0 0.3894248604774475
its O 0 0.01923470012843609
affinity O 0 0.08352944999933243
for O 0 0.020690293982625008
ligand O 0 0.14513923227787018
binding O 0 0.06767372041940689
. O 0 0.0295786801725626

We O 0 0.02524750493466854
recently O 0 0.032774075865745544
reported O 0 0.028149686753749847
the O 0 0.01292671449482441
positional O 0 0.07752551883459091
cloning O 0 0.049323324114084244
of O 0 0.008959650062024593
a O 0 0.01676064170897007
candidate O 0 0.03207817301154137
gene O 0 0.07595852762460709
for O 0 0.023126907646656036
hereditary B-Disease 1 0.9999997615814209
hemochromatosis I-Disease 1 1.0
called O 0 0.1478859782218933
HFE O 1 0.9999734163284302
. O 0 0.03712846338748932

The O 0 0.03259819373488426
gene O 0 0.0740385577082634
product O 0 0.02289537899196148
, O 0 0.009338682517409325
a O 0 0.010694565251469612
member O 0 0.011281434446573257
of O 0 0.006130727473646402
the O 0 0.0116244712844491
major O 0 0.03192926198244095
histocompatibility O 1 0.999653697013855
complex O 0 0.054814502596855164
class O 0 0.07411681115627289
I O 0 0.34503549337387085
- O 0 0.05822912976145744
like O 0 0.01658807508647442
family O 0 0.022305883467197418
, O 0 0.008777731098234653
was O 0 0.011238306760787964
found O 0 0.009087841026484966
to O 0 0.005666556768119335
have O 0 0.007505312096327543
a O 0 0.020538320764899254
mutation O 0 0.1262311339378357
, O 0 0.030451670289039612
Cys O 1 0.9999525547027588
- O 0 0.42303839325904846
282 O 1 0.5287721157073975
- O 1 0.9129140973091125
- O 0 0.3166853189468384
> O 0 0.291553258895874
Tyr O 1 0.9941746592521667
( O 0 0.06305839866399765
C282Y O 0 0.17961177229881287
) O 0 0.023662833496928215
, O 0 0.00960351899266243
in O 0 0.00986048486083746
85 O 0 0.04726022109389305
% O 0 0.02225523255765438
of O 0 0.01431722566485405
patient O 1 0.9980613589286804
chromosomes O 0 0.09823846071958542
. O 0 0.031046658754348755

This O 0 0.031628821045160294
mutation O 0 0.14251910150051117
eliminates O 0 0.10602642595767975
the O 0 0.015245507471263409
ability O 0 0.026383044198155403
of O 0 0.01294021587818861
HFE O 1 0.9983170032501221
to O 0 0.014352516271173954
associate O 0 0.03505224734544754
with O 0 0.02028517611324787
beta2 O 1 0.9905992150306702
- O 0 0.14938707649707794
microglobulin O 1 0.8514698147773743
( O 0 0.04925229400396347
beta2m O 1 0.8856985569000244
) O 0 0.022099733352661133
and O 0 0.014248570427298546
prevents O 0 0.2529541552066803
cell O 0 0.20376284420490265
- O 0 0.09222860634326935
surface O 0 0.06123178079724312
expression O 0 0.06724437326192856
. O 0 0.029449932277202606

A O 0 0.05325227230787277
second O 0 0.03703167662024498
mutation O 0 0.11002401262521744
that O 0 0.00963508989661932
has O 0 0.011899632401764393
no O 0 0.012775113806128502
effect O 0 0.024507839232683182
on O 0 0.01280491054058075
beta2m O 1 0.9085299372673035
association O 0 0.05145947262644768
, O 0 0.020629510283470154
H63D O 1 0.9903432130813599
, O 0 0.013302145525813103
was O 0 0.014223101548850536
found O 0 0.011411909013986588
in O 0 0.006775329355150461
eight O 0 0.00956046488136053
out O 0 0.008243790827691555
of O 0 0.008876991458237171
nine O 0 0.02935772016644478
patients O 1 0.9989509582519531
heterozygous O 0 0.10094191133975983
for O 0 0.011514855548739433
the O 0 0.01852288655936718
C282Y O 0 0.2025340050458908
mutant O 0 0.1421779990196228
. O 0 0.03725728020071983

In O 0 0.016670916229486465
this O 0 0.008907401002943516
report O 0 0.012870718725025654
, O 0 0.008620953187346458
we O 0 0.008077748119831085
demonstrate O 0 0.025685641914606094
in O 0 0.013602882623672485
cultured O 0 0.13558444380760193
293 O 0 0.488827109336853
cells O 0 0.1536666303873062
overexpressing O 1 0.9850776195526123
wild O 0 0.08291883021593094
- O 0 0.11463525146245956
type O 0 0.07823251932859421
or O 0 0.02931753732264042
mutant O 0 0.14046207070350647
HFE O 1 0.9879611134529114
proteins O 0 0.03723251819610596
that O 0 0.007212419528514147
both O 0 0.007229819428175688
the O 0 0.011464780196547508
wild O 0 0.04441145062446594
- O 0 0.08299381285905838
type O 0 0.07054859399795532
and O 0 0.024013418704271317
H63D O 1 0.9980619549751282
HFE O 1 0.9985873699188232
proteins O 0 0.06207162141799927
form O 0 0.03763589262962341
stable O 0 0.08641593158245087
complexes O 0 0.06883751600980759
with O 0 0.014394992962479591
the O 0 0.02503451704978943
transferrin O 1 0.9947904348373413
receptor O 0 0.3725159764289856
( O 0 0.06853694468736649
TfR O 1 0.9996392726898193
) O 0 0.04466366395354271
. O 0 0.0313052274286747

The O 0 0.044943492859601974
C282Y O 0 0.2668159008026123
mutation O 0 0.16657158732414246
nearly O 0 0.04306674003601074
completely O 0 0.04236814007163048
prevents O 0 0.06117772310972214
the O 0 0.011576816439628601
association O 0 0.02857781946659088
of O 0 0.008147048763930798
the O 0 0.016935819759964943
mutant O 0 0.1539037674665451
HFE O 1 0.9982607960700989
protein O 0 0.06498118489980698
with O 0 0.016742058098316193
the O 0 0.02917759120464325
TfR O 1 0.9996634721755981
. O 0 0.04041541367769241

Studies O 0 0.04839686304330826
on O 0 0.02017543464899063
cell O 0 0.09835242480039597
- O 0 0.08338410407304764
associated O 0 0.04211163893342018
transferrin O 0 0.2945427894592285
at O 0 0.032558344304561615
37 O 0 0.044749144464731216
degrees O 0 0.04963081330060959
C O 0 0.08753401041030884
suggest O 0 0.022338859736919403
that O 0 0.00783433299511671
the O 0 0.015837950631976128
overexpressed O 0 0.4949154555797577
wild O 0 0.07947789877653122
- O 0 0.13699646294116974
type O 0 0.13891437649726868
HFE O 1 0.9963900446891785
protein O 0 0.09243984520435333
decreases O 0 0.0716668888926506
the O 0 0.015505561605095863
affinity O 0 0.05720596760511398
of O 0 0.008627811446785927
the O 0 0.017153071239590645
TfR O 1 0.9998089671134949
for O 0 0.023449519649147987
transferrin O 1 0.9883258938789368
. O 0 0.03440866246819496

The O 0 0.05531391128897667
overexpressed O 1 0.9110985398292542
H63D O 1 0.9883478283882141
protein O 0 0.07366397976875305
does O 0 0.017151203006505966
not O 0 0.006802664604038
have O 0 0.006482339464128017
this O 0 0.0066426037810742855
effect O 0 0.021898366510868073
, O 0 0.006925029680132866
providing O 0 0.01442389003932476
the O 0 0.006748318672180176
first O 0 0.009191757068037987
direct O 0 0.015760593116283417
evidence O 0 0.010768762789666653
for O 0 0.007601396180689335
a O 0 0.01576535589993
functional O 0 0.04180414229631424
consequence O 0 0.03913465142250061
of O 0 0.009921647608280182
the O 0 0.021522145718336105
H63D O 1 0.9994868040084839
mutation O 0 0.17909488081932068
. O 0 0.035465359687805176

Addition O 0 0.03440295159816742
of O 0 0.0186091810464859
soluble O 0 0.14360234141349792
wild O 0 0.07596287876367569
- O 0 0.33928796648979187
type O 1 0.7284404635429382
HFE O 1 0.9999784231185913
/ O 1 0.998377799987793
beta2m O 1 0.888317883014679
heterodimers O 1 0.7270779609680176
to O 0 0.02489076368510723
cultured O 0 0.11973375082015991
cells O 0 0.06883250921964645
also O 0 0.012681697495281696
decreased O 0 0.045477867126464844
the O 0 0.013104721903800964
apparent O 0 0.05671677738428116
affinity O 0 0.057391684502363205
of O 0 0.008937320671975613
the O 0 0.01764136552810669
TfR O 1 0.9985775947570801
for O 0 0.010733936913311481
its O 0 0.013224078342318535
ligand O 0 0.10235347598791122
under O 0 0.02038412354886532
steady O 0 0.07757600396871567
- O 0 0.0578402541577816
state O 0 0.016631847247481346
conditions O 0 0.03260559216141701
, O 0 0.007913057692348957
both O 0 0.007101751863956451
in O 0 0.011291512288153172
293 O 0 0.20805267989635468
cells O 0 0.06774770468473434
and O 0 0.011844377964735031
in O 0 0.0224398672580719
HeLa O 1 0.9980553388595581
cells O 0 0.13408629596233368
. O 0 0.03524588793516159

Furthermore O 0 0.06844618916511536
, O 0 0.017610525712370872
at O 0 0.02226877771317959
4 O 0 0.027994126081466675
degrees O 0 0.046866558492183685
C O 0 0.07696066796779633
, O 0 0.008981946855783463
the O 0 0.010696006938815117
added O 0 0.021730242297053337
soluble O 0 0.10245830565690994
complex O 0 0.04328738898038864
of O 0 0.025838425382971764
HFE O 1 0.9999927282333374
/ O 1 0.9988362193107605
beta2m O 1 0.9058360457420349
inhibited O 0 0.15854263305664062
binding O 0 0.05120507627725601
of O 0 0.016565391793847084
transferrin O 1 0.656270444393158
to O 0 0.02865120954811573
HeLa O 1 0.9947329759597778
cell O 0 0.14085885882377625
TfR O 1 0.9957520961761475
in O 0 0.016172975301742554
a O 0 0.027440819889307022
concentration O 0 0.16255830228328705
- O 0 0.08838111907243729
dependent O 0 0.06742393225431442
manner O 0 0.04329458624124527
. O 0 0.02860601805150509

Scatchard O 0 0.2078700065612793
plots O 0 0.04086904227733612
of O 0 0.008273037150502205
these O 0 0.0071616219356656075
data O 0 0.012902302667498589
indicate O 0 0.018075821921229362
that O 0 0.006325974594801664
the O 0 0.01012346614152193
added O 0 0.027062159031629562
heterodimer O 1 0.8754356503486633
substantially O 0 0.06477807462215424
reduced O 0 0.03779458999633789
the O 0 0.016144229099154472
affinity O 0 0.07748313993215561
of O 0 0.0174446739256382
TfR O 1 0.9996111989021301
for O 0 0.02807118557393551
transferrin O 1 0.9881430268287659
. O 0 0.03664220869541168

These O 0 0.014026300050318241
results O 0 0.021753735840320587
establish O 0 0.029782826080918312
a O 0 0.022186778485774994
molecular O 0 0.059629641473293304
link O 0 0.05681409686803818
between O 0 0.022235624492168427
HFE O 1 0.9987867474555969
and O 0 0.01287715882062912
a O 0 0.01939452439546585
key O 0 0.025087863206863403
protein O 0 0.04189302399754524
involved O 0 0.021105946972966194
in O 0 0.01313344482332468
iron O 0 0.07373032718896866
transport O 0 0.033426955342292786
, O 0 0.014013458974659443
the O 0 0.018202591687440872
TfR O 1 0.9999203681945801
, O 0 0.013554935343563557
and O 0 0.007824072614312172
raise O 0 0.021736260503530502
the O 0 0.009006734937429428
possibility O 0 0.024132639169692993
that O 0 0.008550690487027168
alterations O 0 0.02973175421357155
in O 0 0.009595004841685295
this O 0 0.009994897060096264
regulatory O 0 0.057915665209293365
mechanism O 0 0.057754192501306534
may O 0 0.01680908352136612
play O 0 0.00946602039039135
a O 0 0.009479792788624763
role O 0 0.014538981951773167
in O 0 0.009112435393035412
the O 0 0.015158507972955704
pathogenesis O 1 0.999991774559021
of O 0 0.02848977781832218
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.029275067150592804
. O 0 0.02955755405128002

Genomic O 0 0.13826453685760498
organization O 0 0.03525394946336746
of O 0 0.011918216943740845
the O 0 0.028035065159201622
UBE3A O 1 0.9999910593032837
/ O 1 0.9998736381530762
E6 O 1 0.9999200105667114
- O 0 0.4526515603065491
AP O 0 0.1122630164027214
gene O 0 0.06992517411708832
and O 0 0.013507461175322533
related O 0 0.03715306520462036
pseudogenes O 0 0.1496172994375229
. O 0 0.037285614758729935

The O 0 0.05283372476696968
UBE3A O 1 0.9525017738342285
gene O 0 0.11981182545423508
encodes O 0 0.09222777187824249
the O 0 0.032006461173295975
E6 O 1 0.9990549683570862
- O 0 0.14206312596797943
AP O 0 0.13478973507881165
ubiquitin O 0 0.18944315612316132
- O 0 0.11129020154476166
protein O 0 0.08265228569507599
ligase O 0 0.08890340477228165
and O 0 0.0112480279058218
has O 0 0.014289024285972118
recently O 0 0.02355632185935974
been O 0 0.010838470421731472
shown O 0 0.017131382599473
to O 0 0.008666882291436195
be O 0 0.011645829305052757
mutated O 0 0.2410666048526764
in O 1 0.5467793345451355
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
who O 0 0.04031020775437355
lack O 0 0.0687461867928505
15q11 O 1 0.9973690509796143
- O 0 0.17156565189361572
q13 O 0 0.3493739664554596
deletions O 0 0.14044956862926483
or O 0 0.04407245293259621
chromosome O 0 0.16450004279613495
15 O 0 0.05252278968691826
paternal O 0 0.34702855348587036
uniparental B-Disease 1 0.9999613761901855
disomy I-Disease 1 0.9856598377227783
. O 0 0.04648170620203018

Previous O 0 0.08303501456975937
UBE3A O 1 0.9635366797447205
cDNA O 0 0.17341241240501404
analysis O 0 0.03310222923755646
has O 0 0.017452972009778023
shown O 0 0.02251608297228813
a O 0 0.020168742164969444
coding O 0 0.07587642967700958
region O 0 0.025682391598820686
of O 0 0.009435763582587242
approximately O 0 0.02847844362258911
2 O 0 0.03225936368107796
. O 0 0.025367917492985725

6 O 0 0.06864798814058304
kb O 0 0.11508415639400482
and O 0 0.01277554128319025
a O 0 0.02042533829808235
3 O 0 0.04026810824871063
- O 0 0.09310299158096313
untranslated O 0 0.16672077775001526
region O 0 0.06435801833868027
( O 0 0.052339810878038406
UTR O 1 0.6623981595039368
) O 0 0.02810104563832283
of O 0 0.01492445357143879
< O 0 0.15418410301208496
50 O 0 0.03960606828331947
bp O 0 0.09151599556207657
, O 0 0.01648511365056038
whereas O 0 0.031319569796323776
Northern O 0 0.02802591398358345
analysis O 0 0.026193516328930855
has O 0 0.017969945445656776
indicated O 0 0.039378903806209564
mRNA O 0 0.04612299054861069
sizes O 0 0.023344583809375763
of O 0 0.010520712472498417
5 O 0 0.03503565862774849
- O 0 0.0856749415397644
8 O 0 0.0446723997592926
kb O 0 0.14821398258209229
. O 0 0.03678223863244057

We O 0 0.018591484054923058
have O 0 0.0116347661241889
analyzed O 0 0.04363807663321495
additional O 0 0.028588347136974335
cDNA O 0 0.131746307015419
clones O 0 0.06929531693458557
and O 0 0.009841298684477806
provide O 0 0.015492874197661877
evidence O 0 0.011120692826807499
for O 0 0.00630650669336319
an O 0 0.011183813214302063
additional O 0 0.023072293028235435
0 O 0 0.056135326623916626
. O 0 0.02707984670996666

5 O 0 0.054736390709877014
kb O 0 0.10851435363292694
of O 0 0.01673157513141632
5 O 0 0.04636363685131073
- O 0 0.1027778834104538
UTR O 0 0.21526244282722473
and O 0 0.022837549448013306
> O 0 0.11903782933950424
2 O 0 0.032483309507369995
kb O 0 0.09696050733327866
of O 0 0.016192272305488586
3 O 0 0.04566070809960365
- O 0 0.1290377974510193
UTR O 0 0.43383270502090454
. O 0 0.04426588863134384

We O 0 0.015522923320531845
have O 0 0.007946432568132877
established O 0 0.01352666225284338
the O 0 0.011644693091511726
genomic O 0 0.07933886349201202
organization O 0 0.031613707542419434
of O 0 0.013199199922382832
UBE3A O 1 0.9918438792228699
and O 0 0.009551419876515865
the O 0 0.01009075902402401
sequence O 0 0.027035463601350784
of O 0 0.01831357553601265
intron O 1 0.9961779117584229
- O 0 0.15347440540790558
exon O 0 0.17008358240127563
borders O 0 0.06386767327785492
. O 0 0.03709811717271805

We O 0 0.01746896654367447
have O 0 0.009742782451212406
also O 0 0.010385378263890743
mapped O 0 0.04089704528450966
two O 0 0.012003974057734013
highly O 0 0.03533918410539627
homologous O 0 0.11609366536140442
processed O 0 0.04910315200686455
pseudogenes O 0 0.1475827544927597
, O 0 0.025200700387358665
UBE3AP1 O 1 0.9812911748886108
and O 0 0.020523322746157646
UBE3AP2 O 1 0.933112621307373
, O 0 0.011906100437045097
to O 0 0.01137281209230423
chromosomes O 0 0.04892176762223244
2 O 0 0.020167440176010132
and O 0 0.00892468448728323
21 O 0 0.016922367736697197
, O 0 0.008217213675379753
respectively O 0 0.016689984127879143
, O 0 0.008444025181233883
and O 0 0.0075530363246798515
determined O 0 0.02261708490550518
their O 0 0.011092567816376686
genomic O 0 0.09557123482227325
organization O 0 0.04688308387994766
. O 0 0.029235901311039925

These O 0 0.017702361568808556
results O 0 0.02274152636528015
will O 0 0.009780129417777061
form O 0 0.01335755456238985
the O 0 0.007475265301764011
basis O 0 0.010091952979564667
for O 0 0.008604944683611393
studies O 0 0.022083230316638947
of O 0 0.010569002479314804
mutation O 0 0.10655791312456131
and O 0 0.018661633133888245
imprinting O 0 0.41961798071861267
of O 0 0.02609146758913994
UBE3A O 1 0.999567449092865
. O 0 0.03935212641954422

Mutation O 0 0.24441871047019958
spectrum O 0 0.09805223345756531
and O 0 0.02572278305888176
genotype O 1 0.9895879030227661
- O 0 0.17763453722000122
phenotype O 0 0.49500876665115356
analyses O 0 0.0747208446264267
in O 0 0.03530432656407356
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.029204798862338066
Bannayan B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999853372573853
Zonana I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 0.028242819011211395
two O 0 0.030483873561024666
hamartoma B-Disease 1 0.9999995231628418
syndromes I-Disease 1 0.9999995231628418
with O 0 0.059785857796669006
germline O 1 0.998741090297699
PTEN O 1 0.9998754262924194
mutation O 0 0.289963960647583
. O 0 0.04393986985087395

The O 0 0.08235806971788406
tumour B-Disease 1 0.9999988079071045
suppressor O 1 0.9902315735816956
gene O 0 0.1865631490945816
PTEN O 1 0.9994937181472778
, O 0 0.01780085265636444
which O 0 0.009612257592380047
maps O 0 0.02206290327012539
to O 0 0.015206619165837765
10q23 O 0 0.1642615646123886
. O 0 0.030245760455727577

3 O 0 0.043150901794433594
and O 0 0.015450548380613327
encodes O 0 0.0646151453256607
a O 0 0.03302300348877907
403 O 0 0.14068256318569183
amino O 0 0.09486596286296844
acid O 0 0.1630791425704956
dual O 0 0.11614007502794266
specificity O 0 0.15845096111297607
phosphatase O 1 0.8974616527557373
( O 0 0.0649183914065361
protein O 0 0.11143230646848679
tyrosine O 0 0.21017523109912872
phosphatase O 1 0.9783620238304138
; O 0 0.04044266417622566
PTPase O 1 0.8047584891319275
) O 0 0.02171555906534195
, O 0 0.010276325047016144
was O 0 0.01329334918409586
shown O 0 0.017291318625211716
recently O 0 0.01742267794907093
to O 0 0.006920727901160717
play O 0 0.01024795975536108
a O 0 0.012263018637895584
broad O 0 0.03112051822245121
role O 0 0.023263823240995407
in O 0 0.015985511243343353
human O 0 0.04952032119035721
malignancy B-Disease 1 0.999994158744812
. O 0 0.03176380693912506

Somatic O 1 0.8573645353317261
PTEN O 1 0.9984604120254517
deletions O 0 0.14001023769378662
and O 0 0.02487224154174328
mutations O 0 0.09060750901699066
were O 0 0.011994087137281895
observed O 0 0.027862384915351868
in O 0 0.016496645286679268
sporadic B-Disease 1 0.9552760720252991
breast I-Disease 1 0.9999998807907104
, I-Disease 0 0.03244299069046974
brain I-Disease 1 0.9999966621398926
, I-Disease 0 0.06895430386066437
prostate I-Disease 1 1.0
and I-Disease 1 0.7868373990058899
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.2428002655506134
lines O 0 0.019333474338054657
and O 0 0.006166209001094103
in O 0 0.006959641817957163
several O 0 0.010002407245337963
primary O 0 0.04982830211520195
tumours B-Disease 1 0.9999990463256836
such O 0 0.014575091190636158
as O 0 0.029612988233566284
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9998356103897095
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9649995565414429
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.04006706550717354

In O 0 0.02186828851699829
addition O 0 0.02904810756444931
, O 0 0.02438977360725403
PTEN O 1 0.9995490908622742
was O 0 0.02237240970134735
identified O 0 0.02162204124033451
as O 0 0.008175195194780827
the O 0 0.015133684501051903
susceptibility O 1 0.612514078617096
gene O 0 0.07558577507734299
for O 0 0.015147363767027855
two O 0 0.030569443479180336
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.05782976746559143
CD B-Disease 0 0.12591396272182465
; O 0 0.0384121872484684
MIM O 1 0.9998395442962646
158350 O 1 0.6291147470474243
) O 0 0.03403564915060997
and O 0 0.020751826465129852
Bannayan B-Disease 1 0.9984731078147888
- I-Disease 1 0.5126445889472961
Zonana I-Disease 1 0.9834657907485962
( I-Disease 0 0.08138447254896164
BZS I-Disease 1 0.9925986528396606
) I-Disease 0 0.038274724036455154
or I-Disease 0 0.035401541739702225
Ruvalcaba I-Disease 1 0.9999879598617554
- I-Disease 1 0.9934198260307312
Riley I-Disease 1 0.9994142055511475
- I-Disease 1 0.9983915686607361
Smith I-Disease 1 0.9974094033241272
syndrome I-Disease 1 1.0
( O 0 0.10730981081724167
MIM O 1 0.9999810457229614
153480 O 1 0.9612526893615723
) O 0 0.038792021572589874
. O 0 0.02655986323952675

Constitutive O 0 0.22711604833602905
DNA O 0 0.09333301335573196
from O 0 0.02245369367301464
37 O 0 0.04438720643520355
CD B-Disease 0 0.05596866086125374
families O 0 0.024065421894192696
and O 0 0.012243956327438354
seven O 0 0.030704012140631676
BZS B-Disease 1 0.9842591881752014
families O 0 0.03402281552553177
was O 0 0.02448318526148796
screened O 0 0.08411730080842972
for O 0 0.03488759696483612
germline O 1 0.9820917248725891
PTEN O 1 0.9994851350784302
mutations O 0 0.20048190653324127
. O 0 0.0387217253446579

PTEN O 1 0.9992526173591614
mutations O 0 0.14339172840118408
were O 0 0.013674065470695496
identified O 0 0.02261272259056568
in O 0 0.010064220055937767
30 O 0 0.01708034798502922
of O 0 0.009722555987536907
37 O 0 0.04352286085486412
( O 0 0.03092341683804989
81 O 0 0.061885952949523926
% O 0 0.026417460292577744
) O 0 0.0224489476531744
CD B-Disease 0 0.04841553047299385
families O 0 0.022908825427293777
, O 0 0.010827846825122833
including O 0 0.01440333854407072
missense O 0 0.1278483122587204
and O 0 0.018959548324346542
nonsense O 0 0.08162562549114227
point O 0 0.035996872931718826
mutations O 0 0.10909781605005264
, O 0 0.0203859806060791
deletions O 0 0.0853700339794159
, O 0 0.01956065557897091
insertions O 0 0.11500982195138931
, O 0 0.01827028952538967
a O 0 0.03203044459223747
deletion O 0 0.325150728225708
/ O 1 0.9628076553344727
insertion O 0 0.15545125305652618
and O 0 0.027170566841959953
splice O 0 0.21028190851211548
site O 0 0.06822072714567184
mutations O 0 0.14328424632549286
. O 0 0.03957389295101166

These O 0 0.02704772539436817
mutations O 0 0.08752112090587616
were O 0 0.009597388096153736
scattered O 0 0.021193712949752808
over O 0 0.009131873957812786
the O 0 0.009123275056481361
entire O 0 0.023767875507473946
length O 0 0.02822030521929264
of O 0 0.016163036227226257
PTEN O 1 0.999818742275238
, O 0 0.011415922082960606
with O 0 0.007151989731937647
the O 0 0.008733903989195824
exception O 0 0.0192476287484169
of O 0 0.005807485431432724
the O 0 0.007848681882023811
first O 0 0.010891103185713291
, O 0 0.009189446456730366
fourth O 0 0.022222518920898438
and O 0 0.009932001121342182
last O 0 0.024838009849190712
exons O 0 0.11364317685365677
. O 0 0.03266249597072601

A O 0 0.05857311934232712
hot O 0 0.0856499969959259
spot O 0 0.05454394593834877
for O 0 0.024839797988533974
PTEN O 1 0.9988324046134949
mutation O 0 0.13991208374500275
in O 0 0.0163333248347044
CD B-Disease 0 0.05095219984650612
was O 0 0.015718089416623116
identified O 0 0.024059882387518883
in O 0 0.014020439237356186
exon O 0 0.10022806376218796
5 O 0 0.021160120144486427
that O 0 0.00735912099480629
contains O 0 0.013841741718351841
the O 0 0.014747890643775463
PTPase O 0 0.33293792605400085
core O 0 0.055056218057870865
motif O 0 0.0757378563284874
, O 0 0.011424362659454346
with O 0 0.00847181398421526
13 O 0 0.01767699047923088
of O 0 0.008181833662092686
30 O 0 0.022215889766812325
( O 0 0.023382510989904404
43 O 0 0.04418155178427696
% O 0 0.030055465176701546
) O 0 0.03272242099046707
CD B-Disease 0 0.0774761512875557
mutations O 0 0.09091772139072418
identified O 0 0.024306194856762886
in O 0 0.01133472379297018
this O 0 0.01324082538485527
exon O 0 0.13844291865825653
. O 0 0.03419666737318039

Seven O 0 0.02726687490940094
of O 0 0.013619321398437023
30 O 0 0.02691570483148098
( O 0 0.02526089921593666
23 O 0 0.025583423674106598
% O 0 0.022860975936055183
) O 0 0.01447232998907566
were O 0 0.005840545054525137
within O 0 0.008785376325249672
the O 0 0.010161424055695534
core O 0 0.03891519457101822
motif O 0 0.07641418278217316
, O 0 0.010877822525799274
the O 0 0.010906039737164974
majority O 0 0.020979151129722595
( O 0 0.015555545687675476
five O 0 0.008160185068845749
of O 0 0.006088073365390301
seven O 0 0.01370569970458746
) O 0 0.012380344793200493
of O 0 0.0068672397173941135
which O 0 0.011015025898814201
were O 0 0.015269449912011623
missense O 0 0.19516721367835999
mutations O 0 0.1170126348733902
, O 0 0.018814995884895325
possibly O 0 0.03723019361495972
pointing O 0 0.030409062281250954
to O 0 0.0074736205860972404
the O 0 0.008811324834823608
functional O 0 0.02950272522866726
significance O 0 0.018470536917448044
of O 0 0.007550881709903479
this O 0 0.009760592132806778
region O 0 0.035871364176273346
. O 0 0.024239730089902878

Germline O 1 0.9922732710838318
PTEN O 1 0.999313235282898
mutations O 0 0.13538746535778046
were O 0 0.012622957117855549
identified O 0 0.020250460132956505
in O 0 0.007604904938489199
four O 0 0.007760734762996435
of O 0 0.0069583263248205185
seven O 0 0.02047116495668888
( O 0 0.030958199873566628
57 O 0 0.058284200727939606
% O 0 0.03619861230254173
) O 0 0.04140579700469971
BZS B-Disease 1 0.9949424862861633
families O 0 0.04203946143388748
studied O 0 0.041774969547986984
. O 0 0.026955168694257736

Interestingly O 0 0.11403019726276398
, O 0 0.017895450815558434
none O 0 0.018252991139888763
of O 0 0.007288501597940922
these O 0 0.01117933914065361
mutations O 0 0.07735387235879898
was O 0 0.019643539562821388
observed O 0 0.023496590554714203
in O 0 0.009228804148733616
the O 0 0.0163252055644989
PTPase O 1 0.8924638628959656
core O 0 0.06533945351839066
motif O 0 0.12138582766056061
. O 0 0.034277863800525665

It O 0 0.016090458258986473
is O 0 0.011397436261177063
also O 0 0.00998277310281992
worthy O 0 0.033191580325365067
of O 0 0.007231387309730053
note O 0 0.023917697370052338
that O 0 0.005967689678072929
a O 0 0.014271431602537632
single O 0 0.028553061187267303
nonsense O 0 0.07782544940710068
point O 0 0.03443923220038414
mutation O 0 0.12108007818460464
, O 0 0.020530998706817627
R233X O 0 0.12056666612625122
, O 0 0.013609616085886955
was O 0 0.014268084429204464
observed O 0 0.02253611758351326
in O 0 0.009129638783633709
the O 0 0.01518950518220663
germline O 0 0.30226364731788635
DNA O 0 0.056003205478191376
from O 0 0.011637270450592041
two O 0 0.008906987495720387
unrelated O 0 0.045910418033599854
CD B-Disease 0 0.05296013504266739
families O 0 0.021840376779437065
and O 0 0.009994953870773315
one O 0 0.019689597189426422
BZS B-Disease 1 0.9974405765533447
family O 0 0.045647259801626205
. O 0 0.028904711827635765

Genotype O 1 0.9967688322067261
- O 1 0.7737401723861694
phenotype O 1 0.880802571773529
studies O 0 0.03582775220274925
were O 0 0.007449120283126831
not O 0 0.006930254865437746
performed O 0 0.018441522493958473
on O 0 0.006229221820831299
this O 0 0.0059814127162098885
small O 0 0.013708856888115406
group O 0 0.024814242497086525
of O 0 0.015238500200212002
BZS B-Disease 1 0.9969490170478821
families O 0 0.047784578055143356
. O 0 0.03136157616972923

However O 0 0.031183436512947083
, O 0 0.026630807667970657
genotype O 1 0.9826420545578003
- O 0 0.16237981617450714
phenotype O 0 0.4216427803039551
analysis O 0 0.05474322289228439
inthe O 0 0.16971150040626526
group O 0 0.03460284322500229
of O 0 0.011184420436620712
CD B-Disease 0 0.04943724349141121
families O 0 0.02333061583340168
revealed O 0 0.026535192504525185
two O 0 0.007660812232643366
possible O 0 0.01734858937561512
associations O 0 0.03012165054678917
worthy O 0 0.04135145619511604
of O 0 0.01016329973936081
follow O 0 0.02576543018221855
- O 0 0.04868023097515106
up O 0 0.013019951060414314
in O 0 0.01076913345605135
independent O 0 0.022102084010839462
analyses O 0 0.052785806357860565
. O 0 0.02885509468615055

The O 0 0.020860709249973297
first O 0 0.014850339852273464
was O 0 0.01528980303555727
an O 0 0.014154529199004173
association O 0 0.03168374300003052
noted O 0 0.014414194040000439
in O 0 0.006791044492274523
the O 0 0.007982646115124226
group O 0 0.01969211921095848
of O 0 0.007816373370587826
CD B-Disease 0 0.05773914232850075
families O 0 0.02935427986085415
with O 0 0.03797716647386551
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.03680004924535751

A O 0 0.05381736159324646
correlation O 0 0.07512251287698746
was O 0 0.021153835579752922
observed O 0 0.025817733258008957
between O 0 0.01020237896591425
the O 0 0.014155812561511993
presence O 0 0.044776950031518936
/ O 1 0.9870403409004211
absence O 0 0.03291609138250351
of O 0 0.011740394867956638
a O 0 0.035746559500694275
PTEN O 1 0.999873161315918
mutation O 0 0.12849825620651245
and O 0 0.009787767194211483
the O 0 0.0097186965867877
type O 0 0.05102373659610748
of O 0 0.018475603312253952
breast O 1 0.9999995231628418
involvement O 1 0.7818459272384644
( O 0 0.043782759457826614
unaffected O 1 0.9945631623268127
versus O 1 0.9800946712493896
benign O 1 0.9999946355819702
versus O 1 0.9992306232452393
malignant O 1 0.9999996423721313
) O 0 0.044894926249980927
. O 0 0.02301356941461563

Specifically O 0 0.03272727504372597
and O 0 0.008619988337159157
more O 0 0.006598229520022869
directly O 0 0.01369362510740757
, O 0 0.008636376820504665
an O 0 0.01172824576497078
association O 0 0.03242090716958046
was O 0 0.014864695258438587
also O 0 0.009811850264668465
observed O 0 0.016329478472471237
between O 0 0.007171590346843004
the O 0 0.007445448078215122
presence O 0 0.02170197106897831
of O 0 0.009410500526428223
a O 0 0.03606973960995674
PTEN O 1 0.9999955892562866
mutation O 1 0.9949544072151184
and O 1 0.5610383749008179
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.04214249551296234

Secondly O 0 0.08223924040794373
, O 0 0.015296583995223045
there O 0 0.008766258135437965
appeared O 0 0.015925437211990356
to O 0 0.007018445525318384
be O 0 0.007490663789212704
an O 0 0.013966514728963375
interdependent O 0 0.12299028038978577
association O 0 0.05032547935843468
between O 0 0.022672615945339203
mutations O 0 0.09806342422962189
upstream O 0 0.05148353427648544
and O 0 0.00933519471436739
within O 0 0.012172120623290539
the O 0 0.01569320075213909
PTPase O 1 0.9232897162437439
core O 0 0.05258684605360031
motif O 0 0.07632045447826385
, O 0 0.010797164402902126
the O 0 0.012033218517899513
core O 0 0.04050719365477562
motif O 0 0.07218123227357864
containing O 0 0.01943940855562687
the O 0 0.010312833823263645
majority O 0 0.01801224984228611
of O 0 0.012972584925591946
missense O 0 0.19139695167541504
mutations O 0 0.09946278482675552
, O 0 0.011775300838053226
and O 0 0.00711544044315815
the O 0 0.008944115601480007
involvement O 0 0.036176037043333054
of O 0 0.005918002687394619
all O 0 0.006998404860496521
major O 0 0.022119227796792984
organ O 1 0.684857189655304
systems O 0 0.04102815315127373
( O 0 0.02685939334332943
central O 0 0.03392065688967705
nervous O 1 0.9999473094940186
system O 0 0.05286317691206932
, O 0 0.0242839977145195
thyroid O 1 1.0
, O 0 0.12664657831192017
breast O 1 1.0
, O 0 0.19865430891513824
skin O 1 1.0
and O 0 0.12602077424526215
gastrointestinal O 1 1.0
tract O 1 0.9999980926513672
) O 0 0.035899799317121506
. O 0 0.0264970101416111

However O 0 0.021848779171705246
, O 0 0.00984037946909666
these O 0 0.005146574229001999
observations O 0 0.021625040099024773
would O 0 0.007555242162197828
need O 0 0.011204103007912636
to O 0 0.005941398441791534
be O 0 0.00662753963842988
confirmed O 0 0.018007149919867516
by O 0 0.00784450862556696
studying O 0 0.016950314864516258
a O 0 0.01364169642329216
larger O 0 0.013957515358924866
number O 0 0.009004577994346619
of O 0 0.009015783667564392
CD B-Disease 0 0.058231037110090256
families O 0 0.03738486021757126
. O 0 0.030541984364390373

Molecular O 0 0.16639727354049683
defects O 1 0.9719913601875305
leading O 0 0.03133537247776985
to O 0 0.012143794447183609
human O 0 0.028715401887893677
complement B-Disease 0 0.09454839676618576
component I-Disease 1 0.9977103471755981
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.016305215656757355
an O 0 0.014632174745202065
African O 0 0.053246866911649704
- O 0 0.0787140354514122
American O 0 0.036621928215026855
family O 0 0.04501967877149582
. O 0 0.03209885582327843

Complement B-Disease 0 0.17946204543113708
component I-Disease 1 0.9980827569961548
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.07593376189470291
C6D B-Disease 1 0.9998704195022583
) O 0 0.029278304427862167
was O 0 0.0245348047465086
diagnosed O 1 0.9999978542327881
in O 0 0.012017050758004189
a O 0 0.016239456832408905
16 O 0 0.022430768236517906
- O 0 0.05943984165787697
year O 0 0.022192463278770447
- O 0 0.06090491637587547
old O 0 0.03911407291889191
African O 0 0.05807161703705788
- O 0 0.08185409009456635
American O 0 0.04068709909915924
male O 0 0.08726625889539719
with O 0 0.05226445570588112
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.04665391519665718

The O 0 0.03659595176577568
patients O 1 0.999884843826294
father O 0 0.029310129582881927
and O 0 0.007755867671221495
two O 0 0.00820976309478283
brothers O 0 0.03507557511329651
also O 0 0.011131073348224163
had O 0 0.020069651305675507
C6D B-Disease 1 0.996752917766571
, O 0 0.011138441041111946
but O 0 0.007752785459160805
gave O 0 0.01666441559791565
no O 0 0.009719274938106537
history O 0 0.015337981283664703
of O 0 0.01681133732199669
meningitis B-Disease 1 1.0
or O 0 0.027357423678040504
other O 0 0.018008900806307793
neisserial B-Disease 1 0.9999924898147583
infection I-Disease 1 0.9999995231628418
. O 0 0.03157985210418701

By O 0 0.02739357016980648
using O 0 0.03310099244117737
exon O 0 0.1589673012495041
- O 0 0.1037324070930481
specific O 0 0.043978042900562286
polymerase O 0 0.18941307067871094
chain O 0 0.11038721352815628
reaction O 0 0.10629671812057495
( O 0 0.05946063622832298
PCR O 0 0.23562641441822052
) O 0 0.04256846383213997
/ O 1 0.5772501826286316
single O 0 0.043077412992715836
- O 0 0.10613790899515152
strand O 0 0.1369968205690384
conformation O 0 0.14181558787822723
polymorphism O 0 0.10851993411779404
as O 0 0.015240374952554703
a O 0 0.023741837590932846
screening O 0 0.07989837974309921
step O 0 0.0318131260573864
and O 0 0.01399711612612009
nucleotide O 0 0.07831480354070663
sequencing O 0 0.049573469907045364
of O 0 0.01140721794217825
target O 0 0.038928478956222534
exons O 0 0.0804031565785408
, O 0 0.011288361623883247
we O 0 0.008905733935534954
determined O 0 0.018164698034524918
that O 0 0.006399571895599365
the O 0 0.011914358474314213
proband O 0 0.16221760213375092
was O 0 0.01834275759756565
a O 0 0.024501275271177292
compound O 0 0.09240318089723587
heterozygote O 0 0.4854735732078552
for O 0 0.01767737977206707
two O 0 0.02444157935678959
C6 O 1 0.9998063445091248
gene O 0 0.16909709572792053
mutations O 0 0.15419715642929077
. O 0 0.03417910262942314

The O 0 0.023688793182373047
first O 0 0.018638575449585915
, O 0 0.015978805720806122
1195delC O 0 0.1137363612651825
located O 0 0.027946503832936287
in O 0 0.014185990206897259
exon O 0 0.11213337630033493
7 O 0 0.029037753120064735
, O 0 0.009945245459675789
is O 0 0.010235792957246304
a O 0 0.01741909608244896
novel O 0 0.037494808435440063
mutation O 0 0.09612656384706497
, O 0 0.010727396234869957
while O 0 0.008230561390519142
the O 0 0.00877110380679369
second O 0 0.020458126440644264
, O 0 0.01820329762995243
1936delG O 0 0.12725216150283813
in O 0 0.017938988283276558
exon O 0 0.10029400885105133
12 O 0 0.023043520748615265
, O 0 0.010279301553964615
has O 0 0.010745772160589695
been O 0 0.0096231484785676
described O 0 0.018470508977770805
before O 0 0.011158661916851997
to O 0 0.010733814910054207
cause O 0 0.05970267578959465
C6D B-Disease 1 0.9480028748512268
in O 0 0.010931025259196758
an O 0 0.011822977103292942
unrelated O 0 0.052247051149606705
African O 0 0.06034579500555992
- O 0 0.07481848448514938
American O 0 0.03200366720557213
individual O 0 0.03004985861480236
. O 0 0.028458647429943085

Both O 0 0.04176188260316849
mutations O 0 0.12765488028526306
result O 0 0.03500283882021904
in O 0 0.02266044169664383
premature O 1 0.9910964965820312
termination O 1 0.8475948572158813
codons O 0 0.134409561753273
and O 0 0.03240229934453964
C6 O 1 0.9996486902236938
null O 0 0.13884150981903076
alleles O 0 0.20192751288414001
. O 0 0.0432158038020134

Allele O 0 0.273245632648468
- O 0 0.12474020570516586
specific O 0 0.04587513580918312
PCR O 0 0.17642463743686676
indicated O 0 0.037672530859708786
that O 0 0.00795652810484171
the O 0 0.01299563329666853
probands O 0 0.12918154895305634
two O 0 0.012273470871150494
brothers O 0 0.04542234167456627
also O 0 0.017807483673095703
inherited O 0 0.10192648321390152
the O 0 0.027960022911429405
1195delC O 1 0.663325846195221
mutation O 0 0.13112634420394897
from O 0 0.015423025004565716
their O 0 0.013176129199564457
heterozygous O 0 0.1157468631863594
mother O 0 0.04608314111828804
and O 0 0.01242547482252121
the O 0 0.018204694613814354
1936delG O 1 0.7741439342498779
mutation O 0 0.12846019864082336
from O 0 0.013995561748743057
their O 0 0.013980187475681305
homozygous O 0 0.11090175062417984
father O 0 0.042156681418418884
. O 0 0.017448721453547478
. O 0 0.024548251181840897

PAX6 O 1 0.9991287589073181
mutations O 0 0.23120830953121185
reviewed O 0 0.07311318069696426
. O 0 0.03453163057565689

Mutations O 0 0.1998571902513504
in O 0 0.03201618790626526
PAX6 O 1 0.9986618757247925
are O 0 0.011347678489983082
responsible O 0 0.022848986089229584
for O 0 0.010545273311436176
human O 0 0.029877401888370514
aniridia B-Disease 1 0.9998212456703186
and O 0 0.009257975034415722
have O 0 0.0064019374549388885
also O 0 0.007456611841917038
been O 0 0.009117715060710907
found O 0 0.013270433060824871
in O 0 0.014345132745802402
patients O 1 0.9999734163284302
with O 0 0.021511591970920563
Peters B-Disease 1 0.9999827146530151
anomaly I-Disease 1 0.9999786615371704
, O 0 0.024208880960941315
with O 0 0.045026928186416626
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.024235745891928673
with O 0 0.023779623210430145
autosomal B-Disease 1 0.9999743700027466
dominant I-Disease 1 0.9974632263183594
keratitis I-Disease 1 1.0
, O 0 0.014693054370582104
and O 0 0.009624448604881763
with O 0 0.019183335825800896
isolated B-Disease 1 0.8411210775375366
foveal I-Disease 1 0.999991774559021
hypoplasia I-Disease 1 0.9999991655349731
. O 0 0.047879334539175034

No O 0 0.040830232203006744
locus O 0 0.12188999354839325
other O 0 0.01622755452990532
than O 0 0.02195058949291706
chromosome O 0 0.1434500366449356
11p13 O 0 0.1439206600189209
has O 0 0.01892143487930298
been O 0 0.0166705884039402
implicated O 0 0.09089687466621399
in O 0 0.01800728775560856
aniridia B-Disease 1 0.9998983144760132
, O 0 0.01670924574136734
and O 0 0.016294710338115692
PAX6 O 1 0.9998997449874878
is O 0 0.015213312581181526
clearly O 0 0.015786323696374893
the O 0 0.007944846525788307
major O 0 0.015783967450261116
, O 0 0.008812646381556988
if O 0 0.009639745578169823
not O 0 0.006620060186833143
only O 0 0.007407731842249632
, O 0 0.01233668066561222
gene O 0 0.07006813585758209
responsible O 0 0.04213637858629227
. O 0 0.025145744904875755

Twenty O 0 0.06546440720558167
- O 0 0.06495385617017746
eight O 0 0.022064493969082832
percent O 0 0.026496384292840958
of O 0 0.012656455859541893
identified O 0 0.06475644558668137
PAX6 O 1 0.9997270703315735
mutations O 0 0.13816000521183014
are O 0 0.019350379705429077
C O 1 0.996819019317627
- O 1 0.7828806042671204
T O 1 0.976230263710022
changes O 0 0.03390652686357498
at O 0 0.042018476873636246
CpG O 1 0.5911737680435181
dinucleotides O 0 0.2859574854373932
, O 0 0.018504133448004723
20 O 0 0.01848939061164856
% O 0 0.022115185856819153
are O 0 0.012533856555819511
splicing O 0 0.10351065546274185
errors O 0 0.03723509609699249
, O 0 0.009166854433715343
and O 0 0.006190161686390638
more O 0 0.005536028649657965
than O 0 0.0090652946382761
30 O 0 0.01819135993719101
% O 0 0.018355177715420723
are O 0 0.011028195731341839
deletion O 0 0.10890863835811615
or O 0 0.03400857374072075
insertion O 0 0.1359574943780899
events O 0 0.041775308549404144
. O 0 0.029202386736869812

There O 0 0.02022620104253292
is O 0 0.014394303783774376
a O 0 0.020897457376122475
noticeably O 0 0.0886131301522255
elevated O 0 0.09325031191110611
level O 0 0.028681911528110504
of O 0 0.011974027380347252
mutation O 0 0.08793997764587402
in O 0 0.011164167895913124
the O 0 0.014977958053350449
paired O 0 0.07526363432407379
domain O 0 0.03863316774368286
compared O 0 0.023053329437971115
with O 0 0.007292263209819794
the O 0 0.008497527800500393
rest O 0 0.018314968794584274
of O 0 0.007969108410179615
the O 0 0.01598397269845009
gene O 0 0.09036405384540558
. O 0 0.029917076230049133

Increased O 0 0.07441358268260956
mutation O 0 0.12316323816776276
in O 0 0.015064072795212269
the O 0 0.018530981615185738
homeodomain O 1 0.5498328804969788
is O 0 0.016292966902256012
accounted O 0 0.029650162905454636
for O 0 0.007473309524357319
by O 0 0.009290747344493866
the O 0 0.019908053800463676
hypermutable O 1 0.9508340358734131
CpG O 1 0.9303671717643738
dinucleotide O 0 0.2651219367980957
in O 0 0.03316318243741989
codon O 0 0.15093731880187988
240 O 0 0.08700563758611679
. O 0 0.03721482306718826

Very O 0 0.031198307871818542
nearly O 0 0.02491714246571064
all O 0 0.012693805620074272
mutations O 0 0.08965469151735306
appear O 0 0.023126540705561638
to O 0 0.01326369121670723
cause O 0 0.07111606001853943
loss O 0 0.039565518498420715
of O 0 0.009000038728117943
function O 0 0.02166931703686714
of O 0 0.007294640876352787
the O 0 0.013930149376392365
mutant O 0 0.10887400805950165
allele O 0 0.12715543806552887
, O 0 0.011952973902225494
and O 0 0.007305298466235399
more O 0 0.006452420260757208
than O 0 0.00909040030092001
80 O 0 0.02425019070506096
% O 0 0.01757439784705639
of O 0 0.012962768785655499
exonic O 1 0.6403878927230835
substitutions O 0 0.07615070790052414
result O 0 0.0306901466101408
in O 0 0.019653595983982086
nonsense O 0 0.10792721807956696
codons O 0 0.12227580696344376
. O 0 0.0300988107919693

In O 0 0.025200244039297104
a O 0 0.026293082162737846
gene O 0 0.06361297518014908
with O 0 0.012461178004741669
such O 0 0.01289087813347578
extraordinarily O 0 0.08614172041416168
high O 0 0.03659719601273537
sequence O 0 0.03610892593860626
conservation O 0 0.03950759023427963
throughout O 0 0.017705032601952553
evolution O 0 0.024327274411916733
, O 0 0.009117750450968742
there O 0 0.00959288515150547
are O 0 0.011341373436152935
presumed O 0 0.08934386819601059
undiscovered O 0 0.2245759218931198
missense O 0 0.25407373905181885
mutations O 0 0.13092730939388275
, O 0 0.013734940439462662
these O 0 0.006319470703601837
are O 0 0.007221465930342674
hypothesized O 0 0.06026822328567505
to O 0 0.008194301277399063
exist O 0 0.010999603196978569
in O 0 0.009051225148141384
as O 0 0.012379620224237442
- O 0 0.06581103801727295
yet O 0 0.032656554132699966
unidentified O 0 0.09643109887838364
phenotypes O 0 0.1682497262954712
. O 0 0.021575091406702995
. O 0 0.02586393989622593

Genetic O 0 0.1692189872264862
heterogeneity O 0 0.15691155195236206
and O 0 0.020986191928386688
penetrance O 0 0.3490024507045746
analysis O 0 0.022673822939395905
of O 0 0.0077187963761389256
the O 0 0.017086567357182503
BRCA1 O 1 0.9983702301979065
and O 0 0.028233405202627182
BRCA2 O 1 0.9995138645172119
genes O 0 0.11885810643434525
in O 0 0.041881393641233444
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0453120581805706
. O 0 0.028624892234802246

The O 0 0.3003688156604767
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9966347813606262
Consortium O 0 0.4229772984981537
. O 0 0.03442291170358658

The O 0 0.0214388407766819
contribution O 0 0.041248589754104614
of O 0 0.015338145196437836
BRCA1 O 1 0.9985291957855225
and O 0 0.026239506900310516
BRCA2 O 1 0.9999618530273438
to O 0 0.03727346658706665
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.028598487377166748
assessed O 0 0.048857759684324265
by O 0 0.01577765867114067
linkage O 0 0.11859258264303207
and O 0 0.018023360520601273
mutation O 0 0.11629260331392288
analysis O 0 0.02411578968167305
in O 0 0.01178162731230259
237 O 0 0.06990180909633636
families O 0 0.020366504788398743
, O 0 0.00874910969287157
each O 0 0.007249525282531977
with O 0 0.008704198524355888
at O 0 0.012656752951443195
least O 0 0.01068133395165205
four O 0 0.009974920190870762
cases O 0 0.0217253677546978
of O 0 0.019495202228426933
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.010579139925539494
collected O 0 0.010264566168189049
by O 0 0.010898343287408352
the O 0 0.03316135331988335
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9953989386558533
Consortium O 0 0.20518945157527924
. O 0 0.03359555825591087

Families O 0 0.04147933050990105
were O 0 0.009442782029509544
included O 0 0.010231832042336464
without O 0 0.01014332938939333
regard O 0 0.015714023262262344
to O 0 0.00662577897310257
the O 0 0.012083166278898716
occurrence O 0 0.07814516872167587
of O 0 0.02208038978278637
ovarian B-Disease 1 1.0
or I-Disease 0 0.029549555853009224
other I-Disease 0 0.018769215792417526
cancers I-Disease 1 0.9999856948852539
. O 0 0.0363684706389904

Overall O 0 0.09861784428358078
, O 0 0.03322625532746315
disease O 1 0.9999988079071045
was O 0 0.02325502038002014
linked O 0 0.051971714943647385
to O 0 0.01429450511932373
BRCA1 O 1 0.9465340375900269
in O 0 0.013598200865089893
an O 0 0.011881542392075062
estimated O 0 0.02973014861345291
52 O 0 0.04241744056344032
% O 0 0.02050100453197956
of O 0 0.007665910758078098
families O 0 0.02050013653934002
, O 0 0.01232119556516409
to O 0 0.015109943225979805
BRCA2 O 1 0.8744374513626099
in O 0 0.01920928806066513
32 O 0 0.03040722757577896
% O 0 0.017516613006591797
of O 0 0.006438089534640312
families O 0 0.018418515101075172
, O 0 0.008320332504808903
and O 0 0.006075817160308361
to O 0 0.009785424917936325
neither O 0 0.03129514306783676
gene O 0 0.05451904237270355
in O 0 0.012022892944514751
16 O 0 0.023290935903787613
% O 0 0.024756738916039467
( O 0 0.02666436694562435
95 O 0 0.04457464441657066
% O 0 0.027365557849407196
confidence O 0 0.05808454006910324
interval O 0 0.12019181996583939
[ O 0 0.11033814400434494
CI O 1 0.999930739402771
] O 0 0.09076086431741714
6 O 0 0.03395971655845642
% O 0 0.02753302827477455
- O 0 0.0645686462521553
28 O 0 0.032917819917201996
% O 0 0.030184859409928322
) O 0 0.021527843549847603
, O 0 0.012454496696591377
suggesting O 0 0.043162230402231216
other O 0 0.015825720503926277
predisposition O 1 0.988167941570282
genes O 0 0.0879376083612442
. O 0 0.03250732645392418

The O 0 0.024300087243318558
majority O 0 0.03468601033091545
( O 0 0.03603532910346985
81 O 0 0.0561557412147522
% O 0 0.020530132576823235
) O 0 0.0119185084477067
of O 0 0.0073254164308309555
the O 0 0.05261334776878357
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03308709338307381
were O 0 0.009246365167200565
due O 0 0.01686439849436283
to O 0 0.01513577438890934
BRCA1 O 1 0.9952162504196167
, O 0 0.011251183226704597
with O 0 0.00954919122159481
most O 0 0.009852306917309761
others O 0 0.01858721859753132
( O 0 0.02272523194551468
14 O 0 0.02015969716012478
% O 0 0.022028110921382904
) O 0 0.0162495244294405
due O 0 0.019375639036297798
to O 0 0.017168710008263588
BRCA2 O 1 0.9973080158233643
. O 0 0.03711068630218506

Conversely O 0 0.11106188595294952
, O 0 0.012088250368833542
the O 0 0.008409915491938591
majority O 0 0.014458787627518177
of O 0 0.006386226508766413
families O 0 0.017504636198282242
with O 0 0.01202241238206625
male B-Disease 0 0.04560131952166557
and I-Disease 0 0.01493188738822937
female I-Disease 1 0.9924768805503845
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
were O 0 0.010525837540626526
due O 0 0.0201254952698946
to O 0 0.018544835969805717
BRCA2 O 1 0.9966852068901062
( O 0 0.04391933232545853
76 O 0 0.08399474620819092
% O 0 0.033680323511362076
) O 0 0.029588688164949417
. O 0 0.023077333346009254

The O 0 0.027061454951763153
largest O 0 0.035708505660295486
proportion O 0 0.05170739069581032
( O 0 0.033590178936719894
67 O 0 0.056124091148376465
% O 0 0.020168622955679893
) O 0 0.013608955778181553
of O 0 0.006483927834779024
families O 0 0.017742739990353584
due O 0 0.014172498136758804
to O 0 0.007907239720225334
other O 0 0.008214956149458885
genes O 0 0.033643752336502075
was O 0 0.015095893293619156
found O 0 0.012654168531298637
in O 0 0.007666600402444601
families O 0 0.014695055782794952
with O 0 0.00718399602919817
four O 0 0.007824205793440342
or O 0 0.01019505225121975
five O 0 0.011061555705964565
cases O 0 0.019784215837717056
of O 0 0.014574289321899414
female O 1 0.9981383085250854
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
only O 0 0.016174279153347015
. O 0 0.021487243473529816

These O 0 0.017593689262866974
estimates O 0 0.026499593630433083
were O 0 0.009148557670414448
not O 0 0.01002875529229641
substantially O 0 0.043750129640102386
affected O 0 0.03498681262135506
either O 0 0.01324894092977047
by O 0 0.008301367051899433
changing O 0 0.023199232295155525
the O 0 0.014515654183924198
assumed O 0 0.058339014649391174
penetrance O 1 0.9348855018615723
model O 0 0.04412307217717171
for O 0 0.019198140129446983
BRCA1 O 1 0.996553897857666
or O 0 0.017398931086063385
by O 0 0.008437979966402054
including O 0 0.011275473982095718
or O 0 0.02183721959590912
excluding O 0 0.060351189225912094
BRCA1 O 1 0.9994660019874573
mutation O 0 0.1770242303609848
data O 0 0.02916337549686432
. O 0 0.026778066530823708

Among O 0 0.022378718480467796
those O 0 0.012127410620450974
families O 0 0.025868235155940056
with O 0 0.02081192098557949
disease O 1 0.9999990463256836
due O 0 0.02813217230141163
to O 0 0.018682964146137238
BRCA1 O 1 0.9981282353401184
that O 0 0.010104681365191936
were O 0 0.007951734587550163
tested O 0 0.03851062431931496
by O 0 0.006560183130204678
one O 0 0.00588436983525753
of O 0 0.004912183620035648
the O 0 0.01045062206685543
standard O 0 0.037773631513118744
screening O 0 0.07839669287204742
methods O 0 0.025996845215559006
, O 0 0.01598772220313549
mutations O 0 0.07483825832605362
were O 0 0.010670823976397514
detected O 0 0.052555330097675323
in O 0 0.010272039100527763
the O 0 0.01484302431344986
coding O 0 0.09681418538093567
sequence O 0 0.04062097892165184
or O 0 0.024350063875317574
splice O 0 0.11958230286836624
sites O 0 0.019677355885505676
in O 0 0.00884812418371439
an O 0 0.01297781802713871
estimated O 0 0.031674206256866455
63 O 0 0.06341784447431564
% O 0 0.02959728054702282
( O 0 0.02705991081893444
95 O 0 0.056516263633966446
% O 0 0.04548203572630882
CI O 1 0.9994828701019287
51 O 0 0.06980562210083008
% O 0 0.03600824624300003
- O 0 0.08813702315092087
77 O 0 0.08296943455934525
% O 0 0.03881077840924263
) O 0 0.032437752932310104
. O 0 0.02647990547120571

The O 0 0.02770868130028248
estimated O 0 0.03912690281867981
sensitivity O 0 0.08437875658273697
was O 0 0.018521539866924286
identical O 0 0.0250854454934597
for O 0 0.011006856337189674
direct O 0 0.026337740942835808
sequencing O 0 0.046197615563869476
and O 0 0.009293798357248306
other O 0 0.007753629237413406
techniques O 0 0.03742949664592743
. O 0 0.02264852449297905

The O 0 0.04170895367860794
penetrance O 0 0.48608553409576416
of O 0 0.023778168484568596
BRCA2 O 1 0.9945541620254517
was O 0 0.02805396541953087
estimated O 0 0.02655775286257267
by O 0 0.012691469863057137
maximizing O 0 0.07792851328849792
the O 0 0.023452727124094963
LOD O 1 0.9981836676597595
score O 0 0.03722349554300308
in O 0 0.024798614904284477
BRCA2 O 1 0.9999630451202393
- O 1 0.5968253016471863
mutation O 0 0.16375288367271423
families O 0 0.02864917181432247
, O 0 0.009550247341394424
over O 0 0.009340571239590645
all O 0 0.008785899728536606
possible O 0 0.02789241261780262
penetrance O 0 0.23917701840400696
functions O 0 0.03252653777599335
. O 0 0.0293137039989233

The O 0 0.027921415865421295
estimated O 0 0.04562888294458389
cumulative O 0 0.17598523199558258
risk O 1 0.9426720142364502
of O 0 0.02965187095105648
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
reached O 0 0.03659426420927048
28 O 0 0.028689326718449593
% O 0 0.024084456264972687
( O 0 0.028090380132198334
95 O 0 0.05242757499217987
% O 0 0.0436117947101593
CI O 1 0.9996657371520996
9 O 0 0.03919056057929993
% O 0 0.03019568882882595
- O 0 0.05965116247534752
44 O 0 0.03879137709736824
% O 0 0.024333007633686066
) O 0 0.01879034750163555
by O 0 0.011251571588218212
age O 0 0.028566695749759674
50 O 0 0.020217932760715485
years O 0 0.012814275920391083
and O 0 0.010497071780264378
84 O 0 0.05949418991804123
% O 0 0.027233557775616646
( O 0 0.02806217595934868
95 O 0 0.05172853171825409
% O 0 0.04334452003240585
CI O 1 0.9997535347938538
43 O 0 0.05746321380138397
% O 0 0.03529254347085953
- O 0 0.07378514856100082
95 O 0 0.05634037405252457
% O 0 0.030280422419309616
) O 0 0.019722728058695793
by O 0 0.011490457691252232
age O 0 0.0292674470692873
70 O 0 0.03515937179327011
years O 0 0.021723618730902672
. O 0 0.028366465121507645

The O 0 0.04621133208274841
corresponding O 1 0.9808595180511475
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9789329767227173
were O 0 0.018489832058548927
0 O 0 0.051928166300058365
. O 0 0.02355201728641987

4 O 0 0.05165564641356468
% O 0 0.03656754270195961
( O 0 0.03479903191328049
95 O 0 0.060312412679195404
% O 0 0.043827299028635025
CI O 1 0.9998076558113098
0 O 0 0.07174929976463318
% O 0 0.037100475281476974
- O 0 0.07005361467599869
1 O 0 0.03039265051484108
% O 0 0.02289440482854843
) O 0 0.017208358272910118
by O 0 0.01022769883275032
age O 0 0.025539187714457512
50 O 0 0.020918216556310654
years O 0 0.013357956893742085
and O 0 0.009357402101159096
27 O 0 0.02715982496738434
% O 0 0.024810176342725754
( O 0 0.02705930732190609
95 O 0 0.055821631103754044
% O 0 0.04399818927049637
CI O 1 0.9998799562454224
0 O 0 0.0649992823600769
% O 0 0.03529023751616478
- O 0 0.07667019218206406
47 O 0 0.055725179612636566
% O 0 0.030750053003430367
) O 0 0.020060386508703232
by O 0 0.011767702177166939
age O 0 0.030492233112454414
70 O 0 0.03456062451004982
years O 0 0.02047124318778515
. O 0 0.022826047614216805

The O 0 0.030714958906173706
lifetime O 1 0.8448207378387451
risk O 1 0.9910408854484558
of O 0 0.028775498270988464
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.039167046546936035
similar O 0 0.014783947728574276
to O 0 0.00777534069493413
the O 0 0.012715690769255161
risk O 0 0.33819377422332764
in O 0 0.019887441769242287
BRCA1 O 1 0.9998981952667236
carriers O 0 0.10324054211378098
, O 0 0.012532155960798264
but O 0 0.007428112905472517
there O 0 0.006157411728054285
was O 0 0.009557954035699368
some O 0 0.006911158561706543
suggestion O 0 0.02998112514615059
of O 0 0.008326323702931404
a O 0 0.018820788711309433
lower O 0 0.04578029736876488
risk O 1 0.788564920425415
in O 0 0.02483581379055977
BRCA2 O 1 0.9998155236244202
carriers O 1 0.6214840412139893
< O 0 0.23543541133403778
50 O 0 0.02777899242937565
years O 0 0.012941427528858185
of O 0 0.00982773955911398
age O 0 0.03395278751850128
. O 0 0.026147833094000816

Eye B-Disease 1 0.9996089339256287
movement I-Disease 0 0.0948408991098404
abnormalities I-Disease 1 0.994511604309082
correlate O 0 0.10115744918584824
with O 0 0.0230136439204216
genotype O 1 0.7024492025375366
in O 0 0.026531193405389786
autosomal O 1 0.9998383522033691
dominant O 1 0.9960483908653259
cerebellar B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999998807907104
type I-Disease 1 0.9982329607009888
I I-Disease 0 0.2499745637178421
. O 0 0.02670561894774437

We O 0 0.03241646662354469
compared O 0 0.04501330852508545
horizontal O 0 0.12547923624515533
eye O 1 0.9647930264472961
movements O 0 0.048186276108026505
( O 0 0.03246353566646576
visually O 0 0.08767183125019073
guided O 0 0.11436551809310913
saccades O 1 0.9986791014671326
, O 0 0.028251025825738907
antisaccades O 0 0.19900162518024445
, O 0 0.013063343241810799
and O 0 0.011652116663753986
smooth O 0 0.052436601370573044
pursuit O 0 0.07403967529535294
) O 0 0.018008647486567497
in O 0 0.010610095225274563
control O 0 0.03388829901814461
subjects O 0 0.04326948523521423
( O 0 0.035512082278728485
n O 0 0.07682837545871735
= O 0 0.09751252084970474
14 O 0 0.02725505270063877
) O 0 0.020245373249053955
and O 0 0.01252592634409666
patients O 1 0.9968006610870361
with O 0 0.008992242626845837
three O 0 0.007844356819987297
forms O 0 0.019952965900301933
of O 0 0.016346408054232597
autosomal O 1 0.9994803071022034
dominant O 1 0.9572538733482361
cerebellar B-Disease 1 0.9999988079071045
ataxias I-Disease 1 0.9998942613601685
type I-Disease 1 0.9787082076072693
I I-Disease 1 0.850034773349762
spinocerebellar B-Disease 1 0.9999797344207764
ataxias I-Disease 1 0.7788398265838623
1 I-Disease 0 0.024473518133163452
and I-Disease 0 0.011795737780630589
2 I-Disease 0 0.028101259842514992
( O 0 0.03711526840925217
SCA1 B-Disease 1 0.9794756174087524
, O 0 0.025737237185239792
n O 0 0.08282898366451263
= O 0 0.10250303894281387
11 O 0 0.03292420506477356
; O 0 0.027763592079281807
SCA2 B-Disease 1 0.7773163318634033
, O 0 0.02339128963649273
n O 0 0.07226882129907608
= O 0 0.08855664730072021
10 O 0 0.022688662633299828
) O 0 0.02393769472837448
and O 0 0.024801110848784447
SCA3 B-Disease 1 0.9999984502792358
/ O 1 0.999853253364563
Machado B-Disease 1 0.9979339838027954
- I-Disease 1 0.9653903841972351
Joseph I-Disease 0 0.4881943464279175
disease I-Disease 1 0.9999988079071045
( O 0 0.06900272518396378
MJD B-Disease 1 0.9999814033508301
) O 0 0.04009339213371277
( O 0 0.03968411684036255
n O 0 0.08437571674585342
= O 0 0.10573118180036545
16 O 0 0.03270470350980759
) O 0 0.02616957016289234
. O 0 0.026874711737036705

In O 0 0.03837784752249718
SCA1 B-Disease 1 0.956709086894989
, O 0 0.03717980906367302
saccade O 1 0.7103456258773804
amplitude O 0 0.12017026543617249
was O 0 0.02874913439154625
significantly O 0 0.04545571282505989
increased O 0 0.027985824272036552
, O 0 0.013332949951291084
resulting O 0 0.03273946791887283
in O 0 0.017405828461050987
hypermetria B-Disease 1 0.9515235424041748
. O 0 0.031109288334846497

The O 0 0.032821983098983765
smooth O 0 0.08690698444843292
pursuit O 0 0.09998147934675217
gain O 0 0.052582379430532455
was O 0 0.030664218589663506
decreased O 0 0.08900036662817001
. O 0 0.03271982818841934

In O 0 0.03945988789200783
SCA2 B-Disease 1 0.9446199536323547
, O 0 0.03826767951250076
saccade O 1 0.8873631954193115
velocity O 0 0.10894814878702164
was O 0 0.032209333032369614
markedly O 0 0.10129684954881668
decreased O 0 0.09453274309635162
. O 0 0.03153569623827934

The O 0 0.024240989238023758
percentage O 0 0.03497762978076935
of O 0 0.010294250212609768
errors O 0 0.036514852195978165
in O 0 0.014468807727098465
antisaccades O 1 0.5539529323577881
was O 0 0.01898857392370701
greatly O 0 0.029873130843043327
increased O 0 0.018459828570485115
and O 0 0.00793613214045763
was O 0 0.01586010679602623
significantly O 0 0.04371369257569313
correlated O 0 0.07995554059743881
with O 0 0.017930319532752037
age O 0 0.05509520694613457
at O 0 0.24631552398204803
disease O 1 1.0
onset O 1 0.9999978542327881
. O 0 0.0393715463578701

In O 0 0.020551811903715134
addition O 0 0.017975877970457077
, O 0 0.011044610291719437
a O 0 0.016297737136483192
correlation O 0 0.054341260343790054
between O 0 0.015467706136405468
smooth O 0 0.057569533586502075
pursuit O 0 0.06649678200483322
gain O 0 0.02575571835041046
and O 0 0.006084231194108725
the O 0 0.006361240055412054
number O 0 0.008171483874320984
of O 0 0.013040578924119473
trinucleotide O 1 0.9962945580482483
repeats O 0 0.08779475092887878
was O 0 0.022602669894695282
found O 0 0.024549759924411774
. O 0 0.022325847297906876

In O 0 0.04714268073439598
SCA3 B-Disease 1 0.9999736547470093
, O 0 0.036134906113147736
gaze B-Disease 1 0.9970220923423767
- I-Disease 1 0.6421437859535217
evoked I-Disease 1 0.8068631291389465
nystagmus I-Disease 1 0.9997921586036682
was O 0 0.025051698088645935
often O 0 0.015411261469125748
present O 0 0.01206532958894968
as O 0 0.010982113890349865
was O 0 0.023330751806497574
saccade O 1 0.9843287467956543
hypometria O 0 0.33248937129974365
and O 0 0.015507294796407223
smooth O 0 0.05749278515577316
pursuit O 0 0.08345590531826019
gain O 0 0.042146917432546616
was O 0 0.026875663548707962
markedly O 0 0.0939679741859436
decreased O 0 0.08616545796394348
. O 0 0.028439154848456383

Three O 0 0.021362589672207832
major O 0 0.02720552682876587
criteria O 0 0.04365886002779007
, O 0 0.026466069743037224
saccade O 1 0.5926494002342224
amplitude O 0 0.11315000802278519
, O 0 0.027721060439944267
saccade O 1 0.6190270185470581
velocity O 0 0.07476753741502762
, O 0 0.010775123722851276
and O 0 0.008264060132205486
presence O 0 0.025791093707084656
of O 0 0.014793064445257187
gaze B-Disease 1 0.997220516204834
- I-Disease 1 0.566066563129425
evoked I-Disease 1 0.6436092257499695
nystagmus I-Disease 1 0.9992840886116028
, O 0 0.01832188293337822
permitted O 0 0.023082951083779335
the O 0 0.011941931210458279
correct O 0 0.052883077412843704
assignment O 0 0.04803163558244705
of O 0 0.010209141299128532
90 O 0 0.027798764407634735
% O 0 0.015068450942635536
of O 0 0.0074468632228672504
the O 0 0.015159832313656807
SCA1 B-Disease 1 0.979219377040863
, O 0 0.01427300926297903
90 O 0 0.026289017871022224
% O 0 0.01407120656222105
of O 0 0.007054703310132027
the O 0 0.014166496694087982
SCA2 B-Disease 1 0.9969791173934937
, O 0 0.012458614073693752
and O 0 0.010235308669507504
93 O 0 0.051175083965063095
% O 0 0.014755693264305592
of O 0 0.006845297757536173
the O 0 0.015381119213998318
patients O 1 0.9999419450759888
with O 0 0.018571309745311737
SCA3 B-Disease 1 0.9999645948410034
to O 0 0.009615017101168633
their O 0 0.010040739551186562
genetically O 0 0.055119987577199936
confirmed O 0 0.0588216558098793
patient O 1 0.9987252354621887
group O 0 0.025165637955069542
and O 0 0.008228624239563942
, O 0 0.008493278175592422
therefore O 0 0.012857523746788502
, O 0 0.0098031684756279
may O 0 0.01652512326836586
help O 0 0.02969522960484028
orient O 0 0.10104133933782578
diagnoses O 1 0.9866998195648193
of O 0 0.020666256546974182
SCA1 B-Disease 1 0.9991982579231262
, O 0 0.025515511631965637
SCA2 B-Disease 1 0.9976181387901306
, O 0 0.016223032027482986
and O 0 0.015257488004863262
SCA3 B-Disease 1 0.9998750686645508
at O 0 0.028079982846975327
early O 0 0.0280031468719244
clinical O 1 0.6705269813537598
stages O 0 0.04607124999165535
of O 0 0.009516848251223564
the O 0 0.0176161527633667
diseases O 1 0.9999983310699463
. O 0 0.015970418229699135
. O 0 0.023410789668560028

Genetic O 0 0.09421592205762863
basis O 0 0.017958203330636024
and O 0 0.012724636122584343
molecular O 0 0.06085033714771271
mechanism O 0 0.08927016705274582
for O 0 0.036912593990564346
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.0489049069583416

Ventricular B-Disease 1 0.9999997615814209
fibrillation I-Disease 1 0.9999998807907104
causes O 1 0.8803608417510986
more O 0 0.011366616934537888
than O 0 0.010949341580271721
300 O 0 0.03200118616223335
, O 0 0.015531896613538265
000 O 0 0.08038487285375595
sudden O 1 0.8319276571273804
deaths O 0 0.05415043234825134
each O 0 0.009995785541832447
year O 0 0.013420650735497475
in O 0 0.008856923319399357
the O 0 0.014274832792580128
USA O 0 0.11457017064094543
alone O 0 0.041655924171209335
. O 0 0.022976567968726158

In O 0 0.021695759147405624
approximately O 0 0.0287538543343544
5 O 0 0.027694955468177795
- O 0 0.050884947180747986
12 O 0 0.0223162230104208
% O 0 0.014718680642545223
of O 0 0.006388253998011351
these O 0 0.007360158953815699
cases O 0 0.018242569640278816
, O 0 0.009019163437187672
there O 0 0.007770563010126352
are O 0 0.006722422782331705
no O 0 0.02251313626766205
demonstrable O 1 0.9998739957809448
cardiac O 1 0.9999998807907104
or O 0 0.03400550037622452
non O 1 0.8835945129394531
- O 1 0.9997400641441345
cardiac O 1 0.9999998807907104
causes O 0 0.2378787398338318
to O 0 0.008675255812704563
account O 0 0.010768890380859375
for O 0 0.0056382715702056885
the O 0 0.008041858673095703
episode O 0 0.03180881589651108
, O 0 0.008938377723097801
which O 0 0.007460128981620073
is O 0 0.009942322038114071
therefore O 0 0.014795699156820774
classified O 0 0.035781487822532654
as O 0 0.03510000556707382
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.8063850402832031
IVF B-Disease 1 0.9999990463256836
) O 0 0.04050352796912193
. O 0 0.028008194640278816

A O 0 0.04781828820705414
distinct O 0 0.04356071352958679
group O 0 0.037414778023958206
of O 0 0.024458641186356544
IVF B-Disease 1 1.0
patients O 1 0.9999921321868896
has O 0 0.014595204964280128
been O 0 0.009989011101424694
found O 0 0.009190819226205349
to O 0 0.005419679917395115
present O 0 0.00980541855096817
with O 0 0.010685664601624012
a O 0 0.022416891530156136
characteristic O 0 0.07804744690656662
electrocardiographic O 1 0.9930828809738159
pattern O 0 0.10160868614912033
. O 0 0.033219609409570694

Because O 0 0.018289200961589813
of O 0 0.006994619034230709
the O 0 0.008791910484433174
small O 0 0.013621040619909763
size O 0 0.014036042615771294
of O 0 0.0067565664649009705
most O 0 0.010838204063475132
pedigrees O 0 0.07008977979421616
and O 0 0.007950237952172756
the O 0 0.012702850624918938
high O 0 0.041537582874298096
incidence O 1 0.9985029697418213
of O 0 0.016519183292984962
sudden B-Disease 1 0.9987233281135559
death I-Disease 0 0.035111140459775925
, O 0 0.010291563346982002
however O 0 0.010404376313090324
, O 0 0.011477687396109104
molecular O 0 0.05792371928691864
genetic O 0 0.06319347769021988
studies O 0 0.028363270685076714
of O 0 0.0149274542927742
IVF B-Disease 1 0.999997615814209
have O 0 0.010606816969811916
not O 0 0.007755063474178314
yet O 0 0.012899811379611492
been O 0 0.010520177893340588
done O 0 0.019659314304590225
. O 0 0.020996365696191788

Because O 0 0.22111602127552032
IVF B-Disease 1 0.9999997615814209
causes O 1 0.9999884366989136
cardiac O 1 1.0
rhythm O 1 0.9970999956130981
disturbance O 1 0.9943230152130127
, O 0 0.014207002706825733
we O 0 0.012045401148498058
investigated O 0 0.04119741916656494
whether O 0 0.026514986529946327
malfunction O 1 0.8734424114227295
of O 0 0.016067618504166603
ion O 0 0.10884149372577667
channels O 0 0.042811017483472824
could O 0 0.020580660551786423
cause O 0 0.0641428530216217
the O 0 0.02089083194732666
disorder O 1 0.9999953508377075
by O 0 0.014581460505723953
studying O 0 0.03368889540433884
mutations O 0 0.08235522359609604
in O 0 0.01398133672773838
the O 0 0.0285574309527874
cardiac O 1 0.9999972581863403
sodium O 0 0.19511045515537262
channel O 0 0.08709915727376938
gene O 0 0.11901028454303741
SCN5A O 1 0.9649289846420288
. O 0 0.03869736194610596

We O 0 0.022172294557094574
have O 0 0.012681386433541775
now O 0 0.014314595609903336
identified O 0 0.025679683312773705
a O 0 0.030495356768369675
missense O 0 0.19508856534957886
mutation O 0 0.1489202380180359
, O 0 0.02036023885011673
a O 0 0.03258137404918671
splice O 0 0.4827785789966583
- O 0 0.2617056369781494
donor O 1 0.6255448460578918
mutation O 0 0.15818846225738525
, O 0 0.015013222582638264
and O 0 0.01148357056081295
a O 0 0.030563000589609146
frameshift O 1 0.896097719669342
mutation O 0 0.1210513561964035
in O 0 0.012735447846353054
the O 0 0.016056455671787262
coding O 0 0.0893969014286995
region O 0 0.03273819759488106
of O 0 0.013862240128219128
SCN5A O 1 0.996982991695404
in O 0 0.014303281903266907
three O 0 0.021890882402658463
IVF B-Disease 1 0.9999954700469971
families O 0 0.047567762434482574
. O 0 0.03033827617764473

We O 0 0.021662231534719467
show O 0 0.027215030044317245
that O 0 0.013178211636841297
sodium O 0 0.08656956255435944
channels O 0 0.029868271201848984
with O 0 0.011320723220705986
the O 0 0.020647764205932617
missense O 0 0.24948282539844513
mutation O 0 0.20021450519561768
recover O 0 0.32195010781288147
from O 0 0.026141630485653877
inactivation O 0 0.4771421253681183
more O 0 0.011997811496257782
rapidly O 0 0.026814226061105728
than O 0 0.010121503844857216
normal O 0 0.02592463232576847
and O 0 0.00753923412412405
that O 0 0.0097498232498765
the O 0 0.023830557242035866
frameshift O 1 0.9867957830429077
mutation O 0 0.20439447462558746
causes O 0 0.10987303406000137
the O 0 0.022632744163274765
sodium O 0 0.09497708082199097
channel O 0 0.028733067214488983
to O 0 0.008421216160058975
be O 0 0.008457187563180923
non O 0 0.03880923613905907
- O 0 0.08206289261579514
functional O 0 0.07179001718759537
. O 0 0.034451715648174286

Our O 0 0.02938750945031643
results O 0 0.028590982779860497
indicate O 0 0.030112512409687042
that O 0 0.013300956226885319
mutations O 0 0.10161563754081726
in O 0 0.03297014907002449
cardiac O 1 0.9999991655349731
ion O 1 0.5440607070922852
- O 0 0.08259735256433487
channel O 0 0.05677616968750954
genes O 0 0.058035045862197876
contribute O 0 0.03467532992362976
to O 0 0.009184855036437511
the O 0 0.012692680582404137
risk O 0 0.07725299149751663
of O 0 0.014366237446665764
developing O 0 0.09381955116987228
IVF B-Disease 1 0.9999969005584717
. O 0 0.02197134681046009
. O 0 0.025042982771992683

Molecular O 0 0.13066723942756653
heterogeneity O 0 0.1550023853778839
in O 0 0.027211496606469154
mucopolysaccharidosis B-Disease 1 0.9854177236557007
IVA I-Disease 1 0.9989905953407288
in O 0 0.014079649932682514
Australia O 0 0.017938317731022835
and O 0 0.00875349435955286
Northern O 0 0.02040308341383934
Ireland O 0 0.025741640478372574
: O 0 0.01620500721037388
nine O 0 0.019952518865466118
novel O 0 0.038595814257860184
mutations O 0 0.09227524697780609
including O 0 0.02118236944079399
T312S O 0 0.12631599605083466
, O 0 0.01268075406551361
a O 0 0.017460620030760765
common O 0 0.028349535539746284
allele O 0 0.12295503169298172
that O 0 0.01722693257033825
confers O 0 0.374374657869339
a O 0 0.04789017513394356
mild O 1 0.9996981620788574
phenotype O 1 0.9911276698112488
. O 0 0.04017850384116173

Mucopolysaccharidosis B-Disease 1 0.9992432594299316
IVA I-Disease 1 0.9999430179595947
( O 0 0.08564342558383942
MPS B-Disease 1 0.9981993436813354
IVA I-Disease 1 0.9999973773956299
) O 0 0.028421597555279732
is O 0 0.016260046511888504
an O 0 0.025016872212290764
autosomal B-Disease 1 0.999855637550354
recessive I-Disease 1 0.9999829530715942
lysosomal I-Disease 1 0.9999991655349731
storage I-Disease 1 0.9998488426208496
disorder I-Disease 1 1.0
caused O 0 0.4820333421230316
by O 0 0.014147491194307804
a O 0 0.029232539236545563
genetic B-Disease 1 0.8615039587020874
defect I-Disease 1 0.9997870326042175
in O 0 0.02699742279946804
N O 0 0.4997129738330841
- O 0 0.22831560671329498
acetylgalactosamine O 1 0.9954110980033875
- O 0 0.25264960527420044
6 O 0 0.07224898040294647
- O 1 0.9130927920341492
sulfate O 1 0.9996711015701294
sulfatase O 1 0.9998916387557983
( O 0 0.08207916468381882
GALNS O 1 0.9982632994651794
) O 0 0.034868594259023666
. O 0 0.026848018169403076

Previous O 0 0.04354776814579964
studies O 0 0.03236277773976326
of O 0 0.01272408477962017
patients O 1 0.9997733235359192
from O 0 0.014738940633833408
a O 0 0.019534114748239517
British O 0 0.03474019095301628
- O 0 0.06948588788509369
Irish O 0 0.04056333377957344
population O 0 0.022814223542809486
showed O 0 0.025088131427764893
that O 0 0.00885115284472704
the O 0 0.014807775616645813
I113F O 0 0.43274208903312683
mutation O 0 0.11469996720552444
is O 0 0.010017598047852516
the O 0 0.007364786695688963
most O 0 0.008731105364859104
common O 0 0.0209942739456892
single O 0 0.037988606840372086
mutation O 0 0.14112263917922974
among O 0 0.03565257787704468
MPS B-Disease 1 0.9999090433120728
IVA I-Disease 1 1.0
patients O 1 0.999991774559021
and O 0 0.01580486260354519
produces O 0 0.05062740296125412
a O 0 0.03464604169130325
severe O 1 0.9999943971633911
clinical O 1 0.9999269247055054
phenotype O 1 0.996900200843811
. O 0 0.04317091405391693

We O 0 0.02839437499642372
studied O 0 0.03719322010874748
mutations O 0 0.07419095933437347
in O 0 0.012780564837157726
the O 0 0.017735792323946953
GALNS O 1 0.9947333335876465
gene O 0 0.07588907331228256
from O 0 0.017338495701551437
23 O 0 0.029818277806043625
additional O 0 0.041069768369197845
MPS B-Disease 1 0.9989194869995117
IVA I-Disease 1 1.0
patients O 1 0.9999850988388062
( O 0 0.028759628534317017
15 O 0 0.016814883798360825
from O 0 0.00962757132947445
Australia O 0 0.01595463789999485
, O 0 0.00912514515221119
8 O 0 0.015551813878118992
from O 0 0.010173691436648369
Northern O 0 0.02277080900967121
Ireland O 0 0.0271952822804451
) O 0 0.015779763460159302
, O 0 0.006880745757371187
with O 0 0.00706211943179369
various O 0 0.012182771228253841
clinical O 1 0.9997367262840271
phenotypes O 1 0.9954403638839722
( O 0 0.05053219199180603
severe O 1 0.9999264478683472
, O 0 0.013439680449664593
16 O 0 0.0194696057587862
cases O 0 0.020443463698029518
; O 0 0.017600638791918755
intermediate O 0 0.043672870844602585
, O 0 0.012755908071994781
4 O 0 0.022881895303726196
cases O 0 0.028229426592588425
; O 0 0.025928232818841934
mild O 1 0.9995890259742737
, O 0 0.014618836343288422
3 O 0 0.02296348474919796
cases O 0 0.026500029489398003
) O 0 0.026605498045682907
. O 0 0.02216123417019844

We O 0 0.021815191954374313
found O 0 0.015293646603822708
two O 0 0.010856726206839085
common O 0 0.028753703460097313
mutations O 0 0.07484723627567291
that O 0 0.0088396817445755
together O 0 0.011904634535312653
accounted O 0 0.03127707913517952
for O 0 0.009529818780720234
32 O 0 0.022942017763853073
% O 0 0.013388250023126602
of O 0 0.006102939136326313
the O 0 0.01304139569401741
44 O 0 0.04201231524348259
unrelated O 0 0.06780359894037247
alleles O 0 0.12870420515537262
in O 0 0.016451524570584297
these O 0 0.01651742309331894
patients O 1 0.9999573230743408
. O 0 0.03015519306063652

One O 0 0.020228222012519836
is O 0 0.015692582353949547
the O 0 0.01754487305879593
T312S O 0 0.3711857199668884
mutation O 0 0.1370718628168106
, O 0 0.015228715725243092
a O 0 0.019688967615365982
novel O 0 0.0357370488345623
mutation O 0 0.09907926619052887
found O 0 0.019193580374121666
exclusively O 0 0.023480920121073723
in O 0 0.019597258418798447
milder O 1 0.9992033839225769
patients O 1 0.9999781847000122
. O 0 0.029513854533433914

The O 0 0.017229054123163223
other O 0 0.006764452904462814
is O 0 0.008634445257484913
the O 0 0.00875542126595974
previously O 0 0.02081182412803173
described O 0 0.03253555670380592
I113F O 0 0.11956574767827988
that O 0 0.014831041917204857
produces O 0 0.053291186690330505
a O 0 0.039675384759902954
severe O 1 0.9999756813049316
phenotype O 1 0.9962103366851807
. O 0 0.036739517003297806

The O 0 0.041707735508680344
I113F O 0 0.18425986170768738
and O 0 0.029193274676799774
T312S O 0 0.22597458958625793
mutations O 0 0.12841224670410156
accounted O 0 0.053890228271484375
for O 0 0.015318253077566624
8 O 0 0.03020809218287468
( O 0 0.023222241550683975
18 O 0 0.020162273198366165
% O 0 0.019705209881067276
) O 0 0.01709490455687046
and O 0 0.009803343564271927
6 O 0 0.025929348543286324
( O 0 0.02175082452595234
14 O 0 0.02114100381731987
% O 0 0.021059442311525345
) O 0 0.01512813474982977
of O 0 0.008841127157211304
44 O 0 0.03758227452635765
unrelated O 0 0.058339376002550125
alleles O 0 0.13864333927631378
, O 0 0.02057340368628502
respectively O 0 0.032390572130680084
. O 0 0.028618820011615753

The O 0 0.02914322540163994
relatively O 0 0.04412803426384926
high O 0 0.05506061390042305
residual O 0 0.34941697120666504
GALNS O 1 0.9938129186630249
activity O 0 0.04910951480269432
seen O 0 0.02561522275209427
when O 0 0.016885962337255478
the O 0 0.01990436390042305
T312S O 0 0.17552830278873444
mutant O 0 0.13390761613845825
cDNA O 0 0.15172125399112701
is O 0 0.028523525223135948
overexpressed O 0 0.15867570042610168
in O 0 0.01970941387116909
mutant O 0 0.1106972023844719
cells O 0 0.06555265933275223
provides O 0 0.029927968978881836
an O 0 0.011726769618690014
explanation O 0 0.02361178956925869
for O 0 0.008186306804418564
the O 0 0.017678694799542427
mild O 1 0.999957799911499
phenotype O 1 0.998484194278717
in O 0 0.02392369508743286
patients O 1 0.9999196529388428
with O 0 0.014573904685676098
this O 0 0.015562914311885834
mutation O 0 0.14665734767913818
. O 0 0.0338478609919548

The O 0 0.02037336863577366
distribution O 0 0.021502116695046425
and O 0 0.008575043641030788
relative O 0 0.027231423184275627
frequencies O 0 0.025232547894120216
of O 0 0.007751893252134323
the O 0 0.015752531588077545
I113F O 0 0.16907624900341034
and O 0 0.021783916279673576
T312S O 0 0.18514467775821686
mutations O 0 0.08058419823646545
in O 0 0.011620625853538513
Australia O 0 0.01869676634669304
corresponded O 0 0.03228452429175377
to O 0 0.006857237312942743
those O 0 0.00795772485435009
observed O 0 0.01877066120505333
in O 0 0.007885814644396305
Northern O 0 0.017255879938602448
Ireland O 0 0.017757520079612732
and O 0 0.006098342593759298
are O 0 0.004334375727921724
unique O 0 0.010419439524412155
to O 0 0.004807167686522007
these O 0 0.004661667626351118
two O 0 0.006947856862097979
populations O 0 0.03316834568977356
, O 0 0.0125108128413558
suggesting O 0 0.028942450881004333
that O 0 0.007834198884665966
both O 0 0.011051342822611332
mutations O 0 0.07424812763929367
were O 0 0.009996346198022366
probably O 0 0.02277648076415062
introduced O 0 0.015337800607085228
to O 0 0.00770164281129837
Australia O 0 0.01769731380045414
by O 0 0.010366169735789299
Irish O 0 0.03294849023222923
migrants O 0 0.03375548869371414
during O 0 0.01849684678018093
the O 0 0.011662235483527184
19th O 0 0.030658520758152008
century O 0 0.03296374902129173
. O 0 0.024575602263212204

Haplotype O 1 0.8858737945556641
analysis O 0 0.04594068601727486
using O 0 0.028865262866020203
6 O 0 0.04107140004634857
RFLPs O 0 0.21680596470832825
provides O 0 0.03226538375020027
additional O 0 0.015605672262609005
data O 0 0.010584651492536068
that O 0 0.007028777152299881
the O 0 0.01576775312423706
I113F O 0 0.21832896769046783
mutation O 0 0.1455327570438385
originated O 0 0.05179949849843979
from O 0 0.014309375546872616
a O 0 0.01919844001531601
common O 0 0.030029214918613434
ancestor O 0 0.0727519765496254
. O 0 0.030265871435403824

The O 0 0.018252819776535034
other O 0 0.011605688370764256
9 O 0 0.03534119948744774
novel O 0 0.04152396321296692
mutations O 0 0.10119272768497467
identified O 0 0.02729859948158264
in O 0 0.010101785883307457
these O 0 0.008561567403376102
23 O 0 0.03205784782767296
patients O 1 0.9940394163131714
were O 0 0.006567747797816992
each O 0 0.006783459335565567
limited O 0 0.015699131414294243
to O 0 0.007567920256406069
a O 0 0.013909009285271168
single O 0 0.022502779960632324
family O 0 0.033784352242946625
. O 0 0.02616649679839611

These O 0 0.015420686453580856
data O 0 0.013378018513321877
provide O 0 0.013857899233698845
further O 0 0.009679751470685005
evidence O 0 0.012301608920097351
for O 0 0.010195629671216011
extensive O 0 0.04496953636407852
allelic O 0 0.4147871732711792
heterogeneity O 0 0.1444486677646637
in O 0 0.025190722197294235
MPS B-Disease 1 0.9812572002410889
IVA I-Disease 1 0.9999908208847046
in O 0 0.02233794890344143
British O 0 0.05887576937675476
- O 0 0.3391965627670288
Irish O 0 0.07741167396306992
patients O 1 0.9998074173927307
and O 0 0.009626285172998905
provide O 0 0.01481616124510765
evidence O 0 0.010983766056597233
for O 0 0.005854349583387375
their O 0 0.007279705721884966
transmission O 0 0.05085894837975502
to O 0 0.007804198190569878
Australia O 0 0.01582697592675686
by O 0 0.010396439582109451
British O 0 0.03644877299666405
- O 0 0.0749361515045166
Irish O 0 0.04677828028798103
migrants O 0 0.049348194152116776
. O 0 0.0168906357139349
. O 0 0.02534772828221321

Identification O 0 0.056589409708976746
of O 0 0.016827186569571495
constitutional O 0 0.05124489217996597
WT1 O 1 0.9999219179153442
mutations O 0 0.12661069631576538
, O 0 0.015920743346214294
in O 0 0.015065332874655724
patients O 1 0.9999836683273315
with O 0 0.023134367540478706
isolated O 1 0.9959986209869385
diffuse B-Disease 1 0.9999992847442627
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.020350832492113113
and O 0 0.009400983341038227
analysis O 0 0.022409211844205856
of O 0 0.017532145604491234
genotype O 1 0.9995255470275879
/ O 1 0.999250590801239
phenotype O 1 0.659622073173523
correlations O 0 0.06986190378665924
by O 0 0.00944215152412653
use O 0 0.011211586184799671
of O 0 0.00950012356042862
a O 0 0.025221658870577812
computerized O 0 0.13556978106498718
mutation O 0 0.16732311248779297
database O 0 0.06506228446960449
. O 0 0.028939731419086456

Constitutional O 0 0.06325838714838028
mutations O 0 0.09932691603899002
of O 0 0.014206075109541416
the O 0 0.028054166585206985
WT1 O 1 0.9998459815979004
gene O 0 0.09068746119737625
, O 0 0.0159575417637825
encoding O 0 0.04630710184574127
a O 0 0.032334912568330765
zinc O 1 0.9980071187019348
- O 0 0.12494299560785294
finger O 0 0.16335806250572205
transcription O 0 0.10571495443582535
factor O 0 0.05881360545754433
involved O 0 0.028566451743245125
in O 0 0.02279587648808956
renal O 1 1.0
and O 0 0.024332748726010323
gonadal O 1 0.9999932050704956
development O 0 0.026744432747364044
, O 0 0.008904900401830673
are O 0 0.005163647700101137
found O 0 0.01016126200556755
in O 0 0.00798017717897892
most O 0 0.013368537649512291
patients O 1 0.9999886751174927
with O 0 0.022884363308548927
Denys B-Disease 1 0.9999986886978149
- I-Disease 1 0.999946117401123
Drash I-Disease 1 0.9999978542327881
syndrome I-Disease 1 1.0
( O 1 0.8967372179031372
DDS B-Disease 1 1.0
) O 0 0.033435896039009094
, O 0 0.018374592065811157
or O 0 0.038738880306482315
diffuse B-Disease 1 0.9999978542327881
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9666441082954407
DMS B-Disease 1 0.9999997615814209
) O 0 0.02436423860490322
associated O 0 0.019233420491218567
with O 0 0.017202487215399742
pseudohermaphroditism B-Disease 1 0.9999655485153198
and O 0 0.0226314514875412
/ O 1 0.999966025352478
or O 0 0.22337666153907776
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.999998927116394
( O 0 0.09576350450515747
WT B-Disease 1 0.9999918937683105
) O 0 0.04206528142094612
. O 0 0.03069405071437359

Most O 0 0.04247087985277176
mutations O 0 0.15033823251724243
in O 0 0.043394967913627625
DDS B-Disease 1 1.0
patients O 1 0.999991774559021
lie O 0 0.04906708374619484
in O 0 0.015735706314444542
exon O 0 0.11498723924160004
8 O 0 0.03345029801130295
or O 0 0.022934360429644585
exon O 0 0.11171619594097137
9 O 0 0.037342749536037445
, O 0 0.01864781230688095
encoding O 0 0.07673214375972748
zinc O 1 0.682541012763977
finger O 0 0.1556851863861084
2 O 0 0.04300854727625847
or O 0 0.034789297729730606
zinc O 1 0.9442679286003113
finger O 0 0.12690311670303345
3 O 0 0.023961776867508888
, O 0 0.0101923868060112
respectively O 0 0.016661664471030235
, O 0 0.008091422729194164
with O 0 0.008752417750656605
a O 0 0.02084266021847725
hot O 0 0.0785488411784172
spot O 0 0.06149701029062271
( O 0 0.040867045521736145
R394W O 0 0.14517627656459808
) O 0 0.022003792226314545
in O 0 0.013929867185652256
exon O 0 0.12887272238731384
9 O 0 0.048909999430179596
. O 0 0.02868206799030304

We O 0 0.021607881411910057
analyzed O 0 0.03204754739999771
a O 0 0.013820881955325603
series O 0 0.016943752765655518
of O 0 0.010651485063135624
24 O 0 0.03231152147054672
patients O 1 0.9996223449707031
, O 0 0.0124046104028821
10 O 0 0.015518452040851116
with O 0 0.01672101952135563
isolated B-Disease 0 0.48356977105140686
DMS I-Disease 1 0.9999979734420776
( O 0 0.07158476859331131
IDMS B-Disease 1 0.9999788999557495
) O 0 0.023883048444986343
, O 0 0.010622174479067326
10 O 0 0.015495985746383667
with O 0 0.019367776811122894
DDS B-Disease 1 0.9999998807907104
, O 0 0.01438806764781475
and O 0 0.00881177093833685
4 O 0 0.024838460609316826
with O 0 0.022196291014552116
urogenital B-Disease 1 0.9999982118606567
abnormalities I-Disease 1 0.9999645948410034
and O 0 0.030228955671191216
/ O 1 0.9998480081558228
or O 0 0.052690282464027405
WT B-Disease 1 0.9999855756759644
. O 0 0.03563408553600311

We O 0 0.034178726375103
report O 0 0.04738497734069824
WT1 O 1 0.9924963712692261
heterozygous O 0 0.21881425380706787
mutations O 0 0.12757812440395355
in O 0 0.020865824073553085
16 O 0 0.03569271042943001
patients O 1 0.9997665286064148
, O 0 0.012006236240267754
4 O 0 0.014184142462909222
of O 0 0.007399930618703365
whom O 0 0.022216083481907845
presented O 0 0.023966584354639053
with O 0 0.02788771130144596
IDMS B-Disease 1 0.9999433755874634
. O 0 0.045201655477285385

One O 0 0.0286685973405838
male O 0 0.04870888590812683
and O 0 0.010026189498603344
two O 0 0.013299254700541496
female O 0 0.15254735946655273
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.99998939037323
with O 0 0.03994925692677498
WT1 O 1 0.9999905824661255
mutations O 1 0.5240430235862732
underwent O 1 0.9995623230934143
normal O 0 0.10008514672517776
puberty O 1 0.9892690777778625
. O 0 0.03493531420826912

Two O 0 0.03411562368273735
mutations O 0 0.12836003303527832
associated O 0 0.03632638603448868
with O 0 0.025267651304602623
IDMS B-Disease 1 0.9998959302902222
are O 0 0.007703728042542934
different O 0 0.006459219381213188
from O 0 0.008875683881342411
those O 0 0.009549958631396294
described O 0 0.03288567066192627
in O 0 0.029111744835972786
DDS B-Disease 1 1.0
patients O 1 0.9999967813491821
. O 0 0.032411184161901474

No O 0 0.0729268342256546
WT1 O 1 0.9993810653686523
mutations O 0 0.13893115520477295
were O 0 0.015777362510561943
detected O 0 0.05791621282696724
in O 0 0.008782985620200634
the O 0 0.008967172354459763
six O 0 0.018863525241613388
other O 0 0.02295435406267643
IDMS B-Disease 1 1.0
patients O 1 0.9999966621398926
, O 0 0.022316554561257362
suggesting O 0 0.05187493935227394
genetic O 0 0.07435091584920883
heterogeneity O 0 0.10767433792352676
of O 0 0.0126060014590621
this O 0 0.022751500830054283
disease O 1 0.9999990463256836
. O 0 0.03170335292816162

We O 0 0.03891628235578537
analyzed O 0 0.10079042613506317
genotype O 1 0.9852516651153564
/ O 1 0.9972249269485474
phenotype O 1 0.886916995048523
correlations O 0 0.08088837563991547
, O 0 0.009053911082446575
on O 0 0.00554738100618124
the O 0 0.0058509972877800465
basis O 0 0.006998914759606123
of O 0 0.004713850561529398
the O 0 0.008191472850739956
constitution O 0 0.013428021222352982
of O 0 0.009574942290782928
a O 0 0.03545407950878143
WT1 O 1 0.9986819624900818
mutation O 0 0.15878088772296906
database O 0 0.03641593083739281
of O 0 0.0135947922244668
84 O 0 0.1515805572271347
germ O 1 0.9998650550842285
- O 0 0.11764401942491531
line O 0 0.048736512660980225
mutations O 0 0.08926241844892502
, O 0 0.010525569319725037
to O 0 0.009925249963998795
compare O 0 0.03284734487533569
the O 0 0.008878297172486782
distribution O 0 0.01727127656340599
and O 0 0.009158802218735218
type O 0 0.04144236817955971
of O 0 0.01214734185487032
mutations O 0 0.07910677790641785
, O 0 0.010085630230605602
according O 0 0.00806624349206686
to O 0 0.00660028075799346
the O 0 0.010982545092701912
different O 0 0.01714077778160572
symptoms O 1 0.999998927116394
. O 0 0.03059929423034191

This O 0 0.025673961266875267
demonstrated O 0 0.052143801003694534
( O 0 0.024883903563022614
1 O 0 0.02127600833773613
) O 0 0.013834485784173012
the O 0 0.010812276042997837
association O 0 0.03573162853717804
between O 0 0.02036226913332939
mutations O 0 0.08463875204324722
in O 0 0.01613321341574192
exons O 0 0.08261275291442871
8 O 0 0.02725006453692913
and O 0 0.010080794803798199
9 O 0 0.026307199150323868
and O 0 0.01864476315677166
DMS B-Disease 1 0.9999948740005493
; O 0 0.029713699594140053
( O 0 0.025990022346377373
2 O 0 0.025306785479187965
) O 0 0.020400814712047577
among O 0 0.01927180588245392
patients O 1 0.999769389629364
with O 0 0.023887725546956062
DMS B-Disease 1 0.9999935626983643
, O 0 0.014291354455053806
a O 0 0.017846373841166496
higher O 0 0.028003154322504997
frequency O 0 0.04454230144619942
of O 0 0.013842645101249218
exon O 0 0.1376744508743286
8 O 0 0.05312720313668251
mutations O 0 0.0963125079870224
among O 0 0.022559242323040962
46 O 0 0.05157773196697235
, O 0 0.029538562521338463
XY O 1 0.9999868869781494
patients O 1 0.999725878238678
with O 0 0.021480947732925415
female O 0 0.05553702265024185
phenotype O 1 0.7366213202476501
than O 0 0.015031583607196808
among O 0 0.01675453595817089
46 O 0 0.05145017430186272
, O 0 0.02785198576748371
XY O 1 0.9999955892562866
patients O 1 0.9999608993530273
with O 0 0.018314750865101814
sexual O 0 0.04928816482424736
ambiguity O 0 0.06129243224859238
or O 0 0.026689210906624794
male O 0 0.10486204922199249
phenotype O 1 0.9966647028923035
; O 0 0.020196953788399696
and O 0 0.011285626329481602
( O 0 0.02625761739909649
3 O 0 0.02366696670651436
) O 0 0.01607704907655716
statistically O 0 0.030640453100204468
significant O 0 0.015917694196105003
evidence O 0 0.014652145095169544
that O 0 0.011913741007447243
mutations O 0 0.07114963978528976
in O 0 0.01379240583628416
exons O 0 0.08350073546171188
8 O 0 0.025781283155083656
and O 0 0.013354319147765636
9 O 0 0.038493767380714417
preferentially O 0 0.11533409357070923
affect O 0 0.055780768394470215
amino O 0 0.056435491889715195
acids O 0 0.03741307184100151
with O 0 0.009415822103619576
different O 0 0.00728036742657423
functions O 0 0.014577412977814674
. O 0 0.011653763242065907
. O 0 0.021152062341570854

The O 0 0.05466960743069649
185delAG O 1 0.9151626825332642
BRCA1 O 1 0.995969295501709
mutation O 0 0.2307722121477127
originated O 0 0.0557350255548954
before O 0 0.015758400782942772
the O 0 0.010831682942807674
dispersion O 0 0.07036875188350677
of O 0 0.007139113731682301
Jews O 0 0.01564379781484604
in O 0 0.007665080018341541
the O 0 0.009478887543082237
diaspora O 0 0.03780168294906616
and O 0 0.0082585783675313
is O 0 0.009273768402636051
not O 0 0.006847621873021126
limited O 0 0.01900135539472103
to O 0 0.015575310215353966
Ashkenazim O 0 0.4882386326789856
. O 0 0.03473054990172386

The O 0 0.04720696806907654
185delAG O 1 0.5490850806236267
mutation O 0 0.15522325038909912
in O 0 0.03395485505461693
BRCA1 O 1 0.9951121211051941
is O 0 0.027997856959700584
detected O 0 0.07279283553361893
in O 0 0.014279329217970371
Ashkenazi O 0 0.09113848209381104
Jews O 0 0.018551290035247803
both O 0 0.011277259327471256
in O 0 0.01764633134007454
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9982283711433411
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.010137385688722134
in O 0 0.006889148615300655
the O 0 0.008073943667113781
general O 0 0.014245676808059216
population O 0 0.026378843933343887
. O 0 0.024427663534879684

All O 0 0.026920892298221588
tested O 0 0.1296452283859253
Ashkenazi O 0 0.30437496304512024
mutation O 0 0.1896502524614334
carriers O 0 0.08122973144054413
share O 0 0.026525279507040977
the O 0 0.012971167452633381
same O 0 0.02310427464544773
allelic O 1 0.5400592684745789
pattern O 0 0.06820648163557053
at O 0 0.023904401808977127
the O 0 0.021262120455503464
BRCA1 O 1 0.9936667084693909
locus O 0 0.2253137230873108
. O 0 0.04595210403203964

Our O 0 0.027112776413559914
previous O 0 0.022742534056305885
study O 0 0.02454467862844467
showed O 0 0.024076735600829124
that O 0 0.007962922565639019
this O 0 0.012403763830661774
Ashkenazi O 0 0.32129940390586853
mutation O 0 0.13110791146755219
also O 0 0.015005625784397125
occurs O 0 0.03203275799751282
in O 0 0.00752128753811121
Iraqi O 0 0.02200050838291645
Jews O 0 0.016580531373620033
with O 0 0.009938783012330532
a O 0 0.01928318664431572
similar O 0 0.029081735759973526
allelic O 1 0.7044564485549927
pattern O 0 0.10204832255840302
. O 0 0.03171509504318237

We O 0 0.021511930972337723
extended O 0 0.026807406917214394
our O 0 0.01303891185671091
analysis O 0 0.014985115267336369
to O 0 0.00673262495547533
other O 0 0.007129315752536058
non O 0 0.04536417871713638
- O 0 0.09925740212202072
Ashkenazi O 0 0.16331282258033752
subsets O 0 0.10905201733112335
354 O 0 0.11834513396024704
of O 0 0.01662810519337654
Moroccan O 0 0.06831815093755722
origin O 0 0.029321402311325073
, O 0 0.016142547130584717
200 O 0 0.04161406680941582
Yemenites O 1 0.7018875479698181
and O 0 0.014491738751530647
150 O 0 0.034348264336586
Iranian O 0 0.02985362522304058
Jews O 0 0.029773740097880363
. O 0 0.025521131232380867

Heteroduplex O 0 0.4146871864795685
analysis O 0 0.0405803807079792
complemented O 0 0.05931807681918144
by O 0 0.015777917578816414
direct O 0 0.035461004823446274
DNA O 0 0.06647443771362305
sequencing O 0 0.0604473352432251
of O 0 0.018532585352659225
abnormally O 0 0.2094210982322693
migrating O 0 0.08940534293651581
bands O 0 0.050056181848049164
were O 0 0.013712726533412933
employed O 0 0.04414931312203407
. O 0 0.027114007622003555

Four O 0 0.023246269673109055
of O 0 0.015582251362502575
Moroccan O 0 0.07639908790588379
origin O 0 0.033701732754707336
( O 0 0.026201223954558372
1 O 0 0.01793966069817543
. O 0 0.009287964552640915
1 O 0 0.01967756822705269
% O 0 0.019035579636693
) O 0 0.013751953840255737
and O 0 0.006978930905461311
none O 0 0.013560720719397068
of O 0 0.006042820401489735
the O 0 0.013259355910122395
Yemenites O 1 0.9891170859336853
or O 0 0.02043268084526062
Iranians O 0 0.027964748442173004
was O 0 0.013483273796737194
a O 0 0.014154436066746712
carrier O 0 0.053151391446590424
of O 0 0.010734600014984608
the O 0 0.020794061943888664
185delAG O 1 0.879291296005249
mutation O 0 0.18729737401008606
. O 0 0.03515984117984772

BRCA1 O 1 0.997657299041748
allelic O 1 0.7676888704299927
patterns O 0 0.04835241660475731
were O 0 0.00965420063585043
determined O 0 0.01844462938606739
for O 0 0.005334651097655296
four O 0 0.006103032268583775
of O 0 0.004692059475928545
these O 0 0.005581740755587816
individuals O 0 0.010982664301991463
and O 0 0.005628986284136772
for O 0 0.006233462132513523
12 O 0 0.0144907645881176
additional O 0 0.019041715189814568
non O 0 0.04622168093919754
- O 0 0.12298589199781418
Ashkenazi O 0 0.41201746463775635
185delAG O 1 0.9471638798713684
mutation O 0 0.4094422161579132
carriers O 0 0.30985498428344727
who O 0 0.04476730898022652
had O 1 0.9973651766777039
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.03729092329740524

Six O 0 0.04525841027498245
non O 0 0.06741125136613846
- O 0 0.10008444637060165
Ashkenazi O 0 0.13707120716571808
individuals O 0 0.026231709867715836
shared O 0 0.024948706850409508
the O 0 0.014334247447550297
common O 0 0.04319474846124649
Ashkenazi O 1 0.9716199636459351
haplotype O 1 0.9955260157585144
, O 0 0.012715655378997326
four O 0 0.009821505285799503
had O 0 0.013050772249698639
a O 0 0.012577762827277184
closely O 0 0.018620233982801437
related O 0 0.026714030653238297
pattern O 0 0.04399483650922775
, O 0 0.008031374774873257
and O 0 0.006321183871477842
the O 0 0.00895546656101942
rest O 0 0.030221002176404
( O 0 0.034699950367212296
n O 0 0.07174130529165268
= O 0 0.09206515550613403
6 O 0 0.030938493087887764
) O 0 0.01635783538222313
displayed O 0 0.02351558394730091
a O 0 0.024812541902065277
distinct O 0 0.0639028549194336
BRCA1 O 1 0.9985916018486023
allelic O 1 0.9729617834091187
pattern O 0 0.12201464176177979
. O 0 0.03719775378704071

We O 0 0.024446818977594376
conclude O 0 0.04807233065366745
that O 0 0.010232719592750072
the O 0 0.02303004264831543
185delAG O 1 0.9660029411315918
BRCA1 O 1 0.9988238215446472
mutation O 0 0.21425768733024597
occurs O 0 0.05486489459872246
in O 0 0.010798666626214981
some O 0 0.011256303638219833
non O 0 0.04804648831486702
- O 0 0.10187891870737076
Ashkenazi O 0 0.18256095051765442
populations O 0 0.065754234790802
at O 0 0.027995670214295387
rates O 0 0.03980894386768341
comparable O 0 0.030781026929616928
with O 0 0.007928319275379181
that O 0 0.007466831710189581
of O 0 0.013315821997821331
Ashkenazim O 1 0.9721659421920776
. O 0 0.034449510276317596

The O 0 0.02063753455877304
majority O 0 0.021306006237864494
of O 0 0.012681136839091778
Jewish O 0 0.057925187051296234
185delAG O 1 0.9879899621009827
mutation O 0 0.17845329642295837
carriers O 0 0.07634473592042923
have O 0 0.011809107847511768
a O 0 0.018231617286801338
common O 0 0.033422987908124924
allelic O 1 0.9407133460044861
pattern O 0 0.06551530212163925
, O 0 0.012955737300217152
supporting O 0 0.02173922024667263
the O 0 0.01374487392604351
founder O 0 0.057045772671699524
effect O 0 0.035870715975761414
notion O 0 0.030517229810357094
, O 0 0.010667405091226101
but O 0 0.009992123581469059
dating O 0 0.02659646049141884
the O 0 0.015050077810883522
mutations O 0 0.07851026207208633
origin O 0 0.017104314640164375
to O 0 0.007838329300284386
an O 0 0.010153154842555523
earlier O 0 0.016840413212776184
date O 0 0.013037670403718948
than O 0 0.008775603957474232
currently O 0 0.014523876830935478
estimated O 0 0.0319085568189621
. O 0 0.02490122802555561

However O 0 0.02399737946689129
, O 0 0.010546134784817696
the O 0 0.011469224467873573
different O 0 0.015326534397900105
allelic O 0 0.20556485652923584
pattern O 0 0.06559458374977112
at O 0 0.02610449679195881
the O 0 0.021409789100289345
BRCA1 O 1 0.9964369535446167
locus O 0 0.14322541654109955
even O 0 0.016166677698493004
in O 0 0.009478695690631866
some O 0 0.012093170545995235
Jewish O 0 0.04869872331619263
mutation O 0 0.2356807142496109
carriers O 0 0.11313953995704651
, O 0 0.015064503066241741
might O 0 0.024494683369994164
suggest O 0 0.021984077990055084
that O 0 0.008045347407460213
the O 0 0.014077060855925083
mutation O 0 0.12409386038780212
arose O 0 0.045409660786390305
independently O 0 0.03187934309244156
. O 0 0.016616404056549072
. O 0 0.022174259647727013

Crystal O 0 0.11083929240703583
structure O 0 0.033223047852516174
of O 0 0.013105541467666626
the O 0 0.03593320772051811
hemochromatosis B-Disease 1 1.0
protein O 0 0.13455578684806824
HFE O 1 0.9995294809341431
and O 0 0.015517685562372208
characterization O 0 0.04702019318938255
of O 0 0.008015845902264118
its O 0 0.012693583965301514
interaction O 0 0.0385303869843483
with O 0 0.02453092485666275
transferrin O 1 0.9909000396728516
receptor O 0 0.245186910033226
. O 0 0.03882060572504997

HFE O 1 0.9962050318717957
is O 0 0.028949016705155373
an O 0 0.029509026557207108
MHC O 1 0.9997368454933167
- O 0 0.1013965830206871
related O 0 0.035191379487514496
protein O 0 0.0384305976331234
that O 0 0.007665881421416998
is O 0 0.010855823755264282
mutated O 0 0.07171569019556046
in O 0 0.011158693581819534
the O 0 0.01602959632873535
iron B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999973773956299
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.05990219861268997

HFE O 1 0.9945194125175476
binds O 0 0.17543244361877441
to O 0 0.03846818208694458
transferrin O 1 0.9832672476768494
receptor O 0 0.329530268907547
( O 0 0.06518147885799408
TfR O 1 0.9995204210281372
) O 0 0.025848394259810448
and O 0 0.011323044076561928
reduces O 0 0.06888148933649063
its O 0 0.012883520685136318
affinity O 0 0.06918729841709137
for O 0 0.017341846600174904
iron O 1 0.7768750190734863
- O 0 0.08499652147293091
loaded O 0 0.07950550317764282
transferrin O 1 0.8920938968658447
, O 0 0.02950664423406124
implicating O 0 0.24679841101169586
HFE O 1 0.9991123080253601
in O 0 0.032267965376377106
iron O 1 0.7703667283058167
metabolism O 1 0.5226507782936096
. O 0 0.03624292463064194

The O 0 0.030886251479387283
2 O 0 0.039994146674871445
. O 0 0.026073522865772247

6 O 0 0.04765543341636658
A O 0 0.03934803605079651
crystal O 0 0.069124735891819
structure O 0 0.027237914502620697
of O 0 0.015632344409823418
HFE O 1 0.9995896220207214
reveals O 0 0.058956459164619446
the O 0 0.012347492389380932
locations O 0 0.028152113780379295
of O 0 0.021440332755446434
hemochromatosis B-Disease 1 1.0
mutations O 0 0.14012889564037323
and O 0 0.012384547851979733
a O 0 0.0220381710678339
patch O 1 0.993190348148346
of O 0 0.013932205736637115
histidines O 1 0.9040707945823669
that O 0 0.009063458070158958
could O 0 0.01000418234616518
be O 0 0.00662199454382062
involved O 0 0.017466075718402863
in O 0 0.01887233555316925
pH O 1 0.9798648357391357
- O 0 0.09391721338033676
dependent O 0 0.07846549898386002
interactions O 0 0.0607270672917366
. O 0 0.027344275265932083

We O 0 0.02131902426481247
also O 0 0.013514590449631214
demonstrate O 0 0.034395188093185425
that O 0 0.018125951290130615
soluble O 0 0.18810825049877167
TfR O 1 0.9997488856315613
and O 0 0.03024643287062645
HFE O 1 0.9997333884239197
bind O 0 0.09814805537462234
tightly O 0 0.05269044265151024
at O 0 0.015522699803113937
the O 0 0.010771958157420158
basic O 0 0.025105955079197884
pH O 0 0.1258377879858017
of O 0 0.00851519126445055
the O 0 0.014967916533350945
cell O 0 0.06736409664154053
surface O 0 0.0326288565993309
, O 0 0.008429409936070442
but O 0 0.006209289655089378
not O 0 0.006790218409150839
at O 0 0.013497787527740002
the O 0 0.015381227247416973
acidic O 0 0.2007419764995575
pH O 0 0.20822595059871674
of O 0 0.023032160475850105
intracellular O 0 0.2035699188709259
vesicles O 0 0.23696982860565186
. O 0 0.042757049202919006

TfR O 1 0.999789297580719
HFE O 1 0.9994956254959106
stoichiometry O 0 0.3783678114414215
( O 0 0.04108097404241562
2 O 0 0.029614685103297234
1 O 0 0.02439415641129017
) O 0 0.020472101867198944
differs O 0 0.04481619596481323
from O 0 0.031195279210805893
TfR O 1 0.9997269511222839
transferrin O 1 0.9919394850730896
stoichiometry O 0 0.2052333503961563
( O 0 0.03527025878429413
2 O 0 0.027939727529883385
2 O 0 0.023969372734427452
) O 0 0.017183760181069374
, O 0 0.011854070238769054
implying O 0 0.04769463837146759
a O 0 0.014498618431389332
different O 0 0.00895016174763441
mode O 0 0.043068110942840576
of O 0 0.00935391429811716
binding O 0 0.03509356826543808
for O 0 0.019209079444408417
HFE O 1 0.9991017580032349
and O 0 0.021326160058379173
transferrin O 1 0.9457142353057861
to O 0 0.02389715611934662
TfR O 1 0.9997592568397522
, O 0 0.015501406043767929
consistent O 0 0.02715305984020233
with O 0 0.009473534300923347
our O 0 0.015694940462708473
demonstration O 0 0.047557808458805084
that O 0 0.017400626093149185
HFE O 1 0.9997337460517883
, O 0 0.027323806658387184
transferrin O 1 0.970346987247467
, O 0 0.018166106194257736
and O 0 0.0176394060254097
TfR O 1 0.9994744658470154
form O 0 0.02622319757938385
a O 0 0.02274581603705883
ternary O 0 0.08831178396940231
complex O 0 0.04702382534742355
. O 0 0.025919489562511444

Identification O 0 0.04488030821084976
of O 0 0.009288560599088669
three O 0 0.011968291364610195
novel O 0 0.03413985297083855
mutations O 0 0.0733853206038475
and O 0 0.009673569351434708
a O 0 0.015723032876849174
high O 0 0.028621850535273552
frequency O 0 0.036772023886442184
of O 0 0.008335589431226254
the O 0 0.020026762038469315
Arg778Leu O 1 0.9804609417915344
mutation O 0 0.13436555862426758
in O 0 0.019343312829732895
Korean O 0 0.24414435029029846
patients O 1 0.9999916553497314
with O 0 0.02710779383778572
Wilson B-Disease 1 0.99973064661026
disease I-Disease 1 0.9999997615814209
. O 0 0.034658752381801605

Four O 0 0.054695695638656616
mutations O 0 0.20753926038742065
- O 0 0.2335815280675888
- O 0 0.12990742921829224
R778L O 0 0.19024783372879028
, O 0 0.028681162744760513
A874V O 0 0.14380884170532227
, O 0 0.022280378267169
L1083F O 0 0.11907894164323807
, O 0 0.014623617753386497
and O 0 0.015004214830696583
2304delC O 1 0.9607997536659241
- O 0 0.09567415714263916
- O 0 0.054135553538799286
in O 0 0.01063360646367073
the O 0 0.0131039684638381
copper O 0 0.10430800169706345
- O 0 0.0777244046330452
transporting O 0 0.06648042798042297
enzyme O 0 0.11176784336566925
, O 0 0.02780301868915558
P O 1 0.9876704216003418
- O 0 0.13600760698318481
type O 0 0.12896792590618134
ATPase O 1 0.9875624179840088
( O 0 0.06182686984539032
ATP7B O 1 0.984398365020752
) O 0 0.022528648376464844
, O 0 0.009586499072611332
were O 0 0.006458723451942205
identified O 0 0.01946227438747883
in O 0 0.013099640607833862
Korean O 0 0.14631134271621704
Patients O 1 0.9999948740005493
with O 0 0.03126660734415054
Wilson B-Disease 1 0.9996660947799683
disease I-Disease 1 0.9999995231628418
. O 0 0.03386116772890091

Arg778Leu O 1 0.7105010747909546
, O 0 0.016160035505890846
the O 0 0.010912317782640457
most O 0 0.011541132815182209
frequently O 0 0.029156632721424103
reported O 0 0.03551921620965004
mutation O 0 0.08018480241298676
of O 0 0.008397040888667107
this O 0 0.012070393189787865
enzyme O 0 0.06894230097532272
, O 0 0.011813860386610031
was O 0 0.01317124255001545
found O 0 0.012184236198663712
in O 0 0.005899961106479168
six O 0 0.01025649905204773
of O 0 0.007924378849565983
eight O 0 0.02139153890311718
unrelated O 0 0.09288088977336884
patients O 1 0.9998288154602051
studied O 0 0.029246728867292404
, O 0 0.00957227498292923
an O 0 0.014043448492884636
allele O 0 0.12620484828948975
frequency O 0 0.05580835044384003
of O 0 0.011781694367527962
37 O 0 0.049235112965106964
. O 0 0.028831753879785538

5 O 0 0.04145920276641846
% O 0 0.02487541176378727
, O 0 0.010187268257141113
which O 0 0.007892820052802563
is O 0 0.009740053676068783
considerably O 0 0.02797652967274189
higher O 0 0.015315095894038677
than O 0 0.006103868130594492
those O 0 0.005564895924180746
in O 0 0.006696897093206644
other O 0 0.007497717626392841
Asian O 0 0.05533049628138542
populations O 0 0.061029914766550064
. O 0 0.02786634862422943

The O 0 0.027768710628151894
novel O 0 0.04030357301235199
single O 0 0.047377683222293854
nucleotide O 0 0.1224246397614479
deletion O 0 0.14297492802143097
, O 0 0.02358722686767578
2304delC O 0 0.14743568003177643
, O 0 0.01232962403446436
was O 0 0.01248924806714058
found O 0 0.011470607481896877
in O 0 0.009259531274437904
one O 0 0.01633109338581562
patient O 1 0.999381422996521
. O 0 0.02760262042284012

Since O 0 0.045033782720565796
a O 0 0.03973883390426636
mutation O 0 0.15864065289497375
at O 0 0.04706865921616554
cDNA O 0 0.21125122904777527
nucleotide O 0 0.20092974603176117
2302 O 1 0.9803183674812317
( O 0 0.06082409992814064
2302insC O 0 0.27007344365119934
) O 0 0.019466519355773926
had O 0 0.013542955741286278
been O 0 0.010473492555320263
previously O 0 0.016422631219029427
described O 0 0.018941422924399376
, O 0 0.006809891667217016
this O 0 0.005991803947836161
region O 0 0.01782524771988392
of O 0 0.007468684110790491
the O 0 0.016747331246733665
ATP7B O 1 0.9998314380645752
gene O 0 0.1000313088297844
may O 0 0.023513678461313248
be O 0 0.012647002004086971
susceptible O 0 0.13746893405914307
to O 0 0.022630762308835983
gene O 0 0.12129895389080048
rearrangements O 0 0.35703426599502563
causing O 1 0.9964140057563782
Wilson B-Disease 1 0.9991845488548279
disease I-Disease 1 0.9999992847442627
. O 0 0.03190380334854126

Disruption O 0 0.15037420392036438
of O 0 0.024838261306285858
splicing O 0 0.10977905243635178
regulated O 0 0.057384125888347626
by O 0 0.016182202845811844
a O 0 0.03212062641978264
CUG O 1 0.9962467551231384
- O 0 0.1086897924542427
binding O 0 0.07935541868209839
protein O 0 0.09285969287157059
in O 0 0.04709816724061966
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.047821782529354095

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9985752105712891
DM B-Disease 1 1.0
) O 0 0.037276528775691986
is O 0 0.017377356067299843
caused O 0 0.046881455928087234
by O 0 0.012427729554474354
a O 0 0.02933943271636963
CTG O 1 0.9920443296432495
expansion O 0 0.03311876580119133
in O 0 0.009571678005158901
the O 0 0.011074269190430641
3 O 0 0.030024252831935883
untranslated O 0 0.10620994865894318
region O 0 0.030987953767180443
of O 0 0.011939478106796741
the O 0 0.03596380725502968
DM B-Disease 1 1.0
gene O 0 0.1476576179265976
. O 0 0.03904937580227852

One O 0 0.026529349386692047
model O 0 0.05046107992529869
of O 0 0.03281364217400551
DM B-Disease 1 1.0
pathogenesis O 1 0.9999891519546509
suggests O 0 0.05426449701189995
that O 0 0.015146013349294662
RNAs O 0 0.09247950464487076
from O 0 0.008656248450279236
the O 0 0.009101221337914467
expanded O 0 0.025867924094200134
allele O 0 0.10507100820541382
create O 0 0.027928022667765617
a O 0 0.02040731906890869
gain O 0 0.04263192042708397
- O 0 0.06295250356197357
of O 0 0.015754172578454018
- O 0 0.08130455762147903
function O 0 0.04933878406882286
mutation O 0 0.10673684626817703
by O 0 0.011635394766926765
the O 0 0.01427583210170269
inappropriate O 0 0.05522587522864342
binding O 0 0.031239960342645645
of O 0 0.010021231137216091
proteins O 0 0.026011180132627487
to O 0 0.013260253705084324
the O 0 0.023441381752490997
CUG O 1 0.9926623106002808
repeats O 0 0.13691167533397675
. O 0 0.037366535514593124

Data O 0 0.02785709872841835
presented O 0 0.023416444659233093
here O 0 0.012850329279899597
indicate O 0 0.021430453285574913
that O 0 0.00669878488406539
the O 0 0.01215550396591425
conserved O 0 0.05944910645484924
heterogeneous O 0 0.1271418184041977
nuclear O 0 0.08695165067911148
ribonucleoprotein O 1 0.9937230944633484
, O 0 0.0330299437046051
CUG O 1 0.9963756203651428
- O 0 0.10933234542608261
binding O 0 0.07803207635879517
protein O 0 0.08566264063119888
( O 0 0.04745382070541382
CUG O 1 0.9995007514953613
- O 0 0.11899799108505249
BP O 0 0.19187100231647491
) O 0 0.02505240961909294
, O 0 0.013418535701930523
may O 0 0.019929751753807068
mediate O 0 0.08175333589315414
the O 0 0.023014875128865242
trans O 1 0.6862819194793701
- O 0 0.0921689048409462
dominant O 0 0.06895281374454498
effect O 0 0.0293439794331789
of O 0 0.009306850843131542
the O 0 0.018383324146270752
RNA O 0 0.11253625899553299
. O 0 0.029459984973073006

CUG O 1 0.9993742108345032
- O 0 0.15909239649772644
BP O 0 0.14755702018737793
was O 0 0.02033669874072075
found O 0 0.013904085382819176
to O 0 0.00892452523112297
bind O 0 0.04374733567237854
to O 0 0.009907975792884827
the O 0 0.017756422981619835
human O 0 0.07083497196435928
cardiac O 1 1.0
troponin O 1 0.9999995231628418
T O 1 0.9998227953910828
( O 0 0.056543633341789246
cTNT O 1 0.7799429893493652
) O 0 0.03981640189886093
pre O 0 0.11347704380750656
- O 0 0.11358019709587097
messenger O 0 0.13059654831886292
RNA O 0 0.08212799578905106
and O 0 0.01300035696476698
regulate O 0 0.045560628175735474
its O 0 0.01539074257016182
alternative O 0 0.05375361815094948
splicing O 0 0.13772551715373993
. O 0 0.03765460476279259

Splicing O 0 0.17567279934883118
of O 0 0.026076331734657288
cTNT O 0 0.46581485867500305
was O 0 0.035268668085336685
disrupted O 0 0.11764077097177505
in O 0 0.046482209116220474
DM B-Disease 1 1.0
striated O 1 0.9999747276306152
muscle O 1 0.9998369216918945
and O 0 0.014743388630449772
in O 0 0.014091835357248783
normal O 0 0.052610382437705994
cells O 0 0.07825174182653427
expressing O 0 0.050930723547935486
transcripts O 0 0.041526202112436295
that O 0 0.014477710239589214
contain O 0 0.04681970924139023
CUG O 1 0.9733730554580688
repeats O 0 0.1289847046136856
. O 0 0.03229620307683945

Altered O 0 0.08937288075685501
expression O 0 0.04827530309557915
of O 0 0.013724960386753082
genes O 0 0.06259922683238983
regulated O 0 0.0777328684926033
posttranscriptionally O 1 0.5352818369865417
by O 0 0.025098327547311783
CUG O 1 0.9998170733451843
- O 0 0.13398446142673492
BP O 0 0.32452765107154846
therefore O 0 0.02465183287858963
may O 0 0.02239048480987549
contribute O 0 0.047910358756780624
to O 0 0.03190658614039421
DM B-Disease 1 1.0
pathogenesis O 1 0.9999724626541138
. O 0 0.023830004036426544
. O 0 0.02510422095656395

Identification O 0 0.046889763325452805
of O 0 0.012469847686588764
a O 0 0.023379506543278694
novel O 0 0.046610865741968155
nonsense O 0 0.10618120431900024
mutation O 0 0.1227516382932663
and O 0 0.014991492964327335
a O 0 0.02862570807337761
missense O 0 0.14467935264110565
substitution O 0 0.060185518115758896
in O 0 0.013382142409682274
the O 0 0.02295062318444252
vasopressin O 1 0.9971886277198792
- O 0 0.27753540873527527
neurophysin O 1 0.9103345274925232
II O 0 0.2318938672542572
gene O 0 0.06619865447282791
in O 0 0.011394803412258625
two O 0 0.011025065556168556
Spanish O 0 0.04846905171871185
kindreds O 1 0.610542893409729
with O 0 0.035136520862579346
familial B-Disease 1 0.9999938011169434
neurohypophyseal I-Disease 1 0.999998927116394
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999996423721313
. O 0 0.05249682441353798

Familial B-Disease 1 0.999993085861206
neurohypophyseal I-Disease 1 0.9999934434890747
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
( O 0 0.19394074380397797
FNDI B-Disease 1 0.9999951124191284
) O 0 0.02656562812626362
is O 0 0.014233929105103016
an O 0 0.02500702254474163
autosomal B-Disease 1 0.9999825954437256
dominant I-Disease 1 0.9999469518661499
disease I-Disease 1 1.0
caused O 1 0.9991282820701599
by O 0 0.02960316464304924
deficiency O 1 1.0
in O 0 0.018395734950900078
the O 0 0.027173113077878952
antidiuretic O 1 0.9998002648353577
hormone O 1 0.9973680377006531
arginine O 1 0.7775525450706482
vasopressin O 1 0.9884387850761414
( O 0 0.06650681793689728
AVP O 1 0.9965428709983826
) O 0 0.023884382098913193
encoded O 0 0.021973490715026855
by O 0 0.010383599437773228
the O 0 0.02310643531382084
AVP O 1 0.9999738931655884
- O 0 0.36280837655067444
neurophysin O 1 0.9547004103660583
II O 1 0.9550915360450745
( O 0 0.060877371579408646
AVP O 1 0.9999852180480957
- O 0 0.37069937586784363
NPII O 1 0.9717931747436523
) O 0 0.04570361599326134
gene O 0 0.07050410658121109
on O 0 0.0215439610183239
chromosome O 0 0.17546841502189636
20p13 O 0 0.199578657746315
. O 0 0.03920796513557434

In O 0 0.01745414175093174
this O 0 0.009320683777332306
study O 0 0.02157936617732048
, O 0 0.009741405956447124
we O 0 0.008085316978394985
analyzed O 0 0.02583770453929901
two O 0 0.00831292849034071
families O 0 0.01988276280462742
with O 0 0.0180670153349638
FNDI B-Disease 1 0.9988848567008972
using O 0 0.02458062767982483
direct O 0 0.03410544991493225
automated O 0 0.07385959476232529
fluorescent O 0 0.11253692954778671
, O 0 0.01845461130142212
solid O 0 0.0474713072180748
phase O 0 0.06890066713094711
, O 0 0.016580602154135704
single O 0 0.035750050097703934
- O 0 0.08599936217069626
stranded O 0 0.11764263361692429
DNA O 0 0.07728559523820877
sequencing O 0 0.07253335416316986
of O 0 0.02419782429933548
PCR O 0 0.4788796603679657
- O 0 0.1436024308204651
amplified O 0 0.19090799987316132
AVP O 1 0.9996788501739502
- O 0 0.20649375021457672
NPII O 1 0.9578803181648254
DNA O 0 0.11311115324497223
. O 0 0.042302947491407394

In O 0 0.013673756271600723
one O 0 0.008536207489669323
of O 0 0.006098207086324692
the O 0 0.010228471830487251
families O 0 0.024545500054955482
, O 0 0.013637206517159939
affected O 0 0.042784254997968674
individuals O 0 0.01942848414182663
presented O 0 0.02115674689412117
a O 0 0.02014443464577198
novel O 0 0.043917592614889145
nonsense O 0 0.09343507140874863
mutation O 0 0.12192900478839874
in O 0 0.017885003238916397
exon O 0 0.10773991048336029
3 O 0 0.021716283634305
of O 0 0.007078522816300392
the O 0 0.012188608758151531
gene O 0 0.05238227918744087
, O 0 0.01003202237188816
consisting O 0 0.017021195963025093
in O 0 0.010726061649620533
a O 0 0.02614377997815609
G O 0 0.13004329800605774
to O 0 0.01990213617682457
T O 1 0.9407001733779907
transition O 0 0.0540614016354084
at O 0 0.036877114325761795
nucleotide O 0 0.12452221661806107
2101 O 1 0.5140863060951233
, O 0 0.015713956207036972
which O 0 0.012028775177896023
produces O 0 0.03789999708533287
a O 0 0.019266178831458092
stop O 0 0.04705104976892471
signal O 0 0.053534477949142456
in O 0 0.01885560154914856
codon O 0 0.14375923573970795
82 O 0 0.1071300283074379
( O 0 0.055967360734939575
Glu O 1 0.997218132019043
) O 0 0.030693914741277695
of O 0 0.017084188759326935
NPII O 1 0.9939311742782593
. O 0 0.033693667501211166

The O 0 0.04723675176501274
premature O 1 0.9723940491676331
termination O 1 0.7075577974319458
eliminates O 0 0.09896046668291092
part O 0 0.017225341871380806
of O 0 0.007718343287706375
the O 0 0.01644025556743145
C O 1 0.7963725924491882
- O 0 0.08107074350118637
terminal O 0 0.06894680857658386
domain O 0 0.03262035921216011
of O 0 0.012050474062561989
NPII O 1 0.9665560126304626
, O 0 0.0121710654348135
including O 0 0.010426078923046589
a O 0 0.021786777302622795
cysteine O 0 0.1038583442568779
residue O 0 0.09242453426122665
in O 0 0.013222996145486832
position O 0 0.021095680072903633
85 O 0 0.04497227817773819
, O 0 0.008210676722228527
which O 0 0.007748362608253956
could O 0 0.008432790637016296
be O 0 0.005733812227845192
involved O 0 0.012510441243648529
in O 0 0.00607925932854414
the O 0 0.01045734528452158
correct O 0 0.04282532259821892
folding O 0 0.0669393539428711
of O 0 0.011547639966011047
the O 0 0.02522723563015461
prohormone O 1 0.9986878037452698
. O 0 0.043911539018154144

In O 0 0.01801290735602379
the O 0 0.012388474307954311
second O 0 0.019587263464927673
family O 0 0.024436136707663536
, O 0 0.01210600696504116
a O 0 0.02387494035065174
G279A O 0 0.14713038504123688
substitution O 0 0.06411854922771454
at O 0 0.019437091425061226
position O 0 0.019381821155548096
- O 0 0.04501192271709442
1 O 0 0.01839991845190525
of O 0 0.007692079525440931
the O 0 0.015137601643800735
signal O 0 0.06867413222789764
peptide O 0 0.10340102016925812
was O 0 0.016396639868617058
observed O 0 0.021091977134346962
in O 0 0.007526692934334278
all O 0 0.00734722102060914
affected O 0 0.039805635809898376
individuals O 0 0.02660643495619297
. O 0 0.02390378713607788

This O 0 0.036160167306661606
missense O 0 0.20518416166305542
mutation O 0 0.1603512018918991
, O 0 0.02085278369486332
which O 0 0.01884361170232296
replaces O 0 0.25323575735092163
Ala O 1 0.9882908463478088
with O 0 0.032420575618743896
Thr O 1 0.9999192953109741
, O 0 0.018794503062963486
is O 0 0.015451992861926556
frequent O 0 0.061512257903814316
among O 0 0.030631452798843384
FNDI B-Disease 1 0.9999997615814209
patients O 1 0.9999808073043823
and O 0 0.010250183753669262
is O 0 0.010574025101959705
thought O 0 0.01686946116387844
to O 0 0.006888698786497116
reduce O 0 0.02926095947623253
the O 0 0.011033018119633198
efficiency O 0 0.039127860218286514
of O 0 0.013244900852441788
cleavage O 0 0.27677854895591736
by O 0 0.019569892436265945
signal O 0 0.0786699578166008
peptidases O 0 0.3916563391685486
. O 0 0.020338157191872597
. O 0 0.02478131279349327

Genetic O 0 0.13733606040477753
heterogeneity O 0 0.137531578540802
of O 0 0.02776520326733589
Saethre B-Disease 1 0.9999866485595703
- I-Disease 1 0.9999040365219116
Chotzen I-Disease 1 0.9999964237213135
syndrome I-Disease 1 1.0
, O 0 0.019900007173419
due O 0 0.0231045912951231
to O 0 0.015583873726427555
TWIST O 0 0.2800392210483551
and O 0 0.024411825463175774
FGFR O 1 0.9989142417907715
mutations O 0 0.16433708369731903
. O 0 0.03513963893055916

Thirty O 0 0.08990778774023056
- O 0 0.08116895705461502
two O 0 0.018823571503162384
unrelated O 0 0.08222588151693344
patients O 1 0.9997240900993347
with O 0 0.011644560843706131
features O 0 0.018739698454737663
of O 0 0.016878556460142136
Saethre B-Disease 1 0.9999924898147583
- I-Disease 1 0.9997233748435974
Chotzen I-Disease 1 0.9999963045120239
syndrome I-Disease 1 1.0
, O 0 0.01765216700732708
a O 0 0.020249109715223312
common O 0 0.03471978381276131
autosomal B-Disease 1 0.9997568726539612
dominant I-Disease 1 0.7221292853355408
condition I-Disease 1 0.9995203018188477
of O 0 0.024236425757408142
craniosynostosis B-Disease 1 0.9999998807907104
and O 0 0.036324985325336456
limb B-Disease 1 0.9999974966049194
anomalies I-Disease 1 0.9859121441841125
, O 0 0.0125510822981596
were O 0 0.010301077738404274
screened O 0 0.056834373623132706
for O 0 0.015103977173566818
mutations O 0 0.08944369107484818
in O 0 0.02026384323835373
TWIST O 0 0.29833582043647766
, O 0 0.023518318310379982
FGFR2 O 1 0.9928569793701172
, O 0 0.01739153079688549
and O 0 0.01535196602344513
FGFR3 O 1 0.9964746832847595
. O 0 0.031134357675909996

Nine O 0 0.03730179741978645
novel O 0 0.033367544412612915
and O 0 0.012914617545902729
three O 0 0.02127179503440857
recurrent O 1 0.9990320205688477
TWIST O 1 0.8398127555847168
mutations O 0 0.10159068554639816
were O 0 0.011158389039337635
found O 0 0.014686118811368942
in O 0 0.010248069651424885
12 O 0 0.020540596917271614
families O 0 0.03021961823105812
. O 0 0.028453698381781578

Seven O 0 0.031241342425346375
families O 0 0.025861622765660286
were O 0 0.00826194230467081
found O 0 0.011732535436749458
to O 0 0.0060593849048018456
have O 0 0.008835095912218094
the O 0 0.01762240193784237
FGFR3 O 1 0.9983704686164856
P250R O 1 0.829201340675354
mutation O 0 0.12590745091438293
, O 0 0.011455003172159195
and O 0 0.0068304045125842094
one O 0 0.008248900063335896
individual O 0 0.012510447762906551
was O 0 0.012565185315907001
found O 0 0.011218232102692127
to O 0 0.006695901043713093
have O 0 0.008711779490113258
an O 0 0.01839410327374935
FGFR2 O 1 0.9992881417274475
VV269 O 1 0.8982449173927307
- O 0 0.1390180140733719
270 O 0 0.15987519919872284
deletion O 0 0.19557183980941772
. O 0 0.04195472225546837

To O 0 0.018569257110357285
date O 0 0.017621632665395737
, O 0 0.011077424511313438
our O 0 0.01736183650791645
detection O 0 0.08130408823490143
rate O 0 0.032138172537088394
for O 0 0.013274086639285088
TWIST O 0 0.12829799950122833
or O 0 0.031172828748822212
FGFR O 1 0.9967664480209351
mutations O 0 0.1088380217552185
is O 0 0.017810603603720665
68 O 0 0.046945907175540924
% O 0 0.016955764964222908
in O 0 0.008853902108967304
our O 0 0.021777790039777756
Saethre B-Disease 1 0.9999923706054688
- I-Disease 1 0.9999690055847168
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.9999985694885254
, O 0 0.011366798542439938
including O 0 0.009361491538584232
our O 0 0.011964435689151287
five O 0 0.01779117062687874
patients O 1 0.9999599456787109
elsewhere O 0 0.03071404993534088
reported O 0 0.027583938091993332
with O 0 0.019206257537007332
TWIST O 1 0.7886292934417725
mutations O 0 0.15285606682300568
. O 0 0.03665873780846596

More O 0 0.016544802114367485
than O 0 0.013316887430846691
35 O 0 0.02619207091629505
different O 0 0.01306308526545763
TWIST O 0 0.33698269724845886
mutations O 0 0.08561452478170395
are O 0 0.008151034824550152
now O 0 0.012592286802828312
known O 0 0.014484699815511703
in O 0 0.0069411750882864
the O 0 0.010579569265246391
literature O 0 0.02115354873239994
. O 0 0.022166486829519272

The O 0 0.018971804529428482
most O 0 0.013202645815908909
common O 0 0.026288816705346107
phenotypic O 0 0.07286454737186432
features O 0 0.020792819559574127
, O 0 0.008740263059735298
present O 0 0.009607192128896713
in O 0 0.005942832678556442
more O 0 0.005088508129119873
than O 0 0.006126336753368378
a O 0 0.009147781878709793
third O 0 0.014922644011676311
of O 0 0.0075270733796060085
our O 0 0.0212765634059906
patients O 1 0.9999454021453857
with O 0 0.021330030634999275
TWIST O 1 0.9827766418457031
mutations O 0 0.11110018193721771
, O 0 0.013769762590527534
are O 0 0.011576663702726364
coronal B-Disease 1 0.7959228157997131
synostosis I-Disease 1 0.8716288208961487
, O 0 0.020953165367245674
brachycephaly B-Disease 1 0.8151194453239441
, O 0 0.022543860599398613
low B-Disease 0 0.09489218890666962
frontal I-Disease 1 0.9999886751174927
hairline I-Disease 1 0.9999996423721313
, O 0 0.041194040328264236
facial B-Disease 1 0.9999939203262329
asymmetry I-Disease 1 0.998095691204071
, O 0 0.0346512570977211
ptosis B-Disease 1 0.9999996423721313
, O 0 0.036906126886606216
hypertelorism B-Disease 1 0.9998672008514404
, O 0 0.01935286819934845
broad B-Disease 0 0.04301997274160385
great I-Disease 0 0.028070904314517975
toes I-Disease 1 0.6221497654914856
, O 0 0.014155720360577106
and O 0 0.01526790950447321
clinodactyly B-Disease 1 0.8654102683067322
. O 0 0.028733719140291214

Significant O 0 0.06082579493522644
intra O 0 0.16731233894824982
- O 0 0.1133289486169815
and O 0 0.026504429057240486
interfamilial O 0 0.2926119267940521
phenotypic O 0 0.13754288852214813
variability O 0 0.11241351813077927
is O 0 0.013535484671592712
present O 0 0.013384155929088593
for O 0 0.01073184609413147
either O 0 0.025848910212516785
TWIST O 1 0.879516065120697
mutations O 0 0.14960461854934692
or O 0 0.04497784748673439
FGFR O 1 0.9993147850036621
mutations O 0 0.1725127398967743
. O 0 0.032272085547447205

The O 0 0.023462897166609764
overlap O 0 0.04354843124747276
in O 0 0.015072409063577652
clinical O 1 0.8304545283317566
features O 0 0.016710415482521057
and O 0 0.007015564013272524
the O 0 0.009047997184097767
presence O 0 0.021545827388763428
, O 0 0.007383689749985933
in O 0 0.0068262722343206406
the O 0 0.008324229158461094
same O 0 0.013855057768523693
genes O 0 0.03649881109595299
, O 0 0.009767336770892143
of O 0 0.00881186779588461
mutations O 0 0.0612325593829155
for O 0 0.007648001424968243
more O 0 0.006417528260499239
than O 0 0.010040048509836197
one O 0 0.01561237033456564
craniosynostotic B-Disease 1 0.9991607666015625
condition I-Disease 1 0.9992577433586121
- O 0 0.0549018494784832
such O 0 0.010146831162273884
as O 0 0.014700926840305328
Saethre B-Disease 1 0.9987199306488037
- I-Disease 0 0.21833549439907074
Chotzen I-Disease 1 0.9560238122940063
, I-Disease 0 0.02715926244854927
Crouzon I-Disease 1 0.9829776287078857
, I-Disease 0 0.01939265802502632
and I-Disease 0 0.023911476135253906
Pfeiffer I-Disease 1 0.9999995231628418
syndromes I-Disease 1 0.9999998807907104
- O 0 0.08291582763195038
support O 0 0.0219886414706707
the O 0 0.015048324130475521
hypothesis O 0 0.06223149225115776
that O 0 0.013942894525825977
TWIST O 0 0.10134304314851761
and O 0 0.015677623450756073
FGFRs O 0 0.2819461524486542
are O 0 0.006639816798269749
components O 0 0.0159468837082386
of O 0 0.005873534828424454
the O 0 0.009864102117717266
same O 0 0.01662175916135311
molecular O 0 0.06806686520576477
pathway O 0 0.09095346927642822
involved O 0 0.021296212449669838
in O 0 0.009245535358786583
the O 0 0.014554552733898163
modulation O 0 0.1164034903049469
of O 0 0.020052805542945862
craniofacial O 1 0.9999998807907104
and O 0 0.02354917861521244
limb O 1 0.9999338388442993
development O 0 0.0260279793292284
in O 0 0.013070649467408657
humans O 0 0.03562469780445099
. O 0 0.015160643495619297
. O 0 0.02229342795908451

Mutation O 0 0.21590431034564972
analysis O 0 0.04321233555674553
of O 0 0.024467142298817635
UBE3A O 1 0.9999973773956299
in O 1 0.9829251766204834
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.03380654752254486

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.06160768121480942
AS B-Disease 0 0.03497360274195671
) O 0 0.019452979788184166
is O 0 0.013346153311431408
caused O 0 0.05084652081131935
by O 0 0.018981873989105225
chromosome O 0 0.18669046461582184
15q11 O 1 0.9197654724121094
- O 0 0.1282503604888916
q13 O 0 0.20585188269615173
deletions O 0 0.08985134214162827
of O 0 0.014236249960958958
maternal O 0 0.0933760330080986
origin O 0 0.02457483671605587
, O 0 0.012774476781487465
by O 0 0.017636926844716072
paternal O 0 0.2894866466522217
uniparental B-Disease 1 0.9999606609344482
disomy I-Disease 1 0.9993952512741089
( O 0 0.08480924367904663
UPD B-Disease 1 0.9999986886978149
) O 0 0.02912846952676773
15 O 0 0.018181052058935165
, O 0 0.012166897766292095
by O 0 0.018588516861200333
imprinting O 1 0.9957771301269531
defects O 1 0.9967852830886841
, O 0 0.014836660586297512
and O 0 0.008823493495583534
by O 0 0.013444019481539726
mutations O 0 0.07715987414121628
in O 0 0.012724636122584343
the O 0 0.023585835471749306
UBE3A O 1 0.9994038343429565
gene O 0 0.1221688911318779
. O 0 0.030374903231859207

UBE3A O 1 0.88742995262146
encodes O 0 0.13263610005378723
a O 0 0.05225984379649162
ubiquitin O 0 0.21001921594142914
- O 0 0.11724335700273514
protein O 0 0.08473687618970871
ligase O 0 0.09618885815143585
and O 0 0.016882432624697685
shows O 0 0.040565650910139084
brain O 1 0.9985519051551819
- O 0 0.08606904000043869
specific O 0 0.03546638414263725
imprinting O 0 0.28109651803970337
. O 0 0.039026807993650436

Here O 0 0.02905525267124176
we O 0 0.02223559282720089
describe O 0 0.07216765731573105
UBE3A O 1 0.9937671422958374
coding O 0 0.20729248225688934
- O 0 0.1302758902311325
region O 0 0.0850924402475357
mutations O 0 0.1585444211959839
detected O 0 0.0975046381354332
by O 0 0.020047394558787346
SSCP O 1 0.828161358833313
analysis O 0 0.024812910705804825
in O 0 0.010571406222879887
13 O 0 0.017407802864909172
AS B-Disease 0 0.019159315153956413
individuals O 0 0.01668122224509716
or O 0 0.015636153519153595
families O 0 0.030509047210216522
. O 0 0.02420789934694767

Two O 0 0.024893682450056076
identical O 0 0.05690629780292511
de O 0 0.09807407110929489
novo O 0 0.18760952353477478
5 O 0 0.04956403747200966
- O 0 0.09466401487588882
bp O 0 0.1366250067949295
duplications O 0 0.10709378123283386
in O 0 0.020889071747660637
exon O 0 0.11513527482748032
16 O 0 0.02651866152882576
were O 0 0.011567582376301289
found O 0 0.02225993573665619
. O 0 0.024257835000753403

Among O 0 0.020709196105599403
the O 0 0.010220701806247234
other O 0 0.007880016230046749
11 O 0 0.023906325921416283
unique O 0 0.03411072865128517
mutations O 0 0.09587372839450836
, O 0 0.01455029845237732
8 O 0 0.019934460520744324
were O 0 0.008454144932329655
small O 0 0.01817001774907112
deletions O 0 0.0769268125295639
or O 0 0.028867805376648903
insertions O 0 0.12989814579486847
predicted O 0 0.04896092042326927
to O 0 0.0163242407143116
cause O 0 0.071384958922863
frameshifts O 1 0.7044692039489746
, O 0 0.01493068691343069
1 O 0 0.017696989700198174
was O 0 0.016179848462343216
a O 0 0.019770339131355286
mutation O 0 0.08651498705148697
to O 0 0.011109097860753536
a O 0 0.019279800355434418
stop O 0 0.04547373577952385
codon O 0 0.10460837185382843
, O 0 0.017009496688842773
1 O 0 0.022024402394890785
was O 0 0.018459081649780273
a O 0 0.027496665716171265
missense O 0 0.17969325184822083
mutation O 0 0.1275419145822525
, O 0 0.012464805506169796
and O 0 0.008874240331351757
1 O 0 0.01803533174097538
was O 0 0.014332852326333523
predicted O 0 0.03128376975655556
to O 0 0.013409082777798176
cause O 0 0.05748405307531357
insertion O 0 0.08522360026836395
of O 0 0.011231070384383202
an O 0 0.019866134971380234
isoleucine O 0 0.1380472034215927
in O 0 0.014019752852618694
the O 0 0.017277056351304054
hect O 0 0.1450255662202835
domain O 0 0.03301094099879265
of O 0 0.010687139816582203
the O 0 0.022301875054836273
UBE3A O 1 0.9936112761497498
protein O 0 0.060647327452898026
, O 0 0.01054038479924202
which O 0 0.008058084174990654
functions O 0 0.014140528626739979
in O 0 0.015449918806552887
E2 O 1 0.9359355568885803
binding O 0 0.04638681188225746
and O 0 0.015997635200619698
ubiquitin O 0 0.11864278465509415
transfer O 0 0.03405657038092613
. O 0 0.027840876951813698

Eight O 0 0.02445472776889801
of O 0 0.00833998154848814
the O 0 0.011229773052036762
cases O 0 0.02039964124560356
were O 0 0.012686224654316902
familial O 1 0.9999262094497681
, O 0 0.009878680109977722
and O 0 0.007134475279599428
five O 0 0.010812596417963505
were O 0 0.012766126543283463
sporadic O 0 0.07893463224172592
. O 0 0.030133340507745743

In O 0 0.020039893686771393
two O 0 0.017195772379636765
familial O 1 0.9998340606689453
cases O 0 0.032665129750967026
and O 0 0.009361762553453445
one O 0 0.013630370609462261
sporadic O 0 0.07075604796409607
case O 0 0.026808805763721466
, O 0 0.023368360474705696
mosaicism O 1 0.9977433681488037
for O 0 0.030289610847830772
UBE3A O 1 0.9988747239112854
mutations O 0 0.14321325719356537
was O 0 0.026625700294971466
detected O 0 0.053486939519643784
in O 0 0.007490322459489107
the O 0 0.009252439253032207
mother O 0 0.023022811859846115
of O 0 0.005221351515501738
three O 0 0.008551256731152534
AS B-Disease 0 0.019225487485527992
sons O 0 0.03186684474349022
, O 0 0.007961858995258808
in O 0 0.007879900746047497
the O 0 0.012876704335212708
maternal O 0 0.09567954391241074
grandfather O 0 0.04596184939146042
of O 0 0.006678360514342785
two O 0 0.0074251145124435425
AS B-Disease 0 0.019125137478113174
first O 0 0.015204491093754768
cousins O 0 0.04807091876864433
, O 0 0.008785609155893326
and O 0 0.0060403551906347275
in O 0 0.00574598740786314
the O 0 0.009107718244194984
mother O 0 0.02831549197435379
of O 0 0.007448489312082529
an O 0 0.012592137791216373
AS B-Disease 0 0.030299406498670578
daughter O 0 0.08185256272554398
. O 0 0.028440531343221664

The O 0 0.023158926516771317
frequencies O 0 0.038463179022073746
with O 0 0.010555597953498363
which O 0 0.012427201494574547
we O 0 0.018240101635456085
detected O 0 0.09034492075443268
mutations O 0 0.07623453438282013
were O 0 0.012536605820059776
5 O 0 0.026106303557753563
( O 0 0.022605344653129578
14 O 0 0.020850954577326775
% O 0 0.019262254238128662
) O 0 0.013038738630712032
of O 0 0.007256103213876486
35 O 0 0.025147130712866783
in O 0 0.012427102774381638
sporadic O 0 0.062004465609788895
cases O 0 0.026454346254467964
and O 0 0.012707418762147427
8 O 0 0.028154371306300163
( O 0 0.02374618873000145
80 O 0 0.028981944546103477
% O 0 0.01952386647462845
) O 0 0.011450192891061306
of O 0 0.00590884406119585
10 O 0 0.014905250631272793
in O 0 0.01415239367634058
familial O 1 0.9999523162841797
cases O 0 0.034639082849025726
. O 0 0.016304658725857735
. O 0 0.022740742191672325

The O 0 0.06675665825605392
hemochromatosis B-Disease 1 1.0
845 O 1 0.999897837638855
G O 1 0.9998350143432617
- O 1 0.928970992565155
- O 0 0.12980513274669647
> O 0 0.11857559531927109
A O 0 0.03087596222758293
and O 0 0.014571030624210835
187 O 0 0.09720736742019653
C O 1 0.9892768859863281
- O 1 0.8822169303894043
- O 0 0.3010658323764801
> O 0 0.43748944997787476
G O 1 0.5375669598579407
mutations O 0 0.14889533817768097
: O 0 0.03763119876384735
prevalence O 1 0.7184176445007324
in O 0 0.01841120980679989
non O 0 0.058145616203546524
- O 0 0.14397881925106049
Caucasian O 1 0.9556732177734375
populations O 0 0.08282982558012009
. O 0 0.028932910412549973

Hemochromatosis B-Disease 1 0.9999991655349731
, O 0 0.026398494839668274
the O 0 0.02367696911096573
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
of I-Disease 0 0.018902679905295372
iron I-Disease 1 0.9987083673477173
metabolism I-Disease 1 0.9890949130058289
, O 0 0.01582505740225315
leads O 0 0.047852493822574615
, O 0 0.011940108612179756
if O 0 0.016445230692625046
untreated O 1 0.9998247027397156
, O 0 0.011165978386998177
to O 0 0.01398871373385191
progressive O 1 0.8940318822860718
iron B-Disease 1 0.9995841383934021
overload I-Disease 1 0.9999082088470459
and O 0 0.02709883265197277
premature B-Disease 1 0.9948809146881104
death I-Disease 0 0.05640024319291115
. O 0 0.02961844950914383

The O 0 0.07841915637254715
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.14754121005535126
, O 0 0.03261016681790352
HFE O 1 0.9998389482498169
, O 0 0.01790141873061657
recently O 0 0.027784503996372223
has O 0 0.01273274328559637
been O 0 0.00989279430359602
identified O 0 0.017613546922802925
, O 0 0.007485400885343552
and O 0 0.007009050343185663
characterization O 0 0.037650346755981445
of O 0 0.00789649598300457
this O 0 0.011219893582165241
gene O 0 0.057946816086769104
has O 0 0.014947519637644291
shown O 0 0.01624821312725544
that O 0 0.005625715013593435
it O 0 0.006767958868294954
contains O 0 0.011527378112077713
two O 0 0.010445298627018929
mutations O 0 0.06735679507255554
that O 0 0.008236074820160866
result O 0 0.019474411383271217
in O 0 0.01376158744096756
amino O 0 0.07296247035264969
acid O 0 0.1443445086479187
substitutions O 0 0.09921318292617798
- O 0 0.11725234240293503
cDNA O 0 0.1774483621120453
nucleotides O 0 0.14704541862010956
845 O 1 0.9786702990531921
G O 1 0.9940401315689087
- O 0 0.4599410593509674
- O 0 0.1552349478006363
> O 0 0.16264139115810394
A O 0 0.04894745722413063
( O 0 0.04312868416309357
C282Y O 0 0.14606498181819916
) O 0 0.02114499919116497
and O 0 0.013467286713421345
187 O 0 0.10014673322439194
C O 1 0.9737622141838074
- O 1 0.8139001131057739
- O 0 0.27439624071121216
> O 0 0.30562418699264526
G O 0 0.2859190106391907
( O 0 0.05642257258296013
H63D O 1 0.9900302886962891
) O 0 0.03575246036052704
. O 0 0.030035151168704033

Although O 0 0.0689973458647728
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 0.024268096312880516
common O 0 0.02375408448278904
in O 0 0.014478056691586971
Caucasians O 1 0.8204970955848694
, O 0 0.02641422301530838
affecting O 0 0.10734258592128754
> O 1 0.7178840041160583
= O 0 0.13933761417865753
1 O 0 0.04551630839705467
/ O 0 0.22702698409557343
300 O 0 0.031976860016584396
individuals O 0 0.014460337348282337
of O 0 0.008044736459851265
northern O 0 0.018911203369498253
European O 0 0.02044009231030941
origin O 0 0.016274668276309967
, O 0 0.008693737909197807
it O 0 0.006470704451203346
has O 0 0.008951900526881218
not O 0 0.006071522366255522
been O 0 0.008744551800191402
recognized O 0 0.017604628577828407
in O 0 0.008427996188402176
other O 0 0.008885218761861324
populations O 0 0.04455781355500221
. O 0 0.024146173149347305

The O 0 0.02070680819451809
present O 0 0.02395676262676716
study O 0 0.029830964282155037
used O 0 0.023203281685709953
PCR O 0 0.14667567610740662
and O 0 0.01623961701989174
restriction O 0 0.06516026705503464
- O 0 0.11412177234888077
enzyme O 0 0.14385613799095154
digestion O 0 0.13925744593143463
to O 0 0.014669112861156464
analyze O 0 0.037038546055555344
the O 0 0.012153957970440388
frequency O 0 0.031834132969379425
of O 0 0.008701615035533905
the O 0 0.01834241859614849
845 O 1 0.997473418712616
G O 1 0.9979786276817322
- O 1 0.6306021213531494
- O 0 0.12285009026527405
> O 0 0.12586191296577454
A O 0 0.02930193580687046
and O 0 0.016917023807764053
187 O 0 0.11914828419685364
C O 1 0.953932523727417
- O 1 0.567564070224762
- O 0 0.19896765053272247
> O 0 0.2504834532737732
G O 0 0.2336198091506958
mutations O 0 0.14630277454853058
in O 0 0.031369343400001526
HLA O 1 0.9999382495880127
- O 0 0.10533948242664337
typed O 0 0.07020571082830429
samples O 0 0.04590165615081787
from O 0 0.0184226892888546
non O 0 0.058022622019052505
- O 0 0.1064150258898735
Caucasian O 1 0.5610302686691284
populations O 0 0.058331262320280075
, O 0 0.016320528462529182
comprising O 0 0.02948363870382309
Australian O 0 0.037066664546728134
Aboriginal O 0 0.05431133508682251
, O 0 0.012594610452651978
Chinese O 0 0.013941063545644283
, O 0 0.010588530451059341
and O 0 0.010984300635755062
Pacific O 0 0.053017668426036835
Islanders O 0 0.10413656383752823
. O 0 0.03242325410246849

Results O 0 0.041560862213373184
showed O 0 0.023667866364121437
that O 0 0.007259546313434839
the O 0 0.015653586015105247
845 O 1 0.9994840621948242
G O 1 0.9998086094856262
- O 1 0.9561431407928467
- O 0 0.16445708274841309
> O 0 0.1568405032157898
A O 0 0.05204291641712189
mutation O 0 0.11082854866981506
was O 0 0.01560678705573082
present O 0 0.01165283378213644
in O 0 0.008217120543122292
these O 0 0.008928857743740082
populations O 0 0.044537950307130814
( O 0 0.0344487763941288
allele O 0 0.1549624800682068
frequency O 0 0.07425452023744583
0 O 0 0.043418049812316895
. O 0 0.011897418648004532
32 O 0 0.030840162187814713
% O 0 0.02313402108848095
) O 0 0.01492720190435648
, O 0 0.008299360983073711
and O 0 0.007115999702364206
, O 0 0.009573586285114288
furthermore O 0 0.021156515926122665
, O 0 0.007927528582513332
it O 0 0.007306543178856373
was O 0 0.01295885257422924
always O 0 0.015382131561636925
seen O 0 0.014471199363470078
in O 0 0.009615335613489151
conjunction O 0 0.05125164985656738
with O 0 0.025655003264546394
HLA O 1 0.9999592304229736
haplotypes O 0 0.40861380100250244
common O 0 0.03439857065677643
in O 0 0.017616359516978264
Caucasians O 1 0.6410390138626099
, O 0 0.015628574416041374
suggesting O 0 0.03792018070816994
that O 0 0.01845885068178177
845 O 1 0.9988980293273926
G O 1 0.9997654557228088
- O 1 0.9896748661994934
- O 0 0.28208082914352417
> O 0 0.15809538960456848
A O 0 0.03271469473838806
may O 0 0.017058713361620903
have O 0 0.008118617348372936
been O 0 0.009285973384976387
introduced O 0 0.014723148196935654
into O 0 0.01077472884207964
these O 0 0.008830352686345577
populations O 0 0.03742989897727966
by O 0 0.020067816600203514
Caucasian O 1 0.9801744222640991
admixture O 1 0.9779742360115051
. O 0 0.04470882564783096

187 O 0 0.19290955364704132
C O 1 0.9914678335189819
- O 1 0.9358246922492981
- O 0 0.3137769401073456
> O 0 0.20820853114128113
G O 0 0.14823472499847412
was O 0 0.023672690615057945
present O 0 0.015809841454029083
at O 0 0.017835719510912895
an O 0 0.014971022494137287
allele O 0 0.11748739331960678
frequency O 0 0.0514674074947834
of O 0 0.012803815305233002
2 O 0 0.030480239540338516
. O 0 0.02432839572429657

68 O 0 0.10130886733531952
% O 0 0.026298386976122856
in O 0 0.00823543593287468
the O 0 0.00972866453230381
two O 0 0.009154618717730045
populations O 0 0.04379413276910782
analyzed O 0 0.04627339914441109
( O 0 0.025182193145155907
Australian O 0 0.028832487761974335
Aboriginal O 0 0.04506789520382881
and O 0 0.010594872757792473
Chinese O 0 0.02059100940823555
) O 0 0.02703334391117096
. O 0 0.022777924314141273

In O 0 0.017405355349183083
the O 0 0.012448101304471493
Australian O 0 0.03529494255781174
Aboriginal O 0 0.062137823551893234
samples O 0 0.04663845896720886
, O 0 0.018518539145588875
187 O 0 0.10176637768745422
C O 1 0.9836699962615967
- O 1 0.8178365230560303
- O 0 0.21140967309474945
> O 0 0.1945345252752304
G O 0 0.12726496160030365
was O 0 0.01753687672317028
found O 0 0.013096952810883522
to O 0 0.006436705123633146
be O 0 0.007875275798141956
associated O 0 0.022037114948034286
with O 0 0.025301672518253326
HLA O 1 0.9999788999557495
haplotypes O 1 0.5920682549476624
common O 0 0.03519111126661301
in O 0 0.01732894591987133
Caucasians O 1 0.6907327771186829
, O 0 0.016813291236758232
suggesting O 0 0.03153258562088013
that O 0 0.007880016230046749
it O 0 0.006702663842588663
was O 0 0.010272697545588017
introduced O 0 0.015880869701504707
by O 0 0.011603101156651974
recent O 0 0.034226227551698685
admixture O 0 0.48325788974761963
. O 0 0.03658471629023552

In O 0 0.01774859055876732
the O 0 0.012602167204022408
Chinese O 0 0.01876760832965374
samples O 0 0.0444914847612381
analyzed O 0 0.0493520088493824
, O 0 0.01882709376513958
187 O 0 0.10290983319282532
C O 1 0.9716169238090515
- O 1 0.8122408986091614
- O 0 0.2390681356191635
> O 0 0.2082134485244751
G O 0 0.13685128092765808
was O 0 0.019216123968362808
present O 0 0.013683555647730827
in O 0 0.009332271292805672
association O 0 0.02553616277873516
with O 0 0.007379595655947924
a O 0 0.011294972151517868
wide O 0 0.017300032079219818
variety O 0 0.01904001273214817
of O 0 0.018405023962259293
HLA O 1 0.9999817609786987
haplotypes O 1 0.803724467754364
, O 0 0.017504578456282616
showing O 0 0.02928280271589756
this O 0 0.012309983372688293
mutation O 0 0.0872495099902153
to O 0 0.009574987925589085
be O 0 0.008157027885317802
widespread O 0 0.02363152988255024
and O 0 0.0091248145326972
likely O 0 0.01837318204343319
to O 0 0.009570982307195663
predate O 0 0.05276297405362129
the O 0 0.008891317993402481
more O 0 0.010767458006739616
genetically O 0 0.049092862755060196
restricted O 0 0.07022605836391449
845 O 1 0.9984412789344788
G O 1 0.9993728995323181
- O 1 0.9521744251251221
- O 0 0.1877010613679886
> O 0 0.17837963998317719
A O 0 0.06021180748939514
mutation O 0 0.16901206970214844
. O 0 0.03385920822620392

Genotype O 1 0.9933197498321533
- O 0 0.36754339933395386
phenotype O 1 0.7255951166152954
correlations O 0 0.14895255863666534
in O 0 0.04939328506588936
attenuated B-Disease 1 0.999985933303833
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999984502792358
. O 0 0.059255484491586685

Germ O 1 0.9999161958694458
- O 0 0.14157326519489288
line O 0 0.052615270018577576
mutations O 0 0.08627844601869583
of O 0 0.014068784192204475
the O 0 0.034878917038440704
tumor B-Disease 1 0.9999915361404419
suppressor O 1 0.9961497783660889
APC O 1 0.986624002456665
are O 0 0.017272070050239563
implicated O 0 0.39707866311073303
in O 0 0.03704847767949104
attenuated B-Disease 1 0.9999949932098389
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
( O 1 0.8296889066696167
AAPC B-Disease 1 0.9999998807907104
) O 0 0.02857799455523491
, O 0 0.012799602001905441
a O 0 0.022435219958424568
variant O 0 0.10883895307779312
of O 0 0.03293206915259361
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9868839383125305
FAP B-Disease 1 0.9999995231628418
) O 0 0.04672542214393616
. O 0 0.029509223997592926

AAPC B-Disease 1 0.9999747276306152
is O 0 0.028519196435809135
recognized O 0 0.02632458508014679
by O 0 0.010121296159923077
the O 0 0.01570725440979004
occurrence O 0 0.08147116005420685
of O 0 0.02207535319030285
< O 0 0.41917523741722107
100 O 0 0.06314872205257416
colonic B-Disease 1 0.9995760321617126
adenomas I-Disease 1 0.9999046325683594
and O 0 0.013322439976036549
a O 0 0.020130274817347527
later O 0 0.03051157109439373
onset O 1 0.9999972581863403
of O 0 0.08814486116170883
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.052837979048490524
age O 0 0.04958073049783707
> O 0 0.13552019000053406
40 O 0 0.0298015009611845
years O 0 0.019738731905817986
) O 0 0.024920200929045677
. O 0 0.02212013676762581

The O 0 0.01993267796933651
aim O 0 0.0341588519513607
of O 0 0.006944090593606234
this O 0 0.008840265683829784
study O 0 0.019569939002394676
was O 0 0.013499660417437553
to O 0 0.013919267803430557
assess O 0 0.10224105417728424
genotype O 1 0.9824642539024353
- O 0 0.24238303303718567
phenotype O 1 0.6308311223983765
correlations O 0 0.13248805701732635
in O 0 0.03351063281297684
AAPC B-Disease 1 0.9999982118606567
families O 0 0.05772368609905243
. O 0 0.03411737456917763

By O 0 0.039126645773649216
protein O 0 0.10235095769166946
- O 0 0.11716973781585693
truncation O 0 0.16629444062709808
test O 0 0.07468930631875992
( O 0 0.043515585362911224
PTT O 0 0.16908298432826996
) O 0 0.033229704946279526
assay O 0 0.09332502633333206
, O 0 0.011198451742529869
the O 0 0.011493588797748089
entire O 0 0.032652612775564194
coding O 0 0.09058164805173874
region O 0 0.028688471764326096
of O 0 0.009939308278262615
the O 0 0.02140265703201294
APC B-Disease 1 0.9904878735542297
gene O 0 0.08689147233963013
was O 0 0.023022565990686417
screened O 0 0.06028327718377113
in O 0 0.014793620444834232
affected O 0 0.046863824129104614
individuals O 0 0.02400052733719349
from O 0 0.01963675580918789
11 O 0 0.05052660033106804
AAPC B-Disease 1 0.9999996423721313
kindreds O 1 0.9823924899101257
, O 0 0.014708892442286015
and O 0 0.007788462098687887
their O 0 0.00840741116553545
phenotypic O 0 0.07225605845451355
differences O 0 0.024426305666565895
were O 0 0.015451846644282341
examined O 0 0.07170096784830093
. O 0 0.030707506462931633

Five O 0 0.03944956511259079
novel O 0 0.07680052518844604
germ O 1 0.9994625449180603
- O 0 0.16034682095050812
line O 0 0.07368253171443939
APC B-Disease 1 0.9911165237426758
mutations O 0 0.11800646781921387
were O 0 0.011830237694084644
identified O 0 0.02242482826113701
in O 0 0.010901416651904583
seven O 0 0.027824167162179947
kindreds O 1 0.7838549017906189
. O 0 0.03615967929363251

Mutations O 0 0.13107681274414062
were O 0 0.013906865380704403
located O 0 0.020490353927016258
in O 0 0.0065022604539990425
three O 0 0.006069197319447994
different O 0 0.005419623106718063
regions O 0 0.01603114791214466
of O 0 0.008642624132335186
the O 0 0.02186964452266693
APC B-Disease 1 0.9933832287788391
gene O 0 0.11416333168745041
( O 0 0.03670387715101242
1 O 0 0.02447490021586418
) O 0 0.016174068674445152
at O 0 0.012681124731898308
the O 0 0.008526084013283253
5 O 0 0.02123446576297283
end O 0 0.02539094351232052
spanning O 0 0.04698582738637924
exons O 0 0.08857496827840805
4 O 0 0.026367103680968285
and O 0 0.010855833999812603
5 O 0 0.021418962627649307
, O 0 0.012393458746373653
( O 0 0.025090649724006653
2 O 0 0.02452061139047146
) O 0 0.01795377768576145
within O 0 0.01713382452726364
exon O 0 0.09942852705717087
9 O 0 0.028263479471206665
, O 0 0.012287415564060211
and O 0 0.010379763320088387
( O 0 0.022883472964167595
3 O 0 0.023968303576111794
) O 0 0.01591883786022663
at O 0 0.013838935643434525
the O 0 0.01130249910056591
3 O 0 0.03223264962434769
distal O 0 0.41946977376937866
end O 0 0.019313331693410873
of O 0 0.008466027677059174
the O 0 0.018562227487564087
gene O 0 0.0924638956785202
. O 0 0.02902825176715851

Variability O 0 0.12726522982120514
in O 0 0.01316610537469387
the O 0 0.012095865793526173
number O 0 0.01277439296245575
of O 0 0.022851573303341866
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.023822961375117302
most O 0 0.011786793358623981
apparent O 0 0.04058874025940895
in O 0 0.010249965824186802
individuals O 0 0.015998514369130135
with O 0 0.014306994155049324
mutations O 0 0.0711822435259819
in O 0 0.012275385670363903
region O 0 0.02817646786570549
1 O 0 0.01860031858086586
, O 0 0.009088127873837948
and O 0 0.012283656746149063
upper O 1 0.999927282333374
- O 1 0.9998456239700317
gastrointestinal O 1 0.9999998807907104
manifestations O 1 0.9787986874580383
were O 0 0.010602965019643307
more O 0 0.011380932293832302
severe O 1 0.9991408586502075
in O 0 0.009057916700839996
them O 0 0.010257099755108356
. O 0 0.022726984694600105

In O 0 0.021730856969952583
individuals O 0 0.023635832592844963
with O 0 0.015266596339643002
mutations O 0 0.07738905400037766
in O 0 0.01116851158440113
either O 0 0.016826318576931953
region O 0 0.02697748877108097
2 O 0 0.01970134861767292
or O 0 0.012702611275017262
region O 0 0.026029467582702637
3 O 0 0.016363512724637985
, O 0 0.0077746263705194
the O 0 0.008912988938391209
average O 0 0.026815321296453476
number O 0 0.010097433812916279
of O 0 0.012648342177271843
adenomas B-Disease 1 0.9999631643295288
tended O 0 0.05067053064703941
to O 0 0.009326620027422905
be O 0 0.008046829141676426
lower O 0 0.0215305183082819
than O 0 0.0068703144788742065
those O 0 0.004983300343155861
in O 0 0.007608004380017519
individuals O 0 0.012268651276826859
with O 0 0.011726880446076393
mutations O 0 0.0706498771905899
in O 0 0.011289234273135662
region O 0 0.03129632771015167
1 O 0 0.019331611692905426
, O 0 0.009426720440387726
although O 0 0.013594127260148525
age O 0 0.031472329050302505
at O 0 0.031994450837373734
diagnosis O 1 0.9999938011169434
was O 0 0.020184975117444992
similar O 0 0.023263324052095413
. O 0 0.023315079510211945

In O 0 0.02830095775425434
all O 0 0.025899900123476982
AAPC B-Disease 1 0.9999978542327881
kindreds O 1 0.766228199005127
, O 0 0.018230535089969635
a O 0 0.021007433533668518
predominance O 0 0.0998300090432167
of O 0 0.015022662468254566
right O 0 0.49697133898735046
- O 1 0.9997596144676208
sided O 1 0.9999951124191284
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.5714083909988403
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9914166331291199
was O 0 0.03155769780278206
observed O 0 0.047687944024801254
. O 0 0.02723272331058979

No O 0 0.06493645161390305
desmoid B-Disease 1 0.9996250867843628
tumors I-Disease 1 0.9999916553497314
were O 0 0.01473413035273552
found O 0 0.016678908839821815
in O 0 0.010316295549273491
these O 0 0.01377607136964798
kindreds O 1 0.7078598737716675
. O 0 0.034542061388492584

Our O 0 0.027320362627506256
data O 0 0.01846567541360855
suggest O 0 0.019368216395378113
that O 0 0.0063842060044407845
, O 0 0.010645100846886635
in O 0 0.016181958839297295
AAPC B-Disease 1 0.9999996423721313
families O 0 0.030789118260145187
, O 0 0.009581346996128559
the O 0 0.009102702140808105
location O 0 0.01847699284553528
of O 0 0.009008130058646202
the O 0 0.022725561633706093
APC B-Disease 1 0.9993771910667419
mutation O 0 0.22312593460083008
may O 0 0.037559594959020615
partially O 0 0.08199350535869598
predict O 0 0.06110873445868492
specific O 0 0.027225764468312263
phenotypic O 0 0.1096281111240387
expression O 0 0.0659424290060997
. O 0 0.029888596385717392

This O 0 0.01585204154253006
should O 0 0.011747649870812893
help O 0 0.015158138237893581
in O 0 0.0065146032720804214
the O 0 0.00817437656223774
design O 0 0.018399709835648537
of O 0 0.010881312191486359
tailored O 1 0.5034095048904419
clinical O 1 0.9998118281364441
- O 0 0.27654406428337097
management O 0 0.06848584860563278
protocols O 0 0.04540175572037697
in O 0 0.00896749459207058
this O 0 0.010976465418934822
subset O 0 0.06770507991313934
of O 0 0.02411505952477455
FAP B-Disease 1 1.0
patients O 1 0.99998939037323
. O 0 0.018650947138667107
. O 0 0.02440725639462471

Wilms B-Disease 1 0.9999911785125732
' I-Disease 1 0.6772270202636719
tumor I-Disease 1 0.9993721842765808
1 O 0 0.03269735351204872
and O 0 0.018695365637540817
Dax O 1 0.9995755553245544
- O 0 0.09850028902292252
1 O 0 0.039099693298339844
modulate O 0 0.14874109625816345
the O 0 0.03231247514486313
orphan O 1 0.9864763021469116
nuclear O 0 0.1293051540851593
receptor O 1 0.6319515109062195
SF O 1 0.9997798800468445
- O 0 0.08908278495073318
1 O 0 0.026815539225935936
in O 0 0.013902698643505573
sex O 0 0.048152051866054535
- O 0 0.07472206652164459
specific O 0 0.03578488528728485
gene O 0 0.09514056146144867
expression O 0 0.05641547590494156
. O 0 0.029720423743128777

Products O 0 0.055895108729600906
of O 0 0.026560066267848015
steroidogenic O 1 0.997605562210083
factor O 0 0.08562618494033813
1 O 0 0.03923271596431732
( O 0 0.04797287657856941
SF O 1 0.9999656677246094
- O 0 0.09420034289360046
1 O 0 0.03394624963402748
) O 0 0.029512181878089905
and O 0 0.025527486577630043
Wilms B-Disease 1 0.9999974966049194
tumor I-Disease 1 0.9999140501022339
1 O 0 0.051656968891620636
( O 0 0.05428231507539749
WT1 O 1 0.999487042427063
) O 0 0.030319204553961754
genes O 0 0.03485007956624031
are O 0 0.007403816096484661
essential O 0 0.021176358684897423
for O 0 0.015161100775003433
mammalian O 0 0.13008281588554382
gonadogenesis O 0 0.23482339084148407
prior O 0 0.025652416050434113
to O 0 0.013577900826931
sexual O 0 0.04799036681652069
differentiation O 0 0.09340012073516846
. O 0 0.03252661973237991

In O 0 0.03180784359574318
males O 0 0.07105756551027298
, O 0 0.031776007264852524
SF O 1 0.9999336004257202
- O 0 0.08584824204444885
1 O 0 0.030716434121131897
participates O 0 0.05557514727115631
in O 0 0.010658925399184227
sexual O 0 0.028546864166855812
development O 0 0.01979096606373787
by O 0 0.011653153225779533
regulating O 0 0.05409998819231987
expression O 0 0.03201859071850777
of O 0 0.010161683894693851
the O 0 0.02584994211792946
polypeptide O 0 0.3121817111968994
hormone O 1 0.9979451298713684
Mullerian O 1 0.9996252059936523
inhibiting O 1 0.933464527130127
substance O 1 0.987349808216095
( O 0 0.07480861991643906
MIS O 1 0.9997912049293518
) O 0 0.037103645503520966
. O 0 0.02580341137945652

Here O 0 0.022227786481380463
, O 0 0.012307444587349892
we O 0 0.01036399882286787
show O 0 0.023489773273468018
that O 0 0.02110174670815468
WT1 O 1 0.9999439716339111
- O 0 0.42413052916526794
KTS O 1 0.9976638555526733
isoforms O 0 0.09775559604167938
associate O 0 0.04758536070585251
and O 0 0.01863071322441101
synergize O 1 0.9666146039962769
with O 0 0.03277365118265152
SF O 1 0.9999781847000122
- O 0 0.07616207748651505
1 O 0 0.022782476618885994
to O 0 0.01356944814324379
promote O 0 0.049028024077415466
MIS O 1 0.9882281422615051
expression O 0 0.07521629333496094
. O 0 0.029713619500398636

In O 0 0.030253635719418526
contrast O 0 0.05301131680607796
, O 0 0.03282797709107399
WT1 O 1 0.9997367262840271
missense O 0 0.4514957666397095
mutations O 0 0.1259794533252716
, O 0 0.015529382973909378
associated O 0 0.02046695537865162
with O 0 0.014018910005688667
male B-Disease 0 0.07074328511953354
pseudohermaphroditism I-Disease 1 0.9997462630271912
in O 0 0.03227080777287483
Denys B-Disease 1 0.9999778270721436
- I-Disease 1 0.999829888343811
Drash I-Disease 1 0.9999935626983643
syndrome I-Disease 1 1.0
, O 0 0.026901502162218094
fail O 0 0.064811110496521
to O 0 0.01689828559756279
synergize O 1 0.9803198575973511
with O 0 0.03596131503582001
SF O 1 0.9999841451644897
- O 0 0.11579164117574692
1 O 0 0.046904001384973526
. O 0 0.030147016048431396

Additionally O 0 0.05705071985721588
, O 0 0.014814116060733795
the O 0 0.01641613058745861
X O 1 0.7140141129493713
- O 0 0.09960552304983139
linked O 0 0.07206479460000992
, O 0 0.018565673381090164
candidate O 0 0.043378498405218124
dosage O 1 0.9994350075721741
- O 0 0.14253748953342438
sensitive O 0 0.06483673304319382
sex O 0 0.07507120817899704
- O 0 0.15391018986701965
reversal O 0 0.141463041305542
gene O 0 0.09656962752342224
, O 0 0.027865998446941376
Dax O 1 0.9998058676719666
- O 0 0.09767983853816986
1 O 0 0.03823976218700409
, O 0 0.027382787317037582
antagonizes O 1 0.9283736348152161
synergy O 0 0.2542773187160492
between O 0 0.03830723464488983
SF O 1 0.9999374151229858
- O 0 0.09959130734205246
1 O 0 0.03574460744857788
and O 0 0.019548267126083374
WT1 O 1 0.9996479749679565
, O 0 0.01219860278069973
most O 0 0.008887448348104954
likely O 0 0.017441829666495323
through O 0 0.011024187318980694
a O 0 0.01414403971284628
direct O 0 0.021047277376055717
interaction O 0 0.03920191898941994
with O 0 0.0237476397305727
SF O 1 0.999990701675415
- O 0 0.10700788348913193
1 O 0 0.03990393504500389
. O 0 0.030231673270463943

We O 0 0.027771318331360817
propose O 0 0.06531482189893723
that O 0 0.02307562716305256
WT1 O 1 0.9969243407249451
and O 0 0.028857609257102013
Dax O 1 0.9995760321617126
- O 0 0.10422520339488983
1 O 0 0.03886208310723305
functionally O 0 0.09080978482961655
oppose O 0 0.03540978580713272
each O 0 0.009984555654227734
other O 0 0.0075876968912780285
in O 0 0.015322662889957428
testis O 1 0.9589694142341614
development O 0 0.030727004632353783
by O 0 0.024175310507416725
modulating O 1 0.9825906157493591
SF O 1 0.9999837875366211
- O 0 0.16407498717308044
1 O 0 0.05005130171775818
- O 0 0.12716278433799744
mediated O 0 0.2682567238807678
transactivation O 1 0.78903728723526
. O 0 0.0282748993486166
. O 0 0.030975401401519775

A O 0 0.06035653129220009
mouse O 0 0.12765443325042725
model O 0 0.04676913097500801
for O 0 0.0323125459253788
Prader B-Disease 1 1.0
- I-Disease 1 0.9999969005584717
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9994508624076843
- O 0 0.491956889629364
centre O 0 0.10525166243314743
mutations O 0 0.15693525969982147
. O 0 0.03623306378722191

Imprinting O 0 0.2547721266746521
in O 0 0.0231417715549469
the O 0 0.020527170971035957
15q11 O 1 0.8132588267326355
- O 0 0.10474275797605515
q13 O 0 0.15067051351070404
region O 0 0.04998102784156799
involves O 0 0.05025899037718773
an O 0 0.022939756512641907
imprinting O 0 0.42336931824684143
centre O 0 0.08282403647899628
( O 0 0.0542936697602272
IC O 1 0.9959253072738647
) O 0 0.021884860470891
, O 0 0.009515260346233845
mapping O 0 0.030159423127770424
in O 0 0.007963275536894798
part O 0 0.010363705456256866
to O 0 0.006692121736705303
the O 0 0.009633788838982582
promoter O 0 0.09496734291315079
and O 0 0.010436582379043102
first O 0 0.017137784510850906
exon O 0 0.11131397634744644
of O 0 0.024132076650857925
SNRPN O 1 0.9949978590011597
. O 0 0.03529767319560051

Deletion O 0 0.16283203661441803
of O 0 0.01753232814371586
this O 0 0.025355838239192963
IC O 1 0.9958831071853638
abolishes O 0 0.25498223304748535
local O 0 0.0366767942905426
paternally O 0 0.1812725067138672
derived O 0 0.057032015174627304
gene O 0 0.07859054207801819
expression O 0 0.03852033615112305
and O 0 0.009326172061264515
results O 0 0.029215918853878975
in O 0 0.0261477492749691
Prader B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9825582504272461
PWS B-Disease 1 1.0
) O 0 0.04503260925412178
. O 0 0.028906462714076042

We O 0 0.01860838755965233
have O 0 0.01102450955659151
created O 0 0.02143753133714199
two O 0 0.0156424380838871
deletion O 0 0.15631331503391266
mutations O 0 0.1175830215215683
in O 0 0.020264562219381332
mice O 0 0.1209062933921814
to O 0 0.01796538382768631
understand O 0 0.06019081920385361
PWS B-Disease 1 0.9999998807907104
and O 0 0.012546073645353317
the O 0 0.012059333734214306
mechanism O 0 0.04047048091888428
of O 0 0.010262956842780113
this O 0 0.017493387684226036
IC O 1 0.9979817867279053
. O 0 0.032308921217918396

Mice O 1 0.6187396049499512
harbouring O 1 0.9633864164352417
an O 0 0.040393341332674026
intragenic O 1 0.7769092917442322
deletion O 0 0.15214350819587708
in O 0 0.023479975759983063
Snrpn O 1 0.8735625743865967
are O 0 0.015796402469277382
phenotypically O 0 0.1522851139307022
normal O 0 0.046188078820705414
, O 0 0.013894476927816868
suggesting O 0 0.03675009682774544
that O 0 0.01227321196347475
mutations O 0 0.07557529956102371
of O 0 0.012358114123344421
SNRPN O 1 0.9877155423164368
are O 0 0.007830193266272545
not O 0 0.006982929538935423
sufficient O 0 0.02439115010201931
to O 0 0.021809842437505722
induce O 1 0.97923743724823
PWS B-Disease 1 0.9999998807907104
. O 0 0.04905642941594124

Mice O 0 0.1665475070476532
with O 0 0.020323876291513443
a O 0 0.02635088749229908
larger O 0 0.03346911817789078
deletion O 0 0.11104342341423035
involving O 0 0.03678370267152786
both O 0 0.01780194602906704
Snrpn O 0 0.47748488187789917
and O 0 0.012760719284415245
the O 0 0.018296735361218452
putative O 1 0.9984837174415588
PWS O 1 1.0
- O 1 0.9952534437179565
IC O 1 0.9977399110794067
lack O 0 0.0390726700425148
expression O 0 0.03194000944495201
of O 0 0.007780403830111027
the O 0 0.017944464460015297
imprinted O 0 0.16689516603946686
genes O 0 0.11167745292186737
Zfp127 O 1 0.9092316031455994
( O 0 0.05627300217747688
mouse O 0 0.15416410565376282
homologue O 0 0.17501012980937958
of O 0 0.023002443835139275
ZNF127 O 1 0.9945912957191467
) O 0 0.03226449340581894
, O 0 0.020808394998311996
Ndn O 1 0.9995006322860718
and O 0 0.019461721181869507
Ipw O 0 0.26880842447280884
, O 0 0.013673410750925541
and O 0 0.009869510307908058
manifest O 0 0.04483785107731819
several O 0 0.014074176549911499
phenotypes O 0 0.13630226254463196
common O 0 0.040268100798130035
to O 0 0.03740890324115753
PWS B-Disease 1 1.0
infants O 1 0.9994770884513855
. O 0 0.04118187725543976

These O 0 0.01427973248064518
data O 0 0.01249883696436882
demonstrate O 0 0.019001444801688194
that O 0 0.004824727773666382
both O 0 0.00444025220349431
the O 0 0.006340296473354101
position O 0 0.011315060779452324
of O 0 0.005432311911135912
the O 0 0.012144812382757664
IC O 1 0.9920017719268799
and O 0 0.006530144717544317
its O 0 0.006766036152839661
role O 0 0.01402612216770649
in O 0 0.0070862555876374245
the O 0 0.010478475131094456
coordinate O 0 0.05367011949419975
expression O 0 0.031148046255111694
of O 0 0.009525756351649761
genes O 0 0.040765181183815
is O 0 0.013987255282700062
conserved O 0 0.0341203548014164
between O 0 0.01663668267428875
mouse O 0 0.08977516740560532
and O 0 0.010419979691505432
human O 0 0.01702786237001419
, O 0 0.008126008324325085
and O 0 0.006751688662916422
indicate O 0 0.018452879041433334
that O 0 0.005855737254023552
the O 0 0.01156872883439064
mouse O 0 0.07799241691827774
is O 0 0.013505479320883751
a O 0 0.016683366149663925
suitable O 0 0.03320998698472977
model O 0 0.026675984263420105
system O 0 0.01933934912085533
in O 0 0.006365233100950718
which O 0 0.005954646971076727
to O 0 0.0062307449989020824
investigate O 0 0.026036672294139862
the O 0 0.012418351136147976
molecular O 0 0.048554498702287674
mechanisms O 0 0.039441317319869995
of O 0 0.011222521774470806
imprinting O 0 0.12249068170785904
in O 0 0.009938145987689495
this O 0 0.006585003808140755
region O 0 0.016266759485006332
of O 0 0.00675323698669672
the O 0 0.012751045636832714
genome O 0 0.07267588376998901
. O 0 0.01908714324235916
. O 0 0.028485462069511414

Mutations O 0 0.12592869997024536
of O 0 0.014706031419336796
the O 0 0.022657841444015503
ATM O 0 0.19017009437084198
gene O 0 0.10176516324281693
detected O 0 0.08289365470409393
in O 0 0.01886795088648796
Japanese O 1 0.8835262060165405
ataxia B-Disease 1 1.0
- I-Disease 1 0.999992847442627
telangiectasia I-Disease 1 1.0
patients O 1 0.9999995231628418
: O 0 0.02430787868797779
possible O 0 0.023157482966780663
preponderance O 0 0.08690176904201508
of O 0 0.007664227858185768
the O 0 0.008610694669187069
two O 0 0.012834981083869934
founder O 0 0.07523529976606369
mutations O 0 0.1467374712228775
4612del165 O 0 0.18562209606170654
and O 0 0.02432641014456749
7883del5 O 0 0.18375244736671448
. O 0 0.030447037890553474

The O 0 0.03853059932589531
ATM O 0 0.21459661424160004
( O 0 0.04097147658467293
A O 1 0.985898494720459
- O 1 0.9948840737342834
T O 1 0.9999507665634155
, O 0 0.02937597595155239
mutated O 0 0.1327568143606186
) O 0 0.030867820605635643
gene O 0 0.06055985018610954
on O 0 0.013355838134884834
human O 0 0.041077062487602234
chromosome O 0 0.17583240568637848
11q22 O 0 0.211588516831398
. O 0 0.03088381700217724

3 O 0 0.04114735871553421
has O 0 0.016724765300750732
recently O 0 0.024370169267058372
been O 0 0.011794781312346458
identified O 0 0.01656821183860302
as O 0 0.007918044924736023
the O 0 0.011905639432370663
gene O 0 0.05460907518863678
responsible O 0 0.02090280130505562
for O 0 0.007987715303897858
the O 0 0.014387587085366249
human O 0 0.12125418335199356
recessive B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999738931655884
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.44401946663856506
A B-Disease 1 0.9995506405830383
- I-Disease 1 0.9986826777458191
T I-Disease 1 0.999990701675415
) O 0 0.03824247419834137
. O 0 0.027145611122250557

In O 0 0.017524754628539085
order O 0 0.012671886011958122
to O 0 0.009081629104912281
define O 0 0.022653335705399513
the O 0 0.010964716784656048
types O 0 0.02552378922700882
of O 0 0.01624748669564724
disease O 1 1.0
- O 1 0.9883527159690857
causing O 1 0.6850507855415344
ATM O 0 0.17597664892673492
mutations O 0 0.09548277407884598
in O 0 0.012560163624584675
Japanese O 0 0.044223852455616
A B-Disease 1 0.9997934699058533
- I-Disease 1 0.9999786615371704
T I-Disease 1 0.9999998807907104
patients O 1 0.9998852014541626
as O 0 0.008254654705524445
well O 0 0.006845333147794008
as O 0 0.005448631010949612
to O 0 0.007671251893043518
look O 0 0.01906919851899147
for O 0 0.011092634871602058
possible O 0 0.0364273339509964
mutational O 1 0.9837468266487122
hotspots O 0 0.19335418939590454
, O 0 0.022356713190674782
reverse O 0 0.0885169729590416
- O 0 0.1018998846411705
transcribed O 0 0.09609139710664749
RNA O 0 0.09878663718700409
derived O 0 0.033698514103889465
from O 0 0.013951157219707966
ten O 0 0.026534145697951317
patients O 1 0.9974998831748962
belonging O 0 0.02717018872499466
to O 0 0.00835488922894001
eight O 0 0.015976646915078163
unrelated O 0 0.04693349823355675
Japanese O 0 0.04925963655114174
A B-Disease 1 0.9833545088768005
- I-Disease 1 0.9975172281265259
T I-Disease 1 0.9999790191650391
families O 0 0.03175078704953194
was O 0 0.018624193966388702
analyzed O 0 0.03928476199507713
for O 0 0.013924255035817623
mutations O 0 0.07256237417459488
by O 0 0.012403874658048153
the O 0 0.01828058250248432
restriction O 0 0.08495432883501053
endonuclease O 1 0.8144339919090271
fingerprinting O 0 0.14143149554729462
method O 0 0.057740431278944016
. O 0 0.02856968156993389

As O 0 0.02024765871465206
has O 0 0.015509231016039848
been O 0 0.013691737316548824
reported O 0 0.02616952918469906
by O 0 0.011250903829932213
others O 0 0.019466262310743332
, O 0 0.015451615676283836
mutations O 0 0.06902672350406647
that O 0 0.008145754225552082
lead O 0 0.025893697515130043
to O 0 0.014283518306910992
exon O 0 0.14730282127857208
skipping O 0 0.15286694467067719
or O 0 0.048331551253795624
premature O 1 0.7303910255432129
protein O 0 0.08101416379213333
truncation O 0 0.10206425189971924
were O 0 0.01106872595846653
also O 0 0.013540208339691162
predominant O 0 0.04451712593436241
in O 0 0.010053488425910473
our O 0 0.019316725432872772
mutants O 0 0.11584911495447159
. O 0 0.03236321732401848

Six O 0 0.03138766437768936
different O 0 0.015206390991806984
mutations O 0 0.07147952914237976
were O 0 0.009116323664784431
identified O 0 0.016331223770976067
on O 0 0.00750629510730505
12 O 0 0.011626356281340122
of O 0 0.005780633073300123
the O 0 0.01181375328451395
16 O 0 0.03439901024103165
alleles O 0 0.1549474447965622
examined O 0 0.0986010730266571
. O 0 0.03516267612576485

Four O 0 0.022187327966094017
were O 0 0.013506406918168068
deletions O 0 0.07348714023828506
involving O 0 0.029406046494841576
a O 0 0.01906377077102661
loss O 0 0.03848033770918846
of O 0 0.00909440778195858
a O 0 0.021088097244501114
single O 0 0.03682832792401314
exon O 0 0.1507159322500229
exon O 0 0.1601497381925583
7 O 0 0.04432441666722298
, O 0 0.02065247669816017
exon O 0 0.12110061198472977
16 O 0 0.0331713929772377
, O 0 0.018954942002892494
exon O 0 0.12315808981657028
33 O 0 0.05271704122424126
or O 0 0.03153282776474953
exon O 0 0.1444731205701828
35 O 0 0.0629429817199707
. O 0 0.031513359397649765

The O 0 0.021947825327515602
others O 0 0.02173740044236183
were O 0 0.011498178355395794
minute O 0 0.035567861050367355
deletions O 0 0.0836365595459938
, O 0 0.022857867181301117
4649delA O 0 0.12902769446372986
in O 0 0.01766035705804825
exon O 0 0.11844810843467712
33 O 0 0.04570498690009117
and O 0 0.015546202659606934
7883del5 O 0 0.12078085541725159
in O 0 0.01889408566057682
exon O 0 0.15307524800300598
55 O 0 0.07820253819227219
. O 0 0.03477765619754791

The O 0 0.04215775802731514
mutations O 0 0.17464140057563782
4612del165 O 0 0.17195454239845276
and O 0 0.0196747537702322
7883del5 O 0 0.11181216686964035
were O 0 0.009459114633500576
found O 0 0.012611700221896172
in O 0 0.005810911767184734
more O 0 0.005171939264982939
than O 0 0.0072474912740290165
two O 0 0.008953740820288658
unrelated O 0 0.05098032206296921
families O 0 0.03038586489856243
; O 0 0.01894613727927208
44 O 0 0.03350206837058067
% O 0 0.026316018775105476
( O 0 0.018406914547085762
7 O 0 0.016662633046507835
of O 0 0.006296104751527309
16 O 0 0.016318323090672493
) O 0 0.011295126751065254
of O 0 0.005987522192299366
the O 0 0.014933807775378227
mutant O 0 0.10484613478183746
alleles O 0 0.12107556313276291
had O 0 0.016891220584511757
one O 0 0.008948542177677155
of O 0 0.006069962400943041
the O 0 0.010623523034155369
two O 0 0.01655844785273075
mutations O 0 0.12429368495941162
. O 0 0.034915752708911896

The O 0 0.04312716796994209
4612del165 O 0 0.24901601672172546
mutations O 0 0.09384249895811081
in O 0 0.00892186351120472
three O 0 0.007841933518648148
different O 0 0.007095588371157646
families O 0 0.014115072786808014
were O 0 0.006018490996211767
all O 0 0.005401450674980879
ascribed O 0 0.0344623401761055
to O 0 0.0076224287040531635
the O 0 0.010910028591752052
same O 0 0.025213316082954407
T O 1 0.9999977350234985
- O 1 0.9345017075538635
- O 0 0.13045451045036316
> O 0 0.1303328424692154
A O 0 0.03439755737781525
substitution O 0 0.0599716491997242
at O 0 0.022334259003400803
the O 0 0.019672058522701263
splice O 0 0.18427810072898865
donor O 0 0.12301307171583176
site O 0 0.03611116111278534
in O 0 0.020461222156882286
intron O 1 0.818042516708374
33 O 0 0.07154994457960129
. O 0 0.02822212316095829

Microsatellite O 1 0.7133153676986694
genotyping O 0 0.23286843299865723
around O 0 0.030477790161967278
the O 0 0.019890686497092247
ATM O 0 0.14943790435791016
locus O 0 0.11956248432397842
also O 0 0.01658427156507969
indicated O 0 0.02657763846218586
that O 0 0.007793991826474667
a O 0 0.015168135054409504
common O 0 0.029199710115790367
haplotype O 1 0.9850668907165527
was O 0 0.016587523743510246
shared O 0 0.017950616776943207
by O 0 0.009154736064374447
the O 0 0.013983868062496185
mutant O 0 0.10847535729408264
alleles O 0 0.13010892271995544
in O 0 0.01629316806793213
both O 0 0.01799798384308815
mutations O 0 0.11767645925283432
. O 0 0.034214794635772705

This O 0 0.0175919272005558
suggests O 0 0.02822718396782875
that O 0 0.0060252780094742775
these O 0 0.005217491649091244
two O 0 0.009928343817591667
founder O 0 0.06819131970405579
mutations O 0 0.10396092385053635
may O 0 0.022217029705643654
be O 0 0.010983441025018692
predominant O 0 0.049691323190927505
among O 0 0.02113020233809948
Japanese O 0 0.04855261370539665
ATM O 0 0.17223615944385529
mutant O 0 0.1486622840166092
alleles O 0 0.1986769139766693
. O 0 0.046030446887016296

W474C O 0 0.30332863330841064
amino O 0 0.14492550492286682
acid O 0 0.2165140062570572
substitution O 0 0.11448096483945847
affects O 0 0.10396601259708405
early O 0 0.022644782438874245
processing O 0 0.01729169674217701
of O 0 0.00649056863039732
the O 0 0.01314577553421259
alpha O 0 0.07997245341539383
- O 0 0.08327391743659973
subunit O 0 0.09846372902393341
of O 0 0.01873251423239708
beta O 0 0.10605922341346741
- O 0 0.09565197676420212
hexosaminidase O 0 0.14412866532802582
A O 0 0.025293054059147835
and O 0 0.008765516802668571
is O 0 0.010904327034950256
associated O 0 0.023111460730433464
with O 0 0.025360699743032455
subacute O 1 0.9999990463256836
G B-Disease 1 0.993536651134491
( I-Disease 0 0.05826295167207718
M2 I-Disease 1 0.9804792404174805
) I-Disease 0 0.044482458382844925
gangliosidosis I-Disease 1 0.5955565571784973
. O 0 0.030795827507972717

Mutations O 0 0.15583951771259308
in O 0 0.021203357726335526
the O 0 0.030250683426856995
HEXA O 1 0.9989223480224609
gene O 0 0.09829704463481903
, O 0 0.016091620549559593
encoding O 0 0.0371735505759716
the O 0 0.016820907592773438
alpha O 0 0.08662308752536774
- O 0 0.08907857537269592
subunit O 0 0.09709151834249496
of O 0 0.018824739381670952
beta O 0 0.11416718363761902
- O 0 0.1134360283613205
hexosaminidase O 0 0.18974310159683228
A O 0 0.0465141236782074
( O 0 0.03446468710899353
Hex O 0 0.09070827066898346
A O 0 0.02909066341817379
) O 0 0.015452406369149685
, O 0 0.008463847450911999
that O 0 0.008582466281950474
abolish O 0 0.06946875154972076
Hex O 0 0.11008133739233017
A O 0 0.048958878964185715
enzyme O 0 0.14464335143566132
activity O 0 0.15393193066120148
cause O 1 0.9999845027923584
Tay B-Disease 1 1.0
- I-Disease 1 0.9999954700469971
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.09992748498916626
TSD B-Disease 1 0.9999974966049194
) O 0 0.025881780311465263
, O 0 0.011280923150479794
the O 0 0.017994331195950508
fatal O 1 0.9999911785125732
infantile B-Disease 1 0.9999598264694214
form I-Disease 0 0.03565431013703346
of I-Disease 0 0.01971483789384365
G I-Disease 1 0.9693126678466797
( I-Disease 0 0.04558752104640007
M2 I-Disease 1 0.9433950185775757
) I-Disease 0 0.0405525341629982
gangliosidosis I-Disease 0 0.19016525149345398
, I-Disease 0 0.021392880007624626
Type I-Disease 0 0.0668017640709877
1 I-Disease 0 0.03209981694817543
. O 0 0.026956412941217422

Less O 0 0.0557989701628685
severe O 1 0.9999812841415405
, O 0 0.03450538218021393
subacute O 1 1.0
( O 1 0.7042880058288574
juvenile O 1 0.9999884366989136
- O 1 0.9991651773452759
onset O 1 0.9999896287918091
) O 0 0.03486299514770508
and O 0 0.02172950655221939
chronic O 1 1.0
( O 0 0.04704835265874863
adult O 1 0.5235977172851562
- O 1 0.9882150888442993
onset O 1 0.9998595714569092
) O 0 0.030565103515982628
variants O 0 0.04341031238436699
are O 0 0.009579619392752647
characterized O 0 0.04339292645454407
by O 0 0.008600682020187378
a O 0 0.017574114724993706
broad O 0 0.04199576750397682
spectrum O 0 0.058717601001262665
of O 0 0.013841981999576092
clinical O 1 0.9994561076164246
manifestations O 1 0.6712693572044373
and O 0 0.007662883028388023
are O 0 0.006261650938540697
associated O 0 0.015896154567599297
with O 0 0.012349620461463928
residual O 0 0.09812700003385544
levels O 0 0.03651798516511917
of O 0 0.012541194446384907
Hex O 0 0.10369313508272171
A O 0 0.045334309339523315
enzyme O 0 0.12359518557786942
activity O 0 0.05878837779164314
. O 0 0.02960023283958435

We O 0 0.02489103004336357
identified O 0 0.03788682818412781
a O 0 0.0393313504755497
1422 O 1 0.9997275471687317
G O 1 0.9986864924430847
- O 1 0.9393729567527771
- O 0 0.2328536957502365
> O 0 0.2299138456583023
C O 0 0.16554483771324158
( O 0 0.053895629942417145
amino O 0 0.09520129859447479
acid O 0 0.17789717018604279
W474C O 0 0.1740666776895523
) O 0 0.02893703803420067
substitution O 0 0.03903520107269287
in O 0 0.007379875052720308
the O 0 0.006778368726372719
first O 0 0.00955847930163145
position O 0 0.01365787535905838
of O 0 0.009350239299237728
exon O 0 0.1073445975780487
13 O 0 0.026265840977430344
of O 0 0.0161348395049572
HEXA O 1 0.9947435855865479
of O 0 0.011308480985462666
a O 0 0.021821212023496628
non O 0 0.046330079436302185
- O 0 0.08962523192167282
Jewish O 0 0.060032714158296585
proband O 1 0.9095599055290222
who O 0 0.031281232833862305
manifested O 0 0.2259625643491745
a O 0 0.041896115988492966
subacute O 1 0.9999969005584717
variant O 0 0.1481909155845642
of O 0 0.02385760471224785
G B-Disease 1 0.9145609140396118
( I-Disease 0 0.04965044930577278
M2 I-Disease 1 0.9742913842201233
) I-Disease 0 0.04685947671532631
gangliosidosis I-Disease 0 0.41382279992103577
. O 0 0.030762379989027977

On O 0 0.017698615789413452
the O 0 0.01645650900900364
second O 0 0.03674696013331413
maternally O 0 0.2124294936656952
inherited O 0 0.2909458577632904
allele O 0 0.14459921419620514
, O 0 0.014377491548657417
we O 0 0.00893906969577074
identified O 0 0.018241174519062042
the O 0 0.011817391030490398
common O 1 0.7493231892585754
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9923770427703857
causing O 1 0.763042688369751
4 O 0 0.052218228578567505
- O 0 0.12570124864578247
bp O 0 0.17355158925056458
insertion O 0 0.16605940461158752
, O 0 0.03809753432869911
+ O 0 0.415423721075058
TATC O 1 0.9954966306686401
1278 O 1 0.9805622696876526
, O 0 0.02007446065545082
in O 0 0.01655178889632225
exon O 0 0.13478727638721466
11 O 0 0.04227867349982262
. O 0 0.029474973678588867

Pulse O 1 0.9599485993385315
- O 0 0.13662397861480713
chase O 0 0.12585851550102234
analysis O 0 0.038181230425834656
using O 0 0.03256963565945625
proband O 1 0.6284701228141785
fibroblasts O 0 0.44881343841552734
revealed O 0 0.04013562574982643
that O 0 0.009301558136940002
the O 0 0.019014541059732437
W474C O 0 0.23728786408901215
- O 0 0.08947396278381348
containing O 0 0.04786320775747299
alpha O 0 0.10705646127462387
- O 0 0.12060719728469849
subunit O 0 0.14703796803951263
precursor O 0 0.10370970517396927
was O 0 0.028879916295409203
normally O 0 0.04171477258205414
synthesized O 0 0.07432244718074799
, O 0 0.012966052629053593
but O 0 0.009407291188836098
not O 0 0.011704090051352978
phosphorylated O 0 0.08615145832300186
or O 0 0.02308441326022148
secreted O 0 0.07356396317481995
, O 0 0.009271415881812572
and O 0 0.007965197786688805
the O 0 0.015976864844560623
mature O 0 0.09234744310379028
lysosomal O 1 0.9902094602584839
alpha O 0 0.11946021765470505
- O 0 0.10685676336288452
subunit O 0 0.1144062951207161
was O 0 0.02543666586279869
not O 0 0.019994176924228668
detected O 0 0.09550147503614426
. O 0 0.03090454451739788

When O 0 0.02907653898000717
the O 0 0.02281126379966736
W474C O 0 0.18461394309997559
- O 0 0.0812019556760788
containing O 0 0.038322433829307556
alpha O 0 0.10024694353342056
- O 0 0.11080291867256165
subunit O 0 0.1287630796432495
was O 0 0.038613468408584595
transiently O 1 0.9176083207130432
co O 0 0.17156843841075897
- O 0 0.05523926392197609
expressed O 0 0.020181413739919662
with O 0 0.010123681277036667
the O 0 0.01575407013297081
beta O 0 0.08939507603645325
- O 0 0.08491408079862595
subunit O 0 0.08303412795066833
to O 0 0.013039412908256054
produce O 0 0.03033190593123436
Hex O 0 0.10262686759233475
A O 0 0.04177034646272659
( O 0 0.03768251836299896
alphabeta O 0 0.18548138439655304
) O 0 0.027853652834892273
in O 0 0.02041880413889885
COS O 1 0.9999713897705078
- O 0 0.09756898134946823
7 O 0 0.04236159846186638
cells O 0 0.05797921121120453
, O 0 0.010447737760841846
the O 0 0.014227728359401226
mature O 0 0.06886998564004898
alpha O 0 0.07583751529455185
- O 0 0.08448460698127747
subunit O 0 0.09081707149744034
was O 0 0.01920214109122753
present O 0 0.01381121575832367
, O 0 0.008032324723899364
but O 0 0.006826404482126236
its O 0 0.00829089991748333
level O 0 0.019750727340579033
was O 0 0.012288100086152554
much O 0 0.0112480279058218
lower O 0 0.020943930372595787
than O 0 0.008987169712781906
that O 0 0.007030102424323559
from O 0 0.013158389367163181
normal O 0 0.05371789634227753
alpha O 0 0.08984974771738052
- O 0 0.11301752179861069
subunit O 0 0.15647561848163605
transfections O 0 0.20077992975711823
, O 0 0.013597048819065094
although O 0 0.011852327734231949
higher O 0 0.016127346083521843
than O 0 0.007093314081430435
in O 0 0.008610885590314865
those O 0 0.01283098291605711
cells O 0 0.08008626848459244
transfected O 0 0.20268985629081726
with O 0 0.015164852142333984
an O 0 0.021770527586340904
alpha O 0 0.09797303378582001
- O 0 0.10513310134410858
subunit O 0 0.13838694989681244
associated O 0 0.04401673376560211
with O 0 0.039963118731975555
infantile O 1 0.9999942779541016
TSD B-Disease 1 0.9999586343765259
. O 0 0.050331294536590576

Furthermore O 0 0.05882907658815384
, O 0 0.012531047686934471
the O 0 0.012054062448441982
precursor O 0 0.06523484736680984
level O 0 0.023732028901576996
of O 0 0.008664018474519253
the O 0 0.019623201340436935
W474C O 0 0.1857592761516571
alpha O 0 0.10522244870662689
- O 0 0.10249347984790802
subunit O 0 0.1022314578294754
was O 0 0.020334869623184204
found O 0 0.018726835027337074
to O 0 0.01281537301838398
accumulate O 0 0.058866117149591446
in O 0 0.010249055922031403
comparison O 0 0.020063715055584908
to O 0 0.007529193069785833
the O 0 0.01308363489806652
normal O 0 0.054710712283849716
alpha O 0 0.09596779942512512
- O 0 0.11152435839176178
subunit O 0 0.1538938283920288
precursor O 0 0.11908100545406342
levels O 0 0.07112673670053482
. O 0 0.03198332339525223

We O 0 0.02185126580297947
conclude O 0 0.04837806522846222
that O 0 0.01152863260358572
the O 0 0.021576296538114548
1422 O 1 0.9999324083328247
G O 1 0.999488115310669
- O 1 0.9669683575630188
- O 0 0.35345369577407837
> O 0 0.2596162259578705
C O 0 0.1822374314069748
mutation O 0 0.13182367384433746
is O 0 0.015292302705347538
the O 0 0.011105583049356937
cause O 0 0.046123649924993515
of O 0 0.013259954750537872
Hex B-Disease 0 0.12292970716953278
A I-Disease 0 0.06650273501873016
enzyme I-Disease 1 0.9996199607849121
deficiency I-Disease 1 1.0
in O 0 0.01862003654241562
the O 0 0.02105116844177246
proband O 1 0.9775190353393555
. O 0 0.03114863857626915

The O 0 0.03491620346903801
resulting O 0 0.0847039446234703
W474C O 0 0.19216851890087128
substitution O 0 0.09805320203304291
clearly O 0 0.04588423669338226
interferes O 0 0.11859329789876938
with O 0 0.018741734325885773
alpha O 0 0.0850735455751419
- O 0 0.09131157398223877
subunit O 0 0.10407652705907822
processing O 0 0.03131290525197983
, O 0 0.010703063569962978
but O 0 0.008278869092464447
because O 0 0.010268889367580414
the O 0 0.011785713955760002
base O 0 0.041724108159542084
substitution O 0 0.07134313881397247
falls O 0 0.06926140189170837
at O 0 0.013773777522146702
the O 0 0.006988113280385733
first O 0 0.010050109587609768
position O 0 0.0143175283446908
of O 0 0.010737820528447628
exon O 0 0.11782423406839371
13 O 0 0.032224997878074646
, O 0 0.023077435791492462
aberrant O 0 0.16827307641506195
splicing O 0 0.1279492825269699
may O 0 0.02408045530319214
also O 0 0.009872459806501865
contribute O 0 0.0360342375934124
to O 0 0.01446820143610239
Hex B-Disease 0 0.11281272768974304
A I-Disease 0 0.06836012005805969
deficiency I-Disease 1 0.9999995231628418
in O 0 0.017717717215418816
this O 0 0.015202048234641552
proband O 1 0.6644875407218933
. O 0 0.017336472868919373
. O 0 0.02293621003627777

Two O 0 0.033475231379270554
frequent O 0 0.11271289736032486
missense O 0 0.2712540626525879
mutations O 0 0.1672871708869934
in O 0 0.04575422406196594
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 0.048026736825704575

Pendred B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
is O 0 0.042693715542554855
an O 0 0.04993680119514465
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9996153116226196
by O 0 0.018321506679058075
early O 0 0.11825026571750641
childhood O 1 0.9999996423721313
deafness B-Disease 1 1.0
and O 0 0.07590756565332413
goiter B-Disease 1 1.0
. O 0 0.04146513342857361

A O 0 0.03815966472029686
century O 0 0.022290155291557312
after O 0 0.016756154596805573
its O 0 0.010194636881351471
recognition O 0 0.027552222833037376
as O 0 0.013830330222845078
a O 0 0.04244115203619003
syndrome O 1 1.0
by O 0 0.021956712007522583
Vaughan O 1 0.5575774908065796
Pendred O 1 0.9798634648323059
, O 0 0.019685186445713043
the O 0 0.025449151173233986
disease O 1 0.9999992847442627
gene O 0 0.13912731409072876
( O 0 0.04667630046606064
PDS O 1 0.999921441078186
) O 0 0.020739000290632248
was O 0 0.017416253685951233
mapped O 0 0.04693487659096718
to O 0 0.01935388147830963
chromosome O 0 0.1648312211036682
7q22 O 1 0.8416844010353088
- O 0 0.1492961198091507
q31 O 0 0.20842412114143372
. O 0 0.039840247482061386

1 O 0 0.03603639826178551
and O 0 0.01301492564380169
, O 0 0.011773564852774143
recently O 0 0.025723014026880264
, O 0 0.009151492267847061
found O 0 0.010921905748546124
to O 0 0.00864332728087902
encode O 0 0.03920688480138779
a O 0 0.036083418875932693
putative O 0 0.2147449105978012
sulfate O 1 0.9990968704223633
transporter O 1 0.9574415683746338
. O 0 0.038851965218782425

We O 0 0.02824566699564457
performed O 0 0.0424247607588768
mutation O 0 0.10205339640378952
analysis O 0 0.02228606306016445
of O 0 0.009338779374957085
the O 0 0.022025195881724358
PDS B-Disease 1 0.9999575614929199
gene O 0 0.09857016056776047
in O 0 0.02300172485411167
patients O 1 0.9998114705085754
from O 0 0.019821330904960632
14 O 0 0.028647255152463913
Pendred B-Disease 1 0.8708990216255188
families O 0 0.029036017134785652
originating O 0 0.03822758048772812
from O 0 0.00965457409620285
seven O 0 0.01165204867720604
countries O 0 0.00970365945249796
and O 0 0.007620031014084816
identified O 0 0.022682592272758484
all O 0 0.011676709167659283
mutations O 0 0.11168402433395386
. O 0 0.029243050143122673

The O 0 0.035469021648168564
mutations O 0 0.10589385777711868
include O 0 0.016352074220776558
three O 0 0.011972532607614994
single O 0 0.029977476224303246
base O 0 0.04263735190033913
deletions O 0 0.06903781741857529
, O 0 0.014393007382750511
one O 0 0.01954243704676628
splice O 0 0.16162176430225372
site O 0 0.04986145347356796
mutation O 0 0.11840567737817764
and O 0 0.019164087250828743
10 O 0 0.04252922162413597
missense O 0 0.2202167510986328
mutations O 0 0.15938007831573486
. O 0 0.036068230867385864

One O 0 0.05935951694846153
missense O 0 0.27468186616897583
mutation O 0 0.2391299456357956
( O 0 0.06032704561948776
L236P O 0 0.2257530242204666
) O 0 0.021464096382260323
was O 0 0.015352621674537659
found O 0 0.012780913151800632
in O 0 0.008470260538160801
a O 0 0.016982030123472214
homozygous O 0 0.0717884749174118
state O 0 0.011871795170009136
in O 0 0.009419131092727184
two O 0 0.012999126687645912
consanguineous O 1 0.8192651271820068
families O 0 0.023000769317150116
and O 0 0.008136067539453506
in O 0 0.008730478584766388
a O 0 0.016417687758803368
heterozygous O 0 0.07019450515508652
state O 0 0.00900014117360115
in O 0 0.007285282947123051
five O 0 0.010304131545126438
additional O 0 0.02166621759533882
non O 0 0.05689428746700287
- O 0 0.1468227654695511
consanguineous O 1 0.8681111335754395
families O 0 0.05213477090001106
. O 0 0.03261086344718933

Another O 0 0.0927726998925209
missense O 0 0.2937004566192627
mutation O 0 0.23819586634635925
( O 0 0.0589294508099556
T416P O 0 0.17956727743148804
) O 0 0.019070087000727654
was O 0 0.012653416953980923
found O 0 0.011506667360663414
in O 0 0.007781595923006535
a O 0 0.01576950028538704
homozygous O 0 0.06587295234203339
state O 0 0.010197659954428673
in O 0 0.006988579872995615
one O 0 0.00883406400680542
family O 0 0.015423482283949852
and O 0 0.006426169071346521
in O 0 0.00757345138117671
a O 0 0.016191618517041206
heterozygous O 0 0.07580527663230896
state O 0 0.011398435570299625
in O 0 0.00845091138035059
four O 0 0.014193840324878693
families O 0 0.030446983873844147
. O 0 0.027241352945566177

Pendred B-Disease 1 0.9985604882240295
patients O 1 0.99968421459198
in O 0 0.014636370353400707
three O 0 0.017194781452417374
non O 0 0.05682132765650749
- O 0 0.12587913870811462
consanguineous O 1 0.8785015344619751
families O 0 0.031511399894952774
were O 0 0.01019806507974863
shown O 0 0.019451867789030075
to O 0 0.00923819188028574
be O 0 0.011191162280738354
compound O 0 0.08582057803869247
heterozygotes O 1 0.8458112478256226
for O 0 0.01923329569399357
L236P O 0 0.15705935657024384
and O 0 0.023141421377658844
T416P O 0 0.24772247672080994
. O 0 0.029732419177889824

In O 0 0.017890095710754395
total O 0 0.015547633171081543
, O 0 0.010097768157720566
one O 0 0.0074861301109194756
or O 0 0.008482777513563633
both O 0 0.005967296659946442
of O 0 0.005849583074450493
these O 0 0.00955637451261282
mutations O 0 0.06561925262212753
were O 0 0.007770467083901167
found O 0 0.011626060120761395
in O 0 0.006334285251796246
nine O 0 0.009419269859790802
of O 0 0.005594725254923105
the O 0 0.010917939245700836
14 O 0 0.02347598969936371
families O 0 0.028219206258654594
analyzed O 0 0.06020233780145645
. O 0 0.027110926806926727

The O 0 0.020938437432050705
identification O 0 0.02952420711517334
of O 0 0.009134428575634956
two O 0 0.013537866063416004
frequent O 0 0.08555062860250473
PDS B-Disease 1 0.9999163150787354
mutations O 0 0.10808075219392776
will O 0 0.012767431326210499
facilitate O 0 0.02766600251197815
the O 0 0.016495492309331894
molecular O 0 0.09240370243787766
diagnosis O 1 0.9999980926513672
of O 0 0.0336553193628788
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.046579957008361816

Insertional O 1 0.9249997138977051
mutation O 0 0.1914079189300537
by O 0 0.027624191716313362
transposable O 0 0.42511701583862305
element O 0 0.06585181504487991
, O 0 0.021779833361506462
L1 O 1 0.9933627843856812
, O 0 0.01105191558599472
in O 0 0.00985816027969122
the O 0 0.022603897377848625
DMD B-Disease 1 1.0
gene O 0 0.09437241405248642
results O 0 0.029400058090686798
in O 0 0.01741201989352703
X B-Disease 1 0.9935302138328552
- I-Disease 1 0.8306312561035156
linked I-Disease 1 0.9511933326721191
dilated I-Disease 1 0.9999980926513672
cardiomyopathy I-Disease 1 1.0
. O 0 0.06062978133559227

X B-Disease 1 0.9896017909049988
- I-Disease 1 0.9296714663505554
linked I-Disease 1 0.9751096367835999
dilated I-Disease 1 0.999997615814209
cardiomyopathy I-Disease 1 1.0
( O 0 0.09883755445480347
XLDCM B-Disease 1 0.9996813535690308
) O 0 0.02433374524116516
is O 0 0.014438968151807785
a O 0 0.024498462677001953
clinical O 1 0.983258068561554
phenotype O 1 0.7304344773292542
of O 0 0.01707320660352707
dystrophinopathy B-Disease 1 0.8451420068740845
which O 0 0.013015281409025192
is O 0 0.014194754883646965
characterized O 0 0.053167667239904404
by O 0 0.018604952841997147
preferential O 1 0.9985834360122681
myocardial B-Disease 1 1.0
involvement I-Disease 0 0.14607593417167664
without O 0 0.016539404168725014
any O 0 0.014510546810925007
overt O 0 0.3982976973056793
clinical O 1 0.9996782541275024
signs O 0 0.07976414263248444
of O 0 0.022047897800803185
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.04302765056490898

To O 0 0.01633124053478241
date O 0 0.015096651390194893
, O 0 0.009622957557439804
several O 0 0.010531261563301086
mutations O 0 0.06389602273702621
in O 0 0.012681256979703903
the O 0 0.0285018440335989
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.8910424709320068
, O 0 0.04513413831591606
DMD O 1 1.0
, O 0 0.017770817503333092
have O 0 0.009363189339637756
been O 0 0.011434120126068592
identified O 0 0.02180715650320053
in O 0 0.013756687752902508
patients O 1 0.9998990297317505
with O 0 0.016114646568894386
XLDCM B-Disease 1 0.9997122883796692
, O 0 0.012000711634755135
but O 0 0.010490951128304005
a O 0 0.018046747893095016
pathogenic O 0 0.09050757437944412
correlation O 0 0.05857927352190018
of O 0 0.01084811519831419
these O 0 0.014080245979130268
cardiospecific O 1 0.9268448948860168
mutations O 0 0.13986244797706604
in O 0 0.027709495276212692
DMD O 1 1.0
with O 0 0.019230373203754425
the O 0 0.022300081327557564
XLDCM B-Disease 1 0.999884843826294
phenotype O 1 0.930450439453125
has O 0 0.016318485140800476
remained O 0 0.017347419634461403
to O 0 0.00762874074280262
be O 0 0.01170129980891943
elucidated O 0 0.12106470763683319
. O 0 0.029981547966599464

We O 0 0.018174361437559128
report O 0 0.014436301775276661
here O 0 0.008466364815831184
the O 0 0.007851594127714634
identification O 0 0.01920301839709282
of O 0 0.006956501863896847
a O 0 0.016985232010483742
unique O 0 0.03221423551440239
de O 0 0.08938509970903397
novo O 0 0.28343522548675537
L1 O 1 0.9703826904296875
insertion O 0 0.11508633196353912
in O 0 0.014736075885593891
the O 0 0.020744483917951584
muscle O 1 0.9980711340904236
exon O 0 0.14777237176895142
1 O 0 0.034974321722984314
in O 0 0.027226483449339867
DMD O 1 1.0
in O 0 0.018798938021063805
three O 0 0.0233645960688591
XLDCM B-Disease 1 0.9999819993972778
patients O 1 0.9998568296432495
from O 0 0.013655061833560467
two O 0 0.00979490578174591
unrelated O 0 0.04447329789400101
Japanese O 0 0.03452751412987709
families O 0 0.03638032451272011
. O 0 0.027629176154732704

The O 0 0.032548341900110245
insertion O 0 0.11111384630203247
was O 0 0.02389632537961006
a O 0 0.02153799682855606
5 O 0 0.03314413130283356
- O 0 0.06759807467460632
truncated O 0 0.08842135220766068
form O 0 0.019898362457752228
of O 0 0.01019028015434742
human O 0 0.04008382931351662
L1 O 1 0.9809951186180115
inversely O 0 0.09060149639844894
integrated O 0 0.04315642639994621
in O 0 0.009266936220228672
the O 0 0.012590637430548668
5 O 0 0.032469186931848526
- O 0 0.07843860983848572
untranslated O 0 0.12986601889133453
region O 0 0.035074383020401
in O 0 0.013378170318901539
the O 0 0.020878229290246964
muscle O 1 0.9968037605285645
exon O 0 0.1536724865436554
1 O 0 0.02864767238497734
, O 0 0.010660579428076744
which O 0 0.010061283595860004
affected O 0 0.032949645072221756
the O 0 0.013267031870782375
transcription O 0 0.05729317292571068
or O 0 0.013519182801246643
the O 0 0.008147415705025196
stability O 0 0.023455101996660233
of O 0 0.007288042921572924
the O 0 0.01446186751127243
muscle O 1 0.9992101192474365
form O 0 0.021722925826907158
of O 0 0.01417461782693863
dystrophin O 1 0.9988200068473816
transcripts O 0 0.041337866336107254
but O 0 0.009390057995915413
not O 0 0.0055844890885055065
that O 0 0.004441548604518175
of O 0 0.00619811937212944
the O 0 0.01715715043246746
brain O 1 0.9997310042381287
or O 0 0.04015403985977173
Purkinje O 1 0.9999582767486572
cell O 0 0.0919814333319664
form O 0 0.02325126901268959
, O 0 0.011021608486771584
probably O 0 0.01745711825788021
due O 0 0.011308277025818825
to O 0 0.005674079060554504
its O 0 0.007238083053380251
unique O 0 0.017097510397434235
site O 0 0.017359377816319466
of O 0 0.007981104776263237
integration O 0 0.039826374500989914
. O 0 0.025365686044096947

We O 0 0.027643846347928047
speculate O 0 0.05042518302798271
that O 0 0.008566648699343204
this O 0 0.009515988640487194
insertion O 0 0.07112843543291092
of O 0 0.01040972862392664
an O 0 0.022152215242385864
L1 O 1 0.984478235244751
sequence O 0 0.049343179911375046
in O 0 0.02837234176695347
DMD O 1 1.0
is O 0 0.016172276809811592
responsible O 0 0.01962297596037388
for O 0 0.006329935509711504
some O 0 0.005176062695682049
of O 0 0.004995380062609911
the O 0 0.008583800867199898
population O 0 0.01616232469677925
of O 0 0.009138616733253002
Japanese O 0 0.0429261289536953
patients O 1 0.9999662637710571
with O 0 0.018842216581106186
XLDCM B-Disease 1 0.999411940574646
. O 0 0.016236890107393265
. O 0 0.02305905893445015

Severe O 1 0.9999954700469971
early O 1 0.5671769380569458
- O 1 0.9999561309814453
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.6777759790420532
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.027699556201696396
red O 1 0.9997302889823914
hair O 1 0.9999834299087524
pigmentation O 1 0.9999995231628418
caused O 1 0.9760228395462036
by O 0 0.034270212054252625
POMC O 1 0.9999736547470093
mutations O 0 0.13375352323055267
in O 0 0.018750036135315895
humans O 0 0.05233233794569969
. O 0 0.027014248073101044

Sequential O 0 0.13186153769493103
cleavage O 0 0.16958680748939514
of O 0 0.013631589710712433
the O 0 0.01819777861237526
precursor O 0 0.10186298936605453
protein O 0 0.0718962550163269
pre O 0 0.12031185626983643
- O 0 0.12317226082086563
pro O 0 0.08471761643886566
- O 0 0.1428254246711731
opiomelanocortin O 1 0.8225048780441284
( O 0 0.08015233278274536
POMC O 1 0.9988659620285034
) O 0 0.044880982488393784
generates O 0 0.07124559581279755
the O 0 0.03327072784304619
melanocortin O 1 0.9790608286857605
peptides O 0 0.21076607704162598
adrenocorticotrophin O 1 0.8181256651878357
( O 0 0.07331381738185883
ACTH O 1 0.9995861649513245
) O 0 0.044924091547727585
, O 0 0.02978140115737915
melanocyte O 1 0.9997987151145935
- O 0 0.30963054299354553
stimulating O 1 0.5388341546058655
hormones O 0 0.3973899781703949
( O 0 0.09063250571489334
MSH O 1 0.9999774694442749
) O 0 0.03746332600712776
alpha O 0 0.06669905036687851
, O 0 0.01687864400446415
beta O 0 0.0657585933804512
and O 0 0.013937114737927914
gamma O 0 0.0724887102842331
as O 0 0.008288226090371609
well O 0 0.008290441706776619
as O 0 0.0074817412532866
the O 0 0.01949099823832512
opioid O 1 0.999072790145874
- O 0 0.2030075043439865
receptor O 0 0.26954570412635803
ligand O 0 0.2381807565689087
beta O 0 0.16696088016033173
- O 0 0.2742616832256317
endorphin O 1 0.9916663765907288
. O 0 0.05605936795473099

While O 0 0.023764869198203087
a O 0 0.017904216423630714
few O 0 0.014401835389435291
cases O 0 0.022880302742123604
of O 0 0.017581891268491745
isolated O 1 0.9975079298019409
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.016344115138053894
been O 0 0.0187813900411129
reported O 0 0.047098010778427124
( O 0 0.05435876548290253
OMIM O 1 0.9999895095825195
201400 O 1 0.8921836018562317
) O 0 0.02443758025765419
, O 0 0.012426253408193588
an O 0 0.02186628058552742
inherited O 1 0.9996730089187622
POMC O 1 0.9999997615814209
defect O 1 0.9998347759246826
has O 0 0.01566760428249836
not O 0 0.00691528944298625
been O 0 0.009884437546133995
described O 0 0.0238560251891613
so O 0 0.015079963020980358
far O 0 0.02331564947962761
. O 0 0.023170480504631996

Recent O 0 0.04673197492957115
studies O 0 0.03240092843770981
in O 0 0.012167143635451794
animal O 0 0.04540904611349106
models O 0 0.03911997750401497
elucidated O 0 0.09705205261707306
a O 0 0.01700425334274769
central O 0 0.019369542598724365
role O 0 0.020176460966467857
of O 0 0.013326037675142288
alpha O 0 0.09436199069023132
- O 0 0.18548744916915894
MSH O 1 0.9997599720954895
in O 0 0.015864498913288116
the O 0 0.013575424440205097
regulation O 0 0.03270991891622543
of O 0 0.011109873652458191
food O 0 0.03600086271762848
intake O 0 0.10754074156284332
by O 0 0.01395824272185564
activation O 0 0.08454429358243942
of O 0 0.010360732674598694
the O 0 0.024873072281479836
brain O 1 0.9997363686561584
melanocortin O 1 0.9999754428863525
- O 0 0.2041984349489212
4 O 0 0.062355656176805496
- O 0 0.14685198664665222
receptor O 0 0.25306227803230286
( O 0 0.08334702998399734
MC4 O 1 0.9999945163726807
- O 0 0.4567464292049408
R O 0 0.20300346612930298
; O 0 0.035585060715675354
refs O 0 0.16279147565364838
3 O 0 0.03862517327070236
- O 0 0.06791504472494125
5 O 0 0.02909894660115242
) O 0 0.015181018970906734
and O 0 0.007195402402430773
the O 0 0.01206574309617281
linkage O 0 0.08837973326444626
of O 0 0.013304324820637703
human O 0 0.046979255974292755
obesity B-Disease 1 0.9999924898147583
to O 0 0.02267986536026001
chromosome O 0 0.11013730615377426
2 O 0 0.020956706255674362
in O 0 0.008389492519199848
close O 0 0.019935373216867447
proximity O 0 0.03366708382964134
to O 0 0.010789492167532444
the O 0 0.018417738378047943
POMC O 1 0.9994879961013794
locus O 0 0.13705608248710632
, O 0 0.016831351444125175
led O 0 0.01683422364294529
to O 0 0.006533443927764893
the O 0 0.008501843549311161
proposal O 0 0.021072261035442352
of O 0 0.007732724770903587
an O 0 0.014274832792580128
association O 0 0.03966296836733818
of O 0 0.016783012077212334
POMC O 1 0.9999816417694092
with O 0 0.024674221873283386
human O 0 0.06463009119033813
obesity B-Disease 1 0.9999983310699463
. O 0 0.04100039228796959

The O 0 0.022784626111388206
dual O 0 0.0525791272521019
role O 0 0.027027031406760216
of O 0 0.015530183911323547
alpha O 0 0.10567538440227509
- O 0 0.18402673304080963
MSH O 1 0.9997460246086121
in O 0 0.022588999941945076
regulating O 0 0.07256744801998138
food O 0 0.046391431242227554
intake O 0 0.15207891166210175
and O 0 0.019404152408242226
influencing O 0 0.11512064188718796
hair O 1 0.9997838139533997
pigmentation O 1 0.999982476234436
predicts O 0 0.09823978692293167
that O 0 0.011014619842171669
the O 0 0.01491028442978859
phenotype O 1 0.9339467883110046
associated O 0 0.02209407649934292
with O 0 0.010784586891531944
a O 0 0.024113962426781654
defect O 1 0.9899984002113342
in O 0 0.026775604113936424
POMC O 1 0.9999350309371948
function O 0 0.03981366753578186
would O 0 0.013969698920845985
include O 0 0.024895792827010155
obesity B-Disease 1 0.9999990463256836
, O 0 0.019816182553768158
alteration O 0 0.07966393232345581
in O 0 0.02364705502986908
pigmentation O 1 0.9999943971633911
and O 0 0.0683489590883255
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04896003380417824

The O 0 0.029058095067739487
observation O 0 0.06355937570333481
of O 0 0.01149382721632719
these O 0 0.014338836073875427
symptoms O 1 0.999991774559021
in O 0 0.011696784757077694
two O 0 0.013514083810150623
probands O 1 0.9590484499931335
prompted O 0 0.05445892736315727
us O 0 0.021482760086655617
to O 0 0.008130751550197601
search O 0 0.02151860110461712
for O 0 0.012660299427807331
mutations O 0 0.07489294558763504
within O 0 0.01636924035847187
their O 0 0.022822599858045578
POMC O 1 0.9993489384651184
genes O 0 0.10413433611392975
. O 0 0.03858039155602455

Patient O 1 0.9990092515945435
1 O 0 0.027526024729013443
was O 0 0.015086337924003601
found O 0 0.012266254052519798
to O 0 0.006753937806934118
be O 0 0.007713320665061474
a O 0 0.019631560891866684
compound O 0 0.08655858784914017
heterozygote O 0 0.45376861095428467
for O 0 0.01209293119609356
two O 0 0.01233695913106203
mutations O 0 0.08755482733249664
in O 0 0.021456504240632057
exon O 0 0.13896620273590088
3 O 0 0.04937246814370155
( O 0 0.043500516563653946
G7013T O 0 0.16752956807613373
, O 0 0.02497665397822857
C7133delta O 1 0.5500462651252747
) O 0 0.019589990377426147
which O 0 0.00993344932794571
interfere O 0 0.04044047370553017
with O 0 0.011040689423680305
appropriate O 0 0.03207649663090706
synthesis O 0 0.05179573968052864
of O 0 0.014358616434037685
ACTH O 1 0.999563992023468
and O 0 0.022798674181103706
alpha O 0 0.1160607859492302
- O 1 0.7367755174636841
MSH O 1 0.9998676776885986
. O 0 0.05208314582705498

Patient O 1 0.9969850182533264
2 O 0 0.035192884504795074
was O 0 0.021171757951378822
homozygous O 0 0.08150602132081985
for O 0 0.012622274458408356
a O 0 0.0247164536267519
mutation O 0 0.11317986249923706
in O 0 0.022329537197947502
exon O 0 0.13278250396251678
2 O 0 0.04598810523748398
( O 0 0.04150095582008362
C3804A O 0 0.19441752135753632
) O 0 0.02966580167412758
which O 0 0.02327946200966835
abolishes O 1 0.9610787630081177
POMC O 1 0.9978100657463074
translation O 0 0.06572628021240234
. O 0 0.038516949862241745

These O 0 0.014651698060333729
findings O 0 0.024194996803998947
represent O 0 0.011785446666181087
the O 0 0.008226806297898293
first O 0 0.009720412082970142
examples O 0 0.01428345125168562
of O 0 0.007096166722476482
a O 0 0.02703390270471573
genetic B-Disease 1 0.8194374442100525
defect I-Disease 1 0.9996917247772217
within O 0 0.018516773357987404
the O 0 0.022244030609726906
POMC O 1 0.9999356269836426
gene O 0 0.07644558697938919
and O 0 0.011134374886751175
define O 0 0.029456129297614098
a O 0 0.019337700679898262
new O 0 0.03516216576099396
monogenic B-Disease 1 0.9999980926513672
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
resulting O 0 0.04465046897530556
in O 0 0.014789283275604248
early O 0 0.06000370904803276
- O 1 0.9999219179153442
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.6717461943626404
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.028912071138620377
red O 1 0.9994924068450928
hair O 1 0.9999762773513794
pigmentation O 1 0.9999933242797852
. O 0 0.019947607070207596
. O 0 0.025165533646941185

A O 0 0.05122655630111694
European O 0 0.04696735367178917
multicenter O 1 0.9960575103759766
study O 0 0.044232774525880814
of O 0 0.028606541454792023
phenylalanine B-Disease 1 0.9999289512634277
hydroxylase I-Disease 1 0.9999958276748657
deficiency I-Disease 1 1.0
: O 0 0.04124496877193451
classification O 0 0.06611718237400055
of O 0 0.014246063306927681
105 O 0 0.0753520131111145
mutations O 0 0.08402614295482635
and O 0 0.008936692029237747
a O 0 0.01269574835896492
general O 0 0.013378813862800598
system O 0 0.02316403016448021
for O 0 0.015064701437950134
genotype O 1 0.9211695194244385
- O 0 0.0801837295293808
based O 0 0.03211304917931557
prediction O 0 0.0788753405213356
of O 0 0.0243152417242527
metabolic O 1 0.995294988155365
phenotype O 1 0.9861416220664978
. O 0 0.042347926646471024

Phenylketonuria B-Disease 1 0.9999979734420776
( O 0 0.4373955726623535
PKU B-Disease 1 0.9999998807907104
) O 0 0.036635223776102066
and O 0 0.018994607031345367
mild B-Disease 1 0.9999916553497314
hyperphenylalaninemia I-Disease 1 0.9999969005584717
( O 1 0.7197519540786743
MHP B-Disease 1 1.0
) O 0 0.03325695917010307
are O 0 0.01841026544570923
allelic B-Disease 1 0.999942421913147
disorders I-Disease 1 0.9999998807907104
caused O 0 0.19988411664962769
by O 0 0.016698377206921577
mutations O 0 0.07250852137804031
in O 0 0.012238623574376106
the O 0 0.018417295068502426
gene O 0 0.10870356112718582
encoding O 0 0.09354182332754135
phenylalanine O 0 0.3209550380706787
hydroxylase O 1 0.9710963368415833
( O 0 0.11018703877925873
PAH O 1 0.9999977350234985
) O 0 0.04976081848144531
. O 0 0.02933651953935623

Previous O 0 0.03652311861515045
studies O 0 0.027334075421094894
have O 0 0.008280159905552864
suggested O 0 0.015042205341160297
that O 0 0.006361987441778183
the O 0 0.011227845214307308
highly O 0 0.03958648443222046
variable O 0 0.12255721539258957
metabolic O 1 0.9957976341247559
phenotypes O 1 0.9821898937225342
of O 0 0.052704520523548126
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.6481263041496277
with O 0 0.0576229952275753
PAH O 1 0.9999997615814209
genotypes O 1 0.9770068526268005
. O 0 0.046635258942842484

We O 0 0.025045983493328094
identified O 0 0.031854432076215744
both O 0 0.018610533326864243
causative O 1 0.7658720016479492
mutations O 0 0.12894554436206818
in O 0 0.029501846060156822
686 O 1 0.9997139573097229
patients O 1 0.9998493194580078
from O 0 0.01660645753145218
seven O 0 0.019549142569303513
European O 0 0.029653901234269142
centers O 0 0.04987902194261551
. O 0 0.0285020899027586

On O 0 0.012949001975357533
the O 0 0.00815540086477995
basis O 0 0.009004241786897182
of O 0 0.00554521894082427
the O 0 0.011677601374685764
phenotypic O 0 0.0795244574546814
characteristics O 0 0.03889433294534683
of O 0 0.017716679722070694
297 O 0 0.42288801074028015
functionally O 1 0.8013362288475037
hemizygous O 1 0.999434769153595
patients O 1 0.9999586343765259
, O 0 0.014272371307015419
105 O 0 0.04093029722571373
of O 0 0.007980909198522568
the O 0 0.01489407941699028
mutations O 0 0.06528885662555695
were O 0 0.008849479258060455
assigned O 0 0.021757114678621292
to O 0 0.007328184321522713
one O 0 0.008520325645804405
of O 0 0.006993059068918228
four O 0 0.013844754546880722
arbitrary O 0 0.042945656925439835
phenotype O 0 0.4944499433040619
categories O 0 0.045223575085401535
. O 0 0.029683828353881836

We O 0 0.0180507842451334
proposed O 0 0.019833113998174667
and O 0 0.012037821114063263
tested O 0 0.04940161854028702
a O 0 0.015857337042689323
simple O 0 0.0211410541087389
model O 0 0.02814926765859127
for O 0 0.01266014389693737
correlation O 0 0.06567255407571793
between O 0 0.02387016825377941
genotype O 0 0.22953298687934875
and O 0 0.020335102453827858
phenotypic O 0 0.10739292949438095
outcome O 0 0.06170101463794708
. O 0 0.03077327460050583

The O 0 0.03438469022512436
observed O 0 0.07190454751253128
phenotype O 1 0.544287383556366
matched O 0 0.0715818852186203
the O 0 0.019290704280138016
predicted O 0 0.0553300715982914
phenotype O 0 0.19449295103549957
in O 0 0.017126549035310745
79 O 0 0.053643710911273956
% O 0 0.01451166532933712
of O 0 0.00541317043825984
the O 0 0.008653396740555763
cases O 0 0.018327269703149796
, O 0 0.007441805209964514
and O 0 0.005394042003899813
in O 0 0.006330151576548815
only O 0 0.006623968482017517
5 O 0 0.015881279483437538
of O 0 0.00972141232341528
184 O 0 0.12050573527812958
patients O 1 0.9995297193527222
was O 0 0.017557229846715927
the O 0 0.014238138683140278
observed O 0 0.04904408007860184
phenotype O 0 0.21540793776512146
more O 0 0.0117335245013237
than O 0 0.010508047416806221
one O 0 0.0109033714979887
category O 0 0.028384199365973473
away O 0 0.016900494694709778
from O 0 0.009267820976674557
that O 0 0.007806967478245497
expected O 0 0.01863921992480755
. O 0 0.021847371011972427

Among O 0 0.023208316415548325
the O 0 0.013376867398619652
seven O 0 0.019469941034913063
contributing O 0 0.04213063791394234
centers O 0 0.031403277069330215
, O 0 0.008294562809169292
the O 0 0.009952121414244175
proportion O 0 0.03108426369726658
of O 0 0.01420062780380249
patients O 1 0.9999287128448486
for O 0 0.011790742166340351
whom O 0 0.0236518494784832
the O 0 0.012842996045947075
observed O 0 0.04193221032619476
phenotype O 1 0.6484131813049316
did O 0 0.016367299482226372
not O 0 0.007997245527803898
match O 0 0.018912017345428467
the O 0 0.015011362731456757
predicted O 0 0.06139316409826279
phenotype O 0 0.1931406408548355
was O 0 0.023647883906960487
4 O 0 0.030595362186431885
% O 0 0.029085613787174225
- O 0 0.07315976917743683
23 O 0 0.03852168843150139
% O 0 0.03524753078818321
( O 0 0.04902750626206398
P O 1 0.9941482543945312
< O 0 0.29891377687454224
. O 0 0.029299236834049225
0001 O 1 0.9288325309753418
) O 0 0.028233962133526802
, O 0 0.011099271476268768
suggesting O 0 0.02516491897404194
that O 0 0.007485853973776102
differences O 0 0.01423576194792986
in O 0 0.008221372961997986
methods O 0 0.01746765710413456
used O 0 0.013161093927919865
for O 0 0.014817449264228344
mutation O 0 0.16805866360664368
detection O 0 0.13976773619651794
or O 0 0.040797412395477295
phenotype O 1 0.997847318649292
classification O 0 0.38722530007362366
may O 0 0.015613931231200695
account O 0 0.010452022776007652
for O 0 0.006507163401693106
a O 0 0.013210942968726158
considerable O 0 0.026685133576393127
proportion O 0 0.030488166958093643
of O 0 0.019109167158603668
genotype O 1 0.9993902444839478
- O 1 0.9208889603614807
phenotype O 1 0.9528381824493408
inconsistencies O 0 0.09084758162498474
. O 0 0.033892638981342316

Our O 0 0.028815770521759987
data O 0 0.019626762717962265
indicate O 0 0.02195923589169979
that O 0 0.010504672303795815
the O 0 0.02568202093243599
PAH O 1 0.9999998807907104
- O 0 0.34524670243263245
mutation O 0 0.2092927247285843
genotype O 0 0.20533409714698792
is O 0 0.01656295172870159
the O 0 0.011476535350084305
main O 0 0.025649921968579292
determinant O 0 0.09062470495700836
of O 0 0.019921328872442245
metabolic O 1 0.9885381460189819
phenotype O 1 0.9370418190956116
in O 0 0.016457080841064453
most O 0 0.0205365139991045
patients O 1 0.9999997615814209
with O 1 0.8351907134056091
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04694738611578941

In O 0 0.017014155164361
the O 0 0.010530596598982811
present O 0 0.014165252447128296
study O 0 0.019165296107530594
, O 0 0.007545351982116699
the O 0 0.010188336484134197
classification O 0 0.05379221588373184
of O 0 0.018728075549006462
105 O 1 0.9525795578956604
PAH O 1 0.9999997615814209
mutations O 0 0.16712385416030884
may O 0 0.024430589750409126
allow O 0 0.01390030700713396
the O 0 0.011726239696145058
prediction O 0 0.04847807064652443
of O 0 0.009811465628445148
the O 0 0.018679071217775345
biochemical O 0 0.13677285611629486
phenotype O 1 0.5921408534049988
in O 0 0.02947297692298889
> O 0 0.12598568201065063
10 O 0 0.019106172025203705
, O 0 0.015768952667713165
000 O 0 0.06792772561311722
genotypes O 0 0.16197569668293
, O 0 0.014030368998646736
which O 0 0.009873111732304096
may O 0 0.012898591347038746
be O 0 0.005759869702160358
useful O 0 0.01217105332762003
for O 0 0.004964741412550211
the O 0 0.00843871757388115
management O 0 0.039612092077732086
of O 0 0.014865696430206299
hyperphenylalaninemia B-Disease 1 0.9998980760574341
in O 0 0.030106795951724052
newborns O 1 0.9984949827194214
. O 0 0.03261060267686844

Somatic O 0 0.26850229501724243
instability O 0 0.10702181607484818
of O 0 0.013797986321151257
the O 0 0.02123446576297283
CTG O 1 0.9993671774864197
repeat O 0 0.08758561313152313
in O 0 0.020716024562716484
mice O 0 0.13005317747592926
transgenic O 0 0.08495688438415527
for O 0 0.018093708902597427
the O 0 0.03888578712940216
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.07003156840801239
is O 0 0.020261190831661224
age O 0 0.030011747032403946
dependent O 0 0.040054354816675186
but O 0 0.010342433117330074
not O 0 0.00848523061722517
correlated O 0 0.04872531071305275
to O 0 0.009076776914298534
the O 0 0.012370075099170208
relative O 0 0.05168384686112404
intertissue O 1 0.6297792792320251
transcription O 0 0.11357147991657257
levels O 0 0.0619807243347168
and O 0 0.027942126616835594
proliferative O 1 0.9999716281890869
capacities O 0 0.08894897997379303
. O 0 0.03570166975259781

A O 0 0.08023358136415482
( O 0 0.06282512098550797
CTG O 1 0.9949061870574951
) O 0 0.03415997326374054
nexpansion O 0 0.10748949646949768
in O 0 0.009680826216936111
the O 0 0.012619118206202984
3 O 0 0.03669363260269165
- O 0 0.09250093251466751
untranslated O 0 0.1700838953256607
region O 0 0.06573585420846939
( O 0 0.047632280737161636
UTR O 0 0.3462654948234558
) O 0 0.02079315297305584
of O 0 0.011102134361863136
the O 0 0.034290727227926254
DM O 1 0.9999997615814209
protein O 0 0.17612439393997192
kinase O 0 0.31225043535232544
gene O 0 0.13295799493789673
( O 0 0.05113394930958748
DMPK O 1 0.9865103363990784
) O 0 0.02269817143678665
is O 0 0.012543751858174801
responsible O 0 0.02728675864636898
for O 0 0.020387696102261543
causing O 1 0.9997496008872986
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9991199374198914
DM B-Disease 1 1.0
) O 0 0.048815879970788956
. O 0 0.0303783118724823

Major O 0 0.055283598601818085
instability O 0 0.09585053473711014
, O 0 0.011554031632840633
with O 0 0.009356760419905186
very O 0 0.011115559376776218
large O 0 0.013437467627227306
expansions O 0 0.044796478003263474
between O 0 0.013458002358675003
generations O 0 0.030086958780884743
and O 0 0.011041584424674511
high O 0 0.028311660513281822
levels O 0 0.038218338042497635
of O 0 0.017451589927077293
somatic O 0 0.27507808804512024
mosaicism O 1 0.9987142086029053
, O 0 0.017272967845201492
is O 0 0.01243515219539404
observed O 0 0.02661101333796978
in O 0 0.017054682597517967
patients O 1 0.9999532699584961
. O 0 0.02996116876602173

There O 0 0.019210251048207283
is O 0 0.011635049246251583
a O 0 0.015915770083665848
good O 0 0.021121671423316002
correlation O 0 0.04633777216076851
between O 0 0.018641304224729538
repeat O 0 0.07795508950948715
size O 0 0.033167675137519836
( O 0 0.02308952622115612
at O 0 0.01759769581258297
least O 0 0.014641445130109787
in O 0 0.014469582587480545
leucocytes O 1 0.818450927734375
) O 0 0.026778051629662514
, O 0 0.017491403967142105
clinical O 1 0.9989845156669617
severity O 1 0.9979507327079773
and O 0 0.013925179839134216
age O 0 0.027747394517064095
of O 0 0.017690541222691536
onset O 1 0.9999620914459229
. O 0 0.0375097393989563

The O 0 0.050491806119680405
trinucleotide O 1 0.9981709718704224
repeat O 0 0.3002440631389618
instability O 0 0.14560090005397797
mechanisms O 0 0.06180116906762123
involved O 0 0.03338886424899101
in O 0 0.02239898219704628
DM B-Disease 1 1.0
and O 0 0.013575832359492779
other O 0 0.010138534009456635
human O 0 0.053855281323194504
genetic B-Disease 1 0.9999669790267944
diseases I-Disease 1 1.0
are O 0 0.012805996462702751
unknown O 0 0.0361991785466671
. O 0 0.023085961118340492

We O 0 0.028439804911613464
studied O 0 0.048029299825429916
somatic O 0 0.1618291735649109
instability O 0 0.09308508783578873
by O 0 0.01800718531012535
measuring O 0 0.058160778135061264
the O 0 0.02363785356283188
CTG O 1 0.9982424974441528
repeat O 0 0.10019905120134354
length O 0 0.03223049268126488
at O 0 0.015699006617069244
several O 0 0.009135602973401546
ages O 0 0.02898111194372177
in O 0 0.007892828434705734
various O 0 0.009584633633494377
tissues O 0 0.0706028863787651
of O 0 0.014821222983300686
transgenic O 0 0.11221297830343246
mice O 0 0.12877009809017181
carrying O 0 0.04251067340373993
a O 0 0.03166898712515831
( O 0 0.05098394304513931
CTG O 1 0.9978793859481812
) O 0 0.039954885840415955
55expansion O 0 0.1692150980234146
surrounded O 0 0.047938816249370575
by O 0 0.013930208049714565
45 O 0 0.029727425426244736
kb O 0 0.07510880380868912
of O 0 0.009443201124668121
the O 0 0.013305739499628544
human O 0 0.052341967821121216
DM B-Disease 1 1.0
region O 0 0.043446097522974014
, O 0 0.013269166462123394
using O 0 0.01732340082526207
small O 0 0.025364568457007408
- O 0 0.10429592430591583
pool O 0 0.1506095975637436
PCR O 0 0.24391861259937286
. O 0 0.040920693427324295

These O 0 0.023624610155820847
mice O 0 0.11409066617488861
have O 0 0.012006666511297226
been O 0 0.011192443780601025
shown O 0 0.017409540712833405
to O 0 0.008639439009130001
reproduce O 0 0.036834124475717545
the O 0 0.017513543367385864
intergenerational O 0 0.28555160760879517
and O 0 0.01974364183843136
somatic O 0 0.14770133793354034
instability O 0 0.08643504232168198
of O 0 0.010738803073763847
the O 0 0.017450911924242973
55 O 0 0.07541817426681519
CTG O 1 0.9996192455291748
repeat O 0 0.11100711673498154
suggesting O 0 0.04502805694937706
that O 0 0.010615206323564053
surrounding O 0 0.02760648913681507
sequences O 0 0.02837648242712021
and O 0 0.008921732194721699
the O 0 0.012729441747069359
chromatin O 0 0.0836484283208847
environment O 0 0.024780845269560814
are O 0 0.007094933185726404
involved O 0 0.02013389952480793
in O 0 0.014862826094031334
instability O 0 0.1166594848036766
mechanisms O 0 0.07125674933195114
. O 0 0.030092306435108185

As O 0 0.020069198682904243
observed O 0 0.02448880486190319
in O 0 0.006867292802780867
some O 0 0.00524129020050168
of O 0 0.0062317694537341595
the O 0 0.013905472122132778
tissues O 1 0.7892633080482483
of O 0 0.030452482402324677
DM B-Disease 1 1.0
patients O 1 0.9999991655349731
, O 0 0.011982114054262638
there O 0 0.0075681814923882484
is O 0 0.008545614778995514
a O 0 0.014752548187971115
tendency O 0 0.04575657472014427
for O 0 0.012632381170988083
repeat O 0 0.06683617830276489
length O 0 0.03354441374540329
and O 0 0.016821594908833504
somatic O 0 0.17479705810546875
mosaicism O 1 0.99064040184021
to O 0 0.012118143029510975
increase O 0 0.015688061714172363
with O 0 0.007288722321391106
the O 0 0.008520741015672684
age O 0 0.016798745840787888
of O 0 0.006653530523180962
the O 0 0.015391052700579166
mouse O 0 0.11602926254272461
. O 0 0.02852610871195793

Furthermore O 0 0.0645337626338005
, O 0 0.01654776744544506
we O 0 0.012089401483535767
observed O 0 0.02737332507967949
no O 0 0.01297872792929411
correlation O 0 0.05024479702115059
between O 0 0.011581390164792538
the O 0 0.01680859550833702
somatic O 0 0.18954332172870636
mutation O 0 0.17304189503192902
rate O 0 0.04781772568821907
and O 0 0.020433334633708
tissue O 1 0.9970169067382812
proliferation O 0 0.12792886793613434
capacity O 0 0.0406760573387146
. O 0 0.023484323173761368

The O 0 0.04325465112924576
somatic O 0 0.22753167152404785
mutation O 0 0.18705902993679047
rates O 0 0.04729276895523071
in O 0 0.009809938259422779
different O 0 0.009721770882606506
tissues O 0 0.054532524198293686
were O 0 0.006656118202954531
also O 0 0.00801353994756937
not O 0 0.007788513787090778
correlated O 0 0.048210058361291885
to O 0 0.007802227046340704
the O 0 0.013068410567939281
relative O 0 0.043008118867874146
inter O 0 0.37052059173583984
- O 0 0.338966429233551
tissue O 0 0.44754329323768616
difference O 0 0.03163975477218628
in O 0 0.01324248407036066
transcriptional O 0 0.09568780660629272
levels O 0 0.02965688332915306
of O 0 0.006441736128181219
the O 0 0.010002563707530499
three O 0 0.013742746785283089
genes O 0 0.06331328302621841
( O 0 0.042493585497140884
DMAHP O 1 0.9976308345794678
, O 0 0.023317299783229828
DMPK O 1 0.9643193483352661
and O 0 0.016537217423319817
59 O 0 0.045278873294591904
) O 0 0.01850302889943123
surrounding O 0 0.022189611569046974
the O 0 0.013280940242111683
repeat O 0 0.06486677378416061
. O 0 0.015602477826178074
. O 0 0.022565122693777084

A O 0 0.06976423412561417
novel O 0 0.07875316590070724
missense O 0 0.23655132949352264
mutation O 0 0.1830991804599762
in O 0 0.025755904614925385
patients O 1 0.9999184608459473
from O 0 0.019062954932451248
a O 0 0.030955595895648003
retinoblastoma B-Disease 1 0.9999675750732422
pedigree O 1 0.5404229164123535
showing O 0 0.040260206907987595
only O 0 0.015803180634975433
mild O 1 0.9966232776641846
expression O 0 0.03637725114822388
of O 0 0.010307527147233486
the O 0 0.027108943089842796
tumor B-Disease 1 0.9999901056289673
phenotype O 1 0.9938848614692688
. O 0 0.03741007298231125

We O 0 0.017400432378053665
have O 0 0.010775882750749588
used O 0 0.01624816656112671
single O 0 0.0312274768948555
strand O 0 0.12001696228981018
conformation O 0 0.1255834549665451
polymorphism O 0 0.11032714694738388
analysis O 0 0.023461388424038887
to O 0 0.009741237387061119
study O 0 0.019031893461942673
the O 0 0.011197105050086975
27 O 0 0.030013786628842354
exons O 0 0.0742231085896492
of O 0 0.011554651893675327
the O 0 0.026117494329810143
RB1 O 1 0.9999762773513794
gene O 0 0.07889194786548615
in O 0 0.011500600725412369
individuals O 0 0.014131358824670315
from O 0 0.01019768975675106
a O 0 0.01656799390912056
family O 0 0.031469836831092834
showing O 0 0.046745117753744125
mild O 1 0.9963122010231018
expression O 0 0.036100972443819046
of O 0 0.011144659481942654
the O 0 0.02542324922978878
retinoblastoma B-Disease 1 0.9999563694000244
phenotype O 1 0.9946417808532715
. O 0 0.047511640936136246

In O 0 0.01948581077158451
this O 0 0.012278982438147068
family O 0 0.03023352473974228
affected O 0 0.04827821999788284
individuals O 0 0.0280674509704113
developed O 0 0.06382779031991959
unilateral B-Disease 1 0.957411527633667
tumors I-Disease 1 0.9999994039535522
and O 0 0.011633788235485554
, O 0 0.008644581772387028
as O 0 0.006776619236916304
a O 0 0.012441487982869148
result O 0 0.017902348190546036
of O 0 0.01131580863147974
linkage O 0 0.1197286993265152
analysis O 0 0.03531983122229576
, O 0 0.021648209542036057
unaffected O 1 0.8727495670318604
mutation O 0 0.17630654573440552
carriers O 0 0.0681191012263298
were O 0 0.009160065092146397
also O 0 0.009653005748987198
identified O 0 0.021117325872182846
within O 0 0.012589097954332829
the O 0 0.01646745577454567
pedigree O 0 0.12678590416908264
. O 0 0.03545699641108513

A O 0 0.04502324387431145
single O 0 0.036809615790843964
band O 0 0.05591970309615135
shift O 0 0.05404223874211311
using O 0 0.030815187841653824
SSCP O 1 0.8864212036132812
was O 0 0.020461175590753555
identified O 0 0.024921534582972527
in O 0 0.013720931485295296
exon O 0 0.10182416439056396
21 O 0 0.025392048060894012
which O 0 0.009770709089934826
resulted O 0 0.025576893240213394
in O 0 0.01207047887146473
a O 0 0.029084308072924614
missense O 0 0.18198898434638977
mutation O 0 0.14469321072101593
converting O 0 0.06518195569515228
a O 0 0.05356179550290108
cys O 1 0.99998939037323
- O 1 0.994193971157074
- O 1 0.7571955919265747
> O 0 0.46713146567344666
arg O 1 0.902236819267273
at O 0 0.04545818269252777
nucleotide O 0 0.07871583104133606
position O 0 0.024889444932341576
28 O 0 0.022509705275297165
in O 0 0.010263891890645027
the O 0 0.01596342958509922
exon O 0 0.1486676186323166
. O 0 0.03243675082921982

The O 0 0.039297547191381454
mutation O 0 0.15631148219108582
destroyed O 0 0.05755317583680153
an O 0 0.02808045968413353
NdeI O 0 0.48738911747932434
restriction O 0 0.08245596289634705
enzyme O 0 0.11651774495840073
site O 0 0.04020833224058151
. O 0 0.0279639083892107

Analysis O 0 0.030151396989822388
of O 0 0.006473991554230452
all O 0 0.006735132075846195
family O 0 0.019099827855825424
members O 0 0.012510671280324459
demonstrated O 0 0.028491104021668434
that O 0 0.008638793602585793
the O 0 0.01900564879179001
missense O 0 0.25012072920799255
mutation O 1 0.6788467168807983
co O 1 0.9396346211433411
- O 0 0.12196817994117737
segregated O 0 0.10432778298854828
with O 0 0.025196120142936707
patients O 1 0.9999977350234985
with O 0 0.027384990826249123
tumors B-Disease 1 0.9999997615814209
or O 0 0.019208330661058426
who O 0 0.012451834045350552
, O 0 0.007214974611997604
as O 0 0.0057964385487139225
a O 0 0.011890233494341373
result O 0 0.01790250651538372
of O 0 0.010345694608986378
linkage O 0 0.1059313416481018
analysis O 0 0.026184437796473503
had O 0 0.013587075285613537
been O 0 0.011381994932889938
predicted O 0 0.021974055096507072
to O 0 0.008274680003523827
carry O 0 0.019839229062199593
the O 0 0.02398828975856304
predisposing O 1 0.5630958080291748
mutation O 0 0.19040921330451965
. O 0 0.03833489120006561

These O 0 0.01623961701989174
observations O 0 0.028909629210829735
point O 0 0.013073055073618889
to O 0 0.007055368740111589
another O 0 0.013414149172604084
region O 0 0.021273907274007797
of O 0 0.008595048449933529
the O 0 0.024457652121782303
RB1 O 1 0.9999945163726807
gene O 0 0.10844419151544571
where O 0 0.02596105821430683
mutations O 0 0.07260982692241669
only O 0 0.010696815326809883
modify O 0 0.03977816924452782
the O 0 0.011389249935746193
function O 0 0.020504258573055267
of O 0 0.007821704261004925
the O 0 0.013442323543131351
gene O 0 0.06002955511212349
and O 0 0.010127943940460682
raise O 0 0.022597244009375572
important O 0 0.010373245924711227
questions O 0 0.01393818762153387
for O 0 0.010598192922770977
genetic O 0 0.06867465376853943
counseling O 1 0.9872552156448364
in O 0 0.010566788725554943
families O 0 0.01670205593109131
with O 0 0.008398614823818207
these O 0 0.00939952302724123
distinctive O 0 0.07375624775886536
phenotypes O 0 0.2551786005496979
. O 0 0.01944248005747795
. O 0 0.024479243904352188

Maternal B-Disease 1 0.8571439385414124
disomy I-Disease 1 0.9984537363052368
and O 0 0.13478726148605347
Prader B-Disease 1 1.0
- I-Disease 1 0.9999985694885254
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.07765419781208038
with O 0 0.030655693262815475
gamete O 1 0.98276686668396
complementation O 1 0.9993340373039246
in O 0 0.015995308756828308
a O 0 0.016557499766349792
case O 0 0.02269454300403595
of O 0 0.015800584107637405
familial O 1 0.9996907711029053
translocation O 1 0.7010272145271301
( O 0 0.03466366231441498
3 O 0 0.02753230184316635
; O 0 0.016944848001003265
15 O 0 0.022380085662007332
) O 0 0.02631266787648201
( O 0 0.039177533239126205
p25 O 1 0.9870087504386902
; O 0 0.032637521624565125
q11 O 0 0.13001649081707
. O 0 0.016187623143196106
2 O 0 0.02643483690917492
) O 0 0.024259623140096664
. O 0 0.020362701267004013

Maternal B-Disease 1 0.9792982339859009
uniparental I-Disease 1 0.9999583959579468
disomy I-Disease 1 0.9982420206069946
( I-Disease 0 0.09290187805891037
UPD I-Disease 1 0.9999963045120239
) I-Disease 0 0.0320778414607048
for I-Disease 0 0.014949626289308071
chromosome I-Disease 0 0.10459517687559128
15 I-Disease 0 0.020892752334475517
is O 0 0.011808862909674644
responsible O 0 0.018316777423024178
for O 0 0.006955398246645927
an O 0 0.009845509193837643
estimated O 0 0.021219119429588318
30 O 0 0.016696732491254807
% O 0 0.014044082723557949
of O 0 0.0071676974184811115
cases O 0 0.02494753710925579
of O 0 0.02437698282301426
Prader B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9916890263557434
PWS B-Disease 1 1.0
) O 0 0.04372396692633629
. O 0 0.025329533964395523

We O 0 0.015335057862102985
report O 0 0.012119147926568985
on O 0 0.006982467137277126
an O 0 0.009816544130444527
unusual O 0 0.02543872408568859
case O 0 0.02032880112528801
of O 0 0.01357377041131258
maternal B-Disease 0 0.2865108847618103
disomy I-Disease 1 0.9489505290985107
15 I-Disease 0 0.029783548787236214
in O 0 0.021876541897654533
PWS B-Disease 1 1.0
that O 0 0.012164621613919735
is O 0 0.010067303664982319
most O 0 0.008275600150227547
consistent O 0 0.023980142548680305
with O 0 0.011343340389430523
adjacent O 0 0.03857869654893875
- O 0 0.0686778798699379
1 O 0 0.030731091275811195
segregation O 0 0.05555170401930809
of O 0 0.01116221584379673
a O 0 0.028056200593709946
paternal O 0 0.24782027304172516
t O 1 0.9221797585487366
( O 0 0.03313048556447029
3 O 0 0.026075206696987152
; O 0 0.017171461135149002
15 O 0 0.022872185334563255
) O 0 0.026012873277068138
( O 0 0.039866261184215546
p25 O 1 0.9838416576385498
; O 0 0.03389999270439148
q11 O 0 0.13795432448387146
. O 0 0.014895262196660042
2 O 0 0.021697795018553734
) O 0 0.015920491889119148
with O 0 0.011141239665448666
simultaneous O 0 0.05605261027812958
maternal O 0 0.19605788588523865
meiotic O 1 0.9870460033416748
nondisjunction O 1 0.6034841537475586
for O 0 0.023204898461699486
chromosome O 0 0.13195256888866425
15 O 0 0.031359028071165085
. O 0 0.024040045216679573

The O 0 0.048145752400159836
patient O 1 0.9994027614593506
( O 0 0.058986302465200424
J O 1 0.9986032843589783
. O 0 0.020356012508273125
B O 0 0.0812331810593605
. O 0 0.010122448205947876
) O 0 0.011561412364244461
, O 0 0.007990489713847637
a O 0 0.014030290767550468
17 O 0 0.02763611637055874
- O 0 0.07077290117740631
year O 0 0.03031792864203453
- O 0 0.07692385464906693
old O 0 0.046875305473804474
white O 0 0.05840284377336502
male O 0 0.06823139637708664
with O 0 0.029911886900663376
PWS B-Disease 1 1.0
, O 0 0.014281945303082466
was O 0 0.013331870548427105
found O 0 0.010981799103319645
to O 0 0.007394888903945684
have O 0 0.008668553084135056
47 O 0 0.03331342712044716
chromosomes O 0 0.04201143607497215
with O 0 0.012730825692415237
a O 0 0.02706984430551529
supernumerary O 0 0.18396010994911194
, O 0 0.028006156906485558
paternal O 0 0.21567317843437195
der O 1 0.9492623805999756
( O 0 0.027830125764012337
15 O 0 0.019362740218639374
) O 0 0.01397490780800581
consisting O 0 0.013660131022334099
of O 0 0.005987465847283602
the O 0 0.011158126406371593
short O 0 0.0333014540374279
arm O 0 0.34001395106315613
and O 0 0.010562727227807045
the O 0 0.01579718291759491
proximal O 1 0.9900885224342346
long O 0 0.04403547942638397
arm O 0 0.19369208812713623
of O 0 0.014502367004752159
chromosome O 0 0.1121387630701065
15 O 0 0.023068279027938843
, O 0 0.012698222883045673
and O 0 0.018216583877801895
distal O 1 0.997534990310669
chromosome O 1 0.6010864973068237
arm O 1 0.9979560375213623
3p O 1 0.9988044500350952
. O 0 0.04307350143790245

The O 0 0.04271847382187843
t O 1 0.7282971739768982
( O 0 0.036645714193582535
3 O 0 0.026331406086683273
; O 0 0.016467828303575516
15 O 0 0.01757192052900791
) O 0 0.013682770542800426
was O 0 0.010699566453695297
present O 0 0.010098281316459179
in O 0 0.006034629885107279
the O 0 0.0084583954885602
balanced O 0 0.027556631714105606
state O 0 0.009785816073417664
in O 0 0.00809217244386673
the O 0 0.014402228407561779
patients O 1 0.9999910593032837
father O 0 0.024517910555005074
and O 0 0.009095224551856518
a O 0 0.019495680928230286
sister O 0 0.05308522284030914
. O 0 0.026831330731511116

Fluorescent O 0 0.18952789902687073
in O 0 0.032481394708156586
situ O 0 0.19034463167190552
hybridization O 0 0.11860743910074234
analysis O 0 0.03730860352516174
demonstrated O 0 0.037397351115942
that O 0 0.009677086025476456
the O 0 0.023980576545000076
PWS B-Disease 1 0.9999998807907104
critical O 0 0.056622933596372604
region O 0 0.03564086928963661
resided O 0 0.04842524230480194
on O 0 0.008924921974539757
the O 0 0.013935423456132412
derivative O 0 0.0924144983291626
chromosome O 0 0.10987816751003265
3 O 0 0.019940223544836044
and O 0 0.0063841454684734344
that O 0 0.005278969649225473
there O 0 0.006894050166010857
was O 0 0.012569734826683998
no O 0 0.01254951674491167
deletion O 0 0.0723850280046463
of O 0 0.010834196582436562
the O 0 0.024619463831186295
PWS B-Disease 1 0.9999998807907104
region O 0 0.035413406789302826
on O 0 0.009211311116814613
the O 0 0.010766801424324512
normal O 0 0.03175920248031616
pair O 0 0.028738463297486305
of O 0 0.011215582489967346
15s O 0 0.15925461053848267
present O 0 0.022186068817973137
in O 0 0.02139364555478096
J O 1 0.9984869956970215
. O 0 0.03405298665165901

B O 0 0.23192891478538513
. O 0 0.04130900651216507

Methylation O 0 0.16043579578399658
analysis O 0 0.046152759343385696
at O 0 0.027431504800915718
exon O 0 0.10929078608751297
alpha O 0 0.048742324113845825
of O 0 0.008288548327982426
the O 0 0.011908422224223614
small O 0 0.02726065181195736
nuclear O 0 0.08199115097522736
ribonucleoprotein O 1 0.9986516833305359
- O 0 0.12590591609477997
associated O 0 0.06310970336198807
polypeptide O 0 0.19156523048877716
N O 0 0.14302189648151398
( O 0 0.057689499109983444
SNRPN O 1 0.9912968873977661
) O 0 0.03815611079335213
gene O 0 0.06886790692806244
showed O 0 0.033908501267433167
a O 0 0.022087205201387405
pattern O 0 0.05437011271715164
characteristic O 0 0.03555743396282196
of O 0 0.00679864501580596
only O 0 0.0073721944354474545
the O 0 0.01326457317918539
maternal O 0 0.12458812445402145
chromosome O 0 0.1189541444182396
15 O 0 0.026397880166769028
in O 0 0.02009858749806881
J O 1 0.9983214735984802
. O 0 0.03504228964447975

B O 0 0.2858211100101471
. O 0 0.0468243844807148

Maternal B-Disease 1 0.6536799669265747
disomy I-Disease 1 0.6443852186203003
was O 0 0.03397778049111366
confirmed O 0 0.038724496960639954
by O 0 0.021351374685764313
polymerase O 0 0.1618538349866867
chain O 0 0.09675639122724533
reaction O 0 0.07275699079036713
analysis O 0 0.025875339284539223
of O 0 0.0145806185901165
microsatellite O 0 0.22468321025371552
repeats O 0 0.09097851067781448
at O 0 0.026148002594709396
the O 0 0.023157143965363503
gamma O 0 0.1810750663280487
- O 0 0.16236372292041779
aminobutyric O 1 0.6331610679626465
acid O 0 0.33610600233078003
receptor O 0 0.29406309127807617
beta3 O 0 0.2751941978931427
subunit O 0 0.1889498084783554
( O 0 0.062495529651641846
GABRB3 O 1 0.9816581010818481
) O 0 0.04223103076219559
locus O 0 0.15631358325481415
. O 0 0.035727109760046005

A O 0 0.06925627589225769
niece O 0 0.22099876403808594
( O 0 0.048067357391119
B O 0 0.1717679649591446
. O 0 0.016862578690052032
B O 0 0.08696173876523972
. O 0 0.011199427768588066
) O 0 0.013894372619688511
with O 0 0.010443015955388546
45 O 0 0.024095559492707253
chromosomes O 0 0.042535070329904556
and O 0 0.009313567541539669
the O 0 0.013779847882688046
derivative O 0 0.08045791834592819
3 O 0 0.02060246840119362
but O 0 0.008500609546899796
without O 0 0.01172606460750103
the O 0 0.014631884172558784
der O 1 0.8606906533241272
( O 0 0.02910454384982586
15 O 0 0.022999944165349007
) O 0 0.019594885408878326
demonstrated O 0 0.03626270592212677
a O 0 0.024287037551403046
phenotype O 1 0.5373736619949341
consistent O 0 0.03921731561422348
with O 0 0.009650608524680138
that O 0 0.008132893592119217
reported O 0 0.021599415689706802
for O 0 0.011738138273358345
haploinsufficiency O 0 0.14115473628044128
of O 0 0.01616682857275009
distal O 1 0.9935110211372375
3 O 0 0.05146760493516922
p O 0 0.14448687434196472
. O 0 0.02827518992125988

Uniparental B-Disease 1 0.9999979734420776
disomy I-Disease 1 0.9995115995407104
associated O 0 0.049633145332336426
with O 0 0.0203398410230875
unbalanced O 0 0.33389371633529663
segregation O 0 0.07931357622146606
of O 0 0.016209006309509277
non O 0 0.06067829206585884
- O 0 0.30835267901420593
Robertsonian O 1 0.9795756936073303
translocations O 0 0.206148162484169
has O 0 0.02030661515891552
been O 0 0.014291523024439812
reported O 0 0.023429566994309425
previously O 0 0.016525574028491974
but O 0 0.008387407287955284
has O 0 0.009027485735714436
not O 0 0.0051491353660821915
, O 0 0.0053104315884411335
to O 0 0.00504702515900135
our O 0 0.007307661231607199
knowledge O 0 0.013572180643677711
, O 0 0.007188599556684494
been O 0 0.009973922744393349
observed O 0 0.019384019076824188
in O 0 0.0073073385283350945
a O 0 0.014475282281637192
case O 0 0.02295815199613571
of O 0 0.024347346276044846
PWS B-Disease 1 1.0
. O 0 0.04268418624997139

Furthermore O 0 0.06375432014465332
, O 0 0.015279427170753479
our O 0 0.0124974949285388
findings O 0 0.020792266353964806
are O 0 0.005560153163969517
best O 0 0.013315759599208832
interpreted O 0 0.022301826626062393
as O 0 0.012928229756653309
true O 0 0.03987716883420944
gamete O 1 0.913334846496582
complementation O 1 0.9993976354598999
resulting O 0 0.06712459027767181
in O 0 0.024697747081518173
maternal B-Disease 1 0.9879990816116333
UPD I-Disease 1 0.9999983310699463
15 I-Disease 0 0.05606405809521675
and O 0 0.03958038240671158
PWS B-Disease 1 0.9999997615814209

Schwartz B-Disease 1 0.9997542500495911
- I-Disease 1 0.9995662569999695
Jampel I-Disease 1 0.999990701675415
syndrome I-Disease 1 1.0
type I-Disease 0 0.1245383620262146
2 I-Disease 0 0.027995876967906952
and O 0 0.017922814935445786
Stuve B-Disease 1 0.9999966621398926
- I-Disease 1 0.9999494552612305
Wiedemann I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
: O 0 0.027264757081866264
a O 0 0.015446189790964127
case O 0 0.017125217244029045
for O 0 0.010183212347328663
" O 0 0.0191523227840662
lumping O 0 0.12015150487422943
" O 0 0.029489312320947647
. O 0 0.027334993705153465

Recent O 0 0.050024379044771194
studies O 0 0.03586621582508087
demonstrated O 0 0.030709905549883842
the O 0 0.009146627970039845
existence O 0 0.018658258020877838
of O 0 0.007893776521086693
a O 0 0.01706351898610592
genetically O 0 0.04094884917140007
distinct O 0 0.030628792941570282
, O 0 0.014338498935103416
usually O 0 0.022972488775849342
lethal O 0 0.06907952576875687
form O 0 0.01572885550558567
of O 0 0.007753830868750811
the O 0 0.020391495898365974
Schwartz B-Disease 1 0.9999547004699707
- I-Disease 1 0.9998658895492554
Jampel I-Disease 1 0.9999977350234985
syndrome I-Disease 1 1.0
( O 1 0.6818315982818604
SJS B-Disease 1 0.9999998807907104
) O 0 0.036640726029872894
of O 0 0.022073717787861824
myotonia B-Disease 1 0.9999992847442627
and O 0 0.03407130390405655
skeletal B-Disease 1 0.9999988079071045
dysplasia I-Disease 1 1.0
, O 0 0.013922651298344135
which O 0 0.01068176794797182
we O 0 0.014382436871528625
called O 0 0.04531924054026604
SJS B-Disease 1 0.9999995231628418
type I-Disease 0 0.08514618128538132
2 I-Disease 0 0.03628798946738243
. O 0 0.02810913510620594

This O 0 0.04484100639820099
disorder O 1 0.9999865293502808
is O 0 0.020265597850084305
reminiscent O 0 0.047540005296468735
of O 0 0.009262187406420708
another O 0 0.023947741836309433
rare O 0 0.052942242473363876
condition O 1 0.9513452053070068
, O 0 0.014032519422471523
the O 0 0.021456895396113396
Stuve B-Disease 1 0.9999973773956299
- I-Disease 1 0.9999403953552246
Wiedemann I-Disease 1 0.9999982118606567
syndrome I-Disease 1 1.0
( O 0 0.09032952785491943
SWS B-Disease 1 0.9999942779541016
) O 0 0.02476724050939083
, O 0 0.0106948371976614
which O 0 0.010251959785819054
comprises O 0 0.036104217171669006
campomelia B-Disease 0 0.45946601033210754
at O 0 0.029552174732089043
birth O 0 0.04907815158367157
with O 0 0.024783726781606674
skeletal B-Disease 1 0.9999995231628418
dysplasia I-Disease 1 1.0
, O 0 0.03477509319782257
contractures B-Disease 1 0.9999954700469971
, O 0 0.013703648932278156
and O 0 0.009669695980846882
early B-Disease 0 0.02320495806634426
death I-Disease 0 0.04021402820944786
. O 0 0.024924295023083687

To O 0 0.02218392863869667
test O 0 0.03653011843562126
for O 0 0.011907237581908703
possible O 0 0.026317019015550613
nosologic O 0 0.4846009910106659
identity O 0 0.029284987598657608
between O 0 0.014192752540111542
these O 0 0.012934455648064613
disorders O 1 0.9999994039535522
, O 0 0.010541075840592384
we O 0 0.006635371129959822
reviewed O 0 0.01511403825134039
the O 0 0.006762057542800903
literature O 0 0.010583702474832535
and O 0 0.005272440612316132
obtained O 0 0.01128070056438446
a O 0 0.011095366440713406
follow O 0 0.02015269175171852
- O 0 0.03657713532447815
up O 0 0.008890695869922638
of O 0 0.004547894466668367
the O 0 0.006807019002735615
only O 0 0.006184689700603485
two O 0 0.008630067110061646
surviving O 0 0.06641904264688492
patients O 1 0.9999105930328369
, O 0 0.011802230961620808
one O 0 0.012708926573395729
with O 0 0.02431328408420086
SJS B-Disease 1 0.9999992847442627
type I-Disease 0 0.08038373291492462
2 I-Disease 0 0.026067670434713364
at O 0 0.01695912703871727
age O 0 0.020625054836273193
10 O 0 0.010380150750279427
years O 0 0.008618325926363468
and O 0 0.00702950032427907
another O 0 0.017198367044329643
with O 0 0.017497273162007332
SWS B-Disease 1 0.9999699592590332
at O 0 0.031776949763298035
age O 0 0.031130488961935043
7 O 0 0.022153222933411598
years O 0 0.017983902245759964
. O 0 0.024175358936190605

Patients O 1 0.9999793767929077
reported O 0 0.03878992423415184
as O 0 0.01280937809497118
having O 0 0.02877119928598404
either O 0 0.05291761830449104
neonatal O 1 1.0
SJS B-Disease 1 0.9999998807907104
or O 0 0.049500271677970886
SWS B-Disease 1 0.9999350309371948
presented O 0 0.026159366592764854
a O 0 0.01796368509531021
combination O 0 0.04249053820967674
of O 0 0.008073943667113781
a O 0 0.023997262120246887
severe O 1 0.9999959468841553
, O 0 0.03432060033082962
prenatal O 1 0.9999998807907104
- O 1 0.9999953508377075
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.08764784783124924
with O 0 0.04125353693962097
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999438524246216
contractures I-Disease 1 1.0
, O 1 0.6061263680458069
respiratory O 1 1.0
and O 0 0.01831180416047573
feeding O 0 0.08338715881109238
difficulties O 0 0.3947715163230896
, O 0 0.015680067241191864
tendency O 0 0.06602666527032852
to O 0 0.0208292156457901
hyperthermia B-Disease 1 0.9999991655349731
, O 0 0.014294289983808994
and O 0 0.010179777629673481
frequent O 0 0.052970435470342636
death O 0 0.03246912360191345
in O 0 0.014071384444832802
infancy O 0 0.16845236718654633
) O 0 0.015795957297086716
with O 0 0.009107735939323902
a O 0 0.017612406983971596
distinct O 0 0.051912982016801834
campomelic B-Disease 1 0.9997932314872742
- I-Disease 1 0.9963701963424683
metaphyseal I-Disease 1 0.9997878670692444
skeletal I-Disease 1 0.9999924898147583
dysplasia I-Disease 1 0.9999998807907104
. O 0 0.048574093729257584

The O 0 0.0234666895121336
similarity O 0 0.03598182275891304
of O 0 0.009553969837725163
the O 0 0.015683555975556374
clinical O 1 0.9986347556114197
and O 0 0.015398822724819183
radiographic O 1 0.9995137453079224
findings O 0 0.03769303858280182
is O 0 0.012499913573265076
so O 0 0.010274462401866913
extensive O 0 0.022164519876241684
that O 0 0.008705543354153633
these O 0 0.01239079050719738
disorders O 1 0.9999983310699463
appear O 0 0.016614330932497978
to O 0 0.006070811301469803
be O 0 0.005461437162011862
a O 0 0.011171223595738411
single O 0 0.02419288270175457
entity O 0 0.053153231739997864
. O 0 0.027628419920802116

The O 0 0.026744944974780083
follow O 0 0.03669110685586929
- O 0 0.06185786426067352
up O 0 0.020564725622534752
observation O 0 0.049656011164188385
of O 0 0.007971510291099548
an O 0 0.011542117223143578
identical O 0 0.025545908138155937
and O 0 0.010388039983808994
unique O 0 0.02412252500653267
pattern O 0 0.0486990325152874
of O 0 0.01554140169173479
progressive O 1 0.9993829727172852
bone B-Disease 1 0.9999997615814209
dysplasia I-Disease 1 1.0
in O 0 0.014561476185917854
the O 0 0.011262770742177963
two O 0 0.014351929537951946
patients O 1 0.9999756813049316
( O 0 0.022311653941869736
one O 0 0.013755329884588718
with O 0 0.022131698206067085
SJS B-Disease 1 0.9999990463256836
type I-Disease 0 0.06722556054592133
2 I-Disease 0 0.020801721140742302
, O 0 0.00985210295766592
one O 0 0.010079109109938145
with O 0 0.019087668508291245
SWS B-Disease 1 0.9999046325683594
) O 0 0.03640447184443474
surviving O 0 0.054573167115449905
beyond O 0 0.04198124259710312
infancy O 1 0.6301781535148621
adds O 0 0.037174757570028305
to O 0 0.007596092764288187
the O 0 0.00759580172598362
evidence O 0 0.012095934711396694
in O 0 0.008195767179131508
favor O 0 0.01649908907711506
of O 0 0.008875674568116665
identity O 0 0.03568844497203827
. O 0 0.025851568207144737

The O 0 0.03380806744098663
hypothesis O 0 0.09175845235586166
that O 0 0.026164842769503593
SWS B-Disease 1 0.9999823570251465
and O 0 0.040394026786088943
SJS B-Disease 1 0.9999996423721313
type I-Disease 0 0.06764989346265793
2 I-Disease 0 0.018008537590503693
are O 0 0.005784546956419945
the O 0 0.010676921345293522
same O 0 0.027082126587629318
disorder O 1 0.9999971389770508
should O 0 0.01527330745011568
be O 0 0.009731489233672619
testable O 0 0.055104635655879974
by O 0 0.012989422306418419
molecular O 0 0.04683087393641472
methods O 0 0.023701416328549385
. O 0 0.013265852816402912
. O 0 0.02122701331973076

A O 0 0.06432593613862991
mouse O 0 0.12726713716983795
model O 0 0.04605758935213089
of O 0 0.022387033328413963
severe O 1 0.9999998807907104
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.20105122029781342
defects O 1 0.999901294708252
in O 0 0.025053907185792923
hemostasis O 1 0.9999992847442627
and O 0 0.036786895245313644
thrombosis B-Disease 1 1.0
. O 0 0.038487013429403305

von B-Disease 1 0.990829586982727
Willebrand I-Disease 1 0.9999669790267944
factor I-Disease 0 0.29410597681999207
( I-Disease 0 0.07877326011657715
vWf I-Disease 1 0.9999817609786987
) I-Disease 1 0.9981295466423035
deficiency I-Disease 1 1.0
causes O 1 0.9999997615814209
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.02425440400838852
humans O 0 0.055959075689315796
. O 0 0.028209157288074493

We O 0 0.02513519674539566
generated O 0 0.03788074478507042
a O 0 0.023723430931568146
mouse O 0 0.09034249931573868
model O 0 0.03093649260699749
for O 0 0.010529921390116215
this O 0 0.013917447067797184
disease O 1 0.9999687671661377
by O 0 0.015267736278474331
using O 0 0.02738751843571663
gene O 0 0.09532717615365982
targeting O 0 0.07709047198295593
. O 0 0.029423000290989876

vWf B-Disease 1 0.9995850920677185
- I-Disease 1 0.9641517400741577
deficient I-Disease 1 0.9978943467140198
mice O 0 0.18632853031158447
appeared O 0 0.0450410321354866
normal O 0 0.043511226773262024
at O 0 0.02446824684739113
birth O 0 0.04294782876968384
; O 0 0.012786461040377617
they O 0 0.006654564756900072
were O 0 0.009268539026379585
viable O 0 0.0459226593375206
and O 0 0.014459794387221336
fertile O 0 0.09806933999061584
. O 0 0.03339353948831558

Neither O 0 0.1310465931892395
vWf O 1 0.9655957221984863
nor O 0 0.12167726457118988
vWf O 1 0.9886847138404846
propolypeptide O 1 0.9884045124053955
( O 0 0.09202727675437927
von B-Disease 1 0.9970648884773254
Willebrand I-Disease 1 0.9999984502792358
antigen O 1 0.9997747540473938
II O 1 0.8906703591346741
) O 0 0.023580534383654594
were O 0 0.01257550809532404
detectable O 0 0.09791367501020432
in O 0 0.020642457529902458
plasma O 0 0.11635134369134903
, O 0 0.02290000207722187
platelets O 1 0.9480496644973755
, O 0 0.018969833850860596
or O 0 0.027479926124215126
endothelial O 1 0.9991445541381836
cells O 0 0.06364196538925171
of O 0 0.008295147679746151
the O 0 0.018225722014904022
homozygous O 0 0.15463091433048248
mutant O 0 0.17666181921958923
mice O 0 0.20837265253067017
. O 0 0.03816818445920944

The O 0 0.0382634773850441
mutant O 0 0.176273375749588
mice O 1 0.626318097114563
exhibited O 1 0.5306574106216431
defects O 1 0.9964942336082458
in O 0 0.021175099536776543
hemostasis O 1 0.9999433755874634
with O 0 0.012508981861174107
a O 0 0.020922383293509483
highly O 0 0.05484044924378395
prolonged O 1 0.9999768733978271
bleeding O 1 0.9999995231628418
time O 0 0.021443475037813187
and O 0 0.01743179000914097
spontaneous O 0 0.3342559039592743
bleeding O 1 0.9999767541885376
events O 0 0.022100485861301422
in O 0 0.009250297211110592
approximately O 0 0.0212850458920002
10 O 0 0.01618250645697117
% O 0 0.020373167470097542
of O 0 0.01660800725221634
neonates O 1 0.9950392842292786
. O 0 0.034975577145814896

As O 0 0.013148552738130093
in O 0 0.009219430387020111
the O 0 0.012003397569060326
human O 0 0.04440708085894585
disease O 1 0.9999995231628418
, O 0 0.011117970570921898
the O 0 0.01475711539387703
factor O 0 0.06893715262413025
VIII O 1 0.9874775409698486
level O 0 0.026808317750692368
in O 0 0.009013197384774685
these O 0 0.008848719298839569
mice O 0 0.09406822919845581
was O 0 0.0182445477694273
reduced O 0 0.030096188187599182
strongly O 0 0.020629527047276497
as O 0 0.006536310072988272
a O 0 0.0101129449903965
result O 0 0.01133793592453003
of O 0 0.005227896850556135
the O 0 0.00943829957395792
lack O 0 0.022961152717471123
of O 0 0.00879831612110138
protection O 0 0.03263543173670769
provided O 0 0.02459801360964775
by O 0 0.018728062510490417
vWf O 1 0.9532776474952698
. O 0 0.03998364880681038

Defective O 1 0.9998059868812561
thrombosis B-Disease 1 0.9999997615814209
in O 0 0.03341641277074814
mutant O 0 0.1451389342546463
mice O 0 0.13818669319152832
was O 0 0.0179462730884552
also O 0 0.010663633234798908
evident O 0 0.023569168522953987
in O 0 0.006829660851508379
an O 0 0.008655614219605923
in O 0 0.011748706921935081
vivo O 0 0.13611388206481934
model O 0 0.03942330181598663
of O 0 0.02319028042256832
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999914169311523
. O 0 0.034488923847675323

In O 0 0.01858709752559662
this O 0 0.011273358017206192
model O 0 0.027272047474980354
, O 0 0.010551802814006805
the O 0 0.01594400964677334
exteriorized O 1 0.7381558418273926
mesentery O 1 0.9701746106147766
was O 0 0.03663552924990654
superfused O 1 0.9598243832588196
with O 0 0.02711261436343193
ferric O 1 0.9999909400939941
chloride O 1 0.9851131439208984
and O 0 0.012224819511175156
the O 0 0.014707328751683235
accumulation O 0 0.09869521856307983
of O 0 0.020372863858938217
fluorescently O 1 0.9744812250137329
labeled O 0 0.13235746324062347
platelets O 1 0.8343307375907898
was O 0 0.028068477287888527
observed O 0 0.034136299043893814
by O 0 0.018814828246831894
intravital O 1 0.5286374092102051
microscopy O 0 0.16660359501838684
. O 0 0.03653452545404434

We O 0 0.023526983335614204
conclude O 0 0.04357219114899635
that O 0 0.00849794503301382
these O 0 0.0095943883061409
mice O 0 0.09212231636047363
very O 0 0.019207462668418884
closely O 0 0.04148799926042557
mimic O 1 0.9995864033699036
severe O 1 0.9999994039535522
human O 1 0.9885822534561157
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.011382724158465862
will O 0 0.007649384438991547
be O 0 0.006317881401628256
very O 0 0.008989283815026283
useful O 0 0.012897870503365993
for O 0 0.006944627035409212
investigating O 0 0.027257636189460754
the O 0 0.009330151602625847
role O 0 0.01991664059460163
of O 0 0.012932191602885723
vWf O 1 0.7833812832832336
in O 0 0.017110072076320648
normal O 0 0.046402737498283386
physiology O 0 0.35826969146728516
and O 0 0.01184740848839283
in O 0 0.01900331676006317
disease O 1 0.9999991655349731
models O 0 0.03837928548455238
. O 0 0.013159893453121185
. O 0 0.020818963646888733

Oral O 1 0.7751704454421997
contraceptives O 1 0.7014613747596741
and O 0 0.011318464763462543
the O 0 0.01377725601196289
risk O 1 0.9895226359367371
of O 0 0.026719287037849426
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04054027423262596

Hereditary B-Disease 1 0.9999998807907104
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999761581420898
Study O 0 0.04788045957684517
Group O 0 0.041931841522455215
. O 0 0.026448069140315056

BACKGROUND O 0 0.08835490792989731
Women O 0 0.03721343353390694
with O 0 0.018154632300138474
mutations O 0 0.07629963010549545
in O 0 0.010387490503489971
either O 0 0.01393852848559618
the O 0 0.0161959957331419
BRCA1 O 1 0.9969624876976013
or O 0 0.022281957790255547
the O 0 0.022427603602409363
BRCA2 O 1 0.9990354776382446
gene O 0 0.07653827965259552
have O 0 0.011514659970998764
a O 0 0.01711454428732395
high O 0 0.033387817442417145
lifetime O 1 0.9357790350914001
risk O 1 0.9993768334388733
of O 0 0.03720426931977272
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04231880605220795

Oral O 1 0.9717931747436523
contraceptives O 1 0.9990131855010986
protect O 0 0.450400710105896
against O 1 0.9438247680664062
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.012881754897534847
general O 0 0.013090446591377258
, O 0 0.00804536696523428
but O 0 0.007100461050868034
it O 0 0.005871825851500034
is O 0 0.007149811834096909
not O 0 0.006200545933097601
known O 0 0.01096915453672409
whether O 0 0.00885747093707323
they O 0 0.005218503996729851
also O 0 0.008025034330785275
protect O 0 0.023950571194291115
against O 0 0.01856870949268341
hereditary B-Disease 1 0.9867358803749084
forms I-Disease 0 0.0407322458922863
of I-Disease 0 0.05347632244229317
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.044226616621017456

METHODS O 0 0.06342575699090958
We O 0 0.02381209470331669
enrolled O 0 0.08140604197978973
207 O 0 0.20213982462882996
women O 0 0.044936083257198334
with O 0 0.03672661632299423
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.016723355278372765
161 O 0 0.04859178140759468
of O 0 0.006494259927421808
their O 0 0.0074977995827794075
sisters O 0 0.03181852400302887
as O 0 0.008933057077229023
controls O 0 0.024496302008628845
in O 0 0.007506547495722771
a O 0 0.01536643784493208
case O 0 0.026843588799238205
- O 0 0.06989123672246933
control O 0 0.043890226632356644
study O 0 0.03527010604739189
. O 0 0.02787994034588337

All O 0 0.015238155610859394
the O 0 0.019691385328769684
patients O 1 0.9990911483764648
carried O 0 0.029456254094839096
a O 0 0.02983388863503933
pathogenic O 0 0.12709060311317444
mutation O 0 0.13157033920288086
in O 0 0.01941751502454281
either O 0 0.037828922271728516
BRCA1 O 1 0.9974225759506226
( O 0 0.042695384472608566
179 O 0 0.09777004271745682
women O 0 0.04340975359082222
) O 0 0.028298215940594673
or O 0 0.02997184917330742
BRCA2 O 1 0.999087929725647
( O 0 0.0366547629237175
28 O 0 0.03050955757498741
women O 0 0.032744329422712326
) O 0 0.025639405474066734
. O 0 0.021087458357214928

The O 0 0.026135997846722603
control O 0 0.04003268852829933
women O 0 0.026870008558034897
were O 0 0.010874083265662193
enrolled O 0 0.04470720514655113
regardless O 0 0.021869972348213196
of O 0 0.006251494400203228
whether O 0 0.011531355790793896
or O 0 0.010203682817518711
not O 0 0.005624973680824041
they O 0 0.006493392400443554
had O 0 0.0156929362565279
either O 0 0.023933278396725655
mutation O 0 0.139974907040596
. O 0 0.033355239778757095

Lifetime O 0 0.11639267951250076
histories O 0 0.0637793242931366
of O 0 0.014240668155252934
oral O 1 0.9929185509681702
- O 1 0.868578314781189
contraceptive O 1 0.9961885809898376
use O 0 0.017556458711624146
were O 0 0.007197534665465355
obtained O 0 0.013376251794397831
by O 0 0.009359501302242279
interview O 0 0.025885188952088356
or O 0 0.011376823298633099
by O 0 0.007833357900381088
written O 0 0.011473333463072777
questionnaire O 0 0.049605898559093475
and O 0 0.007587991654872894
were O 0 0.006970416288822889
compared O 0 0.022024577483534813
between O 0 0.016163719817996025
patients O 1 0.999964714050293
and O 0 0.010565518401563168
control O 0 0.02795894630253315
women O 0 0.02392919361591339
, O 0 0.010201574303209782
after O 0 0.017441650852560997
adjustment O 0 0.04257388412952423
for O 0 0.007875126786530018
year O 0 0.011897961609065533
of O 0 0.008553270250558853
birth O 0 0.04255805164575577
and O 0 0.01639680378139019
parity O 0 0.09574802219867706
. O 0 0.027626343071460724

RESULTS O 0 0.054019227623939514
The O 0 0.01671387068927288
adjusted O 0 0.056559134274721146
odds O 0 0.08999130129814148
ratio O 0 0.10770522803068161
for O 0 0.1545090675354004
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.025067612528800964
with O 0 0.007221131585538387
any O 0 0.006661180406808853
past O 0 0.010683883912861347
use O 0 0.00967433676123619
of O 0 0.008771402761340141
oral O 0 0.1298181712627411
contraceptives O 1 0.891934871673584
was O 0 0.030667047947645187
0 O 0 0.058232951909303665
. O 0 0.026326844468712807

5 O 0 0.048782944679260254
( O 0 0.030702920630574226
95 O 0 0.044425543397665024
percent O 0 0.027652090415358543
confidence O 0 0.04559044539928436
interval O 0 0.06729980558156967
, O 0 0.016500869765877724
0 O 0 0.03534107655286789
. O 0 0.009557601995766163
3 O 0 0.01485907007008791
to O 0 0.010082987137138844
0 O 0 0.03476986661553383
. O 0 0.011375696398317814
8 O 0 0.02912127785384655
) O 0 0.024109236896038055
. O 0 0.024709878489375114

The O 0 0.037021711468696594
risk O 1 0.8442628979682922
decreased O 0 0.06652899086475372
with O 0 0.012853698804974556
increasing O 0 0.02737382799386978
duration O 0 0.04992987588047981
of O 0 0.007872805930674076
use O 0 0.019053714349865913
( O 0 0.033058200031518936
P O 1 0.5726335644721985
for O 0 0.015347135253250599
trend O 0 0.05757040157914162
, O 0 0.024021711200475693
< O 0 0.14904028177261353
0 O 0 0.052532318979501724
. O 0 0.019411947578191757
001 O 0 0.3068180978298187
) O 0 0.019495857879519463
; O 0 0.011148369871079922
use O 0 0.008259211666882038
for O 0 0.0067963991314172745
six O 0 0.012371293269097805
or O 0 0.009854596108198166
more O 0 0.006495444569736719
years O 0 0.010535615496337414
was O 0 0.011401541531085968
associated O 0 0.013349325396120548
with O 0 0.008286325260996819
a O 0 0.015179229900240898
60 O 0 0.030891668051481247
percent O 0 0.030210506170988083
reduction O 0 0.06138516217470169
in O 0 0.01959974691271782
risk O 1 0.7792649269104004
. O 0 0.027387073263525963

Oral O 1 0.9863826036453247
- O 1 0.8307539820671082
contraceptive O 1 0.9977219700813293
use O 0 0.034169312566518784
protected O 0 0.17915794253349304
against O 1 0.560754120349884
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.011021223850548267
for O 0 0.008532753214240074
carriers O 0 0.04861341044306755
of O 0 0.012148234993219376
the O 0 0.026146315038204193
BRCA1 O 1 0.9982397556304932
mutation O 0 0.23214669525623322
( O 0 0.04475688934326172
odds O 0 0.09075165539979935
ratio O 0 0.05799181014299393
, O 0 0.014990239404141903
0 O 0 0.03576665744185448
. O 0 0.010427465662360191
5 O 0 0.018177585676312447
; O 0 0.014570092782378197
95 O 0 0.035632167011499405
percent O 0 0.027246136218309402
confidence O 0 0.04706503823399544
interval O 0 0.07233523577451706
, O 0 0.015192531049251556
0 O 0 0.0331612154841423
. O 0 0.009486070834100246
3 O 0 0.016303595155477524
to O 0 0.010178729891777039
0 O 0 0.03409337252378464
. O 0 0.010160781443119049
9 O 0 0.021642830222845078
) O 0 0.013034413568675518
and O 0 0.006426927167922258
for O 0 0.008333263918757439
carriers O 0 0.04539002478122711
of O 0 0.011178821325302124
the O 0 0.024372173473238945
BRCA2 O 1 0.999516487121582
mutation O 0 0.23638667166233063
( O 0 0.04161135107278824
odds O 0 0.08559227734804153
ratio O 0 0.0642518401145935
, O 0 0.015628566965460777
0 O 0 0.034917015582323074
. O 0 0.00976562686264515
4 O 0 0.019698182120919228
; O 0 0.013740207999944687
95 O 0 0.04030504450201988
percent O 0 0.029446246102452278
confidence O 0 0.048169467598199844
interval O 0 0.06231733039021492
, O 0 0.014986804686486721
0 O 0 0.03090127557516098
. O 0 0.00786906760185957
2 O 0 0.01344893965870142
to O 0 0.008638998493552208
1 O 0 0.017827417701482773
. O 0 0.01198282465338707
1 O 0 0.02435184083878994
) O 0 0.02491552010178566
. O 0 0.023382458835840225

CONCLUSIONS O 0 0.11054111272096634
Oral O 1 0.9832348823547363
- O 1 0.6198612451553345
contraceptive O 1 0.9981593489646912
use O 0 0.024897446855902672
may O 0 0.019633162766695023
reduce O 0 0.03913692384958267
the O 0 0.01577642932534218
risk O 1 0.9989270567893982
of O 0 0.06753090023994446
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.017340324819087982
women O 0 0.026674211025238037
with O 0 0.016571274027228355
pathogenic O 0 0.14438679814338684
mutations O 0 0.09303196519613266
in O 0 0.013817399740219116
the O 0 0.025720341131091118
BRCA1 O 1 0.9995637536048889
or O 0 0.07298978418111801
BRCA2 O 1 0.9992828965187073
gene O 0 0.23851238191127777

A O 0 0.04424086958169937
Japanese O 0 0.04037249833345413
family O 0 0.037481024861335754
with O 0 0.026743192225694656
adrenoleukodystrophy B-Disease 1 0.9999997615814209
with O 0 0.02348627895116806
a O 0 0.03312590718269348
codon O 0 0.16198764741420746
291 O 0 0.1649109423160553
deletion O 0 0.1551411747932434
: O 0 0.029700370505452156
a O 0 0.0255636777728796
clinical O 1 0.9917478561401367
, O 0 0.017529649659991264
biochemical O 0 0.08943270146846771
, O 0 0.01732054352760315
pathological O 1 0.9211180210113525
, O 0 0.013242914341390133
and O 0 0.011498812586069107
genetic O 0 0.0598420724272728
report O 0 0.024116503074765205
. O 0 0.023893045261502266

We O 0 0.018001940101385117
report O 0 0.015899600461125374
a O 0 0.015505451709032059
Japanese O 0 0.02955089695751667
family O 0 0.03329623490571976
with O 0 0.03301399201154709
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.8978006839752197
ALD B-Disease 1 1.0
) O 0 0.02365891821682453
with O 0 0.007752953562885523
a O 0 0.01218700222671032
three O 0 0.011323758400976658
base O 0 0.0390273854136467
pair O 0 0.05808505043387413
deletion O 0 0.17002694308757782
( O 0 0.059094689786434174
delGAG O 1 0.6716083288192749
291 O 0 0.13245932757854462
) O 0 0.021591341122984886
in O 0 0.013905052095651627
the O 0 0.03436093032360077
ALD B-Disease 1 1.0
gene O 0 0.14816750586032867
. O 0 0.03262980282306671

A O 0 0.03637892007827759
variety O 0 0.021714581176638603
of O 0 0.013913123868405819
phenotypes O 0 0.11906787008047104
were O 0 0.013005081564188004
observed O 0 0.025985093787312508
within O 0 0.01162791159003973
this O 0 0.009767872281372547
family O 0 0.029585937038064003
. O 0 0.026973189786076546

While O 0 0.03161158040165901
the O 0 0.025115344673395157
proband O 1 0.9777772426605225
( O 0 0.053104594349861145
patient O 1 0.9959724545478821
1 O 0 0.02839883230626583
) O 0 0.017657874152064323
was O 0 0.01301096472889185
classified O 0 0.023208752274513245
as O 0 0.008276483975350857
having O 0 0.018299555405974388
a O 0 0.015100047923624516
rare O 0 0.038989536464214325
intermediate O 0 0.05910486355423927
type O 0 0.045573461800813675
of O 0 0.011379387229681015
adult O 0 0.07283984124660492
cerebral O 1 0.9999986886978149
and O 0 0.025776538997888565
cerebello O 1 0.9999949932098389
- O 1 0.9987976551055908
brain O 1 0.9994489550590515
stem O 0 0.08301626890897751
forms O 0 0.021602226421236992
, O 0 0.009095526300370693
his O 0 0.013554023578763008
younger O 0 0.03894349932670593
brother O 0 0.0506296269595623
( O 0 0.035871151834726334
patient O 1 0.993953287601471
2 O 0 0.02730691432952881
) O 0 0.018290530890226364
and O 0 0.013613455928862095
nephew O 0 0.11984752863645554
( O 0 0.04627228155732155
patient O 1 0.9962512850761414
3 O 0 0.026013208553195
) O 0 0.0164046473801136
had O 0 0.01517279352992773
a O 0 0.03211170434951782
childhood O 1 0.9999058246612549
ALD B-Disease 1 1.0
type O 1 0.5218837261199951
. O 0 0.03493088483810425

Another O 0 0.067361980676651
nephew O 0 0.20525123178958893
( O 0 0.05330612137913704
patient O 1 0.9909818768501282
4 O 0 0.030217785388231277
) O 0 0.017756454646587372
of O 0 0.011043605394661427
patient O 1 0.9952468276023865
1 O 0 0.020526723936200142
was O 0 0.01406317763030529
classified O 0 0.021780412644147873
as O 0 0.008320157416164875
having O 0 0.017719699069857597
an O 0 0.017588259652256966
adolescent O 1 0.9908100366592407
form O 0 0.03637315332889557
. O 0 0.028128482401371002

The O 0 0.03569990023970604
tau O 0 0.1309160590171814
level O 0 0.032592903822660446
in O 0 0.012614646926522255
the O 0 0.023861903697252274
cerebrospinal O 1 0.9996558427810669
fluid O 1 0.9414855241775513
( O 0 0.062324993312358856
CSF O 1 0.9998587369918823
) O 0 0.02454207092523575
in O 0 0.014658707194030285
patient O 1 0.9953789710998535
1 O 0 0.01584409549832344
was O 0 0.011194593273103237
as O 0 0.006195255555212498
high O 0 0.014422832988202572
as O 0 0.006348107010126114
that O 0 0.006972823292016983
of O 0 0.011953216046094894
patients O 1 0.9999994039535522
with O 0 0.37520477175712585
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.06069538742303848
AD B-Disease 1 0.5575504302978516
) O 0 0.03218970447778702
. O 0 0.023576654493808746

His O 0 0.05632267892360687
brain O 1 0.9149346947669983
magnetic O 0 0.10754918307065964
resonance O 0 0.1328393816947937
image O 0 0.08117951452732086
( O 0 0.04929177090525627
MRI O 1 0.9997785687446594
) O 0 0.029635604470968246
showed O 0 0.04265426844358444
abnormalities B-Disease 1 0.7142593860626221
in I-Disease 0 0.009313007816672325
the I-Disease 0 0.010838117450475693
bilateral I-Disease 0 0.04847622290253639
cerebellar I-Disease 1 0.9999197721481323
hemispheres I-Disease 1 0.8013291358947754
and O 0 0.02560804970562458
brain O 1 0.9999686479568481
stem O 0 0.09491495788097382
, O 0 0.009690294042229652
but O 0 0.006572663318365812
not O 0 0.004840091802179813
in O 0 0.007792945019900799
the O 0 0.016424894332885742
cerebral O 1 0.999998927116394
white O 0 0.0543028824031353
matter O 0 0.014348556287586689
, O 0 0.008873683400452137
where O 0 0.011762606911361217
marked O 0 0.0272050853818655
reductions O 0 0.039465002715587616
of O 0 0.007969877682626247
the O 0 0.019951997324824333
cerebral O 1 0.9999988079071045
blood O 1 0.9844654202461243
flow O 0 0.05502692610025406
and O 0 0.01778440549969673
oxygen O 1 0.7731887698173523
metabolism O 0 0.1317289024591446
were O 0 0.012226548045873642
clearly O 0 0.027515657246112823
demonstrated O 0 0.040998075157403946
by O 0 0.022868778556585312
positron O 0 0.2874319851398468
emission O 0 0.17997778952121735
tomography O 0 0.27347150444984436
( O 0 0.05558053404092789
PET O 1 0.8623194098472595
) O 0 0.03438345342874527
. O 0 0.025278763845562935

In O 0 0.03726290911436081
patients O 1 0.9995762705802917
2 O 0 0.024245858192443848
and O 0 0.008234154433012009
3 O 0 0.016467303037643433
, O 0 0.008481749333441257
the O 0 0.011696922592818737
autopsy O 1 0.6586617231369019
findings O 0 0.03730262815952301
showed O 0 0.04426727443933487
massive O 0 0.0922340378165245
demyelination B-Disease 1 0.9999958276748657
of I-Disease 0 0.013955658301711082
the I-Disease 0 0.020842302590608597
cerebral I-Disease 1 0.9999994039535522
white I-Disease 0 0.04018374904990196
matter I-Disease 0 0.015464941039681435
with O 0 0.010424544103443623
sparing O 0 0.07536909729242325
of O 0 0.010908042080700397
the O 0 0.018191594630479813
U O 1 0.9941529631614685
- O 0 0.2735389173030853
fibers O 0 0.25262749195098877
, O 0 0.01297653466463089
compatible O 0 0.023022951558232307
with O 0 0.008599206805229187
the O 0 0.00973961316049099
findings O 0 0.031195560470223427
of O 0 0.020606499165296555
childhood O 1 0.9999198913574219
ALD B-Disease 1 1.0
. O 0 0.047440286725759506

Oleic O 0 0.49209877848625183
and O 0 0.047224365174770355
erucic O 1 0.9867416024208069
acids O 0 0.11169056594371796
( O 0 0.04819688946008682
Lorenzos O 1 0.6345279812812805
Oil O 0 0.04272602126002312
) O 0 0.01833890751004219
were O 0 0.009775876998901367
administered O 0 0.061907779425382614
to O 0 0.01760110817849636
patients O 1 0.9991481304168701
1 O 0 0.01969362236559391
and O 0 0.008137637749314308
4 O 0 0.016166072338819504
, O 0 0.00818691123276949
but O 0 0.008221886120736599
sufficient O 0 0.026057792827486992
effectiveness O 0 0.059151891618967056
was O 0 0.0142130758613348
not O 0 0.008793332614004612
obtained O 0 0.022873040288686752
. O 0 0.02377178892493248

The O 0 0.02162456139922142
findings O 0 0.029871191829442978
in O 0 0.009834098629653454
this O 0 0.008494258858263493
family O 0 0.022756068035960197
suggest O 0 0.023166414350271225
that O 0 0.009918726049363613
delGAG291 O 0 0.09741178154945374
is O 0 0.0105582969263196
part O 0 0.010564484633505344
of O 0 0.0059927524998784065
the O 0 0.011496773920953274
cause O 0 0.049228161573410034
of O 0 0.01321545708924532
Japanese O 0 0.24453747272491455
ALD B-Disease 1 1.0
with O 0 0.023788999766111374
phenotypic O 0 0.11017587780952454
variations O 0 0.0508497916162014
. O 0 0.03008561208844185

Moreover O 0 0.05958952009677887
, O 0 0.012114164419472218
although O 0 0.009905216284096241
the O 0 0.0069496468640863895
scale O 0 0.021371448412537575
of O 0 0.00619124760851264
the O 0 0.011150803416967392
study O 0 0.020772438496351242
is O 0 0.01032017171382904
limited O 0 0.017410503700375557
, O 0 0.0077216532081365585
there O 0 0.006346278358250856
is O 0 0.007895359769463539
a O 0 0.013316059485077858
possibility O 0 0.027068303897976875
that O 0 0.011796827428042889
PET O 1 0.6669310331344604
can O 0 0.022926833480596542
detect O 0 0.08249998837709427
an O 0 0.02612062357366085
insidious B-Disease 1 0.999776303768158
lesion I-Disease 1 0.9999983310699463
which O 0 0.018677784129977226
is O 0 0.019064832478761673
undetectable O 1 0.7557865381240845
by O 0 0.02449679747223854
computed O 0 0.1146990954875946
tomogram O 1 0.9662508368492126
( O 0 0.07525865733623505
CT O 1 0.9999915361404419
) O 0 0.03226838633418083
or O 0 0.02581891603767872
MRI O 1 0.9935021996498108
analysis O 0 0.023969095200300217
, O 0 0.007656058296561241
and O 0 0.00496246200054884
that O 0 0.004512966610491276
the O 0 0.00739738903939724
higher O 0 0.020048242062330246
level O 0 0.019591275602579117
of O 0 0.00956751685589552
tau O 0 0.08641546964645386
reflects O 0 0.029686853289604187
the O 0 0.00897665973752737
process O 0 0.015707802027463913
of O 0 0.01609584130346775
neuronal B-Disease 1 0.9984082579612732
degeneration I-Disease 1 1.0
in O 0 0.05610679090023041
ALD B-Disease 1 1.0
. O 0 0.050372473895549774

Lorenzos O 1 0.7651041746139526
Oil O 0 0.04335568845272064
should O 0 0.012829357758164406
be O 0 0.005807028617709875
given O 0 0.008663790300488472
in O 0 0.006536136381328106
the O 0 0.009965135715901852
early O 0 0.024553343653678894
stage O 0 0.051427677273750305
. O 0 0.016368847340345383
. O 0 0.022259129211306572

Nonsense O 0 0.18462321162223816
mutation O 0 0.15554489195346832
in O 0 0.023913292214274406
exon O 0 0.12007559090852737
4 O 0 0.023128293454647064
of O 0 0.009569919668138027
human O 0 0.028361408039927483
complement O 0 0.08758490532636642
C9 O 1 0.999480664730072
gene O 0 0.08451709151268005
is O 0 0.012418802827596664
the O 0 0.009789763018488884
major O 0 0.0198013037443161
cause O 0 0.03859846293926239
of O 0 0.009255845099687576
Japanese O 0 0.04998983442783356
complement B-Disease 1 0.6096356511116028
C9 I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
. O 0 0.05241141840815544

Deficiency B-Disease 1 0.9999991655349731
of I-Disease 0 0.016760913655161858
the I-Disease 0 0.014785964041948318
ninth I-Disease 0 0.06584393233060837
component I-Disease 0 0.04460284113883972
of I-Disease 0 0.009859427809715271
human I-Disease 0 0.033614423125982285
complement I-Disease 0 0.07900568842887878
( O 0 0.04978567361831665
C9 O 1 0.9998236298561096
) O 0 0.021274706348776817
is O 0 0.008738966658711433
the O 0 0.008105064742267132
most O 0 0.011511924676597118
common O 0 0.03426428511738777
complement B-Disease 1 0.999850869178772
deficiency I-Disease 1 1.0
in O 0 0.013880829326808453
Japan O 0 0.022593142464756966
but O 0 0.008728119544684887
is O 0 0.011042194440960884
rare O 0 0.022842342033982277
in O 0 0.006522613111883402
other O 0 0.005961026065051556
countries O 0 0.013016201555728912
. O 0 0.021103302016854286

We O 0 0.021014006808400154
studied O 0 0.02351658046245575
the O 0 0.011318790726363659
molecular O 0 0.041272517293691635
basis O 0 0.017777927219867706
of O 0 0.023302452638745308
C9 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
in O 0 0.014687884598970413
four O 0 0.017780931666493416
Japanese O 0 0.09330141544342041
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9998083710670471
deficient I-Disease 1 0.9999958276748657
patients O 1 0.9999977350234985
who O 0 0.03302576020359993
had O 0 0.060016706585884094
suffered O 1 0.9999997615814209
from O 1 0.5855036377906799
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.04808966442942619

Direct O 0 0.06718514859676361
sequencing O 0 0.08142433315515518
of O 0 0.021901942789554596
amplified O 0 0.16010348498821259
C9 O 1 0.9879649877548218
cDNA O 0 0.1503220796585083
and O 0 0.018617957830429077
DNA O 0 0.05770666152238846
revealed O 0 0.03721312806010246
a O 0 0.02365747094154358
nonsense O 0 0.08067245781421661
substitution O 0 0.08798137307167053
( O 0 0.04799066111445427
CGA O 1 0.9977631568908691
- O 1 0.9712703824043274
- O 1 0.6137514710426331
> O 1 0.7163165211677551
TGA O 1 0.9987988471984863
) O 0 0.038508620113134384
at O 0 0.0334949865937233
codon O 0 0.11064498871564865
95 O 0 0.04280777648091316
in O 0 0.014910944737493992
exon O 0 0.09596643596887589
4 O 0 0.021832406520843506
in O 0 0.009289289824664593
the O 0 0.011880545876920223
four O 0 0.030291059985756874
C9 B-Disease 1 0.9999946355819702
- I-Disease 1 0.9276597499847412
deficient I-Disease 1 0.9973502159118652
individuals O 0 0.04168243333697319
. O 0 0.02920718304812908

An O 0 0.049805860966444016
allele O 0 0.2004561722278595
- O 0 0.11174844205379486
specific O 0 0.05057016387581825
polymerase O 0 0.17893166840076447
chain O 0 0.0956864058971405
reaction O 0 0.07022156566381454
system O 0 0.029727136716246605
designed O 0 0.026334548369050026
to O 0 0.011407675221562386
detect O 0 0.048175666481256485
exclusively O 0 0.015016946941614151
only O 0 0.005747803952544928
one O 0 0.006360209081321955
of O 0 0.005479024723172188
the O 0 0.011288436129689217
normal O 0 0.03564799949526787
and O 0 0.01361091434955597
mutant O 0 0.1178504154086113
alleles O 0 0.1384158879518509
indicated O 0 0.03899981081485748
that O 0 0.006874063517898321
all O 0 0.004502154421061277
the O 0 0.007795382756739855
four O 0 0.016254296526312828
patients O 1 0.9986658096313477
were O 0 0.011605212464928627
homozygous O 0 0.06640823185443878
for O 0 0.009822900407016277
the O 0 0.01557148713618517
mutation O 0 0.1229114830493927
in O 0 0.019415326416492462
exon O 0 0.11061881482601166
4 O 0 0.023767106235027313
and O 0 0.007052192464470863
that O 0 0.005857441574335098
the O 0 0.009379737079143524
parents O 0 0.023229673504829407
of O 0 0.010326876305043697
patient O 1 0.9981496334075928
2 O 0 0.0220939964056015
were O 0 0.011912832967936993
heterozygous O 0 0.12127701193094254
. O 0 0.027232343330979347

The O 0 0.02983441948890686
common O 0 0.050054095685482025
mutation O 0 0.14802981913089752
at O 0 0.04031672328710556
codon O 0 0.11525794118642807
95 O 0 0.046427708119153976
in O 0 0.016967779025435448
exon O 0 0.11341042071580887
4 O 0 0.026621976867318153
might O 0 0.017875541001558304
be O 0 0.007113792933523655
responsible O 0 0.017661986872553825
for O 0 0.007858769036829472
most O 0 0.012449764646589756
Japanese O 0 0.39140936732292175
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.026085883378982544
. O 0 0.02684718184173107

BRCA1 O 1 0.9618000984191895
required O 0 0.04082891345024109
for O 0 0.020354527980089188
transcription O 0 0.11213220655918121
- O 0 0.11685097962617874
coupled O 0 0.11027955263853073
repair O 1 0.9341806769371033
of O 0 0.02119714580476284
oxidative O 1 0.8172879219055176
DNA O 0 0.10768626630306244
damage O 0 0.15538530051708221
. O 0 0.029246194288134575

The O 0 0.054447025060653687
breast B-Disease 1 1.0
and I-Disease 1 0.974780797958374
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9997958540916443
gene O 0 0.17492863535881042
BRCA1 O 1 0.9777872562408447
encodes O 0 0.10668487101793289
a O 0 0.039751794189214706
zinc O 1 0.9527603387832642
finger O 0 0.14621306955814362
protein O 0 0.054776933044195175
of O 0 0.011048585176467896
unknown O 0 0.03525065258145332
function O 0 0.04139728099107742
. O 0 0.03084336593747139

Association O 0 0.06306900084018707
of O 0 0.011985106393694878
the O 0 0.024488046765327454
BRCA1 O 1 0.979828417301178
protein O 0 0.060700297355651855
with O 0 0.013456547632813454
the O 0 0.015965227037668228
DNA O 0 0.09368401765823364
repair O 1 0.8432958722114563
protein O 0 0.10367318242788315
Rad51 O 1 0.9860568046569824
and O 0 0.013001800514757633
changes O 0 0.014909885823726654
in O 0 0.007997953332960606
the O 0 0.011479542590677738
phosphorylation O 0 0.0505022369325161
and O 0 0.01270708441734314
cellular O 0 0.062371626496315
localization O 0 0.06395751237869263
of O 0 0.008601637557148933
the O 0 0.01413570437580347
protein O 0 0.05382050946354866
after O 0 0.03020741418004036
exposure O 1 0.9696962833404541
to O 0 0.015417449176311493
DNA O 0 0.07863222807645798
- O 0 0.09095623344182968
damaging O 0 0.0854475349187851
agents O 0 0.03513726219534874
are O 0 0.006628654431551695
consistent O 0 0.020895496010780334
with O 0 0.007489766459912062
a O 0 0.014788311906158924
role O 0 0.02080249972641468
for O 0 0.015161505900323391
BRCA1 O 1 0.9958429932594299
in O 0 0.022055568173527718
DNA O 0 0.09150832146406174
repair O 1 0.9811367988586426
. O 0 0.03294387087225914

Here O 0 0.022239355370402336
, O 0 0.009222197346389294
it O 0 0.007639950141310692
is O 0 0.009519008919596672
shown O 0 0.020816493779420853
that O 0 0.014691653661429882
mouse O 0 0.1696910709142685
embryonic O 0 0.17916448414325714
stem O 0 0.15567392110824585
cells O 0 0.138145312666893
deficient B-Disease 1 0.9873247146606445
in I-Disease 0 0.023442856967449188
BRCA1 I-Disease 1 0.9970786571502686
are O 0 0.013191239908337593
defective O 0 0.15652145445346832
in O 0 0.00945663545280695
the O 0 0.008059441111981869
ability O 0 0.01917135901749134
to O 0 0.007168216165155172
carry O 0 0.016177300363779068
out O 0 0.017176950350403786
transcription O 0 0.09295067191123962
- O 0 0.1095900908112526
coupled O 0 0.11428740620613098
repair O 1 0.7515242099761963
of O 0 0.022049468010663986
oxidative O 1 0.9316149950027466
DNA O 0 0.10486793518066406
damage O 0 0.11939803510904312
, O 0 0.01002456247806549
and O 0 0.008882003836333752
are O 0 0.009971050545573235
hypersensitive O 1 0.8841910362243652
to O 0 0.028715699911117554
ionizing O 1 0.9754660129547119
radiation O 1 0.9087089896202087
and O 0 0.02140829898416996
hydrogen O 0 0.11063224822282791
peroxide O 0 0.42130693793296814
. O 0 0.04182378947734833

These O 0 0.018237320706248283
results O 0 0.02923874370753765
suggest O 0 0.03311484307050705
that O 0 0.015759393572807312
BRCA1 O 1 0.9899806380271912
participates O 0 0.09160719811916351
, O 0 0.012634058482944965
directly O 0 0.017043864354491234
or O 0 0.015756983309984207
indirectly O 0 0.04100082442164421
, O 0 0.010533508844673634
in O 0 0.014240131713449955
transcription O 0 0.09470897912979126
- O 0 0.10242993384599686
coupled O 0 0.11125768721103668
repair O 1 0.8621679544448853
of O 0 0.021868474781513214
oxidative O 1 0.9723111987113953
DNA O 0 0.10378456860780716
damage O 0 0.09648898988962173
. O 0 0.019054854288697243
. O 0 0.02623753249645233

Truncation O 0 0.2683074176311493
mutations O 0 0.1183432936668396
in O 0 0.014539717696607113
the O 0 0.019307617098093033
transactivation O 0 0.3231216371059418
region O 0 0.04655498266220093
of O 0 0.017726507037878036
PAX6 O 1 0.999910831451416
result O 0 0.033840835094451904
in O 0 0.01727137342095375
dominant O 0 0.08996018022298813
- O 0 0.12125739455223083
negative O 0 0.08643359690904617
mutants O 0 0.14418065547943115
. O 0 0.03742120787501335

PAX6 O 1 0.9943419694900513
is O 0 0.027359720319509506
a O 0 0.02789458818733692
transcription O 0 0.0689859539270401
factor O 0 0.03657566010951996
with O 0 0.00928978156298399
two O 0 0.011670327745378017
DNA O 0 0.07945355027914047
- O 0 0.0917491540312767
binding O 0 0.06373331695795059
domains O 0 0.07454478740692139
( O 0 0.037265799939632416
paired O 0 0.08841355890035629
box O 0 0.06196160614490509
and O 0 0.020769204944372177
homeobox O 1 0.9065245985984802
) O 0 0.021845301613211632
and O 0 0.01106729544699192
a O 0 0.028974520042538643
proline O 0 0.36768096685409546
- O 0 0.14784759283065796
serine O 0 0.2326149344444275
- O 0 0.15900588035583496
threonine O 0 0.27014654874801636
( O 0 0.07840316742658615
PST O 1 0.9995458722114563
) O 0 0.04238134250044823
- O 0 0.08758639544248581
rich O 0 0.07708249986171722
transactivation O 0 0.2512461245059967
domain O 0 0.07144451886415482
. O 0 0.03420722112059593

PAX6 O 1 0.9993382096290588
regulates O 1 0.5225451588630676
eye O 1 0.9936037659645081
development O 0 0.028217952698469162
in O 0 0.013296152465045452
animals O 0 0.025118712335824966
ranging O 0 0.030190493911504745
from O 0 0.018497157841920853
jellyfish O 0 0.09149504452943802
to O 0 0.015886429697275162
Drosophila O 0 0.0760621577501297
to O 0 0.017430245876312256
humans O 0 0.05089062079787254
. O 0 0.030521759763360023

Heterozygous O 0 0.23270666599273682
mutations O 0 0.13228687644004822
in O 0 0.016943465918302536
the O 0 0.017686739563941956
human O 0 0.05159861221909523
PAX6 O 1 0.9999305009841919
gene O 0 0.08893062174320221
result O 0 0.022444752976298332
in O 0 0.00831584632396698
various O 0 0.009969102218747139
phenotypes O 0 0.12588031589984894
, O 0 0.016203638166189194
including O 0 0.021539771929383278
aniridia B-Disease 1 0.9999709129333496
, O 0 0.03441727161407471
Peters B-Disease 1 0.9999270439147949
anomaly I-Disease 1 0.9999229907989502
, O 0 0.030299611389636993
autosomal B-Disease 1 0.9997746348381042
dominant I-Disease 1 0.9953568577766418
keratitis I-Disease 1 1.0
, O 0 0.025573519989848137
and O 0 0.02520960383117199
familial B-Disease 1 0.9999988079071045
foveal I-Disease 1 0.9999924898147583
dysplasia I-Disease 1 1.0
. O 0 0.046743154525756836

It O 0 0.017219070345163345
is O 0 0.013574249111115932
believed O 0 0.02213011309504509
that O 0 0.008183114230632782
the O 0 0.015344937331974506
mutated O 0 0.13672301173210144
allele O 0 0.15844742953777313
of O 0 0.028529781848192215
PAX6 O 1 0.9984954595565796
produces O 0 0.08182468265295029
an O 0 0.025268573313951492
inactive O 0 0.1249256581068039
protein O 0 0.07198704034090042
and O 0 0.024008654057979584
aniridia B-Disease 1 0.9997448325157166
is O 0 0.02428303472697735
caused O 0 0.06059145927429199
due O 0 0.02703224867582321
to O 0 0.01886601559817791
genetic O 0 0.09585235267877579
haploinsufficiency O 1 0.8038076162338257
. O 0 0.03290797770023346

However O 0 0.025891130790114403
, O 0 0.014849943108856678
several O 0 0.015890201553702354
truncation O 0 0.17081163823604584
mutations O 0 0.09061741828918457
have O 0 0.01077998336404562
been O 0 0.009938975796103477
found O 0 0.01064328197389841
to O 0 0.006818921305239201
occur O 0 0.01834094524383545
in O 0 0.007962127216160297
the O 0 0.014719745144248009
C O 1 0.9352847337722778
- O 0 0.0816158875823021
terminal O 0 0.07539772987365723
half O 0 0.021923303604125977
of O 0 0.016751745715737343
PAX6 O 1 0.9998986721038818
in O 0 0.028858255594968796
patients O 1 0.9999709129333496
with O 0 0.02457546442747116
Aniridia B-Disease 1 0.9999457597732544
resulting O 0 0.04534069448709488
in O 0 0.013620514422655106
mutant O 0 0.08295130729675293
proteins O 0 0.03307310491800308
that O 0 0.009086153469979763
retain O 0 0.0318298377096653
the O 0 0.017921684309840202
DNA O 0 0.07606464624404907
- O 0 0.08506739884614944
binding O 0 0.05770855396986008
domains O 0 0.04263977333903313
but O 0 0.010322869755327702
have O 0 0.007973535917699337
lost O 0 0.01778756082057953
most O 0 0.005560034420341253
of O 0 0.00674400245770812
the O 0 0.017786912620067596
transactivation O 1 0.6256291270256042
domain O 0 0.06144735962152481
. O 0 0.0271260105073452

It O 0 0.017314521595835686
is O 0 0.010517438873648643
not O 0 0.0071433912962675095
clear O 0 0.014901100657880306
whether O 0 0.011678658425807953
such O 0 0.01013330090790987
mutants O 0 0.09807015210390091
really O 0 0.03379610553383827
behave O 0 0.04611947387456894
as O 0 0.014112557284533978
loss O 0 0.08871137350797653
- O 0 0.0595359243452549
of O 0 0.01549144834280014
- O 0 0.07698595523834229
function O 0 0.04611540958285332
mutants O 0 0.10402166843414307
as O 0 0.017872795462608337
predicted O 0 0.04507085308432579
by O 0 0.019333455711603165
haploinsufficiency O 0 0.26341694593429565
. O 0 0.03384007140994072

Contrary O 0 0.03623113036155701
to O 0 0.009020403027534485
this O 0 0.007289330009371042
theory O 0 0.015564982779324055
, O 0 0.00741853192448616
our O 0 0.008094553835690022
data O 0 0.010829598642885685
showed O 0 0.018819212913513184
that O 0 0.005520213395357132
these O 0 0.0058942921459674835
mutants O 0 0.06366945803165436
are O 0 0.01003837026655674
dominant O 0 0.06426962465047836
- O 0 0.08512862771749496
negative O 0 0.05878666043281555
in O 0 0.023116931319236755
transient O 1 0.9842536449432373
transfection O 1 0.9971355199813843
assays O 0 0.09940888732671738
when O 0 0.017146609723567963
they O 0 0.006779379677027464
are O 0 0.007548423483967781
coexpressed O 0 0.21143628656864166
with O 0 0.015053555369377136
wild O 0 0.05952341482043266
- O 0 0.16399039328098297
type O 0 0.16436748206615448
PAX6 O 1 0.9997877478599548
. O 0 0.04112142324447632

We O 0 0.015830496326088905
found O 0 0.013124308548867702
that O 0 0.00667167641222477
the O 0 0.012889155186712742
dominant O 0 0.0832577794790268
- O 0 0.25610119104385376
negative O 0 0.0706949308514595
effects O 0 0.08683262765407562
result O 0 0.020566336810588837
from O 0 0.010129732079803944
the O 0 0.011811700649559498
enhanced O 0 0.06007733568549156
DNA O 0 0.05988304316997528
binding O 0 0.0368451327085495
ability O 0 0.021963847801089287
of O 0 0.007531891111284494
these O 0 0.010676764883100986
mutants O 0 0.11304796487092972
. O 0 0.03167502209544182

Kinetic O 0 0.12412979453802109
studies O 0 0.03404906019568443
of O 0 0.011106339283287525
binding O 0 0.04074792191386223
and O 0 0.015704212710261345
dissociation O 0 0.14481329917907715
revealed O 0 0.030877308920025826
that O 0 0.007759259082376957
various O 0 0.01141433510929346
truncation O 0 0.12477251142263412
mutants O 0 0.10045534372329712
have O 0 0.014736364595592022
3 O 0 0.03505655750632286
- O 0 0.07553809881210327
5 O 0 0.03996322304010391
- O 0 0.08305702358484268
fold O 0 0.07529608905315399
higher O 0 0.03391870856285095
affinity O 0 0.06288853287696838
to O 0 0.011218782514333725
various O 0 0.011324991472065449
DNA O 0 0.07043501734733582
- O 0 0.06879738718271255
binding O 0 0.04017310589551926
sites O 0 0.018215809017419815
when O 0 0.013880843296647072
compared O 0 0.015716861933469772
with O 0 0.007571957539767027
the O 0 0.011463564820587635
wild O 0 0.04910365119576454
- O 0 0.21619164943695068
type O 0 0.18834678828716278
PAX6 O 1 0.9995961785316467
. O 0 0.04621874913573265

These O 0 0.014185789972543716
results O 0 0.019994769245386124
provide O 0 0.015051322057843208
a O 0 0.013489681296050549
new O 0 0.013564139604568481
insight O 0 0.04903325438499451
into O 0 0.008726393803954124
the O 0 0.007281060330569744
role O 0 0.01798762008547783
of O 0 0.012648068368434906
mutant O 0 0.13689835369586945
PAX6 O 1 0.9999074935913086
in O 0 0.027967695146799088
causing O 1 0.8869516849517822
aniridia B-Disease 1 0.9998588562011719
. O 0 0.02083400823175907
. O 0 0.026044286787509918

Reversal O 1 0.7465088367462158
of O 0 0.0421626977622509
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.025417733937501907
excellent O 0 0.060018446296453476
neuropsychologic O 1 0.9257206916809082
outcome O 0 0.02627132087945938
in O 0 0.009533150121569633
very B-Disease 0 0.0162657517939806
- I-Disease 0 0.07414466887712479
long I-Disease 0 0.050179604440927505
- I-Disease 0 0.12098941206932068
chain I-Disease 0 0.1283748596906662
acyl I-Disease 1 0.9877886176109314
- I-Disease 0 0.21614468097686768
coenzyme I-Disease 1 0.5103955268859863
A I-Disease 0 0.19915328919887543
dehydrogenase I-Disease 1 0.9999688863754272
deficiency I-Disease 1 1.0
. O 0 0.050634704530239105

Very B-Disease 0 0.046658955514431
- I-Disease 0 0.10598777234554291
long I-Disease 0 0.061882901936769485
- I-Disease 0 0.13199299573898315
chain I-Disease 0 0.1272422820329666
acyl I-Disease 1 0.9550432562828064
- I-Disease 0 0.15002256631851196
coenzyme I-Disease 0 0.23119722306728363
A I-Disease 0 0.09379944950342178
dehydrogenase I-Disease 1 0.9876708984375
( I-Disease 0 0.07574435323476791
VLCAD I-Disease 1 0.9999716281890869
) I-Disease 0 0.10825395584106445
deficiency I-Disease 1 1.0
is O 0 0.02127562090754509
a O 0 0.033950548619031906
disorder O 1 0.9999948740005493
of O 0 0.02513224072754383
fatty O 1 0.8097835779190063
acid O 1 0.6236605048179626
beta O 0 0.12597092986106873
oxidation O 0 0.10997098684310913
that O 0 0.01326176431030035
reportedly O 0 0.03825600817799568
has O 0 0.014665665104985237
high O 0 0.027992822229862213
rates O 0 0.03412994369864464
of O 0 0.014543477445840836
morbidity O 1 0.9991298317909241
and O 0 0.019976522773504257
mortality O 1 0.9484149813652039
. O 0 0.0314788818359375

We O 0 0.019511209800839424
describe O 0 0.029455630108714104
the O 0 0.010020928457379341
outcome O 0 0.020166754722595215
of O 0 0.007007530424743891
a O 0 0.016159003600478172
5 O 0 0.02734287828207016
- O 0 0.06845244020223618
year O 0 0.02549065090715885
- O 0 0.0801319107413292
old O 0 0.04685085266828537
girl O 1 0.7230021953582764
with O 0 0.04020620509982109
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.026185618713498116
was O 0 0.015176479704678059
first O 0 0.01214594580233097
seen O 0 0.018378624692559242
at O 0 0.014788685366511345
5 O 0 0.016514478251338005
months O 0 0.014888910576701164
of O 0 0.007500482723116875
age O 0 0.028298284858465195
with O 0 0.028317904099822044
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9844889640808105
hepatomegaly B-Disease 1 1.0
, O 1 0.8904180526733398
encephalopathy B-Disease 1 1.0
, O 0 0.020770687609910965
and O 0 0.021036040037870407
hypotonia B-Disease 1 0.9999610185623169
. O 0 0.03242134675383568

Biochemical O 0 0.3169883191585541
studies O 0 0.07637068629264832
indicated O 1 0.9859732389450073
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.5043337941169739
by O 0 0.013756073080003262
a O 0 0.02156567946076393
stable O 0 0.07264568656682968
yet O 0 0.0313279964029789
inactive O 0 0.1414199024438858
enzyme O 0 0.1379416286945343
. O 0 0.036524057388305664

Molecular O 0 0.12322939187288284
genetic O 0 0.07890306413173676
analysis O 0 0.027998467907309532
of O 0 0.009726118296384811
her O 0 0.03435364365577698
VLCAD O 1 0.9991387128829956
gene O 0 0.09167558699846268
revealed O 0 0.04541042447090149
a O 0 0.031412672251462936
T1372C O 0 0.3436795771121979
( O 0 0.051113832741975784
F458L O 1 0.6879371404647827
) O 0 0.04656815528869629
missense O 0 0.18421949446201324
mutation O 0 0.13177454471588135
and O 0 0.017946187406778336
a O 0 0.03917780518531799
1668 O 1 0.9918791055679321
ACAG O 1 0.9970284104347229
1669 O 1 0.8998278379440308
splice O 0 0.24519729614257812
site O 0 0.07704290002584457
mutation O 0 0.1658787727355957
. O 0 0.03608180209994316

After O 0 0.04921872168779373
initial O 0 0.07221922278404236
treatment O 1 0.999366819858551
with O 0 0.02517528273165226
intravenous O 1 0.9994794726371765
glucose O 1 0.7392820119857788
and O 0 0.02692416124045849
carnitine O 1 0.9998037219047546
, O 0 0.01794915460050106
the O 0 0.017082011327147484
patient O 1 0.9986346364021301
has O 0 0.01577449031174183
thrived O 0 0.0559915192425251
on O 0 0.010708553716540337
a O 0 0.02189895324409008
low O 0 0.06887996196746826
- O 0 0.11277679353952408
fat O 0 0.10839412361383438
diet O 0 0.09291808307170868
supplemented O 0 0.055915653705596924
with O 0 0.019128434360027313
medium O 0 0.06753648072481155
- O 0 0.10855979472398758
chain O 0 0.10646910965442657
triglyceride O 0 0.2858439087867737
oil O 0 0.04775901883840561
and O 0 0.02207908220589161
carnitine O 1 0.9997604489326477
and O 0 0.025093119591474533
avoidance O 1 0.973005473613739
of O 0 0.01710834540426731
fasting O 0 0.14209407567977905
. O 0 0.03434043005108833

Her O 0 0.1597519963979721
ventricular O 1 0.9999961853027344
hypertrophy O 1 0.9999905824661255
resolved O 0 0.06843169033527374
significantly O 0 0.046010494232177734
over O 0 0.014329727739095688
1 O 0 0.020869189873337746
year O 0 0.014792689122259617
, O 0 0.011200553737580776
and O 0 0.011673045344650745
cognitively O 1 0.8957124948501587
, O 0 0.01196505967527628
she O 0 0.012980548664927483
is O 0 0.007313130889087915
in O 0 0.006650055758655071
the O 0 0.009531592950224876
superior O 0 0.034977708011865616
range O 0 0.021570885553956032
for O 0 0.009867268614470959
age O 0 0.028828691691160202
. O 0 0.020908160135149956

Clinical O 1 0.9725837707519531
recognition O 0 0.054980527609586716
of O 0 0.029262006282806396
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.016363274306058884
important O 0 0.009589278139173985
because O 0 0.008516842499375343
it O 0 0.00515771983191371
is O 0 0.005503878928720951
one O 0 0.005090859718620777
of O 0 0.0041940826922655106
the O 0 0.0077871582470834255
few O 0 0.01513365563005209
directly O 0 0.034263480454683304
treatable O 1 0.9999998807907104
causes O 1 0.9984692931175232
of O 0 0.025677016004920006
cardiomyopathy B-Disease 1 1.0
in O 0 0.017259059473872185
children O 0 0.029949510470032692
. O 0 0.01259495411068201
. O 0 0.02077615261077881

Cloning O 0 0.0873662531375885
of O 0 0.010350791737437248
a O 0 0.016282668337225914
novel O 0 0.022454798221588135
member O 0 0.014375874772667885
of O 0 0.007291233632713556
the O 0 0.015015296638011932
low O 0 0.0718609020113945
- O 0 0.13256098330020905
density O 0 0.1263192594051361
lipoprotein O 1 0.9988123178482056
receptor O 0 0.24989157915115356
family O 0 0.057115983217954636
. O 0 0.030897794291377068

A O 0 0.06452871859073639
gene O 0 0.09415937960147858
encoding O 0 0.05918952822685242
a O 0 0.02913472056388855
novel O 0 0.050873104482889175
transmembrane O 0 0.1527383178472519
protein O 0 0.059635333716869354
was O 0 0.017703408375382423
identified O 0 0.023633675649762154
by O 0 0.01229933276772499
DNA O 0 0.047241490334272385
sequence O 0 0.025354880839586258
analysis O 0 0.017770567908883095
within O 0 0.013281608000397682
the O 0 0.020097045227885246
insulin B-Disease 1 0.9999340772628784
- I-Disease 1 0.9918546676635742
dependent I-Disease 1 0.9939714074134827
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.09285378456115723
IDDM B-Disease 1 0.9995490908622742
) O 0 0.04482777789235115
locus O 0 0.15689639747142792
IDDM4 O 1 0.9217811822891235
on O 0 0.025522472336888313
chromosome O 0 0.16672876477241516
11q13 O 0 0.2092757523059845
. O 0 0.0324929840862751

Based O 0 0.022885050624608994
on O 0 0.009822780266404152
its O 0 0.0137029392644763
chromosomal O 0 0.12005607783794403
position O 0 0.021843651309609413
, O 0 0.009236691519618034
this O 0 0.009078445844352245
gene O 0 0.046427447348833084
is O 0 0.010513419285416603
a O 0 0.011531219817698002
candidate O 0 0.018656644970178604
for O 0 0.012055028229951859
conferring O 0 0.12845812737941742
susceptibility O 1 0.9954675436019897
to O 0 0.03887347877025604
diabetes B-Disease 1 1.0
. O 0 0.03709722310304642

The O 0 0.03292197361588478
gene O 0 0.08918445557355881
, O 0 0.024039562791585922
termed O 0 0.10067746788263321
low O 0 0.09043432027101517
- O 0 0.13793618977069855
density O 0 0.12741723656654358
lipoprotein O 1 0.9976791739463806
receptor O 0 0.24388472735881805
related O 0 0.054195210337638855
protein O 0 0.0697002038359642
5 O 0 0.03880719095468521
( O 0 0.03866596892476082
LRP5 O 1 0.9872095584869385
) O 0 0.02298940345644951
, O 0 0.013557633385062218
encodes O 0 0.05131956934928894
a O 0 0.023945579305291176
protein O 0 0.04484182968735695
of O 0 0.0146176191046834
1615 O 0 0.16027790307998657
amino O 0 0.07248026132583618
acids O 0 0.05071215704083443
that O 0 0.010201539844274521
contains O 0 0.018452368676662445
conserved O 0 0.037422142922878265
modules O 0 0.03767869994044304
which O 0 0.008049797266721725
are O 0 0.005421972833573818
characteristic O 0 0.023011067882180214
of O 0 0.006640882696956396
the O 0 0.013489263132214546
low O 0 0.07127402722835541
- O 0 0.14223474264144897
density O 0 0.13147535920143127
lipoprotein O 1 0.99967360496521
( O 0 0.10104963183403015
LDL O 1 0.9999885559082031
) O 0 0.06330705434083939
receptor O 0 0.17496661841869354
family O 0 0.042062532156705856
. O 0 0.026871168985962868

These O 0 0.01907769963145256
modules O 0 0.045053496956825256
include O 0 0.01900278963148594
a O 0 0.02967493236064911
putative O 0 0.1338673084974289
signal O 0 0.0853402391076088
peptide O 0 0.10801468789577484
for O 0 0.014690355397760868
protein O 0 0.043081384152173996
export O 0 0.021069906651973724
, O 0 0.013225559145212173
four O 0 0.027159277349710464
epidermal O 1 0.9997170567512512
growth O 0 0.0750519409775734
factor O 0 0.10269290953874588
( O 0 0.05991021916270256
EGF O 1 0.9993446469306946
) O 0 0.03465277701616287
repeats O 0 0.06429295241832733
with O 0 0.015875207260251045
associated O 0 0.03481942415237427
spacer O 0 0.20481760799884796
domains O 0 0.06354505568742752
, O 0 0.0183818731456995
three O 0 0.027985239401459694
LDL O 1 0.9999881982803345
- O 0 0.2653007209300995
receptor O 0 0.2579003870487213
( O 0 0.0558415949344635
LDLR O 1 0.9762842059135437
) O 0 0.030573543161153793
repeats O 0 0.06073003262281418
, O 0 0.010777061805129051
a O 0 0.01495350431650877
single O 0 0.029595905914902687
transmembrane O 0 0.11508189141750336
spanning O 0 0.05164925009012222
domain O 0 0.0341777428984642
, O 0 0.01048511266708374
and O 0 0.0093759186565876
a O 0 0.023371059447526932
cytoplasmic O 0 0.12102437019348145
domain O 0 0.05733529478311539
. O 0 0.026963738724589348

The O 0 0.027995413169264793
encoded O 0 0.03707412630319595
protein O 0 0.04476466029882431
has O 0 0.012872656807303429
a O 0 0.013379056937992573
unique O 0 0.02208866737782955
organization O 0 0.027111195027828217
of O 0 0.017333175987005234
EGF O 1 0.9995701909065247
and O 0 0.02655888721346855
LDLR O 1 0.9976744055747986
repeats O 0 0.09677840024232864
; O 0 0.017436690628528595
therefore O 0 0.01677701808512211
, O 0 0.01390335988253355
LRP5 O 1 0.9952325224876404
likely O 0 0.027739379554986954
represents O 0 0.02112670987844467
a O 0 0.012815481051802635
new O 0 0.011779731139540672
category O 0 0.0219314843416214
of O 0 0.007399392314255238
the O 0 0.01773509383201599
LDLR O 1 0.9986340403556824
family O 0 0.04267279803752899
. O 0 0.026864901185035706

Both O 0 0.02057649753987789
human O 0 0.02762044034898281
and O 0 0.01854323036968708
mouse O 0 0.29989317059516907
LRP5 O 1 0.9993613362312317
cDNAs O 1 0.8781018257141113
have O 0 0.013011527247726917
been O 0 0.01371608767658472
isolated O 0 0.04592582955956459
and O 0 0.008637163788080215
the O 0 0.011182501912117004
encoded O 0 0.03557121381163597
mature O 0 0.06125512346625328
proteins O 0 0.029914865270256996
are O 0 0.008876798674464226
95 O 0 0.035373505204916
% O 0 0.019942985847592354
identical O 0 0.02498643286526203
, O 0 0.01258646510541439
indicating O 0 0.033299848437309265
a O 0 0.01514067966490984
high O 0 0.026159828528761864
degree O 0 0.025513246655464172
of O 0 0.00892496295273304
evolutionary O 0 0.041869472712278366
conservation O 0 0.04405737295746803
. O 0 0.01709858514368534
. O 0 0.02337074466049671

The O 0 0.04564774036407471
APC B-Disease 1 0.953616738319397
variants O 0 0.09329003095626831
I1307K O 0 0.16534875333309174
and O 0 0.018230972811579704
E1317Q O 0 0.12352306395769119
are O 0 0.010489001870155334
associated O 0 0.028169330209493637
with O 0 0.1757301390171051
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.015036341734230518
but O 0 0.007995301857590675
not O 0 0.006497026886790991
always O 0 0.011726913042366505
with O 0 0.007463044952601194
a O 0 0.013244746252894402
family O 0 0.021947799250483513
history O 0 0.022329017519950867
. O 0 0.025370178744196892

Classical O 0 0.2381022572517395
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9378857016563416
FAP B-Disease 1 0.9999997615814209
) O 0 0.023624148219823837
is O 0 0.010970094241201878
a O 0 0.015868905931711197
high O 0 0.04676973819732666
- O 1 0.9022470712661743
penetrance O 1 0.9997027516365051
autosomal B-Disease 1 0.9999843835830688
dominant I-Disease 1 0.9996293783187866
disease I-Disease 1 0.9999998807907104
that O 0 0.01824321039021015
predisposes O 1 0.9993236064910889
to O 0 0.012536836788058281
hundreds O 0 0.018550222739577293
or O 0 0.014395076781511307
thousands O 0 0.023400211706757545
of O 0 0.03148185834288597
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.8043355941772461
carcinoma I-Disease 1 1.0
and O 0 0.011853165924549103
that O 0 0.008205779828131199
results O 0 0.023628056049346924
from O 0 0.019647397100925446
truncating O 0 0.30582430958747864
mutations O 0 0.09983793646097183
in O 0 0.015184463001787663
the O 0 0.022815868258476257
APC B-Disease 1 0.9972277283668518
gene O 0 0.1301766186952591
. O 0 0.037646252661943436

A O 0 0.061484768986701965
variant O 0 0.13220778107643127
of O 0 0.03131218999624252
FAP B-Disease 1 0.9999991655349731
is O 0 0.07396742701530457
attenuated B-Disease 1 0.9999856948852539
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999991655349731
, O 0 0.020972618833184242
which O 0 0.01170426793396473
results O 0 0.026161715388298035
from O 0 0.02234397456049919
germ O 1 0.9998749494552612
- O 0 0.10710946470499039
line O 0 0.04254215583205223
mutations O 0 0.07385266572237015
in O 0 0.008703543804585934
the O 0 0.009303786791861057
5 O 0 0.016534363850951195
and O 0 0.007407647091895342
3 O 0 0.016010956838726997
regions O 0 0.016985232010483742
of O 0 0.008528091944754124
the O 0 0.020389029756188393
APC B-Disease 1 0.9963343143463135
gene O 0 0.13389059901237488
. O 0 0.037084415555000305

Attenuated B-Disease 1 0.9999949932098389
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999994039535522
have O 0 0.01782265119254589
" O 0 0.01934332214295864
multiple O 0 0.04275573417544365
" O 1 0.6794888377189636
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.04135856032371521
typically O 0 0.02538367174565792
fewer O 0 0.020350592210888863
than O 0 0.011357714422047138
100 O 0 0.021680034697055817
) O 0 0.015545355156064034
without O 0 0.012168840505182743
the O 0 0.0183486957103014
florid O 1 0.9334221482276917
phenotype O 0 0.4591437578201294
of O 0 0.019593345001339912
classical O 0 0.07557982206344604
FAP B-Disease 1 0.999994158744812
. O 0 0.04122305288910866

Another O 0 0.039953697472810745
group O 0 0.03281938657164574
of O 0 0.014453652314841747
patients O 1 0.9999696016311646
with O 0 0.014509251341223717
multiple O 0 0.04989747703075409
adenomas B-Disease 1 0.9999840259552002
has O 0 0.0182466059923172
no O 0 0.015530752018094063
mutations O 0 0.06575575470924377
in O 0 0.009463440626859665
the O 0 0.019090157002210617
APC B-Disease 1 0.9984512329101562
gene O 0 0.08628586679697037
, O 0 0.0113731874153018
and O 0 0.009116388857364655
their O 0 0.014641382731497288
phenotype O 1 0.9598134160041809
probably O 0 0.035195913165807724
results O 0 0.024242151528596878
from O 0 0.012752024456858635
variation O 0 0.03344733640551567
at O 0 0.017549270763993263
a O 0 0.023047514259815216
locus O 0 0.11052875220775604
, O 0 0.01821249909698963
or O 0 0.020489027723670006
loci O 0 0.11754658073186874
, O 0 0.013155403546988964
elsewhere O 0 0.020131543278694153
in O 0 0.008395950309932232
the O 0 0.015035806223750114
genome O 0 0.0963430106639862
. O 0 0.03619144484400749

Recently O 0 0.051664188504219055
, O 0 0.013699240982532501
however O 0 0.011231166310608387
, O 0 0.010919828899204731
a O 0 0.02529318444430828
missense O 0 0.17156699299812317
variant O 0 0.12300191074609756
of O 0 0.025185327976942062
APC B-Disease 1 0.9977210164070129
( O 0 0.04685194790363312
I1307K O 0 0.281165212392807
) O 0 0.019787166267633438
was O 0 0.014661862514913082
described O 0 0.02189529873430729
that O 0 0.009158494882285595
confers O 0 0.07134793698787689
an O 0 0.014984398148953915
increased O 0 0.037800226360559464
risk O 1 0.9982732534408569
of O 0 0.055619362741708755
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.01628953032195568
including O 0 0.013675140216946602
multiple O 0 0.0541331022977829
adenomas B-Disease 1 0.9999892711639404
, O 0 0.01645231805741787
in O 0 0.017742497846484184
Ashkenazim O 1 0.9491294026374817
. O 0 0.03486400470137596

We O 0 0.016128195449709892
have O 0 0.008752926252782345
studied O 0 0.017363032326102257
a O 0 0.011463915929198265
set O 0 0.010292835533618927
of O 0 0.009576457552611828
164 O 0 0.10461298376321793
patients O 1 0.9999492168426514
with O 0 0.02194894477725029
multiple O 1 0.9812726974487305
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.18931689858436584
/ I-Disease 1 0.9999984502792358
or I-Disease 0 0.11049626767635345
carcinoma I-Disease 1 1.0
and O 0 0.021968122571706772
analyzed O 0 0.08592347800731659
codons O 0 0.17189747095108032
1263 O 1 0.9978939890861511
- O 0 0.19737543165683746
1377 O 1 0.7110541462898254
( O 0 0.06586296111345291
exon O 0 0.19669996201992035
15G O 0 0.23426780104637146
) O 0 0.02181871421635151
of O 0 0.008945539593696594
the O 0 0.01826714724302292
APC B-Disease 1 0.9864517450332642
gene O 0 0.08595876395702362
for O 0 0.022331729531288147
germ O 1 0.9998030066490173
- O 0 0.09734740108251572
line O 0 0.0405430905520916
variants O 0 0.07361313700675964
. O 0 0.031824350357055664

Three O 0 0.03705034777522087
patients O 1 0.9974114298820496
with O 0 0.012866884469985962
the O 0 0.01993633434176445
I1307K O 0 0.23144733905792236
allele O 0 0.1375976800918579
were O 0 0.0169706828892231
detected O 0 0.06624127924442291
, O 0 0.009715722873806953
each O 0 0.00932665728032589
of O 0 0.012979863211512566
Ashkenazi O 0 0.14479979872703552
descent O 0 0.09549219906330109
. O 0 0.033634528517723083

Four O 0 0.041509199887514114
patients O 1 0.9999346733093262
had O 0 0.022421177476644516
a O 0 0.029793232679367065
germ O 1 0.9998468160629272
- O 0 0.12077823281288147
line O 0 0.05847124382853508
E1317Q O 0 0.2620455026626587
missense O 0 0.21790093183517456
variant O 0 0.1143903061747551
of O 0 0.019231300801038742
APC O 1 0.9806405305862427
that O 0 0.010642453096807003
was O 0 0.011457833461463451
not O 0 0.005733403842896223
present O 0 0.008757412433624268
in O 0 0.008567471988499165
controls O 0 0.031918931752443314
; O 0 0.009953470900654793
one O 0 0.005372578278183937
of O 0 0.0042192405089735985
these O 0 0.00521153025329113
individuals O 0 0.012777467258274555
had O 0 0.011653422378003597
an O 0 0.011964811943471432
unusually O 0 0.047668687999248505
large O 0 0.013442057184875011
number O 0 0.009463328868150711
of O 0 0.014522306621074677
metaplastic B-Disease 1 0.9975298047065735
polyps I-Disease 1 0.9976623058319092
of I-Disease 0 0.012720150873064995
the I-Disease 0 0.02001667581498623
colorectum I-Disease 1 0.9684785008430481
. O 0 0.029622849076986313

There O 0 0.017465446144342422
is O 0 0.011426862329244614
increasing O 0 0.019644496962428093
evidence O 0 0.013354790396988392
that O 0 0.007415210362523794
there O 0 0.010301953181624413
exist O 0 0.02338256686925888
germ O 1 0.9997287392616272
- O 0 0.07344082742929459
line O 0 0.02814570814371109
variants O 0 0.0343766026198864
of O 0 0.009511168114840984
the O 0 0.020402634516358376
APC B-Disease 1 0.9906688332557678
gene O 0 0.09237940609455109
that O 0 0.013816489838063717
predispose O 0 0.10874266922473907
to O 0 0.008051310665905476
the O 0 0.008529252372682095
development O 0 0.019012218341231346
of O 0 0.015115885064005852
multiple O 1 0.9834708571434021
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.7454278469085693
carcinoma I-Disease 1 1.0
, O 0 0.015271853655576706
but O 0 0.009303896687924862
without O 0 0.012448305264115334
the O 0 0.017715584486722946
florid O 1 0.8459610342979431
phenotype O 0 0.32155919075012207
of O 0 0.018527017906308174
classical O 0 0.058655496686697006
FAP B-Disease 1 0.9999974966049194
, O 0 0.013474232517182827
and O 0 0.007948609068989754
possibly O 0 0.02157994732260704
with O 0 0.009850083850324154
importance O 0 0.025268884375691414
for O 0 0.23914778232574463
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.997902512550354
in O 0 0.008766602724790573
the O 0 0.007460523396730423
general O 0 0.013427776284515858
population O 0 0.020272545516490936
. O 0 0.013080346398055553
. O 0 0.022209836170077324

Genomic O 0 0.12868645787239075
structure O 0 0.028130359947681427
of O 0 0.008465022780001163
the O 0 0.015485236421227455
human O 1 0.9735047817230225
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9838150143623352
CLD B-Disease 1 0.9999998807907104
) O 0 0.05396027863025665
gene O 0 0.1005437970161438
. O 0 0.02867196500301361

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9917235970497131
CLD B-Disease 1 0.9999998807907104
) O 0 0.033511169254779816
is O 0 0.017033768817782402
caused O 0 0.05302267149090767
by O 0 0.015726279467344284
mutations O 0 0.08182815462350845
in O 0 0.013118121773004532
a O 0 0.020968865603208542
gene O 0 0.06255785375833511
which O 0 0.016375606879591942
encodes O 0 0.07928463816642761
an O 0 0.03945804387331009
intestinal O 1 0.9999991655349731
anion O 1 0.9976534247398376
transporter O 1 0.9816024899482727
. O 0 0.04571378603577614

We O 0 0.01698913238942623
report O 0 0.0147254578769207
here O 0 0.00952979177236557
the O 0 0.008704275824129581
complete O 0 0.024719268083572388
genomic O 0 0.07648684829473495
organization O 0 0.024430235847830772
of O 0 0.008367078378796577
the O 0 0.013751518912613392
human O 0 0.048680540174245834
CLD B-Disease 1 0.9999970197677612
gene O 0 0.0962039902806282
which O 0 0.01718556508421898
spans O 0 0.06291767954826355
approximately O 0 0.03821682929992676
39kb O 0 0.16091042757034302
, O 0 0.01252793800085783
and O 0 0.010182789526879787
comprises O 0 0.03192109614610672
21 O 0 0.03491556644439697
exons O 0 0.11264750361442566
. O 0 0.02936629205942154

All O 0 0.03154411166906357
exon O 0 0.21115374565124512
/ O 1 0.5651175379753113
intron O 0 0.24135960638523102
boundaries O 0 0.029875515028834343
conform O 0 0.037047404795885086
to O 0 0.012572665698826313
the O 0 0.02473633736371994
GT O 1 0.9999641180038452
/ O 1 0.9999066591262817
AG O 1 0.9999088048934937
rule O 0 0.04073755443096161
. O 0 0.0237143374979496

An O 0 0.01995762437582016
analysis O 0 0.018293030560016632
of O 0 0.007202484644949436
the O 0 0.01474193949252367
putative O 0 0.13728024065494537
promoter O 0 0.1535753309726715
region O 0 0.046204328536987305
sequence O 0 0.03234138339757919
shows O 0 0.024593090638518333
a O 0 0.02607904002070427
putative O 0 0.14675955474376678
TATA O 1 0.9921959638595581
box O 0 0.06044798716902733
and O 0 0.016404563561081886
predicts O 0 0.08841291069984436
multiple O 0 0.053125444799661636
transcription O 0 0.10549400001764297
factor O 0 0.07300196588039398
binding O 0 0.052046988159418106
sites O 0 0.033475738018751144
. O 0 0.02845018357038498

The O 0 0.03001379780471325
genomic O 0 0.1089043840765953
structure O 0 0.02943587303161621
was O 0 0.01793014444410801
determined O 0 0.026099156588315964
using O 0 0.01619477942585945
DNA O 0 0.037685561925172806
from O 0 0.00843905657529831
several O 0 0.00660001439973712
sources O 0 0.012196051888167858
including O 0 0.009020487777888775
multiple O 0 0.02619803510606289
large O 0 0.025733621791005135
- O 0 0.0968858078122139
insert O 0 0.14926187694072723
libaries O 0 0.18665730953216553
and O 0 0.018367109820246696
genomic O 0 0.11396751552820206
DNA O 0 0.07180709391832352
from O 0 0.025961188599467278
Finnish O 1 0.9804531335830688
CLD B-Disease 1 1.0
patients O 1 0.99997878074646
and O 0 0.01587529480457306
controls O 0 0.05374567210674286
. O 0 0.0303055327385664

Exon O 0 0.2551848590373993
- O 0 0.10918287187814713
specific O 0 0.0379367358982563
primers O 0 0.13391536474227905
developed O 0 0.03368467092514038
in O 0 0.00846046581864357
this O 0 0.007865478284657001
study O 0 0.01853139139711857
will O 0 0.01119934394955635
facilitate O 0 0.04210334271192551
mutation O 0 0.1400827318429947
screening O 0 0.08761006593704224
studies O 0 0.027738649398088455
of O 0 0.012431158684194088
patients O 1 0.9999700784683228
with O 0 0.015128680504858494
the O 0 0.02361605130136013
disease O 1 0.9999998807907104
. O 0 0.03051188215613365

Genomic O 0 0.15998156368732452
sequencing O 0 0.07497835904359818
of O 0 0.015827033668756485
a O 0 0.04663916677236557
BAC O 1 0.9998527765274048
clone O 1 0.9895482063293457
H O 1 0.9999191761016846
_ O 0 0.05546863004565239
RG364P16 O 0 0.14888909459114075
revealed O 0 0.036992695182561874
the O 0 0.010540638118982315
presence O 0 0.02317548543214798
of O 0 0.007310507819056511
another O 0 0.01632849872112274
, O 0 0.01402030698955059
highly O 0 0.03922642394900322
homologous O 0 0.13100412487983704
gene O 0 0.08206208050251007
3 O 0 0.022051099687814713
of O 0 0.009645683690905571
the O 0 0.024264227598905563
CLD B-Disease 1 0.9999986886978149
gene O 0 0.0852239578962326
, O 0 0.010636476799845695
with O 0 0.008336408995091915
a O 0 0.015154622495174408
similar O 0 0.019662197679281235
genomic O 0 0.0911407396197319
structure O 0 0.02926413156092167
, O 0 0.011786459013819695
recently O 0 0.023054765537381172
identified O 0 0.02027505449950695
as O 0 0.01049196720123291
the O 0 0.029100259765982628
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.39491355419158936
( O 0 0.055978283286094666
PDS B-Disease 1 0.999975323677063
) O 0 0.023917987942695618
. O 0 0.013521592132747173
. O 0 0.02437661960721016

The O 0 0.05122889578342438
APCI1307K O 1 0.9982478618621826
allele O 0 0.4238061308860779
and O 0 0.0324392206966877
cancer B-Disease 1 0.9999998807907104
risk O 1 0.617723286151886
in O 0 0.010740197263658047
a O 0 0.016546757891774178
community O 0 0.03065360151231289
- O 0 0.05046098306775093
based O 0 0.019977452233433723
study O 0 0.02209590934216976
of O 0 0.0133218327537179
Ashkenazi O 0 0.1491049975156784
Jews O 0 0.03605635464191437
. O 0 0.028440656140446663

Mutations O 0 0.17709584534168243
in O 0 0.029706494882702827
APC O 1 0.9881877303123474
are O 0 0.020597048103809357
classically O 1 0.97944176197052
associated O 0 0.044716741889715195
with O 0 0.03963717073202133
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.989685595035553
FAP B-Disease 1 0.9999998807907104
) O 0 0.026435144245624542
, O 0 0.011149332858622074
a O 0 0.021706411615014076
highly O 0 0.06827898323535919
penetrant O 1 0.9999974966049194
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.999967098236084
disorder I-Disease 1 1.0
characterized O 1 0.996208667755127
by O 0 0.02067543938755989
multiple O 1 0.7591589689254761
intestinal O 1 1.0
polyps B-Disease 1 0.9999946355819702
and O 0 0.013627595268189907
, O 0 0.01263201143592596
without O 0 0.018000423908233643
surgical O 1 0.9999947547912598
intervention O 0 0.26038670539855957
, O 0 0.008583156391978264
the O 0 0.008122957311570644
development O 0 0.02485201694071293
of O 0 0.030101604759693146
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.3506052494049072
CRC B-Disease 1 0.9998407363891602
) O 0 0.031045308336615562
. O 0 0.025203540921211243

APC B-Disease 1 0.9835473895072937
is O 0 0.03659164160490036
a O 0 0.05801691487431526
tumour O 1 1.0
- O 1 0.9887261986732483
suppressor O 1 0.9518073201179504
gene O 0 0.09157843142747879
, O 0 0.015257961116731167
and O 0 0.01672111265361309
somatic O 0 0.1962006539106369
loss O 0 0.22732366621494293
occurs O 0 0.06398139148950577
in O 0 0.024310071021318436
tumours B-Disease 1 0.9999992847442627
. O 0 0.03360523656010628

The O 0 0.05617490038275719
germline O 1 0.9985976815223694
T O 1 0.9998319149017334
- O 0 0.07826355844736099
to O 0 0.01841086894273758
- O 0 0.07187576591968536
A O 0 0.0464402474462986
transversion O 0 0.15176096558570862
responsible O 0 0.034871987998485565
for O 0 0.01074844878166914
the O 0 0.021219899877905846
APC O 1 0.9136316776275635
I1307K O 0 0.21832045912742615
allele O 0 0.16446131467819214
converts O 0 0.062327008694410324
the O 0 0.018342813476920128
wild O 0 0.053995903581380844
- O 0 0.08234146237373352
type O 0 0.061667174100875854
sequence O 0 0.030352775007486343
to O 0 0.013708471320569515
a O 0 0.03240856155753136
homopolymer O 1 0.9938263297080994
tract O 1 0.9997560381889343
( O 0 0.06060248613357544
A8 O 1 0.9998645782470703
) O 0 0.0214120764285326
that O 0 0.007863295264542103
is O 0 0.014407536014914513
genetically O 0 0.05155753716826439
unstable O 1 0.5780345797538757
and O 0 0.018498998135328293
prone O 1 0.591838002204895
to O 0 0.02446882054209709
somatic O 0 0.21613584458827972
mutation O 0 0.180807963013649
. O 0 0.03693326935172081

The O 0 0.03907741233706474
I1307K O 0 0.20938430726528168
allele O 0 0.16444426774978638
was O 0 0.024418285116553307
found O 0 0.016997113823890686
in O 0 0.012071439996361732
6 O 0 0.030257293954491615
. O 0 0.021063407883048058

1 O 0 0.0461893230676651
% O 0 0.03047030046582222
of O 0 0.018526311963796616
unselected O 1 0.6213168501853943
Ashkenazi O 0 0.18518096208572388
Jews O 0 0.02857525274157524
and O 0 0.011827909387648106
higher O 0 0.028999019414186478
proportions O 0 0.0634094625711441
of O 0 0.013012158684432507
Ashkenazim O 1 0.7162799835205078
with O 0 0.013593200594186783
family O 0 0.022682953625917435
or O 0 0.013090020976960659
personal O 0 0.018955983221530914
histories O 0 0.047850556671619415
of O 0 0.016078542917966843
CRC B-Disease 1 0.9995189905166626
( O 0 0.04909323900938034
ref O 0 0.376876562833786
. O 0 0.0160095002502203
2 O 0 0.028166402131319046
) O 0 0.0256202295422554
. O 0 0.022372262552380562

To O 0 0.020028967410326004
evaluate O 0 0.044811926782131195
the O 0 0.011811640113592148
role O 0 0.02083590067923069
of O 0 0.012188655324280262
I1307K O 1 0.852797269821167
in O 0 0.023324018344283104
cancer B-Disease 1 0.9999986886978149
, O 0 0.0156843438744545
we O 0 0.0145665118470788
genotyped O 0 0.18881571292877197
5 O 0 0.03287600725889206
, O 0 0.025684108957648277
081 O 1 0.9866389036178589
Ashkenazi O 0 0.1592223346233368
volunteers O 0 0.05174284800887108
in O 0 0.011436335742473602
a O 0 0.01705615594983101
community O 0 0.03192438557744026
survey O 0 0.04270153120160103
. O 0 0.025803828611969948

Risk O 1 0.9031574726104736
of O 0 0.023050419986248016
developing O 1 0.9903111457824707
colorectal B-Disease 1 1.0
, I-Disease 0 0.045080434530973434
breast I-Disease 1 0.9999995231628418
and I-Disease 0 0.013046841137111187
other I-Disease 0 0.012007933109998703
cancers I-Disease 1 0.9999406337738037
were O 0 0.010784821584820747
compared O 0 0.02639404498040676
between O 0 0.02338971011340618
genotyped O 1 0.9794315695762634
I1307K O 1 0.7575726509094238
carriers O 0 0.07521576434373856
and O 0 0.013751759193837643
non O 0 0.04480106011033058
- O 0 0.0742788016796112
carriers O 0 0.05779509246349335
and O 0 0.008292469196021557
their O 0 0.008084757253527641
first O 0 0.017405064776539803
- O 0 0.07090692967176437
degree O 0 0.05258463695645332
relatives O 0 0.06119128316640854
. O 0 0.03228512033820152

Sperm O 0 0.16236039996147156
DNA O 0 0.0780089944601059
analysis O 0 0.028229501098394394
in O 0 0.016634929925203323
a O 0 0.04190061241388321
Friedreich B-Disease 1 0.9999673366546631
ataxia I-Disease 1 0.9999802112579346
premutation O 1 0.9897938966751099
carrier O 0 0.2998804450035095
suggests O 0 0.05531255528330803
both O 0 0.017721759155392647
meiotic O 1 0.8072640299797058
and O 0 0.02193874679505825
mitotic O 0 0.14657902717590332
expansion O 0 0.036928724497556686
in O 0 0.012662462890148163
the O 0 0.02178647555410862
FRDA B-Disease 1 0.9969839453697205
gene O 0 0.12197814881801605
. O 0 0.030963817611336708

Friedreich B-Disease 1 0.9999881982803345
ataxia I-Disease 1 0.9999854564666748
is O 0 0.03277153521776199
usually O 0 0.025635523721575737
caused O 0 0.03660248592495918
by O 0 0.007046131417155266
an O 0 0.009215067140758038
expansion O 0 0.022216005250811577
of O 0 0.00870443694293499
a O 0 0.025994528084993362
GAA O 0 0.49871399998664856
trinucleotide O 1 0.9947370886802673
repeat O 0 0.0930459126830101
in O 0 0.023947373032569885
intron O 0 0.2749098241329193
1 O 0 0.02672700211405754
of O 0 0.009796740487217903
the O 0 0.02126401662826538
FRDA B-Disease 1 0.9970380067825317
gene O 0 0.11722033470869064
. O 0 0.03707265853881836

Occasionally O 0 0.061056043952703476
, O 0 0.013741789385676384
a O 0 0.01618017628788948
fully O 0 0.028940200805664062
expanded O 0 0.031222527846693993
allele O 0 0.11001497507095337
has O 0 0.01520463451743126
been O 0 0.009526209905743599
found O 0 0.0104322899132967
to O 0 0.008624773472547531
arise O 0 0.03036794625222683
from O 0 0.010850122198462486
a O 0 0.018358921632170677
premutation O 0 0.10762601345777512
of O 0 0.0101478211581707
100 O 0 0.026223234832286835
or O 0 0.0185688529163599
less O 0 0.02817150577902794
triplet O 1 0.5278618931770325
repeats O 0 0.12164746969938278
. O 0 0.032403066754341125

We O 0 0.0200330913066864
have O 0 0.01094573363661766
examined O 0 0.04173902049660683
the O 0 0.014008564874529839
sperm O 0 0.08281239867210388
DNA O 0 0.04568513110280037
of O 0 0.011748447082936764
a O 0 0.02626149356365204
premutation O 1 0.8858751058578491
carrier O 0 0.15349845588207245
. O 0 0.03407802805304527

This O 0 0.0313628651201725
mans O 0 0.1532091200351715
leucocyte O 1 0.7413702011108398
DNA O 0 0.07750144600868225
showed O 0 0.03314441069960594
one O 0 0.014477601274847984
normal O 0 0.039960701018571854
allele O 0 0.10710486769676208
and O 0 0.010930052027106285
one O 0 0.014032019302248955
allele O 0 0.09303691983222961
of O 0 0.011099353432655334
approximately O 0 0.02749454788863659
100 O 0 0.03507938235998154
repeats O 0 0.08917517215013504
. O 0 0.02910507656633854

His O 0 0.03772231191396713
sperm O 0 0.09539142996072769
showed O 0 0.03144974261522293
an O 0 0.014345893636345863
expanded O 0 0.02691543847322464
allele O 0 0.10290007293224335
in O 0 0.013353276066482067
a O 0 0.018706491217017174
tight O 0 0.04085734486579895
range O 0 0.029097924008965492
centering O 0 0.050811391323804855
on O 0 0.00904761254787445
a O 0 0.014525596052408218
size O 0 0.018487045541405678
of O 0 0.010272019542753696
approximately O 0 0.040027499198913574
320 O 0 0.1415516883134842
trinucleotide O 1 0.9804835319519043
repeats O 0 0.1383814662694931
. O 0 0.040028758347034454

His O 0 0.04038742184638977
affected O 0 0.07506319880485535
son O 0 0.06388057768344879
has O 0 0.019975541159510612
repeat O 0 0.06895323097705841
sizes O 0 0.028170695528388023
of O 0 0.013159633614122868
1040 O 1 0.9497477412223816
and O 0 0.02222036011517048
540 O 0 0.1405154913663864
. O 0 0.034008026123046875

These O 0 0.01717963255941868
data O 0 0.017307497560977936
suggest O 0 0.02227064222097397
that O 0 0.008396691642701626
expansion O 0 0.03138476237654686
occurs O 0 0.030612783506512642
in O 0 0.006880450062453747
two O 0 0.007859951816499233
stages O 0 0.03334343060851097
, O 0 0.007654189132153988
the O 0 0.008179577067494392
first O 0 0.01344977505505085
during O 0 0.023389454931020737
meiosis O 0 0.10086394101381302
followed O 0 0.020520934835076332
by O 0 0.009054519236087799
a O 0 0.016461728140711784
second O 0 0.02713531069457531
mitotic O 0 0.17075055837631226
expansion O 0 0.06348913162946701
. O 0 0.03351930156350136

We O 0 0.019922638311982155
also O 0 0.011551057919859886
show O 0 0.014629795216023922
that O 0 0.005199133418500423
in O 0 0.006563745904713869
all O 0 0.00734608992934227
informative O 0 0.047171253710985184
carrier O 0 0.0776616781949997
father O 0 0.03138001263141632
to O 0 0.013179345987737179
affected O 0 0.05000244081020355
child O 0 0.05414297431707382
transmissions O 0 0.06658625602722168
, O 0 0.009332900866866112
with O 0 0.006696097552776337
the O 0 0.008593061938881874
notable O 0 0.016069961711764336
exception O 0 0.022882141172885895
of O 0 0.007388864178210497
the O 0 0.016613271087408066
premutation O 1 0.9303383827209473
carrier O 0 0.09640012681484222
, O 0 0.011744583025574684
the O 0 0.010561168193817139
expansion O 0 0.03562745824456215
size O 0 0.03537268191576004
decreases O 0 0.07460849732160568
. O 0 0.01481118518859148
. O 0 0.022640502080321312

The O 0 0.04849213361740112
R496H O 0 0.2236071079969406
mutation O 0 0.13957597315311432
of O 0 0.01758732832968235
arylsulfatase O 1 0.8437741994857788
A O 0 0.0323939248919487
does O 0 0.02225503697991371
not O 0 0.016045937314629555
cause O 1 0.9186180830001831
metachromatic B-Disease 1 0.9999905824661255
leukodystrophy I-Disease 1 0.9999997615814209
. O 0 0.05427103862166405

Deficiency B-Disease 1 0.9999996423721313
of I-Disease 0 0.02676892839372158
arylsulfatase I-Disease 1 0.9415895342826843
A I-Disease 0 0.05564603582024574
( O 0 0.05399206653237343
ARSA O 1 0.9998891353607178
) O 0 0.04905550554394722
enzyme O 0 0.13607126474380493
activity O 0 0.0758780986070633
causes O 1 0.9992157220840454
metachromatic B-Disease 1 0.9999969005584717
leukodystrophy I-Disease 1 1.0
( O 1 0.6860717535018921
MLD B-Disease 1 0.9999998807907104
) O 0 0.04127269610762596
. O 0 0.025035332888364792

A O 0 0.037140678614377975
number O 0 0.014046981930732727
of O 0 0.022768018767237663
ARSA O 1 0.999514102935791
gene O 0 0.15272337198257446
mutations O 0 0.12542201578617096
responsible O 0 0.038899004459381104
for O 0 0.022106222808361053
MLD B-Disease 1 0.9999998807907104
have O 0 0.015956254675984383
been O 0 0.015553631819784641
identified O 0 0.03349601477384567
. O 0 0.024226393550634384

Recently O 0 0.05653349682688713
, O 0 0.015268423594534397
the O 0 0.018822303041815758
R496H O 0 0.21126557886600494
mutation O 0 0.13873764872550964
of O 0 0.020698925480246544
ARSA O 1 0.9995416402816772
was O 0 0.019914325326681137
proposed O 0 0.01653287559747696
to O 0 0.008419662714004517
be O 0 0.008671140298247337
a O 0 0.017778225243091583
cause O 0 0.06208234652876854
of O 0 0.02637239173054695
MLD B-Disease 1 0.9999997615814209
( O 0 0.06461261957883835
Draghia O 1 0.9902464151382446
et O 0 0.13319209218025208
al O 0 0.07121190428733826
. O 0 0.01246851496398449
, O 0 0.013331160880625248
1997 O 0 0.037965189665555954
) O 0 0.02686215750873089
. O 0 0.02355887182056904

We O 0 0.02077805995941162
have O 0 0.014504384249448776
investigated O 0 0.050237987190485
the O 0 0.019355718046426773
R496H O 1 0.607354998588562
mutation O 0 0.12101646512746811
and O 0 0.011302169412374496
found O 0 0.018656088039278984
this O 0 0.013918939977884293
mutation O 0 0.10127412527799606
at O 0 0.020619262009859085
a O 0 0.018626399338245392
relatively O 0 0.02601086162030697
high O 0 0.02635129913687706
frequency O 0 0.0341215543448925
in O 0 0.007679841481149197
an O 0 0.010558216832578182
African O 0 0.03589467331767082
American O 0 0.0315946601331234
population O 0 0.03172971308231354
( O 0 0.041558198630809784
f O 0 0.11150433123111725
= O 0 0.10820038616657257
0 O 0 0.046384297311306
. O 0 0.015375301241874695
09 O 0 0.09868542850017548
, O 0 0.024372829124331474
n O 0 0.08828145265579224
= O 0 0.11596611887216568
61 O 0 0.06532339006662369
subjects O 0 0.03661366552114487
) O 0 0.029126586392521858
. O 0 0.0249803364276886

The O 0 0.061328087002038956
ARSA O 1 0.9984201192855835
enzyme O 0 0.15221476554870605
activity O 0 0.037086788564920425
in O 0 0.008979834616184235
subjects O 0 0.019754065200686455
with O 0 0.007017288822680712
and O 0 0.0069253575056791306
without O 0 0.01210266537964344
the O 0 0.017963768914341927
R496H O 0 0.3055320680141449
mutation O 0 0.12992341816425323
was O 0 0.020903630182147026
determined O 0 0.02463199570775032
and O 0 0.008144560270011425
found O 0 0.010613634251058102
to O 0 0.007254160009324551
be O 0 0.009126046672463417
normal O 0 0.03806081786751747
. O 0 0.0213214922696352

It O 0 0.019823135808110237
is O 0 0.013446802273392677
therefore O 0 0.016623832285404205
concluded O 0 0.03113502636551857
that O 0 0.009061992168426514
the O 0 0.017933402210474014
R496H O 0 0.2821623384952545
mutation O 0 0.14533112943172455
of O 0 0.025684723630547523
ARSA O 1 0.9998936653137207
does O 0 0.025557897984981537
not O 0 0.01119685173034668
negatively O 0 0.04310309886932373
influence O 0 0.017924394458532333
the O 0 0.009447488002479076
activity O 0 0.027606507763266563
of O 0 0.013294187374413013
ARSA O 1 0.9999346733093262
and O 0 0.010305114090442657
is O 0 0.00983278825879097
not O 0 0.007273088674992323
a O 0 0.019416533410549164
cause O 0 0.06830855458974838
of O 0 0.029374757781624794
MLD B-Disease 1 0.9999994039535522

Down O 0 0.07062067836523056
- O 0 0.09518874436616898
regulation O 0 0.055116765201091766
of O 0 0.021612972021102905
transmembrane O 0 0.2879788279533386
carbonic O 1 0.9986091256141663
anhydrases O 1 0.9980863332748413
in O 0 0.06211309880018234
renal B-Disease 1 1.0
cell I-Disease 1 0.9999707937240601
carcinoma I-Disease 1 1.0
cell O 0 0.20078769326210022
lines O 0 0.028776561841368675
by O 0 0.014030593447387218
wild O 0 0.054208531975746155
- O 0 0.21550673246383667
type O 0 0.27107104659080505
von B-Disease 1 0.9839311242103577
Hippel I-Disease 1 0.9993403553962708
- I-Disease 1 0.8311338424682617
Lindau I-Disease 1 0.995672881603241
transgenes O 1 0.6954522132873535
. O 0 0.049604859203100204

To O 0 0.03309144079685211
discover O 0 0.0883733481168747
genes O 0 0.0575677864253521
involved O 0 0.032875776290893555
in O 0 0.024293577298521996
von B-Disease 1 0.9852396249771118
Hippel I-Disease 1 0.9998252987861633
- I-Disease 1 0.9346965551376343
Lindau I-Disease 1 0.9994866847991943
( O 0 0.08717368543148041
VHL B-Disease 1 0.9999874830245972
) O 0 0.05190829560160637
- O 0 0.2035977840423584
mediated O 1 0.8784338235855103
carcinogenesis O 1 0.9994456171989441
, O 0 0.01924237795174122
we O 0 0.013894581235945225
used O 0 0.03653202950954437
renal B-Disease 1 1.0
cell I-Disease 1 0.9999344348907471
carcinoma I-Disease 1 1.0
cell O 0 0.18254967033863068
lines O 0 0.048402804881334305
stably O 0 0.16061560809612274
transfected O 1 0.8645017743110657
with O 0 0.022473450750112534
wild O 0 0.07110094279050827
- O 1 0.7342432141304016
type O 1 0.9177237153053284
VHL O 1 0.9999881982803345
- O 0 0.1871543675661087
expressing O 0 0.12175395339727402
transgenes O 0 0.44468867778778076
. O 0 0.04492392763495445

Large O 0 0.05888206884264946
- O 0 0.12065143138170242
scale O 0 0.09254860132932663
RNA O 0 0.12815475463867188
differential O 0 0.09060246497392654
display O 0 0.033053088933229446
technology O 0 0.031143194064497948
applied O 0 0.018624737858772278
to O 0 0.008362884633243084
these O 0 0.009511315263807774
cell O 0 0.05361521989107132
lines O 0 0.02657732553780079
identified O 0 0.025961577892303467
several O 0 0.013933012261986732
differentially O 0 0.13101248443126678
expressed O 0 0.03842280060052872
genes O 0 0.04929685592651367
, O 0 0.011703262105584145
including O 0 0.01177979726344347
an O 0 0.02395663410425186
alpha O 0 0.1431100070476532
carbonic O 1 0.9800889492034912
anhydrase O 1 0.9956681728363037
gene O 0 0.1326618790626526
, O 0 0.029528962448239326
termed O 0 0.12275367230176926
CA12 O 1 0.9944382905960083
. O 0 0.045357439666986465

The O 0 0.037374552339315414
deduced O 0 0.10691717267036438
protein O 0 0.057552434504032135
sequence O 0 0.029139483347535133
was O 0 0.015315253287553787
classified O 0 0.023865779861807823
as O 0 0.008377858437597752
a O 0 0.014340130612254143
one O 0 0.013116493821144104
- O 0 0.06862606108188629
pass O 0 0.05494365468621254
transmembrane O 0 0.17807558178901672
CA O 0 0.07534331828355789
possessing O 0 0.036800090223550797
an O 0 0.01636791229248047
apparently O 0 0.04654186964035034
intact O 0 0.06344934552907944
catalytic O 0 0.09434698522090912
domain O 0 0.03056253492832184
in O 0 0.011390571482479572
the O 0 0.017609883099794388
extracellular O 0 0.12979203462600708
CA O 0 0.27488040924072266
module O 0 0.12202801555395126
. O 0 0.03174963966012001

Reintroduced O 0 0.1906147599220276
wild O 0 0.10887040197849274
- O 0 0.176008403301239
type O 0 0.16467951238155365
VHL B-Disease 1 0.9997519850730896
strongly O 0 0.06784424185752869
inhibited O 0 0.13651365041732788
the O 0 0.019744275137782097
overexpression O 0 0.1179245188832283
of O 0 0.010617194697260857
the O 0 0.01744016446173191
CA12 O 1 0.9958546757698059
gene O 0 0.06899242848157883
in O 0 0.012369050644338131
the O 0 0.022754300385713577
parental O 1 0.9999767541885376
renal B-Disease 1 1.0
cell I-Disease 1 0.9999971389770508
carcinoma I-Disease 1 1.0
cell O 1 0.7405684590339661
lines O 0 0.0408523865044117
. O 0 0.024230847135186195

Similar O 0 0.042180389165878296
results O 0 0.026813505217432976
were O 0 0.009402071125805378
obtained O 0 0.020071037113666534
with O 0 0.01956300437450409
CA9 O 1 0.9999591112136841
, O 0 0.019204162061214447
encoding O 0 0.0475664958357811
another O 0 0.031448718160390854
transmembrane O 0 0.1439494788646698
CA O 0 0.05906687676906586
with O 0 0.009925643913447857
an O 0 0.016136785969138145
intact O 0 0.07207261770963669
catalytic O 0 0.131747767329216
domain O 0 0.06077960506081581
. O 0 0.030259259045124054

Although O 0 0.021886451169848442
both O 0 0.010539225302636623
domains O 0 0.034642718732357025
of O 0 0.009331936948001385
the O 0 0.022925112396478653
VHL B-Disease 1 0.9996026158332825
protein O 0 0.0817764401435852
contribute O 0 0.040510259568691254
to O 0 0.011359668336808681
regulation O 0 0.03726299852132797
of O 0 0.014009026810526848
CA12 O 1 0.9963527917861938
expression O 0 0.0448305606842041
, O 0 0.012125703506171703
the O 0 0.0157136470079422
elongin O 0 0.1783147007226944
binding O 0 0.05341779813170433
domain O 0 0.04320811480283737
alone O 0 0.0357217900454998
could O 0 0.018031775951385498
effectively O 0 0.048499688506126404
regulate O 0 0.12634217739105225
CA9 O 1 0.9999361038208008
expression O 0 0.08933331072330475
. O 0 0.03387361764907837

We O 0 0.034007489681243896
mapped O 0 0.09690089523792267
CA12 O 1 0.9641223549842834
and O 0 0.04131621867418289
CA9 O 1 0.9995719790458679
loci O 0 0.190528005361557
to O 0 0.027276724576950073
chromosome O 0 0.14565345644950867
bands O 0 0.07190123945474625
15q22 O 0 0.15464693307876587
and O 0 0.02292039431631565
17q21 O 0 0.22779856622219086
. O 0 0.03743347153067589

2 O 0 0.041082896292209625
respectively O 0 0.026306869462132454
, O 0 0.014396407641470432
regions O 0 0.032653503119945526
prone O 0 0.20748615264892578
to O 0 0.017436420544981956
amplification O 0 0.11419076472520828
in O 0 0.012203395366668701
some O 0 0.013647145591676235
human O 0 0.04254838824272156
cancers B-Disease 1 0.999972939491272
. O 0 0.03368782252073288

Additional O 0 0.038570206612348557
experiments O 0 0.040334030985832214
are O 0 0.007309583947062492
needed O 0 0.018360350281000137
to O 0 0.0062073227018117905
define O 0 0.018621915951371193
the O 0 0.00863513071089983
role O 0 0.01961001381278038
of O 0 0.012428348883986473
CA O 1 0.9660121202468872
IX O 1 0.9967222809791565
and O 0 0.019978130236268044
CA O 1 0.5299028754234314
XII O 1 0.9531468152999878
enzymes O 0 0.04178818687796593
in O 0 0.00897308997809887
the O 0 0.011550737544894218
regulation O 0 0.0359848327934742
of O 0 0.012389350682497025
pH O 0 0.13368262350559235
in O 0 0.0126668531447649
the O 0 0.01709114760160446
extracellular O 0 0.11050906777381897
microenvironment O 1 0.8373101949691772
and O 0 0.011456158943474293
its O 0 0.011877256445586681
potential O 0 0.03189613297581673
impact O 0 0.038793906569480896
on O 0 0.021237961947917938
cancer B-Disease 1 0.9999998807907104
cell O 0 0.38378581404685974
growth O 0 0.046482644975185394
. O 0 0.023197490721940994

A O 0 0.06365275382995605
gene O 0 0.09588851034641266
encoding O 0 0.06171353906393051
a O 0 0.03704705834388733
transmembrane O 0 0.16323667764663696
protein O 0 0.06970565766096115
is O 0 0.022036755457520485
mutated O 0 0.1086750477552414
in O 0 0.02309964969754219
patients O 1 0.999998927116394
with O 0 0.27266502380371094
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.7465066313743591
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9996179342269897
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.0464356355369091
. O 0 0.03006983920931816

Wolfram B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 1 0.7995344400405884
WFS B-Disease 1 0.9999997615814209
; O 0 0.0717046782374382
OMIM O 1 0.9999444484710693
222300 O 1 0.7615118622779846
) O 0 0.028737394139170647
is O 0 0.017320536077022552
an O 0 0.028863973915576935
autosomal B-Disease 1 0.9999696016311646
recessive I-Disease 1 0.9999992847442627
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 0.03693192079663277
by O 0 0.015341040678322315
young O 1 0.5168001651763916
- O 1 0.994671642780304
onset O 1 0.9999849796295166
non O 1 0.8861685395240784
- O 1 0.9995535016059875
immune O 1 0.9999990463256836
insulin B-Disease 1 0.9999916553497314
- I-Disease 1 0.9989832043647766
dependent I-Disease 1 0.998580813407898
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.04459090158343315
progressive O 1 0.9998815059661865
optic B-Disease 1 0.9999998807907104
atrophy I-Disease 1 0.9999912977218628
. O 0 0.04183419421315193

Linkage O 0 0.18552792072296143
to O 0 0.019933681935071945
markers O 0 0.07184259593486786
on O 0 0.02317352406680584
chromosome O 0 0.18534067273139954
4p O 1 0.9932397603988647
was O 0 0.0249633751809597
confirmed O 0 0.02518622577190399
in O 0 0.0089386822655797
five O 0 0.014741586521267891
families O 0 0.03198752552270889
. O 0 0.025903701782226562

On O 0 0.011911389417946339
the O 0 0.008838043548166752
basis O 0 0.012226143851876259
of O 0 0.013725139200687408
meiotic O 1 0.9998668432235718
recombinants O 1 0.9998641014099121
and O 0 0.03380225598812103
disease O 1 1.0
- O 0 0.29463717341423035
associated O 0 0.051563337445259094
haplotypes O 0 0.22308073937892914
, O 0 0.019719602540135384
the O 0 0.025364316999912262
WFS B-Disease 1 0.9999929666519165
gene O 0 0.09713219851255417
was O 0 0.025213152170181274
localized O 0 0.08507250994443893
to O 0 0.01716720499098301
a O 0 0.039958655834198
BAC O 1 0.9999104738235474
/ O 1 0.9970575571060181
P1 O 1 0.989489734172821
contig O 0 0.146763414144516
of O 0 0.01056752074509859
less O 0 0.01576867140829563
than O 0 0.013341068290174007
250 O 0 0.05510801449418068
kb O 0 0.13608968257904053
. O 0 0.03374199569225311

Mutations O 0 0.1430233120918274
in O 0 0.01701982505619526
a O 0 0.022832654416561127
novel O 0 0.05138877406716347
gene O 0 0.10831553488969803
( O 0 0.051302094012498856
WFS1 O 1 0.9460732340812683
) O 0 0.0311298631131649
encoding O 0 0.04325466230511665
a O 0 0.030448492616415024
putative O 0 0.15175223350524902
transmembrane O 0 0.16246552765369415
protein O 0 0.049448393285274506
were O 0 0.008753025904297829
found O 0 0.010675200261175632
in O 0 0.0069138165563344955
all O 0 0.006770745385438204
affected O 0 0.02978578209877014
individuals O 0 0.016667094081640244
in O 0 0.010546487756073475
six O 0 0.02721465192735195
WFS B-Disease 1 0.9999990463256836
families O 0 0.033439282327890396
, O 0 0.011248389258980751
and O 0 0.007727259770035744
these O 0 0.009950881823897362
mutations O 0 0.0618375800549984
were O 0 0.00813975092023611
associated O 0 0.01682589203119278
with O 0 0.011686519719660282
the O 0 0.026991911232471466
disease O 1 0.9999998807907104
phenotype O 1 0.999601423740387
. O 0 0.03936989605426788

WFS1 O 1 0.9834449291229248
appears O 0 0.04386122152209282
to O 0 0.011479013599455357
function O 0 0.02221313677728176
in O 0 0.010953427292406559
survival O 0 0.07231612503528595
of O 0 0.014497269876301289
islet O 1 0.5278702974319458
beta O 0 0.424568235874176
- O 0 0.18118521571159363
cells O 0 0.09412747621536255
and O 0 0.017305245622992516
neurons O 0 0.12063959985971451
. O 0 0.016627363860607147
. O 0 0.022832617163658142

Stable O 0 0.09736714512109756
interaction O 0 0.03786710649728775
between O 0 0.010192286223173141
the O 0 0.007818644866347313
products O 0 0.014074030332267284
of O 0 0.007781842723488808
the O 0 0.018628906458616257
BRCA1 O 1 0.9993209838867188
and O 0 0.043043773621320724
BRCA2 O 1 0.9999914169311523
tumor B-Disease 1 0.9999940395355225
suppressor O 1 0.8841716051101685
genes O 0 0.06896522641181946
in O 0 0.019787603989243507
mitotic O 0 0.19703122973442078
and O 0 0.0253811813890934
meiotic O 1 0.9966669678688049
cells O 0 0.13490882515907288
. O 0 0.036566149443387985

BRCA1 O 1 0.9903959631919861
and O 0 0.03569411486387253
BRCA2 O 1 0.99639493227005
account O 0 0.021514419466257095
for O 0 0.006983109284192324
most O 0 0.008350178599357605
cases O 0 0.017026696354150772
of O 0 0.010451150126755238
familial O 1 0.9999722242355347
, O 0 0.019525326788425446
early O 0 0.09131275862455368
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 0 0.3437139689922333
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.999647855758667
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.012884000316262245
encode O 0 0.031673893332481384
products O 0 0.019242040812969208
that O 0 0.006969755981117487
each O 0 0.011414394713938236
interact O 0 0.04017973318696022
with O 0 0.019306927919387817
hRAD51 O 0 0.2658793032169342
. O 0 0.037699781358242035

Results O 0 0.05157022178173065
presented O 0 0.025700271129608154
here O 0 0.01546176802366972
show O 0 0.02651921845972538
that O 0 0.015973949804902077
BRCA1 O 1 0.9887795448303223
and O 0 0.023785419762134552
BRCA2 O 1 0.9985596537590027
coexist O 0 0.06743314862251282
in O 0 0.013209215365350246
a O 0 0.022854944691061974
biochemical O 0 0.09549423307180405
complex O 0 0.03573450446128845
and O 0 0.015150921419262886
colocalize O 0 0.1616426408290863
in O 0 0.024825965985655785
subnuclear O 1 0.8211684226989746
foci O 0 0.19306525588035583
in O 0 0.02331697754561901
somatic O 0 0.16387571394443512
cells O 0 0.06482361257076263
and O 0 0.009130967780947685
on O 0 0.007882499136030674
the O 0 0.013410932384431362
axial O 0 0.11077585816383362
elements O 0 0.020636675879359245
of O 0 0.012908315286040306
developing O 0 0.06692476570606232
synaptonemal O 1 0.9767313003540039
complexes O 0 0.13349220156669617
. O 0 0.035801928490400314

Like O 0 0.0690273568034172
BRCA1 O 1 0.9914342164993286
and O 0 0.03227929025888443
RAD51 O 1 0.9998652935028076
, O 0 0.03869353607296944
BRCA2 O 1 0.9914799928665161
relocates O 0 0.318185955286026
to O 0 0.04457476735115051
PCNA O 1 0.9974979758262634
+ O 0 0.2015364021062851
replication O 0 0.1452881246805191
sites O 0 0.03016340546309948
following O 0 0.02478494867682457
exposure O 1 0.8077540397644043
of O 0 0.015698814764618874
S O 1 0.9981325268745422
phase O 0 0.10258596390485764
cells O 0 0.08287975937128067
to O 0 0.023729514330625534
hydroxyurea O 1 0.999921441078186
or O 0 0.049342576414346695
UV O 1 0.9999544620513916
irradiation O 0 0.2241491973400116
. O 0 0.03879975154995918

Thus O 0 0.043368883430957794
, O 0 0.02558249607682228
BRCA1 O 1 0.9764503836631775
and O 0 0.027145452797412872
BRCA2 O 1 0.9937933683395386
participate O 0 0.027654552832245827
, O 0 0.010317211970686913
together O 0 0.007859233766794205
, O 0 0.007515879347920418
in O 0 0.00881507433950901
a O 0 0.02431921288371086
pathway O 0 0.13320253789424896
( O 0 0.0381656251847744
s O 0 0.10701592266559601
) O 0 0.017499767243862152
associated O 0 0.01341884583234787
with O 0 0.0075475373305380344
the O 0 0.011775145307183266
activation O 0 0.08357033878564835
of O 0 0.012947598472237587
double O 0 0.06740612536668777
- O 0 0.11001894623041153
strand O 0 0.12351316213607788
break O 0 0.0597832091152668
repair O 1 0.9923750758171082
and O 0 0.02027295157313347
/ O 1 0.9695013165473938
or O 0 0.02779977023601532
homologous O 0 0.15381021797657013
recombination O 0 0.20058920979499817
. O 0 0.03740473836660385

Dysfunction O 1 0.999983549118042
of O 0 0.016662446781992912
this O 0 0.017095305025577545
pathway O 0 0.12199531495571136
may O 0 0.01745009422302246
be O 0 0.006761967204511166
a O 0 0.011985977180302143
general O 0 0.01410872396081686
phenomenon O 0 0.03971000388264656
in O 0 0.006568286567926407
the O 0 0.00667200842872262
majority O 0 0.011720892041921616
of O 0 0.006489625200629234
cases O 0 0.018293259665369987
of O 0 0.012346935458481312
hereditary B-Disease 1 0.9999994039535522
breast I-Disease 1 1.0
and I-Disease 1 0.8521122336387634
/ I-Disease 1 1.0
or I-Disease 1 0.9999126195907593
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.022798661142587662
. O 0 0.022690966725349426

A O 0 0.06321790814399719
novel O 0 0.06976041197776794
Arg362Ser O 1 0.5905141830444336
mutation O 0 0.1355038285255432
in O 0 0.015003876760601997
the O 0 0.02308465912938118
sterol O 1 0.958599328994751
27 O 0 0.06989997625350952
- O 0 0.15690290927886963
hydroxylase O 1 0.5270895957946777
gene O 0 0.12913523614406586
( O 0 0.05608309432864189
CYP27 O 1 0.9949929118156433
) O 0 0.0280934926122427
: O 0 0.015508417040109634
its O 0 0.013563181273639202
effects O 0 0.05977942422032356
on O 0 0.01524569932371378
pre O 0 0.0933016911149025
- O 0 0.0997251495718956
mRNA O 0 0.09063944220542908
splicing O 0 0.11838594079017639
and O 0 0.02488679252564907
enzyme O 0 0.12730196118354797
activity O 0 0.05983976274728775
. O 0 0.03058643266558647

A O 0 0.05055251717567444
novel O 0 0.0465502068400383
C O 0 0.08156850188970566
to O 0 0.011068224906921387
A O 0 0.02902986854314804
mutation O 0 0.09080888330936432
in O 0 0.014298799447715282
the O 0 0.02434271201491356
sterol O 1 0.9722495675086975
27 O 0 0.07003366202116013
- O 0 0.13929645717144012
hydroxylase O 0 0.44862085580825806
gene O 0 0.13795334100723267
( O 0 0.056939225643873215
CYP27 O 1 0.9792807698249817
) O 0 0.026539254933595657
was O 0 0.01613762602210045
identified O 0 0.02560259960591793
by O 0 0.015233849175274372
sequencing O 0 0.09487837553024292
amplified O 0 0.15745674073696136
CYP27 O 1 0.9263358116149902
gene O 0 0.0967174544930458
products O 0 0.03040287084877491
from O 0 0.017772864550352097
a O 0 0.025694450363516808
patient O 1 0.9981040954589844
with O 0 0.026421524584293365
cerebrotendinous B-Disease 1 0.9999691247940063
xanthomatosis I-Disease 1 0.999964714050293
( O 0 0.07626442611217499
CTX B-Disease 1 0.9999988079071045
) O 0 0.04250624030828476
. O 0 0.02828495018184185

The O 0 0.03968269005417824
mutation O 0 0.14983409643173218
changed O 0 0.03801144286990166
the O 0 0.024384809657931328
adrenodoxin O 1 0.7973079681396484
cofactor O 0 0.2632462680339813
binding O 0 0.08277713507413864
residue O 0 0.1564367115497589
362Arg O 0 0.16114157438278198
to O 0 0.026788081973791122
362Ser O 0 0.3083086609840393
( O 0 0.05780532583594322
CGT O 1 0.983896017074585
362Arg O 1 0.6208347082138062
to O 0 0.04004933312535286
AGT O 1 0.9999970197677612
362Ser O 1 0.7522680759429932
) O 0 0.024818196892738342
, O 0 0.009551736526191235
and O 0 0.007006870117038488
was O 0 0.013176140375435352
responsible O 0 0.025762083008885384
for O 0 0.016375504434108734
deficiency O 1 0.9999998807907104
in O 0 0.015239043161273003
the O 0 0.023100342601537704
sterol O 1 0.995316743850708
27 O 0 0.06098277121782303
- O 0 0.141196608543396
hydroxylase O 0 0.3995428681373596
activity O 0 0.04369508475065231
, O 0 0.011300266720354557
as O 0 0.008115514181554317
confirmed O 0 0.02133782207965851
by O 0 0.009892924688756466
expression O 0 0.029519814997911453
of O 0 0.013565274886786938
mutant O 0 0.11308073252439499
cDNA O 0 0.15315990149974823
into O 0 0.036464475095272064
COS O 1 0.9994813799858093
- O 0 0.1250401884317398
1 O 0 0.048575449734926224
cells O 0 0.09684538096189499
. O 0 0.02861051820218563

Quantitative O 0 0.10394533723592758
analysis O 0 0.02908964641392231
showed O 0 0.021985860541462898
that O 0 0.006585936062037945
the O 0 0.008266393095254898
expression O 0 0.030617937445640564
of O 0 0.013369329273700714
CYP27 O 1 0.9859247803688049
gene O 0 0.08520866185426712
mRNA O 0 0.05335327982902527
in O 0 0.01235920935869217
the O 0 0.016394363716244698
patient O 1 0.9431584477424622
represented O 0 0.025915300473570824
52 O 0 0.049805257469415665
. O 0 0.025128493085503578

5 O 0 0.039204198867082596
% O 0 0.018301529809832573
of O 0 0.006365074776113033
the O 0 0.012026825919747353
normal O 0 0.04238700121641159
level O 0 0.040053993463516235
. O 0 0.026335623115301132

As O 0 0.02356705069541931
the O 0 0.02473359741270542
mutation O 0 0.13650433719158173
occurred O 0 0.05165865644812584
at O 0 0.02044736035168171
the O 0 0.016677547246217728
penultimate O 0 0.13700756430625916
nucleotide O 0 0.0866384282708168
of O 0 0.01757880300283432
exon O 0 0.14753863215446472
6 O 0 0.05209265649318695
( O 0 0.037628643214702606
- O 0 0.059325262904167175
2 O 0 0.0234365276992321
position O 0 0.017150074243545532
of O 0 0.012365905568003654
exon O 0 0.14510248601436615
6 O 0 0.06906814873218536
- O 0 0.13978932797908783
intron O 1 0.5841317176818848
6 O 0 0.06178802624344826
splice O 0 0.15095926821231842
site O 0 0.03305758163332939
) O 0 0.014041216112673283
of O 0 0.006941231433302164
the O 0 0.015006612986326218
gene O 0 0.06684628874063492
, O 0 0.012121494859457016
we O 0 0.011519921012222767
hypothesized O 0 0.06725317239761353
that O 0 0.009756187908351421
the O 0 0.018394503742456436
mutation O 0 0.1540215164422989
may O 0 0.03039252758026123
partially O 0 0.06151779368519783
affect O 0 0.03684838488698006
the O 0 0.016315758228302002
normal O 0 0.054448556154966354
splicing O 0 0.10740674287080765
efficiency O 0 0.04728148877620697
in O 0 0.015210053883492947
exon O 0 0.11544936895370483
6 O 0 0.032720837742090225
and O 0 0.014679605141282082
cause O 0 0.06408296525478363
alternative O 0 0.050769783556461334
splicing O 0 0.10065647214651108
elsewhere O 0 0.02859177626669407
, O 0 0.009922318160533905
which O 0 0.00937306135892868
resulted O 0 0.027521025389432907
in O 0 0.012202326208353043
decreased O 0 0.059841301292181015
transcript O 0 0.05154196545481682
in O 0 0.011706517077982426
the O 0 0.018912846222519875
patient O 1 0.9996271133422852
. O 0 0.029364435002207756

Transfection O 1 0.7420763969421387
of O 0 0.023486947640776634
constructed O 0 0.050366152077913284
minigenes O 1 0.513152003288269
, O 0 0.012157496064901352
with O 0 0.010102888569235802
or O 0 0.012535556219518185
without O 0 0.010774895548820496
the O 0 0.013299673795700073
mutation O 0 0.09626328945159912
, O 0 0.015379861928522587
into O 0 0.024186545982956886
COS O 1 0.9999833106994629
- O 0 0.11580859869718552
1 O 0 0.044087424874305725
cells O 0 0.07115043699741364
confirmed O 0 0.027370667085051537
that O 0 0.008387395180761814
the O 0 0.014496819116175175
mutant O 0 0.11620272696018219
minigene O 0 0.3405951261520386
was O 0 0.021426286548376083
responsible O 0 0.024681521579623222
for O 0 0.009734030812978745
a O 0 0.02067568525671959
mRNA O 0 0.06091165170073509
species O 0 0.03173811361193657
alternatively O 0 0.08432725071907043
spliced O 0 0.11217834800481796
at O 0 0.02529718168079853
an O 0 0.023064540699124336
activated O 0 0.15463921427726746
cryptic O 0 0.1397835910320282
5 O 0 0.05222582817077637
splice O 0 0.17609044909477234
site O 0 0.05481681972742081
88 O 0 0.08751866966485977
bp O 0 0.10776762664318085
upstream O 0 0.05345810949802399
from O 0 0.011009691283106804
the O 0 0.01034256536513567
3 O 0 0.020046649500727654
end O 0 0.020312344655394554
of O 0 0.014513316564261913
exon O 0 0.13565222918987274
6 O 0 0.04975135251879692
. O 0 0.030939241871237755

Our O 0 0.02652783878147602
data O 0 0.01733648031949997
suggest O 0 0.019324418157339096
that O 0 0.005701667629182339
the O 0 0.01117738801985979
C O 0 0.0694413110613823
to O 0 0.011184858158230782
A O 0 0.028086889535188675
mutation O 0 0.10222452878952026
at O 0 0.020614204928278923
the O 0 0.015859423205256462
penultimate O 0 0.140717014670372
nucleotide O 0 0.08821778744459152
of O 0 0.017405224964022636
exon O 0 0.11768714338541031
6 O 0 0.027119755744934082
of O 0 0.008656223304569721
the O 0 0.0179323460906744
CYP27 O 1 0.9941629767417908
gene O 0 0.07566043734550476
not O 0 0.010078595951199532
only O 0 0.011006835848093033
causes O 0 0.2957899272441864
the O 0 0.02343728393316269
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.017204446718096733
the I-Disease 0 0.021155977621674538
sterol I-Disease 1 0.9938219785690308
27 I-Disease 0 0.0600946843624115
- I-Disease 0 0.1184382513165474
hydroxylase I-Disease 0 0.38463476300239563
activity I-Disease 0 0.04565611481666565
, O 0 0.011297998949885368
but O 0 0.008155129849910736
also O 0 0.011714573949575424
partially O 0 0.05341961607336998
leads O 0 0.04046918824315071
to O 0 0.013227986171841621
alternative O 0 0.04833422601222992
pre O 0 0.10108321160078049
- O 0 0.08582758158445358
mRNA O 0 0.07585658878087997
splicing O 0 0.08369229733943939
of O 0 0.01176223624497652
the O 0 0.02006859891116619
gene O 0 0.09911009669303894
. O 0 0.0325598269701004

To O 0 0.017657950520515442
our O 0 0.013028384186327457
knowledge O 0 0.01826559007167816
, O 0 0.007297024596482515
this O 0 0.005044554825872183
is O 0 0.006709399167448282
the O 0 0.006121437530964613
first O 0 0.009681794792413712
report O 0 0.015614493750035763
regarding O 0 0.02042059786617756
effects O 0 0.056955546140670776
on O 0 0.013632806949317455
pre O 0 0.0809076800942421
- O 0 0.08389361202716827
mRNA O 0 0.07222660630941391
splicing O 0 0.08908011019229889
of O 0 0.013321543112397194
a O 0 0.027145907282829285
mutation O 0 0.1041354089975357
at O 0 0.020862873643636703
the O 0 0.013979470357298851
- O 0 0.05435386300086975
2 O 0 0.018407054245471954
position O 0 0.012341027148067951
of O 0 0.006839720997959375
a O 0 0.01827995292842388
5 O 0 0.03228330612182617
splice O 0 0.15544576942920685
site O 0 0.045344673097133636
. O 0 0.02857893519103527

ATM O 1 0.6648954153060913
germline O 1 0.664239227771759
mutations O 0 0.15410366654396057
in O 0 0.02694864198565483
classical O 0 0.11295998841524124
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999779462814331
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.999977707862854
in O 0 0.012271316722035408
the O 0 0.012962330132722855
Dutch O 0 0.046800944954156876
population O 0 0.03461013734340668
. O 0 0.025453245267271996

Germline O 1 0.8941134214401245
mutations O 0 0.1272922307252884
in O 0 0.015029634349048138
the O 0 0.021212587133049965
ATM O 0 0.13759464025497437
gene O 0 0.05834222957491875
are O 0 0.008440488949418068
responsible O 0 0.020397033542394638
for O 0 0.011672253720462322
the O 0 0.02911953628063202
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999954700469971
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.3872099220752716
A B-Disease 1 0.9997275471687317
- I-Disease 1 0.9994359612464905
T I-Disease 1 0.999994158744812
) O 0 0.03459290787577629
. O 0 0.025814514607191086

In O 0 0.02047623135149479
our O 0 0.015361079014837742
study O 0 0.020905647426843643
, O 0 0.008527825586497784
we O 0 0.006844302639365196
have O 0 0.007976987399160862
determined O 0 0.02495400980114937
the O 0 0.019621487706899643
ATM O 0 0.15109002590179443
mutation O 0 0.13378190994262695
spectrum O 0 0.05131610855460167
in O 0 0.012674959376454353
19 O 0 0.02992566116154194
classical O 0 0.041421063244342804
A B-Disease 1 0.9993119239807129
- I-Disease 1 0.9999743700027466
T I-Disease 1 0.9999998807907104
patients O 1 0.9999690055847168
, O 0 0.011263481341302395
including O 0 0.009014582261443138
some O 0 0.009974086657166481
immigrant O 0 0.047563616186380386
populations O 0 0.03923265263438225
, O 0 0.008947150781750679
as O 0 0.007106245961040258
well O 0 0.007399875670671463
as O 0 0.007284241728484631
12 O 0 0.01364599633961916
of O 0 0.007175067439675331
Dutch O 0 0.03490172699093819
ethnic O 0 0.023326164111495018
origin O 0 0.03162449970841408
. O 0 0.02826637215912342

Both O 0 0.021142220124602318
the O 0 0.02092049829661846
protein O 0 0.08219975233078003
truncation O 0 0.16196753084659576
test O 0 0.07468562573194504
( O 0 0.041234858334064484
PTT O 0 0.15644408762454987
) O 0 0.01943257264792919
and O 0 0.009129786863923073
the O 0 0.015618600882589817
restriction O 0 0.0882246196269989
endonuclease O 1 0.8265179991722107
fingerprinting O 0 0.19871780276298523
( O 0 0.053767990320920944
REF O 1 0.8482645153999329
) O 0 0.02194352261722088
method O 0 0.019230475649237633
were O 0 0.006758941803127527
used O 0 0.009772845543920994
and O 0 0.006313383113592863
compared O 0 0.016015391796827316
for O 0 0.007435495033860207
their O 0 0.013192486949265003
detection O 0 0.09103961288928986
efficiency O 0 0.047737281769514084
, O 0 0.014396070502698421
identifying O 0 0.04612644016742706
76 O 0 0.06395784020423889
% O 0 0.021601703017950058
and O 0 0.009585728868842125
60 O 0 0.021424399688839912
% O 0 0.016213910654187202
of O 0 0.006055888719856739
the O 0 0.014985396526753902
mutations O 0 0.09508751332759857
, O 0 0.016332022845745087
respectively O 0 0.03347402438521385
. O 0 0.0258992500603199

Most O 0 0.03594135120511055
patients O 1 0.9993886947631836
were O 0 0.010306499898433685
found O 0 0.013404201716184616
to O 0 0.008816499263048172
be O 0 0.014236210845410824
compound O 0 0.09600894153118134
heterozygote O 1 0.9653713703155518
. O 0 0.03594177961349487

Seventeen O 0 0.10469584167003632
mutations O 0 0.10578996688127518
were O 0 0.012364506721496582
distinct O 0 0.02574438415467739
, O 0 0.00863844994455576
of O 0 0.0059336451813578606
which O 0 0.007977512665092945
10 O 0 0.011431780643761158
were O 0 0.006931144744157791
not O 0 0.008092195726931095
reported O 0 0.02696286141872406
previously O 0 0.028414342552423477
. O 0 0.026274358853697777

Mutations O 0 0.16117584705352783
are O 0 0.014378111809492111
small O 0 0.02558129094541073
deletions O 0 0.08362939953804016
or O 0 0.026451488956809044
point O 0 0.034522175788879395
mutations O 0 0.11562136560678482
frequently O 0 0.04900156706571579
affecting O 0 0.09087209403514862
splice O 0 0.17000262439250946
sites O 0 0.038427796214818954
. O 0 0.027739277109503746

Moreover O 0 0.06530536711215973
, O 0 0.014447016641497612
a O 0 0.021219585090875626
16 O 0 0.033127814531326294
. O 0 0.026654435321688652

7 O 0 0.07490301877260208
- O 0 0.12189578264951706
kb O 0 0.17298798263072968
genomic O 0 0.1331196427345276
deletion O 0 0.09258997440338135
of O 0 0.008526785299181938
the O 0 0.01061412412673235
3 O 0 0.017722919583320618
end O 0 0.013069265522062778
of O 0 0.006339732091873884
the O 0 0.013363382779061794
gene O 0 0.05958564579486847
, O 0 0.010404052212834358
most O 0 0.009694146923720837
likely O 0 0.018289847299456596
a O 0 0.012122545391321182
result O 0 0.0136587368324399
of O 0 0.007960322313010693
recombination O 0 0.08423655480146408
between O 0 0.01001936849206686
two O 0 0.008346565067768097
LINE O 0 0.02679303102195263
elements O 0 0.015055032446980476
, O 0 0.00988639798015356
was O 0 0.01607203483581543
identified O 0 0.0297023206949234
. O 0 0.022051043808460236

The O 0 0.018686799332499504
most O 0 0.013241007924079895
frequently O 0 0.02824268490076065
found O 0 0.02417008765041828
mutation O 0 0.09513477236032486
, O 0 0.011136449873447418
identified O 0 0.018287284299731255
in O 0 0.007062895689159632
three O 0 0.009420533664524555
unrelated O 0 0.04205827787518501
Turkish O 0 0.0499899685382843
A B-Disease 1 0.978287398815155
- I-Disease 1 0.9980327486991882
T I-Disease 1 0.999981164932251
individuals O 0 0.022887013852596283
, O 0 0.010073940269649029
was O 0 0.01092657819390297
previously O 0 0.013964807614684105
described O 0 0.015472172759473324
to O 0 0.006595727521926165
be O 0 0.00629294291138649
a O 0 0.01399128045886755
Turkish O 0 0.0359363779425621
A B-Disease 1 0.9589434266090393
- I-Disease 1 0.996215283870697
T I-Disease 1 0.9999874830245972
founder O 0 0.13655990362167358
mutation O 0 0.18703582882881165
. O 0 0.03980891779065132

The O 0 0.02122994139790535
presence O 0 0.029793666675686836
of O 0 0.010552903637290001
a O 0 0.02539493888616562
founder O 0 0.07938797771930695
mutation O 0 0.10777673125267029
among O 0 0.016973484307527542
relatively O 0 0.023681024089455605
small O 0 0.014838122762739658
ethnic O 0 0.015809278935194016
population O 0 0.018314741551876068
groups O 0 0.012748386710882187
in O 0 0.008884294889867306
Western O 0 0.021515008062124252
Europe O 0 0.023135192692279816
could O 0 0.014402689412236214
indicate O 0 0.024505354464054108
a O 0 0.016740627586841583
high O 0 0.03340050205588341
carrier O 0 0.08178508281707764
frequency O 0 0.04556499794125557
in O 0 0.00926609430462122
such O 0 0.00905347615480423
communities O 0 0.028462879359722137
. O 0 0.02658970281481743

In O 0 0.032733894884586334
patients O 1 0.9977847933769226
of O 0 0.010724453255534172
Dutch O 0 0.03227364271879196
ethnic O 0 0.016410205513238907
origin O 0 0.01960674114525318
, O 0 0.010431807488203049
however O 0 0.009756851010024548
, O 0 0.008906811475753784
no O 0 0.010753300972282887
significant O 0 0.020906321704387665
founder O 0 0.050410714000463486
effect O 0 0.0320858359336853
could O 0 0.012013347819447517
be O 0 0.008605851791799068
identified O 0 0.028510915115475655
. O 0 0.022814007475972176

The O 0 0.03160298988223076
observed O 0 0.059235382825136185
genetic O 0 0.07692395895719528
heterogeneity O 0 0.10173463076353073
including O 0 0.01140310987830162
the O 0 0.01238756999373436
relative O 0 0.035562992095947266
high O 0 0.028713151812553406
percentage O 0 0.02726677432656288
of O 0 0.013198653236031532
splice O 0 0.20945298671722412
- O 0 0.11514966934919357
site O 0 0.047482192516326904
mutations O 0 0.0868857204914093
had O 0 0.017421012744307518
no O 0 0.01316074188798666
reflection O 0 0.04316898062825203
on O 0 0.010603063739836216
the O 0 0.019913479685783386
phenotype O 1 0.9455959796905518
. O 0 0.035814423114061356

All O 0 0.02850625477731228
patients O 1 0.9995520710945129
manifested O 0 0.25121456384658813
classical O 0 0.05434439703822136
A B-Disease 1 0.9771772027015686
- I-Disease 1 0.9890809059143066
T I-Disease 1 0.9998958110809326
and O 0 0.018708938732743263
increased O 0 0.04250917211174965
cellular O 0 0.11217480152845383
radioresistant O 0 0.47379270195961
DNA O 0 0.0989682674407959
synthesis O 0 0.09763387590646744
. O 0 0.0316634476184845

Determination O 0 0.05828068032860756
of O 0 0.010232212953269482
the O 0 0.013809176161885262
genomic O 0 0.08444099873304367
structure O 0 0.022251542657613754
of O 0 0.008165605366230011
the O 0 0.01925702951848507
COL4A4 O 1 0.9974028468132019
gene O 0 0.0633271187543869
and O 0 0.009329820983111858
of O 0 0.009978762827813625
novel O 0 0.053435325622558594
mutations O 0 0.30329033732414246
causing O 1 0.9936455488204956
autosomal B-Disease 1 0.999997615814209
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.05421186983585358

Autosomal B-Disease 1 0.9999969005584717
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0295537319034338
a O 0 0.03280150890350342
progressive O 1 0.9899405837059021
hematuric B-Disease 1 0.9999349117279053
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.8647527694702148
by O 0 0.032283227890729904
glomerular B-Disease 1 0.9999794960021973
basement I-Disease 1 0.9987978935241699
membrane I-Disease 1 0.6809660196304321
abnormalities I-Disease 1 0.9943625926971436
and O 0 0.014839348383247852
associated O 0 0.023803064599633217
with O 0 0.014786922372877598
mutations O 0 0.0781446099281311
in O 0 0.010914498940110207
either O 0 0.015752561390399933
the O 0 0.017130281776189804
COL4A3 O 1 0.9981667995452881
or O 0 0.018660997971892357
the O 0 0.0182842668145895
COL4A4 O 1 0.9981953501701355
gene O 0 0.07168211787939072
, O 0 0.010490204207599163
which O 0 0.009475781582295895
encode O 0 0.031097186729311943
the O 0 0.01776782050728798
alpha3 O 0 0.2949378490447998
and O 0 0.023491907864809036
alpha4 O 1 0.9951462149620056
type O 1 0.9539540410041809
IV O 1 0.9999618530273438
collagen O 1 0.9998549222946167
chains O 0 0.06869278103113174
, O 0 0.016122519969940186
respectively O 0 0.0311668012291193
. O 0 0.026162872090935707

To O 0 0.022004807367920876
date O 0 0.026754528284072876
, O 0 0.020111998543143272
mutation O 0 0.12441392987966537
screening O 0 0.06607848405838013
in O 0 0.008521812036633492
the O 0 0.008274798281490803
two O 0 0.009996360167860985
genes O 0 0.0387016125023365
has O 0 0.014225346967577934
been O 0 0.014806337654590607
hampered O 0 0.4199226498603821
by O 0 0.009537373669445515
the O 0 0.00938327331095934
lack O 0 0.024470852687954903
of O 0 0.011291192844510078
genomic O 0 0.09124749153852463
structure O 0 0.029407378286123276
information O 0 0.019248927012085915
. O 0 0.024269895628094673

We O 0 0.01795223169028759
report O 0 0.013857574202120304
here O 0 0.009199768304824829
the O 0 0.008395811542868614
complete O 0 0.021383879706263542
characterization O 0 0.04497351869940758
of O 0 0.007688593585044146
the O 0 0.012080592103302479
48 O 0 0.035659901797771454
exons O 0 0.06137721240520477
of O 0 0.010631896555423737
the O 0 0.019149985164403915
COL4A4 O 1 0.9969511032104492
gene O 0 0.08318571001291275
, O 0 0.013685500249266624
a O 0 0.017644651234149933
comprehensive O 0 0.04875728487968445
gene O 0 0.06761612743139267
screen O 0 0.03128307685256004
, O 0 0.0086795873939991
and O 0 0.0067074233666062355
the O 0 0.010243761353194714
subsequent O 0 0.029342815279960632
detection O 0 0.06710019707679749
of O 0 0.009292217902839184
10 O 0 0.021056288853287697
novel O 0 0.04056605324149132
mutations O 0 0.08848104625940323
in O 0 0.016146214678883553
eight O 0 0.04052238166332245
patients O 1 0.9999998807907104
diagnosed O 1 1.0
with O 0 0.06190875172615051
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.055639706552028656

Furthermore O 0 0.05536589398980141
, O 0 0.01451500691473484
we O 0 0.010309288278222084
identified O 0 0.025512533262372017
a O 0 0.025577152147889137
glycine O 0 0.12614946067333221
to O 0 0.021932559087872505
alanine O 0 0.138636976480484
substitution O 0 0.05863163247704506
in O 0 0.012525908648967743
the O 0 0.017754724249243736
collagenous O 1 0.9967094659805298
domain O 0 0.0435371920466423
that O 0 0.010557341389358044
is O 0 0.015308381989598274
apparently O 0 0.03884653374552727
silent O 0 0.045650944113731384
in O 0 0.009768208488821983
the O 0 0.015919892117381096
heterozygous O 0 0.11933016777038574
carriers O 0 0.07302628457546234
, O 0 0.012394741177558899
in O 0 0.01151237078011036
11 O 0 0.029874127358198166
. O 0 0.023330561816692352

5 O 0 0.036608271300792694
% O 0 0.017769984900951385
of O 0 0.006040701176971197
all O 0 0.006886578164994717
control O 0 0.025051599368453026
individuals O 0 0.015082420781254768
, O 0 0.008760315366089344
and O 0 0.0064544654451310635
in O 0 0.007637943606823683
one O 0 0.009727166034281254
control O 0 0.02960464358329773
individual O 0 0.02457427605986595
homozygous O 0 0.082412488758564
for O 0 0.01128394529223442
this O 0 0.015669841319322586
glycine O 0 0.16990672051906586
substitution O 0 0.09198901802301407
. O 0 0.03359893336892128

There O 0 0.019320596009492874
has O 0 0.01249396987259388
been O 0 0.009080174379050732
no O 0 0.008405657485127449
previous O 0 0.013532423414289951
finding O 0 0.019391071051359177
of O 0 0.008563939481973648
a O 0 0.022928426042199135
glycine O 0 0.13210467994213104
substitution O 0 0.05761240795254707
that O 0 0.009916843846440315
is O 0 0.00905187614262104
not O 0 0.006546300370246172
associated O 0 0.012628640048205853
with O 0 0.008135237731039524
any O 0 0.013015748001635075
obvious O 0 0.05949179455637932
phenotype O 1 0.5527275800704956
in O 0 0.021656503900885582
homozygous O 0 0.13252991437911987
individuals O 0 0.03804891183972359
. O 0 0.032295726239681244

Founder O 0 0.20475392043590546
BRCA1 O 1 0.9901796579360962
and O 0 0.040521275252103806
BRCA2 O 1 0.9980707764625549
mutations O 0 0.12235230207443237
in O 0 0.017390334978699684
French O 0 0.05576493591070175
Canadian O 1 0.9854281544685364
breast B-Disease 1 1.0
and I-Disease 1 0.9955535531044006
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.04813604801893234
. O 0 0.02979578822851181

We O 0 0.019627422094345093
have O 0 0.010499360039830208
identified O 0 0.021801581606268883
four O 0 0.012620599009096622
mutations O 0 0.0571141242980957
in O 0 0.007301799952983856
each O 0 0.006962859071791172
of O 0 0.007840309292078018
the O 0 0.02768494375050068
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9817675948143005
susceptibility O 1 0.9577295780181885
genes O 0 0.08611266314983368
, O 0 0.025082582607865334
BRCA1 O 1 0.995137631893158
and O 0 0.02398412674665451
BRCA2 O 1 0.9983391761779785
, O 0 0.013534292578697205
in O 0 0.010514967143535614
French O 0 0.049473609775304794
Canadian O 1 0.9985690116882324
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9924547672271729
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03800586238503456
from O 0 0.01794302836060524
Quebec O 0 0.07359467446804047
. O 0 0.028122548013925552

To O 0 0.028803685680031776
identify O 0 0.0533742681145668
founder O 0 0.07771845906972885
effects O 0 0.07856564968824387
, O 0 0.015083512291312218
we O 0 0.011636080220341682
examined O 0 0.047753363847732544
independently O 0 0.03357832133769989
ascertained O 0 0.09041647613048553
French O 0 0.055090922862291336
Canadian O 0 0.15504790842533112
cancer B-Disease 1 0.9999955892562866
families O 0 0.02291042171418667
for O 0 0.0071185436099767685
the O 0 0.008446721360087395
distribution O 0 0.013596243225038052
of O 0 0.0071491822600364685
these O 0 0.00814681127667427
eight O 0 0.024931030347943306
mutations O 0 0.11995832622051239
. O 0 0.03537478670477867

Mutations O 0 0.14031773805618286
were O 0 0.013010995462536812
found O 0 0.015523252077400684
in O 0 0.010438325814902782
41 O 0 0.030593235045671463
of O 0 0.010681167244911194
97 O 0 0.07116634398698807
families O 0 0.03242887556552887
. O 0 0.02978299930691719

Six O 0 0.028063302859663963
of O 0 0.012924962677061558
eight O 0 0.03035934455692768
mutations O 0 0.09019884467124939
were O 0 0.012123332358896732
observed O 0 0.030435940250754356
at O 0 0.01827557384967804
least O 0 0.01814061589539051
twice O 0 0.031948868185281754
. O 0 0.022268814966082573

The O 0 0.05702105537056923
BRCA1 O 1 0.9967979788780212
C4446T O 1 0.6470115184783936
mutation O 0 0.1403651088476181
was O 0 0.018229026347398758
the O 0 0.009907797910273075
most O 0 0.011956884525716305
common O 0 0.03185488283634186
mutation O 0 0.1276812106370926
found O 0 0.02037365734577179
, O 0 0.011330434121191502
followed O 0 0.01721656695008278
by O 0 0.01067202165722847
the O 0 0.02694752998650074
BRCA2 O 1 0.9993435740470886
8765delAG O 1 0.9560584425926208
mutation O 0 0.21809068322181702
. O 0 0.04472175985574722

Together O 0 0.026694225147366524
, O 0 0.014270258136093616
these O 0 0.011520424857735634
mutations O 0 0.06900419294834137
were O 0 0.008972936309874058
found O 0 0.012964166700839996
in O 0 0.008702123537659645
28 O 0 0.01707320660352707
of O 0 0.0076905507594347
41 O 0 0.03333002328872681
families O 0 0.021759431809186935
identified O 0 0.02038242481648922
to O 0 0.007687175180763006
have O 0 0.010930778458714485
a O 0 0.025099247694015503
mutation O 0 0.14406996965408325
. O 0 0.029995853081345558

The O 0 0.025521276518702507
odds O 0 0.06222577393054962
of O 0 0.01205820869654417
detection O 0 0.057715997099876404
of O 0 0.006027294788509607
any O 0 0.006185347214341164
of O 0 0.005715405102819204
the O 0 0.01202302984893322
four O 0 0.026803402230143547
BRCA1 O 1 0.9964262843132019
mutations O 0 0.14316944777965546
was O 0 0.025596430525183678
18 O 0 0.02801978960633278
. O 0 0.025854704901576042

7x O 1 0.99400794506073
greater O 0 0.046966973692178726
if O 0 0.015304169617593288
one O 0 0.009116638451814651
or O 0 0.01154543086886406
more O 0 0.007799200247973204
cases O 0 0.025152284651994705
of O 0 0.026873569935560226
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.010794766247272491
also O 0 0.007647354155778885
present O 0 0.009621049277484417
in O 0 0.007027157116681337
the O 0 0.01042973529547453
family O 0 0.029958514496684074
. O 0 0.024402262642979622

The O 0 0.0237873587757349
odds O 0 0.07082002609968185
of O 0 0.014962243847548962
detection O 0 0.056527454406023026
of O 0 0.006077815778553486
any O 0 0.006923527456820011
of O 0 0.005916529335081577
the O 0 0.011180519126355648
four O 0 0.021455273032188416
BRCA2 O 1 0.9982677698135376
mutations O 0 0.12955394387245178
was O 0 0.026279015466570854
5 O 0 0.029096651822328568
. O 0 0.02342686988413334

3x O 1 0.6065303087234497
greater O 0 0.03923933207988739
if O 0 0.014250463806092739
there O 0 0.006971132475882769
were O 0 0.006077970843762159
at O 0 0.011025460436940193
least O 0 0.01074976660311222
five O 0 0.01111338846385479
cases O 0 0.021290767937898636
of O 0 0.01799003779888153
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
in O 0 0.010654078796505928
the O 0 0.011945154517889023
family O 0 0.03371315076947212
. O 0 0.024866702035069466

Interestingly O 0 0.09875985234975815
, O 0 0.012036511674523354
the O 0 0.009630987420678139
presence O 0 0.024024661630392075
of O 0 0.010400822386145592
a O 0 0.1494150608778
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.0569535568356514
< O 0 0.3186054825782776
36 O 0 0.02972228080034256
years O 0 0.010576155036687851
of O 0 0.007591978646814823
age O 0 0.023065999150276184
was O 0 0.016256224364042282
strongly O 0 0.02652258425951004
predictive O 0 0.06282268464565277
of O 0 0.006384481210261583
the O 0 0.008107679896056652
presence O 0 0.018533051013946533
of O 0 0.00452906871214509
any O 0 0.005544961430132389
of O 0 0.0055018276907503605
the O 0 0.010777020826935768
eight O 0 0.028422771021723747
mutations O 0 0.12962885200977325
screened O 0 0.11299942433834076
. O 0 0.03482326120138168

Carriers O 0 0.09183064103126526
of O 0 0.010664328001439571
the O 0 0.012649687938392162
same O 0 0.0200313962996006
mutation O 0 0.10909798741340637
, O 0 0.011026246473193169
from O 0 0.008965447545051575
different O 0 0.006532412953674793
families O 0 0.019620127975940704
, O 0 0.01155093777924776
shared O 0 0.028195718303322792
similar O 0 0.027722077444195747
haplotypes O 0 0.4319918751716614
, O 0 0.01644970290362835
indicating O 0 0.03662186115980148
that O 0 0.008626130409538746
the O 0 0.013744128867983818
mutant O 0 0.11017891764640808
alleles O 0 0.11155173927545547
were O 0 0.011505664326250553
likely O 0 0.017897721379995346
to O 0 0.0072843171656131744
be O 0 0.00653045391663909
identical O 0 0.019943540915846825
by O 0 0.0095640504732728
descent O 0 0.04421389102935791
for O 0 0.010471753776073456
a O 0 0.019460981711745262
mutation O 0 0.08273275941610336
in O 0 0.011383733712136745
the O 0 0.014819697476923466
founder O 0 0.054363444447517395
population O 0 0.03327779099345207
. O 0 0.026333879679441452

The O 0 0.0210095327347517
identification O 0 0.03307865560054779
of O 0 0.010924681089818478
common O 0 0.04124366492033005
BRCA1 O 1 0.9996899366378784
and O 0 0.03083842061460018
BRCA2 O 1 0.9994795918464661
mutations O 0 0.12249579280614853
will O 0 0.014700179919600487
facilitate O 0 0.04139610007405281
carrier O 0 0.10178615152835846
detection O 0 0.08272143453359604
in O 0 0.012622322887182236
French O 0 0.046685416251420975
Canadian O 1 0.9939702749252319
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9952594637870789
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.051584236323833466
. O 0 0.027658116072416306

Are O 0 0.027462948113679886
Dp71 O 0 0.4954094886779785
and O 0 0.028747104108333588
Dp140 O 1 0.9833115339279175
brain O 1 0.9982947707176208
dystrophin O 1 0.9829764366149902
isoforms O 0 0.09590118378400803
related O 0 0.03639217093586922
to O 0 0.020500605925917625
cognitive B-Disease 1 0.9626040458679199
impairment I-Disease 1 0.9999911785125732
in O 0 0.05780298262834549
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9121695756912231

Molecular O 0 0.10563246160745621
study O 0 0.03960901126265526
and O 0 0.017237380146980286
neuropsychological O 0 0.3949006497859955
analysis O 0 0.026099998503923416
were O 0 0.0080897007137537
performed O 0 0.024473391473293304
concurrently O 0 0.026167813688516617
on O 0 0.011636803857982159
49 O 0 0.0598304383456707
patients O 1 0.999992847442627
with O 0 0.05160131677985191
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9965793490409851
DMD B-Disease 1 1.0
) O 0 0.02191586047410965
in O 0 0.007111072074621916
order O 0 0.007824068889021873
to O 0 0.007428274489939213
find O 0 0.017078198492527008
a O 0 0.015150601044297218
molecular O 0 0.041517093777656555
explanation O 0 0.027578286826610565
for O 0 0.008130543865263462
the O 0 0.016319463029503822
cognitive B-Disease 1 0.5343385934829712
impairment I-Disease 1 0.9996600151062012
observed O 0 0.04150567948818207
in O 0 0.016044029965996742
most O 0 0.03257698193192482
DMD B-Disease 1 1.0
patients O 1 0.9999988079071045
. O 0 0.03549772500991821

Complete O 0 0.0426560640335083
analysis O 0 0.025872472673654556
of O 0 0.009697552770376205
the O 0 0.023094886913895607
dystrophin O 1 0.9884681105613708
gene O 0 0.0855923518538475
was O 0 0.019236525520682335
performed O 0 0.022280165925621986
to O 0 0.007949724793434143
define O 0 0.022134222090244293
the O 0 0.010751546360552311
localization O 0 0.06034785881638527
of O 0 0.010837149806320667
deletions O 0 0.0676686093211174
and O 0 0.013430737890303135
duplications O 0 0.07318666577339172
in O 0 0.011365223675966263
relation O 0 0.02137484960258007
to O 0 0.007188806775957346
the O 0 0.012091713026165962
different O 0 0.0247198436409235
DMD B-Disease 1 1.0
promoters O 1 0.9698601961135864
. O 0 0.04126236215233803

Qualitative O 0 0.08777672797441483
analysis O 0 0.029198970645666122
of O 0 0.008895214647054672
the O 0 0.016527749598026276
Dp71 O 1 0.8993062376976013
transcript O 0 0.06319116801023483
and O 0 0.009556049481034279
testing O 0 0.02802867256104946
for O 0 0.0056517962366342545
the O 0 0.008111522532999516
specific O 0 0.014768954366445541
first O 0 0.015836864709854126
exon O 0 0.09146782755851746
of O 0 0.0132985794916749
Dp140 O 0 0.10793934017419815
were O 0 0.010841455310583115
also O 0 0.00886582676321268
carried O 0 0.015330938622355461
out O 0 0.015525417402386665
. O 0 0.022835830226540565

Neuropsychological O 1 0.9180944561958313
analysis O 0 0.05254100635647774
assessed O 0 0.06797339767217636
verbal O 0 0.0698193684220314
and O 0 0.01997106522321701
visuospatial O 1 0.9987395405769348
intelligence O 0 0.04225833714008331
, O 0 0.015425007790327072
verbal O 0 0.0706849992275238
memory O 0 0.04286470264196396
, O 0 0.01018479373306036
and O 0 0.008834690786898136
reading O 0 0.024885810911655426
skills O 0 0.04875565692782402
. O 0 0.026773832738399506

Comparison O 0 0.056648947298526764
of O 0 0.014856802299618721
molecular O 0 0.06569541990756989
and O 0 0.01759898103773594
psychometric O 0 0.4423002600669861
findings O 0 0.039742596447467804
demonstrated O 0 0.03544360399246216
that O 0 0.010069613344967365
deletions O 0 0.07121268659830093
and O 0 0.013656925410032272
duplications O 0 0.07252591848373413
that O 0 0.00900094024837017
were O 0 0.009562533348798752
localized O 0 0.06712227314710617
in O 0 0.009133091196417809
the O 0 0.013759950175881386
distal O 1 0.906550407409668
part O 0 0.018581436946988106
of O 0 0.007626037113368511
the O 0 0.013886770233511925
gene O 0 0.07125253975391388
seemed O 0 0.030048830434679985
to O 0 0.00810177717357874
be O 0 0.010747149586677551
preferentially O 0 0.08506853878498077
associated O 0 0.02668197825551033
with O 0 0.0226267222315073
cognitive B-Disease 1 0.9504317045211792
impairment I-Disease 1 0.999956488609314
. O 0 0.036244481801986694

Two O 0 0.02620476856827736
altered O 0 0.07678250968456268
Dp71 O 0 0.3235226571559906
transcripts O 0 0.05127181485295296
and O 0 0.01130378432571888
two O 0 0.013899280689656734
deleted O 0 0.07364924252033234
Dp140 O 0 0.16017824411392212
DNA O 0 0.06379442662000656
sequences O 0 0.02964792028069496
were O 0 0.008138038218021393
found O 0 0.0107676200568676
in O 0 0.007587485481053591
four O 0 0.015902195125818253
patients O 1 0.9999990463256836
with O 0 0.030396685004234314
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.038672540336847305

These O 0 0.019025301560759544
findings O 0 0.0343463160097599
suggest O 0 0.020904788747429848
that O 0 0.006534864194691181
some O 0 0.007050933316349983
sequences O 0 0.023399267345666885
located O 0 0.016757404431700706
in O 0 0.0075246552005410194
the O 0 0.011417762376368046
distal O 1 0.68611741065979
part O 0 0.014805849641561508
of O 0 0.006009867414832115
the O 0 0.011799484491348267
gene O 0 0.05093001946806908
and O 0 0.008615841157734394
, O 0 0.007668254431337118
in O 0 0.007996054366230965
particular O 0 0.015791378915309906
, O 0 0.013447635807096958
some O 0 0.0195474810898304
DMD B-Disease 1 0.9999997615814209
isoforms O 0 0.07907717674970627
expressed O 0 0.022979222238063812
in O 0 0.011320316232740879
the O 0 0.018132392317056656
brain O 1 0.9998201727867126
may O 0 0.018704934045672417
be O 0 0.006372347474098206
related O 0 0.013073996640741825
to O 0 0.008179349824786186
the O 0 0.014988768845796585
cognitive B-Disease 1 0.9913957715034485
impairment I-Disease 1 0.9999926090240479
associated O 0 0.03646392747759819
with O 0 0.031101714819669724
DMD B-Disease 1 1.0
. O 0 0.027131622657179832
. O 0 0.02789156138896942

I1307K O 1 0.705349862575531
APC O 1 0.9634653925895691
and O 0 0.030246229842305183
hMLH1 O 0 0.2521200478076935
mutations O 0 0.0921000987291336
in O 0 0.01187113393098116
a O 0 0.020007291808724403
non O 0 0.042815372347831726
- O 0 0.06170281767845154
Jewish O 0 0.03562571108341217
family O 0 0.026147818192839622
with O 0 0.017040347680449486
hereditary B-Disease 1 0.9999353885650635
non I-Disease 1 0.9999066591262817
- I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.051623910665512085

We O 0 0.020128943026065826
describe O 0 0.030793070793151855
a O 0 0.01880524680018425
French O 0 0.041463762521743774
Canadian O 0 0.06366600096225739
hereditary B-Disease 1 0.9999004602432251
non I-Disease 1 0.9998998641967773
- I-Disease 1 0.9999996423721313
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.978325605392456
HNPCC B-Disease 1 1.0
) O 0 0.04603566974401474
kindred O 1 0.9973040819168091
which O 0 0.011635960079729557
carries O 0 0.02913794293999672
a O 0 0.021416516974568367
novel O 0 0.051586367189884186
truncating O 0 0.2940858006477356
mutation O 0 0.17736254632472992
in O 0 0.028888825327157974
hMLH1 O 0 0.19325172901153564
. O 0 0.03348378837108612

Interestingly O 0 0.11406826972961426
, O 0 0.020078813657164574
the O 0 0.02398866042494774
I1307K O 1 0.7811439633369446
APC O 1 0.9776718020439148
polymorphism O 0 0.12285511195659637
, O 0 0.013247184455394745
associated O 0 0.01446358673274517
with O 0 0.007398803718388081
an O 0 0.013167480006814003
increased O 0 0.03757266700267792
risk O 1 0.999745786190033
of O 0 0.09572885930538177
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.01285169180482626
is O 0 0.008124870248138905
also O 0 0.006209649611264467
present O 0 0.007510289549827576
in O 0 0.005693741142749786
this O 0 0.00817884597927332
family O 0 0.026071662083268166
. O 0 0.02646942064166069

The O 0 0.045707959681749344
I1307K O 0 0.20044876635074615
polymorphism O 0 0.11781889200210571
has O 0 0.017699461430311203
previously O 0 0.01485197152942419
only O 0 0.0070480164140462875
been O 0 0.007955222390592098
identified O 0 0.01528488751500845
in O 0 0.00630074180662632
individuals O 0 0.01269024983048439
of O 0 0.009376521222293377
self O 0 0.07716450840234756
- O 0 0.0950210839509964
reported O 0 0.05848250165581703
Ashkenazi O 0 0.15811219811439514
Jewish O 0 0.05752943456172943
origins O 0 0.0715116336941719
. O 0 0.02971643954515457

In O 0 0.01869921199977398
addition O 0 0.017370445653796196
, O 0 0.009914414025843143
in O 0 0.006849727127701044
this O 0 0.008167689666152
family O 0 0.024027526378631592
, O 0 0.010510631836950779
there O 0 0.009600960649549961
appears O 0 0.021136891096830368
to O 0 0.006828189827501774
be O 0 0.006717120762914419
no O 0 0.010739614255726337
relationship O 0 0.021652372553944588
between O 0 0.009583646431565285
the O 0 0.01467867475003004
I1307K O 0 0.15374910831451416
polymorphism O 0 0.08994988352060318
and O 0 0.009631114080548286
the O 0 0.010095441713929176
presence O 0 0.02866477333009243
or O 0 0.016194185242056847
absence O 0 0.03522215411067009
of O 0 0.014945296570658684
cancer B-Disease 1 0.9999998807907104
. O 0 0.01714187301695347
. O 0 0.02207818441092968

Identification O 0 0.04714111238718033
of O 0 0.012033559381961823
a O 0 0.019524646922945976
novel O 0 0.03538781777024269
mutation O 0 0.09575813263654709
of O 0 0.00908218789845705
the O 0 0.015117155387997627
CPO O 0 0.3079918920993805
gene O 0 0.06099874898791313
in O 0 0.012805374339222908
a O 0 0.022644823417067528
Japanese O 0 0.049307651817798615
hereditary B-Disease 1 0.9651809930801392
coproporphyria I-Disease 1 0.9841295480728149
family O 0 0.062075115740299225
. O 0 0.03382403403520584

Hereditary B-Disease 1 0.9982498288154602
coproporphyria I-Disease 1 0.997289776802063
( O 0 0.07703910022974014
HCP B-Disease 1 0.9996578693389893
) O 0 0.02565844915807247
is O 0 0.01483902893960476
an O 0 0.023490451276302338
autosomal B-Disease 1 0.9999107122421265
dominant I-Disease 1 0.9994875192642212
disease I-Disease 1 1.0
characterized O 1 0.815724790096283
by O 0 0.017755871638655663
a O 0 0.03771631419658661
deficiency B-Disease 1 1.0
of I-Disease 0 0.02766100876033306
coproporphyrinogen I-Disease 1 0.9985877275466919
oxidase I-Disease 1 0.9824578166007996
( O 0 0.04824289306998253
CPO O 1 0.8548712730407715
) O 0 0.029639115557074547
caused O 0 0.043101996183395386
by O 0 0.011225158348679543
a O 0 0.02216428332030773
mutation O 0 0.09094204008579254
in O 0 0.011761665344238281
the O 0 0.018322749063372612
CPO O 1 0.7921959161758423
gene O 0 0.10424047708511353
. O 0 0.03211665153503418

Only O 0 0.02107473462820053
11 O 0 0.03257513418793678
mutations O 0 0.0719553679227829
of O 0 0.009878847748041153
the O 0 0.013822566717863083
gene O 0 0.056059930473566055
have O 0 0.010617876425385475
been O 0 0.013326289132237434
reported O 0 0.03374328091740608
in O 0 0.023584865033626556
HCP B-Disease 1 0.9999988079071045
patients O 1 0.9999879598617554
. O 0 0.03328976035118103

We O 0 0.02144169621169567
report O 0 0.022134829312562943
another O 0 0.02700762264430523
mutation O 0 0.09115411341190338
in O 0 0.011790641583502293
a O 0 0.01744086481630802
Japanese O 0 0.03487268090248108
family O 0 0.03808397427201271
. O 0 0.023263584822416306

Polymerase O 0 0.3054792881011963
chain O 0 0.14873582124710083
reaction O 0 0.10492036491632462
- O 0 0.09255526214838028
single O 0 0.05827184394001961
strand O 0 0.1487351804971695
conformational O 0 0.1576813906431198
polymorphism O 0 0.10165160149335861
and O 0 0.01138154324144125
direct O 0 0.024651315063238144
sequence O 0 0.028954895213246346
analyses O 0 0.03473552316427231
demonstrated O 0 0.03823348507285118
a O 0 0.022812986746430397
C O 0 0.09162963926792145
to O 0 0.016273826360702515
T O 1 0.889427125453949
substitution O 0 0.059385694563388824
in O 0 0.015470575541257858
exon O 0 0.10090959817171097
1 O 0 0.022575197741389275
of O 0 0.008959717117249966
the O 0 0.018250685185194016
CPO O 0 0.18949514627456665
gene O 0 0.09087667614221573
at O 0 0.032040100544691086
nucleotide O 0 0.06946021318435669
position O 0 0.025244232267141342
85 O 0 0.04499317333102226
, O 0 0.009916584938764572
which O 0 0.009902785532176495
lies O 0 0.023776493966579437
in O 0 0.009746411815285683
the O 0 0.01428393367677927
putative O 0 0.12285862118005753
presequence O 0 0.1618366837501526
for O 0 0.014681833796203136
targeting O 0 0.04989560693502426
to O 0 0.016691431403160095
mitochondria O 0 0.0993528887629509
. O 0 0.028914883732795715

This O 0 0.03010217286646366
mutation O 0 0.13157975673675537
changes O 0 0.02451241947710514
the O 0 0.018008317798376083
codon O 0 0.10402113199234009
for O 0 0.01654786802828312
glutamine O 0 0.12723466753959656
to O 0 0.015597939491271973
a O 0 0.031595516949892044
termination O 0 0.159756138920784
codon O 0 0.15317079424858093
at O 0 0.041371289640665054
amino O 0 0.07598968595266342
acid O 0 0.12768954038619995
position O 0 0.029823286458849907
29 O 0 0.04063625633716583
. O 0 0.027346400544047356

MaeI O 1 0.6698373556137085
restriction O 0 0.08270949870347977
analysis O 0 0.03099208138883114
showed O 0 0.020565247163176537
two O 0 0.0070811607874929905
other O 0 0.0080466503277421
carriers O 0 0.04318200424313545
in O 0 0.010000127367675304
the O 0 0.012038490734994411
family O 0 0.034603800624608994
. O 0 0.029037604108452797

The O 0 0.047499921172857285
C O 1 0.995558500289917
- O 1 0.9645472764968872
T O 1 0.9937081336975098
mutation O 0 0.14026270806789398
is O 0 0.016608988866209984
located O 0 0.020305784419178963
within O 0 0.010532260872423649
a O 0 0.015268195420503616
recently O 0 0.027594786137342453
proposed O 0 0.024842409417033195
putative O 0 0.10019108653068542
alternative O 0 0.05010199919342995
translation O 0 0.03939393535256386
initiation O 0 0.12035419791936874
codon O 0 0.18579700589179993
( O 0 0.06583841890096664
TIC O 1 0.9999841451644897
- O 0 0.10211411118507385
1 O 0 0.03351391851902008
) O 0 0.018716394901275635
, O 0 0.010447008535265923
supporting O 0 0.023660769686102867
that O 0 0.016498973593115807
TIC O 1 0.9999887943267822
- O 0 0.07941878587007523
1 O 0 0.0242997407913208
is O 0 0.012148205190896988
the O 0 0.01180545799434185
real O 0 0.04232979193329811
TIC O 1 0.9999145269393921
rather O 0 0.025402242317795753
than O 0 0.02416100539267063
TIC O 1 0.9999982118606567
- O 0 0.09210173785686493
2 O 0 0.0296334121376276
. O 0 0.014627691358327866
. O 0 0.023367272689938545

Human B-Disease 0 0.05656435713171959
complement I-Disease 0 0.11121702194213867
factor I-Disease 1 0.9938843846321106
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.352681964635849
with O 1 0.9558379650115967
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.05573341250419617

This O 0 0.0175312589854002
study O 0 0.021623855456709862
reports O 0 0.011668088845908642
on O 0 0.006193758919835091
six O 0 0.013250148855149746
cases O 0 0.020702745765447617
of O 0 0.01479390449821949
deficiency B-Disease 1 1.0
in I-Disease 0 0.010767071507871151
the I-Disease 0 0.008823336102068424
human I-Disease 0 0.022196374833583832
complement I-Disease 0 0.05647333711385727
regulatory I-Disease 0 0.0842905193567276
protein I-Disease 0 0.09457569569349289
Factor I-Disease 0 0.13019824028015137
H I-Disease 1 0.9999158382415771
( O 0 0.06565965712070465
FH O 1 0.9999887943267822
) O 0 0.01803043857216835
in O 0 0.00600730674341321
the O 0 0.006629941985011101
context O 0 0.018526136875152588
of O 0 0.010922444984316826
an O 0 0.25519856810569763
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.051402829587459564

Five O 0 0.0173339806497097
of O 0 0.008273887448012829
the O 0 0.009764731861650944
cases O 0 0.01853540726006031
were O 0 0.007813781499862671
observed O 0 0.020613232627511024
in O 0 0.008356797508895397
children O 0 0.02253492921590805
presenting O 0 0.05688473954796791
with O 0 0.33445852994918823
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9974433183670044
HUS B-Disease 1 1.0
) O 0 0.04039999097585678
. O 0 0.024980127811431885

Two O 0 0.014506182633340359
of O 0 0.007720495108515024
the O 0 0.0112709179520607
children O 0 0.03047795593738556
exhibited O 0 0.0717523843050003
a O 0 0.04027894511818886
homozygous O 1 0.9967606663703918
deficiency O 1 1.0
characterized O 0 0.18981339037418365
by O 0 0.009521033614873886
the O 0 0.009931592270731926
absence O 0 0.024988433346152306
of O 0 0.006765125319361687
the O 0 0.013503444381058216
150 O 0 0.0480213426053524
- O 0 0.11239799112081528
kD O 1 0.5145450234413147
form O 0 0.029463140293955803
of O 0 0.015871617943048477
Factor O 0 0.08914805203676224
H O 1 0.9943037629127502
and O 0 0.009823027066886425
the O 0 0.01065025944262743
presence O 0 0.024859588593244553
, O 0 0.009692315943539143
upon O 0 0.015768375247716904
immunoblotting O 0 0.1158452108502388
, O 0 0.008205675520002842
of O 0 0.005610934924334288
the O 0 0.011639568023383617
42 O 0 0.06077045574784279
- O 0 0.30638521909713745
kD O 1 0.9981065988540649
Factor O 0 0.15170668065547943
H O 1 0.9996488094329834
- O 0 0.0932767391204834
like O 0 0.033575378358364105
protein O 0 0.07061006128787994
1 O 0 0.041068434715270996
( O 0 0.05401644855737686
FHL O 1 0.9999465942382812
- O 0 0.0873832032084465
1 O 0 0.028061674907803535
) O 0 0.016140373423695564
and O 0 0.00882765743881464
other O 0 0.01590604893863201
FH O 1 0.9999986886978149
- O 0 0.11512380093336105
related O 0 0.056956954300403595
protein O 0 0.09283272176980972
( O 0 0.05039868503808975
FHR O 1 0.9896864295005798
) O 0 0.03730521723628044
bands O 0 0.05621455982327461
. O 0 0.02786914072930813

Southern O 0 0.08891358971595764
blot O 0 0.22087635099887848
and O 0 0.028363456949591637
PCR O 0 0.14651256799697876
analysis O 0 0.022259389981627464
of O 0 0.009067912586033344
DNA O 0 0.03946547955274582
of O 0 0.010214920155704021
one O 0 0.019271669909358025
patient O 1 0.9997047781944275
with O 0 0.027175595983862877
homozygous O 1 0.995245635509491
deficiency O 1 1.0
ruled O 0 0.045029301196336746
out O 0 0.012044225819408894
the O 0 0.008185312151908875
presence O 0 0.020621908828616142
of O 0 0.00702107697725296
a O 0 0.01420160848647356
large O 0 0.01695897802710533
deletion O 0 0.07775978744029999
of O 0 0.010621817782521248
the O 0 0.02260424941778183
FH O 1 0.999997615814209
gene O 0 0.06648655980825424
as O 0 0.00949662085622549
the O 0 0.012430233880877495
underlying O 1 0.6459285616874695
defect O 1 0.9989702701568604
for O 0 0.014595129527151585
the O 0 0.02738262340426445
deficiency O 1 1.0
. O 0 0.03681528940796852

The O 0 0.015781378373503685
other O 0 0.007448446936905384
four O 0 0.011371814645826817
children O 0 0.023243525996804237
presented O 0 0.021717732772231102
with O 0 0.021364498883485794
heterozygous O 1 0.9754102230072021
deficiency O 1 1.0
and O 0 0.01728249527513981
exhibited O 0 0.0573025606572628
a O 0 0.025108689442276955
normal O 0 0.05216129124164581
immunoblotting O 1 0.66817307472229
pattern O 0 0.049582771956920624
of O 0 0.00852446723729372
proteins O 0 0.025560349225997925
of O 0 0.009371078573167324
the O 0 0.02299395762383938
FH O 1 0.9999980926513672
family O 0 0.05226433649659157
. O 0 0.029673250392079353

Factor B-Disease 1 0.9935199618339539
H I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
is O 0 0.016715532168745995
the O 0 0.010746774263679981
only O 0 0.017227673903107643
complement B-Disease 1 0.9994731545448303
deficiency I-Disease 1 1.0
associated O 0 0.04506650194525719
with O 0 0.03258325904607773
HUS B-Disease 1 0.9999996423721313
. O 0 0.040413860231637955

These O 0 0.014939854852855206
observations O 0 0.02944035828113556
suggest O 0 0.02521437592804432
a O 0 0.014730115421116352
role O 0 0.02313574030995369
for O 0 0.01913054846227169
FH O 1 0.9999984502792358
and O 0 0.02565034292638302
/ O 1 0.9993791580200195
or O 0 0.03922932222485542
FH O 1 0.9999880790710449
receptors O 0 0.12063513696193695
in O 0 0.012328185141086578
the O 0 0.016256919130682945
pathogenesis O 1 0.9999551773071289
of O 0 0.031617116183042526
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.02849939838051796
. O 0 0.02688826620578766

Further O 0 0.02518288977444172
evidence O 0 0.01632799208164215
for O 0 0.00778981065377593
a O 0 0.01390819065272808
major O 0 0.02149786241352558
ancient O 0 0.03993122652173042
mutation O 1 0.9759540557861328
underlying O 1 0.9998761415481567
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.05059978365898132
linkage O 1 0.9852495789527893
disequilibrium O 1 0.9953627586364746
studies O 0 0.02870667353272438
in O 0 0.008054232224822044
the O 0 0.0101381940767169
Japanese O 0 0.029569363221526146
population O 0 0.02607504278421402
. O 0 0.021102920174598694

The O 0 0.10567586869001389
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9985203146934509
DM B-Disease 1 1.0
) O 0 0.05513663589954376
mutation O 0 0.11818195134401321
is O 0 0.01717199943959713
an O 0 0.020421743392944336
unstable O 1 0.9852404594421387
( O 0 0.05571264773607254
CTG O 1 0.9995429515838623
) O 0 0.040057044476270676
n O 0 0.06559721380472183
repeat O 0 0.06596782803535461
, O 0 0.0105449752882123
present O 0 0.012449992820620537
at O 0 0.013342801481485367
a O 0 0.01222643256187439
copy O 0 0.02032337337732315
number O 0 0.007601253688335419
of O 0 0.007899664342403412
5 O 0 0.03290577232837677
- O 0 0.07436364889144897
37 O 0 0.053298112004995346
repeats O 0 0.06614864617586136
on O 0 0.014504533261060715
normal O 0 0.04142721742391586
chromosomes O 0 0.0546836256980896
but O 0 0.014139320701360703
amplified O 0 0.06742414832115173
to O 0 0.01263031642884016
50 O 0 0.032561495900154114
- O 0 0.07634428143501282
3000 O 0 0.122222900390625
copies O 0 0.030965344980359077
on O 0 0.030807508155703545
DM B-Disease 1 0.9999997615814209
chromosomes O 0 0.1202365979552269
. O 0 0.036399371922016144

Previous O 0 0.036488261073827744
findings O 0 0.03456605225801468
in O 0 0.0157377440482378
Caucasian O 0 0.3097264766693115
populations O 0 0.04612795263528824
of O 0 0.015309595502912998
a O 0 0.05443236604332924
DM B-Disease 1 1.0
founder O 0 0.1284339874982834
chromosome O 0 0.13551746308803558
raise O 0 0.04251690208911896
a O 0 0.01971590332686901
question O 0 0.01837877184152603
about O 0 0.010390848852694035
the O 0 0.010385304689407349
molecular O 0 0.04266127943992615
events O 0 0.017881711944937706
involved O 0 0.01671634614467621
in O 0 0.008475924842059612
the O 0 0.012473618611693382
expansion O 0 0.05263093113899231
mutation O 0 0.15674877166748047
. O 0 0.033589769154787064

To O 0 0.020542433485388756
investigate O 0 0.03657868504524231
whether O 0 0.015690328553318977
a O 0 0.01985260285437107
founder O 0 0.0589153952896595
chromosome O 0 0.09813043475151062
for O 0 0.015018456615507603
the O 0 0.03094313107430935
DM B-Disease 1 1.0
mutation O 0 0.18198993802070618
exists O 0 0.031389832496643066
in O 0 0.007341815158724785
the O 0 0.009571650996804237
Japanese O 0 0.025744643062353134
population O 0 0.02082403376698494
, O 0 0.01160381268709898
we O 0 0.014040635898709297
genotyped O 0 0.13513141870498657
families O 0 0.029128996655344963
using O 0 0.028039978817105293
polymorphic O 0 0.1940096914768219
markers O 0 0.08770421892404556
near O 0 0.03988955542445183
the O 0 0.02039194293320179
( O 0 0.04943706467747688
CTG O 1 0.9982534050941467
) O 0 0.035528622567653656
n O 0 0.0658784881234169
repeat O 0 0.07379234582185745
region O 0 0.034400369971990585
and O 0 0.014226924628019333
constructed O 0 0.04949740692973137
haplotypes O 0 0.29578325152397156
. O 0 0.038389090448617935

Six O 0 0.033755455166101456
different O 0 0.01702929101884365
haplotypes O 0 0.15697602927684784
were O 0 0.013831116259098053
found O 0 0.024800699204206467
and O 0 0.028948025777935982
DM B-Disease 1 1.0
alleles O 0 0.17224429547786713
were O 0 0.018224166706204414
always O 0 0.040594104677438736
haplotype O 1 0.9674543738365173
A O 0 0.03724176064133644
. O 0 0.026849986985325813

To O 0 0.018479589372873306
find O 0 0.021252566948533058
an O 0 0.009469524957239628
origin O 0 0.01254046056419611
of O 0 0.00683135911822319
the O 0 0.01637052372097969
( O 0 0.05019728094339371
CTG O 1 0.9995124340057373
) O 0 0.041111722588539124
n O 0 0.08557195961475372
repeat O 0 0.09999050945043564
mutation O 0 0.11047878861427307
and O 0 0.009073509834706783
to O 0 0.008265173062682152
investigate O 0 0.02658175490796566
the O 0 0.011567163281142712
mechanism O 0 0.03828958794474602
of O 0 0.007296272087842226
the O 0 0.012715415097773075
expansion O 0 0.044535212218761444
mutation O 0 0.08793637156486511
in O 0 0.010001136921346188
the O 0 0.010788967832922935
Japanese O 0 0.023870589211583138
population O 0 0.01779513619840145
we O 0 0.008144453167915344
have O 0 0.008783665485680103
studied O 0 0.028471840545535088
90 O 0 0.046717822551727295
Japanese O 0 0.06401090323925018
DM B-Disease 1 0.9999996423721313
families O 0 0.04739503189921379
comprising O 0 0.03922608122229576
190 O 0 0.0810905322432518
affected O 0 0.05195837467908859
and O 0 0.014849446713924408
130 O 0 0.06369706243276596
unaffected O 0 0.13058042526245117
members O 0 0.02462294138967991
. O 0 0.027705656364560127

The O 0 0.02601001039147377
results O 0 0.032319821417331696
suggest O 0 0.02213188074529171
that O 0 0.007238196209073067
a O 0 0.013228185474872589
few O 0 0.012637621723115444
common O 0 0.0249423086643219
ancestral O 0 0.08281291276216507
mutations O 0 0.10297324508428574
in O 0 0.014179802499711514
both O 0 0.015104586258530617
Caucasian O 1 0.9556320905685425
and O 0 0.013851514086127281
Japanese O 0 0.032502759248018265
populations O 0 0.03416585549712181
have O 0 0.010755939409136772
originated O 0 0.026509370654821396
by O 0 0.007546443957835436
expansion O 0 0.0197419635951519
of O 0 0.007307576946914196
an O 0 0.015721473842859268
ancestral O 0 0.08873342722654343
n O 0 0.09080357104539871
= O 0 0.10874868184328079
5 O 0 0.03625736013054848
repeat O 0 0.06817231327295303
to O 0 0.020112212747335434
n O 0 0.0923171117901802
= O 0 0.12204306572675705
19 O 0 0.0443556122481823
- O 0 0.06996529549360275
37 O 0 0.04697137698531151
copies O 0 0.02877231128513813
. O 0 0.02959444746375084

These O 0 0.015764838084578514
data O 0 0.017442189157009125
support O 0 0.028228532522916794
multistep O 0 0.1470649689435959
models O 0 0.04240291938185692
of O 0 0.018787432461977005
triplet O 1 0.6425963044166565
repeat O 0 0.09068703651428223
expansion O 0 0.03440895304083824
that O 0 0.006420091725885868
have O 0 0.005718064494431019
been O 0 0.008529970422387123
proposed O 0 0.014706376940011978
for O 0 0.010614736005663872
both O 0 0.021193265914916992
DM B-Disease 1 1.0
and O 0 0.03259028121829033
Friedreichs B-Disease 1 0.9998134970664978
ataxia I-Disease 1 0.9999748468399048
. O 0 0.025046272203326225
. O 0 0.029216907918453217

The O 0 0.024757089093327522
molecular O 0 0.053601838648319244
basis O 0 0.021759431809186935
of O 0 0.02719530276954174
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.014762191101908684
the O 0 0.012889155186712742
western O 0 0.02778848260641098
Cape O 0 0.08109606057405472
, O 0 0.013651748187839985
South O 0 0.029409993439912796
Africa O 0 0.05166863650083542
. O 0 0.026869036257267

Deficiency B-Disease 1 0.9999992847442627
of I-Disease 0 0.01344443578273058
the I-Disease 0 0.01402018778026104
sixth I-Disease 0 0.04766641929745674
component I-Disease 0 0.04714536666870117
of I-Disease 0 0.008973229676485062
human I-Disease 0 0.02615266665816307
complement I-Disease 0 0.06910130381584167
( O 0 0.04792891442775726
C6 O 1 0.9999420642852783
) O 0 0.020515423268079758
has O 0 0.009199986234307289
been O 0 0.0087464964017272
reported O 0 0.017103401944041252
in O 0 0.006384823005646467
a O 0 0.008985807187855244
number O 0 0.006135244853794575
of O 0 0.005432015750557184
families O 0 0.016409510746598244
from O 0 0.008558593690395355
the O 0 0.010091328993439674
western O 0 0.02645755559206009
Cape O 0 0.06754263490438461
, O 0 0.01359675545245409
South O 0 0.029012838378548622
Africa O 0 0.053919535130262375
. O 0 0.026394180953502655

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
is O 0 0.02850784920156002
endemic O 0 0.08668560534715652
in O 0 0.010139155201613903
the O 0 0.011315769515931606
Cape O 0 0.05330285429954529
and O 0 0.009097391739487648
almost O 0 0.011316752061247826
all O 0 0.007598289288580418
pedigrees O 0 0.07510901987552643
of O 0 0.014588870108127594
total O 0 0.0654999166727066
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.07357507199048996
C6Q0 O 1 0.9997996687889099
) O 0 0.019406260922551155
have O 0 0.007822606712579727
been O 0 0.013615090399980545
ascertained O 0 0.06701724976301193
because O 0 0.01882128231227398
of O 0 0.017354588955640793
recurrent O 1 0.9999996423721313
disease O 1 1.0
. O 0 0.040390968322753906

We O 0 0.019262073561549187
have O 0 0.0114718833938241
sequenced O 0 0.05446496605873108
the O 0 0.0121929831802845
expressed O 0 0.026375096291303635
exons O 0 0.06615833938121796
of O 0 0.012005394324660301
the O 0 0.027269525453448296
C6 O 1 0.9997584223747253
gene O 0 0.07477865368127823
from O 0 0.012789711356163025
selected O 0 0.014147575944662094
cases O 0 0.016768546774983406
and O 0 0.0068708122707903385
have O 0 0.00687785679474473
found O 0 0.013139133341610432
three O 0 0.0121760293841362
molecular O 0 0.07414446771144867
defects O 1 0.9833395481109619
leading O 0 0.027729233726859093
to O 0 0.012823737226426601
total O 0 0.04150993749499321
deficiency O 1 1.0
879delG O 1 0.9398490786552429
, O 0 0.013161614537239075
which O 0 0.006875309627503157
is O 0 0.00812371727079153
the O 0 0.009554171934723854
common O 0 0.031073544174432755
defect O 1 0.9889277219772339
in O 0 0.008640091866254807
the O 0 0.010279088281095028
Cape O 0 0.076203852891922
and O 0 0.013940533623099327
hitherto O 0 0.07441789656877518
unreported O 0 0.08381340652704239
, O 0 0.012890951707959175
and O 0 0.011617959477007389
1195delC O 0 0.12920187413692474
and O 0 0.01446251105517149
1936delG O 0 0.19995427131652832
, O 0 0.00864996574819088
which O 0 0.006399041507393122
have O 0 0.005966218654066324
been O 0 0.009044085629284382
previously O 0 0.014602310955524445
reported O 0 0.02252781018614769
in O 0 0.011717390269041061
African O 0 0.05414249002933502
- O 0 0.09738306701183319
Americans O 0 0.048689089715480804
. O 0 0.03210044652223587

We O 0 0.019657419994473457
also O 0 0.010699418373405933
show O 0 0.016706528142094612
that O 0 0.006399838253855705
the O 0 0.013763056136667728
879delG O 0 0.46939241886138916
and O 0 0.02063162811100483
1195delC O 1 0.9990102052688599
defects O 1 0.9929383397102356
are O 0 0.00955144315958023
associated O 0 0.02268100716173649
with O 0 0.019602132961153984
characteristic O 0 0.4356289207935333
C6 O 1 0.9999994039535522
/ O 1 0.9998843669891357
C7 O 1 0.9995052814483643
region O 0 0.07549577951431274
DNA O 0 0.11206752061843872
marker O 0 0.14977024495601654
haplotypes O 0 0.35493916273117065
, O 0 0.016110075637698174
although O 0 0.013807397335767746
small O 0 0.01671583019196987
variations O 0 0.02729780413210392
were O 0 0.010024060495197773
observed O 0 0.03483274579048157
. O 0 0.022970907390117645

The O 0 0.043278325349092484
1936delG O 1 0.9669636487960815
defect O 1 0.9882628321647644
was O 0 0.025691119953989983
observed O 0 0.026711834594607353
only O 0 0.006939716171473265
once O 0 0.011811990290880203
in O 0 0.007126791402697563
the O 0 0.009828872047364712
Cape O 0 0.06283199787139893
, O 0 0.010492446832358837
but O 0 0.008874853141605854
its O 0 0.011976663023233414
associated O 0 0.035769470036029816
haplotype O 1 0.9754704833030701
could O 0 0.017038831487298012
be O 0 0.013048291206359863
deduced O 0 0.07106032967567444
. O 0 0.02752295695245266

The O 0 0.01770281046628952
data O 0 0.015429969877004623
from O 0 0.010839726775884628
the O 0 0.015758076682686806
haplotypes O 1 0.5694836974143982
indicate O 0 0.028747109696269035
that O 0 0.006094207987189293
these O 0 0.00534991268068552
three O 0 0.011414706707000732
molecular O 0 0.0710507184267044
defects O 1 0.7595534920692444
account O 0 0.016634656116366386
for O 0 0.009388088248670101
the O 0 0.014174723997712135
defects O 1 0.8416408896446228
in O 0 0.008938060142099857
all O 0 0.006069825030863285
the O 0 0.011014459654688835
38 O 0 0.045411061495542526
unrelated O 0 0.06540144979953766
C6Q0 O 1 0.9989985823631287
individuals O 0 0.019103728234767914
we O 0 0.007239628583192825
have O 0 0.0070348335430026054
studied O 0 0.015857413411140442
from O 0 0.00917353481054306
the O 0 0.012285600416362286
Cape O 0 0.09127581119537354
. O 0 0.028391720727086067

We O 0 0.018097080290317535
have O 0 0.008830143138766289
also O 0 0.010967900976538658
observed O 0 0.026175841689109802
the O 0 0.0174094270914793
879delG O 1 0.8773413300514221
defect O 1 0.7469390630722046
in O 0 0.013139455579221249
two O 0 0.015807177871465683
Dutch O 1 0.6969203948974609
C6 B-Disease 1 1.0
- I-Disease 1 0.996787428855896
deficient I-Disease 1 0.9999722242355347
kindreds O 1 0.9605181217193604
, O 0 0.017402762547135353
but O 0 0.010567067191004753
the O 0 0.016014235094189644
879delG O 1 0.9822194576263428
defect O 1 0.8793751001358032
in O 0 0.011192640289664268
the O 0 0.013218088075518608
Cape O 0 0.14415140450000763
probably O 0 0.026205500587821007
did O 0 0.010430754162371159
not O 0 0.005331398453563452
come O 0 0.009374722838401794
from O 0 0.007314007263630629
The O 0 0.009851888753473759
Netherlands O 0 0.03543911874294281
. O 0 0.016781296581029892
. O 0 0.025989990681409836

Complement B-Disease 1 0.9919579029083252
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.0367945060133934
seven O 0 0.023772936314344406
further O 0 0.023359274491667747
molecular O 0 0.07809741795063019
defects O 1 0.961504340171814
and O 0 0.010480828583240509
their O 0 0.012579202651977539
associated O 0 0.03762906417250633
marker O 0 0.14215421676635742
haplotypes O 1 0.8833951354026794
. O 0 0.03405009210109711

Seven O 0 0.034789297729730606
further O 0 0.0256756991147995
molecular O 0 0.056492019444704056
bases O 0 0.03730563074350357
of O 0 0.028277462348341942
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.01576327718794346
described O 0 0.036578379571437836
. O 0 0.027034031227231026

All O 0 0.012346905656158924
these O 0 0.009128301404416561
new O 0 0.022496765479445457
molecular O 0 0.0889381468296051
defects O 1 0.881156861782074
involve O 0 0.04889615252614021
single O 0 0.04456578567624092
- O 0 0.09208539128303528
nucleotide O 0 0.09631530940532684
events O 0 0.03191429004073143
, O 0 0.017683135345578194
deletions O 0 0.06658570468425751
and O 0 0.01373867504298687
substitutions O 0 0.038148511201143265
, O 0 0.009328498505055904
some O 0 0.006045979913324118
of O 0 0.006508915219455957
which O 0 0.012716162949800491
alter O 0 0.08114610612392426
splice O 0 0.1420157104730606
sites O 0 0.02483632229268551
, O 0 0.011293577961623669
and O 0 0.010338416323065758
others O 0 0.02327922359108925
codons O 0 0.09678002446889877
. O 0 0.03075016289949417

They O 0 0.015445973724126816
are O 0 0.006431959569454193
distributed O 0 0.016826167702674866
along O 0 0.015221857465803623
the O 0 0.023435957729816437
C7 O 1 0.9993700385093689
gene O 0 0.08734533190727234
, O 0 0.01186591200530529
but O 0 0.008615128695964813
predominantly O 0 0.020992865785956383
towards O 0 0.01679513417184353
the O 0 0.011101746000349522
3 O 0 0.022008080035448074
end O 0 0.026176918298006058
. O 0 0.02361510507762432

All O 0 0.0115471500903368
were O 0 0.009175460785627365
found O 0 0.016601568087935448
in O 0 0.013118954375386238
compound O 0 0.08351165801286697
heterozygous O 0 0.12442470341920853
individuals O 0 0.03412945568561554
. O 0 0.0247355904430151

The O 0 0.07399493455886841
C6 O 1 0.9999939203262329
/ O 1 0.9996780157089233
C7 O 1 0.9995075464248657
marker O 0 0.20389726758003235
haplotypes O 1 0.5059590339660645
associated O 0 0.03205534443259239
with O 0 0.016924994066357613
most O 0 0.027350980788469315
C7 B-Disease 1 0.9999967813491821
defects I-Disease 1 0.9983647465705872
are O 0 0.011352180503308773
tabulated O 0 0.045368436723947525
. O 0 0.01578606478869915
. O 0 0.020856542512774467

A O 0 0.05925247445702553
genome O 0 0.10731250792741776
- O 0 0.07294259965419769
wide O 0 0.033044617623090744
search O 0 0.03718098998069763
for O 0 0.020167827606201172
chromosomal O 0 0.21833714842796326
loci O 0 0.20009052753448486
linked O 0 0.08598139882087708
to O 0 0.022712115198373795
mental O 1 0.9999974966049194
health O 1 0.9992627501487732
wellness O 1 0.9997782111167908
in O 0 0.013154166750609875
relatives O 0 0.03635795786976814
at O 0 0.022505268454551697
high O 0 0.036746058613061905
risk O 1 0.9977352619171143
for O 0 0.03331946209073067
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999998807907104
among O 0 0.014865757897496223
the O 0 0.011818359605967999
Old O 0 0.029643505811691284
Order O 0 0.02091854251921177
Amish O 0 0.13952909409999847
. O 0 0.03259270638227463

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
( O 1 0.9686239361763
BPAD B-Disease 1 1.0
; O 1 0.9943928718566895
manic B-Disease 1 1.0
- I-Disease 1 0.9999985694885254
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999997615814209
) O 0 0.028750399127602577
is O 0 0.013798472471535206
characterized O 0 0.043229784816503525
by O 0 0.01020804326981306
episodes O 0 0.03257619962096214
of O 0 0.01652468927204609
mania B-Disease 1 0.9999995231628418
and O 0 0.024350402876734734
/ O 1 0.9998748302459717
or O 0 0.040847502648830414
hypomania B-Disease 1 0.9999978542327881
interspersed O 0 0.06933598220348358
with O 0 0.016522977501153946
periods O 0 0.042584631592035294
of O 0 0.01773986406624317
depression B-Disease 1 0.9999377727508545
. O 0 0.035060785710811615

Compelling O 0 0.0598185658454895
evidence O 0 0.025664152577519417
supports O 0 0.03460482135415077
a O 0 0.017826242372393608
significant O 0 0.027193745598196983
genetic O 0 0.06105286255478859
component O 0 0.04371323063969612
in O 0 0.010762841440737247
the O 0 0.016367696225643158
susceptibility O 1 0.6640430688858032
to O 0 0.019687224179506302
develop O 0 0.08558966964483261
BPAD B-Disease 1 0.9999657869338989
. O 0 0.040817126631736755

To O 0 0.01830700784921646
date O 0 0.018748020753264427
, O 0 0.010260701179504395
however O 0 0.011379215866327286
, O 0 0.014186442829668522
linkage O 0 0.09945333749055862
studies O 0 0.022215960547327995
have O 0 0.008025124669075012
attempted O 0 0.022517774254083633
only O 0 0.007003271020948887
to O 0 0.010484656319022179
identify O 0 0.04576485604047775
chromosomal O 0 0.1874096691608429
loci O 0 0.15875829756259918
that O 0 0.012996993027627468
cause O 0 0.05001094192266464
or O 0 0.01336716115474701
increase O 0 0.01769346557557583
the O 0 0.01174649316817522
risk O 0 0.21393334865570068
of O 0 0.012566285207867622
developing O 0 0.08866801857948303
BPAD B-Disease 1 0.9999947547912598
. O 0 0.03831122815608978

To O 0 0.019799672067165375
determine O 0 0.025199448689818382
whether O 0 0.0158687736839056
there O 0 0.008991884998977184
could O 0 0.01288407202810049
be O 0 0.01274992898106575
protective O 1 0.969356894493103
alleles O 0 0.12302576005458832
that O 0 0.012027840130031109
prevent O 0 0.038734596222639084
or O 0 0.01539065595716238
reduce O 0 0.03979233279824257
the O 0 0.016274750232696533
risk O 0 0.35655754804611206
of O 0 0.013421952724456787
developing O 0 0.07254870980978012
BPAD B-Disease 1 0.9999959468841553
, O 0 0.013491237536072731
similar O 0 0.012332946993410587
to O 0 0.007562793325632811
what O 0 0.009817535988986492
is O 0 0.009452170692384243
observed O 0 0.019813058897852898
in O 0 0.00793330930173397
other O 0 0.012472801841795444
genetic B-Disease 1 0.9998900890350342
disorders I-Disease 1 1.0
, O 0 0.015342460945248604
we O 0 0.01104686688631773
used O 0 0.022150663658976555
mental O 1 0.9999979734420776
health O 1 0.9998338222503662
wellness O 1 0.9999618530273438
( O 0 0.030190682038664818
absence O 0 0.034621164202690125
of O 0 0.011787503957748413
any O 0 0.025830892845988274
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
) O 0 0.0185879934579134
as O 0 0.008471566252410412
the O 0 0.013156316243112087
phenotype O 0 0.3042103350162506
in O 0 0.012577621266245842
our O 0 0.01906505413353443
genome O 0 0.09263934195041656
- O 0 0.09248480945825577
wide O 0 0.04907330125570297
linkage O 0 0.14424832165241241
scan O 0 0.09217353165149689
of O 0 0.009073483757674694
several O 0 0.010359279811382294
large O 0 0.01979214884340763
multigeneration O 0 0.26371702551841736
Old O 0 0.03999108448624611
Order O 0 0.02484438382089138
Amish O 0 0.14312177896499634
pedigrees O 0 0.1486937254667282
exhibiting O 0 0.09336774796247482
an O 0 0.02122059464454651
extremely O 0 0.04539867490530014
high O 0 0.04895969480276108
incidence O 1 0.9921693205833435
of O 0 0.022723395377397537
BPAD B-Disease 1 0.9999948740005493
. O 0 0.03602752462029457

We O 0 0.017946584150195122
have O 0 0.009734274819493294
found O 0 0.014402741566300392
strong O 0 0.014239276759326458
evidence O 0 0.011167926713824272
for O 0 0.007041559088975191
a O 0 0.020410535857081413
locus O 0 0.11200258880853653
on O 0 0.026218241080641747
chromosome O 0 0.1932756006717682
4p O 1 0.9761745929718018
at O 0 0.049247827380895615
D4S2949 O 0 0.15071021020412445
( O 0 0.03708580881357193
maximum O 0 0.06485886871814728
GENEHUNTER O 1 0.9972712397575378
- O 0 0.12043219804763794
PLUS O 0 0.10540993511676788
nonparametric O 0 0.19466014206409454
linkage O 0 0.14581725001335144
score O 0 0.04618162661790848
= O 0 0.09580298513174057
4 O 0 0.029439911246299744
. O 0 0.016704626381397247
05 O 0 0.13256652653217316
, O 0 0.025194792076945305
P O 0 0.4165046513080597
= O 0 0.09215176105499268
5 O 0 0.023925436660647392
. O 0 0.010591655038297176
22 O 0 0.02650369517505169
x O 0 0.06223076581954956
10 O 0 0.0260798130184412
( O 0 0.03517371788620949
- O 0 0.07801622897386551
4 O 0 0.03751901909708977
) O 0 0.031132005155086517
; O 0 0.032879628241062164
SIBPAL O 1 0.939113199710846
Pempirical O 0 0.21005779504776
value O 0 0.037940818816423416
< O 0 0.14500105381011963
3 O 0 0.03380166366696358
x O 0 0.06449461728334427
10 O 0 0.027243077754974365
( O 0 0.03441990539431572
- O 0 0.06700657308101654
5 O 0 0.03381606191396713
) O 0 0.022226860746741295
) O 0 0.01754792220890522
and O 0 0.009968414902687073
suggestive O 0 0.07047631591558456
evidence O 0 0.013420335948467255
for O 0 0.008615604601800442
a O 0 0.021518440917134285
locus O 0 0.11819452047348022
on O 0 0.02782970480620861
chromosome O 0 0.22320984303951263
4q O 1 0.9992836117744446
at O 0 0.04231610521674156
D4S397 O 0 0.1611565351486206
( O 0 0.03954383358359337
maximum O 0 0.06573263555765152
GENEHUNTER O 1 0.9977715015411377
- O 0 0.12161432951688766
PLUS O 0 0.10906758904457092
nonparametric O 0 0.21551395952701569
linkage O 0 0.16439856588840485
score O 0 0.04727410525083542
= O 0 0.09146162122488022
3 O 0 0.023871518671512604
. O 0 0.011229812167584896
29 O 0 0.03038136661052704
, O 0 0.019250210374593735
P O 0 0.39993345737457275
= O 0 0.08908960223197937
2 O 0 0.022731073200702667
. O 0 0.011736169457435608
57 O 0 0.04715254530310631
x O 0 0.060921262949705124
10 O 0 0.024370739236474037
( O 0 0.03172089532017708
- O 0 0.0674760490655899
3 O 0 0.03825670853257179
) O 0 0.030324019491672516
; O 0 0.03301354870200157
SIBPAL O 1 0.9630230665206909
Pempirical O 0 0.20498071610927582
value O 0 0.03929216414690018
< O 0 0.14187836647033691
1 O 0 0.033398497849702835
x O 0 0.06511378288269043
10 O 0 0.02581647038459778
( O 0 0.03394422307610512
- O 0 0.06797987967729568
3 O 0 0.02808450721204281
) O 0 0.019597478210926056
) O 0 0.01535885687917471
that O 0 0.007589737419039011
are O 0 0.007803489454090595
linked O 0 0.04842308908700943
to O 0 0.02046493999660015
mental O 1 0.9999961853027344
health O 1 0.9996459484100342
wellness O 1 0.9999333620071411
. O 0 0.031290195882320404

These O 0 0.01680942252278328
findings O 0 0.027164341881871223
are O 0 0.005991616286337376
consistent O 0 0.02031715214252472
with O 0 0.007614666596055031
the O 0 0.010449640452861786
hypothesis O 0 0.04810214787721634
that O 0 0.00915115512907505
certain O 0 0.01761709526181221
alleles O 0 0.11979182064533234
could O 0 0.021772639825940132
prevent O 0 0.039282411336898804
or O 0 0.018383527174592018
modify O 0 0.048686087131500244
the O 0 0.01605657860636711
clinical O 1 0.9975054860115051
manifestations O 0 0.49977242946624756
of O 0 0.01431969553232193
BPAD B-Disease 1 0.9999983310699463
and O 0 0.011075548827648163
perhaps O 0 0.019286472350358963
other O 0 0.011414151638746262
related O 0 0.15623073279857635
affective B-Disease 1 0.9999985694885254
disorders I-Disease 1 1.0
. O 0 0.034928712993860245

Segregation O 1 0.65382319688797
distortion O 1 0.8275327086448669
in O 0 0.059270843863487244
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.06286965310573578

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9967206120491028
DM B-Disease 1 1.0
) O 0 0.032216958701610565
is O 0 0.016727713868021965
an O 0 0.023115307092666626
autosomal B-Disease 1 0.9999462366104126
dominant I-Disease 1 0.9980658888816833
disease I-Disease 1 0.9999998807907104
which O 0 0.011992132291197777
, O 0 0.007431590463966131
in O 0 0.007339573930948973
the O 0 0.01170935295522213
typical O 0 0.046381983906030655
pedigree O 0 0.08404567837715149
, O 0 0.010957344435155392
shows O 0 0.013573329895734787
a O 0 0.0107718575745821
three O 0 0.012465937994420528
generation O 0 0.061548661440610886
anticipation O 0 0.09928145259618759
cascade O 0 0.22596099972724915
. O 0 0.04255635663866997

This O 0 0.01932515762746334
results O 0 0.03140312060713768
in O 0 0.024409759789705276
infertility B-Disease 1 1.0
and O 1 0.918889045715332
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8423181772232056
CDM B-Disease 1 0.9999943971633911
) O 0 0.020313316956162453
with O 0 0.008893134072422981
the O 0 0.010530144907534122
disappearance O 0 0.06461576372385025
of O 0 0.02118445560336113
DM B-Disease 1 1.0
in O 0 0.017205793410539627
that O 0 0.014753974042832851
pedigree O 0 0.12096084654331207
. O 0 0.029312359169125557

The O 0 0.02335410751402378
concept O 0 0.03321816772222519
of O 0 0.016479140147566795
segregation O 0 0.13269494473934174
distortion O 0 0.13067315518856049
, O 0 0.01292925700545311
where O 0 0.01194915734231472
there O 0 0.008985845372080803
is O 0 0.01341262273490429
preferential O 0 0.08233048766851425
transmission O 0 0.06318090111017227
of O 0 0.007283027749508619
the O 0 0.00995705183595419
larger O 0 0.029461214318871498
allele O 0 0.13483826816082
at O 0 0.03405838832259178
the O 0 0.033420685678720474
DM B-Disease 1 1.0
locus O 0 0.15114857256412506
, O 0 0.016170408576726913
has O 0 0.010406379587948322
been O 0 0.010234463028609753
put O 0 0.016043690964579582
forward O 0 0.015926003456115723
to O 0 0.010164542123675346
explain O 0 0.03338576853275299
partially O 0 0.046697914600372314
the O 0 0.015206247568130493
maintenance O 0 0.07355432212352753
of O 0 0.02127593755722046
DM B-Disease 1 1.0
in O 0 0.015452057123184204
the O 0 0.01260784175246954
population O 0 0.026726799085736275
. O 0 0.024143075570464134

In O 0 0.02279035560786724
a O 0 0.022810550406575203
survey O 0 0.03719682991504669
of O 0 0.021634165197610855
DM B-Disease 1 0.9999996423721313
in O 0 0.018920719623565674
Northern O 0 0.024390118196606636
Ireland O 0 0.02994455210864544
, O 0 0.014916897751390934
59 O 0 0.05400091037154198
pedigrees O 0 0.1044808030128479
were O 0 0.018360696732997894
ascertained O 0 0.1056346520781517
. O 0 0.029246758669614792

Sibships O 0 0.3122981786727905
where O 0 0.01882195472717285
the O 0 0.008688441477715969
status O 0 0.015512129291892052
of O 0 0.004652231931686401
all O 0 0.00441557914018631
the O 0 0.006721855141222477
members O 0 0.009738820604979992
had O 0 0.01302267238497734
been O 0 0.01076835673302412
identified O 0 0.019720662385225296
were O 0 0.008331069722771645
examined O 0 0.03158856928348541
to O 0 0.00779251242056489
determine O 0 0.01632612571120262
the O 0 0.01066453754901886
transmission O 0 0.06050390377640724
of O 0 0.012476643547415733
the O 0 0.028491461649537086
DM B-Disease 1 1.0
expansion O 0 0.05149617791175842
from O 0 0.016443494707345963
affected O 0 0.03817594051361084
parents O 0 0.02258957549929619
to O 0 0.007583461236208677
their O 0 0.01070253923535347
offspring O 0 0.08617706596851349
. O 0 0.030611921101808548

Where O 0 0.029945949092507362
the O 0 0.019469069316983223
transmitting O 0 0.11615442484617233
parent O 0 0.10065804421901703
was O 0 0.02482142299413681
male O 0 0.051697444170713425
, O 0 0.01731221005320549
58 O 0 0.06476758420467377
. O 0 0.026518482714891434

3 O 0 0.03555656224489212
% O 0 0.017089953646063805
of O 0 0.006919240579009056
the O 0 0.012372295372188091
offspring O 0 0.05488651245832443
were O 0 0.010269764810800552
affected O 0 0.031696442514657974
, O 0 0.008015182800590992
and O 0 0.005464988760650158
in O 0 0.005443734582513571
the O 0 0.007516615558415651
case O 0 0.013129349797964096
of O 0 0.006681046448647976
a O 0 0.019228557124733925
female O 0 0.046948883682489395
transmitting O 0 0.13100144267082214
parent O 0 0.10719244182109833
, O 0 0.022882146760821342
68 O 0 0.07022403925657272
. O 0 0.027531011030077934

7 O 0 0.057100992649793625
% O 0 0.02763644978404045
were O 0 0.01561709027737379
affected O 0 0.05651257187128067
. O 0 0.027170896530151367

Studies O 0 0.050607871264219284
on O 0 0.02244843915104866
meiotic O 1 0.9816495776176453
drive O 0 0.0715174674987793
in O 0 0.02966584451496601
DM B-Disease 1 1.0
have O 0 0.01500754151493311
shown O 0 0.02357150986790657
increased O 0 0.02432413399219513
transmission O 0 0.04900312051177025
of O 0 0.006484117824584246
the O 0 0.010544521734118462
larger O 0 0.024133717641234398
allele O 0 0.11920134723186493
at O 0 0.028003178536891937
the O 0 0.031760454177856445
DM B-Disease 1 0.9999998807907104
locus O 0 0.14173483848571777
in O 0 0.024568304419517517
non O 0 0.21574287116527557
- O 1 0.9994307160377502
DM O 1 1.0
heterozygotes O 1 0.990056574344635
for O 0 0.03318989649415016
CTGn O 1 0.8722034692764282
. O 0 0.03496298938989639

This O 0 0.018998341634869576
study O 0 0.028568517416715622
provides O 0 0.025892361998558044
further O 0 0.012776292860507965
evidence O 0 0.012050645425915718
that O 0 0.009561917744576931
the O 0 0.024804769083857536
DM B-Disease 1 1.0
expansion O 0 0.05439508706331253
tends O 0 0.05283018574118614
to O 0 0.010524818673729897
be O 0 0.01436118595302105
transmitted O 0 0.10010609030723572
preferentially O 0 0.1475135236978531
. O 0 0.03829116001725197

Diagnosis O 1 0.999994158744812
of O 0 0.04320400208234787
hemochromatosis B-Disease 1 1.0
. O 0 0.048199933022260666

If O 0 0.07694128900766373
untreated O 1 0.9999984502792358
, O 1 0.6424171924591064
hemochromatosis B-Disease 1 1.0
can O 0 0.11963146179914474
cause O 1 0.999657392501831
serious O 1 0.9999123811721802
illness O 1 0.9999995231628418
and O 0 0.010844781063497066
early B-Disease 0 0.01882774755358696
death I-Disease 0 0.02787378802895546
, O 0 0.008537986315786839
but O 0 0.008310863748192787
the O 0 0.015820752829313278
disease O 1 0.999998927116394
is O 0 0.014033217914402485
still O 0 0.014877920038998127
substantially O 0 0.04146242514252663
under O 0 0.024590101093053818
- O 1 0.9970986843109131
diagnosed O 1 0.9999996423721313
. O 0 0.04371742531657219

The O 0 0.02501937747001648
cornerstone O 0 0.07167545706033707
of O 0 0.011670091189444065
screening O 0 0.07814204692840576
and O 0 0.01140377763658762
case O 0 0.02645864523947239
detection O 0 0.07067081332206726
is O 0 0.010957312770187855
the O 0 0.011787137016654015
measurement O 0 0.04818535968661308
of O 0 0.017521323636174202
serum O 1 0.9979665279388428
transferrin O 1 0.9971565008163452
saturation O 0 0.18258079886436462
and O 0 0.016471263021230698
the O 0 0.025608070194721222
serum O 1 0.9959428906440735
ferritin O 1 0.9718138575553894
level O 0 0.05489189922809601
. O 0 0.029451893642544746

Once O 0 0.04548649489879608
the O 0 0.02611044980585575
diagnosis O 1 0.9999932050704956
is O 0 0.022801829501986504
suspected O 0 0.07445871084928513
, O 0 0.018779175356030464
physicians O 1 0.7267687916755676
must O 0 0.018843142315745354
use O 0 0.026334024965763092
serum O 1 0.9963873624801636
ferritin O 1 0.9815448522567749
levels O 0 0.06913559883832932
and O 0 0.028105316683650017
hepatic O 1 0.9999997615814209
iron O 1 0.984758734703064
stores O 0 0.03486785292625427
on O 0 0.023042961955070496
liver O 1 0.9999996423721313
biopsy O 1 0.999982476234436
specimens O 0 0.046825822442770004
to O 0 0.014955610036849976
assess O 0 0.1635165512561798
patients O 1 0.9989913105964661
for O 0 0.0069887456484138966
the O 0 0.009615238755941391
presence O 0 0.03023388981819153
of O 0 0.016010956838726997
iron B-Disease 1 0.998238205909729
overload I-Disease 1 0.9996833801269531
. O 0 0.03415090590715408

Liver O 1 0.9999990463256836
biopsy O 1 0.9997760653495789
is O 0 0.01442073192447424
also O 0 0.007886677049100399
used O 0 0.007058288902044296
to O 0 0.006233970634639263
establish O 0 0.01647224649786949
the O 0 0.009126887656748295
presence O 0 0.027914976701140404
or O 0 0.015816088765859604
absence O 0 0.033176880329847336
of O 0 0.01555783860385418
cirrhosis B-Disease 1 0.9999994039535522
, O 0 0.013056189753115177
which O 0 0.010899911634624004
can O 0 0.016511844471096992
affect O 0 0.05254991725087166
prognosis O 1 0.9999997615814209
and O 0 0.015355641953647137
management O 0 0.3045075535774231
. O 0 0.02238444797694683

A O 0 0.05425942316651344
DNA O 0 0.08196308463811874
- O 0 0.06168689951300621
based O 0 0.020103925839066505
test O 0 0.027833087369799614
for O 0 0.009843556210398674
the O 0 0.021154677495360374
HFE O 1 0.9995895028114319
gene O 0 0.08782839775085449
is O 0 0.01507408544421196
commercially O 0 0.02491961605846882
available O 0 0.0114015256986022
, O 0 0.007157405372709036
but O 0 0.0047662281431257725
its O 0 0.006185088772326708
place O 0 0.009810215793550014
in O 0 0.007892170920968056
the O 0 0.017372960224747658
diagnosis O 1 0.9999986886978149
of O 0 0.022788848727941513
hemochromatosis B-Disease 1 1.0
is O 0 0.01999291591346264
still O 0 0.01699042320251465
being O 0 0.017334679141640663
evaluated O 0 0.06940717995166779
. O 0 0.022655289620161057

Currently O 0 0.029407262802124023
, O 0 0.009738954715430737
the O 0 0.007053290493786335
most O 0 0.008284795098006725
useful O 0 0.015607388690114021
role O 0 0.01323771197348833
for O 0 0.0065889316610991955
this O 0 0.0066929589956998825
test O 0 0.022128503769636154
is O 0 0.007737756706774235
in O 0 0.0068502528592944145
the O 0 0.011790568940341473
detection O 0 0.07275846600532532
of O 0 0.01571795530617237
hemochromatosis B-Disease 1 0.9999998807907104
in O 0 0.011919474229216576
the O 0 0.009595965035259724
family O 0 0.019660407677292824
members O 0 0.011580199934542179
of O 0 0.009623792953789234
patients O 1 0.9999276399612427
with O 0 0.009548470377922058
a O 0 0.015194883570075035
proven O 0 0.050967201590538025
case O 0 0.014592099003493786
of O 0 0.007651469204574823
the O 0 0.020579097792506218
disease O 1 0.9999995231628418
. O 0 0.03496842831373215

It O 0 0.017556721344590187
is O 0 0.015349463559687138
crucial O 0 0.03002047911286354
to O 0 0.029060591012239456
diagnose O 1 0.9999997615814209
hemochromatosis B-Disease 1 1.0
before O 1 0.9146298170089722
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.999954342842102
because O 0 0.2604130506515503
phlebotomy O 1 0.9999998807907104
therapy O 1 1.0
can O 0 0.09800563752651215
avert O 1 0.9999843835830688
serious O 1 0.9999994039535522
chronic O 1 1.0
disease O 1 1.0
and O 0 0.012584084644913673
can O 0 0.01113660167902708
even O 0 0.010924702510237694
lead O 0 0.020282527431845665
to O 0 0.009230932220816612
normal O 0 0.040449123829603195
life O 0 0.0264247078448534
expectancy O 0 0.0850713849067688
. O 0 0.017786571756005287
. O 0 0.02275979518890381

Prevalence O 1 0.8980522155761719
of O 0 0.016604091972112656
the O 0 0.027288876473903656
I1307K O 1 0.9590059518814087
APC B-Disease 1 0.9958425164222717
gene O 0 0.1127966046333313
variant O 0 0.08748006075620651
in O 0 0.013672503642737865
Israeli O 0 0.025241907685995102
Jews O 0 0.017058439552783966
of O 0 0.006904037203639746
differing O 0 0.022296961396932602
ethnic O 0 0.01689680479466915
origin O 0 0.020458130165934563
and O 0 0.015525140799582005
risk O 1 0.9998258948326111
for O 0 0.2891121208667755
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04083314538002014

BACKGROUND O 0 0.11319791525602341
& O 0 0.09079281985759735
AIMS O 0 0.07231941819190979
Israeli O 0 0.03392151743173599
Jews O 0 0.01972551830112934
of O 0 0.008070644922554493
European O 0 0.024720849469304085
birth O 0 0.04284929484128952
, O 0 0.014391112141311169
i O 0 0.02004176750779152
. O 0 0.011179174296557903
e O 0 0.03953521326184273
. O 0 0.009468887001276016
, O 0 0.012620099820196629
Ashkenazim O 1 0.5692262649536133
, O 0 0.011801464483141899
have O 0 0.009376738220453262
the O 0 0.0167683195322752
highest O 1 0.9996892213821411
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999297857284546
of O 0 0.009607129730284214
any O 0 0.009566064924001694
Israeli O 0 0.022895563393831253
ethnic O 0 0.021212896332144737
group O 0 0.038142308592796326
. O 0 0.02714795246720314

The O 0 0.04478568583726883
I1307K O 1 0.5246030688285828
APC B-Disease 1 0.9825471043586731
gene O 0 0.12811237573623657
variant O 0 0.11464212834835052
was O 0 0.02017694152891636
found O 0 0.015564778819680214
in O 0 0.011356305330991745
6 O 0 0.029046442359685898
. O 0 0.021698886528611183

1 O 0 0.03611762821674347
% O 0 0.01910572685301304
of O 0 0.008802422322332859
American O 0 0.02185826562345028
Jews O 0 0.02022222988307476
, O 0 0.009937906637787819
28 O 0 0.017885053530335426
% O 0 0.014246038161218166
of O 0 0.00821880716830492
their O 0 0.022982902824878693
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.08139656484127045
, O 0 0.008831304498016834
but O 0 0.005686604883521795
not O 0 0.005416678264737129
in O 0 0.007890483364462852
non O 0 0.034921105951070786
- O 0 0.06896331161260605
Jews O 0 0.03347987309098244
. O 0 0.02754252217710018

We O 0 0.026011893525719643
assessed O 0 0.06229306012392044
the O 0 0.022540559992194176
I1307K O 1 0.7868318557739258
prevalence O 1 0.937240719795227
in O 0 0.014374915510416031
Israeli O 0 0.02615826204419136
Jews O 0 0.01679537072777748
of O 0 0.0070563871413469315
differing O 0 0.021404415369033813
ethnic O 0 0.0161827951669693
origin O 0 0.024721739813685417
and O 0 0.016126424074172974
risk O 1 0.9999293088912964
for O 0 0.4311203956604004
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04690330848097801

METHODS O 0 0.08548277616500854
DNA O 0 0.08198632299900055
samples O 0 0.04934706166386604
from O 0 0.017069516703486443
500 O 0 0.044430796056985855
unrelated O 0 0.04408222436904907
Jews O 0 0.018360400572419167
of O 0 0.007478389423340559
European O 0 0.0202619731426239
or O 0 0.017713245004415512
non O 0 0.036522313952445984
- O 0 0.048540741205215454
European O 0 0.02185634896159172
origin O 0 0.018137173727154732
, O 0 0.008124539628624916
with O 0 0.00807596743106842
or O 0 0.011644880287349224
without O 0 0.009642627090215683
a O 0 0.012067470699548721
personal O 0 0.020489579066634178
and O 0 0.015022463165223598
/ O 1 0.998444139957428
or O 0 0.016242070123553276
family O 0 0.021035121753811836
history O 0 0.017473271116614342
of O 0 0.016492128372192383
neoplasia B-Disease 1 0.9999891519546509
, O 0 0.01237496454268694
were O 0 0.008098620921373367
examined O 0 0.03632371500134468
for O 0 0.008720307610929012
the O 0 0.014053605496883392
I1307K O 0 0.14955203235149384
variant O 0 0.08431322127580643
by O 0 0.013216010294854641
the O 0 0.022041024640202522
allele O 0 0.18340380489826202
- O 0 0.10117435455322266
specific O 0 0.04547489434480667
oligonucleotide O 0 0.31651660799980164
( O 0 0.05486076697707176
ASO O 1 0.9953893423080444
) O 0 0.032573338598012924
method O 0 0.04371724650263786
. O 0 0.024284591898322105

RESULTS O 0 0.05284304544329643
In O 0 0.013927758671343327
persons O 0 0.02483605034649372
at O 0 0.0210098959505558
average O 0 0.04220418632030487
risk O 1 0.9996997117996216
for O 0 0.1318494826555252
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.02220853976905346
I1307K O 0 0.29356706142425537
was O 0 0.015774905681610107
found O 0 0.01560910139232874
in O 0 0.011879515834152699
5 O 0 0.02889794483780861
. O 0 0.021769573912024498

0 O 0 0.06955581158399582
% O 0 0.023622559383511543
of O 0 0.009210145100951195
120 O 0 0.032223887741565704
European O 0 0.022552480921149254
and O 0 0.013194113969802856
1 O 0 0.02855667471885681
. O 0 0.021956531330943108

6 O 0 0.050336889922618866
% O 0 0.023918814957141876
of O 0 0.011838546022772789
188 O 0 0.08394870907068253
non O 0 0.0516667440533638
- O 0 0.07237352430820465
European O 0 0.03291050344705582
Jews O 0 0.03823067992925644
( O 0 0.04770825803279877
P O 1 0.9492015838623047
= O 0 0.12455034255981445
0 O 0 0.05632995441555977
. O 0 0.017053356394171715
08 O 0 0.0960926041007042
) O 0 0.035086680203676224
. O 0 0.02701684460043907

It O 0 0.02055523917078972
occurred O 0 0.03560083359479904
in O 0 0.013475493527948856
15 O 0 0.02474154159426689
. O 0 0.02474946342408657

4 O 0 0.042120322585105896
% O 0 0.025399815291166306
of O 0 0.012525844387710094
52 O 0 0.05564030632376671
Ashkenazi O 0 0.1425599455833435
Israelis O 0 0.0705588087439537
with O 0 0.03608325868844986
familial O 1 0.999998927116394
cancer B-Disease 1 1.0
( O 0 0.08140236884355545
P O 1 0.995965838432312
= O 0 0.1282804161310196
0 O 0 0.052358124405145645
. O 0 0.017401596531271935
02 O 1 0.928041398525238
) O 0 0.018694818019866943
and O 0 0.008151636458933353
was O 0 0.012707408517599106
not O 0 0.009951094165444374
detected O 0 0.050408847630023956
in O 0 0.011161825619637966
51 O 0 0.04506803676486015
non O 0 0.042506467550992966
- O 0 0.06129704415798187
European O 0 0.028885727748274803
Jews O 0 0.029564253985881805
at O 0 0.02809537947177887
increased O 0 0.16529275476932526
cancer B-Disease 1 0.9999998807907104
risk O 1 0.9957519769668579
. O 0 0.03227910026907921

Colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9999973773956299
occurred O 0 0.0875445231795311
personally O 0 0.05929052457213402
or O 0 0.012962305918335915
in O 0 0.0062203314155340195
the O 0 0.007246448192745447
families O 0 0.014804089441895485
of O 0 0.0067057120613753796
13 O 0 0.01748364046216011
of O 0 0.009495099075138569
20 O 0 0.03289606422185898
Ashkenazi O 0 0.17817839980125427
I1307K O 1 0.5008668899536133
carriers O 0 0.08338313549757004
, O 0 0.013140078634023666
8 O 0 0.015672089532017708
of O 0 0.0070306044071912766
whom O 0 0.019603002816438675
also O 0 0.008113814517855644
had O 0 0.00971963256597519
a O 0 0.01084943488240242
personal O 0 0.016481921076774597
or O 0 0.013725747354328632
family O 0 0.021354133263230324
history O 0 0.01763588935136795
of O 0 0.01711598038673401
noncolonic O 1 0.9994434714317322
neoplasia B-Disease 1 0.9999716281890869
. O 0 0.046978387981653214

CONCLUSIONS O 0 0.06878524273633957
The O 0 0.03113989531993866
I1307K O 1 0.7320234179496765
APC O 1 0.9965173006057739
variant O 0 0.134957954287529
may O 0 0.023268762975931168
represent O 0 0.019894137978553772
a O 0 0.030354076996445656
susceptibility O 1 0.9694210886955261
gene O 0 0.10564300417900085
for O 0 0.02777036465704441
colorectal B-Disease 1 1.0
, I-Disease 0 0.017179736867547035
or I-Disease 0 0.015757568180561066
other I-Disease 0 0.010102515108883381
, I-Disease 0 0.018606817349791527
cancers I-Disease 1 0.9997735619544983
in O 0 0.018586035817861557
Ashkenazi O 0 0.20305436849594116
Jews O 0 0.02584058605134487
, O 0 0.010761333629488945
and O 0 0.009858538396656513
partially O 0 0.053628649562597275
explains O 0 0.040987201035022736
the O 0 0.01431460864841938
higher O 0 0.04112978279590607
incidence O 1 0.9999758005142212
of O 0 0.07928979396820068
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.018565913662314415
European O 0 0.02748185209929943
Israelis O 0 0.05977736413478851
. O 0 0.026273539289832115

Systematic O 0 0.11269208788871765
analysis O 0 0.03859942406415939
of O 0 0.022110216319561005
coproporphyrinogen O 1 0.9965003728866577
oxidase O 1 0.9899052977561951
gene O 0 0.198874369263649
defects O 1 0.9956887364387512
in O 0 0.029205817729234695
hereditary B-Disease 1 0.9977458119392395
coproporphyria I-Disease 1 0.9948208332061768
and O 0 0.025783509016036987
mutation O 0 0.17365290224552155
update O 0 0.11629059165716171
. O 0 0.029188763350248337

Hereditary B-Disease 1 0.995013415813446
coproporphyria I-Disease 1 0.99775630235672
( O 0 0.07633458822965622
HC B-Disease 1 0.999998927116394
) O 0 0.029819535091519356
is O 0 0.018350884318351746
an O 0 0.032859738916158676
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.04401138424873352
autosomal O 1 0.999920129776001
dominant O 1 0.8045382499694824
inheritance O 1 0.972553014755249
caused O 1 0.8617569208145142
by O 0 0.02150636911392212
deficient B-Disease 1 0.9938166737556458
activity I-Disease 0 0.048144493252038956
of I-Disease 0 0.018744677305221558
coproporphyrinogen I-Disease 1 0.9972851276397705
III I-Disease 1 0.9813328385353088
oxidase I-Disease 1 0.8530596494674683
( O 0 0.062136076390743256
CPO O 0 0.36346006393432617
) O 0 0.03400815278291702
. O 0 0.02558082714676857

Clinical O 1 0.9982838034629822
manifestations O 0 0.371843546628952
of O 0 0.011214635334908962
the O 0 0.02048483118414879
disease O 1 1.0
are O 0 0.011619596742093563
characterized O 1 0.7290173768997192
by O 0 0.01985037699341774
acute O 1 1.0
attacks O 0 0.41534119844436646
of O 0 0.024796688929200172
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.040370337665081024
precipitated O 1 0.9740620851516724
by O 0 0.019865700975060463
drugs O 0 0.2702488303184509
, O 0 0.019046425819396973
fasting O 1 0.5503764152526855
, O 0 0.023972319439053535
cyclical O 1 0.9989953637123108
hormonal O 1 0.9995850920677185
changes O 0 0.031187035143375397
, O 0 0.018941013142466545
or O 1 0.7875461578369141
infectious B-Disease 1 1.0
diseases I-Disease 1 0.9999997615814209
. O 0 0.03686339780688286

Skin O 1 1.0
photosensitivity O 1 0.9999992847442627
may O 0 0.029207414016127586
also O 0 0.009384204633533955
be O 0 0.006792652420699596
present O 0 0.01743704453110695
. O 0 0.01976628601551056

The O 0 0.021359998732805252
seven O 0 0.02527574636042118
exons O 0 0.08364687860012054
, O 0 0.016614621505141258
the O 0 0.020040104165673256
exon O 0 0.20473968982696533
/ O 1 0.7610430121421814
intron O 0 0.24159054458141327
boundaries O 0 0.02113405615091324
and O 0 0.009050559252500534
part O 0 0.016401709988713264
of O 0 0.00965842790901661
3 O 0 0.02912663109600544
noncoding O 0 0.13222487270832062
sequence O 0 0.026313306763768196
of O 0 0.008940344676375389
the O 0 0.01825573481619358
CPO O 0 0.18727876245975494
gene O 0 0.07503532618284225
were O 0 0.013227201998233795
systematically O 0 0.0551459975540638
analyzed O 0 0.03908359259366989
by O 0 0.013029918074607849
an O 0 0.020166488364338875
exon O 0 0.14845243096351624
- O 0 0.09608852863311768
by O 0 0.03165815398097038
- O 0 0.1498376578092575
exon O 0 0.2594815790653229
denaturing O 1 0.7830235958099365
gradient O 1 0.5330590009689331
gel O 1 0.9919729232788086
electrophoresis O 1 0.780025064945221
( O 0 0.06915715336799622
DGGE O 1 0.9985145926475525
) O 0 0.029235877096652985
strategy O 0 0.03779427707195282
followed O 0 0.01858070120215416
by O 0 0.009665368124842644
direct O 0 0.02485952340066433
sequencing O 0 0.04877454787492752
in O 0 0.011238916777074337
seven O 0 0.020656445994973183
unrelated O 0 0.07853376865386963
heterozygous O 0 0.2787465751171112
HC B-Disease 1 0.9999995231628418
patients O 1 0.9999783039093018
from O 0 0.022948335856199265
France O 0 0.04377349466085434
, O 0 0.015908243134617805
Holland O 0 0.07294280081987381
, O 0 0.010013815946877003
and O 0 0.008780992589890957
Czech O 0 0.03976806253194809
Republic O 0 0.029201677069067955
. O 0 0.02781151980161667

Seven O 0 0.04244285076856613
novel O 0 0.05045352876186371
mutations O 0 0.08372430503368378
and O 0 0.010031444951891899
two O 0 0.01040111668407917
new O 0 0.02441752329468727
polymorphisms O 0 0.12428463250398636
were O 0 0.021134717389941216
detected O 0 0.08761806786060333
. O 0 0.028081439435482025

Among O 0 0.028885507956147194
these O 0 0.014322125352919102
mutations O 0 0.07695160061120987
two O 0 0.013022389262914658
are O 0 0.015852991491556168
missense O 0 0.1766032874584198
( O 0 0.04380495101213455
G197W O 0 0.22297726571559906
, O 0 0.02445942908525467
W427R O 0 0.1603219360113144
) O 0 0.019383423030376434
, O 0 0.00863924715667963
two O 0 0.007887721993029118
are O 0 0.011491117998957634
nonsense O 0 0.08232105523347855
( O 0 0.03959785774350166
Q306X O 0 0.2072003334760666
, O 0 0.024130089208483696
Q385X O 0 0.16238033771514893
) O 0 0.02133856900036335
, O 0 0.008604558184742928
two O 0 0.006353173870593309
are O 0 0.0072037456557154655
small O 0 0.02008884772658348
deletions O 0 0.10322514176368713
( O 0 0.04804812744259834
662de14bp O 0 0.40912505984306335
; O 0 0.03355976566672325
1168del3bp O 0 0.2621035575866699
removing O 0 0.05458948016166687
a O 0 0.03431301191449165
glycine O 0 0.13053655624389648
at O 0 0.024197058752179146
position O 0 0.02302376553416252
390 O 0 0.08427782356739044
) O 0 0.017586329951882362
, O 0 0.007296144496649504
and O 0 0.0060939970426261425
one O 0 0.008732781745493412
is O 0 0.011523368768393993
a O 0 0.024606162682175636
splicing O 0 0.14022934436798096
mutation O 0 0.1770695447921753
( O 0 0.06428495049476624
IVS1 O 1 0.9999216794967651
- O 1 0.9244878888130188
15c O 1 0.9983768463134766
- O 1 0.9264310598373413
- O 0 0.2233903408050537
> O 0 0.21890568733215332
g O 0 0.13155396282672882
) O 0 0.0248030424118042
which O 0 0.011288003996014595
creates O 0 0.04252837970852852
a O 0 0.0182874146848917
new O 0 0.02677728608250618
acceptor O 0 0.19379404187202454
splice O 0 0.19363591074943542
site O 0 0.052385810762643814
. O 0 0.03052177093923092

The O 0 0.030302686616778374
pathological O 0 0.11974656581878662
significance O 0 0.021377502009272575
of O 0 0.007111765909940004
the O 0 0.01448706816881895
point O 0 0.034281060099601746
mutations O 0 0.13330253958702087
G197W O 0 0.19900356233119965
, O 0 0.019510867074131966
W427R O 0 0.11150520294904709
, O 0 0.008785534650087357
and O 0 0.00611497787758708
the O 0 0.007865989580750465
in O 0 0.014285733923316002
- O 0 0.08574448525905609
frame O 0 0.09162981808185577
deletion O 0 0.1609078347682953
390delGly O 0 0.15405291318893433
were O 0 0.013250786811113358
assessed O 0 0.03502405062317848
by O 0 0.007949860766530037
their O 0 0.0072579351253807545
respective O 0 0.02271466702222824
expression O 0 0.03177259489893913
in O 0 0.010653013363480568
a O 0 0.01735176146030426
prokaryotic O 0 0.055372174829244614
system O 0 0.029346948489546776
using O 0 0.017744924873113632
site O 0 0.030061667785048485
- O 0 0.07482821494340897
directed O 0 0.051370274275541306
mutagenesis O 0 0.19501779973506927
. O 0 0.03701876476407051

These O 0 0.02484205737709999
mutations O 0 0.09668832272291183
resulted O 0 0.030207712203264236
in O 0 0.008861307054758072
the O 0 0.009754160419106483
absence O 0 0.03317733854055405
or O 0 0.015043243765830994
a O 0 0.01692390628159046
dramatic O 0 0.04440310597419739
decrease O 0 0.04934561625123024
of O 0 0.015322417952120304
CPO O 1 0.7593964338302612
activity O 0 0.061967916786670685
. O 0 0.02640392631292343

The O 0 0.02089047245681286
two O 0 0.017398996278643608
polymorphisms O 0 0.10569921135902405
were O 0 0.01592712476849556
localized O 0 0.09442892670631409
in O 0 0.015657128766179085
noncoding O 0 0.11897528171539307
part O 0 0.017609957605600357
of O 0 0.007461985573172569
the O 0 0.013868551701307297
gene O 0 0.0779925286769867
1 O 0 0.026651985943317413
) O 0 0.023626066744327545
a O 0 0.031769994646310806
C O 1 0.884848952293396
/ O 1 0.9078831672668457
G O 0 0.14576350152492523
polymorphism O 0 0.08466128259897232
in O 0 0.01282570417970419
the O 0 0.019300706684589386
promotor O 1 0.9632910490036011
region O 0 0.045661810785532
, O 0 0.0216678474098444
142 O 0 0.09218952804803848
bp O 0 0.1245286762714386
upstream O 0 0.06511108577251434
from O 0 0.01710805855691433
the O 0 0.01761542819440365
transcriptional O 0 0.12529824674129486
initiation O 0 0.10182894021272659
site O 0 0.040459584444761276
( O 0 0.04501260071992874
- O 0 0.20350879430770874
142C O 1 0.9698277115821838
/ O 1 0.9880833029747009
G O 0 0.1623172014951706
) O 0 0.023033808916807175
, O 0 0.009079809300601482
and O 0 0.00792744942009449
2 O 0 0.02062004618346691
) O 0 0.017053915187716484
a O 0 0.022074436768889427
6 O 0 0.04511004313826561
bp O 0 0.13013912737369537
deletion O 0 0.15446750819683075
polymorphism O 0 0.10248973965644836
in O 0 0.013038516975939274
the O 0 0.014890490099787712
3 O 0 0.03371585160493851
noncoding O 0 0.11882420629262924
part O 0 0.015011051669716835
of O 0 0.0068818870931863785
the O 0 0.017284497618675232
CPO O 0 0.4571331739425659
gene O 0 0.09367901086807251
, O 0 0.024431856349110603
574 O 0 0.19112324714660645
bp O 0 0.1129070296883583
downstream O 0 0.048602841794490814
of O 0 0.00637859757989645
the O 0 0.008948960341513157
last O 0 0.015200343914330006
base O 0 0.022194646298885345
of O 0 0.007487693335860968
the O 0 0.01526362169533968
normal O 0 0.07168368995189667
termination O 1 0.7842376828193665
codon O 0 0.19374066591262817
( O 0 0.0752318874001503
+ O 0 0.35558414459228516
574 O 1 0.6414047479629517
delATTCTT O 1 0.7296448945999146
) O 0 0.0407465361058712
. O 0 0.03021053411066532

Five O 0 0.0479232594370842
intragenic O 1 0.8943521976470947
dimorphisms O 1 0.5334042906761169
are O 0 0.010494749061763287
now O 0 0.015661751851439476
well O 0 0.011591223999857903
characterized O 0 0.044507283717393875
and O 0 0.007595848757773638
the O 0 0.008832843974232674
high O 0 0.02642657794058323
degree O 0 0.030001670122146606
of O 0 0.014616026543080807
allelic O 1 0.5693390369415283
heterogeneity O 0 0.16050037741661072
in O 0 0.02532806247472763
HC B-Disease 1 0.9999970197677612
is O 0 0.017483916133642197
demonstrated O 0 0.026686839759349823
with O 0 0.007493056356906891
seven O 0 0.012349802069365978
new O 0 0.01236258540302515
different O 0 0.010702625848352909
mutations O 0 0.06639952957630157
making O 0 0.013617094606161118
a O 0 0.012143800035119057
total O 0 0.01222900114953518
of O 0 0.010305436328053474
nineteen O 0 0.07416585832834244
CPO O 1 0.9928245544433594
gene B-Disease 0 0.22454892098903656
defects I-Disease 1 0.9983519315719604
reported O 0 0.038468729704618454
so O 0 0.012789049185812473
far O 0 0.014573016203939915
. O 0 0.010708548128604889
. O 0 0.0212908573448658

Coincidence O 0 0.07091934233903885
of O 0 0.009465841576457024
two O 0 0.01171837467700243
novel O 0 0.04194445163011551
arylsulfatase O 0 0.1733551025390625
A O 0 0.04710608720779419
alleles O 0 0.1426357924938202
and O 0 0.030039021745324135
mutation O 0 0.22066491842269897
459 O 1 0.9346132278442383
+ O 1 0.8873193264007568
1G O 1 0.9780583381652832
> O 0 0.13235332071781158
A O 0 0.022973129525780678
within O 0 0.011878950521349907
a O 0 0.01640915870666504
family O 0 0.02603817731142044
with O 0 0.02432332932949066
metachromatic B-Disease 1 0.9999961853027344
leukodystrophy I-Disease 1 1.0
: O 0 0.030096612870693207
molecular O 0 0.040949203073978424
basis O 0 0.014812284149229527
of O 0 0.01221822202205658
phenotypic O 0 0.12474365532398224
heterogeneity O 0 0.18109658360481262
. O 0 0.040115900337696075

In O 0 0.020327655598521233
a O 0 0.01884578727185726
family O 0 0.020719323307275772
with O 0 0.009546400979161263
three O 0 0.011437839828431606
siblings O 0 0.0541202574968338
, O 0 0.012274575419723988
one O 0 0.01206858642399311
developed O 0 0.035195834934711456
classical O 0 0.04356484115123749
late O 0 0.06824185699224472
infantile O 1 0.9999994039535522
metachromatic B-Disease 1 0.9999994039535522
leukodystrophy I-Disease 1 1.0
( O 1 0.868129551410675
MLD B-Disease 1 1.0
) O 0 0.03598211333155632
, O 0 0.021348481997847557
fatal O 1 0.9993739724159241
at O 0 0.023427164182066917
age O 0 0.02517974190413952
5 O 0 0.01777447946369648
years O 0 0.011471587233245373
, O 0 0.010714096017181873
with O 0 0.01700839027762413
deficient O 1 0.9977165460586548
arylsulfatase O 1 0.9369791746139526
A O 0 0.0491739884018898
( O 0 0.05577501654624939
ARSA O 1 0.999861478805542
) O 0 0.030883025377988815
activity O 0 0.028535135090351105
and O 0 0.010092640295624733
increased O 0 0.04093474894762039
galactosylsulfatide O 1 0.9912860989570618
( O 0 0.07531313598155975
GS O 1 0.9999995231628418
) O 0 0.05286521092057228
excretion O 0 0.1828727126121521
. O 0 0.03707566484808922

The O 0 0.018374014645814896
two O 0 0.009307220578193665
other O 0 0.01006782054901123
siblings O 0 0.06524496525526047
, O 0 0.01569334976375103
apparently O 0 0.048992253839969635
healthy O 0 0.0687112808227539
at O 0 0.01962871663272381
12 O 0 0.023002989590168
( O 0 0.025775007903575897
1 O 0 0.03382175415754318
/ O 0 0.44421687722206116
2 O 0 0.023987362161278725
) O 0 0.01335413008928299
and O 0 0.007719636429101229
15 O 0 0.01360838022083044
years O 0 0.011147283017635345
, O 0 0.007747728377580643
respectively O 0 0.013433865271508694
, O 0 0.007372857537120581
and O 0 0.0061524733901023865
their O 0 0.007481080014258623
father O 0 0.02586711384356022
, O 0 0.012809752486646175
apparently O 0 0.04175766929984093
healthy O 0 0.05617021396756172
as O 0 0.009527047164738178
well O 0 0.010160895995795727
, O 0 0.011410752311348915
presented O 0 0.035271015018224716
ARSA O 1 0.9998878240585327
and O 0 0.025966934859752655
GS O 1 0.999958872795105
values O 0 0.022956471890211105
within O 0 0.011136659421026707
the O 0 0.010407567955553532
range O 0 0.03066439926624298
of O 0 0.02572651021182537
MLD B-Disease 1 1.0
patients O 1 0.9999973773956299
. O 0 0.032434552907943726

Mutation O 0 0.3363281190395355
screening O 0 0.10233886539936066
and O 0 0.014885799027979374
sequence O 0 0.03024550899863243
analysis O 0 0.02384462021291256
disclosed O 0 0.03626048192381859
the O 0 0.01035365555435419
involvement O 0 0.03595789149403572
of O 0 0.006553873885422945
three O 0 0.01180923543870449
different O 0 0.019672857597470284
ARSA O 1 0.9998788833618164
mutations O 0 0.10543231666088104
being O 0 0.014460201375186443
the O 0 0.01208835281431675
molecular O 0 0.041786935180425644
basis O 0 0.017360925674438477
of O 0 0.01582072302699089
intrafamilial O 1 0.6879433393478394
phenotypic O 0 0.1529773771762848
heterogeneity O 0 0.1972939372062683
. O 0 0.03503676876425743

The O 0 0.03562784567475319
late O 0 0.07690970599651337
infantile O 1 0.9999996423721313
patient O 1 0.999991774559021
inherited O 1 0.7540258765220642
from O 0 0.013197635300457478
his O 0 0.01418505609035492
mother O 0 0.03204827755689621
the O 0 0.016394471749663353
frequent O 0 0.0713563933968544
0 O 0 0.07254358381032944
- O 0 0.11053746938705444
type O 0 0.11309020221233368
mutation O 0 0.22379060089588165
459 O 1 0.9626240134239197
+ O 1 0.835466206073761
1G O 1 0.983207106590271
> O 0 0.139130100607872
A O 0 0.026528047397732735
, O 0 0.008776519447565079
and O 0 0.005838933866471052
from O 0 0.00830293819308281
his O 0 0.011723654344677925
father O 0 0.022625433281064034
a O 0 0.015895728021860123
novel O 0 0.02840306982398033
, O 0 0.014476852491497993
single O 0 0.04094203561544418
basepair O 0 0.2805038392543793
microdeletion O 0 0.17849811911582947
of O 0 0.020907575264573097
guanine O 0 0.12701229751110077
at O 0 0.03873353451490402
nucleotide O 0 0.08113957941532135
7 O 0 0.03093544952571392
in O 0 0.018053606152534485
exon O 0 0.1285315752029419
1 O 0 0.03931402042508125
( O 0 0.04344142600893974
7delG O 0 0.2907980978488922
) O 0 0.03167034313082695
. O 0 0.02473241277039051

The O 0 0.024257823824882507
two O 0 0.023299450054764748
clinically O 1 0.9280335903167725
unaffected O 0 0.43688151240348816
siblings O 0 0.0816870778799057
carried O 0 0.027061881497502327
the O 0 0.022238455712795258
maternal O 0 0.20225776731967926
mutation O 0 0.2723722457885742
459 O 1 0.9866754412651062
+ O 1 0.9536475539207458
1G O 1 0.9936935305595398
> O 0 0.13526125252246857
A O 0 0.023038016632199287
and O 0 0.008581655099987984
, O 0 0.006682233419269323
on O 0 0.006273174658417702
their O 0 0.010891394689679146
paternal O 0 0.1054794043302536
allele O 0 0.13571596145629883
, O 0 0.016138935461640358
a O 0 0.020683197304606438
novel O 0 0.04217759892344475
cytosine O 0 0.12113194912672043
to O 0 0.022938143461942673
thymidine O 0 0.19808262586593628
transition O 0 0.07041217386722565
at O 0 0.039931777864694595
nucleotide O 0 0.12361934036016464
2435 O 1 0.53981614112854
in O 0 0.028263164684176445
exon O 0 0.11910755932331085
8 O 0 0.03113899566233158
, O 0 0.012974306009709835
resulting O 0 0.029896413907408714
in O 0 0.012865345925092697
substitution O 0 0.0523570254445076
of O 0 0.015642458572983742
alanine O 0 0.20241335034370422
464 O 0 0.19056890904903412
by O 0 0.0362701490521431
valine O 0 0.33488529920578003
( O 0 0.05609433725476265
A464V O 0 0.25608715415000916
) O 0 0.037924252450466156
. O 0 0.02789415791630745

The O 0 0.036057449877262115
fathers O 0 0.0953306257724762
genotype O 0 0.23461894690990448
thus O 0 0.03539770096540451
was O 0 0.03488057479262352
7delG O 1 0.9902262091636658
/ O 1 0.9966335892677307
A464V O 0 0.3428352475166321
. O 0 0.034160081297159195

Mutation O 0 0.2811625003814697
A464V O 0 0.17708535492420197
was O 0 0.018526582047343254
not O 0 0.008701236918568611
found O 0 0.012175306677818298
in O 0 0.010630843229591846
18 O 0 0.030238598585128784
unrelated O 1 0.934384286403656
MLD B-Disease 1 1.0
patients O 1 0.9999891519546509
and O 0 0.013287915848195553
50 O 0 0.025485916063189507
controls O 0 0.04726729914546013
. O 0 0.026895960792899132

A464V O 0 0.23096001148223877
, O 0 0.02439543791115284
although O 0 0.02108289860188961
clearly O 0 0.0357508584856987
modifying O 0 0.11976706981658936
ARSA O 1 0.9999628067016602
and O 0 0.038548991084098816
GS O 1 0.9999991655349731
levels O 0 0.06783311069011688
, O 0 0.016977375373244286
apparently O 0 0.04197404906153679
bears O 0 0.03775588423013687
little O 0 0.022282039746642113
significance O 0 0.021328000351786613
for O 0 0.013529151678085327
clinical O 1 0.9964117407798767
manifestation O 1 0.8681105971336365
of O 0 0.02518499828875065
MLD B-Disease 1 0.9999998807907104
, O 0 0.024439550936222076
mimicking O 0 0.12248184531927109
the O 0 0.026630088686943054
frequent O 0 0.1167929545044899
ARSA O 1 0.9998173117637634
pseudodeficiency O 1 0.9241530299186707
allele O 0 0.22822940349578857
. O 0 0.045491598546504974

Our O 0 0.03046279214322567
results O 0 0.024994278326630592
demonstrate O 0 0.02535162679851055
that O 0 0.006384302396327257
in O 0 0.008136514574289322
certain O 0 0.01934463158249855
genetic O 0 0.09630897641181946
conditions O 1 0.9874510765075684
MLD B-Disease 1 1.0
- O 1 0.859339714050293
like O 0 0.043214697390794754
ARSA O 1 0.9999570846557617
and O 0 0.02664342150092125
GS O 1 0.9999959468841553
values O 0 0.028407154604792595
need O 0 0.01677868328988552
not O 0 0.005990701727569103
be O 0 0.00850662775337696
paralleled O 0 0.06483624130487442
by O 0 0.02277340181171894
clinical O 1 0.9999954700469971
disease O 1 0.9999997615814209
, O 0 0.011047313921153545
a O 0 0.013506717048585415
finding O 0 0.0214568842202425
with O 0 0.014769745990633965
serious O 0 0.46914562582969666
diagnostic O 1 0.9793096780776978
and O 0 0.021054809913039207
prognostic O 1 0.9991094470024109
implications O 0 0.09877096861600876
. O 0 0.03343609347939491

Moreover O 0 0.08635357767343521
, O 0 0.02317456528544426
further O 0 0.03804858401417732
ARSA O 1 0.9986119270324707
alleles O 0 0.20024757087230682
functionally O 0 0.11912751197814941
similar O 0 0.02896667644381523
to O 0 0.017883161082863808
A464V O 0 0.1559435874223709
might O 0 0.02559638023376465
exist O 0 0.013211739249527454
which O 0 0.007541546132415533
, O 0 0.007511831820011139
together O 0 0.00828681979328394
with O 0 0.015112506225705147
0 O 0 0.07262511551380157
- O 0 0.11722192168235779
type O 0 0.0986701026558876
mutations O 0 0.11912044137716293
, O 0 0.020484650507569313
may O 0 0.03384346142411232
cause O 1 0.5526260733604431
pathological O 1 0.9991700649261475
ARSA O 1 0.9999961853027344
and O 0 0.031010156497359276
GS O 1 0.9999997615814209
levels O 0 0.05052052438259125
, O 0 0.009825943037867546
but O 0 0.008023173548281193
not O 0 0.012154141440987587
clinical O 1 0.999178946018219
outbreak O 1 0.9961773157119751
of O 0 0.010740592144429684
the O 0 0.0213595163077116
disease O 1 0.9999997615814209
. O 0 0.01753508672118187
. O 0 0.02482311986386776

Human O 1 0.7641512155532837
MLH1 O 1 0.9999997615814209
deficiency O 1 1.0
predisposes O 1 0.9999750852584839
to O 0 0.04588410258293152
hematological B-Disease 1 0.9999984502792358
malignancy I-Disease 1 0.9999996423721313
and O 0 0.048048198223114014
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.12198083847761154
1 I-Disease 0 0.035738710314035416
. O 0 0.027058567851781845

Heterozygous O 1 0.5862653851509094
germ O 1 0.9997411370277405
- O 0 0.12473521381616592
line O 0 0.04753270372748375
mutations O 0 0.0910985991358757
in O 0 0.013114924542605877
the O 0 0.01651426963508129
DNA O 0 0.09482690691947937
mismatch O 1 0.9929232597351074
repair O 1 0.9853790998458862
genes O 0 0.06703896820545197
lead O 0 0.04121731221675873
to O 0 0.023849820718169212
hereditary B-Disease 1 0.9999945163726807
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04578680172562599

The O 0 0.05343593657016754
disease O 1 0.9999994039535522
susceptibility O 1 0.9705972671508789
of O 0 0.010850178077816963
individuals O 0 0.017177721485495567
who O 0 0.018123138695955276
constitutionally O 0 0.04617214947938919
lack O 0 0.025984883308410645
both O 0 0.012796931900084019
wild O 0 0.04990771412849426
- O 0 0.11365219205617905
type O 0 0.09421303123235703
alleles O 0 0.14269410073757172
is O 0 0.02457466907799244
unknown O 0 0.04059084504842758
. O 0 0.025995880365371704

We O 0 0.015670275315642357
have O 0 0.008768144063651562
identified O 0 0.018882593140006065
three O 0 0.011121075600385666
offspring O 0 0.04882798343896866
in O 0 0.012081890366971493
a O 0 0.029766516759991646
hereditary B-Disease 1 0.9999985694885254
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.106886126101017
who O 0 0.030406532809138298
developed O 1 0.5368819832801819
hematological B-Disease 1 0.9999980926513672
malignancy I-Disease 1 0.9999967813491821
at O 0 0.022330135107040405
a O 0 0.015635764226317406
very O 0 0.01291233953088522
early O 0 0.01605335995554924
age O 0 0.01989252306520939
, O 0 0.007032735738903284
and O 0 0.006026380229741335
at O 0 0.01063394732773304
least O 0 0.008429717272520065
two O 0 0.004282897338271141
of O 0 0.005252514034509659
them O 0 0.006829120218753815
displayed O 0 0.028531799092888832
signs O 0 0.04951376095414162
of O 0 0.024343086406588554
neurofibromatosis B-Disease 1 0.9999997615814209
type I-Disease 0 0.1274319440126419
1 I-Disease 0 0.04613475129008293
( O 0 0.05318603292107582
NF1 B-Disease 1 0.999444305896759
) O 0 0.036493223160505295
. O 0 0.02415318787097931

DNA O 0 0.09518558531999588
sequence O 0 0.043762777000665665
analysis O 0 0.028659820556640625
and O 0 0.016129305586218834
allele O 0 0.15336531400680542
- O 0 0.08175287395715714
specific O 0 0.030744003131985664
amplification O 0 0.11230402439832687
in O 0 0.010612888261675835
two O 0 0.008822784759104252
siblings O 0 0.06021307781338692
revealed O 0 0.04640858247876167
a O 0 0.03626447543501854
homozygous O 0 0.19324417412281036
MLH1 O 1 0.9996899366378784
mutation O 0 0.32624441385269165
( O 0 0.06771891564130783
C676T O 1 0.997477114200592
- O 1 0.9731516242027283
- O 1 0.5004720687866211
> O 0 0.28030434250831604
Arg226Stop O 1 0.658897340297699
) O 0 0.03968624770641327
. O 0 0.028586558997631073

Thus O 0 0.035607729107141495
, O 0 0.015333781950175762
a O 0 0.027667729184031487
homozygous O 0 0.1875934898853302
germ O 1 0.9999032020568848
- O 0 0.15791651606559753
line O 0 0.07312623411417007
MLH1 O 1 0.9999035596847534
mutation O 0 0.21524590253829956
and O 0 0.030210787430405617
consequent O 1 0.9993601441383362
mismatch O 1 0.9999977350234985
repair O 1 0.9999996423721313
deficiency O 1 1.0
results O 0 0.032113295048475266
in O 0 0.013634192757308483
a O 0 0.035060811787843704
mutator O 1 0.9999531507492065
phenotype O 1 0.9990732669830322
characterized O 1 0.8887214660644531
by O 0 0.0396321602165699
leukemia B-Disease 1 1.0
and O 0 0.067381352186203
/ O 1 0.999998927116394
or O 1 0.948319673538208
lymphoma B-Disease 1 1.0
associated O 0 0.046833738684654236
with O 0 0.027876129373908043
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.12206461280584335
1 I-Disease 0 0.026780378073453903
. O 0 0.01308085210621357
. O 0 0.01898583211004734

Missense O 0 0.3459934890270233
mutations O 0 0.11925297230482101
in O 0 0.011362672783434391
the O 0 0.009013453498482704
most O 0 0.009382697753608227
ancient O 0 0.018745938315987587
residues O 0 0.04101458191871643
of O 0 0.010293171741068363
the O 0 0.024046260863542557
PAX6 O 1 0.9997437596321106
paired O 0 0.11570180952548981
domain O 0 0.05914866924285889
underlie O 0 0.1215268075466156
a O 0 0.02191791497170925
spectrum O 0 0.0486881285905838
of O 0 0.014821633696556091
human O 1 0.8655511736869812
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999998807907104
malformations I-Disease 1 0.9999982118606567
. O 0 0.03747563064098358

Mutations O 0 0.12338195741176605
of O 0 0.010759091004729271
the O 0 0.016313906759023666
human O 0 0.054332517087459564
PAX6 O 1 0.9999761581420898
gene O 0 0.4514404535293579
underlie O 1 0.9992994070053101
aniridia B-Disease 1 0.9999969005584717
( O 1 0.716880738735199
congenital B-Disease 1 1.0
absence I-Disease 0 0.04375053197145462
of I-Disease 0 0.00991925597190857
the I-Disease 0 0.01795746199786663
iris I-Disease 1 0.9971241354942322
) O 0 0.01933954656124115
, O 0 0.010274579748511314
a O 0 0.01858932338654995
rare O 0 0.056945573538541794
dominant O 0 0.11199905723333359
malformation B-Disease 1 0.9999713897705078
of I-Disease 0 0.012309061363339424
the I-Disease 0 0.02033408172428608
eye I-Disease 1 0.9997574687004089
. O 0 0.028417270630598068

The O 0 0.02768513560295105
spectrum O 0 0.08177415281534195
of O 0 0.027022864669561386
PAX6 O 1 0.9999072551727295
mutations O 0 0.17643924057483673
in O 0 0.035286132246255875
aniridia B-Disease 1 0.9999939203262329
patients O 1 0.9999551773071289
is O 0 0.016468646004796028
highly O 0 0.028574414551258087
biased O 0 0.050905853509902954
, O 0 0.010138926096260548
with O 0 0.009915846399962902
92 O 0 0.053141944110393524
% O 0 0.015210111625492573
of O 0 0.00671174842864275
all O 0 0.008227751590311527
reported O 0 0.03758399188518524
mutations O 0 0.09525465965270996
leading O 0 0.028141770511865616
to O 0 0.0163161251693964
premature O 0 0.14237482845783234
truncation O 0 0.09733153879642487
of O 0 0.011097804643213749
the O 0 0.017146563157439232
protein O 0 0.06380748748779297
( O 0 0.034340750426054
nonsense O 0 0.07407457381486893
, O 0 0.018179429695010185
splicing O 0 0.09534849971532822
, O 0 0.018935861065983772
insertions O 0 0.11129339784383774
and O 0 0.017223775386810303
deletions O 0 0.0855049192905426
) O 0 0.021154161542654037
and O 0 0.009340925142168999
just O 0 0.014943953603506088
2 O 0 0.017181118950247765
% O 0 0.01866423897445202
leading O 0 0.02020806446671486
to O 0 0.010544253513216972
substitution O 0 0.04179424047470093
of O 0 0.009115554392337799
one O 0 0.01414430607110262
amino O 0 0.05922406539320946
acid O 0 0.09824354201555252
by O 0 0.01677645929157734
another O 0 0.032931260764598846
( O 0 0.04272371903061867
missense O 0 0.19263973832130432
) O 0 0.0374431274831295
. O 0 0.023675987496972084

The O 0 0.027992790564894676
extraordinary O 0 0.04753544554114342
conservation O 0 0.034472476691007614
of O 0 0.008917577564716339
the O 0 0.02035965770483017
PAX6 O 1 0.9992782473564148
protein O 0 0.07154098153114319
at O 0 0.019209060817956924
the O 0 0.015227597206830978
amino O 0 0.07029952108860016
acid O 0 0.11961314082145691
level O 0 0.040623150765895844
amongst O 0 0.04132324457168579
vertebrates O 0 0.07159417122602463
predicts O 0 0.08857201784849167
that O 0 0.020035983994603157
pathological O 1 0.9671789407730103
missense O 1 0.5320862531661987
mutations O 0 0.11402470618486404
should O 0 0.014124603942036629
in O 0 0.008769511245191097
fact O 0 0.010462780483067036
be O 0 0.007051871623843908
common O 0 0.014461682178080082
even O 0 0.010573615320026875
though O 0 0.009285464882850647
they O 0 0.005905946251004934
are O 0 0.005910822656005621
hardly O 0 0.03373531252145767
ever O 0 0.020574666559696198
seen O 0 0.024637481197714806
in O 0 0.022593297064304352
aniridia B-Disease 1 0.9999977350234985
patients O 1 0.9999862909317017
. O 0 0.033159270882606506

This O 0 0.016504043713212013
indicates O 0 0.0316922590136528
that O 0 0.00688484963029623
there O 0 0.007361057214438915
is O 0 0.009357672184705734
a O 0 0.018646016716957092
heavy O 0 0.0746542364358902
ascertainment O 1 0.998230516910553
bias O 0 0.06966763734817505
in O 0 0.008395446464419365
the O 0 0.007696440909057856
selection O 0 0.01959853060543537
of O 0 0.013098197989165783
patients O 1 0.9999090433120728
for O 0 0.025848517194390297
PAX6 O 1 0.999974250793457
mutation O 0 0.15629281103610992
analysis O 0 0.022270023822784424
and O 0 0.006520481314510107
that O 0 0.006521368864923716
the O 0 0.01378837414085865
missing O 0 0.08333587646484375
PAX6 O 1 0.9998950958251953
missense O 1 0.7737508416175842
mutations O 0 0.16531050205230713
frequently O 0 0.05199958756566048
may O 0 0.03883460909128189
underlie O 1 0.7213886380195618
phenotypes O 0 0.15957410633563995
distinct O 0 0.04009244218468666
from O 0 0.025215040892362595
textbook O 0 0.13829943537712097
aniridia B-Disease 1 0.9995324611663818
. O 0 0.04057586193084717

Here O 0 0.02576267533004284
we O 0 0.010798186995089054
present O 0 0.013860532082617283
four O 0 0.01714283600449562
novel O 0 0.0675579234957695
PAX6 O 1 0.9997938275337219
missense O 1 0.5122346878051758
mutations O 0 0.11043613404035568
, O 0 0.011220385320484638
two O 0 0.007516529876738787
in O 0 0.009151569567620754
association O 0 0.04089986905455589
with O 0 0.02183210477232933
atypical O 1 0.9999194145202637
phenotypes O 1 0.9768033027648926
ectopia B-Disease 1 0.9949230551719666
pupillae I-Disease 1 0.9786089062690735
( O 0 0.03983461484313011
displaced B-Disease 0 0.07851006835699081
pupils I-Disease 0 0.08574119955301285
) O 0 0.03253963589668274
and O 0 0.027171147987246513
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999971389770508
( O 0 0.05268840491771698
searching B-Disease 0 0.06890864670276642
gaze I-Disease 0 0.4136412739753723
) O 0 0.017429236322641373
, O 0 0.007605522871017456
and O 0 0.004641334526240826
two O 0 0.005123281851410866
in O 0 0.007220075000077486
association O 0 0.025465620681643486
with O 0 0.009648194536566734
more O 0 0.012857948429882526
recognizable O 0 0.11288214474916458
aniridia B-Disease 1 0.9994392991065979
phenotypes O 0 0.3566976487636566
. O 0 0.041997503489255905

Strikingly O 0 0.11951395869255066
, O 0 0.01394555065780878
all O 0 0.007345523219555616
four O 0 0.013573700562119484
mutations O 0 0.06835531443357468
are O 0 0.007865862920880318
located O 0 0.019992949441075325
within O 0 0.013554036617279053
the O 0 0.021843794733285904
PAX6 O 1 0.999664306640625
paired O 0 0.10499001294374466
domain O 0 0.046325985342264175
and O 0 0.015397694893181324
affect O 0 0.045744601637125015
amino O 0 0.05886844918131828
acids O 0 0.04320262745022774
which O 0 0.009791777469217777
are O 0 0.006879120599478483
highly O 0 0.019711213186383247
conserved O 0 0.028903894126415253
in O 0 0.00922360084950924
all O 0 0.008411108516156673
known O 0 0.026324959471821785
paired O 0 0.08360858261585236
domain O 0 0.05093519389629364
proteins O 0 0.05505095794796944
. O 0 0.031656842678785324

Our O 0 0.025546899065375328
results O 0 0.02148156613111496
support O 0 0.015341033227741718
the O 0 0.010507275350391865
hypothesis O 0 0.04206524416804314
that O 0 0.006148156244307756
the O 0 0.008899650536477566
under O 0 0.015032345429062843
- O 0 0.04980866238474846
representation O 0 0.02549753338098526
of O 0 0.016380315646529198
missense O 0 0.24688370525836945
mutations O 0 0.14606696367263794
is O 0 0.02257966250181198
caused O 0 0.059652041643857956
by O 0 0.02283468097448349
ascertainment O 1 0.9988663196563721
bias O 0 0.10292712599039078
and O 0 0.012174383737146854
suggest O 0 0.018216796219348907
that O 0 0.0063970922492444515
a O 0 0.013908726163208485
substantial O 0 0.026109447702765465
burden O 0 0.1471417248249054
of O 0 0.024341493844985962
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9998189806938171
related I-Disease 1 0.7287938594818115
disease I-Disease 1 0.9999995231628418
remains O 0 0.02315978705883026
to O 0 0.0074775973334908485
be O 0 0.009091414511203766
uncovered O 0 0.049210354685783386
. O 0 0.01266916561871767
. O 0 0.020361540839076042

The O 0 0.0349971167743206
chromosomal O 0 0.1334446221590042
order O 0 0.015617618337273598
of O 0 0.01213569100946188
genes O 0 0.05509917810559273
controlling O 0 0.06470870226621628
the O 0 0.01723557338118553
major O 0 0.043178971856832504
histocompatibility O 1 0.9993583559989929
complex O 0 0.05270542576909065
, O 0 0.021582771092653275
properdin O 1 0.9331046342849731
factor O 0 0.08118504285812378
B O 0 0.1344398409128189
, O 0 0.015077405609190464
and O 0 0.016788527369499207
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.008688470348715782
the I-Disease 0 0.01055015530437231
second I-Disease 0 0.02059377171099186
component I-Disease 0 0.04439901188015938
of I-Disease 0 0.012886703945696354
complement I-Disease 0 0.07044660300016403
. O 0 0.03140163794159889

The O 0 0.02008204162120819
relationship O 0 0.02920544147491455
of O 0 0.00829400960355997
the O 0 0.014324557036161423
genes O 0 0.0682404637336731
coding O 0 0.11161068081855774
for O 0 0.024296199902892113
HLA O 1 0.9980964064598083
to O 0 0.013696728274226189
those O 0 0.0140113839879632
coding O 0 0.0907059833407402
for O 0 0.021992277354002
properdin O 1 0.700851559638977
Factor O 0 0.11150779575109482
B O 0 0.4850403666496277
allotypes O 1 0.6216058135032654
and O 0 0.013211837969720364
for O 0 0.017467623576521873
deficiency B-Disease 1 0.9999990463256836
of I-Disease 0 0.00854075700044632
the I-Disease 0 0.010021533817052841
second I-Disease 0 0.018012525513768196
component I-Disease 0 0.038736872375011444
of I-Disease 0 0.009879542514681816
complement I-Disease 0 0.05947263911366463
( O 0 0.04817373305559158
C2 O 1 0.9999796152114868
) O 0 0.02436112053692341
was O 0 0.014315658248960972
studied O 0 0.01731417328119278
in O 0 0.0077425576746463776
families O 0 0.017642570659518242
of O 0 0.01159066241234541
patients O 1 0.999998927116394
with O 0 0.03422010317444801
connective O 1 0.9999998807907104
tissue O 1 0.9999997615814209
disorders O 1 1.0
. O 0 0.0364653579890728

Patients O 1 0.9998334646224976
were O 0 0.013001373037695885
selected O 0 0.01528895739465952
because O 0 0.012449372559785843
they O 0 0.008353914134204388
were O 0 0.010665071196854115
heterozygous O 0 0.09239909052848816
or O 0 0.029575437307357788
homozygous O 0 0.13563930988311768
for O 0 0.04954681172966957
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04989251121878624

12 O 0 0.03748288005590439
families O 0 0.027427688241004944
with O 0 0.015602655708789825
15 O 0 0.03373902291059494
matings O 0 0.1905786246061325
informative O 0 0.08894297480583191
for O 0 0.04247448593378067
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.02284322679042816
found O 0 0.026875915005803108
. O 0 0.024267034605145454

Of O 0 0.02957155369222164
57 O 0 0.07461690157651901
informative O 0 0.08822352439165115
meioses O 0 0.16108568012714386
, O 0 0.013145471923053265
two O 0 0.00876554660499096
crossovers O 0 0.05348973721265793
were O 0 0.008564778603613377
noted O 0 0.01575068198144436
between O 0 0.015741074457764626
the O 0 0.034061726182699203
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.09892775863409042
and O 0 0.0151051115244627
the O 0 0.026216775178909302
HLA O 1 0.9999964237213135
- O 0 0.3292525112628937
B O 0 0.2312006950378418
gene O 0 0.06966438889503479
, O 0 0.011595034040510654
with O 0 0.010356849990785122
a O 0 0.022733911871910095
recombinant O 0 0.11738892644643784
fraction O 0 0.0491333045065403
of O 0 0.017269251868128777
0 O 0 0.06783467531204224
. O 0 0.028331289067864418

035 O 1 0.9636458158493042
. O 0 0.05390985682606697

A O 0 0.06991837918758392
lod O 1 0.5436326861381531
score O 0 0.02048342674970627
of O 0 0.008199814707040787
13 O 0 0.018794549629092216
was O 0 0.015075418166816235
calculated O 0 0.02752695046365261
for O 0 0.015039611607789993
linkage O 0 0.2226552814245224
between O 0 0.04906853288412094
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.0620366707444191
HLA O 1 0.9999996423721313
- O 0 0.1895868331193924
B O 0 0.10474485903978348
at O 0 0.019545281305909157
a O 0 0.015715433284640312
maximum O 0 0.0312168188393116
likelihood O 0 0.04029528796672821
value O 0 0.009788880124688148
of O 0 0.006358986254781485
the O 0 0.013148832134902477
recombinant O 0 0.10891509801149368
fraction O 0 0.045974187552928925
of O 0 0.014964998699724674
0 O 0 0.06383293122053146
. O 0 0.02778613194823265

04 O 1 0.928164005279541
. O 0 0.05476118624210358

18 O 0 0.037409644573926926
families O 0 0.027211302891373634
with O 0 0.014861463569104671
21 O 0 0.03224891796708107
informative O 0 0.05856329947710037
matings O 0 0.12610647082328796
for O 0 0.013178788125514984
both O 0 0.01907981187105179
properdin O 1 0.5551931262016296
Factor O 0 0.10369958728551865
B O 0 0.4499693512916565
allotype O 1 0.9614946246147156
and O 0 0.029884550720453262
HLA O 1 0.9999954700469971
- O 0 0.17398937046527863
B O 0 0.11584048718214035
were O 0 0.012637164443731308
found O 0 0.023368801921606064
. O 0 0.024512697011232376

Of O 0 0.027624167501926422
72 O 0 0.08489012718200684
informative O 0 0.07745147496461868
meioses O 0 0.2694789171218872
, O 0 0.01435027178376913
three O 0 0.014632848091423512
recombinants O 0 0.25950315594673157
were O 0 0.010416824370622635
found O 0 0.013825731351971626
, O 0 0.010300018824636936
giving O 0 0.023022951558232307
a O 0 0.021592004224658012
recombinant O 0 0.09885580837726593
fraction O 0 0.043864283710718155
of O 0 0.015277612023055553
0 O 0 0.05537261441349983
. O 0 0.023470448330044746

042 O 0 0.42910581827163696
. O 0 0.05191897973418236

A O 0 0.07394114136695862
lod O 1 0.541454017162323
score O 0 0.027570929378271103
of O 0 0.010486210696399212
16 O 0 0.024679213762283325
between O 0 0.02732626162469387
HLA O 1 0.9999798536300659
- O 0 0.14299829304218292
B O 0 0.13544651865959167
and O 0 0.020203249529004097
Factor O 0 0.0809771940112114
B O 0 0.13899248838424683
allotypes O 0 0.16301241517066956
was O 0 0.021773872897028923
calculated O 0 0.029032858088612556
at O 0 0.016271675005555153
a O 0 0.013076076284050941
maximum O 0 0.03094840608537197
likelihood O 0 0.04240284115076065
value O 0 0.010343039408326149
of O 0 0.005899183452129364
the O 0 0.01192651316523552
recombinant O 0 0.10905390977859497
fraction O 0 0.04466312751173973
of O 0 0.014020755887031555
0 O 0 0.06014080345630646
. O 0 0.025113172829151154

04 O 1 0.9341040849685669
. O 0 0.048085298389196396

A O 0 0.0527660958468914
crossover O 0 0.07479596883058548
was O 0 0.017485948279500008
shown O 0 0.018514059484004974
to O 0 0.007105542812496424
have O 0 0.007605362217873335
occurred O 0 0.026404015719890594
between O 0 0.011934371665120125
genes O 0 0.03511246666312218
for O 0 0.014674041420221329
Factor O 0 0.06937010586261749
B O 1 0.7256902456283569
and O 0 0.026950914412736893
HLA O 1 0.9999949932098389
- O 0 0.19712097942829132
D O 0 0.35597464442253113
, O 0 0.014534992165863514
in O 0 0.012031296268105507
which O 0 0.02402622066438198
HLA O 1 0.9999980926513672
- O 1 0.8462101221084595
D O 1 0.9817909002304077
segregared O 1 0.6965785026550293
with O 0 0.03701793774962425
HLA O 1 0.9999692440032959
- O 0 0.09675338119268417
A O 0 0.03301646560430527
and O 0 0.01767781935632229
B O 0 0.13384497165679932
. O 0 0.027151677757501602

These O 0 0.01788180321455002
studies O 0 0.028775248676538467
suggest O 0 0.0219203382730484
that O 0 0.006710371933877468
the O 0 0.010307877324521542
genes O 0 0.03911137580871582
for O 0 0.015974532812833786
Factor O 0 0.07946158200502396
B O 1 0.9837258458137512
and O 0 0.04112384468317032
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.011113541200757027
located O 0 0.021705051884055138
outside O 0 0.014240547083318233
those O 0 0.008761175908148289
for O 0 0.0145916398614645
HLA O 1 0.9998979568481445
, O 0 0.011985721997916698
that O 0 0.005830536596477032
the O 0 0.006847151555120945
order O 0 0.00968526117503643
of O 0 0.011420163325965405
genese O 1 0.9542660117149353
is O 0 0.03593434393405914
HLA O 1 0.9999569654464722
- O 0 0.08310359716415405
A O 0 0.032002661377191544
, O 0 0.01821785978972912
- O 0 0.09491274505853653
B O 0 0.12489452213048935
, O 0 0.023296762257814407
- O 0 0.11903656274080276
D O 1 0.8613374829292297
, O 0 0.02600841410458088
Factor O 0 0.09427691996097565
B O 1 0.8097647428512573
allotype O 1 0.9983208775520325
, O 0 0.1585579663515091
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.016649622470140457
that O 0 0.007657833397388458
the O 0 0.012947202660143375
genes O 0 0.06426582485437393
coding O 0 0.12622764706611633
for O 0 0.041435446590185165
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.030567605048418045
Factor O 0 0.0924687385559082
B O 0 0.2056276500225067
allotypes O 0 0.13131670653820038
are O 0 0.009055768139660358
approximately O 0 0.024667831137776375
3 O 0 0.03082999773323536
- O 0 0.09080299735069275
- O 0 0.08228538185358047
5 O 0 0.03873784840106964
centimorgans O 0 0.13292673230171204
from O 0 0.016356086358428
the O 0 0.02364112064242363
HLA O 1 0.9999794960021973
- O 0 0.11592622846364975
A O 0 0.048607129603624344
and O 0 0.029074089601635933
HLA O 1 0.9999927282333374
- O 0 0.19255845248699188
B O 0 0.18156224489212036
loci O 0 0.12963564693927765
, O 0 0.010738778859376907
and O 0 0.006203825585544109
that O 0 0.005965056829154491
the O 0 0.009096793830394745
apparent O 0 0.040768254548311234
lack O 0 0.02294767275452614
of O 0 0.009089473634958267
recombinants O 0 0.4178619086742401
between O 0 0.012486758641898632
the O 0 0.016032066196203232
Factor O 0 0.0933808982372284
B O 1 0.861537754535675
gene O 0 0.11455903202295303
and O 0 0.048891160637140274
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.1537238359451294
suggests O 0 0.03603997454047203
that O 0 0.005954827647656202
these O 0 0.0050487155094742775
two O 0 0.00813568290323019
genes O 0 0.04212287440896034
lie O 0 0.03698623180389404
in O 0 0.012279827147722244
close O 0 0.022975746542215347
proximity O 0 0.034400686621665955
to O 0 0.008515479974448681
one O 0 0.011580871418118477
another O 0 0.02055896632373333
. O 0 0.025196542963385582

Distribution O 0 0.035839468240737915
of O 0 0.015894534066319466
emerin O 1 0.7805780172348022
and O 0 0.01741304062306881
lamins O 1 0.9969160556793213
in O 0 0.012141483835875988
the O 0 0.014304465614259243
heart O 1 0.9987478256225586
and O 0 0.011598344892263412
implications O 0 0.04880724847316742
for O 0 0.020342594012618065
Emery B-Disease 1 0.999940037727356
- I-Disease 1 0.9995155334472656
Dreifuss I-Disease 1 0.9999984502792358
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
. O 0 0.049968186765909195

Emerin O 0 0.2343646138906479
is O 0 0.021434227004647255
a O 0 0.020963143557310104
nuclear O 0 0.04887620359659195
membrane O 0 0.08054200559854507
protein O 0 0.04693307355046272
which O 0 0.010017958469688892
is O 0 0.012580114416778088
missing O 0 0.031044231727719307
or O 0 0.018955327570438385
defective O 1 0.7682844996452332
in O 0 0.02464926429092884
Emery B-Disease 1 0.9999405145645142
- I-Disease 1 0.9998155236244202
Dreifuss I-Disease 1 0.9999997615814209
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.649646520614624
EDMD B-Disease 1 0.9999979734420776
) O 0 0.04223037138581276
. O 0 0.026600006967782974

It O 0 0.01796397939324379
is O 0 0.009329318068921566
one O 0 0.008348094299435616
member O 0 0.00996252428740263
of O 0 0.005924622993916273
a O 0 0.01497766375541687
family O 0 0.023461446166038513
of O 0 0.015241577289998531
lamina O 1 0.9999822378158569
- O 0 0.08609340339899063
associated O 0 0.037755176424980164
proteins O 0 0.0381576344370842
which O 0 0.013760059140622616
includes O 0 0.026101041585206985
LAP1 O 1 0.9741916060447693
, O 0 0.028910653665661812
LAP2 O 1 0.9837620854377747
and O 0 0.030391840264201164
lamin O 1 0.9799071550369263
B O 1 0.76371169090271
receptor O 0 0.34688493609428406
( O 0 0.07377883046865463
LBR O 1 0.9999785423278809
) O 0 0.04283130168914795
. O 0 0.0257234126329422

A O 0 0.047503624111413956
panel O 0 0.04077976569533348
of O 0 0.014551161788403988
16 O 0 0.04087626934051514
monoclonal O 1 0.8583412170410156
antibodies O 1 0.5299748778343201
( O 0 0.05848553031682968
mAbs O 1 0.9913219809532166
) O 0 0.023105783388018608
has O 0 0.011012785136699677
been O 0 0.010101266205310822
mapped O 0 0.031545817852020264
to O 0 0.007434320170432329
six O 0 0.010767035186290741
specific O 0 0.013189515098929405
sites O 0 0.013782588765025139
throughout O 0 0.013782045803964138
the O 0 0.016706334426999092
emerin O 0 0.3085121810436249
molecule O 0 0.11260204017162323
using O 0 0.042844343930482864
phage O 1 0.9990550875663757
- O 0 0.0959264412522316
displayed O 0 0.04900890588760376
peptide O 0 0.10912562161684036
libraries O 0 0.024998994544148445
and O 0 0.008334075100719929
has O 0 0.009662254713475704
been O 0 0.008178737945854664
used O 0 0.010344218462705612
to O 0 0.01206153817474842
localize O 0 0.16465593874454498
emerin O 0 0.1642092913389206
in O 0 0.014980864711105824
human O 0 0.023270759731531143
and O 0 0.019186705350875854
rabbit O 1 0.9998314380645752
heart O 1 0.9998836517333984
. O 0 0.03273901343345642

Several O 0 0.03705226257443428
mAbs O 0 0.4483966529369354
against O 0 0.03154286369681358
different O 0 0.021565865725278854
emerin O 1 0.8153104782104492
epitopes O 0 0.4906344711780548
did O 0 0.02025173045694828
not O 0 0.009850929491221905
recognize O 0 0.038696371018886566
intercalated O 0 0.4831920266151428
discs O 0 0.0503171868622303
in O 0 0.011239640414714813
the O 0 0.01629486493766308
heart O 1 0.9985254406929016
, O 0 0.012438395991921425
though O 0 0.013508624397218227
they O 0 0.009095190092921257
recognized O 0 0.03625639155507088
cardiomyocyte O 0 0.4813345670700073
nuclei O 0 0.0791708454489708
strongly O 0 0.023116275668144226
, O 0 0.007993774488568306
both O 0 0.006847845856100321
at O 0 0.011703516356647015
the O 0 0.011085430160164833
rim O 0 0.08758866786956787
and O 0 0.010962327010929585
in O 0 0.015502535738050938
intranuclear O 1 0.8524839282035828
spots O 0 0.06661886721849442
or O 0 0.021219007670879364
channels O 0 0.038184456527233124
. O 0 0.02477395534515381

A O 0 0.09613920003175735
polyclonal O 1 0.9852991104125977
rabbit O 1 0.9880125522613525
antiserum O 1 0.9706218242645264
against O 0 0.040868066251277924
emerin O 1 0.8548433780670166
did O 0 0.019183816388249397
recognize O 0 0.02539828233420849
both O 0 0.010545154102146626
nuclear O 0 0.03866027295589447
membrane O 0 0.0652761459350586
and O 0 0.01668003387749195
intercalated O 1 0.9529240727424622
discs O 0 0.05301492288708687
but O 0 0.011920222081243992
, O 0 0.011078140698373318
after O 0 0.021326838061213493
affinity O 0 0.08589544147253036
purification O 0 0.0790475532412529
against O 0 0.016155214980244637
a O 0 0.021243663504719734
pure O 0 0.0545438714325428
- O 0 0.09980548918247223
emerin O 0 0.1812969595193863
band O 0 0.0424644760787487
on O 0 0.010154539719223976
a O 0 0.01586819253861904
western O 0 0.03305437043309212
blot O 1 0.6221694946289062
, O 0 0.014397397637367249
it O 0 0.012641686014831066
stained O 1 0.6163293719291687
only O 0 0.009253323078155518
the O 0 0.012895453721284866
nuclear O 0 0.05176784470677376
membrane O 0 0.09610989689826965
. O 0 0.030430445447564125

These O 0 0.013201436027884483
results O 0 0.020994199439883232
would O 0 0.007798344362527132
not O 0 0.006161521188914776
be O 0 0.00676981545984745
expected O 0 0.015275494195520878
if O 0 0.016974525526165962
immunostaining O 1 0.5879905223846436
at O 0 0.027484655380249023
intercalated O 1 0.7291257381439209
discs O 0 0.04397762566804886
were O 0 0.007565638981759548
due O 0 0.012731095775961876
to O 0 0.007391165941953659
a O 0 0.011632363311946392
product O 0 0.015659693628549576
of O 0 0.007939373143017292
the O 0 0.016424302011728287
emerin O 1 0.9198836088180542
gene O 0 0.07704052329063416
and O 0 0.010996231809258461
, O 0 0.010571212507784367
therefore O 0 0.012641115114092827
, O 0 0.0077705224975943565
cast O 0 0.013952783308923244
some O 0 0.007194012403488159
doubt O 0 0.021217582747340202
upon O 0 0.009047257713973522
the O 0 0.01107046939432621
hypothesis O 0 0.07311439514160156
that O 0 0.025297334417700768
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999569654464722
in O 0 0.023072464391589165
EDMD B-Disease 1 0.9999990463256836
are O 0 0.010363568551838398
caused O 0 0.038818273693323135
by O 0 0.010371381416916847
absence O 0 0.032616544514894485
of O 0 0.014458251185715199
emerin O 1 0.8533197641372681
from O 0 0.025618812069296837
intercalated O 1 0.9881028532981873
discs O 0 0.08690354228019714
. O 0 0.031312696635723114

Although O 0 0.04371150955557823
emerin O 0 0.17640675604343414
was O 0 0.020779907703399658
abundant O 0 0.028678158298134804
in O 0 0.010172880254685879
the O 0 0.013007334433495998
membranes O 0 0.07734043151140213
of O 0 0.01630697026848793
cardiomyocyte O 1 0.9112917184829712
nuclei O 0 0.07571391016244888
, O 0 0.012244920246303082
it O 0 0.008369135670363903
was O 0 0.013375482521951199
absent O 0 0.03711603581905365
from O 0 0.01001778244972229
many O 0 0.010195143520832062
non O 0 0.0563565231859684
- O 1 0.7693975567817688
myocyte O 1 0.9997445940971375
cells O 0 0.07432980090379715
in O 0 0.013239182531833649
the O 0 0.020130349323153496
heart O 1 0.9993823766708374
. O 0 0.030889198184013367

This O 0 0.018237421289086342
distribution O 0 0.02440168336033821
of O 0 0.01399995107203722
emerin O 0 0.2611304819583893
was O 0 0.01488201692700386
similar O 0 0.011271784082055092
to O 0 0.006371085997670889
that O 0 0.005797929130494595
of O 0 0.009310896508395672
lamin O 1 0.6133121252059937
A O 0 0.0274735689163208
, O 0 0.011673524044454098
a O 0 0.0170268714427948
candidate O 0 0.03115137107670307
gene O 0 0.04930528625845909
for O 0 0.008976110257208347
an O 0 0.01780043914914131
autosomal O 1 0.970350444316864
form O 0 0.031118085607886314
of O 0 0.018482167273759842
EDMD B-Disease 1 0.9999953508377075
. O 0 0.03771879896521568

In O 0 0.03257125988602638
contrast O 0 0.05771389603614807
, O 0 0.032839588820934296
lamin O 1 0.9989163875579834
B1 O 1 0.9999953508377075
was O 0 0.03748477250337601
absent O 0 0.06858116388320923
from O 0 0.02478604204952717
cardiomyocyte O 1 0.7247183322906494
nuclei O 0 0.08959048241376877
, O 0 0.015685446560382843
showing O 0 0.03594956174492836
that O 0 0.021575676277279854
lamin O 1 0.998870313167572
B1 O 1 0.9999911785125732
is O 0 0.016377586871385574
not O 0 0.008367936126887798
essential O 0 0.015333025716245174
for O 0 0.009875573217868805
localization O 0 0.0480852909386158
of O 0 0.010097327642142773
emerin O 0 0.11109523475170135
to O 0 0.010900954715907574
the O 0 0.015657149255275726
nuclear O 0 0.06872539967298508
lamina O 1 0.9981561303138733
. O 0 0.03756684064865112

Lamin O 1 0.9990347623825073
B1 O 1 0.9999557733535767
is O 0 0.025704728439450264
also O 0 0.011390173807740211
almost O 0 0.01707039773464203
completely O 0 0.03392946720123291
absent O 0 0.06635831296443939
from O 0 0.031202083453536034
skeletal O 1 0.9999480247497559
muscle O 1 0.9999029636383057
nuclei O 0 0.14491041004657745
. O 0 0.03256851062178612

In O 0 0.038960088044404984
EDMD B-Disease 1 0.9998834133148193
, O 0 0.013331029564142227
the O 0 0.009704205207526684
additional O 0 0.01839003898203373
absence O 0 0.04165678098797798
of O 0 0.021242931485176086
lamin O 1 0.9997323155403137
B1 O 1 0.9999991655349731
from O 0 0.03259189799427986
heart O 1 0.9998449087142944
and O 0 0.021058127284049988
skeletal O 1 0.9999823570251465
muscle O 1 0.9999480247497559
nuclei O 0 0.07661156356334686
which O 0 0.013797232881188393
already O 0 0.026691097766160965
lack O 0 0.04081634059548378
emerin O 1 0.9913334250450134
may O 0 0.020754965022206306
offer O 0 0.018588837236166
an O 0 0.010559323243796825
alternative O 0 0.027673805132508278
explanation O 0 0.027610721066594124
of O 0 0.007619648706167936
why O 0 0.021745149046182632
these O 0 0.008845848962664604
tissues O 0 0.06259292364120483
are O 0 0.009452760219573975
particularly O 0 0.025042174383997917
affected O 0 0.04261745139956474
. O 0 0.014922377653419971
. O 0 0.025355609133839607

Genetic O 0 0.10766812413930893
mapping O 0 0.06022614613175392
of O 0 0.011140082962810993
the O 0 0.021672574803233147
copper B-Disease 1 0.7089233994483948
toxicosis I-Disease 1 0.9997847676277161
locus O 0 0.19012726843357086
in O 0 0.032276079058647156
Bedlington O 1 0.9968559741973877
terriers O 0 0.22842733561992645
to O 0 0.023036394268274307
dog O 0 0.11058663576841354
chromosome O 0 0.1059422716498375
10 O 0 0.016211669892072678
, O 0 0.008616077713668346
in O 0 0.00836896151304245
a O 0 0.014808708801865578
region O 0 0.03807962313294411
syntenic O 0 0.20488187670707703
to O 0 0.013856015168130398
human O 0 0.03309500962495804
chromosome O 0 0.1536586731672287
region O 0 0.06956130266189575
2p13 O 1 0.9944843649864197
- O 0 0.43012067675590515
p16 O 1 0.9539151787757874
. O 0 0.04314609244465828

Abnormal O 1 0.9999427795410156
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9953017234802246
accumulation I-Disease 1 0.6085383892059326
is O 0 0.012804808095097542
recognized O 0 0.019657978788018227
as O 0 0.00985155813395977
an O 0 0.024257084354758263
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
in O 0 0.01824335940182209
man O 0 0.052639223635196686
, O 0 0.016829725354909897
mouse O 0 0.11915978044271469
, O 0 0.023677991703152657
rat O 1 0.9480304718017578
and O 0 0.020171577110886574
dog O 0 0.13470225036144257
. O 0 0.030794139951467514

The O 0 0.02627093531191349
major O 0 0.029984986409544945
cause O 0 0.06553264707326889
of O 0 0.019606923684477806
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9965174198150635
accumulation I-Disease 0 0.41298073530197144
in O 0 0.01319422572851181
man O 0 0.030090676620602608
is O 0 0.012245295569300652
a O 0 0.02477557212114334
dysfunctional O 1 0.9953606724739075
ATP7B O 1 0.9997968077659607
gene O 0 0.12459538131952286
, O 0 0.02760549820959568
causing O 1 0.988669753074646
Wilson B-Disease 1 0.9997448325157166
disease I-Disease 1 0.9999998807907104
( O 0 0.2755811810493469
WD B-Disease 1 0.9999990463256836
) O 0 0.03825993835926056
. O 0 0.027249233797192574

Mutations O 0 0.14464394748210907
in O 0 0.015683431178331375
the O 0 0.02175951562821865
ATP7B O 1 0.9943802952766418
genes O 0 0.05408181622624397
have O 0 0.010028272867202759
also O 0 0.009331364184617996
been O 0 0.011566846631467342
demonstrated O 0 0.03120069019496441
in O 0 0.012369737960398197
mouse O 0 0.09942308068275452
and O 0 0.019867639988660812
rat O 1 0.9827410578727722
. O 0 0.03285128250718117

The O 0 0.048359788954257965
ATP7B O 1 0.9925962686538696
gene O 0 0.08028265833854675
has O 0 0.014453298412263393
been O 0 0.010486778803169727
excluded O 0 0.023956893011927605
in O 0 0.006598055362701416
the O 0 0.008129159919917583
much O 0 0.018155524507164955
rarer O 1 0.861494779586792
human O 0 0.044120389968156815
copper B-Disease 1 0.9999821186065674
overload I-Disease 1 0.9999998807907104
disease O 1 1.0
non B-Disease 0 0.21121162176132202
- I-Disease 0 0.19042226672172546
Indian I-Disease 0 0.0669073760509491
childhood I-Disease 1 0.9997355341911316
cirrhosis I-Disease 1 0.9999988079071045
, O 0 0.026114894077181816
indicating O 0 0.070671945810318
genetic O 0 0.09852064400911331
heterogeneity O 0 0.159794881939888
. O 0 0.037349339574575424

By O 0 0.024472422897815704
investigating O 0 0.044716715812683105
the O 0 0.019552147015929222
common O 0 0.050870832055807114
autosomal O 1 0.9999179840087891
recessive O 1 0.9999860525131226
copper B-Disease 1 0.9999456405639648
toxicosis I-Disease 1 0.9999994039535522
( O 0 0.13236026465892792
CT B-Disease 1 0.9999969005584717
) O 0 0.02930997684597969
in O 0 0.020814040675759315
Bedlington O 1 0.9994088411331177
terriers O 0 0.43748006224632263
, O 0 0.014285571873188019
we O 0 0.008008746430277824
have O 0 0.006982688792049885
identified O 0 0.016650808975100517
a O 0 0.01239748578518629
new O 0 0.016712727025151253
locus O 0 0.09705858677625656
involved O 0 0.03172891587018967
in O 0 0.023108476772904396
progressive O 1 0.9999911785125732
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.04010169208049774

We O 0 0.026697520166635513
examined O 0 0.053549785166978836
whether O 0 0.023966854438185692
the O 0 0.028051869943737984
WD B-Disease 1 0.9999892711639404
gene O 0 0.14368772506713867
ATP7B O 1 0.9808996915817261
was O 0 0.02240331657230854
also O 0 0.014169741421937943
causative O 0 0.1368369460105896
for O 0 0.0185332540422678
CT B-Disease 1 0.9999707937240601
by O 0 0.01269932184368372
investigating O 0 0.04152614623308182
the O 0 0.02192302606999874
chromosomal O 1 0.8470239043235779
co O 0 0.4417792558670044
- O 0 0.09446612000465393
localization O 0 0.09004859626293182
of O 0 0.018657170236110687
ATP7B O 1 0.9829902648925781
and O 0 0.02178514562547207
C04107 O 0 0.13102640211582184
, O 0 0.015616471879184246
using O 0 0.022388214245438576
fluorescence O 0 0.1301196962594986
in O 0 0.02612747997045517
situ O 0 0.17060446739196777
hybridization O 0 0.13051311671733856
( O 0 0.038742341101169586
FISH O 0 0.052701499313116074
) O 0 0.03092932514846325
. O 0 0.025819206610322

C04107 O 0 0.20861268043518066
is O 0 0.026892244815826416
an O 0 0.020777031779289246
anonymous O 0 0.08432099968194962
microsatellite O 0 0.33378538489341736
marker O 0 0.10684897750616074
closely O 0 0.040682949125766754
linked O 0 0.07304073125123978
to O 0 0.025837602093815804
CT B-Disease 1 0.9999860525131226
. O 0 0.033164169639348984

However O 0 0.03875527158379555
, O 0 0.030843162909150124
BAC O 1 0.9990317821502686
clones O 0 0.12761180102825165
containing O 0 0.04526270180940628
ATP7B O 1 0.947216272354126
and O 0 0.0203599501401186
C04107 O 0 0.13185171782970428
mapped O 0 0.054936233907938004
to O 0 0.01380116492509842
the O 0 0.022819526493549347
canine O 1 0.9859802722930908
chromosome O 0 0.17306296527385712
regions O 0 0.06023242697119713
CFA22q11 O 1 0.9400263428688049
and O 0 0.018496496602892876
CFA10q26 O 1 0.9249946475028992
, O 0 0.014783991500735283
respectively O 0 0.01873353123664856
, O 0 0.01078809890896082
demonstrating O 0 0.04094449430704117
that O 0 0.018109658733010292
WD B-Disease 1 0.9999616146087646
cannot O 0 0.026527415961027145
be O 0 0.011358785443007946
homologous O 0 0.10168731212615967
to O 0 0.030988365411758423
CT B-Disease 1 0.9999570846557617
. O 0 0.0411444790661335

The O 0 0.029757974669337273
copper O 0 0.08610881865024567
transport O 0 0.06503551453351974
genes O 0 0.08147994428873062
CTR1 O 1 0.9884059429168701
and O 0 0.018836406990885735
CTR2 O 1 0.9453743100166321
were O 0 0.009856680408120155
also O 0 0.010871784761548042
excluded O 0 0.03176312521100044
as O 0 0.009417480789124966
candidate O 0 0.02582024596631527
genes O 0 0.04508759453892708
for O 0 0.01783754862844944
CT B-Disease 1 0.9999864101409912
since O 0 0.01598956063389778
they O 0 0.006662146188318729
both O 0 0.00793363619595766
mapped O 0 0.046984076499938965
to O 0 0.018949877470731735
canine O 1 0.756538987159729
chromosome O 0 0.17949895560741425
region O 0 0.08119195699691772
CFA11q22 O 1 0.9738520979881287
. O 0 0.03528541699051857

2 O 0 0.06955275684595108
- O 0 0.10339272767305374
22 O 0 0.048237744718790054
. O 0 0.02957010269165039

5 O 0 0.06285658478736877
. O 0 0.036435894668102264

A O 0 0.05821268633008003
transcribed O 0 0.07643534988164902
sequence O 0 0.03669413924217224
identified O 0 0.024946389719843864
from O 0 0.012914776802062988
the O 0 0.015006033703684807
C04107 O 1 0.6224584579467773
- O 0 0.0920078381896019
containing O 0 0.05114205554127693
BAC O 1 0.9912403225898743
was O 0 0.02049344964325428
found O 0 0.01247401349246502
to O 0 0.007490192539989948
be O 0 0.009439962916076183
homologous O 0 0.06907495856285095
to O 0 0.01108251791447401
a O 0 0.020468447357416153
gene O 0 0.06462424248456955
expressed O 0 0.025694899260997772
from O 0 0.016322633251547813
human O 0 0.04073783755302429
chromosome O 0 0.20958416163921356
2p13 O 1 0.9805528521537781
- O 0 0.16852650046348572
p16 O 1 0.5675209164619446
, O 0 0.01638105884194374
a O 0 0.015802912414073944
region O 0 0.03047206439077854
devoid O 0 0.0465790256857872
of O 0 0.008489242754876614
any O 0 0.014416564255952835
positional O 0 0.08680878579616547
candidate O 0 0.04165366291999817
genes O 0 0.06845135241746902
. O 0 0.02893739938735962

Molecular O 0 0.08761881291866302
analysis O 0 0.02676558494567871
of O 0 0.008616684935986996
the O 0 0.019808219745755196
APC B-Disease 1 0.9173606634140015
gene O 0 0.08081775158643723
in O 0 0.01579323224723339
205 O 0 0.09450984001159668
families O 0 0.03646540641784668
: O 0 0.026235157623887062
extended O 0 0.0581451952457428
genotype O 1 0.9893640279769897
- O 0 0.1964881420135498
phenotype O 0 0.4407240152359009
correlations O 0 0.11830997467041016
in O 0 0.027309371158480644
FAP B-Disease 1 0.9999922513961792
and O 0 0.012300211936235428
evidence O 0 0.011617910116910934
for O 0 0.006535127758979797
the O 0 0.00869743525981903
role O 0 0.020648090168833733
of O 0 0.017191149294376373
APC B-Disease 1 0.971436619758606
amino O 0 0.10245689749717712
acid O 0 0.24970777332782745
changes O 0 0.03713679313659668
in O 0 0.2536430358886719
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999825954437256
. O 0 0.04049837589263916

BACKGROUND O 0 0.15622630715370178
/ O 1 0.8546520471572876
AIMS O 0 0.06268242746591568
The O 0 0.013172885403037071
development O 0 0.025013839825987816
of O 0 0.02553419955074787
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.014039687812328339
a O 0 0.019136792048811913
variable O 0 0.06946751475334167
range O 0 0.025661487132310867
of O 0 0.012793723493814468
extracolonic O 1 0.9899202585220337
manifestations O 1 0.9798454642295837
in O 0 0.04294315353035927
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9888229370117188
FAP B-Disease 1 0.9999997615814209
) O 0 0.02263205125927925
is O 0 0.009326286613941193
the O 0 0.007586774416267872
result O 0 0.013997096568346024
of O 0 0.005981821101158857
the O 0 0.013043807819485664
dominant O 0 0.06918279081583023
inheritance O 0 0.30233651399612427
of O 0 0.04657827690243721
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
( O 0 0.13089461624622345
APC B-Disease 1 0.9995393753051758
) O 0 0.05424201488494873
gene O 0 0.12683798372745514
mutations O 0 0.1287716031074524
. O 0 0.029158765450119972

In O 0 0.017055002972483635
this O 0 0.010856029577553272
study O 0 0.021354181692004204
, O 0 0.0120695186778903
direct O 0 0.03202925622463226
mutation O 0 0.09598425030708313
analysis O 0 0.020658113062381744
of O 0 0.008482880890369415
the O 0 0.017800386995077133
APC B-Disease 1 0.9932067394256592
gene O 0 0.07824678719043732
was O 0 0.018427446484565735
performed O 0 0.025201065465807915
to O 0 0.01165177021175623
determine O 0 0.040391676127910614
genotype O 1 0.9913038015365601
- O 0 0.21576304733753204
phenotype O 0 0.4448098838329315
correlations O 0 0.08689972013235092
for O 0 0.01463119126856327
nine O 0 0.03301374986767769
extracolonic O 1 0.776606023311615
manifestations O 0 0.08038876205682755
and O 0 0.008331743068993092
to O 0 0.008599543944001198
investigate O 0 0.032727643847465515
the O 0 0.0163088571280241
incidence O 1 0.9364461898803711
of O 0 0.020027466118335724
APC B-Disease 1 0.9986079335212708
mutations O 0 0.11677959561347961
in O 0 0.024344954639673233
non O 1 0.987188994884491
- O 1 0.9999967813491821
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0476248525083065

METHODS O 0 0.06605120003223419
The O 0 0.03167419135570526
APC B-Disease 1 0.9752299189567566
gene O 0 0.09273887425661087
was O 0 0.024922309443354607
analysed O 0 0.05830847844481468
in O 0 0.017203472554683685
190 O 0 0.08227455615997314
unrelated O 0 0.09043325483798981
FAP B-Disease 1 0.9999961853027344
and O 0 0.01403377391397953
15 O 0 0.02656436897814274
non O 1 0.9959756731987
- O 1 0.9999990463256836
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999972581863403
using O 0 0.04747723415493965
denaturing O 1 0.9941009879112244
gradient O 1 0.6846802234649658
gel O 1 0.9910001158714294
electrophoresis O 0 0.2235119789838791
, O 0 0.017004314810037613
the O 0 0.020355435088276863
protein O 0 0.07449393719434738
truncation O 0 0.137399822473526
test O 0 0.04669632390141487
, O 0 0.011918030679225922
and O 0 0.010259761475026608
direct O 0 0.02911200188100338
sequencing O 0 0.0808638483285904
. O 0 0.030543817207217216

RESULTS O 0 0.10059991478919983
Chain O 0 0.11127229779958725
terminating O 0 0.12620039284229279
signals O 0 0.047789204865694046
were O 0 0.009069539606571198
only O 0 0.007838137447834015
identified O 0 0.019646739587187767
in O 0 0.012987270019948483
patients O 1 0.9991605281829834
belonging O 0 0.03165173530578613
to O 0 0.010970302857458591
the O 0 0.02151341736316681
FAP B-Disease 1 0.999998927116394
group O 0 0.05902859568595886
( O 0 0.04171643406152725
105 O 0 0.18282026052474976
patients O 1 0.9999392032623291
) O 0 0.03230692073702812
. O 0 0.025876745581626892

Amino O 0 0.14452651143074036
acid O 0 0.1494642198085785
changes O 0 0.02375541254878044
were O 0 0.008474137634038925
identified O 0 0.019955338910222054
in O 0 0.009304380044341087
four O 0 0.015595236793160439
patients O 1 0.9994812607765198
, O 0 0.008145153522491455
three O 0 0.0058327363803982735
of O 0 0.00671381875872612
whom O 0 0.022439943626523018
belonged O 0 0.028802119195461273
to O 0 0.007577994372695684
the O 0 0.012901373207569122
non O 0 0.06308724731206894
- O 1 0.9961793422698975
FAP O 1 0.9999994039535522
group O 0 0.3572706878185272
of O 0 0.2039361298084259
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999997615814209
. O 0 0.03793735429644585

Genotype O 1 0.9977317452430725
- O 1 0.7461070418357849
phenotype O 1 0.8802984952926636
correlations O 0 0.12009818851947784
identified O 0 0.03566627949476242
significant O 0 0.017962440848350525
differences O 0 0.015257924795150757
in O 0 0.00846592802554369
the O 0 0.009088561870157719
nature O 0 0.018689608201384544
of O 0 0.007995744235813618
certain O 0 0.01976330578327179
extracolonic O 1 0.9973801970481873
manifestations O 1 0.993569016456604
in O 0 0.03271501138806343
FAP B-Disease 1 1.0
patients O 1 0.9999665021896362
belonging O 0 0.03700500354170799
to O 0 0.011720012873411179
three O 0 0.01862766221165657
mutation O 0 0.15850301086902618
subgroups O 0 0.10974244773387909
. O 0 0.0339982844889164

CONCLUSIONS O 0 0.09912131726741791
Extended O 0 0.08947256207466125
genotype O 1 0.9830401539802551
- O 0 0.18313808739185333
phenotype O 0 0.39925888180732727
correlations O 0 0.07247846573591232
made O 0 0.011857103556394577
in O 0 0.007391424849629402
this O 0 0.007160428911447525
study O 0 0.017829790711402893
may O 0 0.011251736432313919
have O 0 0.00462110573425889
the O 0 0.006680160295218229
potential O 0 0.017299074679613113
to O 0 0.005659532733261585
determine O 0 0.01312270388007164
the O 0 0.007280662655830383
most O 0 0.008818457834422588
appropriate O 0 0.025078020989894867
surveillance O 0 0.04738934338092804
and O 0 0.01852315105497837
prophylactic O 1 0.9999964237213135
treatment O 1 0.9999990463256836
regimens O 1 0.9999806880950928
for O 0 0.011778763495385647
those O 0 0.012462363578379154
patients O 1 0.9999779462814331
with O 0 0.0184251107275486
mutations O 0 0.09454809129238129
associated O 0 0.0230486411601305
with O 0 0.014354757033288479
life O 0 0.0349762961268425
threatening O 1 0.7875359654426575
conditions O 0 0.10101615637540817
. O 0 0.028194285929203033

This O 0 0.019343750551342964
study O 0 0.023977484554052353
also O 0 0.010176648385822773
provided O 0 0.01374316681176424
evidence O 0 0.00974472425878048
for O 0 0.006128816865384579
the O 0 0.011768911965191364
pathological O 0 0.46102166175842285
nature O 0 0.02587777189910412
of O 0 0.010904471389949322
amino O 0 0.06714264303445816
acid O 0 0.1130921021103859
changes O 0 0.024841589853167534
in O 0 0.014856675639748573
APC O 1 0.9427489042282104
associated O 0 0.022258244454860687
with O 0 0.01033518835902214
both O 0 0.015018710866570473
FAP B-Disease 1 0.9999994039535522
and O 0 0.020738624036312103
non O 1 0.9990687966346741
- O 1 0.9999994039535522
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999997615814209
. O 0 0.019808854907751083
. O 0 0.02331792376935482

Inherited B-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.8425880670547485
cancer B-Disease 1 1.0
risk O 1 0.9452704787254333
of O 0 0.01113418024033308
the O 0 0.02235504984855652
APC O 1 0.9987340569496155
I1307K O 1 0.688032865524292
polymorphism O 0 0.15973632037639618
. O 0 0.039183370769023895

Germ O 1 0.9998732805252075
- O 0 0.12273578345775604
line O 0 0.03895767778158188
and O 0 0.02258697897195816
somatic O 0 0.1937292218208313
truncating O 0 0.26859384775161743
mutations O 0 0.10991699993610382
of O 0 0.012562534771859646
the O 0 0.02387596294283867
APC B-Disease 1 0.9943365454673767
gene O 0 0.07635295391082764
are O 0 0.011248103342950344
thought O 0 0.02333846129477024
to O 0 0.017277879640460014
initiate O 1 0.9874914884567261
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999994039535522
formation O 1 0.7951443791389465
in O 0 0.08603781461715698
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.18630120158195496
sporadic O 1 0.9998446702957153
colorectal O 1 1.0
carcinogenesis O 1 0.9999885559082031
, O 0 0.02312779426574707
respectively O 0 0.03166186809539795
. O 0 0.025651540607213974

Recently O 0 0.055801909416913986
, O 0 0.016324661672115326
an O 0 0.021542338654398918
isoleucine O 1 0.9968153834342957
- O 1 0.9651883244514465
- O 0 0.24076035618782043
> O 0 0.23440678417682648
lysine O 0 0.23770208656787872
polymorphism O 0 0.18719245493412018
at O 0 0.060124270617961884
codon O 0 0.19114403426647186
1307 O 1 0.6756643056869507
( O 0 0.055626966059207916
I1307K O 0 0.14381709694862366
) O 0 0.01714842952787876
of O 0 0.007483105640858412
the O 0 0.01823737844824791
APC B-Disease 1 0.9810947179794312
gene O 0 0.07845431566238403
has O 0 0.0167978648096323
been O 0 0.011129593476653099
identified O 0 0.02018776722252369
in O 0 0.009520092979073524
6 O 0 0.026888687163591385
% O 0 0.028005266562104225
- O 0 0.05367021635174751
7 O 0 0.024802053347229958
% O 0 0.015491809695959091
of O 0 0.0072684520855546
the O 0 0.015493950806558132
Ashkenazi O 0 0.14780506491661072
Jewish O 0 0.0468008816242218
population O 0 0.03340887650847435
. O 0 0.02837332710623741

To O 0 0.025973660871386528
assess O 0 0.06265617907047272
the O 0 0.016227737069129944
risk O 0 0.05421794205904007
of O 0 0.007891349494457245
this O 0 0.010769576765596867
common O 0 0.04088747128844261
APC B-Disease 1 0.9994513392448425
allelic O 1 0.9911673665046692
variant O 1 0.5914212465286255
in O 0 0.04824444651603699
colorectal O 1 1.0
carcinogenesis O 1 0.9999903440475464
, O 0 0.01466094609349966
we O 0 0.00815026368945837
have O 0 0.007526008877903223
analyzed O 0 0.025246435776352882
a O 0 0.014745506457984447
large O 0 0.019895032048225403
cohort O 0 0.13179819285869598
of O 0 0.01867474615573883
unselected O 0 0.35986050963401794
Ashkenazi O 0 0.17167848348617554
Jewish O 0 0.05068330466747284
subjects O 0 0.03941817209124565
with O 0 0.03031855635344982
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999966621398926
and O 0 0.018654389306902885
. O 0 0.01986492983996868
or O 1 0.9988000392913818
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.010719146579504013
for O 0 0.008241654373705387
the O 0 0.018984582275152206
APC O 1 0.9987481832504272
I1307K O 0 0.4135497808456421
polymorphism O 0 0.16037964820861816
. O 0 0.03851953148841858

The O 0 0.05655030533671379
APC O 1 0.8735383749008179
I1307K O 0 0.23660661280155182
allele O 0 0.16378186643123627
was O 0 0.02809639647603035
identified O 0 0.02951142005622387
in O 0 0.012486588209867477
48 O 0 0.032478202134370804
( O 0 0.01820933260023594
10 O 0 0.013305488042533398
. O 0 0.008871401660144329
1 O 0 0.017212767153978348
% O 0 0.019431795924901962
) O 0 0.017645686864852905
of O 0 0.014287815429270267
476 O 1 0.9986826777458191
patients O 1 0.9999862909317017
. O 0 0.03896642476320267

Compared O 0 0.0402066670358181
with O 0 0.010924933478236198
the O 0 0.011935180984437466
frequency O 0 0.03679477423429489
in O 0 0.00735164899379015
two O 0 0.006573528051376343
separate O 0 0.014665625058114529
population O 0 0.02084157057106495
control O 0 0.031376082450151443
groups O 0 0.01711444929242134
, O 0 0.010795386508107185
the O 0 0.018339959904551506
APC O 1 0.9909895658493042
I1307K O 0 0.22726552188396454
allele O 0 0.1611609160900116
is O 0 0.017958976328372955
associated O 0 0.017497731372714043
with O 0 0.00865889247506857
an O 0 0.011529339477419853
estimated O 0 0.027412494644522667
relative O 0 0.04733523353934288
risk O 0 0.07555630058050156
of O 0 0.01206942554563284
1 O 0 0.03157654032111168
. O 0 0.025590406730771065

5 O 0 0.06741231679916382
- O 0 0.09069614857435226
1 O 0 0.040658995509147644
. O 0 0.02909208834171295

7 O 0 0.07126181572675705
for O 0 0.043119288980960846
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999867677688599
( O 0 0.045713070780038834
both O 0 0.023794645443558693
P O 1 0.9909884333610535
= O 0 0.12570065259933472
. O 0 0.023651694878935814
01 O 1 0.9662283658981323
) O 0 0.03356017917394638
. O 0 0.0290650837123394

Furthermore O 0 0.06680134683847427
, O 0 0.016750145703554153
compared O 0 0.02843867987394333
with O 0 0.018949298188090324
noncarriers O 1 0.8842368125915527
, O 0 0.036741264164447784
APC O 1 0.9944143295288086
I1307K O 1 0.8058502674102783
carriers O 0 0.07718959450721741
had O 0 0.017875466495752335
increased O 0 0.022441314533352852
numbers O 0 0.014847982674837112
of O 0 0.01496942713856697
adenomas B-Disease 1 0.9999988079071045
and O 0 0.09317425638437271
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.999998927116394
per O 0 0.049697764217853546
patient O 1 0.9999768733978271
( O 0 0.056115951389074326
P O 1 0.9981873631477356
= O 0 0.1137867197394371
. O 0 0.020540103316307068
03 O 1 0.6211761832237244
) O 0 0.01986824907362461
, O 0 0.008029627613723278
as O 0 0.00685109244659543
well O 0 0.00804109126329422
as O 0 0.007281449623405933
a O 0 0.017533034086227417
younger O 0 0.04155139625072479
age O 0 0.03826235607266426
at O 0 0.04043431952595711
diagnosis O 1 0.9999918937683105
. O 0 0.03191675990819931

We O 0 0.02449229173362255
conclude O 0 0.0442977212369442
that O 0 0.010534949600696564
the O 0 0.020059917122125626
APC O 1 0.9971604347229004
I1307K O 1 0.5413808226585388
variant O 0 0.13697145879268646
leads O 0 0.0654010996222496
to O 0 0.01940767467021942
increased O 0 0.06687139719724655
adenoma B-Disease 1 1.0
formation O 0 0.07422273606061935
and O 0 0.01230576355010271
directly O 0 0.020229686051607132
contributes O 0 0.056472793221473694
to O 0 0.010936739854514599
3 O 0 0.022809840738773346
% O 0 0.02329239249229431
- O 0 0.04971369728446007
4 O 0 0.022079214453697205
% O 0 0.015521087683737278
of O 0 0.007767169736325741
all O 0 0.013925964944064617
Ashkenazi O 1 0.9973986148834229
Jewish O 1 0.9992647767066956
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.042139932513237

The O 0 0.023269614204764366
estimated O 0 0.037874434143304825
relative O 0 0.05034757778048515
risk O 0 0.1589304357767105
for O 0 0.01603238843381405
carriers O 0 0.09185613691806793
may O 0 0.023860234767198563
justify O 0 0.04933939129114151
specific O 0 0.024965040385723114
clinical O 1 0.9622204303741455
screening O 0 0.06627853214740753
for O 0 0.008120809681713581
the O 0 0.010680105537176132
360 O 0 0.056917157024145126
, O 0 0.014260562136769295
000 O 0 0.04865642637014389
Americans O 0 0.029860325157642365
expected O 0 0.01683802157640457
to O 0 0.011593618430197239
harbor O 0 0.06270689517259598
this O 0 0.01256781816482544
allele O 0 0.10088641196489334
, O 0 0.013342097401618958
and O 0 0.011473863385617733
genetic O 0 0.0540117584168911
testing O 0 0.0364256389439106
in O 0 0.007755133789032698
the O 0 0.007204181980341673
setting O 0 0.018383489921689034
of O 0 0.008994570933282375
long O 0 0.03485434502363205
- O 0 0.09806898981332779
term O 0 0.04829641804099083
- O 0 0.07472337782382965
outcome O 0 0.04590075835585594
studies O 0 0.03494243696331978
may O 0 0.025004424154758453
impact O 0 0.03914773464202881
significantly O 0 0.05409764498472214
on O 0 0.1527109444141388
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999898672103882
in O 0 0.011068099178373814
this O 0 0.009308204054832458
population O 0 0.02447948232293129
. O 0 0.02185913175344467

Localization O 0 0.11067650467157364
of O 0 0.015917830169200897
human O 0 0.03445475548505783
BRCA1 O 1 0.981512188911438
and O 0 0.011936609633266926
its O 0 0.009794714860618114
loss O 0 0.03780251741409302
in O 0 0.011599604040384293
high O 0 0.03638804703950882
- O 0 0.07300827652215958
grade O 0 0.05308074131608009
, O 0 0.016673950478434563
non B-Disease 0 0.1182454451918602
- I-Disease 1 0.9990839958190918
inherited I-Disease 1 0.9999858140945435
breast I-Disease 1 1.0
carcinomas I-Disease 1 0.9999990463256836
. O 0 0.04663519561290741

Although O 0 0.0221517663449049
the O 0 0.01337948627769947
link O 0 0.04129493609070778
between O 0 0.01731560379266739
the O 0 0.029270293191075325
BRCA1 O 1 0.9999988079071045
tumour B-Disease 1 1.0
- O 1 0.9967415928840637
suppressor O 1 0.982866108417511
gene O 0 0.1172390952706337
and O 0 0.025567565113306046
hereditary B-Disease 1 0.9999980926513672
breast I-Disease 1 1.0
and I-Disease 1 0.9946328401565552
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.01651948317885399
established O 0 0.012866836041212082
, O 0 0.006617751903831959
the O 0 0.00707845576107502
role O 0 0.017530716955661774
, O 0 0.007405908778309822
if O 0 0.008675960823893547
any O 0 0.006281515117734671
, O 0 0.007086623925715685
of O 0 0.010601742193102837
BRCA1 O 1 0.9970393776893616
in O 0 0.019669020548462868
non B-Disease 0 0.17216059565544128
- I-Disease 1 0.9957179427146912
familial I-Disease 1 0.9999983310699463
cancers I-Disease 1 0.999996542930603
is O 0 0.0233579371124506
unclear O 0 0.04261285066604614
. O 0 0.026093285530805588

BRCA1 O 1 0.9978722333908081
mutations O 0 0.1576576828956604
are O 0 0.011885203421115875
rare O 0 0.03652937710285187
in O 0 0.015537681058049202
sporadic B-Disease 1 0.9306674003601074
cancers I-Disease 1 0.9999942779541016
, O 0 0.01557160448282957
but O 0 0.010500559583306313
loss O 0 0.04347012937068939
of O 0 0.014578336849808693
BRCA1 O 1 0.9994074106216431
resulting O 0 0.054826706647872925
from O 0 0.01825808174908161
reduced O 0 0.04591728001832962
expression O 0 0.04669453203678131
or O 0 0.02492493949830532
incorrect O 0 0.07390092313289642
subcellular O 0 0.1285063475370407
localization O 0 0.08870778977870941
is O 0 0.016141008585691452
postulated O 0 0.046588581055402756
to O 0 0.006762697361409664
be O 0 0.005767788738012314
important O 0 0.006635662633925676
in O 0 0.010718252509832382
non B-Disease 0 0.2928212881088257
- I-Disease 1 0.9998134970664978
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9911211729049683
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.04370422661304474

Epigenetic O 0 0.4141550362110138
loss O 0 0.12474808841943741
, O 0 0.012194477021694183
however O 0 0.009579750709235668
, O 0 0.007910637184977531
has O 0 0.008858739398419857
not O 0 0.0061281113885343075
received O 0 0.01498429849743843
general O 0 0.013364563696086407
acceptance O 0 0.04182114824652672
due O 0 0.018309198319911957
to O 0 0.01022715400904417
controversy O 0 0.029716167598962784
regarding O 0 0.01770925521850586
the O 0 0.017418785020709038
subcellular O 0 0.11838240921497345
localization O 0 0.08685314655303955
of O 0 0.021839918568730354
BRCA1 O 1 0.9819096326828003
proteins O 0 0.049984049052000046
, O 0 0.011712742038071156
reports O 0 0.013292373158037663
of O 0 0.006025831215083599
which O 0 0.007002711296081543
have O 0 0.008749444037675858
ranged O 0 0.04126889631152153
from O 0 0.01040568295866251
exclusively O 0 0.020900648087263107
nuclear O 0 0.027343876659870148
, O 0 0.009302113205194473
to O 0 0.010980702005326748
conditionally O 0 0.08604824542999268
nuclear O 0 0.03131379187107086
, O 0 0.009236729703843594
to O 0 0.00933368131518364
the O 0 0.023016849532723427
ER O 1 0.9999634027481079
/ O 1 0.993552565574646
golgi O 1 0.7819077372550964
, O 0 0.01648738607764244
to O 0 0.015012957155704498
cytoplasmic O 0 0.11438798159360886
invaginations O 0 0.13431213796138763
into O 0 0.017000969499349594
the O 0 0.018431592732667923
nucleus O 0 0.10199149698019028
. O 0 0.030654411762952805

In O 0 0.01743859425187111
an O 0 0.01243769284337759
attempt O 0 0.025268955156207085
to O 0 0.009722281247377396
resolve O 0 0.029268303886055946
this O 0 0.007244283799082041
issue O 0 0.011078103445470333
, O 0 0.007368823979049921
we O 0 0.007138519082218409
have O 0 0.008666524663567543
comprehensively O 0 0.07101104408502579
characterized O 0 0.09387467056512833
19 O 0 0.04543597251176834
anti O 0 0.41973742842674255
- O 1 0.8549560308456421
BRCA1 O 1 0.9990907907485962
antibodies O 1 0.541255533695221
. O 0 0.045133382081985474

These O 0 0.026539959013462067
reagents O 0 0.1455058455467224
detect O 0 0.10126892477273941
a O 0 0.03381219506263733
220 O 0 0.09779749810695648
- O 0 0.1527085304260254
kD O 1 0.7616032958030701
protein O 0 0.10509758442640305
localized O 0 0.11194956302642822
in O 0 0.01870717480778694
discrete O 0 0.0691942647099495
nuclear O 0 0.0568387396633625
foci O 0 0.13113465905189514
in O 0 0.013759171590209007
all O 0 0.013489085249602795
epithelial O 1 0.997079610824585
cell O 0 0.08382147550582886
lines O 0 0.02584075927734375
, O 0 0.008762394078075886
including O 0 0.00721916276961565
those O 0 0.009367560036480427
derived O 0 0.033738214522600174
from O 0 0.031164584681391716
breast B-Disease 1 0.9999995231628418
malignancies I-Disease 1 0.999739944934845
. O 0 0.0433548204600811

Immunohistochemical O 1 0.9971675276756287
staining O 1 0.8471017479896545
of O 0 0.021219734102487564
human O 0 0.05686755105853081
breast O 1 0.9999970197677612
specimens O 0 0.04976104572415352
also O 0 0.019559936597943306
revealed O 0 0.06193959340453148
BRCA1 O 1 0.9982553124427795
nuclear O 0 0.081920325756073
foci O 0 0.4742681086063385
in O 0 0.03344764560461044
benign O 1 0.9999996423721313
breast O 1 1.0
, O 0 0.04889102652668953
invasive B-Disease 1 0.9999978542327881
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999992847442627
and O 0 0.021451473236083984
low B-Disease 0 0.4428744912147522
- I-Disease 1 0.981614887714386
grade I-Disease 1 0.9899272918701172
ductal I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999994039535522
. O 0 0.04781372845172882

Conversely O 0 0.1579694300889969
, O 0 0.03655654191970825
BRCA1 O 1 0.9624583721160889
expression O 0 0.05804184451699257
was O 0 0.02221696823835373
reduced O 0 0.038276977837085724
or O 0 0.019387656822800636
undetectable O 0 0.48297032713890076
in O 0 0.00836241152137518
the O 0 0.007317051291465759
majority O 0 0.01421322301030159
of O 0 0.00875861756503582
high O 0 0.039135467261075974
- O 0 0.3773866891860962
grade O 0 0.10814730077981949
, O 0 0.03617706894874573
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999996423721313
, O 0 0.022106288000941277
suggesting O 0 0.03875327855348587
that O 0 0.00994975958019495
absence O 0 0.03603781387209892
of O 0 0.01661784015595913
BRCA1 O 1 0.9996826648712158
may O 0 0.02705671451985836
contribute O 0 0.031081747263669968
to O 0 0.008660681545734406
the O 0 0.011518893763422966
pathogenesis O 1 0.9979952573776245
of O 0 0.008029148913919926
a O 0 0.013793956488370895
significant O 0 0.017324473708868027
percentage O 0 0.02419161982834339
of O 0 0.013889480382204056
sporadic B-Disease 1 0.9981359243392944
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999995231628418
. O 0 0.021951816976070404
. O 0 0.023080941289663315

